Clustering O 0 0.053214192390441895
of O 0 0.01475619338452816
missense O 0 0.045866452157497406
mutations O 0 0.011224295012652874
in O 0 0.0052003683522343636
the O 0 0.016748063266277313
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
telangiectasia I-Disease 1 1.0
gene O 0 0.008851813152432442
in O 0 0.0026885694824159145
a O 0 0.005585537292063236
sporadic B-Disease 1 0.9358694553375244
T I-Disease 1 1.0
- I-Disease 1 0.993536651134491
cell I-Disease 0 0.1448688507080078
leukaemia I-Disease 1 0.9999997615814209
. O 0 0.017928531393408775

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
telangiectasia I-Disease 1 1.0
( O 0 0.45741111040115356
A B-Disease 1 0.9999890327453613
- I-Disease 1 0.9999808073043823
T I-Disease 1 0.9999994039535522
) O 0 0.0033473707735538483
is O 0 0.001636664499528706
a O 0 0.004183495417237282
recessive B-Disease 1 0.9987275004386902
multi I-Disease 1 0.9999985694885254
- I-Disease 1 0.9999922513961792
system I-Disease 1 0.755029022693634
disorder I-Disease 1 1.0
caused O 1 0.9918307662010193
by O 0 0.005623027216643095
mutations O 0 0.008706551976501942
in O 0 0.0036532136145979166
the O 0 0.00704197958111763
ATM O 0 0.03823420777916908
gene O 0 0.006341487169265747
at O 0 0.00930780079215765
11q22 O 1 0.99439537525177
- O 0 0.037943627685308456
q23 O 1 0.9277278780937195
( O 0 0.01436327863484621
ref O 0 0.07880571484565735
. O 0 0.003886918304488063
3 O 0 0.010815243236720562
) O 0 0.006793868727982044
. O 0 0.0066299824975430965

The O 0 0.013783108443021774
risk O 0 0.017045076936483383
of O 0 0.019700204953551292
cancer B-Disease 1 1.0
, O 0 0.012002644129097462
especially O 0 0.015364101156592369
lymphoid B-Disease 1 1.0
neoplasias I-Disease 1 0.9999970197677612
, O 0 0.0048457360826432705
is O 0 0.003158685751259327
substantially O 0 0.010723617859184742
elevated O 1 0.946016788482666
in O 0 0.007574692368507385
A B-Disease 1 0.9999991655349731
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9977249503135681
and O 0 0.0026705446653068066
has O 0 0.0029114915523678064
long O 0 0.003990686032921076
been O 0 0.0029036090709269047
associated O 0 0.006201535928994417
with O 0 0.00662986608222127
chromosomal O 1 1.0
instability O 1 1.0
. O 0 0.183658167719841

By O 0 0.00826261006295681
analysing O 0 0.07142030447721481
tumour B-Disease 1 1.0
DNA O 0 0.013389421626925468
from O 0 0.0035731650423258543
patients O 0 0.013255426660180092
with O 0 0.0024590736720710993
sporadic B-Disease 1 0.9692808389663696
T I-Disease 1 1.0
- I-Disease 0 0.46012869477272034
cell I-Disease 0 0.02415623515844345
prolymphocytic I-Disease 1 0.9999314546585083
leukaemia I-Disease 1 1.0
( O 1 0.8534060120582581
T B-Disease 1 0.9999998807907104
- I-Disease 1 0.9444120526313782
PLL I-Disease 1 0.9999990463256836
) O 0 0.005171164404600859
, O 0 0.0021279165521264076
a O 0 0.0033056631218641996
rare O 0 0.014838061295449734
clonal B-Disease 1 0.9768587946891785
malignancy I-Disease 1 0.9999984502792358
with O 0 0.003097774460911751
similarities O 0 0.00623425655066967
to O 0 0.0023307674564421177
a O 0 0.005619519855827093
mature B-Disease 0 0.1458994299173355
T I-Disease 1 0.9999996423721313
- I-Disease 1 0.5964109301567078
cell I-Disease 0 0.027827182784676552
leukaemia I-Disease 1 0.9999991655349731
seen O 0 0.009363490156829357
in O 0 0.00703689269721508
A B-Disease 1 0.9998457431793213
- I-Disease 1 0.9997919201850891
T I-Disease 1 0.9999921321868896
, O 0 0.0031766542233526707
we O 0 0.0014057288644835353
demonstrate O 0 0.003905667457729578
a O 0 0.0023866973351687193
high O 0 0.0055310847237706184
frequency O 0 0.003041256684809923
of O 0 0.004109970759600401
ATM O 0 0.1053733229637146
mutations O 0 0.0155299361795187
in O 0 0.013969732448458672
T B-Disease 1 0.9999995231628418
- I-Disease 1 0.685052752494812
PLL I-Disease 1 0.9999686479568481
. O 0 0.018205076456069946

In O 0 0.010228220373392105
marked O 0 0.016382135450839996
contrast O 0 0.006740857381373644
to O 0 0.0025197649374604225
the O 0 0.0060206023044884205
ATM O 0 0.045423299074172974
mutation O 0 0.008293182589113712
pattern O 0 0.008026130497455597
in O 0 0.0060349698178470135
A B-Disease 1 0.9999583959579468
- I-Disease 1 0.9999288320541382
T I-Disease 1 0.999981164932251
, O 0 0.0028673578053712845
the O 0 0.002515743486583233
most O 0 0.0016376994317397475
frequent O 0 0.007754179183393717
nucleotide O 0 0.008406703360378742
changes O 0 0.002192990854382515
in O 0 0.002485246630385518
this O 0 0.0045175701379776
leukaemia B-Disease 1 0.9999998807907104
were O 0 0.012362749315798283
missense O 0 0.08142642676830292
mutations O 0 0.03070845641195774
. O 0 0.01289351750165224

These O 0 0.006412713788449764
clustered O 0 0.017278365790843964
in O 0 0.0042791650630533695
the O 0 0.004753038287162781
region O 0 0.00847448967397213
corresponding O 0 0.007424355484545231
to O 0 0.003176787169650197
the O 0 0.006544485688209534
kinase O 0 0.027153586968779564
domain O 0 0.006788497790694237
, O 0 0.002056724624708295
which O 0 0.0011010944144800305
is O 0 0.0017186119221150875
highly O 0 0.00472424179315567
conserved O 0 0.008902926929295063
in O 0 0.006183324381709099
ATM O 0 0.13329581916332245
- O 0 0.016116522252559662
related O 0 0.007060474716126919
proteins O 0 0.005611271131783724
in O 0 0.0055345529690384865
mouse O 0 0.015164418146014214
, O 0 0.004623753949999809
yeast O 0 0.028948040679097176
and O 0 0.009340787306427956
Drosophila O 0 0.06439656764268875
. O 0 0.015331917442381382

The O 0 0.016050897538661957
resulting O 0 0.0214841291308403
amino O 0 0.02528073452413082
- O 0 0.02414925955235958
acid O 0 0.01732722483575344
substitutions O 0 0.010265195742249489
are O 0 0.0015105041675269604
predicted O 0 0.006580071058124304
to O 0 0.002897778060287237
interfere O 0 0.010759451426565647
with O 0 0.004216098692268133
ATP O 1 0.9999940395355225
binding O 0 0.011099510826170444
or O 0 0.006916200276464224
substrate O 0 0.022616922855377197
recognition O 0 0.01984209381043911
. O 0 0.01218911912292242

Two O 0 0.004424333106726408
of O 0 0.008035586215555668
seventeen O 0 0.06779350340366364
mutated O 1 0.6321437358856201
T B-Disease 1 0.9999850988388062
- I-Disease 0 0.04783504828810692
PLL I-Disease 1 0.9985937476158142
samples O 0 0.005442459136247635
had O 0 0.002051210030913353
a O 0 0.0021124323830008507
previously O 0 0.0060376329347491264
reported O 0 0.010224142111837864
A B-Disease 1 0.9995059967041016
- I-Disease 1 0.999935507774353
T I-Disease 1 0.9999988079071045
allele O 0 0.0352037139236927
. O 0 0.009082706645131111

In O 0 0.012099017389118671
contrast O 0 0.013095362111926079
, O 0 0.004705649800598621
no O 0 0.0037306586746126413
mutations O 0 0.005855920724570751
were O 0 0.001836255076341331
detected O 0 0.006177551578730345
in O 0 0.003107987344264984
the O 0 0.006592631805688143
p53 O 0 0.0746183767914772
gene O 0 0.006418726406991482
, O 0 0.0024860294070094824
suggesting O 0 0.006389180198311806
that O 0 0.0023419209755957127
this O 0 0.0068539781495928764
tumour B-Disease 1 1.0
suppressor O 1 0.9995856881141663
is O 0 0.004525812342762947
not O 0 0.0015673796879127622
frequently O 0 0.00393349165096879
altered O 0 0.006729398388415575
in O 0 0.0044464836828410625
this O 0 0.006425079423934221
leukaemia B-Disease 1 0.9999998807907104
. O 0 0.020961999893188477

Occasional O 0 0.051581207662820816
missense O 0 0.08077719807624817
mutations O 0 0.016761789098381996
in O 0 0.005963228177279234
ATM O 0 0.029269708320498466
were O 0 0.00209749024361372
also O 0 0.0021170047111809254
found O 0 0.0028659128583967686
in O 0 0.005460524931550026
tumour B-Disease 1 1.0
DNA O 0 0.012214320711791515
from O 0 0.0032684432808309793
patients O 0 0.015367037616670132
with O 0 0.0025832545943558216
B B-Disease 1 0.9995809197425842
- I-Disease 0 0.030664099380373955
cell I-Disease 0 0.01566322147846222
non I-Disease 0 0.023624015972018242
- I-Disease 1 0.9867035150527954
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 1.0
( O 0 0.026224346831440926
B B-Disease 1 0.9899467825889587
- I-Disease 0 0.018645789474248886
NHL I-Disease 0 0.024684196338057518
) O 0 0.002376647898927331
and O 0 0.0011939177056774497
a O 0 0.004878303501754999
B B-Disease 1 0.9939035773277283
- I-Disease 0 0.035021696239709854
NHL I-Disease 0 0.06285818666219711
cell O 0 0.022770486772060394
line O 0 0.015056419186294079
. O 0 0.009104456752538681

The O 0 0.009776103310286999
evidence O 0 0.004549254663288593
of O 0 0.0034821860026568174
a O 0 0.0043564364314079285
significant O 0 0.0039799935184419155
proportion O 0 0.0068607451394200325
of O 0 0.005911354906857014
loss O 1 0.9974104762077332
- O 0 0.03583290055394173
of O 0 0.011073831468820572
- O 0 0.027354605495929718
function O 0 0.008487899787724018
mutations O 0 0.004678491037338972
and O 0 0.0012814049841836095
a O 0 0.0027180833276361227
complete O 0 0.006524279247969389
absence O 0 0.009019170887768269
of O 0 0.004236714448779821
the O 0 0.005416262429207563
normal O 0 0.006020636297762394
copy O 0 0.006389555521309376
of O 0 0.003698576707392931
ATM O 0 0.015434518456459045
in O 0 0.0019102960359305143
the O 0 0.0021914534736424685
majority O 0 0.002509420271962881
of O 0 0.007642239332199097
mutated O 1 0.8925323486328125
tumours B-Disease 1 1.0
establishes O 1 0.999406099319458
somatic O 0 0.19915930926799774
inactivation O 0 0.15834201872348785
of O 0 0.005953202024102211
this O 0 0.002342833671718836
gene O 0 0.003362127812579274
in O 0 0.0017765624215826392
the O 0 0.00489058718085289
pathogenesis O 1 0.9999909400939941
of O 0 0.01943652704358101
sporadic B-Disease 1 0.9999938011169434
T I-Disease 1 1.0
- I-Disease 1 0.9874048829078674
PLL I-Disease 1 0.999976634979248
and O 0 0.0042308238334953785
suggests O 0 0.006395670585334301
that O 0 0.001691414974629879
ATM O 0 0.0232649277895689
acts O 0 0.005391446407884359
as O 0 0.006432648282498121
a O 0 0.022809596732258797
tumour B-Disease 1 1.0
suppressor O 1 0.9999986886978149
. O 0 0.019849566742777824

As O 0 0.011513694189488888
constitutional O 0 0.015291823074221611
DNA O 0 0.012483896687626839
was O 0 0.004732845816761255
not O 0 0.0008129582856781781
available O 0 0.0012381607666611671
, O 0 0.0013989305589348078
a O 0 0.004115379881113768
putative O 1 0.7393797636032104
hereditary O 1 1.0
predisposition O 1 1.0
to O 1 0.99863201379776
T B-Disease 1 1.0
- I-Disease 1 0.9999485015869141
PLL I-Disease 1 0.9999940395355225
will O 0 0.002752039348706603
require O 0 0.0022410911042243242
further O 0 0.003052096115425229
investigation O 0 0.009703516960144043
. O 0 0.005691505968570709
. O 0 0.008692052215337753

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 1 0.9115028381347656
kinase O 0 0.03703393414616585
is O 0 0.002960363170132041
involved O 0 0.0021427208557724953
in O 0 0.002216131193563342
the O 0 0.004016568418592215
modulation O 0 0.0124720623716712
of O 0 0.0044177682138979435
the O 0 0.011702866293489933
Ca2 O 1 0.9998229146003723
+ O 1 0.8614014983177185
homeostasis O 1 0.9988793730735779
in O 0 0.015932828187942505
skeletal O 1 1.0
muscle O 1 0.9999998807907104
cells O 0 0.04686414450407028
. O 0 0.013057664968073368

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.009385915473103523
, O 0 0.002244924195110798
the O 0 0.003086081240326166
most O 0 0.004304443020373583
prevalent O 1 0.9999715089797974
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9999390840530396
adults O 1 0.5111818909645081
, O 0 0.003986813593655825
is O 0 0.003204584587365389
caused O 0 0.008289744146168232
by O 0 0.0038589052855968475
( O 0 0.015688695013523102
CTG O 1 0.9999998807907104
) O 0 0.009363518096506596
n O 0 0.017734356224536896
- O 0 0.011305553838610649
repeat O 0 0.011993488296866417
expansion O 0 0.005263677332550287
in O 0 0.002098704222589731
a O 0 0.003191577037796378
gene O 0 0.004499202128499746
encoding O 0 0.004645561799407005
a O 0 0.0038361314218491316
protein O 0 0.014180601574480534
kinase O 0 0.037597909569740295
( O 0 0.02188541181385517
DM B-Disease 1 1.0
protein O 0 0.030411969870328903
kinase O 0 0.03490421921014786
; O 0 0.007049044594168663
DMPK O 1 0.9996103644371033
) O 0 0.004500212613493204
and O 0 0.0018735791090875864
involves O 0 0.005555185489356518
changes O 0 0.0035794894210994244
in O 0 0.005920768715441227
cytoarchitecture O 1 0.9999785423278809
and O 0 0.00947657786309719
ion O 1 0.9986082911491394
homeostasis O 1 0.999997615814209
. O 0 0.019114745780825615

To O 0 0.0077935270965099335
obtain O 0 0.007665831595659256
clues O 0 0.00959168840199709
to O 0 0.0022112128790467978
the O 0 0.0032671710941940546
normal O 0 0.004554729908704758
biological O 0 0.00528394989669323
role O 0 0.006078587379306555
of O 0 0.006677943281829357
DMPK O 1 1.0
in O 0 0.012341341935098171
cellular O 0 0.216164231300354
ion O 1 0.8326462507247925
homeostasis O 1 0.9998376369476318
, O 0 0.004313131328672171
we O 0 0.0013288985937833786
have O 0 0.0006722326506860554
compared O 0 0.003457631915807724
the O 0 0.005839756224304438
resting O 1 0.9997723698616028
[ O 1 0.8748053312301636
Ca2 O 1 0.9992889165878296
+ O 0 0.0842699334025383
] O 0 0.01969858445227146
i O 0 0.004883345682173967
, O 0 0.002251559402793646
the O 0 0.0035090181045234203
amplitude O 0 0.008266963995993137
and O 0 0.002368646441027522
shape O 0 0.012076195329427719
of O 0 0.013131228275597095
depolarization O 1 0.9999982118606567
- O 1 0.9998261332511902
induced O 1 0.9999771118164062
Ca2 O 1 0.9997331500053406
+ O 0 0.06841488182544708
transients O 0 0.034616176038980484
, O 0 0.0023656566627323627
and O 0 0.0012755055213347077
the O 0 0.002490114653483033
content O 0 0.0029520641546696424
of O 0 0.006608865223824978
ATP O 1 1.0
- O 0 0.10249164700508118
driven O 0 0.01917210966348648
ion O 0 0.033245671540498734
pumps O 0 0.03244787082076073
in O 0 0.009272489696741104
cultured O 0 0.10309106856584549
skeletal O 1 0.9999980926513672
muscle O 1 0.9980353713035583
cells O 0 0.007666675373911858
of O 0 0.004868075717240572
wild O 0 0.01128434855490923
- O 0 0.011818560771644115
type O 0 0.00686590326949954
and O 0 0.00386775191873312
DMPK O 1 0.9999997615814209
[ O 1 0.9316403269767761
- O 1 0.7283234000205994
/ O 1 0.9924936294555664
- O 0 0.040865641087293625
] O 0 0.03626446798443794
knockout O 1 0.7861599326133728
mice O 0 0.03591528534889221
. O 0 0.009800196625292301

In O 0 0.013187205418944359
vitro O 0 0.05167955160140991
- O 0 0.05034247785806656
differentiated O 0 0.18785393238067627
DMPK O 1 0.9999997615814209
[ O 1 0.9422364830970764
- O 1 0.8791406750679016
/ O 1 0.9772107005119324
- O 0 0.034728821367025375
] O 0 0.02282898686826229
myotubes O 0 0.04422200098633766
exhibit O 0 0.011249926872551441
a O 0 0.0059203398413956165
higher O 0 0.014216724783182144
resting O 1 0.9966117739677429
[ O 1 0.5127905607223511
Ca2 O 1 0.9994121789932251
+ O 0 0.06945253163576126
] O 0 0.017947886139154434
i O 0 0.0038509161677211523
than O 0 0.001244280138053
do O 0 0.0021543363109230995
wild O 0 0.009732353501021862
- O 0 0.01929871179163456
type O 0 0.02008461393415928
myotubes O 0 0.44541069865226746
because O 0 0.0022600709926337004
of O 0 0.0029198562260717154
an O 0 0.0038718858268111944
altered O 0 0.007940875366330147
open O 0 0.0047384933568537235
probability O 0 0.004127916414290667
of O 0 0.006342836655676365
voltage O 0 0.029803523793816566
- O 0 0.02928277477622032
dependent O 0 0.018617279827594757
l O 0 0.060284119099378586
- O 0 0.022153206169605255
type O 0 0.02550947666168213
Ca2 O 0 0.4723910689353943
+ O 0 0.043816108256578445
and O 0 0.007929962128400803
Na O 1 0.9999994039535522
+ O 0 0.05358899012207985
channels O 0 0.010508240200579166
. O 0 0.0075283595360815525

The O 0 0.03080303966999054
mutant O 0 0.07672138512134552
myotubes O 1 0.7684585452079773
exhibit O 0 0.0241068247705698
smaller O 0 0.00668595964089036
and O 0 0.0055267950519919395
slower O 0 0.02955588512122631
Ca2 O 0 0.3261239230632782
+ O 0 0.024603992700576782
responses O 0 0.0041740937158465385
upon O 0 0.004282435867935419
triggering O 0 0.016363443806767464
by O 0 0.003810536814853549
acetylcholine O 0 0.06696312874555588
or O 0 0.0060197520069777966
high O 0 0.015840550884604454
external O 0 0.027938757091760635
K O 1 0.9989253878593445
+ O 0 0.05248570814728737
. O 0 0.006980365142226219

In O 0 0.010780100710690022
addition O 0 0.006611169315874577
, O 0 0.0024760537780821323
we O 0 0.0011466906871646643
observed O 0 0.001983614405617118
that O 0 0.0011134083615615964
these O 0 0.002619060454890132
Ca2 O 1 0.99470055103302
+ O 0 0.14857062697410583
transients O 0 0.06650248169898987
partially O 0 0.017175637185573578
result O 0 0.0031181550584733486
from O 0 0.0018403884023427963
an O 0 0.0028039945755153894
influx O 0 0.015560869127511978
of O 0 0.008794009685516357
extracellular O 0 0.06746243685483932
Ca2 O 0 0.37249472737312317
+ O 0 0.018891263753175735
through O 0 0.0027503904420882463
the O 0 0.006544219329953194
l O 1 0.547558605670929
- O 0 0.03718363493680954
type O 0 0.03865669667720795
Ca2 O 1 0.7330948710441589
+ O 0 0.056616682559251785
channel O 0 0.01633683405816555
. O 0 0.009127862751483917

Neither O 0 0.019199900329113007
the O 0 0.006374189164489508
content O 0 0.003695243038237095
nor O 0 0.003976126201450825
the O 0 0.002998393028974533
activity O 0 0.004442553035914898
of O 0 0.010131338611245155
Na O 1 1.0
+ O 1 0.9955300688743591
/ O 1 0.8588466644287109
K O 0 0.4704953134059906
+ O 0 0.05955452471971512
ATPase O 0 0.10551780462265015
and O 0 0.013911920599639416
sarcoplasmic O 1 0.9999998807907104
reticulum O 1 0.9999998807907104
Ca2 O 1 0.9999973773956299
+ O 1 0.9028849005699158
- O 0 0.03578514978289604
ATPase O 0 0.05425236374139786
are O 0 0.0018342896364629269
affected O 0 0.005636812187731266
by O 0 0.004282144829630852
DMPK O 1 0.9999982118606567
absence O 0 0.2933747172355652
. O 0 0.01602241024374962

In O 0 0.011936653405427933
conclusion O 0 0.014270338229835033
, O 0 0.0038332135882228613
our O 0 0.0035397978499531746
data O 0 0.0025413744151592255
suggest O 0 0.004160194657742977
that O 0 0.0026113942731171846
DMPK O 1 0.9991986155509949
is O 0 0.0040373834781348705
involved O 0 0.003552444977685809
in O 0 0.003831797046586871
modulating O 0 0.027461381629109383
the O 0 0.004873282741755247
initial O 0 0.006771722808480263
events O 0 0.004725293722003698
of O 0 0.006429098546504974
excitation O 0 0.07599407434463501
- O 0 0.15532296895980835
contraction O 1 0.5930063724517822
coupling O 0 0.024760795757174492
in O 0 0.011096024885773659
skeletal O 1 1.0
muscle O 1 0.9999963045120239
. O 0 0.010329964570701122
. O 0 0.011290382593870163

Constitutional O 0 0.1937706023454666
RB1 O 1 0.9999998807907104
- O 0 0.07173429429531097
gene O 0 0.016195446252822876
mutations O 0 0.008333328180015087
in O 0 0.004943367559462786
patients O 0 0.05420650541782379
with O 0 0.005992709659039974
isolated O 0 0.4091794490814209
unilateral B-Disease 1 0.9685181379318237
retinoblastoma I-Disease 1 1.0
. O 0 0.028591500595211983

In O 0 0.00857292115688324
most O 0 0.004925585817545652
patients O 0 0.024254262447357178
with O 0 0.0037611518055200577
isolated O 0 0.09382747858762741
unilateral B-Disease 1 0.9908372163772583
retinoblastoma I-Disease 1 1.0
, O 0 0.22682194411754608
tumor B-Disease 1 1.0
development O 0 0.011057958006858826
is O 0 0.003908965736627579
initiated O 0 0.011846671812236309
by O 0 0.002973287831991911
somatic O 0 0.0295169185847044
inactivation O 0 0.040606558322906494
of O 0 0.006130339112132788
both O 0 0.0034599476493895054
alleles O 0 0.010987399145960808
of O 0 0.006468102801591158
the O 0 0.025171710178256035
RB1 O 1 1.0
gene O 0 0.022669896483421326
. O 0 0.009551419876515865

However O 0 0.007419907953590155
, O 0 0.00275948247872293
some O 0 0.0010548734571784735
of O 0 0.003262375248596072
these O 0 0.0028209572192281485
patients O 1 0.9926359057426453
can O 0 0.006420203950256109
transmit O 0 0.03814918175339699
retinoblastoma B-Disease 1 0.9999959468841553
predisposition O 1 0.9980664849281311
to O 0 0.0057583460584282875
their O 0 0.005202184896916151
offspring O 0 0.023001134395599365
. O 0 0.008962741121649742

To O 0 0.00777116185054183
determine O 0 0.005891006905585527
the O 0 0.0037596889305859804
frequency O 0 0.002940148813650012
and O 0 0.001105243805795908
nature O 0 0.0036697026807814837
of O 0 0.0064253718592226505
constitutional O 0 0.32161208987236023
RB1 O 1 1.0
- O 0 0.2144383043050766
gene O 0 0.012100784108042717
mutations O 0 0.005921035539358854
in O 0 0.0035299186129122972
patients O 0 0.08322953432798386
with O 0 0.0045625497587025166
isolated O 0 0.044972196221351624
unilateral B-Disease 0 0.1499088704586029
retinoblastoma I-Disease 1 0.9999995231628418
, O 0 0.0047136954963207245
we O 0 0.001831026398576796
analyzed O 0 0.005202086176723242
DNA O 0 0.007264517247676849
from O 0 0.004066887777298689
peripheral O 1 0.9999469518661499
blood O 1 0.9331209659576416
and O 0 0.006300500128418207
from O 0 0.016770662739872932
tumor B-Disease 1 1.0
tissue O 1 0.9999939203262329
. O 0 0.0180327408015728

The O 0 0.011602281592786312
analysis O 0 0.006118305493146181
of O 0 0.009357865899801254
tumors B-Disease 1 0.9999994039535522
from O 0 0.007253274321556091
54 O 0 0.023620132356882095
( O 0 0.006501826923340559
71 O 0 0.01672097109258175
% O 0 0.0037456341087818146
) O 0 0.002288442337885499
of O 0 0.003785741748288274
76 O 0 0.03940404951572418
informative O 0 0.022051259875297546
patients O 0 0.06803423911333084
showed O 0 0.010119701735675335
loss O 0 0.009827480651438236
of O 0 0.006295214872807264
constitutional O 0 0.029912376776337624
heterozygosity O 1 1.0
( O 0 0.4812510907649994
LOH O 1 1.0
) O 0 0.010922260582447052
at O 0 0.016381124034523964
intragenic O 1 0.9653452634811401
loci O 0 0.07852394133806229
. O 0 0.014581947587430477

Three O 0 0.007355711422860622
of O 0 0.00992558803409338
13 O 0 0.030020950362086296
uninformative O 1 0.999964714050293
patients O 1 0.9992062449455261
had O 0 0.011994810774922371
constitutional O 0 0.027861660346388817
deletions O 0 0.05637240409851074
. O 0 0.015274067409336567

For O 0 0.007881846278905869
39 O 0 0.015603607520461082
randomly O 0 0.008803179487586021
selected O 0 0.016445444896817207
tumors B-Disease 1 0.9999986886978149
, O 0 0.015013329684734344
SSCP O 1 0.9999996423721313
, O 0 0.019312230870127678
hetero O 1 0.9999885559082031
- O 0 0.04583589732646942
duplex O 0 0.04876402020454407
analysis O 0 0.004507828038185835
, O 0 0.003567442996427417
sequencing O 0 0.008446505293250084
, O 0 0.0022622484248131514
and O 0 0.0025947922840714455
Southern O 0 0.014748862013220787
blot O 0 0.16659002006053925
analysis O 0 0.004148107022047043
were O 0 0.0019023173954337835
used O 0 0.0021496221888810396
to O 0 0.002850734628736973
identify O 0 0.016380859538912773
mutations O 0 0.020752064883708954
. O 0 0.011066136881709099

Mutations O 0 0.021622352302074432
were O 0 0.0037210688460618258
detected O 0 0.008626477792859077
in O 0 0.0033199621830135584
21 O 0 0.009035516530275345
( O 0 0.005233447533100843
91 O 0 0.016208253800868988
% O 0 0.00376402260735631
) O 0 0.0028244145214557648
of O 0 0.005334282293915749
23 O 1 0.892557680606842
tumors B-Disease 1 1.0
with O 0 0.04595410078763962
LOH O 1 1.0
. O 0 0.030478585511446

In O 0 0.010289815254509449
6 O 0 0.01651948317885399
( O 0 0.005724726244807243
38 O 0 0.008228303864598274
% O 0 0.0027371682226657867
) O 0 0.0021508794743567705
of O 0 0.003893834538757801
16 O 0 0.0610840804874897
tumors B-Disease 1 1.0
without O 0 0.054692238569259644
LOH O 1 1.0
, O 0 0.0057231225073337555
one O 0 0.0038054196629673243
mutation O 0 0.007447378244251013
was O 0 0.0059377411380410194
detected O 0 0.008131144568324089
, O 0 0.0020438479259610176
and O 0 0.0013422671472653747
in O 0 0.0030030719935894012
9 O 0 0.009493718855082989
( O 0 0.004469975363463163
56 O 0 0.008254697546362877
% O 0 0.0031087789684534073
) O 0 0.002390420762822032
of O 0 0.003748084884136915
the O 0 0.01757074147462845
tumors B-Disease 1 1.0
without O 0 0.13106603920459747
LOH O 1 1.0
, O 0 0.0064390418119728565
both O 0 0.0031026690267026424
mutations O 0 0.00728890486061573
were O 0 0.0030205242801457644
found O 0 0.00771331274881959
. O 0 0.009939806535840034

Thus O 0 0.012662927620112896
, O 0 0.003324108198285103
a O 0 0.0031923751812428236
total O 0 0.003556912299245596
of O 0 0.0038296538405120373
45 O 0 0.007166828494518995
mutations O 0 0.0047083632089197636
were O 0 0.0015943121397867799
identified O 0 0.006351982243359089
in O 0 0.006313315127044916
tumors B-Disease 1 0.9999997615814209
of O 0 0.03240761533379555
36 O 1 0.932285726070404
patients O 1 0.9999885559082031
. O 0 0.015029000118374825

Thirty O 0 0.04628373309969902
- O 0 0.016858572140336037
nine O 0 0.004040770698338747
of O 0 0.0036877510137856007
the O 0 0.006170936394482851
mutations O 0 0.010991948656737804
- O 0 0.00833395030349493
including O 0 0.0024649864062666893
34 O 0 0.008856450207531452
small O 0 0.0035883202217519283
mutations O 0 0.007273687981069088
, O 0 0.003247262677177787
2 O 0 0.009065752848982811
large O 0 0.005252414848655462
structural O 1 0.9897816181182861
alterations O 1 0.9486780762672424
, O 0 0.0057441373355686665
and O 0 0.004695574752986431
hypermethylation O 1 0.9999991655349731
in O 0 0.019449647516012192
3 O 1 0.9732205271720886
tumors O 1 1.0
- O 0 0.017471536993980408
were O 0 0.0018892851658165455
not O 0 0.0010255128145217896
detected O 0 0.0036727250553667545
in O 0 0.001693436992354691
the O 0 0.004962478298693895
corresponding O 0 0.024740489199757576
peripheral O 1 1.0
blood O 1 0.999972939491272
DNA O 0 0.03897242620587349
. O 0 0.011014874093234539

In O 0 0.013221838511526585
6 O 0 0.019513797014951706
( O 0 0.006694220472127199
17 O 0 0.008373457938432693
% O 0 0.0029252113308757544
) O 0 0.0015323653351515532
of O 0 0.0019311972428113222
the O 0 0.004815532825887203
36 O 0 0.015485499054193497
patients O 1 0.570780873298645
, O 0 0.0036533561069518328
a O 0 0.004206622019410133
mutation O 0 0.008051694370806217
was O 0 0.006342520471662283
detected O 0 0.0069611878134310246
in O 0 0.0027204728685319424
constitutional O 0 0.008795014582574368
DNA O 0 0.008966976776719093
, O 0 0.002067923778668046
and O 0 0.001975493971258402
1 O 0 0.006362319458276033
of O 0 0.0030627541709691286
these O 0 0.002163287252187729
mutations O 0 0.006704609375447035
is O 0 0.0025134114548563957
known O 0 0.004342670552432537
to O 0 0.0021913074888288975
be O 0 0.0014836128102615476
associated O 0 0.003782563377171755
with O 0 0.004119075834751129
reduced O 0 0.027422133833169937
expressivity O 1 0.9999496936798096
. O 0 0.024773653596639633

The O 0 0.012087401002645493
presence O 0 0.00589331379160285
of O 0 0.004722052253782749
a O 0 0.00642387056723237
constitutional O 0 0.014088481664657593
mutation O 0 0.011024435982108116
was O 0 0.005712918471544981
not O 0 0.0009715043706819415
associated O 0 0.0019212680635973811
with O 0 0.0008926083683036268
an O 0 0.002029378665611148
early O 0 0.0068207369185984135
age O 0 0.009489960968494415
at O 0 0.01657205820083618
treatment O 1 0.999992847442627
. O 0 0.01868867687880993

In O 0 0.012539464049041271
1 O 0 0.028810705989599228
patient O 1 0.9831455945968628
, O 0 0.011225204914808273
somatic O 1 0.9578672647476196
mosaicism O 1 0.9999960660934448
was O 0 0.011411118321120739
demonstrated O 0 0.006774548906832933
by O 0 0.0013028590474277735
molecular O 0 0.003676101565361023
analysis O 0 0.0017993022920563817
of O 0 0.002508351346477866
DNA O 0 0.007437120657414198
and O 0 0.0027579970192164183
RNA O 0 0.018651504069566727
from O 0 0.0075310636311769485
peripheral O 1 0.9999992847442627
blood O 1 0.9988285899162292
. O 0 0.017502134665846825

In O 0 0.013686774298548698
2 O 0 0.01887199841439724
patients O 0 0.021124297752976418
without O 0 0.0034874689299613237
a O 0 0.0068813953548669815
detectable O 0 0.0466410294175148
mutation O 0 0.013873104937374592
in O 0 0.009172512218356133
peripheral O 1 0.9999998807907104
blood O 1 0.9999032020568848
, O 0 0.015571529045701027
mosaicism O 1 0.9999570846557617
was O 0 0.010268761776387691
suggested O 0 0.005573526490479708
because O 0 0.0015913305105641484
1 O 0 0.00429996382445097
of O 0 0.0027315434999763966
the O 0 0.007854602299630642
patients O 1 0.9999969005584717
showed O 1 0.9999380111694336
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.005762193351984024
the O 0 0.004902650602161884
other O 0 0.0018190154805779457
later O 0 0.00603182939812541
developed O 0 0.012390493415296078
bilateral B-Disease 1 0.9365621209144592
retinoblastoma I-Disease 1 1.0
. O 0 0.022080041468143463

In O 0 0.011124305427074432
conclusion O 0 0.012045413255691528
, O 0 0.0038051847368478775
our O 0 0.00365633936598897
results O 0 0.0039003805723041296
emphasize O 0 0.011951346881687641
that O 0 0.0017253875266760588
the O 0 0.005397589411586523
manifestation O 1 0.998878538608551
and O 0 0.010040555149316788
transmissibility O 1 0.9999880790710449
of O 0 0.030301587656140327
retinoblastoma B-Disease 1 0.9999997615814209
depend O 0 0.008446848951280117
on O 0 0.0035852084401994944
the O 0 0.003019253956153989
nature O 0 0.0036652821581810713
of O 0 0.0028073349967598915
the O 0 0.004166287835687399
first O 0 0.005989656783640385
mutation O 0 0.00523875979706645
, O 0 0.00147181935608387
its O 0 0.0014313802821561694
time O 0 0.0018748671282082796
in O 0 0.002604148583486676
development O 0 0.004947739187628031
, O 0 0.0020759417675435543
and O 0 0.0014306142693385482
the O 0 0.0022767779882997274
number O 0 0.0018309034639969468
and O 0 0.0017794566228985786
types O 0 0.0043730405159294605
of O 0 0.006345129571855068
cells O 0 0.007742725312709808
that O 0 0.0011811829172074795
are O 0 0.0012703525135293603
affected O 0 0.006299399305135012
. O 0 0.0035355284344404936
. O 0 0.006809994578361511

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9411906003952026
the I-Disease 0 0.44463416934013367
fifth I-Disease 1 0.9990683197975159
component I-Disease 0 0.017681371420621872
of I-Disease 0 0.0062630316242575645
complement I-Disease 0 0.013036885298788548
in O 0 0.006676051300019026
man O 0 0.023358283564448357
. O 0 0.008551248349249363

I O 0 0.08295401930809021
. O 0 0.020974960178136826

Clinical O 1 0.9998165965080261
, O 0 0.01640797220170498
immunochemical O 1 0.9999494552612305
, O 0 0.005485493689775467
and O 0 0.003383432514965534
family O 0 0.01079283095896244
studies O 0 0.01174737885594368
. O 0 0.010474144481122494

The O 0 0.009767886251211166
first O 0 0.0065590860322117805
recognized O 0 0.009293138980865479
human O 0 0.012000158429145813
kindred O 1 0.9999990463256836
with O 0 0.013878683559596539
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999741315841675
the I-Disease 1 0.9958617091178894
fifth I-Disease 1 0.9999058246612549
component I-Disease 0 0.01978081464767456
of I-Disease 0 0.006375439930707216
complement I-Disease 0 0.02873992919921875
( O 0 0.016919607296586037
C5 O 1 0.9999971389770508
) O 0 0.005255375523120165
is O 0 0.0033304174430668354
described O 0 0.012102797627449036
. O 0 0.0097681675106287

The O 0 0.017264073714613914
proband O 0 0.1566007435321808
, O 0 0.0037034221459180117
a O 0 0.003591718152165413
20 O 0 0.006190601736307144
- O 0 0.009822775609791279
year O 0 0.004671521484851837
- O 0 0.009764141403138638
old O 0 0.009675053879618645
black O 0 0.008836247026920319
female O 0 0.011402799747884274
with O 0 0.0141051160171628
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 1.0
age O 1 0.9998621940612793
11 O 0 0.0302644744515419
, O 0 0.006725658196955919
lacked O 1 0.9978188276290894
serum O 1 1.0
hemolytic O 1 1.0
complement O 0 0.19879992306232452
activity O 0 0.0068382215686142445
, O 0 0.0030813300982117653
even O 0 0.003142408560961485
during O 0 0.014543462544679642
remission O 1 0.9998123049736023
. O 0 0.016965266317129135

C5 O 1 0.9999949932098389
was O 0 0.03343169018626213
undetectable O 1 0.9950320720672607
in O 0 0.007756528444588184
her O 0 0.015826188027858734
serum O 1 0.7758100032806396
by O 0 0.0028510435950011015
both O 0 0.005166345741599798
immunodiffusion O 1 0.9997305274009705
and O 0 0.015772255137562752
hemolytic O 1 1.0
assays O 0 0.407321959733963
. O 0 0.018471088260412216

Other O 0 0.006944278720766306
complement O 0 0.013134009204804897
components O 0 0.005846124142408371
were O 0 0.002142113633453846
normal O 0 0.004712933208793402
during O 0 0.008878922089934349
remission O 1 0.9999943971633911
of O 1 0.9805275201797485
lupus O 1 1.0
, O 0 0.08300590515136719
but O 0 0.0055584716610610485
C1 O 1 1.0
, O 0 0.010000872425734997
C4 O 1 0.9999994039535522
, O 0 0.010625959374010563
C2 O 1 1.0
, O 0 0.007295194547623396
and O 0 0.008495310321450233
C3 O 1 1.0
levels O 0 0.028075626119971275
fell O 0 0.2295108437538147
during O 0 0.029255330562591553
exacerbations O 1 0.9999997615814209
. O 0 0.021136578172445297

A O 0 0.02332228608429432
younger O 0 0.02048444375395775
half O 0 0.008345275186002254
- O 0 0.01895468309521675
sister O 0 0.013748512603342533
, O 0 0.0024643780197948217
who O 0 0.0035705193877220154
had O 0 0.004670433234423399
no O 0 0.006325935013592243
underlying O 1 1.0
disease O 1 1.0
, O 0 0.01340230368077755
was O 0 0.010842177085578442
also O 0 0.003184179775416851
found O 0 0.00302209728397429
to O 0 0.0033941129222512245
lack O 0 0.026586566120386124
immunochemically O 1 0.9999998807907104
detectable O 1 0.9999657869338989
C5 O 1 0.9999983310699463
. O 0 0.015116153284907341

By O 0 0.022793011739850044
hemolytic O 1 1.0
assay O 0 0.21193712949752808
, O 0 0.008438657969236374
she O 0 0.008532954379916191
exhibited O 0 0.02698412537574768
1 O 0 0.020177539438009262
- O 0 0.012309124693274498
2 O 0 0.006048631854355335
% O 0 0.001954892883077264
of O 0 0.002576810074970126
the O 0 0.007480569649487734
normal O 0 0.028224635869264603
serum O 1 0.9999929666519165
C5 O 1 0.9999765157699585
level O 0 0.010820520110428333
and O 0 0.0027620054315775633
normal O 0 0.007530219852924347
concentrations O 0 0.011014469899237156
of O 0 0.003831258276477456
other O 0 0.0033341043163090944
complement O 0 0.02028101496398449
components O 0 0.015742098912596703
. O 0 0.010225160047411919

C5 O 1 0.9999840259552002
levels O 0 0.01248163916170597
of O 0 0.003534097457304597
other O 0 0.0017559746047481894
family O 0 0.005082568619400263
members O 0 0.0016347793862223625
were O 0 0.0012829730985686183
either O 0 0.002362639643251896
normal O 0 0.004601136315613985
or O 0 0.0027081253938376904
approximately O 0 0.005565740168094635
half O 0 0.005674983374774456
- O 0 0.010596372187137604
normal O 0 0.005288146901875734
, O 0 0.002096631797030568
consistent O 0 0.006296074483543634
with O 0 0.003310036612674594
autosomal O 1 0.9993807077407837
codominant O 1 0.999970555305481
inheritance O 0 0.027171188965439796
of O 0 0.010013825260102749
the O 0 0.01873943954706192
gene O 0 0.037749528884887695
determining O 1 0.9913234710693359
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.040089838206768036

Normal O 0 0.2060423195362091
hemolytic O 1 1.0
titers O 1 0.9994121789932251
were O 0 0.00656034704297781
restored O 0 0.010880295187234879
to O 0 0.0021703620441257954
both O 0 0.003518512938171625
homozygous O 0 0.4010925889015198
C5 B-Disease 1 1.0
- I-Disease 1 0.9999953508377075
deficient I-Disease 1 1.0
( O 0 0.07136586308479309
C5D B-Disease 1 1.0
) O 0 0.011357264593243599
sera O 1 0.705263614654541
by O 0 0.0018909078789874911
addition O 0 0.002955487696453929
of O 0 0.00499802827835083
highly O 0 0.02189745008945465
purified O 1 0.96896892786026
human O 0 0.04350607842206955
C5 O 1 0.9999990463256836
. O 0 0.01933128573000431

In O 0 0.01611509546637535
specific O 0 0.023241447284817696
C5 O 1 0.9999998807907104
titrations O 1 0.999795138835907
, O 0 0.007097312249243259
however O 0 0.0036843118723481894
, O 0 0.0025866450741887093
it O 0 0.0015325373969972134
was O 0 0.0053073749877512455
noted O 0 0.004276852123439312
that O 0 0.0010281834984198213
when O 0 0.0018623874057084322
limited O 0 0.0029165982268750668
amounts O 0 0.004664128180593252
of O 0 0.0079121645539999
C5 O 1 0.999987006187439
were O 0 0.0056035337038338184
assayed O 0 0.0267989132553339
in O 0 0.00333034317009151
the O 0 0.003244612365961075
presence O 0 0.004350689705461264
of O 0 0.00539818312972784
low O 0 0.01569945551455021
dilutions O 0 0.12150190770626068
of O 0 0.011952321976423264
either O 0 0.020665425807237625
C5D B-Disease 1 1.0
serum O 1 0.9999792575836182
, O 0 0.007798934821039438
curving O 0 0.022783951833844185
rather O 0 0.0034364312887191772
than O 0 0.0022966046817600727
linear O 0 0.018409205600619316
dose O 1 0.901634693145752
- O 0 0.018011292442679405
response O 0 0.004680400248616934
plots O 0 0.007370310369879007
were O 0 0.002197659807279706
consistently O 0 0.008801577612757683
obtained O 0 0.0059943655505776405
, O 0 0.003976492676883936
suggesting O 0 0.010453161783516407
some O 0 0.003735723439604044
inhibitory O 0 0.03501959517598152
effect O 0 0.013551002368330956
. O 0 0.00842037983238697

Further O 0 0.010382791981101036
studies O 0 0.006567050702869892
suggested O 0 0.00625453470274806
that O 0 0.0025194701738655567
low O 0 0.011992216110229492
dilutions O 0 0.18999764323234558
of O 0 0.02141975238919258
C5D B-Disease 1 1.0
serum O 1 0.9998607635498047
contain O 0 0.008916872553527355
a O 0 0.005212101619690657
factor O 0 0.011698845773935318
( O 0 0.005078302230685949
or O 0 0.0028935237787663937
factors O 0 0.005406082142144442
) O 0 0.003712783567607403
interfering O 0 0.006704901810735464
at O 0 0.0039632185362279415
some O 0 0.0012120883911848068
step O 0 0.005231642629951239
in O 0 0.003241659142076969
the O 0 0.008707423694431782
hemolytic O 1 1.0
assay O 1 0.8594775199890137
of O 0 0.10024258494377136
C5 O 1 1.0
, O 0 0.0038658122066408396
rather O 0 0.0018449269700795412
than O 0 0.001098205684684217
a O 0 0.004500037059187889
true O 0 0.028705434873700142
C5 O 1 0.9999995231628418
inhibitor O 1 0.9997257590293884
or O 0 0.019651245325803757
inactivator O 1 0.9992737174034119
. O 0 0.01938248611986637

Of O 0 0.01709570549428463
clinical O 1 0.9428015351295471
interest O 0 0.005790639203041792
are O 0 0.0013548021670430899
( O 0 0.0028757310938090086
a O 0 0.0023893453180789948
) O 0 0.0021344064734876156
the O 0 0.0021487344056367874
documentation O 0 0.012563180178403854
of O 0 0.022581180557608604
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.999993085861206
vasculitis B-Disease 1 1.0
, O 1 0.9994534850120544
and O 1 0.9942388534545898
arthritis B-Disease 1 1.0
in O 1 0.9440861940383911
an O 0 0.0065752663649618626
individual O 0 0.006846645846962929
lacking O 1 0.9983304142951965
C5 O 1 1.0
( O 0 0.007446405477821827
and O 0 0.0021775795612484217
its O 0 0.00454655010253191
biologic O 1 0.9999599456787109
functions O 0 0.008249156177043915
) O 0 0.003861848032101989
, O 0 0.0021593074779957533
and O 0 0.0024656278546899557
( O 0 0.0074096741154789925
b O 0 0.014249392785131931
) O 0 0.002824736526235938
a O 0 0.002927300985902548
remarkable O 0 0.013891407288610935
propensity O 0 0.1334894299507141
to O 0 0.011566187255084515
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 0.14699041843414307
the O 0 0.015334436669945717
proband O 1 0.9995255470275879
, O 0 0.002742550801485777
even O 0 0.001365068950690329
during O 0 0.004008461721241474
periods O 0 0.00855048093944788
of O 0 0.00675541814416647
low O 0 0.01995338313281536
- O 0 0.020287683233618736
dose O 0 0.02899830788373947
or O 0 0.003580156248062849
alternate O 0 0.017946338281035423
- O 0 0.02454681508243084
day O 0 0.02500949613749981
corticosteroid O 1 0.9999973773956299
therapy O 1 0.9998538494110107
. O 0 0.020977769047021866

Other O 0 0.005413827486336231
observations O 0 0.00864841602742672
indicate O 0 0.007156409788876772
that O 0 0.0016680911649018526
the O 0 0.006355209741741419
C5D B-Disease 1 1.0
state O 0 0.005302971228957176
is O 0 0.003025653539225459
compatible O 0 0.007000267971307039
with O 0 0.002369629219174385
normal O 0 0.015312333591282368
coagulation O 1 0.999757707118988
function O 0 0.008139601908624172
and O 0 0.002532741753384471
the O 0 0.003777359612286091
capacity O 0 0.005859688855707645
to O 0 0.0027037812396883965
mount O 0 0.03249499946832657
a O 0 0.011417912319302559
neutrophilic O 1 1.0
leukocytosis O 1 1.0
during O 1 0.999789297580719
pyogenic B-Disease 1 1.0
infection I-Disease 1 1.0
. O 0 0.010267705656588078
. O 0 0.00971059501171112

Susceptibility O 1 0.9994852542877197
to O 0 0.03938353806734085
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 1 0.9998871088027954
twins O 1 0.9970101118087769
: O 0 0.003962485119700432
the O 0 0.0021055559627711773
role O 0 0.0040474277921020985
of O 0 0.0037471912801265717
genes O 0 0.00966726616024971
, O 0 0.007360158953815699
HLA O 1 1.0
, O 0 0.00524174002930522
and O 0 0.003307666862383485
the O 0 0.006904995068907738
environment O 0 0.016254913061857224
. O 0 0.009214140474796295

OBJECTIVE O 0 0.04366348311305046
To O 0 0.0047566755674779415
determine O 0 0.004799914080649614
the O 0 0.003447876079007983
relative O 0 0.008249609731137753
effects O 0 0.0076394397765398026
of O 0 0.0042885602451860905
genetic O 0 0.008643826469779015
and O 0 0.0024895104579627514
environmental O 0 0.00785171240568161
factors O 0 0.005622584372758865
in O 0 0.005621342454105616
susceptibility O 1 0.9999123811721802
to O 0 0.2925870716571808
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 1.0
AS B-Disease 1 0.9999997615814209
) O 0 0.012297675013542175
. O 0 0.007228292990475893

METHODS O 0 0.034009747207164764
Twins O 0 0.03161272034049034
with O 0 0.002582687186077237
AS B-Disease 0 0.009455515071749687
were O 0 0.001765742665156722
identified O 0 0.00249315332621336
from O 0 0.0011832627933472395
the O 0 0.003051011124625802
Royal O 0 0.15963304042816162
National O 1 0.9986633062362671
Hospital O 1 1.0
for O 1 0.9998674392700195
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9992332458496094
. O 0 0.01575322449207306

Clinical O 1 0.9968485236167908
and O 0 0.01189095713198185
radiographic O 1 0.9997066855430603
examinations O 0 0.07155497372150421
were O 0 0.0032660984434187412
performed O 0 0.00448416406288743
to O 0 0.0022515752352774143
establish O 0 0.01156798005104065
diagnoses O 1 0.9999997615814209
, O 0 0.0068836696445941925
and O 0 0.009571877308189869
disease O 1 1.0
severity O 1 1.0
was O 1 0.997684121131897
assessed O 0 0.013134250417351723
using O 0 0.0021774056367576122
a O 0 0.003020379226654768
combination O 0 0.00781090697273612
of O 0 0.006475163158029318
validated O 0 0.024257546290755272
scoring O 0 0.010832530446350574
systems O 0 0.019535692408680916
. O 0 0.012131198309361935

HLA O 1 0.9999995231628418
typing O 0 0.07087115943431854
for O 0 0.01846393384039402
HLA O 1 1.0
- O 1 0.5415410995483398
B27 O 1 0.9883451461791992
, O 0 0.012617534026503563
HLA O 1 1.0
- O 0 0.06779129803180695
B60 O 0 0.44786372780799866
, O 0 0.007247185334563255
and O 0 0.011645922437310219
HLA O 1 1.0
- O 1 0.9993051290512085
DR1 O 1 0.9999951124191284
was O 0 0.01268288679420948
performed O 0 0.009133929386734962
by O 0 0.00291579426266253
polymerase O 0 0.02562064491212368
chain O 0 0.013282145373523235
reaction O 0 0.004257654305547476
with O 0 0.0018031751969829202
sequence O 0 0.006971060298383236
- O 0 0.00755951227620244
specific O 0 0.0031289421021938324
primers O 0 0.02532612718641758
, O 0 0.002801009453833103
and O 0 0.003717524465173483
zygosity O 1 0.9856040477752686
was O 0 0.011899812147021294
assessed O 0 0.01614159345626831
using O 0 0.008718709461390972
microsatellite O 0 0.1508738100528717
markers O 0 0.0707625076174736
. O 0 0.015232290141284466

Genetic O 0 0.033860474824905396
and O 0 0.007435974199324846
environmental O 0 0.019137080758810043
variance O 0 0.01155299786478281
components O 0 0.008098095655441284
were O 0 0.0034128129482269287
assessed O 0 0.009104542434215546
with O 0 0.002195097506046295
the O 0 0.007251190021634102
program O 0 0.017665570601820946
Mx O 1 0.9946893453598022
, O 0 0.002352169482037425
using O 0 0.0012934425612911582
data O 0 0.0011553007643669844
from O 0 0.000924072926864028
this O 0 0.0006142746424302459
and O 0 0.0009117502486333251
previous O 0 0.0036096058320254087
studies O 0 0.003978857770562172
of O 0 0.004930827766656876
twins O 0 0.05463621765375137
with O 0 0.0038750008679926395
AS B-Disease 1 0.974997341632843
. O 0 0.011653516441583633

RESULTS O 0 0.014936010353267193
Six O 0 0.005779618863016367
of O 0 0.006792711094021797
8 O 0 0.01914859563112259
monozygotic O 1 0.9969367980957031
( O 0 0.027949098497629166
MZ O 1 1.0
) O 0 0.008909656666219234
twin O 0 0.020509302616119385
pairs O 0 0.008837317116558552
were O 0 0.005777114536613226
disease O 1 1.0
concordant O 1 0.9999837875366211
, O 0 0.005853649694472551
compared O 0 0.004255619831383228
with O 0 0.0013429123209789395
4 O 0 0.005572168156504631
of O 0 0.004059420432895422
15 O 0 0.010788952931761742
B27 O 1 0.8025121092796326
- O 0 0.01956145092844963
positive O 0 0.011515229940414429
dizygotic O 1 0.9169305562973022
( O 0 0.018829908221960068
DZ O 1 0.9999969005584717
) O 0 0.008309701457619667
twin O 0 0.022260718047618866
pairs O 0 0.008514964953064919
( O 0 0.0062943147495388985
27 O 0 0.011004531756043434
% O 0 0.004350636620074511
) O 0 0.002638809848576784
and O 0 0.0016559360083192587
4 O 0 0.007665373384952545
of O 0 0.007662871852517128
32 O 0 0.03268242999911308
DZ O 1 0.9999984502792358
twin O 0 0.04120313748717308
pairs O 0 0.009106379002332687
overall O 0 0.011024030856788158
( O 0 0.005149721633642912
12 O 0 0.00482091074809432
. O 0 0.0020038080401718616
5 O 0 0.007708450313657522
% O 0 0.006097706500440836
) O 0 0.0061156731098890305
. O 0 0.008145940490067005

Nonsignificant O 1 0.9986336827278137
increases O 0 0.011566881090402603
in O 0 0.0036761262454092503
similarity O 0 0.006569388322532177
with O 0 0.0012803648132830858
regard O 0 0.004962603095918894
to O 0 0.0022192809265106916
age O 0 0.007636129856109619
at O 0 0.21571102738380432
disease O 1 1.0
onset O 1 1.0
and O 0 0.004716295748949051
all O 0 0.0018438304541632533
of O 0 0.004352306015789509
the O 0 0.01805776171386242
disease O 1 1.0
severity O 1 0.9999995231628418
scores O 0 0.01249465811997652
assessed O 0 0.006862357724457979
were O 0 0.0014838346978649497
noted O 0 0.004569289740175009
in O 0 0.006838525179773569
disease O 1 1.0
- O 1 0.9998596906661987
concordant O 1 0.9999918937683105
MZ O 1 1.0
twins O 0 0.045542843639850616
compared O 0 0.009241091087460518
with O 0 0.00487159937620163
concordant O 1 0.999243974685669
DZ O 1 1.0
twins O 1 0.9686232805252075
. O 0 0.015682347118854523

HLA O 1 1.0
- O 1 0.8918797373771667
B27 O 1 0.8430202007293701
and O 0 0.0051264031790196896
B60 O 0 0.07286830991506577
were O 0 0.002269142773002386
associated O 0 0.0028991447761654854
with O 0 0.0018531050300225616
the O 0 0.009007373824715614
disease O 1 1.0
in O 0 0.026516402140259743
probands O 1 0.9999992847442627
, O 0 0.0028120470233261585
and O 0 0.0013981180964037776
the O 0 0.0033532907254993916
rate O 0 0.005304885562509298
of O 0 0.007683254778385162
disease O 1 1.0
concordance O 1 0.9994458556175232
was O 0 0.020434163510799408
significantly O 0 0.007329599466174841
increased O 0 0.004122269339859486
among O 0 0.008504103869199753
DZ O 1 1.0
twin O 0 0.03090001828968525
pairs O 0 0.004608364310115576
in O 0 0.0017870686715468764
which O 0 0.00174748117569834
the O 0 0.005176970735192299
co O 0 0.22958938777446747
- O 0 0.020772695541381836
twin O 0 0.019717292860150337
was O 0 0.006880986969918013
positive O 0 0.004319976083934307
for O 0 0.0023067158181220293
both O 0 0.0050028301775455475
B27 O 1 0.9967526197433472
and O 0 0.018503820523619652
DR1 O 1 0.9999990463256836
. O 0 0.02367425709962845

Additive O 0 0.09639851748943329
genetic O 0 0.02559700794517994
effects O 0 0.013885920867323875
were O 0 0.0033978247083723545
estimated O 0 0.004603629466146231
to O 0 0.002954876283183694
contribute O 0 0.008075441233813763
97 O 0 0.01913781464099884
% O 0 0.0030162010807543993
of O 0 0.00242828787304461
the O 0 0.004555871244519949
population O 0 0.005309839732944965
variance O 0 0.012959085404872894
. O 0 0.008717612363398075

CONCLUSION O 0 0.0651429072022438
Susceptibility O 0 0.2871631383895874
to O 0 0.0060518658719956875
AS B-Disease 0 0.01798221655189991
is O 0 0.0033723758533596992
largely O 0 0.004641621373593807
genetically O 0 0.005020444747060537
determined O 0 0.004227072931826115
, O 0 0.00204170448705554
and O 0 0.001833163551054895
the O 0 0.004963989835232496
environmental O 0 0.012771084904670715
trigger O 0 0.012878281995654106
for O 0 0.004712982103228569
the O 0 0.01958596147596836
disease O 1 1.0
is O 0 0.013411234132945538
probably O 0 0.018239304423332214
ubiquitous O 0 0.05107883736491203
. O 0 0.009876814670860767

HLA O 1 1.0
- O 0 0.0747368261218071
B27 O 0 0.06403618305921555
accounts O 0 0.003920450806617737
for O 0 0.0018501810263842344
a O 0 0.0022853740956634283
minority O 0 0.003118175780400634
of O 0 0.003349194535985589
the O 0 0.006120607722550631
overall O 0 0.023414600640535355
genetic O 0 0.015363119542598724
susceptibility O 1 0.8634006977081299
to O 0 0.0074569229036569595
AS B-Disease 1 0.9760965704917908
. O 0 0.010332120582461357

Cell O 0 0.06944424659013748
cycle O 0 0.046857818961143494
- O 0 0.02633771300315857
dependent O 0 0.014125408604741096
colocalization O 0 0.06521768867969513
of O 0 0.011258013546466827
BARD1 O 1 0.9999996423721313
and O 0 0.011984914541244507
BRCA1 O 1 0.999004065990448
proteins O 0 0.005278456024825573
in O 0 0.0038401458878070116
discrete O 0 0.014990323223173618
nuclear O 0 0.013895156793296337
domains O 0 0.021700231358408928
. O 0 0.008568495512008667

Germ O 1 0.9999964237213135
- O 0 0.047858599573373795
line O 0 0.013126811012625694
mutations O 0 0.006488004699349403
of O 0 0.005143703427165747
the O 0 0.013592546805739403
BRCA1 O 1 0.999997615814209
gene O 0 0.017303938046097755
predispose O 0 0.03229227289557457
women O 0 0.005628202110528946
to O 0 0.002530735684558749
early O 0 0.0095774931833148
- O 1 0.8312106728553772
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999467134475708
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.009878591634333134
compromising O 1 0.5397521257400513
the O 0 0.00783558189868927
genes O 0 0.007683952804654837
presumptive O 1 0.9829423427581787
function O 0 0.0069909729063510895
as O 0 0.00583127373829484
a O 0 0.015291555784642696
tumor B-Disease 1 1.0
suppressor O 1 0.9998074173927307
. O 0 0.016306394711136818

Although O 0 0.009413007646799088
the O 0 0.007724029012024403
biochemical O 0 0.023752115666866302
properties O 0 0.01411262433975935
of O 0 0.021299045532941818
BRCA1 O 1 1.0
polypeptides O 0 0.03494584560394287
are O 0 0.0018499573925510049
not O 0 0.0013539643259719014
understood O 0 0.005907007493078709
, O 0 0.002652894239872694
their O 0 0.0022846718784421682
expression O 0 0.009086621925234795
pattern O 0 0.013646741397678852
and O 0 0.005113408900797367
subcellular O 0 0.04605958238244057
localization O 0 0.02048114314675331
suggest O 0 0.004746146034449339
a O 0 0.0028331815265119076
role O 0 0.005747332237660885
in O 0 0.0054500289261341095
cell O 0 0.024505959823727608
- O 0 0.029706716537475586
cycle O 0 0.023480325937271118
regulation O 0 0.017360355705022812
. O 0 0.008145862258970737

When O 0 0.021716667339205742
resting O 1 0.9797518849372864
cells O 0 0.015037626959383488
are O 0 0.0023858605418354273
induced O 0 0.025612879544496536
to O 0 0.0048528374172747135
proliferate O 0 0.016816649585962296
, O 0 0.0032680691219866276
the O 0 0.00475804228335619
steady O 0 0.01851445809006691
- O 0 0.00956853199750185
state O 0 0.00322912004776299
levels O 0 0.00530740013346076
of O 0 0.005561228841543198
BRCA1 O 1 0.9997658133506775
increase O 0 0.005126627162098885
in O 0 0.004394739866256714
late O 0 0.019317694008350372
G1 O 1 0.9998584985733032
and O 0 0.0022028572857379913
reach O 0 0.003553452668711543
a O 0 0.0023715123534202576
maximum O 0 0.0065120914950966835
during O 0 0.011604446917772293
S O 1 0.998051643371582
phase O 0 0.04426311329007149
. O 0 0.009670453146100044

Moreover O 0 0.024682823568582535
, O 0 0.006535195279866457
in O 0 0.00824460107833147
S O 1 0.9992614388465881
phase O 1 0.64984530210495
cells O 0 0.015532802790403366
, O 0 0.00726288789883256
BRCA1 O 1 0.715878963470459
polypeptides O 0 0.028508882969617844
are O 0 0.0032151101622730494
hyperphosphorylated O 0 0.054956551641225815
and O 0 0.0043408810161054134
accumulate O 0 0.018991632387042046
into O 0 0.005447442643344402
discrete O 0 0.022310009226202965
subnuclear O 1 0.8390450477600098
foci O 1 0.9892075061798096
termed O 1 0.7886711955070496
" O 0 0.037843987345695496
BRCA1 O 1 0.9998986721038818
nuclear O 0 0.0301424078643322
dots O 0 0.04892152547836304
. O 0 0.011221230961382389

" O 0 0.04996654391288757
BRCA1 O 1 0.9998786449432373
associates O 0 0.03874365985393524
in O 0 0.007582147605717182
vivo O 0 0.022429294884204865
with O 0 0.0022195670753717422
a O 0 0.007012698799371719
structurally O 0 0.045298829674720764
related O 0 0.015229808166623116
protein O 0 0.026404358446598053
termed O 1 0.6460733413696289
BARD1 O 1 0.9999995231628418
. O 0 0.022539492696523666

Here O 0 0.012033291161060333
we O 0 0.0023696934804320335
show O 0 0.0033431134652346373
that O 0 0.00090851477580145
the O 0 0.0033091246150434017
steady O 0 0.01723179966211319
- O 0 0.010210779495537281
state O 0 0.0028961501084268093
levels O 0 0.00508910184726119
of O 0 0.005458816885948181
BARD1 O 1 0.9999929666519165
, O 0 0.004443681333214045
unlike O 0 0.004138261545449495
those O 0 0.0016525577520951629
of O 0 0.006097723729908466
BRCA1 O 1 0.9999635219573975
, O 0 0.004530253354460001
remain O 0 0.005863156169652939
relatively O 0 0.0038152551278471947
constant O 0 0.007775186561048031
during O 0 0.014079702086746693
cell O 0 0.03270193189382553
cycle O 0 0.043193522840738297
progression O 1 0.9405289888381958
. O 0 0.013780477456748486

However O 0 0.011584392748773098
, O 0 0.007567014079540968
immunostaining O 1 0.9314165711402893
revealed O 0 0.0191190242767334
that O 0 0.0046079098246991634
BARD1 O 1 0.9999862909317017
resides O 0 0.04403827711939812
within O 0 0.0088015366345644
BRCA1 O 1 0.9967722296714783
nuclear O 0 0.016020838171243668
dots O 0 0.02461007796227932
during O 0 0.01321811880916357
S O 0 0.20461785793304443
phase O 0 0.015472273342311382
of O 0 0.006351036950945854
the O 0 0.008685201406478882
cell O 0 0.01369636133313179
cycle O 0 0.00989158358424902
, O 0 0.0018823130521923304
but O 0 0.0008926992886699736
not O 0 0.0008078053360804915
during O 0 0.0055571431294083595
the O 0 0.011608644388616085
G1 O 1 0.9999980926513672
phase O 0 0.06003741919994354
. O 0 0.011457395739853382

Nevertheless O 0 0.04856446385383606
, O 0 0.016434695571660995
BARD1 O 1 0.9998886585235596
polypeptides O 0 0.023003147915005684
are O 0 0.00126527005340904
found O 0 0.0018089751247316599
exclusively O 0 0.0034091821871697903
in O 0 0.0021507118362933397
the O 0 0.0033000875264406204
nuclear O 0 0.003625312587246299
fractions O 0 0.005611954722553492
of O 0 0.0035977058578282595
both O 0 0.005797730293124914
G1 O 1 0.9999998807907104
- O 0 0.02717321552336216
and O 0 0.006125994026660919
S O 1 0.9999197721481323
- O 0 0.04173501953482628
phase O 0 0.039608828723430634
cells O 0 0.017903363332152367
. O 0 0.006892156321555376

Therefore O 0 0.01801503635942936
, O 0 0.008540731854736805
progression O 1 0.5161930918693542
to O 0 0.008464215323328972
S O 1 0.9986329674720764
phase O 0 0.019136980175971985
is O 0 0.002814177656546235
accompanied O 0 0.005554982926696539
by O 0 0.0010744151659309864
the O 0 0.0025393518153578043
aggregation O 0 0.008870684541761875
of O 0 0.00567338801920414
nuclear O 0 0.017887800931930542
BARD1 O 1 0.99992835521698
polypeptides O 0 0.0413505956530571
into O 0 0.012295057997107506
BRCA1 O 1 0.9958301186561584
nuclear O 0 0.02612011507153511
dots O 0 0.04827459529042244
. O 0 0.011290446855127811

This O 0 0.007756277918815613
cell O 0 0.01909761317074299
cycle O 0 0.028225498273968697
- O 0 0.019630303606390953
dependent O 0 0.010892752557992935
colocalization O 0 0.05073165148496628
of O 0 0.010061089880764484
BARD1 O 1 0.9999998807907104
and O 0 0.00864183995872736
BRCA1 O 1 0.9998711347579956
indicates O 0 0.00888171698898077
a O 0 0.002563315210863948
role O 0 0.004322262015193701
for O 0 0.0031432185787707567
BARD1 O 1 0.9999920129776001
in O 0 0.013684314675629139
BRCA1 O 1 1.0
- O 1 0.9984803795814514
mediated O 1 0.9947085380554199
tumor B-Disease 1 0.9999998807907104
suppression O 1 0.9999901056289673
. O 0 0.023375272750854492

Ethnic O 0 0.012415597215294838
differences O 0 0.009391344152390957
in O 0 0.006662051659077406
the O 0 0.015914037823677063
HFE O 1 0.9999991655349731
codon O 0 0.07760392874479294
282 O 1 0.7532366514205933
( O 0 0.034800268709659576
Cys O 1 1.0
/ O 1 0.9999849796295166
Tyr O 1 0.9999997615814209
) O 0 0.020342128351330757
polymorphism O 0 0.03614720702171326
. O 0 0.010214364156126976

Recent O 0 0.011794276535511017
studies O 0 0.005613037850707769
have O 0 0.001839693053625524
shown O 0 0.006274078041315079
that O 0 0.006318387575447559
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 1.0
HH B-Disease 1 1.0
) O 0 0.013778455555438995
is O 0 0.003349595470353961
likely O 0 0.002533643040806055
to O 0 0.0016032052226364613
be O 0 0.0014233278343454003
caused O 0 0.00566686550155282
by O 0 0.0023619718849658966
homozygosity O 1 0.6410784721374512
for O 0 0.003963256720453501
a O 0 0.00630298163741827
Cys282Tyr O 1 0.9946340322494507
mutation O 0 0.007731919176876545
in O 0 0.003375704400241375
the O 0 0.008413693867623806
HFE O 1 0.999998927116394
gene O 0 0.01769702322781086
located O 0 0.017532458528876305
4 O 0 0.0171021968126297
. O 0 0.0088832201436162

5 O 0 0.059995848685503006
Mb O 1 0.9995661377906799
telomeric O 1 0.9958042502403259
to O 0 0.02399527281522751
HLA O 1 1.0
- O 0 0.08765660971403122
A O 0 0.023513786494731903
. O 0 0.01153239980340004

Population O 0 0.00920609850436449
studies O 0 0.0053408765234053135
of O 0 0.004471686203032732
this O 0 0.0033152007963508368
polymorphism O 0 0.01024032011628151
are O 0 0.0009662712109275162
facilitated O 0 0.007688829675316811
by O 0 0.0015010535717010498
the O 0 0.0034047553781419992
fact O 0 0.003938339184969664
that O 0 0.0015826766612008214
the O 0 0.0058059776201844215
Cys282Tyr O 1 0.999823272228241
mutation O 0 0.01693481020629406
creates O 0 0.013655177317559719
a O 0 0.010930288583040237
Rsal O 1 0.9991137385368347
restriction O 0 0.02355550415813923
site O 0 0.0203362088650465
. O 0 0.011074405163526535

We O 0 0.003882559947669506
have O 0 0.0010782943572849035
studied O 0 0.005183601286262274
the O 0 0.005941967014223337
codon O 0 0.03801656886935234
282 O 0 0.4811773896217346
( O 0 0.025903841480612755
Cys O 1 1.0
/ O 1 0.9999828338623047
Tyr O 1 0.9999992847442627
) O 0 0.008430019952356815
polymorphism O 0 0.0073516177944839
in O 0 0.0015537639847025275
different O 0 0.000932081718929112
ethnic O 0 0.004251319449394941
groups O 0 0.0034401139710098505
. O 0 0.008963961154222488

In O 0 0.0077827381901443005
agreement O 0 0.004516153130680323
with O 0 0.002105333609506488
previous O 0 0.006732194218784571
observations O 0 0.012372855097055435
the O 0 0.01278563030064106
Tyr O 1 0.9999996423721313
allele O 0 0.02321109175682068
appeared O 0 0.006723450962454081
to O 0 0.0020168665796518326
be O 0 0.0013211217010393739
rare O 0 0.006101088598370552
or O 0 0.003921228926628828
absent O 0 0.01417719665914774
in O 0 0.00678440323099494
Asiatic O 1 0.9999992847442627
( O 0 0.00774416234344244
Indian O 0 0.007158751133829355
, O 0 0.003445705398917198
Chinese O 0 0.014443942345678806
) O 0 0.006121901795268059
populations O 0 0.006713469047099352
. O 0 0.0075736637227237225

The O 0 0.015261157415807247
highest O 0 0.02832820639014244
allele O 0 0.020950162783265114
frequency O 0 0.006331922020763159
( O 0 0.003920632880181074
7 O 0 0.005179830361157656
. O 0 0.001686397474259138
5 O 0 0.004659716505557299
% O 0 0.0034935856238007545
) O 0 0.0031101717613637447
was O 0 0.005246632732450962
found O 0 0.0039939433336257935
in O 0 0.0058177742175757885
Swedes O 0 0.054654598236083984
. O 0 0.01322340127080679

Saamis O 1 0.997886598110199
( O 0 0.016008177772164345
2 O 0 0.01167220901697874
% O 0 0.004268321208655834
) O 0 0.0032345729414373636
and O 0 0.0027997097931802273
Mordvinians O 1 0.999441921710968
( O 0 0.007743488531559706
1 O 0 0.006913528311997652
. O 0 0.0016849699895828962
8 O 0 0.006466877646744251
% O 0 0.003941458649933338
) O 0 0.0038708506617695093
had O 0 0.00431516719982028
significantly O 0 0.007101872935891151
lower O 0 0.01060551032423973
frequencies O 0 0.004433110356330872
of O 0 0.005967802833765745
the O 0 0.017895599827170372
Tyr O 1 0.9999991655349731
allele O 0 0.05942501872777939
. O 0 0.014246352016925812

Comparisons O 0 0.01842641271650791
with O 0 0.004595490638166666
allele O 0 0.011851171031594276
frequencies O 0 0.0030564782209694386
based O 0 0.002551759360358119
on O 0 0.00538838654756546
prevalence O 1 0.5999447703361511
estimates O 0 0.013404548168182373
of O 0 0.015524054877460003
HH B-Disease 1 1.0
showed O 0 0.013432519510388374
some O 0 0.002274191938340664
disagreements O 0 0.01057265792042017
with O 0 0.0026256779674440622
the O 0 0.009013104252517223
RFLP O 1 0.8558386564254761
data O 0 0.00371892680414021
, O 0 0.002559119835495949
particularly O 0 0.005032344721257687
in O 0 0.006592994090169668
Finns O 0 0.08317773789167404
. O 0 0.01167833711951971

The O 0 0.01710561290383339
newly O 0 0.04425123333930969
described O 0 0.047871481627225876
HFE O 1 1.0
marker O 0 0.14191879332065582
provides O 0 0.006792993284761906
a O 0 0.0024463417939841747
new O 0 0.0023521091789007187
approach O 0 0.002737735863775015
to O 0 0.001531987451016903
the O 0 0.003791172755882144
screening O 0 0.013590207323431969
of O 0 0.013024650514125824
HH B-Disease 1 1.0
as O 0 0.00512226577848196
well O 0 0.0016611280152574182
as O 0 0.0012494046241044998
studies O 0 0.0017389461863785982
of O 0 0.0020144188310950994
the O 0 0.0037529098335653543
relationship O 0 0.0060782767832279205
between O 0 0.005515417084097862
the O 0 0.018595442175865173
HFE O 1 1.0
Tyr O 1 1.0
allele O 0 0.020100655034184456
and O 0 0.003513721516355872
different O 0 0.0039047773461788893
disorders O 1 1.0
including O 1 0.9999762773513794
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9999939203262329
dominant I-Disease 1 0.9999961853027344
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
associated O 0 0.025362811982631683
with O 0 0.003838249482214451
a O 0 0.006069663912057877
missense O 0 0.029732760041952133
mutation O 0 0.012339568696916103
encoding O 0 0.019803430885076523
Gly23 O 1 0.9997996687889099
- O 0 0.1432725489139557
- O 0 0.03539973869919777
> O 0 0.04483301565051079
Val O 1 0.9924330711364746
in O 0 0.0139863146468997
neurophysin O 1 0.999996542930603
II O 1 1.0
. O 0 0.019638311117887497

Autosomal B-Disease 1 0.9999934434890747
dominant I-Disease 1 0.9999831914901733
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.999985933303833
ADNDI B-Disease 1 1.0
) O 0 0.006278262007981539
is O 0 0.002377511467784643
an O 0 0.005113986320793629
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 1.0
by O 1 0.8602960109710693
progressive O 1 1.0
degeneration O 1 1.0
of O 1 0.9999998807907104
the O 1 0.9999983310699463
magnocellular O 1 1.0
neurons O 0 0.01627737656235695
of O 0 0.005832863971590996
the O 0 0.010887091979384422
hypothalamus O 1 0.6127870678901672
leading O 0 0.009750568307936192
to O 0 0.0036562627647072077
decreased O 0 0.01224075723439455
ability O 0 0.0027918159030377865
to O 0 0.0017343781655654311
produce O 0 0.0030738383065909147
the O 0 0.006826882716268301
hormone O 1 0.9920040965080261
arginine O 1 0.9262255430221558
vasopressin O 1 0.998354434967041
( O 0 0.026372745633125305
AVP O 1 0.9999998807907104
) O 0 0.01574556902050972
. O 0 0.008947721682488918

Affected O 0 0.018974339589476585
individuals O 0 0.0026997672393918037
are O 0 0.0013085197424516082
not O 0 0.0021586520597338676
symptomatic O 1 0.9999986886978149
at O 0 0.038610294461250305
birth O 1 0.9294745326042175
, O 0 0.003097412409260869
but O 0 0.0012734010815620422
usually O 0 0.0035922946408391
develop O 0 0.03588363528251648
diabetes B-Disease 1 1.0
insipidus I-Disease 1 1.0
at O 1 0.9505862593650818
1 O 0 0.09749633073806763
- O 0 0.028101162984967232
6 O 0 0.019452543929219246
yr O 1 0.8103259801864624
of O 0 0.009447447955608368
age O 0 0.02035735547542572
. O 0 0.01205561775714159

The O 0 0.012306204065680504
genetic O 0 0.013344727456569672
locus O 0 0.0230923593044281
of O 0 0.005905061960220337
the O 0 0.01585894636809826
disease O 1 1.0
is O 0 0.0062153697945177555
the O 0 0.010851586237549782
AVP O 1 1.0
- O 1 0.7557500004768372
neurophysin O 1 0.9998171925544739
II O 1 1.0
( O 0 0.023840198293328285
NPII O 1 0.9999998807907104
) O 0 0.008998601697385311
gene O 0 0.006552188657224178
, O 0 0.0026438117492944
and O 0 0.0032025910913944244
mutations O 0 0.011564318090677261
that O 0 0.004298379644751549
cause O 1 0.989729642868042
ADNDI B-Disease 1 1.0
have O 0 0.00319227809086442
been O 0 0.002348741516470909
found O 0 0.002220946829766035
in O 0 0.0018393121426925063
both O 0 0.001818812103010714
the O 0 0.0039856890216469765
signal O 0 0.00822934228926897
peptide O 0 0.007086154539138079
of O 0 0.003131377976387739
the O 0 0.007815985009074211
prepro O 1 0.9999892711639404
- O 1 0.9845578074455261
AVP O 1 1.0
- O 1 0.8887081742286682
NPII O 1 0.9999804496765137
precursor O 0 0.02601446583867073
and O 0 0.0035530359018594027
within O 0 0.007064513862133026
NPII O 1 0.9999977350234985
itself O 0 0.023955799639225006
. O 0 0.012630918063223362

An O 0 0.014615354128181934
affected O 0 0.019028091803193092
girl O 0 0.03250711411237717
who O 0 0.005607504863291979
presented O 0 0.007598015945404768
at O 0 0.0067096734419465065
9 O 0 0.006678224075585604
months O 0 0.002876367187127471
of O 0 0.0030741856899112463
age O 0 0.0065856087021529675
and O 0 0.002936868229880929
her O 0 0.010759526863694191
similarly O 0 0.01917792484164238
affected O 0 0.015312077477574348
younger O 0 0.025681158527731895
brother O 0 0.035370975732803345
and O 0 0.0034038645680993795
father O 0 0.016567084938287735
were O 0 0.0024701934307813644
all O 0 0.001066253986209631
found O 0 0.0016356301493942738
to O 0 0.0012923021567985415
have O 0 0.0007406291551887989
a O 0 0.0023768183309584856
novel O 0 0.015399206429719925
missense O 0 0.03865406662225723
mutation O 0 0.017001613974571228
( O 0 0.014534445479512215
G1758 O 1 0.9997385144233704
- O 1 0.6790905594825745
- O 0 0.047439370304346085
> O 0 0.05032709985971451
T O 0 0.04455478489398956
) O 0 0.002418224001303315
encoding O 0 0.0029951147735118866
the O 0 0.002471228362992406
amino O 0 0.007692042738199234
acid O 0 0.017535168677568436
substitution O 0 0.029353108257055283
Gly23 O 1 0.9999716281890869
- O 1 0.6760869026184082
- O 0 0.04362194985151291
> O 0 0.056079719215631485
Val O 1 0.918287456035614
within O 0 0.017136458307504654
NPII O 1 0.999987006187439
. O 0 0.017302291467785835

The O 0 0.020136410370469093
mutation O 0 0.018825657665729523
was O 0 0.010405004024505615
confirmed O 0 0.009148599579930305
by O 0 0.0031847686041146517
restriction O 0 0.015557911247015
endonuclease O 0 0.07284101843833923
analysis O 0 0.011743620969355106
. O 0 0.0107828788459301

A O 0 0.07755614072084427
T1 O 1 0.9999997615814209
- O 0 0.0476062186062336
weighted O 0 0.021562237292528152
magnetic O 0 0.014046248979866505
resonance O 0 0.014152432791888714
imaging O 0 0.014945962466299534
of O 0 0.007578409742563963
the O 0 0.018005335703492165
fathers O 1 0.9989768266677856
pituitary O 1 1.0
gland O 1 1.0
demonstrates O 1 0.9969068169593811
an O 0 0.01688939891755581
attenuated O 1 0.9999164342880249
posterior O 1 0.9999983310699463
pituitary O 1 1.0
bright O 1 0.9999536275863647
spot O 1 0.8503952026367188
. O 0 0.014344840310513973

This O 0 0.010968025773763657
mutation O 0 0.013004707172513008
may O 0 0.0034537205938249826
be O 0 0.0011528751347213984
valuable O 0 0.004629621747881174
for O 0 0.0022891086991876364
developing O 0 0.0058694989420473576
models O 0 0.0047986977733671665
of O 0 0.008956212550401688
dominantly B-Disease 1 1.0
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 0.009744245558977127
as O 0 0.0034311343915760517
the O 0 0.00322800618596375
early O 0 0.003775061806663871
age O 0 0.004996381234377623
of O 0 0.007033228408545256
onset O 1 1.0
of O 1 0.9999988079071045
symptoms O 1 1.0
suggests O 1 0.9539376497268677
that O 0 0.00250923540443182
this O 0 0.0020937228109687567
mutation O 0 0.00559510150924325
may O 0 0.0023037372156977654
be O 0 0.001258859527297318
particularly O 0 0.00420515239238739
deleterious O 0 0.025494545698165894
to O 0 0.004719370044767857
the O 0 0.015495054423809052
magnocellular O 1 0.9999997615814209
neuron O 1 0.9993889331817627
. O 0 0.006783310789614916
. O 0 0.007947158068418503

Frequent O 0 0.04167900234460831
inactivation O 1 0.9703152179718018
of O 0 0.3635731041431427
PTEN O 1 1.0
/ O 1 0.9999780654907227
MMAC1 O 1 0.9999984502792358
in O 0 0.015097168274223804
primary O 1 0.9999988079071045
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8345723748207092

Sporadic B-Disease 1 0.9999984502792358
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.05282220244407654
the O 0 0.005408271681517363
most O 0 0.0026078096125274897
common O 0 0.007788646966218948
male B-Disease 1 0.9683641195297241
cancer I-Disease 1 1.0
in O 0 0.007651849649846554
the O 0 0.006814131513237953
Western O 0 0.008175342343747616
world O 0 0.005473950412124395
, O 0 0.001797964097931981
yet O 0 0.00127321423497051
many O 0 0.000697260198649019
of O 0 0.002480498980730772
the O 0 0.00467761792242527
major O 0 0.011460544541478157
genetic O 0 0.006769805680960417
events O 0 0.003967814147472382
involved O 0 0.0023953767959028482
in O 0 0.002616506302729249
the O 0 0.004544926807284355
progression O 1 0.6074601411819458
of O 0 0.004176076501607895
this O 0 0.0022802872117608786
often O 0 0.006229718215763569
fatal O 1 1.0
cancer B-Disease 1 1.0
remain O 0 0.058429572731256485
to O 0 0.0053710113279521465
be O 0 0.004435243085026741
elucidated O 0 0.19379597902297974
. O 0 0.010823562741279602

Numerous O 0 0.03809572756290436
cytogenetic O 1 0.999054491519928
and O 0 0.014982187189161777
allelotype O 1 0.9991938471794128
studies O 0 0.008192388340830803
have O 0 0.001972352620214224
reported O 0 0.007094886619597673
frequent O 0 0.009338815696537495
loss O 0 0.02394767850637436
of O 0 0.017916101962327957
heterozygosity O 1 0.9999998807907104
on O 0 0.01805899664759636
chromosomal O 1 0.9981764554977417
arm O 1 0.9849692583084106
10q O 1 0.9995275735855103
in O 0 0.012854584492743015
sporadic B-Disease 1 0.9999966621398926
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9404100179672241

Deletion O 0 0.0731058120727539
mapping O 0 0.019811522215604782
studies O 0 0.0066772340796887875
have O 0 0.0021479660645127296
unambiguously O 0 0.01896883361041546
identified O 0 0.005450701806694269
a O 0 0.0033098605927079916
region O 0 0.007740931585431099
of O 0 0.009832482784986496
chromosome O 0 0.04422691836953163
10q23 O 1 0.863050103187561
to O 0 0.002832955215126276
be O 0 0.0013574161566793919
the O 0 0.003034004708752036
minimal O 0 0.009164741262793541
area O 0 0.007248749956488609
of O 0 0.00936605129390955
loss O 1 0.9945982694625854
. O 0 0.014044716954231262

A O 0 0.021656474098563194
new O 0 0.01783890090882778
tumor B-Disease 1 0.9999995231628418
suppressor O 1 0.9988883137702942
gene O 0 0.015399530529975891
, O 0 0.011173862963914871
PTEN O 1 1.0
/ O 1 0.9999940395355225
MMAC1 O 1 1.0
, O 0 0.006728844251483679
was O 0 0.009164554998278618
isolated O 0 0.013347220607101917
recently O 0 0.007705251686275005
at O 0 0.005385530646890402
this O 0 0.0016552292509004474
region O 0 0.006494028959423304
of O 0 0.008173633366823196
chromosome O 0 0.12907622754573822
10q23 O 1 0.9993220567703247
and O 0 0.0032767413649708033
found O 0 0.002744000870734453
to O 0 0.001960678491741419
be O 0 0.0015330702299252152
inactivated O 0 0.015126941725611687
by O 0 0.0012403562432155013
mutation O 0 0.003977217245846987
in O 0 0.002931550145149231
three O 0 0.01009418349713087
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999994039535522
lines O 0 0.028009289875626564
. O 0 0.011965787969529629

We O 0 0.010139673948287964
screened O 0 0.03210746869444847
80 O 0 0.05164826661348343
prostate B-Disease 1 1.0
tumors I-Disease 1 1.0
by O 0 0.0073777479119598866
microsatellite O 0 0.16352196037769318
analysis O 0 0.004350908566266298
and O 0 0.002941601211205125
found O 0 0.0064004817977547646
chromosome O 0 0.02113279700279236
10q23 O 0 0.0590055026113987
to O 0 0.0032366833183914423
be O 0 0.002109212102368474
deleted O 0 0.0100710429251194
in O 0 0.0033339455258101225
23 O 0 0.01217237301170826
cases O 0 0.012175915762782097
. O 0 0.013930568471550941

We O 0 0.006642880849540234
then O 0 0.004061375744640827
proceeded O 0 0.007097456604242325
with O 0 0.00126085733063519
sequence O 0 0.0022082417272031307
analysis O 0 0.0012992516858503222
of O 0 0.001974206417798996
the O 0 0.006205014418810606
entire O 0 0.06680022180080414
PTEN O 1 1.0
/ O 1 0.9999970197677612
MMAC1 O 1 0.9999998807907104
coding O 0 0.04400458559393883
region O 0 0.00891927070915699
and O 0 0.002531160367652774
tested O 0 0.010472336784005165
for O 0 0.0042733908630907536
homozygous O 0 0.017103327438235283
deletion O 0 0.012725883163511753
with O 0 0.0022342412266880274
new O 0 0.007967767305672169
intragenic O 1 0.9988800883293152
markers O 0 0.02218087576329708
in O 0 0.003478157799690962
these O 0 0.0014479084638878703
23 O 0 0.006019309628754854
cases O 0 0.004127256106585264
with O 0 0.004092850256711245
10q23 O 1 0.9999624490737915
loss O 1 0.6411977410316467
of O 0 0.026666531339287758
heterozygosity O 1 0.9999994039535522
. O 0 0.021958287805318832

The O 0 0.01309082843363285
identification O 0 0.008953291922807693
of O 0 0.005702883470803499
the O 0 0.007042455952614546
second O 0 0.011969159357249737
mutational O 0 0.14841745793819427
event O 0 0.007425824645906687
in O 0 0.0026065499987453222
10 O 0 0.0033455006778240204
( O 0 0.0033652223646640778
43 O 0 0.008417497389018536
% O 0 0.005201641470193863
) O 0 0.009834209457039833
tumors B-Disease 1 1.0
establishes O 1 0.9999998807907104
PTEN O 1 1.0
/ O 1 0.9999964237213135
MMAC1 O 1 0.9999977350234985
as O 0 0.004383851774036884
a O 0 0.0038525681011378765
main O 0 0.012658118270337582
inactivation O 0 0.0363055095076561
target O 0 0.0048378328792750835
of O 0 0.004803087562322617
10q O 1 0.9877618551254272
loss O 0 0.021029561758041382
in O 0 0.00862890388816595
sporadic B-Disease 1 0.9999992847442627
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.37614724040031433
. O 0 0.014455513097345829

Risk O 0 0.04960159584879875
reversals O 0 0.06606243550777435
in O 0 0.007794113829731941
predictive O 0 0.02204502746462822
testing O 0 0.011777698062360287
for O 0 0.010743921622633934
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.03282345086336136

The O 0 0.009538333863019943
first O 0 0.006883714813739061
predictive O 0 0.01474464125931263
testing O 0 0.008242004550993443
for O 0 0.007989129051566124
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9997794032096863
HD B-Disease 1 0.9999634027481079
) O 0 0.0035106155555695295
was O 0 0.003028114093467593
based O 0 0.0011829766444861889
on O 0 0.001663572620600462
analysis O 0 0.001909187063574791
of O 0 0.0038176511880010366
linked O 0 0.019069364294409752
polymorphic O 0 0.044198598712682724
DNA O 0 0.014687773771584034
markers O 0 0.015304054133594036
to O 0 0.002328420290723443
estimate O 0 0.0034381411969661713
the O 0 0.0021456244867295027
likelihood O 0 0.006548890378326178
of O 0 0.004196797963231802
inheriting O 1 0.5713187456130981
the O 0 0.008655671961605549
mutation O 0 0.01124036218971014
for O 0 0.006954222451895475
HD B-Disease 1 0.9819215536117554
. O 0 0.010953081771731377

Limits O 0 0.010668866336345673
to O 0 0.0032284415792673826
accuracy O 0 0.005284846760332584
included O 0 0.003651052014902234
recombination O 0 0.009855303913354874
between O 0 0.0027984599582850933
the O 0 0.005769254174083471
DNA O 0 0.016026590019464493
markers O 0 0.01979135535657406
and O 0 0.002912434283643961
the O 0 0.007717288564890623
mutation O 0 0.013148701749742031
, O 0 0.0058195567689836025
pedigree O 0 0.03371330723166466
structure O 0 0.010959607549011707
, O 0 0.0031989156268537045
and O 0 0.002317246049642563
whether O 0 0.0033294488675892353
DNA O 0 0.0058483523316681385
samples O 0 0.0028463166672736406
were O 0 0.0010925594251602888
available O 0 0.0014710823306813836
from O 0 0.0017902562394738197
family O 0 0.006600692868232727
members O 0 0.004932028241455555
. O 0 0.007926459424197674

With O 0 0.0048361062072217464
direct O 0 0.004701738245785236
tests O 0 0.004296196158975363
for O 0 0.0033879925031214952
the O 0 0.00970832072198391
HD B-Disease 1 0.9998213648796082
mutation O 0 0.010004371404647827
, O 0 0.0021986470092087984
we O 0 0.0013576423516497016
have O 0 0.0009968099184334278
assessed O 0 0.007570574060082436
the O 0 0.0036848122254014015
accuracy O 0 0.006524863187223673
of O 0 0.004674220457673073
results O 0 0.005817649886012077
obtained O 0 0.005168059375137091
by O 0 0.002472180873155594
linkage O 0 0.020196812227368355
approaches O 0 0.011763238348066807
when O 0 0.0037105302326381207
requested O 0 0.006643126253038645
to O 0 0.0020522852428257465
do O 0 0.0014989724149927497
so O 0 0.0008826790144667029
by O 0 0.0008347047842107713
the O 0 0.0031444693449884653
test O 0 0.00716111995279789
individuals O 0 0.003845070954412222
. O 0 0.007193996105343103

For O 0 0.006123797036707401
six O 0 0.003913488704711199
such O 0 0.0015382758574560285
individuals O 0 0.0018565329955890775
, O 0 0.0025239416863769293
there O 0 0.0021629021503031254
was O 0 0.0072905332781374454
significant O 0 0.0064163063652813435
disparity O 0 0.030055347830057144
between O 0 0.00602627731859684
the O 0 0.008850986137986183
tests O 0 0.015032303519546986
. O 0 0.009655053727328777

Three O 0 0.008410989306867123
went O 0 0.01095499936491251
from O 0 0.004635246004909277
a O 0 0.008028784766793251
decreased O 0 0.03560576215386391
risk O 0 0.008752956055104733
to O 0 0.0025742375291883945
an O 0 0.002648113062605262
increased O 0 0.005611201282590628
risk O 0 0.007107496727257967
, O 0 0.0019102139631286263
while O 0 0.001399610424414277
in O 0 0.0015100855380296707
another O 0 0.0025504971854388714
three O 0 0.002089214511215687
the O 0 0.004767575766891241
risk O 0 0.018165845423936844
was O 0 0.023101022467017174
decreased O 0 0.12052931636571884
. O 0 0.015296094119548798

Knowledge O 0 0.01704823412001133
of O 0 0.00897963996976614
the O 0 0.00738181360065937
potential O 0 0.006722562480717897
reasons O 0 0.0051455143839120865
for O 0 0.0018607378005981445
these O 0 0.001192618627101183
changes O 0 0.0019640913233160973
in O 0 0.002492691157385707
results O 0 0.004238975699990988
and O 0 0.0019409252563491464
impact O 0 0.004886724520474672
of O 0 0.004069399554282427
these O 0 0.002566330833360553
risk O 0 0.011275362223386765
reversals O 0 0.330380916595459
on O 0 0.005892434157431126
both O 0 0.003477103542536497
patients O 1 0.9963952898979187
and O 0 0.0039893705397844315
the O 0 0.0078217638656497
counseling O 1 0.9857189059257507
team O 0 0.005152068100869656
can O 0 0.0010155346244573593
assist O 0 0.0038865397218614817
in O 0 0.00154027808457613
the O 0 0.0023470951709896326
development O 0 0.003065092023462057
of O 0 0.0027898941189050674
strategies O 0 0.007898274809122086
for O 0 0.0029842471703886986
the O 0 0.007229969836771488
prevention O 1 0.9999964237213135
and O 0 0.003881898010149598
, O 0 0.0035274287220090628
where O 0 0.00371928745880723
necessary O 0 0.005646983161568642
, O 0 0.0030126541387289762
management O 0 0.007785020861774683
of O 0 0.0056763822212815285
a O 0 0.008638417348265648
risk O 0 0.015547515824437141
reversal O 0 0.018124917522072792
in O 0 0.0037349218036979437
any O 0 0.0026899841614067554
predictive O 0 0.017661143094301224
testing O 0 0.00950710754841566
program O 0 0.008783948607742786
. O 0 0.0029243603348731995
. O 0 0.005156319588422775

A O 0 0.018266938626766205
novel O 0 0.0233848225325346
common O 0 0.014152700081467628
missense O 0 0.046886343508958817
mutation O 0 0.013606798835098743
G301C O 0 0.04415244981646538
in O 0 0.00457421550527215
the O 0 0.008438210934400558
N O 0 0.3543602526187897
- O 0 0.03640762344002724
acetylgalactosamine O 1 0.9908818006515503
- O 0 0.03201922029256821
6 O 0 0.026524042710661888
- O 0 0.04051709547638893
sulfate O 1 0.9913860559463501
sulfatase O 1 0.999991774559021
gene O 0 0.020099714398384094
in O 0 0.011615505442023277
mucopolysaccharidosis B-Disease 1 0.9999868869781494
IVA I-Disease 1 1.0
. O 0 0.028580239042639732

Mucopolysaccharidosis B-Disease 1 0.9999946355819702
IVA I-Disease 1 1.0
( O 1 0.8102462291717529
MPS B-Disease 1 0.9999809265136719
IVA I-Disease 1 1.0
) O 0 0.009417276829481125
is O 0 0.0027159927412867546
an O 0 0.004348913673311472
autosomal B-Disease 1 0.9999992847442627
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999898672103882
by O 0 0.004988783970475197
a O 0 0.009175725281238556
genetic B-Disease 1 0.9940656423568726
defect I-Disease 1 1.0
in O 0 0.013687849044799805
N O 1 0.9987039566040039
- O 0 0.035470928996801376
acetylgalactosamine O 1 0.9836056232452393
- O 0 0.025587011128664017
6 O 0 0.025922682136297226
- O 0 0.036969903856515884
sulfate O 1 0.999240517616272
sulfatase O 1 0.9999997615814209
( O 0 0.047656990587711334
GALNS O 1 0.9999996423721313
) O 0 0.01618247665464878
. O 0 0.009888553991913795

In O 0 0.010079479776322842
previous O 0 0.009230059571564198
studies O 0 0.0065886229276657104
, O 0 0.0030111633241176605
we O 0 0.001163769164122641
have O 0 0.0005363221280276775
found O 0 0.0013543865643441677
two O 0 0.00116063526365906
common O 0 0.005027297418564558
mutations O 0 0.007198277860879898
in O 0 0.005171355325728655
Caucasians O 1 0.9986710548400879
and O 0 0.0051816171035170555
Japanese O 1 0.8936653733253479
, O 0 0.006741690449416637
respectively O 0 0.018107939511537552
. O 0 0.010831029154360294

To O 0 0.0127802025526762
characterize O 0 0.04132777824997902
the O 0 0.014413644559681416
mutational O 1 0.6615180969238281
spectrum O 0 0.009755312465131283
in O 0 0.002159555908292532
various O 0 0.0016206763684749603
ethnic O 0 0.003198444377630949
groups O 0 0.0015366488369181752
, O 0 0.002692190231755376
mutations O 0 0.004685054533183575
in O 0 0.00324797909706831
the O 0 0.008256939239799976
GALNS O 1 0.9999922513961792
gene O 0 0.010059678927063942
in O 0 0.005295847542583942
Colombian O 0 0.06385646015405655
MPS B-Disease 1 0.9999583959579468
IVA I-Disease 1 1.0
patients O 1 0.9999977350234985
were O 0 0.006411699578166008
investigated O 0 0.01980653591454029
, O 0 0.003919865936040878
and O 0 0.0030360103119164705
genetic O 0 0.007771750446408987
backgrounds O 0 0.006111344322562218
were O 0 0.0024571025278419256
extensively O 0 0.007690994534641504
analyzed O 0 0.005674154032021761
to O 0 0.0020041819661855698
identify O 0 0.0058400435373187065
racial O 0 0.009176491759717464
origin O 0 0.0038241385482251644
, O 0 0.0023663670290261507
based O 0 0.0025055750738829374
on O 0 0.004404817242175341
mitochondrial O 0 0.01869644597172737
DNA O 0 0.014704792760312557
( O 0 0.008877990767359734
mtDNA O 0 0.01706402190029621
) O 0 0.006322687491774559
lineages O 0 0.02148546278476715
. O 0 0.009206446819007397

Three O 0 0.010499450378119946
novel O 0 0.03320155292749405
missense O 0 0.06193552166223526
mutations O 0 0.015515043400228024
never O 0 0.0071032787673175335
identified O 0 0.005917646456509829
previously O 0 0.0045860507525503635
in O 0 0.002344569656997919
other O 0 0.0014639385044574738
populations O 0 0.0025334814563393593
and O 0 0.0013083304511383176
found O 0 0.002219701185822487
in O 0 0.002615871373564005
16 O 0 0.005504152737557888
out O 0 0.001974730519577861
of O 0 0.004688973538577557
19 O 0 0.016967762261629105
Colombian O 0 0.04606402665376663
MPS B-Disease 1 0.9929189085960388
IVA I-Disease 1 1.0
unrelated O 0 0.09664997458457947
alleles O 0 0.019381828606128693
account O 0 0.005378947593271732
for O 0 0.005701277870684862
84 O 0 0.048375602811574936
. O 0 0.014738215133547783

2 O 0 0.021993502974510193
% O 0 0.0043354155495762825
of O 0 0.003861613105982542
the O 0 0.005865077022463083
alleles O 0 0.013073965907096863
in O 0 0.0036437150556594133
this O 0 0.0025891487020999193
study O 0 0.010334295220673084
. O 0 0.008129463531076908

The O 0 0.026221342384815216
G301C O 1 0.5890817046165466
and O 0 0.01056985929608345
S162F O 1 0.9754456281661987
mutations O 0 0.012172749266028404
account O 0 0.0049496362917125225
for O 0 0.005493698641657829
68 O 0 0.0428997203707695
. O 0 0.012809395790100098

4 O 0 0.030520161613821983
% O 0 0.007638247683644295
and O 0 0.004116928670555353
10 O 0 0.011068924330174923
. O 0 0.010395699180662632

5 O 0 0.021506208926439285
% O 0 0.00677205715328455
of O 0 0.006466997321695089
mutations O 0 0.012835429050028324
, O 0 0.004530915059149265
respectively O 0 0.009927555918693542
, O 0 0.0035356595180928707
whereas O 0 0.005143777001649141
the O 0 0.004749286454170942
remaining O 0 0.012456261552870274
F69V O 1 0.9999780654907227
is O 0 0.00359952705912292
limited O 0 0.0022607503924518824
to O 0 0.0016975814942270517
a O 0 0.004232592415064573
single O 0 0.008068432100117207
allele O 0 0.02377687394618988
. O 0 0.009960178285837173

The O 0 0.024774376302957535
skewed O 0 0.03436390310525894
prevalence O 0 0.06819133460521698
of O 0 0.011113211512565613
G301C O 1 0.9989727735519409
in O 0 0.005662163253873587
only O 0 0.003748167073354125
Colombian O 0 0.03958815336227417
patients O 1 0.6145316958427429
and O 0 0.003944138064980507
haplotype O 0 0.02100612036883831
analysis O 0 0.002972250571474433
by O 0 0.00148064608220011
restriction O 0 0.006541690323501825
fragment O 0 0.010347344912588596
length O 0 0.004551902413368225
polymorphisms O 0 0.011341447941958904
in O 0 0.0031367242336273193
the O 0 0.008965078741312027
GALNS O 1 0.9999982118606567
gene O 0 0.009014952927827835
suggest O 0 0.004716620780527592
that O 0 0.0017167412443086505
G301C O 0 0.046105675399303436
originated O 0 0.008844136260449886
from O 0 0.00228082831017673
a O 0 0.003954742569476366
common O 0 0.009985578246414661
ancestor O 0 0.04737880453467369
. O 0 0.014399520121514797

Investigation O 0 0.024737916886806488
of O 0 0.007949110120534897
the O 0 0.008796454407274723
genetic O 0 0.010714540258049965
background O 0 0.00619893241673708
by O 0 0.0018618504982441664
means O 0 0.004646770190447569
of O 0 0.006219547241926193
mtDNA O 0 0.020527193322777748
lineages O 0 0.013340302743017673
indicate O 0 0.005201710853725672
that O 0 0.0014171467628329992
all O 0 0.001892740954644978
our O 0 0.004501671530306339
patients O 0 0.01635320857167244
are O 0 0.0015307231806218624
probably O 0 0.004459094721823931
of O 0 0.004734393209218979
native O 0 0.013136431574821472
American O 0 0.020929483696818352
descent O 0 0.0574076808989048

Low O 0 0.02793925628066063
frequency O 0 0.008760423399508
of O 0 0.011004834435880184
BRCA1 O 1 0.9998658895492554
germline O 0 0.07009773701429367
mutations O 0 0.0057161590084433556
in O 0 0.0028595509938895702
45 O 0 0.008409947156906128
German O 1 0.9998956918716431
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9829825758934021
. O 0 0.018359364941716194

In O 0 0.006214506458491087
this O 0 0.0015906835906207561
study O 0 0.0027990175876766443
we O 0 0.0012456740951165557
investigated O 0 0.008009704761207104
45 O 0 0.009290177375078201
German O 1 0.9996951818466187
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.029050232842564583
for O 0 0.008576690219342709
germline O 0 0.446701318025589
mutations O 0 0.006202199961990118
in O 0 0.0033825947903096676
the O 0 0.009333676658570766
BRCA1 O 1 0.9999982118606567
gene O 0 0.021640516817569733
. O 0 0.010128260590136051

We O 0 0.005894868168979883
identified O 0 0.008810675702989101
four O 0 0.0051760426722466946
germline O 0 0.041371092200279236
mutations O 0 0.00637670885771513
in O 0 0.003494737669825554
three O 0 0.008204301819205284
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.005816986318677664
and O 0 0.0017949518514797091
in O 0 0.0029994649812579155
one O 0 0.007658239454030991
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9998564720153809
. O 0 0.002719506621360779
among O 0 0.001637430745176971
these O 0 0.0007778473664075136
were O 0 0.0015884011518210173
one O 0 0.003662504255771637
frameshift O 1 0.8452160358428955
mutation O 0 0.011479518376290798
, O 0 0.003770626150071621
one O 0 0.004737855400890112
nonsense O 0 0.026898182928562164
mutation O 0 0.009138970635831356
, O 0 0.0026543063577264547
one O 0 0.002999513642862439
novel O 0 0.019652007147669792
splice O 0 0.06813681125640869
site O 0 0.016590384766459465
mutation O 0 0.009346352890133858
, O 0 0.002574323210865259
and O 0 0.002561601810157299
one O 0 0.006738928612321615
missense O 0 0.06827817857265472
mutation O 0 0.03193330764770508
. O 0 0.012545607052743435

The O 0 0.021401578560471535
missense O 0 0.05855932459235191
mutation O 0 0.014527562074363232
was O 0 0.0075356559827923775
also O 0 0.0029995962977409363
found O 0 0.0031037679873406887
in O 0 0.005157738458365202
2 O 0 0.01591055653989315
. O 0 0.008653090335428715

8 O 0 0.021295011043548584
% O 0 0.004579814616590738
of O 0 0.003067531855776906
the O 0 0.005009462125599384
general O 0 0.01200761180371046
population O 0 0.0033581433817744255
, O 0 0.002661545528098941
suggesting O 0 0.004807007499039173
that O 0 0.0011502858251333237
it O 0 0.001099994988180697
is O 0 0.0026092776097357273
not O 0 0.0036729243583977222
disease O 1 1.0
associated O 0 0.03380049765110016
. O 0 0.016855325549840927

The O 0 0.012019836343824863
average O 0 0.010178099386394024
age O 0 0.009718526154756546
of O 0 0.017213430255651474
disease O 1 1.0
onset O 1 1.0
in O 0 0.016866454854607582
those O 0 0.003937076311558485
families O 0 0.008576544001698494
harbouring O 1 0.9990776777267456
causative O 1 0.9998739957809448
mutations O 0 0.015842929482460022
was O 0 0.01099787000566721
between O 0 0.007630711887031794
32 O 0 0.02531108260154724
. O 0 0.013042286969721317

3 O 0 0.02845914103090763
and O 0 0.008022019639611244
37 O 0 0.0332915373146534
. O 0 0.013322652317583561

4 O 0 0.018609244376420975
years O 0 0.005445071496069431
, O 0 0.0029108161106705666
whereas O 0 0.005221170838922262
the O 0 0.00501958467066288
family O 0 0.016531074419617653
harbouring O 1 0.9982581734657288
the O 0 0.012756208889186382
missense O 0 0.05012912675738335
mutation O 0 0.010635086335241795
had O 0 0.0028441210743039846
an O 0 0.0022865135688334703
average O 0 0.005920948460698128
age O 0 0.0064832186326384544
of O 0 0.007475948426872492
onset O 1 0.9999997615814209
of O 1 0.8676063418388367
51 O 1 0.995873749256134
. O 0 0.01526058278977871

2 O 0 0.04084949940443039
years O 0 0.018344813957810402
. O 0 0.013441438786685467

These O 0 0.0054900161921978
findings O 0 0.011204254813492298
show O 0 0.008823277428746223
that O 0 0.0035003251396119595
BRCA1 O 1 0.9957287907600403
is O 0 0.004585742484778166
implicated O 0 0.014575514011085033
in O 0 0.0024921931326389313
a O 0 0.0022178147919476032
small O 0 0.0021280250512063503
fraction O 0 0.0072447434067726135
of O 0 0.014793355949223042
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.020695343613624573
suggesting O 0 0.007943658158183098
the O 0 0.0032501963432878256
involvement O 0 0.008106364868581295
of O 0 0.0052184914238750935
another O 0 0.012753994204103947
susceptibility O 1 0.9998083710670471
gene O 0 0.021607987582683563
( O 0 0.013919181190431118
s O 0 0.06868753582239151
) O 0 0.01744733937084675

Paternal O 1 0.9999384880065918
transmission O 1 0.9997391104698181
of O 1 0.9999701976776123
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9999991655349731

We O 0 0.00543229142203927
report O 0 0.004103585612028837
a O 0 0.002772342646494508
rare O 0 0.005574572831392288
case O 0 0.006130571942776442
of O 0 0.012765694409608841
paternally O 1 1.0
transmitted O 1 0.9999998807907104
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.04177597910165787
. O 0 0.010492313653230667

The O 0 0.02038171887397766
proband O 0 0.15388968586921692
is O 0 0.0034874689299613237
a O 0 0.003282463178038597
23 O 0 0.007872139103710651
year O 0 0.005579888354986906
old O 0 0.017377348616719246
, O 0 0.009814904071390629
mentally B-Disease 1 1.0
retarded I-Disease 1 0.9999998807907104
male O 1 0.8365983963012695
who O 1 0.9926314353942871
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9999113082885742

He O 0 0.012778458185493946
presented O 0 0.014554660767316818
with O 0 0.009061213582754135
respiratory O 1 1.0
and O 1 0.9460899829864502
feeding O 1 0.9990409016609192
difficulties O 1 0.9999411106109619
at O 1 0.8593258261680603
birth O 1 0.9986315369606018
. O 0 0.013348915614187717

His O 0 0.0155014144256711
two O 0 0.009235993027687073
sibs O 1 0.9999994039535522
suffer O 1 0.9999510049819946
from O 0 0.014655636623501778
childhood O 1 1.0
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.07366164028644562

Their O 0 0.005898437462747097
late O 0 0.013003857806324959
father O 0 0.013134602457284927
had O 0 0.0038271185476332903
the O 0 0.004020702093839645
adult O 0 0.008142863400280476
type O 0 0.01114719733595848
of O 0 0.01861223392188549
DM B-Disease 1 1.0
, O 0 0.0061817774549126625
with O 0 0.0036559083964675665
onset O 1 0.9999992847442627
around O 0 0.008807836100459099
30 O 0 0.008158417418599129
years O 0 0.007242370396852493
. O 0 0.007228892296552658

Only O 0 0.004240562207996845
six O 0 0.0026031280867755413
other O 0 0.0010863107163459063
cases O 0 0.003785547334700823
of O 0 0.009424369782209396
paternal O 1 0.9999996423721313
transmission O 1 0.9999815225601196
of O 1 0.9999977350234985
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.013567980378866196
been O 0 0.005700758658349514
reported O 0 0.010016483254730701
recently O 0 0.01493239775300026
. O 0 0.008889460936188698

We O 0 0.004800216760486364
review O 0 0.004243615549057722
the O 0 0.003074659500271082
sex O 0 0.0071378666907548904
related O 0 0.007067136932164431
effects O 0 0.013129028491675854
on O 0 0.011489168740808964
transmission O 1 0.999212384223938
of O 1 0.9997432827949524
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9971275925636292

Decreased O 0 0.3409873843193054
fertility O 0 0.35527756810188293
of O 0 0.010594623163342476
males O 0 0.007895299233496189
with O 0 0.003190021263435483
adult O 0 0.03188703954219818
onset O 1 1.0
DM B-Disease 1 1.0
and O 0 0.013746107928454876
contraction O 0 0.1811649203300476
of O 0 0.005584255792200565
the O 0 0.005681557115167379
repeat O 0 0.022585636004805565
upon O 0 0.007170870900154114
male O 0 0.012474793009459972
transmission O 0 0.010131817311048508
contribute O 0 0.003262525424361229
to O 0 0.001184214954264462
the O 0 0.002224197145551443
almost O 0 0.0025368479546159506
absent O 0 0.008919751271605492
occurrence O 0 0.013183074072003365
of O 0 0.009455505758523941
paternal O 1 0.9999998807907104
transmission O 1 0.9999963045120239
of O 1 0.9999954700469971
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9997851252555847

Also O 0 0.010436899028718472
the O 0 0.006879094056785107
fathers O 0 0.01446964405477047
of O 0 0.005461260676383972
the O 0 0.01157911866903305
reported O 0 0.22356024384498596
congenitally O 1 0.9999957084655762
affected O 0 0.01908629760146141
children O 0 0.012008832767605782
showed O 0 0.009796328842639923
, O 0 0.003296096809208393
on O 0 0.004357519559562206
average O 0 0.00758910458534956
, O 0 0.005005385261029005
shorter O 0 0.019920561462640762
CTG O 1 0.9995852112770081
repeat O 0 0.037482041865587234
lengths O 0 0.02343844808638096
and O 0 0.00345029029995203
hence O 0 0.00909217819571495
less O 0 0.0063095795921981335
severe O 1 0.9999982118606567
clinical O 1 1.0
symptoms O 1 1.0
than O 0 0.00649403827264905
the O 0 0.007111883256584406
mothers O 0 0.016839127987623215
of O 0 0.004958046600222588
children O 0 0.018182354047894478
with O 0 0.02117161452770233
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9983561635017395

We O 0 0.006340164691209793
conclude O 0 0.012158396653831005
that O 0 0.0034016247373074293
paternal O 0 0.27368026971817017
transmission O 1 0.9641785621643066
of O 1 0.999196469783783
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.9967691898345947
rare O 0 0.024229122325778008
and O 0 0.004672450479120016
preferentially O 0 0.014969272539019585
occurs O 0 0.004201033152639866
with O 0 0.00251973164267838
onset O 1 0.9999978542327881
of O 1 0.9973401427268982
DM B-Disease 1 1.0
past O 0 0.011091307736933231
30 O 0 0.004755289759486914
years O 0 0.001963250106200576
in O 0 0.0019407321233302355
the O 0 0.0036722368095070124
father O 0 0.0253136046230793
. O 0 0.005614017136394978
. O 0 0.008724324405193329

The O 0 0.037743501365184784
RB1 O 1 0.9999990463256836
gene O 0 0.01475810818374157
mutation O 0 0.00587621983140707
in O 0 0.002047308487817645
a O 0 0.004455368500202894
child O 0 0.20236271619796753
with O 0 0.009916005656123161
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.24177682399749756

The O 0 0.04135587066411972
RB1 O 1 0.9999998807907104
gene O 0 0.02048606611788273
mutation O 0 0.009782461449503899
was O 0 0.006464062258601189
investigated O 0 0.011367753148078918
in O 0 0.003814421594142914
a O 0 0.0064156437292695045
child O 0 0.06769736856222153
with O 0 0.010128331370651722
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
using O 0 0.009922993369400501
DNA O 0 0.007472984027117491
obtained O 0 0.0030597317963838577
from O 0 0.0015837379032745957
both O 0 0.001633784151636064
the O 0 0.006530420854687691
pineal B-Disease 1 0.9999997615814209
and I-Disease 0 0.01987982913851738
retinal I-Disease 1 1.0
tumours I-Disease 1 1.0
of O 1 0.999734103679657
the O 1 0.9936042428016663
patient O 1 0.9999997615814209
. O 0 0.013734173029661179

A O 0 0.029178928583860397
nonsense O 0 0.0462011881172657
mutation O 0 0.011162029579281807
in O 0 0.005897229071706533
exon O 0 0.04243156313896179
17 O 0 0.01261977944523096
( O 0 0.007983710616827011
codon O 0 0.024391628801822662
556 O 0 0.042952220886945724
) O 0 0.0036395592615008354
of O 0 0.0037697020452469587
the O 0 0.015102160163223743
RB1 O 1 1.0
gene O 0 0.011277036741375923
was O 0 0.005335547029972076
found O 0 0.0018955355044454336
to O 0 0.0013470947742462158
be O 0 0.0010180356912314892
present O 0 0.003298017894849181
homozygously O 0 0.08163075149059296
in O 0 0.002534674946218729
both O 0 0.002059915801510215
the O 0 0.006481326650828123
retinal B-Disease 1 1.0
and I-Disease 0 0.012010789476335049
the I-Disease 1 0.9879958033561707
pineal I-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.032867785543203354

The O 0 0.014384153299033642
same O 0 0.005618315190076828
mutation O 0 0.011074604466557503
was O 0 0.007302256301045418
present O 0 0.006690568290650845
heterozygously O 0 0.0541558675467968
in O 0 0.003534767311066389
the O 0 0.003802347695454955
DNA O 0 0.005157694686204195
from O 0 0.001422826200723648
the O 0 0.002863316796720028
constitutional O 0 0.007343746721744537
cells O 0 0.004903874360024929
of O 0 0.003079179208725691
the O 0 0.00651598023250699
patient O 1 0.9994364380836487
, O 0 0.004597026389092207
proving O 0 0.01869990862905979
it O 0 0.001088951714336872
to O 0 0.0011288428213447332
be O 0 0.0012836409732699394
of O 0 0.0048719970509409904
germline O 0 0.16301052272319794
origin O 0 0.011116031557321548
. O 0 0.010951072908937931

The O 0 0.016930604353547096
initial O 0 0.02002985030412674
mutation O 0 0.014022693037986755
was O 0 0.007323835510760546
shown O 0 0.0033855587244033813
to O 0 0.0012259363429620862
have O 0 0.0007718450506217778
occurred O 0 0.003785658860579133
in O 0 0.002868297044187784
the O 0 0.007778438273817301
paternally O 1 0.9975987076759338
derived O 0 0.04249896854162216
RB1 O 1 0.9999922513961792
allele O 0 0.04874177649617195
. O 0 0.01262724306434393

The O 0 0.01902901940047741
mutation O 0 0.012220386415719986
is O 0 0.0025689294561743736
in O 0 0.0020498011726886034
an O 0 0.0018613542197272182
area O 0 0.003814111463725567
of O 0 0.0035225527826696634
the O 0 0.005568290129303932
gene O 0 0.005131011363118887
that O 0 0.001329611986875534
encodes O 0 0.00889511313289404
the O 0 0.005296121351420879
protein O 0 0.011575627140700817
- O 0 0.010010376572608948
binding O 0 0.0037442552857100964
region O 0 0.005692671984434128
known O 0 0.0066652144305408
as O 0 0.004891125950962305
the O 0 0.009149037301540375
pocket O 1 0.9474155902862549
region O 0 0.010645517148077488
and O 0 0.0032893770840018988
has O 0 0.00344460248015821
been O 0 0.0032365969382226467
detected O 0 0.006338650826364756
in O 0 0.0018354178173467517
other O 0 0.0014697087462991476
cases O 0 0.0056788260117173195
of O 0 0.017049400135874748
retinoblastoma B-Disease 1 1.0
. O 0 0.012144835665822029
. O 0 0.011089371517300606

Low O 0 0.03045697510242462
levels O 0 0.009787507355213165
of O 0 0.006020476575940847
beta O 0 0.03145427629351616
hexosaminidase O 1 0.6931279897689819
A O 0 0.009357999078929424
in O 0 0.004103739280253649
healthy O 0 0.009403808042407036
individuals O 0 0.0017778660403564572
with O 0 0.002911148127168417
apparent O 1 0.9999884366989136
deficiency O 1 1.0
of O 1 0.9997535347938538
this O 0 0.015274177305400372
enzyme O 0 0.033886730670928955
. O 0 0.009815016761422157

Appreciable O 0 0.20851342380046844
beta O 0 0.06015581265091896
hexosaminidase O 1 0.9899237751960754
A O 0 0.021897541359066963
( O 0 0.013664468191564083
hex O 0 0.05081445723772049
A O 0 0.010131209157407284
) O 0 0.0034634368494153023
activity O 0 0.0022017627488821745
has O 0 0.0016834961716085672
been O 0 0.0021769083105027676
detected O 0 0.008587929420173168
in O 0 0.007192071061581373
cultured O 1 0.9986635446548462
skin O 1 1.0
fibroblasts O 1 0.9999998807907104
and O 1 0.975264847278595
melanoma B-Disease 1 1.0
tissue O 1 1.0
from O 0 0.009062789380550385
healthy O 0 0.014437317848205566
individuals O 0 0.0016217591473832726
previously O 0 0.004020304419100285
reported O 0 0.006027525756508112
as O 0 0.004913545213639736
having O 0 0.01777816005051136
deficiency B-Disease 1 1.0
of I-Disease 1 0.9835103750228882
hex I-Disease 1 0.9999263286590576
A I-Disease 0 0.01162988692522049
activity O 0 0.0034862724132835865
indistinguishable O 0 0.006324416026473045
from O 0 0.0008827412384562194
that O 0 0.0006247888086363673
of O 0 0.0025065490044653416
patients O 1 0.9987754225730896
with O 0 0.054440438747406006
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9992406368255615
TSD B-Disease 1 1.0
) O 0 0.0178918968886137
. O 0 0.008628827519714832

Identification O 0 0.02641153708100319
and O 0 0.008763649500906467
quantitation O 1 0.9361827969551086
of O 0 0.019340289756655693
hex O 1 0.8933998942375183
A O 0 0.015899794176220894
, O 0 0.004892227705568075
amounting O 0 0.01773790456354618
to O 0 0.005188521463423967
3 O 0 0.016232047230005264
. O 0 0.007898692041635513

5 O 0 0.028506692498922348
% O 0 0.013909388333559036
- O 0 0.02469208650290966
6 O 0 0.022089028730988503
. O 0 0.008348630741238594

9 O 0 0.0237283818423748
% O 0 0.00520307244732976
of O 0 0.0042565856128931046
total O 0 0.01163998618721962
beta O 0 0.137210413813591
hexosaminidase O 1 0.9851293563842773
activity O 0 0.005164765752851963
, O 0 0.002405086299404502
has O 0 0.0013939928030595183
been O 0 0.0014960533007979393
obtained O 0 0.004112777765840292
by O 0 0.0038125303108245134
cellulose O 1 0.9977446794509888
acetate O 1 0.99988853931427
gel O 1 0.999131977558136
electrophoresis O 0 0.08635804057121277
, O 0 0.014733555726706982
DEAE O 1 0.9999973773956299
- O 0 0.2302655130624771
cellulose O 1 0.7144728899002075
ion O 0 0.059619270265102386
- O 0 0.021719275042414665
exchange O 0 0.01244334690272808
chromatography O 0 0.04827139154076576
, O 0 0.01019737683236599
radial O 1 0.9065399169921875
immunodiffusion O 1 0.9999332427978516
, O 0 0.010033751837909222
and O 0 0.009607424028217793
radioimmunoassay O 1 0.999961256980896
. O 0 0.01794327422976494

Previous O 0 0.020855944603681564
family O 0 0.01460898295044899
studies O 0 0.00790468417108059
suggested O 0 0.005701683461666107
that O 0 0.001280029071494937
these O 0 0.0010094037279486656
individuals O 0 0.001863772515207529
may O 0 0.0036219502799212933
be O 0 0.0022037022281438112
compound O 0 0.015643326565623283
heterozygotes O 0 0.034789953380823135
for O 0 0.002951019909232855
the O 0 0.0048704021610319614
common O 0 0.011248304508626461
mutant O 1 0.7204645276069641
TSD B-Disease 1 1.0
gene O 0 0.008415707387030125
and O 0 0.0017040190286934376
a O 0 0.0034164446406066418
rare O 0 0.01215512678027153
( O 0 0.013050747103989124
allelic O 1 0.9508076310157776
) O 0 0.01144137792289257
mutant O 0 0.03645238280296326
gene O 0 0.017397210001945496
. O 0 0.00892891176044941

Thus O 0 0.013556459918618202
, O 0 0.004409411922097206
the O 0 0.006371571682393551
postulated O 0 0.04169397056102753
rate O 0 0.014284028671681881
mutant O 0 0.031346920877695084
gene O 0 0.0073599908500909805
appears O 0 0.004307278897613287
to O 0 0.0013812455581501126
code O 0 0.0024343817494809628
for O 0 0.0015877895057201385
the O 0 0.003712402656674385
expression O 0 0.004822771530598402
of O 0 0.004450561013072729
low O 0 0.010271145962178707
amounts O 0 0.0053014024160802364
of O 0 0.008067896589636803
hex O 0 0.11703332513570786
A O 0 0.023973166942596436
. O 0 0.010363783687353134

Heterozygotes O 0 0.11232589930295944
for O 0 0.007941021583974361
the O 0 0.009305901825428009
rare O 0 0.01849767006933689
mutant O 0 0.03408295661211014
may O 0 0.0045141917653381824
be O 0 0.001767049077898264
indistinguishable O 0 0.012066585011780262
from O 0 0.0035424833185970783
heterozygotes O 0 0.03776254132390022
for O 0 0.004255528096109629
the O 0 0.009509200230240822
common O 0 0.03203348442912102
TSD B-Disease 1 1.0
mutant O 1 0.9343947172164917
. O 0 0.017758633941411972

However O 0 0.009790003299713135
, O 0 0.004880980588495731
direct O 0 0.007075740955770016
visualization O 0 0.031008517369627953
and O 0 0.005898349918425083
quantitation O 1 0.9893158674240112
of O 0 0.013263186439871788
hex O 0 0.140515998005867
A O 0 0.0068784914910793304
by O 0 0.001217052573338151
the O 0 0.0023887520655989647
methods O 0 0.00436973012983799
described O 0 0.007377326022833586
may O 0 0.004922660067677498
prevent O 0 0.009510956704616547
false O 0 0.018146125599741936
- O 0 0.026545800268650055
positive O 0 0.01447719894349575
prenatal O 1 0.9999667406082153
diagnosis O 1 0.999996542930603
of O 0 0.04555022716522217
TSD B-Disease 1 1.0
in O 0 0.010311763733625412
fetuses O 0 0.038213036954402924
having O 0 0.004306832328438759
the O 0 0.004347716458141804
incomplete O 0 0.01809353567659855
hex B-Disease 1 0.9983487129211426
A I-Disease 0 0.26267847418785095
deficiency I-Disease 1 1.0
of O 0 0.011377209797501564
the O 0 0.010646200738847256
type O 0 0.015537754632532597
described O 0 0.007098243106156588
in O 0 0.0025258229579776525
the O 0 0.004309319891035557
four O 0 0.006402895320206881
healthy O 0 0.02408457361161709
individuals O 0 0.010809975676238537

The O 0 0.04479547590017319
tumor B-Disease 1 1.0
suppressor O 1 0.9999750852584839
gene O 0 0.04153459146618843
Smad4 O 1 0.9999983310699463
/ O 1 0.9979714751243591
Dpc4 O 1 0.9759003520011902
is O 0 0.0036622362677007914
required O 0 0.002544163493439555
for O 0 0.003570280037820339
gastrulation O 1 0.9975087642669678
and O 0 0.003650971921160817
later O 0 0.006419997662305832
for O 0 0.004859985318034887
anterior O 1 0.9998394250869751
development O 0 0.01156966108828783
of O 0 0.008267058059573174
the O 0 0.014293874613940716
mouse O 0 0.03589123487472534
embryo O 0 0.027498221024870872
. O 0 0.009505427442491055

Mutations O 0 0.016965536400675774
in O 0 0.004736865404993296
the O 0 0.011137210763990879
SMAD4 O 1 1.0
/ O 1 1.0
DPC4 O 1 1.0
tumor B-Disease 1 1.0
suppressor O 1 0.9999760389328003
gene O 0 0.008399470709264278
, O 0 0.0022467963863164186
a O 0 0.0033260961063206196
key O 0 0.009415159933269024
signal O 0 0.009695753455162048
transducer O 0 0.017770567908883095
in O 0 0.0029705127235502005
most O 0 0.00433842558413744
TGFbeta O 1 0.9999996423721313
- O 0 0.11146193742752075
related O 0 0.010538509115576744
pathways O 0 0.013033290393650532
, O 0 0.0017107289750128984
are O 0 0.00047627155436202884
involved O 0 0.0014622826129198074
in O 0 0.0023350026458501816
50 O 0 0.0053193699568510056
% O 0 0.004326012451201677
of O 0 0.012798064388334751
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.350448876619339

Homozygous O 0 0.10885606706142426
Smad4 O 1 0.9993906021118164
mutant O 0 0.3382188081741333
mice O 0 0.04567154496908188
die O 0 0.04477094113826752
before O 0 0.005738598294556141
day O 0 0.010879003442823887
7 O 0 0.016410019248723984
. O 0 0.00792117789387703

5 O 0 0.026803819462656975
of O 0 0.01660183258354664
embryogenesis O 1 0.9990682005882263
. O 0 0.019173379987478256

Mutant O 0 0.08174622058868408
embryos O 0 0.01774001307785511
have O 0 0.002179328352212906
reduced O 0 0.00668911449611187
size O 0 0.005405079573392868
, O 0 0.0034840134903788567
fail O 0 0.010011997073888779
to O 0 0.004979417659342289
gastrulate O 1 0.8825945854187012
or O 0 0.004715355578809977
express O 0 0.007972910068929195
a O 0 0.008339970372617245
mesodermal O 1 0.9995951056480408
marker O 1 0.7575637102127075
, O 0 0.005333219189196825
and O 0 0.0046653286553919315
show O 0 0.020768024027347565
abnormal O 1 0.9999326467514038
visceral O 1 0.9999977350234985
endoderm O 1 0.9999994039535522
development O 0 0.03597819432616234
. O 0 0.015155931003391743

Growth B-Disease 1 0.8981001377105713
retardation I-Disease 1 0.9999992847442627
of O 0 0.0353349968791008
the O 1 0.9808774590492249
Smad4 O 1 1.0
- O 1 0.9943851232528687
deficient O 1 0.7945061922073364
embryos O 0 0.008797863498330116
results O 0 0.003544015111401677
from O 0 0.0034293720964342356
reduced O 0 0.011683293618261814
cell O 0 0.016512775793671608
proliferation O 0 0.014312186278402805
rather O 0 0.003681958420202136
than O 0 0.0027226367965340614
increased O 0 0.012360402382910252
apoptosis O 0 0.12005186825990677
. O 0 0.01283169537782669

Aggregation O 0 0.039689987897872925
of O 0 0.01876826584339142
mutant O 1 0.8855128288269043
Smad4 O 1 0.9999971389770508
ES O 1 0.9999978542327881
cells O 0 0.008385570719838142
with O 0 0.0019438620656728745
wild O 0 0.010701216757297516
- O 0 0.017004873603582382
type O 0 0.019568702206015587
tetraploid O 0 0.08962295204401016
morulae O 1 0.8921000957489014
rescues O 0 0.3339052200317383
the O 0 0.021981041878461838
gastrulation B-Disease 1 0.9999996423721313
defect I-Disease 1 0.9999991655349731
. O 0 0.02113846130669117

These O 0 0.006641323212534189
results O 0 0.008804889395833015
indicate O 0 0.009352960623800755
that O 0 0.00354292755946517
Smad4 O 1 0.831710159778595
is O 0 0.0032894143369048834
initially O 0 0.003818575059995055
required O 0 0.0015443918528035283
for O 0 0.001501520979218185
the O 0 0.00361918774433434
differentiation O 0 0.010768159292638302
of O 0 0.005664241034537554
the O 0 0.012475439347326756
visceral O 1 0.9999649524688721
endoderm O 1 0.9999043941497803
and O 0 0.0032133443746715784
that O 0 0.0015551428077742457
the O 0 0.00656549958512187
gastrulation B-Disease 1 0.9999920129776001
defect I-Disease 1 0.9987364411354065
in O 0 0.005877871997654438
the O 0 0.008796041831374168
epiblast O 1 0.9999973773956299
is O 0 0.006292924750596285
secondary O 0 0.01791558973491192
and O 0 0.005241817329078913
non O 0 0.0523042231798172
- O 0 0.27969861030578613
cell O 0 0.0188070610165596
autonomous O 0 0.020092658698558807
. O 0 0.009140869602560997

Rescued O 1 0.5676493048667908
embryos O 0 0.04087549075484276
show O 0 0.02827242948114872
severe O 1 0.9999998807907104
anterior O 1 1.0
truncations O 1 1.0
, O 0 0.01888425648212433
indicating O 0 0.012108687311410904
a O 0 0.003586392616853118
second O 0 0.004089295398443937
important O 0 0.002726846607401967
role O 0 0.004509167280048132
for O 0 0.00412174453958869
Smad4 O 1 0.999983549118042
in O 0 0.01397841889411211
anterior O 1 0.9999990463256836
patterning O 1 0.9999991655349731
during O 1 0.9990195035934448
embryogenesis O 1 0.9999896287918091
. O 0 0.01678009144961834

Prevalence O 1 0.960300624370575
of O 0 0.02660907804965973
p16 O 1 0.996311366558075
and O 0 0.012772433459758759
CDK4 O 1 1.0
germline O 1 0.9698230028152466
mutations O 0 0.010814059525728226
in O 0 0.006301781628280878
48 O 0 0.05878050997853279
melanoma B-Disease 1 1.0
- O 1 0.9996023774147034
prone O 0 0.30200716853141785
families O 0 0.006841019727289677
in O 0 0.005848441272974014
France O 0 0.02551022544503212
. O 0 0.014215494506061077

The O 0 0.01735023222863674
French O 1 0.9300567507743835
Familial B-Disease 1 1.0
Melanoma I-Disease 1 1.0
Study O 1 0.9984641075134277
Group O 0 0.01829994097352028
. O 0 0.009449956938624382

Germline O 1 0.9928037524223328
mutations O 0 0.015798509120941162
in O 0 0.005039413925260305
the O 0 0.009882645681500435
p16 O 1 0.9812833666801453
and O 0 0.009974468499422073
CDK4 O 1 0.9999997615814209
genes O 0 0.006824611220508814
have O 0 0.0010969333816319704
been O 0 0.0016454171855002642
reported O 0 0.0033866886515170336
in O 0 0.0022150224540382624
a O 0 0.0038461736403405666
subset O 0 0.019214047119021416
of O 0 0.018594153225421906
melanoma B-Disease 1 1.0
pedigrees O 1 0.9995155334472656
, O 0 0.00532984035089612
but O 0 0.001933789812028408
their O 0 0.002954917261376977
prevalence O 1 0.9652704000473022
is O 0 0.0035155999939888716
not O 0 0.0015821794513612986
well O 0 0.0032045221887528896
known O 0 0.010502368211746216
. O 0 0.011093398556113243

We O 0 0.006404655519872904
searched O 0 0.014900049194693565
for O 0 0.0035869020503014326
such O 0 0.003985640127211809
germline O 0 0.07502039521932602
mutations O 0 0.009703783318400383
in O 0 0.0045659467577934265
48 O 0 0.023307938128709793
French O 1 0.9999303817749023
melanoma B-Disease 1 1.0
- O 1 0.9999972581863403
prone O 1 0.5490294694900513
families O 0 0.003993878606706858
selected O 0 0.0035231122747063637
according O 0 0.0017890280578285456
to O 0 0.0010635725921019912
two O 0 0.0010011508129537106
major O 0 0.005038479343056679
criteria O 0 0.007239189464598894
families O 0 0.002821079222485423
with O 0 0.001183157553896308
at O 0 0.004467642400413752
least O 0 0.0017323218053206801
three O 0 0.0017936169169843197
affected O 0 0.0043270704336464405
members O 0 0.0027637211605906487
( O 0 0.006858620792627335
n O 0 0.01944844424724579
= O 0 0.020049797371029854
20 O 0 0.0049581644125282764
) O 0 0.002657782519236207
or O 0 0.0015914986142888665
families O 0 0.0016403805930167437
with O 0 0.0012094900012016296
two O 0 0.002001522807404399
affected O 0 0.005969005171209574
members O 0 0.002250054618343711
, O 0 0.0020949069876223803
one O 0 0.0016462744679301977
of O 0 0.0021457041148096323
them O 0 0.0019172965548932552
affected O 0 0.0043749152682721615
before O 0 0.002316536381840706
the O 0 0.0024142565671354532
age O 0 0.004265693482011557
of O 0 0.0036288988776504993
50 O 0 0.006973209325224161
( O 0 0.006030677817761898
n O 0 0.014944157563149929
= O 0 0.017908165231347084
28 O 0 0.007687557488679886
) O 0 0.0024849935434758663
, O 0 0.0015313385520130396
and O 0 0.0013917934847995639
one O 0 0.0024905530735850334
additional O 0 0.005365733057260513
minor O 0 0.216264545917511
criterion O 1 0.9999027252197266
. O 0 0.016669055446982384

Sixteen O 0 0.0530887208878994
different O 0 0.008861851878464222
p16 O 1 0.9141722321510315
germline O 1 0.7283769249916077
mutations O 0 0.010916934348642826
were O 0 0.0024343470577150583
found O 0 0.002758086659014225
in O 0 0.0033044947776943445
21 O 0 0.00882840808480978
families O 0 0.0033617534209042788
, O 0 0.0024255095049738884
while O 0 0.002875142963603139
one O 0 0.005004335194826126
germline O 1 0.7329890727996826
mutation O 0 0.013689336366951466
, O 0 0.006454759743064642
Arg24His O 1 0.9997549653053284
, O 0 0.005373477470129728
was O 0 0.007728722412139177
detected O 0 0.008362133987247944
in O 0 0.004051895346492529
the O 0 0.011205264367163181
CDK4 O 1 0.9999997615814209
gene O 0 0.023692702874541283
. O 0 0.008431303314864635

The O 0 0.014787755906581879
frequency O 0 0.00809417013078928
of O 0 0.009343122132122517
p16 O 0 0.4858684539794922
gene O 0 0.012746951542794704
mutation O 0 0.005688765086233616
in O 0 0.0022527603432536125
our O 0 0.0030982543248683214
sample O 0 0.0040556262247264385
( O 0 0.004318307153880596
44 O 0 0.008279850706458092
% O 0 0.004239256959408522
) O 0 0.0024035261012613773
is O 0 0.001372824888676405
among O 0 0.0017532878555357456
the O 0 0.004043566063046455
highest O 0 0.016480451449751854
rates O 0 0.006190607324242592
yet O 0 0.002711994107812643
reported O 0 0.0049050659872591496
and O 0 0.002384360646829009
the O 0 0.008186972700059414
CDK4 O 1 0.9999958276748657
mutation O 0 0.010276411660015583
is O 0 0.0023190549109131098
the O 0 0.003127695992588997
second O 0 0.0074783191084861755
mutation O 0 0.00810183770954609
detected O 0 0.006742166355252266
in O 0 0.002368477638810873
this O 0 0.002156781265512109
gene O 0 0.007659580558538437
worldwide O 0 0.00756133021786809
. O 0 0.00898671057075262

In O 0 0.013660343363881111
summary O 0 0.024009130895137787
, O 0 0.004083174280822277
our O 0 0.0034806907642632723
results O 0 0.0041299923323094845
show O 0 0.00487052695825696
frequent O 0 0.006174835842102766
involvement O 0 0.009859240613877773
of O 0 0.007168117444962263
the O 0 0.011605847626924515
p16 O 1 0.9967798590660095
gene O 0 0.011632867157459259
in O 0 0.007109738886356354
familial B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 0 0.008714679628610611
confirm O 0 0.007682378403842449
the O 0 0.002874220721423626
role O 0 0.0032266774214804173
of O 0 0.0027378438971936703
the O 0 0.0064390478655695915
CDK4 O 1 0.999998927116394
gene O 0 0.005923902150243521
as O 0 0.0027765780687332153
a O 0 0.009314478375017643
melanoma B-Disease 1 1.0
- O 1 0.9998229146003723
predisposing O 1 0.9999432563781738
gene O 0 0.01746411994099617
. O 0 0.004479655530303717
. O 0 0.007307220716029406

Progression O 1 0.6976444721221924
of O 0 0.02862691506743431
somatic O 1 0.9990119934082031
CTG O 1 0.9999974966049194
repeat O 0 0.037070512771606445
length O 0 0.006950305309146643
heterogeneity O 0 0.014486005529761314
in O 0 0.003323327749967575
the O 0 0.00593370059505105
blood O 1 0.7596156001091003
cells O 0 0.01788248121738434
of O 0 0.0445764884352684
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
. O 0 0.04386856406927109

The O 0 0.010469303466379642
genetic O 0 0.008288403041660786
basis O 0 0.0060462066903710365
of O 0 0.019295677542686462
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.008395303040742874
is O 0 0.0018393918871879578
the O 0 0.0019030652474611998
expansion O 0 0.00449605705216527
of O 0 0.0036956260446459055
an O 0 0.006290026940405369
unstable O 1 0.9999279975891113
CTG O 1 0.9999992847442627
repeat O 0 0.02834898978471756
in O 0 0.004125277046114206
the O 0 0.004360104911029339
34 O 0 0.010940035805106163
UTR O 0 0.06782891601324081
of O 0 0.007316669914871454
the O 0 0.020431578159332275
DM B-Disease 1 1.0
protein O 0 0.03273538872599602
kinase O 0 0.02888571284711361
gene O 0 0.008068317547440529
on O 0 0.005609855521470308
chromosome O 0 0.022217614576220512
19 O 0 0.022318042814731598
. O 0 0.01182871125638485

One O 0 0.00566117512062192
of O 0 0.004456597380340099
the O 0 0.005552805028855801
principal O 0 0.012648580595850945
features O 0 0.004003670997917652
of O 0 0.005414335988461971
the O 0 0.06890130788087845
DM B-Disease 1 1.0
mutation O 0 0.013852791860699654
is O 0 0.0023429407738149166
an O 0 0.0020326918456703424
extraordinarily O 0 0.01804989203810692
high O 0 0.009949088096618652
level O 0 0.008760787546634674
of O 0 0.009440988302230835
somatic O 1 0.9999010562896729
mosaicism O 1 0.9999998807907104
, O 0 0.004621708765625954
due O 0 0.0046127899549901485
to O 0 0.002085481770336628
an O 0 0.001962983049452305
extremely O 0 0.007020586170256138
high O 0 0.008388740010559559
degree O 0 0.008789796382188797
of O 0 0.011073977686464787
somatic O 1 0.999783456325531
instability O 0 0.19728973507881165
both O 0 0.002120938617736101
within O 0 0.0018337273504585028
and O 0 0.0015483496244996786
between O 0 0.0038065225817263126
different O 0 0.0035602175630629063
tissues O 0 0.15326689183712006
. O 0 0.011806248687207699

This O 0 0.013513688929378986
instability O 1 0.5661792755126953
appears O 0 0.013745964504778385
to O 0 0.003950146492570639
be O 0 0.0025930600240826607
biased O 0 0.009390340186655521
towards O 0 0.006237589754164219
further O 0 0.003872446483001113
expansion O 0 0.0069858236238360405
and O 0 0.002258827444165945
continuous O 0 0.008094599470496178
throughout O 0 0.003723947564139962
the O 0 0.0032467686105519533
life O 0 0.00529464753344655
of O 0 0.0033965364564210176
an O 0 0.003113863989710808
individual O 0 0.0035259088035672903
, O 0 0.002893245778977871
features O 0 0.0036148573271930218
that O 0 0.001103576272726059
could O 0 0.0011317057069391012
be O 0 0.0009073287365026772
associated O 0 0.0020980213303118944
with O 0 0.0012580441543832421
the O 0 0.004701543599367142
progressive O 0 0.4335322082042694
nature O 0 0.010258832015097141
of O 0 0.014657833613455296
the O 1 0.9925280809402466
disease O 1 1.0
. O 0 0.028348753228783607

Although O 0 0.011283784173429012
increasing O 0 0.010311088524758816
measured O 0 0.011009495705366135
allele O 0 0.012095985002815723
size O 0 0.004133988171815872
between O 0 0.00474996492266655
patients O 1 0.5679142475128174
clearly O 0 0.009538360871374607
correlates O 0 0.013999802060425282
with O 0 0.0016277232207357883
an O 0 0.002806645119562745
increased O 0 0.007583209779113531
severity O 1 0.9988790154457092
of O 0 0.43026846647262573
symptoms O 1 1.0
and O 0 0.004674766678363085
an O 0 0.0028486642986536026
earlier O 0 0.0049491808749735355
age O 0 0.0062969583086669445
of O 0 0.007919046096503735
onset O 1 1.0
, O 0 0.007693855557590723
this O 0 0.0029170005582273006
correlation O 0 0.009208986535668373
is O 0 0.0027289714198559523
not O 0 0.0013131228042766452
precise O 0 0.0048347339034080505
and O 0 0.0033049089834094048
measured O 0 0.011815809644758701
allele O 0 0.014865485951304436
length O 0 0.005109330639243126
cannot O 0 0.002387100365012884
be O 0 0.0008737038588151336
used O 0 0.001651780679821968
as O 0 0.0016972561134025455
an O 0 0.00187736377120018
accurate O 0 0.00714054424315691
predictor O 0 0.03648381680250168
of O 0 0.005549709312617779
age O 0 0.012477031908929348
of O 0 0.019058965146541595
onset O 1 1.0
. O 0 0.02803019993007183

In O 0 0.0061388458125293255
order O 0 0.003954527899622917
to O 0 0.0021252220030874014
further O 0 0.0031933269929140806
characterize O 0 0.014358149841427803
the O 0 0.005326585844159126
dynamics O 0 0.023654328659176826
of O 0 0.032850928604602814
DM B-Disease 1 1.0
CTG O 1 1.0
repeat O 1 0.9999607801437378
somatic O 1 0.9977660179138184
instability O 1 0.5725401639938354
, O 0 0.0029895624611526728
we O 0 0.0012032917002215981
have O 0 0.0007775186677463353
studied O 0 0.006147043313831091
repeat O 0 0.013396177440881729
length O 0 0.0034852223470807076
changes O 0 0.0013121276861056685
over O 0 0.0016197576187551022
time O 0 0.002461961004883051
in O 0 0.005613180808722973
111 O 1 0.9997840523719788
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
with O 0 0.006543572060763836
varying O 0 0.012131594121456146
clinical O 1 0.9999947547912598
severity O 1 0.9999997615814209
and O 0 0.022866325452923775
CTG O 1 0.9999998807907104
repeat O 0 0.02408025786280632
size O 0 0.003045064164325595
over O 0 0.001201855717226863
time O 0 0.0013492741854861379
intervals O 0 0.0032250741496682167
of O 0 0.0031163133680820465
1 O 0 0.012782236561179161
- O 0 0.012982301414012909
7 O 0 0.009346437640488148
years O 0 0.0070322491228580475
. O 0 0.007616880349814892

We O 0 0.005422850139439106
have O 0 0.0015024206368252635
found O 0 0.0027453890070319176
a O 0 0.003457487327978015
direct O 0 0.006106817163527012
progression O 0 0.1107478141784668
of O 0 0.007593638729304075
the O 0 0.00814406480640173
size O 0 0.00647928798571229
heterogeneity O 0 0.01622375100851059
over O 0 0.0027280477806925774
time O 0 0.002444633049890399
related O 0 0.0039534722454845905
to O 0 0.002965331543236971
initial O 0 0.013925591483712196
CTG O 1 0.9999986886978149
repeat O 0 0.0313054621219635
size O 0 0.003925697412341833
and O 0 0.0013379246229305863
the O 0 0.0030711244326084852
time O 0 0.002787001198157668
interval O 0 0.007356021087616682
and O 0 0.0027701398357748985
always O 0 0.0049087912775576115
biased O 0 0.010783020406961441
towards O 0 0.008277556858956814
further O 0 0.006371046416461468
expansion O 0 0.01897505298256874
. O 0 0.010386108420789242

Attempts O 0 0.017174100503325462
to O 0 0.005142723210155964
mathematically O 0 0.01399110909551382
model O 0 0.006669464986771345
the O 0 0.004515413194894791
dynamics O 0 0.01306840404868126
have O 0 0.0018231067806482315
proved O 0 0.010791019536554813
only O 0 0.0027914883103221655
partially O 0 0.013897978700697422
successful O 0 0.007047412451356649
suggesting O 0 0.005423562601208687
that O 0 0.0010176062351092696
individual O 0 0.0016081893118098378
specific O 0 0.003182938788086176
genetic O 0 0.010671291500329971
and O 0 0.007029982283711433
/ O 1 0.9999309778213501
or O 0 0.005545823834836483
environmental O 0 0.010284902527928352
factors O 0 0.005302931182086468
also O 0 0.002421435434371233
play O 0 0.002143274759873748
a O 0 0.0027364292182028294
role O 0 0.00840284675359726
in O 0 0.009369428269565105
somatic O 1 0.9924995303153992
mosaicism O 1 0.9999814033508301
. O 0 0.011826782487332821
. O 0 0.010941636748611927

Aspartylglucosaminuria B-Disease 1 0.9999898672103882
among O 0 0.021520059555768967
Palestinian O 0 0.049713827669620514
Arabs O 0 0.03786244988441467
. O 0 0.014882939867675304

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.9770947098731995
AGU B-Disease 1 1.0
) O 0 0.008378401398658752
is O 0 0.00248851184733212
a O 0 0.0037072086706757545
rare O 0 0.025661706924438477
disorder B-Disease 1 1.0
of I-Disease 1 0.9999984502792358
glycoprotein I-Disease 1 1.0
metabolism I-Disease 1 0.99997878074646
caused O 0 0.029072070494294167
by O 0 0.003394586965441704
the O 0 0.012107308022677898
deficiency B-Disease 1 1.0
of I-Disease 0 0.02094639651477337
the I-Disease 0 0.28133249282836914
lysosomal I-Disease 1 1.0
enzyme I-Disease 0 0.09414898604154587
aspartylglucosaminidase I-Disease 1 0.999890923500061
( O 0 0.026190942153334618
AGA O 1 0.9999992847442627
) O 0 0.013832286931574345
. O 0 0.009145250543951988

AGU B-Disease 1 1.0
is O 0 0.018662862479686737
inherited O 1 0.9990715980529785
as O 0 0.007149752229452133
an O 0 0.008150325156748295
autosomal O 1 1.0
recessive O 1 1.0
trait O 1 0.9999984502792358
and O 0 0.009611194021999836
occurs O 0 0.008752190507948399
with O 0 0.0025942691136151552
a O 0 0.0050874799489974976
high O 0 0.010422616265714169
frequency O 0 0.0035373696591705084
in O 0 0.0022382845636457205
Finland O 0 0.011296660639345646
because O 0 0.0018065717304125428
of O 0 0.0030632303096354008
a O 0 0.00867196824401617
founder O 1 0.6028763651847839
effect O 0 0.014459657482802868
. O 0 0.009826120920479298

While O 0 0.009163269773125648
very O 0 0.004236631095409393
few O 0 0.00540732080116868
patients O 1 0.9581013917922974
with O 0 0.009360632859170437
AGU B-Disease 1 1.0
have O 0 0.003003844525665045
been O 0 0.0024522242601960897
reported O 0 0.00481610419228673
from O 0 0.0028504962101578712
non O 0 0.011646580882370472
- O 0 0.012888973578810692
Finnish O 0 0.027164066210389137
origin O 0 0.0038385195657610893
, O 0 0.0029650016222149134
we O 0 0.003321335418149829
diagnosed O 1 1.0
the O 0 0.21224965155124664
disorder O 1 1.0
in O 1 0.8071545362472534
8 O 1 0.6092051267623901
patients O 1 0.986935019493103
originating O 0 0.012720204889774323
from O 0 0.004240312147885561
3 O 0 0.008589239791035652
unrelated O 0 0.01021695975214243
families O 0 0.004145865794271231
, O 0 0.00226220628246665
all O 0 0.0017275121062994003
Palestinian O 0 0.010020909830927849
Arabs O 0 0.008393297903239727
from O 0 0.0027368145529180765
the O 0 0.004259239882230759
region O 0 0.008832497522234917
of O 0 0.009373031556606293
Jerusalem O 1 0.975340723991394
. O 0 0.01865105703473091

The O 0 0.019504878669977188
clinical O 1 0.9999994039535522
diagnosis O 1 1.0
of O 1 0.9999995231628418
AGU B-Disease 1 1.0
is O 0 0.009834934026002884
often O 0 0.0026832586154341698
difficult O 0 0.003528931876644492
, O 0 0.0017654356779530644
in O 0 0.0016668153693899512
particular O 0 0.0019107433035969734
early O 0 0.0026062773540616035
in O 0 0.0015800956171005964
the O 0 0.002293599769473076
course O 0 0.00533509673550725
of O 0 0.004050046671181917
the O 0 0.05609521269798279
disease O 1 1.0
, O 0 0.004407921805977821
and O 0 0.0016474472358822823
most O 0 0.0012110561365261674
of O 0 0.002944913227111101
the O 0 0.007499410305172205
patients O 1 0.9999915361404419
are O 0 0.0038186563178896904
diagnosed O 1 1.0
after O 0 0.0065284003503620625
the O 0 0.004733305890113115
age O 0 0.006152236834168434
of O 0 0.004917801823467016
5 O 0 0.010754731483757496
years O 0 0.006672687828540802
. O 0 0.007509451359510422

However O 0 0.009642300195991993
, O 0 0.0038951116148382425
since O 0 0.005199688021093607
these O 0 0.0030514986719936132
patients O 1 0.8492018580436707
excrete O 1 0.9961526989936829
early O 0 0.0074478257447481155
large O 0 0.003106781980022788
amounts O 0 0.00376083399169147
of O 0 0.006014461629092693
aspartylglucosamine O 1 0.9949601888656616
in O 0 0.008620607666671276
urine O 0 0.033369433134794235
, O 0 0.005805668421089649
biochemical O 0 0.01768803969025612
screening O 0 0.011278866790235043
is O 0 0.002674020826816559
easy O 0 0.004669475834816694
by O 0 0.0028239807579666376
urine O 0 0.03626126050949097
chromatography O 0 0.07875204086303711
. O 0 0.008420176804065704
. O 0 0.011256208643317223

Detection O 0 0.028348766267299652
of O 0 0.009298079647123814
heterozygous O 0 0.014387878589332104
carriers O 0 0.007598123978823423
of O 0 0.005285556428134441
the O 0 0.016018861904740334
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
( O 0 0.03119252249598503
ATM O 0 0.24486708641052246
) O 0 0.004693642724305391
gene O 0 0.0042806039564311504
by O 0 0.002514591673389077
G2 O 1 0.9999797344207764
phase O 0 0.051498204469680786
chromosomal O 1 0.9958742260932922
radiosensitivity O 1 0.9999797344207764
of O 1 0.7572612166404724
peripheral O 1 1.0
blood O 1 1.0
lymphocytes O 1 0.9999614953994751
. O 0 0.013120559975504875

In O 0 0.03613889589905739
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
telangiectasia I-Disease 1 1.0
( O 0 0.43295684456825256
A B-Disease 1 0.9999985694885254
- I-Disease 1 0.999997615814209
T I-Disease 1 1.0
) O 0 0.007863953709602356
patients O 0 0.020304493606090546
, O 0 0.003709620563313365
mutations O 0 0.004356841556727886
in O 0 0.0019548749551177025
a O 0 0.003991520032286644
single O 0 0.006006279494613409
gene O 0 0.008152784779667854
, O 0 0.004181485157459974
ATM O 0 0.02408020757138729
, O 0 0.002164955250918865
result O 0 0.0026039478834718466
in O 0 0.0034300244878977537
an O 0 0.010000372305512428
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 1 0.8201107978820801
embraces O 1 0.9715320467948914
a O 0 0.005069154780358076
variety O 0 0.004294389858841896
of O 0 0.005148146767169237
clinical O 1 0.9999974966049194
features O 0 0.012835054658353329
and O 0 0.0049007972702383995
manifests O 1 0.9959478974342346
extreme O 1 0.999390721321106
radiosensitivity O 1 0.9999990463256836
and O 0 0.0032981650438159704
a O 0 0.003794617485255003
strong O 0 0.006744433660060167
pre O 0 0.09176886081695557
- O 0 0.02390662021934986
disposition O 0 0.032613322138786316
to O 0 0.010556354187428951
malignancy B-Disease 1 0.9999982118606567
. O 0 0.022151023149490356

Heterozygotes O 0 0.1710292100906372
for O 0 0.008193588815629482
the O 0 0.012122475542128086
ATM O 1 0.8892412185668945
gene O 0 0.005554919596761465
have O 0 0.000930609880015254
no O 0 0.0017405013786628842
clinical O 0 0.01760377176105976
expression O 0 0.005976507440209389
of O 0 0.007477009668946266
A B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
T I-Disease 1 0.9999995231628418
but O 0 0.0020301397889852524
may O 0 0.0034370794892311096
be O 0 0.0030129447113722563
cancer B-Disease 1 0.9999988079071045
prone O 0 0.46207359433174133
with O 0 0.002619724487885833
a O 0 0.004861512221395969
moderate O 0 0.011777364648878574
increase O 0 0.0033637129236012697
in O 0 0.0035368995741009712
in O 0 0.00801254715770483
vitro O 0 0.15880361199378967
radiosensitivity O 1 0.9991674423217773
. O 0 0.014731272123754025

We O 0 0.007254736497998238
performed O 0 0.010786998085677624
a O 0 0.008471713401377201
blind O 0 0.06743430346250534
chromosomal O 0 0.03620244190096855
analysis O 0 0.00755829643458128
on O 0 0.012535685673356056
G2 O 1 1.0
- O 0 0.02647671103477478
phase O 0 0.024379948154091835
lymphocytes O 0 0.023707106709480286
from O 0 0.002411414636299014
7 O 0 0.00806058757007122
unrelated O 0 0.01644943840801716
A B-Disease 1 0.9979122281074524
- I-Disease 1 0.9999773502349854
T I-Disease 1 1.0
patients O 1 0.5401469469070435
, O 0 0.004261345602571964
13 O 0 0.009541880339384079
obligate O 0 0.02931186370551586
A B-Disease 1 0.9989645481109619
- I-Disease 1 0.9995129108428955
T I-Disease 1 0.9999997615814209
heterozygotes O 1 0.959113597869873
( O 0 0.007019877899438143
parents O 0 0.0035946168936789036
of O 0 0.003283522790297866
the O 0 0.008113005198538303
patients O 1 0.9999865293502808
) O 0 0.004325604531913996
, O 0 0.001693057594820857
and O 0 0.0016571759479120374
14 O 0 0.006830517202615738
normal O 0 0.005762196611613035
controls O 0 0.00576358987018466
following O 0 0.008209879510104656
X O 1 0.8179619312286377
- O 0 0.02017923630774021
irradiation O 0 0.020066767930984497
with O 0 0.0021011680364608765
1 O 0 0.013936207629740238
Gy O 1 0.9895923137664795
in O 0 0.0027381423860788345
order O 0 0.002210100879892707
to O 0 0.002155827358365059
evaluate O 0 0.011919761076569557
this O 0 0.0024374735075980425
cytogenetic O 0 0.037758197635412216
method O 0 0.005884592887014151
as O 0 0.002298223553225398
a O 0 0.0035991938784718513
tool O 0 0.012734392657876015
for O 0 0.003554521594196558
detection O 0 0.016133688390254974
of O 0 0.014837461523711681
ATM O 1 0.9857692122459412
carriers O 0 0.028686728328466415
. O 0 0.01140454038977623

Both O 0 0.013932685367763042
A B-Disease 1 0.9997187256813049
- I-Disease 1 0.9999860525131226
T I-Disease 1 0.9999998807907104
homozygotes O 1 0.9954832792282104
and O 0 0.007555427961051464
heterozygotes O 1 0.9834585189819336
showed O 0 0.013908597640693188
significantly O 0 0.005977876018732786
increased O 0 0.004037264734506607
levels O 0 0.007005652878433466
of O 0 0.010016700252890587
radiation O 1 0.9999978542327881
- O 1 0.9997487664222717
induced O 1 0.9999843835830688
chromatid O 1 0.9999998807907104
damage O 0 0.05806911736726761
relative O 0 0.0093938447535038
to O 0 0.0023752518463879824
that O 0 0.001419808715581894
of O 0 0.0054346490651369095
normal O 0 0.015615212731063366
controls O 0 0.020692691206932068
. O 0 0.010858414694666862

These O 0 0.0055629173293709755
results O 0 0.006023518741130829
show O 0 0.004105163738131523
that O 0 0.0017234660917893052
the O 0 0.008716142736375332
G2 O 1 1.0
- O 0 0.05864829570055008
phase O 0 0.05254700034856796
chromosomal O 1 0.8418337106704712
radiosensitivity O 1 0.999218225479126
assay O 0 0.02498902939260006
can O 0 0.001410885015502572
be O 0 0.000630121270660311
used O 0 0.0010003676870837808
for O 0 0.0011882245307788253
the O 0 0.0028572403825819492
detection O 0 0.009136289358139038
of O 0 0.00853812787681818
A B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999909400939941
T I-Disease 1 0.9999995231628418
heterozygotes O 1 0.9675370454788208
. O 0 0.011878279969096184

In O 0 0.010980482213199139
combination O 0 0.012837736867368221
with O 0 0.003312293440103531
molecular O 0 0.016012180596590042
genetic O 0 0.011035890318453312
analyses O 0 0.008962618187069893
, O 0 0.002550628501921892
this O 0 0.0013923500664532185
test O 0 0.0037687746807932854
may O 0 0.0017585995374247432
be O 0 0.0005913250497542322
of O 0 0.0011655848938971758
value O 0 0.0016769637586548924
in O 0 0.0017073755152523518
studies O 0 0.0031144842505455017
of O 0 0.005726640112698078
familial B-Disease 1 0.9999998807907104
and I-Disease 0 0.014133232645690441
sporadic I-Disease 1 0.9999933242797852
cancers I-Disease 1 1.0
aimed O 0 0.02362973801791668
at O 0 0.008560248650610447
determination O 0 0.007743700407445431
of O 0 0.002705157268792391
the O 0 0.003383321687579155
potential O 0 0.004198609851300716
involvement O 0 0.008868403732776642
of O 0 0.007880814373493195
ATM O 1 0.9936909675598145
mutations O 0 0.013841304928064346
in O 0 0.008795763365924358
tumor B-Disease 1 1.0
risk O 0 0.2604304850101471
or O 0 0.00604630121961236
development O 0 0.009709320031106472
. O 0 0.004488853737711906
. O 0 0.0069074807688593864

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
telangiectasia I-Disease 1 1.0
: O 0 0.016699057072401047
identification O 0 0.009293917566537857
and O 0 0.0033037441316992044
detection O 0 0.011460932902991772
of O 0 0.00950594898313284
founder O 1 0.999964714050293
- O 0 0.02356324903666973
effect O 0 0.004955976270139217
mutations O 0 0.0038874263409525156
in O 0 0.0024181101471185684
the O 0 0.006519406568259001
ATM O 0 0.05864908918738365
gene O 0 0.005435419734567404
in O 0 0.0025388372596353292
ethnic O 0 0.007142045069485903
populations O 0 0.010392569936811924
. O 0 0.009572671726346016

To O 0 0.007257921155542135
facilitate O 0 0.010144205763936043
the O 0 0.0056936112232506275
evaluation O 0 0.019487662240862846
of O 0 0.013436596840620041
ATM O 1 0.9741706848144531
heterozygotes O 0 0.16458788514137268
for O 0 0.0049657635390758514
susceptibility O 0 0.02428739331662655
to O 0 0.00378599320538342
other O 0 0.0038244854658842087
diseases O 1 1.0
, O 0 0.003988673444837332
such O 0 0.0034970403648912907
as O 1 0.9374234676361084
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.009939647279679775
we O 0 0.0018687164410948753
have O 0 0.0007199061219580472
attempted O 0 0.0043091848492622375
to O 0 0.0016657874220982194
define O 0 0.005698658991605043
the O 0 0.0024719974026083946
most O 0 0.002037700731307268
common O 0 0.004527438897639513
mutations O 0 0.004698825068771839
and O 0 0.0013886011438444257
their O 0 0.001670630881562829
frequencies O 0 0.003864515805616975
in O 0 0.00649095606058836
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
( O 0 0.11235489696264267
A B-Disease 1 0.9999589920043945
- I-Disease 1 0.9999743700027466
T I-Disease 1 0.9999996423721313
) O 0 0.007297097239643335
homozygotes O 0 0.04204361140727997
from O 0 0.003410056699067354
10 O 0 0.0044447509571909904
ethnic O 0 0.006791096646338701
populations O 0 0.010678326711058617
. O 0 0.008213421329855919

Both O 0 0.013897105120122433
genomic O 0 0.04345029592514038
mutations O 0 0.012357207015156746
and O 0 0.002925266744568944
their O 0 0.0029230371583253145
effects O 0 0.010960635729134083
on O 0 0.00910832080990076
cDNA O 0 0.03157616779208183
were O 0 0.004019729793071747
characterized O 0 0.02467772178351879
. O 0 0.01336504053324461

Protein O 0 0.044920556247234344
- O 0 0.02898324653506279
truncation O 0 0.04879635572433472
testing O 0 0.01000402681529522
of O 0 0.006041431799530983
the O 0 0.00742744468152523
entire O 0 0.018046174198389053
ATM O 0 0.05879594758152962
cDNA O 0 0.03778696060180664
detected O 0 0.01348898932337761
92 O 0 0.024407317861914635
( O 0 0.007996357046067715
66 O 0 0.020512821152806282
% O 0 0.007113159634172916
) O 0 0.005905078258365393
truncating O 0 0.050687119364738464
mutations O 0 0.009311296977102757
in O 0 0.005088310223072767
140 O 0 0.024296967312693596
mutant O 0 0.04827925190329552
alleles O 0 0.03613479807972908
screened O 0 0.03457042574882507
. O 0 0.012582779861986637

The O 0 0.01978863775730133
haplotyping O 1 0.9913225173950195
of O 0 0.013035474345088005
patients O 1 0.9996203184127808
with O 0 0.005266654305160046
identical O 0 0.01921854354441166
mutations O 0 0.013622322119772434
indicates O 0 0.008063982240855694
that O 0 0.0010816003195941448
almost O 0 0.0014446360291913152
all O 0 0.0006653026794083416
of O 0 0.0020026755519211292
these O 0 0.0013139359652996063
represent O 0 0.004138556774705648
common O 0 0.0062431227415800095
ancestry O 0 0.009371985681355
and O 0 0.003259087912738323
that O 0 0.0016950259450823069
very O 0 0.0032316995784640312
few O 0 0.005150012671947479
spontaneously O 0 0.02934485301375389
recurring O 1 0.9999996423721313
ATM O 1 0.9999786615371704
mutations O 0 0.020405907183885574
exist O 0 0.01020581740885973
. O 0 0.00983801856637001

Assays O 0 0.05192939564585686
requiring O 0 0.014904214069247246
minimal O 0 0.014062952250242233
amounts O 0 0.00672880606725812
of O 0 0.007029134314507246
genomic O 0 0.029617836698889732
DNA O 0 0.00986691564321518
were O 0 0.0022685707081109285
designed O 0 0.003829166293144226
to O 0 0.001798724289983511
allow O 0 0.0022421341855078936
rapid O 0 0.011816835030913353
screening O 0 0.008186956867575645
for O 0 0.002754536923021078
common O 0 0.007594723254442215
ethnic O 0 0.01186312735080719
mutations O 0 0.02092733420431614
. O 0 0.012689657509326935

These O 0 0.00926714576780796
rapid O 0 0.03485452011227608
assays O 0 0.0295216403901577
detected O 0 0.017689209431409836
mutations O 0 0.006940721534192562
in O 0 0.0031840496230870485
76 O 0 0.02003869041800499
% O 0 0.0034723947755992413
of O 0 0.004483610391616821
Costa O 0 0.03839875012636185
Rican O 1 0.6964325308799744
patients O 1 0.9996089339256287
( O 0 0.00909199845045805
3 O 0 0.0076387966983020306
) O 0 0.0020566503517329693
, O 0 0.001080246758647263
50 O 0 0.0024047167971730232
% O 0 0.001700771157629788
of O 0 0.0025819893926382065
Norwegian O 0 0.022499267011880875
patients O 1 0.9978960752487183
( O 0 0.009038954973220825
1 O 0 0.008537006564438343
) O 0 0.0020501012913882732
, O 0 0.0013569309376180172
25 O 0 0.0025622204411774874
% O 0 0.002005784772336483
of O 0 0.0030833359342068434
Polish O 1 0.9999990463256836
patients O 1 1.0
( O 0 0.01707221195101738
4 O 0 0.010832920670509338
) O 0 0.002493663225322962
, O 0 0.0011726091615855694
and O 0 0.0013179772067815065
14 O 0 0.005156772676855326
% O 0 0.002525361953303218
of O 0 0.004020566586405039
Italian O 1 0.9995111227035522
patients O 1 1.0
( O 0 0.030656052753329277
1 O 0 0.015113740228116512
) O 0 0.0027732423041015863
, O 0 0.0013882601633667946
as O 0 0.0013662537094205618
well O 0 0.0012812273344025016
as O 0 0.001901182346045971
in O 0 0.0035595817025750875
patients O 0 0.16419045627117157
of O 0 0.01652917079627514
Amish O 1 0.9999725818634033
/ O 1 0.9896090030670166
Mennonite O 0 0.06059547886252403
and O 0 0.0038825359661132097
Irish O 0 0.01508879754692316
English O 0 0.011562197469174862
backgrounds O 0 0.018290819600224495
. O 0 0.011519952677190304

Additional O 0 0.01817162334918976
mutations O 0 0.009604865685105324
were O 0 0.002298435429111123
observed O 0 0.0033716957550495863
in O 0 0.0029371168930083513
Japanese O 0 0.014211056753993034
, O 0 0.004031979478895664
Utah O 0 0.022281447425484657
Mormon O 0 0.02101348154246807
, O 0 0.0029081907123327255
and O 0 0.002415180904790759
African O 0 0.015763670206069946
American O 0 0.021956609562039375
patients O 1 0.9998995065689087
. O 0 0.016825472936034203

These O 0 0.0070591638796031475
assays O 0 0.015140039846301079
should O 0 0.0029673706740140915
facilitate O 0 0.007427694741636515
screening O 0 0.010753386653959751
for O 0 0.004383930470794439
A B-Disease 1 0.9989294409751892
- I-Disease 1 0.9997842907905579
T I-Disease 1 0.9999977350234985
heterozygotes O 0 0.04508396238088608
in O 0 0.0025905307848006487
the O 0 0.0030450932681560516
populations O 0 0.00488688051700592
studied O 0 0.009731240570545197
. O 0 0.004510764963924885
. O 0 0.009281526319682598

The O 0 0.022552845999598503
von B-Disease 1 0.9979088306427002
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999992847442627
Lindau I-Disease 1 1.0
tumor I-Disease 1 1.0
suppressor O 1 0.9985730648040771
gene O 0 0.007587905507534742
is O 0 0.001909437938593328
required O 0 0.0020337027963250875
for O 0 0.003465390531346202
cell O 0 0.014532752335071564
cycle O 0 0.020938759669661522
exit O 0 0.02894400618970394
upon O 0 0.01890803873538971
serum O 1 0.965704083442688
withdrawal O 0 0.042986396700143814
. O 0 0.014252780936658382

The O 0 0.017206517979502678
inactivation O 0 0.05316946655511856
of O 0 0.009353557601571083
the O 0 0.013083266094326973
von B-Disease 1 0.9997217059135437
Hippel I-Disease 1 0.9999998807907104
- I-Disease 1 0.9993911981582642
Lindau I-Disease 1 1.0
( I-Disease 0 0.06596041470766068
VHL I-Disease 1 1.0
) I-Disease 0 0.04907407984137535
tumor I-Disease 1 1.0
suppressor O 1 0.9999687671661377
gene O 0 0.02974381484091282
predisposes O 0 0.19047589600086212
affected O 0 0.005870940163731575
individuals O 0 0.0013832456897944212
to O 0 0.0019206462893635035
the O 0 0.0056519461795687675
human O 1 0.9992951154708862
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.4921436607837677
is O 0 0.0038400182966142893
associated O 0 0.0035341745242476463
with O 0 0.002459529787302017
sporadic B-Disease 1 0.9999372959136963
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 1 0.9999996423721313
RCC B-Disease 1 1.0
) O 0 0.013002614490687847
and O 0 0.005995451472699642
brain B-Disease 1 0.999975323677063
hemangioblastomas I-Disease 1 0.9999988079071045
. O 0 0.017964130267500877

VHL O 1 0.9999995231628418
- O 0 0.06896303594112396
negative O 0 0.024629199877381325
786 O 1 0.999232292175293
- O 0 0.11732961982488632
0 O 0 0.050588540732860565
RCC B-Disease 1 0.9999998807907104
cells O 0 0.01109054870903492
are O 0 0.0021712149027734995
tumorigenic O 0 0.074187733232975
in O 0 0.00784904696047306
nude O 1 0.9441262483596802
mice O 0 0.01699795573949814
which O 0 0.001700170454569161
is O 0 0.0025586087722331285
suppressed O 0 0.011177809908986092
by O 0 0.0018004784360527992
the O 0 0.006288308184593916
reintroduction O 0 0.05159497261047363
of O 0 0.022123102098703384
VHL B-Disease 1 1.0
. O 0 0.023643266409635544

Remarkably O 0 0.06010258197784424
, O 0 0.006880879867821932
this O 0 0.0030777286738157272
occurs O 0 0.005646509118378162
without O 0 0.003336210735142231
affecting O 0 0.010416877456009388
the O 0 0.00681812409311533
growth O 0 0.007794138975441456
rate O 0 0.004720019642263651
and O 0 0.0023036254569888115
cell O 0 0.010866192169487476
cycle O 0 0.01167675293982029
profile O 0 0.006496813613921404
of O 0 0.0030603776685893536
these O 0 0.0022419015876948833
cells O 0 0.006513603497296572
in O 0 0.004538422916084528
culture O 0 0.018009528517723083
. O 0 0.009494292549788952

The O 0 0.026237761601805687
786 O 1 0.9998021721839905
- O 0 0.05513148382306099
0 O 0 0.02137465588748455
cell O 0 0.010828045196831226
line O 0 0.005221438594162464
, O 0 0.002245907438918948
like O 0 0.003373035928234458
many O 0 0.004518012050539255
cancer B-Disease 1 1.0
cells O 0 0.018478231504559517
, O 0 0.004396815784275532
fails O 0 0.01042876485735178
to O 0 0.0023183554876595736
exit O 0 0.012454847805202007
the O 0 0.005257978104054928
cell O 0 0.012313509359955788
cycle O 0 0.017869604751467705
upon O 0 0.014127693139016628
serum O 1 0.9678872227668762
withdrawal O 0 0.03493760526180267
. O 0 0.010525384917855263

Here O 0 0.01563950814306736
, O 0 0.004703874699771404
it O 0 0.0014847478596493602
is O 0 0.0019438009476289153
shown O 0 0.002739701187238097
that O 0 0.001349826343357563
reintroduction O 0 0.01451776921749115
of O 0 0.003679288551211357
the O 0 0.005817857570946217
wild O 0 0.016709795221686363
- O 0 0.03234526515007019
type O 0 0.035272952169179916
VHL B-Disease 1 0.9999997615814209
gene O 0 0.015719711780548096
restores O 0 0.030079921707510948
the O 0 0.0038573085330426693
ability O 0 0.004000021610409021
of O 0 0.009788229130208492
VHL O 1 1.0
- O 1 0.9956515431404114
negative O 0 0.045526351779699326
RCC B-Disease 1 1.0
cancer I-Disease 1 1.0
cells O 0 0.010238130576908588
to O 0 0.0025370195508003235
exit O 0 0.010031511075794697
the O 0 0.004168412648141384
cell O 0 0.009797504171729088
cycle O 0 0.010265437886118889
and O 0 0.0029426643159240484
enter O 0 0.02494109980762005
G0 O 1 1.0
/ O 1 0.9934059381484985
quiescence O 1 0.9763342142105103
in O 0 0.011044908314943314
low O 0 0.03755456581711769
serum O 1 0.7781339883804321
. O 0 0.013528641313314438

Both O 0 0.023985860869288445
VHL O 1 1.0
- O 0 0.04747321084141731
positive O 0 0.012233919464051723
and O 0 0.008821154944598675
VHL O 1 1.0
- O 1 0.9191228151321411
negative O 0 0.03436920419335365
RCC B-Disease 1 1.0
cells O 0 0.019048457965254784
exit O 0 0.016138918697834015
the O 0 0.005974504631012678
cell O 0 0.012411931529641151
cycle O 0 0.012058288790285587
by O 0 0.002824787748977542
contact O 0 0.018562370911240578
inhibition O 0 0.050224851816892624
. O 0 0.01284121721982956

The O 0 0.0344829224050045
cyclin O 1 0.9995137453079224
- O 0 0.06240992620587349
dependent O 0 0.027080511674284935
kinase O 0 0.059191010892391205
inhibitor O 0 0.2641654908657074
, O 0 0.011319655925035477
p27 O 1 0.9992608428001404
, O 0 0.010071149095892906
accumulates O 0 0.058899108320474625
upon O 0 0.017322394996881485
serum O 1 0.9944463968276978
withdrawal O 0 0.014428242109715939
, O 0 0.0023485312703996897
only O 0 0.0009303365368396044
in O 0 0.0014968571485951543
the O 0 0.0030285518150776625
presence O 0 0.005082104820758104
of O 0 0.008804910816252232
VHL B-Disease 1 1.0
, O 0 0.004910041578114033
as O 0 0.0024673715233802795
a O 0 0.0023542498238384724
result O 0 0.002344354521483183
of O 0 0.0034941397607326508
the O 0 0.007317369803786278
stabilization O 0 0.09984468668699265
of O 0 0.0076835122890770435
the O 0 0.012887237593531609
protein O 0 0.01929480768740177
. O 0 0.00777846435084939

We O 0 0.00582364946603775
propose O 0 0.008493723347783089
that O 0 0.0013306576292961836
the O 0 0.0028183776885271072
loss O 0 0.008984969928860664
of O 0 0.007349235471338034
wild O 0 0.025610070675611496
- O 0 0.06475028395652771
type O 0 0.04757224768400192
VHL B-Disease 1 0.9999998807907104
gene O 0 0.007829107344150543
results O 0 0.0024019284173846245
in O 0 0.00165743927937001
a O 0 0.0024447888135910034
specific O 0 0.004159625619649887
cellular O 0 0.021627265959978104
defect O 1 0.999981164932251
in O 0 0.022129669785499573
serum O 1 1.0
- O 0 0.47362852096557617
dependent O 0 0.011148995719850063
growth O 0 0.005379646085202694
control O 0 0.004742070566862822
, O 0 0.003125142538920045
which O 0 0.00292179174721241
may O 0 0.008514832705259323
initiate O 0 0.34299206733703613
tumor B-Disease 1 0.9999997615814209
formation O 1 0.6127191781997681
. O 0 0.016728600487113

This O 0 0.007237263955175877
is O 0 0.005727625451982021
corrected O 0 0.020741315558552742
by O 0 0.001940512447617948
the O 0 0.004479595925658941
reintroduction O 0 0.02256627194583416
of O 0 0.0066488743759691715
wild O 0 0.017888134345412254
- O 0 0.031430065631866455
type O 0 0.05016980692744255
VHL B-Disease 1 1.0
, O 0 0.013598533347249031
implicating O 1 0.9999524354934692
VHL B-Disease 1 1.0
as O 0 0.007605800870805979
the O 0 0.006976366974413395
first O 0 0.016927897930145264
tumor B-Disease 1 0.9999998807907104
suppressor O 1 0.6767318248748779
involved O 0 0.003724917070940137
in O 0 0.002560325199738145
the O 0 0.003974854946136475
regulation O 0 0.0061900559812784195
of O 0 0.005719688255339861
cell O 0 0.021041354164481163
cycle O 0 0.020036421716213226
exit O 0 0.015619713813066483
, O 0 0.0025206543505191803
which O 0 0.001250460627488792
is O 0 0.0016816684510558844
consistent O 0 0.0038908342830836773
with O 0 0.0014840366784483194
its O 0 0.0035739969462156296
gatekeeper O 1 0.9999175071716309
function O 0 0.007328856736421585
in O 0 0.004688782151788473
the O 0 0.013615965843200684
kidney O 1 1.0
. O 0 0.01237762812525034
. O 0 0.01119159534573555

Piebaldism B-Disease 1 0.9999998807907104
with O 0 0.02595670521259308
deafness B-Disease 1 1.0
: O 0 0.016662022098898888
molecular O 0 0.00903109461069107
evidence O 0 0.0032596145756542683
for O 0 0.0023579616099596024
an O 0 0.004100074991583824
expanded O 0 0.16537582874298096
syndrome O 1 1.0
. O 0 0.0257907472550869

In O 0 0.006954558193683624
a O 0 0.0044982535764575005
South O 0 0.008284433744847775
African O 0 0.00872976053506136
girl O 0 0.017491772770881653
of O 0 0.00659521808847785
Xhosa O 1 0.9999984502792358
stock O 0 0.015826066955924034
with O 0 0.004484823904931545
severe O 1 1.0
piebaldism B-Disease 1 1.0
and O 1 0.9931787252426147
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 1 0.8890652656555176
identified O 0 0.009984993375837803
a O 0 0.004536880645900965
novel O 0 0.014344059862196445
missense O 0 0.025281794369220734
substitution O 0 0.011078239418566227
at O 0 0.0049943639896810055
a O 0 0.003692428581416607
highly O 0 0.008072438649833202
conserved O 0 0.011819918639957905
residue O 0 0.021036168560385704
in O 0 0.004193299915641546
the O 0 0.007758237887173891
intracellular O 0 0.04112428054213524
kinase O 0 0.021946929395198822
domain O 0 0.006042236462235451
of O 0 0.004419129341840744
the O 0 0.011558138765394688
KIT O 1 0.9999996423721313
proto O 1 0.9999954700469971
- O 0 0.2151968628168106
oncogene O 1 0.9972131848335266
, O 0 0.01062620896846056
R796G O 1 0.5977330207824707
. O 0 0.014885582029819489

Though O 0 0.035362135618925095
auditory B-Disease 1 0.9885086417198181
anomalies I-Disease 1 0.9646554589271545
have O 0 0.002807698445394635
been O 0 0.002734064357355237
observed O 0 0.003876804606989026
in O 0 0.0034348852932453156
mice O 0 0.008572515100240707
with O 0 0.0019721256103366613
dominant O 0 0.017027175053954124
white O 0 0.024744927883148193
spotting O 1 0.9995249509811401
( O 0 0.02668849751353264
W O 1 0.9999867677688599
) O 0 0.005098395515233278
due O 0 0.004471877124160528
to O 0 0.005293546710163355
KIT O 1 1.0
mutations O 0 0.0959545448422432
, O 0 0.011153738014400005
deafness B-Disease 1 1.0
is O 0 0.007230798713862896
not O 0 0.0021682025399059057
typical O 0 0.007273801602423191
in O 0 0.0053412290289998055
human O 0 0.01493777148425579
piebaldism B-Disease 1 0.9996918439865112
. O 0 0.015134857967495918

Thus O 0 0.01206574309617281
, O 0 0.0044428082183003426
the O 0 0.005231191404163837
occurrence O 0 0.04174497351050377
of O 1 0.8796834945678711
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 1 0.9992392063140869
this O 0 0.0079086534678936
patient O 1 0.9919102787971497
extends O 0 0.01555250957608223
considerably O 0 0.0060478514060378075
the O 0 0.0030213072896003723
phenotypic O 0 0.014288285747170448
range O 0 0.004849908873438835
of O 0 0.006607994437217712
piebaldism B-Disease 1 0.9200642704963684
due O 0 0.011136176064610481
to O 0 0.007926205173134804
KIT O 1 0.9999954700469971
gene O 0 0.012145934626460075
mutation O 0 0.006262891925871372
in O 0 0.0026654046960175037
humans O 0 0.004532477352768183
and O 0 0.004130055662244558
tightens O 1 0.5148764848709106
the O 0 0.006599386688321829
clinical O 1 0.9091976284980774
similarity O 0 0.01618022844195366
between O 0 0.006354666780680418
piebaldism B-Disease 1 0.8549318909645081
and O 0 0.0017913456540554762
the O 0 0.0022813156247138977
various O 0 0.002362842671573162
forms O 0 0.008473705500364304
of O 1 0.9996552467346191
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.2954332232475281
. O 0 0.016496645286679268

Cycloheximide O 1 0.9910112619400024
facilitates O 0 0.03329293802380562
the O 0 0.007353493012487888
identification O 0 0.00912607740610838
of O 0 0.007409576326608658
aberrant O 0 0.034184522926807404
transcripts O 0 0.013792173005640507
resulting O 0 0.005418440792709589
from O 0 0.002294910838827491
a O 0 0.0036207768134772778
novel O 0 0.020765794441103935
splice O 0 0.36202844977378845
- O 0 0.01477590948343277
site O 0 0.008131290785968304
mutation O 0 0.0060536619275808334
in O 0 0.0034319807309657335
COL17A1 O 1 0.9997099041938782
in O 0 0.0037775340024381876
a O 0 0.005048871040344238
patient O 1 0.9545770287513733
with O 0 0.00681014358997345
generalized O 1 0.9999996423721313
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
. O 0 0.06098901480436325

Patients O 1 0.9939980506896973
with O 0 0.014421220868825912
generalized O 1 0.9999998807907104
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
often O 0 0.01662139967083931
show O 0 0.01329557690769434
decreased O 0 0.015621254220604897
expression O 0 0.007949371822178364
of O 0 0.009509308263659477
type O 1 0.9999551773071289
XVII O 1 1.0
collagen O 1 1.0
, O 0 0.007809408940374851
a O 0 0.007633694447577
transmembrane O 0 0.05481628701090813
hemidesmosomal O 1 0.6656175851821899
protein O 0 0.009981104172766209
encoded O 0 0.005218030884861946
by O 0 0.0037925075739622116
COL17A1 O 1 0.9991181492805481
. O 0 0.014033693820238113

This O 0 0.0056473976001143456
report O 0 0.00501636415719986
documents O 0 0.004815816879272461
a O 0 0.004802770912647247
novel O 0 0.024319618940353394
splice O 1 0.8376697897911072
- O 0 0.02032308466732502
site O 0 0.010861622169613838
mutation O 0 0.006596099119633436
in O 0 0.003435188438743353
COL17A1 O 1 0.9993916749954224
in O 0 0.00409809360280633
a O 0 0.0056701903231441975
patient O 1 0.946307361125946
with O 0 0.007431309204548597
generalized O 1 0.9999997615814209
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.013666125945746899
and O 0 0.0033054908271878958
applies O 0 0.006676247343420982
a O 0 0.0028824482578784227
new O 0 0.003074381733313203
methodology O 0 0.008042573928833008
to O 0 0.0022013538982719183
define O 0 0.007202641107141972
and O 0 0.0025106417015194893
characterize O 0 0.021703913807868958
the O 0 0.008457771502435207
resulting O 0 0.016648482531309128
mRNA O 0 0.034907255321741104
splice O 0 0.08253724873065948
variants O 0 0.02322729304432869
. O 0 0.010226313024759293

Mutational O 0 0.11484258621931076
analysis O 0 0.00785619392991066
of O 0 0.008343656547367573
COL17A1 O 1 0.9994376301765442
identified O 0 0.010017305612564087
a O 0 0.006160382647067308
maternally O 0 0.4780838191509247
inherited O 1 0.9999979734420776
G O 1 0.999997615814209
- O 0 0.03178388625383377
to O 0 0.00626031681895256
- O 0 0.0344080924987793
T O 1 0.8724203705787659
transversion O 0 0.0421731173992157
at O 0 0.005464887712150812
the O 0 0.004208048339933157
- O 0 0.00922616757452488
1 O 0 0.005311106331646442
position O 0 0.004663159139454365
of O 0 0.005528237204998732
exon O 0 0.06862661242485046
32 O 0 0.022386664524674416
. O 0 0.009260634891688824

This O 0 0.012311700731515884
acceptor O 0 0.08330178260803223
splice O 1 0.9919824004173279
- O 0 0.02568676322698593
site O 0 0.012028695084154606
mutation O 0 0.006032141391187906
led O 0 0.0037074023857712746
to O 0 0.0019419759046286345
the O 0 0.0037805908359587193
formation O 0 0.012229316867887974
of O 0 0.00877525843679905
aberrant O 0 0.050415512174367905
transcripts O 0 0.01696012169122696
present O 0 0.006077970843762159
at O 0 0.009491709992289543
extremely O 0 0.013637400232255459
low O 0 0.018741756677627563
levels O 0 0.01654336042702198
. O 0 0.008855688385665417

Based O 0 0.00840657576918602
on O 0 0.004319687373936176
our O 0 0.0032216599211096764
recent O 0 0.0032127362210303545
finding O 0 0.006647469941526651
that O 0 0.003840510966256261
cycloheximide O 1 0.997218132019043
stabilized O 1 0.9994015693664551
mutant O 0 0.07519365847110748
COL17A1 O 1 0.9990649819374084
transcripts O 0 0.021146906539797783
in O 0 0.007958556525409222
keratinocytes O 0 0.05060918629169464
homozygous O 0 0.014483964070677757
for O 0 0.0025905147194862366
a O 0 0.006556050851941109
frameshift O 0 0.29459553956985474
mutation O 0 0.009707275778055191
, O 0 0.0032605163287371397
the O 0 0.003791327588260174
effects O 0 0.00920743029564619
of O 0 0.007077101618051529
the O 0 0.013320358470082283
splice O 1 0.997861921787262
- O 0 0.019715487957000732
site O 0 0.009451509453356266
mutation O 0 0.005780145525932312
on O 0 0.003691323334351182
splicing O 0 0.013024460524320602
of O 0 0.007485861424356699
COL17A1 O 1 0.9992268085479736
transcripts O 0 0.015264210291206837
were O 0 0.002782636322081089
determined O 0 0.005366344004869461
using O 0 0.004706154111772776
reverse O 0 0.032832566648721695
transcriptase O 0 0.3964088559150696
polymerase O 0 0.03897394239902496
chain O 0 0.01653818041086197
reaction O 0 0.0057077556848526
of O 0 0.00435610068961978
total O 0 0.007004242856055498
RNA O 0 0.015636073425412178
from O 0 0.00430515268817544
keratinocytes O 0 0.04273385554552078
incubated O 0 0.02627907134592533
for O 0 0.00535612553358078
2 O 0 0.016376780346035957
. O 0 0.00991491973400116

5 O 0 0.027543865144252777
h O 0 0.02965686097741127
in O 0 0.0036145688500255346
the O 0 0.003796918783336878
presence O 0 0.004510859027504921
or O 0 0.002572215860709548
absence O 0 0.00834050215780735
of O 0 0.007138330489397049
10 O 0 0.014151616021990776
microg O 1 0.9947625994682312
cycloheximide O 1 0.9824509024620056
per O 0 0.015751926228404045
ml O 0 0.1153222844004631
. O 0 0.012171327136456966

Using O 0 0.00645715044811368
this O 0 0.0020740535110235214
approach O 0 0.004379532765597105
, O 0 0.0029322148766368628
an O 0 0.0044318814761936665
abnormally O 1 0.6508508324623108
spliced O 0 0.04432984068989754
transcript O 0 0.024001942947506905
was O 0 0.007802566513419151
identified O 0 0.004358897916972637
that O 0 0.0008950978517532349
contains O 0 0.002352203242480755
an O 0 0.002258510095998645
extra O 0 0.0074250055477023125
264 O 0 0.02457072027027607
bases O 0 0.007996032945811749
upstream O 0 0.0145285464823246
from O 0 0.0046411012299358845
exon O 0 0.0377664752304554
32 O 0 0.010640607215464115
, O 0 0.003150534350425005
resulting O 0 0.005872468464076519
in O 0 0.0047566709108650684
a O 0 0.010846452787518501
premature O 1 0.7856165766716003
termination O 0 0.14854280650615692
codon O 0 0.049909092485904694
27 O 0 0.021244874224066734
bp O 0 0.021626368165016174
downstream O 0 0.011331239715218544
from O 0 0.002571817021816969
the O 0 0.006951028946787119
cryptic O 0 0.07055065780878067
splice O 0 0.2615697383880615
site O 0 0.02607211098074913
. O 0 0.012131994590163231

Three O 0 0.007552654016762972
other O 0 0.004927272908389568
splice O 0 0.052535269409418106
variants O 0 0.009647008962929249
, O 0 0.0021457653492689133
including O 0 0.0018289925064891577
one O 0 0.002316278638318181
derived O 0 0.003939889837056398
from O 0 0.0022273126523941755
the O 0 0.004701927769929171
skipping O 0 0.0209242794662714
of O 0 0.00827493891119957
exon O 0 0.05661755055189133
32 O 0 0.011130928061902523
, O 0 0.002830544952303171
were O 0 0.0024060795549303293
also O 0 0.005029432941228151
identified O 0 0.01521750632673502
. O 0 0.010897587053477764

These O 0 0.005306352861225605
results O 0 0.005566490348428488
indicate O 0 0.0059210071340203285
the O 0 0.004168183542788029
usefulness O 0 0.019389677792787552
of O 0 0.008921024389564991
cycloheximide O 1 0.9999986886978149
treatment O 1 0.9997115731239319
in O 0 0.006521763280034065
evaluating O 0 0.020258694887161255
the O 0 0.006827963050454855
abnormal O 0 0.01906522549688816
processing O 0 0.006494647357612848
of O 0 0.004868500400334597
mRNA O 0 0.00873246043920517
due O 0 0.004583165980875492
to O 0 0.004526018630713224
splice O 0 0.31114906072616577
- O 0 0.01651579700410366
site O 0 0.010803028009831905
mutations O 0 0.007837506011128426
, O 0 0.0029234925750643015
because O 0 0.003323448123410344
( O 0 0.007515978533774614
i O 0 0.006970891263335943
) O 0 0.005664133932441473
aberrant O 0 0.02848711423575878
splicing O 0 0.01660475879907608
often O 0 0.0037396494299173355
generates O 0 0.009057874791324139
a O 0 0.008119807578623295
premature O 0 0.1091938242316246
termination O 0 0.42879536747932434
codon O 0 0.034177880734205246
, O 0 0.006283455528318882
( O 0 0.00852467305958271
ii O 1 0.9432812929153442
) O 0 0.004866119474172592
transcripts O 0 0.010637255385518074
with O 0 0.0042360201478004456
premature O 1 0.7998611927032471
termination O 1 0.8978056907653809
codons O 0 0.03331980109214783
can O 0 0.0024376404471695423
occur O 0 0.0027159613091498613
at O 0 0.006554234307259321
low O 0 0.01271654013544321
or O 0 0.007372410036623478
undetectable O 1 0.9199218153953552
levels O 0 0.011896342039108276
due O 0 0.007327920291572809
to O 0 0.004770479165017605
nonsense O 0 0.043320804834365845
- O 0 0.02276037447154522
mediated O 0 0.023357124999165535
mRNA O 0 0.01566554419696331
decay O 0 0.015509143471717834
, O 0 0.0030433624051511288
and O 0 0.0030278435442596674
( O 0 0.009241937659680843
iii O 1 0.9981100559234619
) O 0 0.0049166749231517315
the O 0 0.003433103207498789
levels O 0 0.004875442944467068
of O 0 0.0026898880023509264
these O 0 0.0018139888998121023
transcripts O 0 0.010574000887572765
can O 0 0.001545237610116601
be O 0 0.0012574457796290517
increased O 0 0.0032260289881378412
by O 0 0.00360311521217227
cycloheximide O 1 0.982910692691803
. O 0 0.015210389159619808

A O 0 0.033826280385255814
deletion O 0 0.05065134912729263
mutation O 0 0.014181174337863922
in O 0 0.006849584169685841
COL17A1 O 1 0.999803364276886
in O 0 0.004901813343167305
five O 0 0.004332863260060549
Austrian O 0 0.02930328994989395
families O 0 0.00678521953523159
with O 0 0.005784898530691862
generalized O 1 0.9999995231628418
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
represents O 0 0.04683273658156395
propagation O 0 0.024690404534339905
of O 0 0.006922655738890171
an O 0 0.007653598673641682
ancestral O 0 0.34559983015060425
allele O 0 0.04011336714029312
. O 0 0.011854679323732853

Patients O 1 0.998304009437561
with O 0 0.013642378151416779
generalized O 1 1.0
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.014793758280575275
a O 0 0.008385250344872475
usually O 0 0.0064076995477080345
nonlethal O 0 0.04027611017227173
form O 0 0.008105380460619926
of O 0 0.020771168172359467
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.009520003572106361
have O 0 0.0030144560150802135
generalized O 0 0.08155864477157593
blistering B-Disease 1 0.9999749660491943
, O 0 0.30031126737594604
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.9882701635360718
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 1 0.9967634677886963
and O 1 0.9946542978286743
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 0.34998369216918945

Skin B-Disease 1 1.0
fragility I-Disease 1 1.0
in O 0 0.010456941090524197
most O 0 0.00386068900115788
cases O 0 0.0048420606181025505
is O 0 0.002783596981316805
due O 0 0.003917435649782419
to O 0 0.0023371009156107903
mutations O 0 0.003233236027881503
in O 0 0.0016178465448319912
the O 0 0.0036563638132065535
gene O 0 0.007832757197320461
encoding O 0 0.013630960136651993
type O 0 0.04574572667479515
XVII O 1 1.0
collagen O 1 1.0
( O 1 0.7896646857261658
COL17A1 O 1 0.9999998807907104
) O 0 0.016521835699677467
. O 0 0.008488004095852375

Recently O 0 0.028095262125134468
, O 0 0.004493535030633211
we O 0 0.0018397158710286021
reported O 0 0.004418038297444582
five O 0 0.002886392641812563
Austrian O 0 0.03703536465764046
families O 0 0.006622107699513435
with O 0 0.005387658253312111
generalized O 1 0.9999991655349731
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 0.02422790788114071
share O 0 0.00886719673871994
the O 0 0.007166191004216671
same O 0 0.00886018481105566
COL17A1 O 1 0.9999997615814209
mutation O 0 0.029965901747345924
. O 0 0.010445283725857735

Affected O 0 0.020962737500667572
individuals O 0 0.002895916113629937
in O 0 0.0031634310726076365
three O 0 0.002237945795059204
families O 0 0.0027195983566343784
are O 0 0.0010737399570643902
homozygous O 0 0.010855588130652905
for O 0 0.004045183304697275
4003delTC O 1 0.9991855025291443
, O 0 0.004579147789627314
whereas O 0 0.005257015582174063
those O 0 0.0011710418621078134
in O 0 0.0019003590568900108
two O 0 0.001553663401864469
others O 0 0.0034684038255363703
are O 0 0.0023550984915345907
compound O 0 0.04992670938372612
heterozygotes O 1 0.9970498085021973
. O 0 0.015301079489290714

To O 0 0.007093488704413176
determine O 0 0.00623910641297698
if O 0 0.002001684857532382
the O 0 0.0033502636943012476
occurrence O 0 0.016166867688298225
of O 0 0.008096057921648026
4003delTC O 1 0.9980083107948303
in O 0 0.00426838593557477
these O 0 0.002074746647849679
unrelated O 0 0.012082231231033802
families O 0 0.007728744763880968
signifies O 0 0.027180450037121773
propagation O 0 0.014478015713393688
of O 0 0.0048536923713982105
an O 0 0.005234685726463795
ancestral O 0 0.15944577753543854
allele O 0 0.01829608716070652
or O 0 0.004626530222594738
a O 0 0.009008735418319702
mutational O 1 0.9981535077095032
hot O 0 0.2647700011730194
spot O 0 0.030952302739024162
, O 0 0.006083955056965351
haplotypes O 0 0.023317787796258926
were O 0 0.0027303409297019243
determined O 0 0.0049770488403737545
for O 0 0.0030112022068351507
polymorphisms O 0 0.01554256770759821
both O 0 0.0022275608498603106
within O 0 0.0034290379844605923
and O 0 0.00729354377835989
flanking O 1 0.9999703168869019
COL17A1 O 1 1.0
. O 0 0.029598424211144447

Five O 0 0.02462804690003395
intragenic O 0 0.371296226978302
polymorphisms O 0 0.030068984255194664
were O 0 0.0030763025861233473
chosen O 0 0.004628172144293785
based O 0 0.00272881961427629
on O 0 0.003901650896295905
their O 0 0.00522515969350934
informativeness O 1 0.9984270334243774
. O 0 0.014098592102527618

One O 0 0.006231589708477259
of O 0 0.003955948166549206
these O 0 0.0013079309137538075
, O 0 0.0020333477295935154
not O 0 0.000990813598036766
previously O 0 0.003997339867055416
reported O 0 0.004741121083498001
, O 0 0.0027211951091885567
was O 0 0.009757394902408123
2988 O 1 0.9941060543060303
A O 0 0.01057179644703865
or O 0 0.0048042843118309975
C O 0 0.020181816071271896
that O 0 0.0014823221135884523
introduces O 0 0.010586060583591461
a O 0 0.002556509105488658
new O 0 0.0025637687649577856
restriction O 0 0.005960935726761818
site O 0 0.0076574524864554405
for O 0 0.006631750613451004
Eco0109 O 1 0.9957112073898315
I O 0 0.03831830248236656
. O 0 0.0118507519364357

All O 0 0.008130751550197601
the O 0 0.01282070018351078
4003delTC O 1 0.9957129955291748
alleles O 0 0.022781318053603172
showed O 0 0.008226132951676846
the O 0 0.004101571161299944
same O 0 0.003321594325825572
haplotype O 0 0.015561819076538086
for O 0 0.002221912844106555
these O 0 0.0017279339954257011
five O 0 0.005873267538845539
polymorphic O 0 0.05986712872982025
markers O 0 0.06132800504565239
. O 0 0.014361714012920856

Fourteen O 0 0.07348905503749847
microsatellite O 0 0.12463963776826859
polymorphisms O 0 0.02852548286318779
were O 0 0.002751908265054226
selected O 0 0.003801108803600073
based O 0 0.0022446936927735806
on O 0 0.0028284178115427494
their O 0 0.002547619165852666
high O 0 0.014071140438318253
heterozygosity O 1 0.8900303244590759
and O 0 0.003047091653570533
their O 0 0.0019442507764324546
location O 0 0.006658146623522043
within O 0 0.005163197871297598
10q23 O 1 0.9974935054779053
- O 0 0.05839475989341736
q25 O 1 0.9865601062774658
near O 0 0.05636841803789139
COL17A1 O 1 0.999954342842102
. O 0 0.019923804327845573

Three O 0 0.007319544907659292
families O 0 0.008171611465513706
shared O 0 0.01591947302222252
microsatellite O 0 0.4670063257217407
polymorphisms O 0 0.04116728529334068
covering O 0 0.019655048847198486
at O 0 0.010168831795454025
most O 0 0.003662967123091221
19 O 0 0.013879484497010708
cM O 0 0.018381137400865555
, O 0 0.00370264844968915
whereas O 0 0.005519827827811241
the O 0 0.003507094457745552
others O 0 0.003594453213736415
shared O 0 0.005729350261390209
smaller O 0 0.003387866774573922
regions O 0 0.004870325792580843
consistent O 0 0.009103162214159966
with O 0 0.0031441315077245235
cross O 0 0.016698116436600685
- O 0 0.011567587964236736
over O 0 0.00224012928083539
events O 0 0.003426642157137394
during O 0 0.004463601857423782
passage O 0 0.005510319024324417
of O 0 0.003362869145348668
this O 0 0.0018214898882433772
mutation O 0 0.004655675496906042
through O 0 0.0021304311230778694
several O 0 0.0030684086959809065
generations O 0 0.01717992126941681
. O 0 0.010826462879776955

These O 0 0.00829236675053835
results O 0 0.007956106215715408
indicate O 0 0.007722289767116308
that O 0 0.003142840461805463
4003delTC O 0 0.05755320563912392
occurs O 0 0.004280051216483116
on O 0 0.002422678517177701
a O 0 0.00356032932177186
single O 0 0.0057845693081617355
ancestral O 0 0.03857175633311272
allele O 0 0.020969711244106293
. O 0 0.00412248820066452
. O 0 0.007231856230646372

The O 0 0.028033416718244553
haptoglobin O 1 0.9996398687362671
- O 0 0.042539581656455994
gene O 0 0.013065655715763569
deletion O 0 0.01806277595460415
responsible O 0 0.00988775584846735
for O 0 0.008719351142644882
anhaptoglobinemia B-Disease 1 0.9999628067016602
. O 0 0.015201392583549023

We O 0 0.006191974505782127
have O 0 0.0017030523158609867
found O 0 0.0029721034225076437
an O 0 0.0032025426626205444
allelic O 0 0.04861197620630264
deletion O 0 0.022395871579647064
of O 0 0.006891843397170305
the O 0 0.016825789585709572
haptoglobin O 1 0.999997615814209
( O 0 0.01790774054825306
Hp O 1 0.5200912356376648
) O 0 0.005339764058589935
gene O 0 0.0030152201652526855
from O 0 0.001073673483915627
an O 0 0.0019147304119542241
individual O 0 0.0034864344634115696
with O 0 0.005100282374769449
anhaptoglobinemia B-Disease 1 0.9998942613601685
. O 0 0.01688190922141075

The O 0 0.0246913842856884
Hp O 0 0.4512360394001007
gene O 0 0.015042219310998917
cluster O 0 0.011261357925832272
consists O 0 0.006448260974138975
of O 0 0.005832509603351355
coding O 0 0.022292647510766983
regions O 0 0.003666027681902051
of O 0 0.0033353595063090324
the O 0 0.008012911304831505
alpha O 0 0.025327768176794052
chain O 0 0.012882621958851814
and O 0 0.0033738217316567898
beta O 0 0.017333876341581345
chain O 0 0.00954130757600069
of O 0 0.005859058350324631
the O 0 0.013140927068889141
haptoglobin O 1 0.9998425245285034
gene O 0 0.017108973115682602
( O 0 0.008014305494725704
Hp O 0 0.02741740271449089
) O 0 0.0026035644114017487
and O 0 0.0011863099643960595
of O 0 0.003721203189343214
the O 0 0.009708852507174015
alpha O 0 0.028955720365047455
chain O 0 0.012219292111694813
and O 0 0.0032238909043371677
beta O 0 0.015504136681556702
chain O 0 0.009978994727134705
of O 0 0.005635336507111788
the O 0 0.013672992587089539
haptoglobin O 1 0.9999604225158691
- O 0 0.02897786535322666
related O 0 0.010983201675117016
gene O 0 0.013297146186232567
( O 0 0.01005745679140091
Hpr O 1 0.9993213415145874
) O 0 0.004223802592605352
, O 0 0.0019246414303779602
in O 0 0.0023897336795926094
tandem O 0 0.012338215485215187
from O 0 0.002786512253805995
the O 0 0.005192037671804428
5 O 0 0.009898297488689423
side O 0 0.012050054967403412
. O 0 0.009372411295771599

Southern O 0 0.06651921570301056
blot O 1 0.9795758128166199
and O 0 0.012116104364395142
PCR O 0 0.04563453420996666
analyses O 0 0.009344834834337234
have O 0 0.001386794843710959
indicated O 0 0.003942286130040884
that O 0 0.0008015636703930795
the O 0 0.001901493757031858
individual O 0 0.0019057192839682102
with O 0 0.0023905003909021616
anhaptoglobinemia B-Disease 1 0.9971315860748291
was O 0 0.009678888134658337
homozygous O 0 0.008822710253298283
for O 0 0.002278044819831848
the O 0 0.004889870062470436
gene O 0 0.008879919536411762
deletion O 0 0.011849049478769302
and O 0 0.0018612445564940572
that O 0 0.0015404247678816319
the O 0 0.004685018677264452
gene O 0 0.00810824055224657
deletion O 0 0.012311114929616451
was O 0 0.00489781191572547
included O 0 0.0029017142951488495
at O 0 0.004505936987698078
least O 0 0.0016984588000923395
from O 0 0.0018475200049579144
the O 0 0.004337886348366737
promoter O 1 0.5630189180374146
region O 0 0.009434248320758343
of O 0 0.00863856915384531
Hp O 1 0.9663277268409729
to O 0 0.010322991758584976
Hpr O 1 0.9992772936820984
alpha O 0 0.016098560765385628
but O 0 0.000954672519583255
not O 0 0.0008371968287974596
to O 0 0.0033651008270680904
Hpr O 1 0.9972785115242004
beta O 0 0.05066920071840286
( O 0 0.018133854493498802
Hpdel O 1 0.9993170499801636
) O 0 0.012256412766873837
. O 0 0.008208801038563251

In O 0 0.012797931209206581
addition O 0 0.00812994409352541
, O 0 0.0030459200497716665
we O 0 0.0014370098942890763
found O 0 0.001840531942434609
seven O 0 0.0022625220008194447
individuals O 0 0.0010980968363583088
with O 0 0.002010882832109928
hypohaptoglobinemia B-Disease 1 0.998695433139801
in O 0 0.003920909017324448
three O 0 0.002592194825410843
families O 0 0.003066601697355509
, O 0 0.0020820561330765486
and O 0 0.0020528396125882864
the O 0 0.005941677838563919
genotypes O 0 0.02863471955060959
of O 0 0.00449027307331562
six O 0 0.0035574312787503004
of O 0 0.0035747408401221037
the O 0 0.004335575271397829
seven O 0 0.0032412612345069647
individuals O 0 0.0011033897753804922
were O 0 0.0012129914248362184
found O 0 0.0022338340058922768
to O 0 0.0027610650286078453
be O 0 0.004779062699526548
Hp2 O 1 0.9999986886978149
/ O 1 0.999963641166687
Hpdel O 1 0.999980092048645
. O 0 0.017605073750019073

The O 0 0.02320859581232071
phenotypes O 0 0.04176953434944153
and O 0 0.006139753386378288
genotypes O 0 0.05543413758277893
in O 0 0.003227248089388013
one O 0 0.0016983989626169205
of O 0 0.001888763508759439
these O 0 0.0008887858712114394
three O 0 0.0015785859432071447
families O 0 0.002648458117619157
showed O 0 0.004531418904662132
the O 0 0.003311745822429657
father O 0 0.010015021078288555
to O 0 0.002177269896492362
be O 0 0.0023563806898891926
hypohaptoglobinemic B-Disease 1 0.949385941028595
( O 0 0.00995419081300497
Hp2 O 1 0.999480664730072
) O 0 0.006140350364148617
and O 0 0.0053544845432043076
Hp2 O 1 0.9999994039535522
/ O 1 0.9999432563781738
Hpdel O 1 0.9996234178543091
, O 0 0.00474842544645071
the O 0 0.004576604813337326
mother O 0 0.01181717962026596
to O 0 0.0029015224426984787
be O 0 0.0026119055692106485
Hp2 O 1 0.999158501625061
- O 0 0.01667815074324608
1 O 0 0.009107871912419796
and O 0 0.004697201773524284
Hp1 O 1 0.999997615814209
/ O 1 0.9997530579566956
Hp2 O 1 0.9984702467918396
, O 0 0.0030237005557864904
one O 0 0.0015142513439059258
of O 0 0.0018239989876747131
the O 0 0.002765853889286518
two O 0 0.0012833422515541315
children O 0 0.003474804572761059
to O 0 0.001899485825560987
be O 0 0.0023049740120768547
hypohaptoglobinemic B-Disease 1 0.8624635934829712
( O 0 0.012329112738370895
Hp2 O 1 0.9992603659629822
) O 0 0.005863809492439032
and O 0 0.005142733454704285
Hp2 O 1 0.9999998807907104
/ O 1 0.9999854564666748
Hpdel O 1 0.9999868869781494
, O 0 0.003790944116190076
and O 0 0.001960835652425885
the O 0 0.0028019819874316454
other O 0 0.0019373140530660748
child O 0 0.008694937452673912
to O 0 0.002709635067731142
be O 0 0.002600106643512845
Hp1 O 1 0.9822278618812561
and O 0 0.008326631039381027
Hp1 O 1 0.9999998807907104
/ O 1 0.9999676942825317
Hpdel O 1 0.9999179840087891
, O 0 0.005311207380145788
showing O 0 0.009775933809578419
an O 0 0.004931129515171051
anomalous O 1 0.6574810743331909
inheritance O 0 0.03228426352143288
of O 0 0.01630689762532711
Hp O 1 0.999957799911499
phenotypes O 0 0.03253263607621193
in O 0 0.00455133244395256
the O 0 0.006520296446979046
child O 0 0.023455873131752014
with O 0 0.0067284805700182915
Hp1 O 1 0.9999486207962036
. O 0 0.019020725041627884

The O 0 0.047775182873010635
Hp2 O 1 0.9999992847442627
/ O 1 0.9998500347137451
Hpdel O 1 0.995995044708252
individuals O 0 0.004327820613980293
had O 0 0.003942287992686033
an O 0 0.003160234075039625
extremely O 0 0.010404964908957481
low O 0 0.009265849366784096
level O 0 0.006467523518949747
of O 0 0.00611854949966073
Hp O 1 0.9210013151168823
( O 0 0.011958551593124866
mean O 0 0.013077503070235252
+ O 0 0.05062912777066231
/ O 0 0.09602656960487366
- O 0 0.034762486815452576
SD O 1 0.9945927262306213
= O 0 0.022220425307750702
0 O 0 0.00859106332063675
. O 0 0.003732037730515003
049 O 1 0.9880984425544739
+ O 0 0.06222591549158096
/ O 0 0.04014163091778755
- O 0 0.014374219812452793
0 O 0 0.010532618500292301
. O 0 0.003881466342136264
043 O 1 0.990915834903717
mg O 1 0.999976396560669
/ O 1 0.9961497783660889
ml O 1 0.9082069396972656
; O 0 0.005963790230453014
n O 0 0.01807837188243866
= O 0 0.021843980997800827
6 O 0 0.008925236761569977
) O 0 0.002318570390343666
, O 0 0.0010965628316625953
compared O 0 0.0020007744897156954
with O 0 0.0009362155105918646
the O 0 0.003008476225659251
level O 0 0.007620283402502537
( O 0 0.004239100497215986
1 O 0 0.005521103274077177
. O 0 0.0018195593729615211
64 O 0 0.011556516401469707
+ O 0 0.036524925380945206
/ O 0 0.031011488288640976
- O 0 0.010374919511377811
1 O 0 0.0066764941439032555
. O 0 0.002833529142662883
07 O 1 0.993881344795227
mg O 1 0.9999922513961792
/ O 1 0.9467493295669556
ml O 0 0.3473702371120453
) O 0 0.002744558732956648
obtained O 0 0.002505744341760874
from O 0 0.002710787346586585
52 O 0 0.014857331290841103
healthy O 0 0.013792263343930244
volunteers O 0 0.014622963964939117
having O 0 0.00827110093086958
phenotype O 0 0.0417671836912632
Hp2 O 1 0.9996067881584167
, O 0 0.006562734954059124
whereas O 0 0.01008803304284811
the O 0 0.009934513829648495
serum O 1 0.9930017590522766
Hp O 0 0.03508225828409195
level O 0 0.005231436807662249
of O 0 0.002022214001044631
an O 0 0.0020030748564749956
individual O 0 0.002533684018999338
with O 0 0.0029472815804183483
Hp1 O 1 0.9999991655349731
/ O 1 0.9995943903923035
Hpdel O 1 0.9998981952667236
was O 0 0.020861869677901268
0 O 0 0.024688294157385826
. O 0 0.007799023296684027

50 O 0 0.054048776626586914
mg O 1 0.9999983310699463
/ O 1 0.9998074173927307
ml O 1 0.9943826198577881
, O 0 0.0039758202619850636
which O 0 0.001742759719491005
was O 0 0.005028435494750738
approximately O 0 0.0031612811144441366
half O 0 0.0019139942014589906
the O 0 0.002463011769577861
level O 0 0.0052332268096506596
of O 0 0.00488071795552969
Hp O 0 0.16455794870853424
in O 0 0.0053652930073440075
control O 0 0.010543671436607838
sera O 1 0.9964163303375244
from O 0 0.004767763894051313
the O 0 0.0073998961597681046
Hp1 O 1 0.9980354905128479
phenotype O 0 0.023290980607271194
( O 0 0.005382108967751265
1 O 0 0.005912649445235729
. O 0 0.002297756727784872
26 O 0 0.012845207005739212
+ O 0 0.03903470188379288
/ O 0 0.031444139778614044
- O 0 0.011339053511619568
0 O 0 0.007186408620327711
. O 0 0.002059319755062461
33 O 0 0.017243675887584686
mg O 1 0.9997263550758362
/ O 1 0.8962005972862244
ml O 1 0.7292066812515259
; O 0 0.0053628659807145596
n O 0 0.01765388809144497
= O 0 0.021968498826026917
9 O 0 0.007885243743658066
) O 0 0.0025209998711943626
, O 0 0.0019258700776845217
showing O 0 0.006688905414193869
a O 0 0.007173287682235241
gene O 0 0.021903259679675102
- O 0 0.029690532013773918
dosage O 0 0.1364060491323471
effect O 0 0.015312247909605503
. O 0 0.008697165176272392

The O 0 0.013280002400279045
other O 0 0.00507092522457242
allele O 0 0.022496603429317474
( O 0 0.011615632101893425
Hp2 O 1 0.6855879426002502
) O 0 0.0034000701270997524
of O 0 0.0022533228620886803
individuals O 0 0.0021534888073801994
with O 0 0.004463228862732649
Hp2 O 1 1.0
/ O 1 0.9999988079071045
Hpdel O 1 0.9999960660934448
was O 0 0.011575071141123772
found O 0 0.0034287890885025263
to O 0 0.0014905404532328248
have O 0 0.0009378751274198294
, O 0 0.0017570331692695618
in O 0 0.0025016276631504297
all O 0 0.0024936930276453495
exons O 0 0.02263452671468258
, O 0 0.003997434861958027
no O 0 0.0037120110355317593
mutation O 0 0.007300444878637791
, O 0 0.00318045262247324
by O 0 0.0027969793882220984
DNA O 0 0.018353350460529327
sequencing O 0 0.026185674592852592
. O 0 0.009451081044971943

On O 0 0.007791911717504263
the O 0 0.003939736634492874
basis O 0 0.0027255124878138304
of O 0 0.0028798782732337713
the O 0 0.0036756477784365416
present O 0 0.003903646022081375
study O 0 0.004003784619271755
, O 0 0.0022732075303792953
the O 0 0.0031055447179824114
mechanism O 0 0.007145304698497057
of O 0 0.005706350784748793
anhaptoglobinemia B-Disease 1 0.9984126091003418
and O 0 0.003092357190325856
the O 0 0.004944256506860256
mechanism O 0 0.009099850431084633
of O 0 0.0061919596046209335
anomalous O 1 0.9994713664054871
inheritance O 0 0.47175678610801697
of O 0 0.02693057991564274
Hp O 1 0.9999873638153076
phenotypes O 0 0.05695326626300812
were O 0 0.004441433120518923
well O 0 0.004611663985997438
explained O 0 0.018527409061789513
. O 0 0.009408507496118546

However O 0 0.008368083275854588
, O 0 0.003593076253309846
the O 0 0.004965669475495815
mechanism O 0 0.01080950628966093
of O 0 0.011490175500512123
hypohaptoglobinemia B-Disease 1 0.999972939491272
remains O 0 0.047596320509910583
unknown O 0 0.04374578222632408

ATM O 0 0.4975645840167999
mutations O 0 0.019179804250597954
and O 0 0.005542610306292772
phenotypes O 0 0.05847581848502159
in O 0 0.023813558742403984
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 0.0071595036424696445
in O 0 0.0029925541020929813
the O 0 0.004217610228806734
British O 0 0.009132669307291508
Isles O 0 0.02199132740497589
: O 0 0.0046744621358811855
expression O 0 0.004419723059982061
of O 0 0.005926016252487898
mutant O 0 0.031244542449712753
ATM O 0 0.02210216037929058
and O 0 0.0018171187257394195
the O 0 0.0032605817541480064
risk O 0 0.007824020460247993
of O 0 0.05762658640742302
leukemia B-Disease 1 1.0
, O 1 0.9999991655349731
lymphoma B-Disease 1 1.0
, O 1 0.9996684789657593
and O 1 0.99173903465271
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.07372508943080902

We O 0 0.0073937661945819855
report O 0 0.005688943900167942
the O 0 0.004210890736430883
spectrum O 0 0.007329342886805534
of O 0 0.006371100898832083
59 O 0 0.034226011484861374
ATM O 0 0.04178507253527641
mutations O 0 0.006991340313106775
observed O 0 0.004385524895042181
in O 0 0.007434200495481491
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
telangiectasia I-Disease 1 1.0
( O 0 0.3779604732990265
A B-Disease 1 0.9999953508377075
- I-Disease 1 0.9999972581863403
T I-Disease 1 1.0
) O 0 0.005821907427161932
patients O 0 0.011442807503044605
in O 0 0.0033528031781315804
the O 0 0.005726851988583803
British O 0 0.014859850518405437
Isles O 0 0.06254717707633972
. O 0 0.013752899132668972

Of O 0 0.025136368349194527
51 O 0 0.0733054056763649
ATM O 1 0.9102823734283447
mutations O 0 0.011980680748820305
identified O 0 0.005314049310982227
in O 0 0.0024082688614726067
families O 0 0.0028857914730906487
native O 0 0.0034588840790092945
to O 0 0.0017145867459475994
the O 0 0.003612618427723646
British O 0 0.00945573765784502
Isles O 0 0.027153244242072105
, O 0 0.003962778486311436
11 O 0 0.007295881398022175
were O 0 0.003492523217573762
founder O 0 0.21517550945281982
mutations O 0 0.010138892568647861
, O 0 0.0030084934551268816
and O 0 0.0024529974907636642
2 O 0 0.0060201906599104404
of O 0 0.002960978541523218
these O 0 0.0017286414513364434
11 O 0 0.0067267282865941525
conferred O 0 0.02343018911778927
a O 0 0.007740696892142296
milder O 0 0.06051252409815788
clinical O 1 0.9999256134033203
phenotype O 0 0.01895592175424099
with O 0 0.0015747068682685494
respect O 0 0.003769254544749856
to O 0 0.0033797891810536385
both O 0 0.00861988216638565
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.9998722076416016
cellular O 1 0.9996823072433472
features O 0 0.020419085398316383
. O 0 0.010172033682465553

We O 0 0.0051134428940713406
report O 0 0.0038849615957587957
, O 0 0.0015182188944891095
in O 0 0.001641815877519548
two O 0 0.0018189549446105957
A B-Disease 1 0.9911706447601318
- I-Disease 1 0.9928625226020813
T I-Disease 1 0.9998194575309753
families O 0 0.003562991740182042
, O 0 0.0018253730377182364
an O 0 0.0028043107595294714
ATM O 0 0.04315677285194397
mutation O 0 0.013610959984362125
( O 0 0.011804851703345776
7271T O 1 0.9998094439506531
- O 1 0.9498285055160522
- O 0 0.06588985025882721
> O 0 0.0628289207816124
G O 0 0.1680256724357605
) O 0 0.003694534068927169
that O 0 0.0011035752249881625
may O 0 0.0020894273184239864
be O 0 0.0008856487111188471
associated O 0 0.001437411061488092
with O 0 0.0008124339510686696
an O 0 0.002190206665545702
increased O 0 0.006073893513530493
risk O 0 0.01599346287548542
of O 1 0.8995194435119629
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.012571741826832294
both O 0 0.006575197447091341
homozygotes O 1 0.9993492960929871
and O 0 0.006444544997066259
heterozygotes O 1 0.9812523722648621
( O 0 0.010057380422949791
relative O 0 0.01040448434650898
risk O 0 0.009580560959875584
12 O 0 0.006230644881725311
. O 0 0.0020955486688762903
7 O 0 0.00892254151403904
; O 0 0.00494289631024003
P O 0 0.12118392437696457
= O 0 0.0281175896525383
. O 0 0.004498644731938839
0025 O 1 0.9997393488883972
) O 0 0.004226507153362036
, O 0 0.0016207604203373194
although O 0 0.001340837450698018
there O 0 0.0011623745085671544
is O 0 0.0013587018474936485
a O 0 0.002906068693846464
less O 0 0.005264711566269398
severe O 1 0.9999983310699463
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999998807907104
phenotype O 0 0.01079244539141655
in O 0 0.0015239401254802942
terms O 0 0.001405986724421382
of O 0 0.0020147524774074554
the O 0 0.00395403616130352
degree O 0 0.016664398834109306
of O 1 0.9336086511611938
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 1 0.9998593330383301

This O 0 0.008261953480541706
mutation O 0 0.018442807719111443
( O 0 0.01460467278957367
7271T O 1 0.9999197721481323
- O 1 0.9333837032318115
- O 0 0.046881143003702164
> O 0 0.05125115439295769
G O 0 0.05676881968975067
) O 0 0.003549917135387659
also O 0 0.0016815019771456718
allows O 0 0.0015058021526783705
expression O 0 0.0032515311613678932
of O 0 0.003473896300420165
full O 0 0.0105932941660285
- O 0 0.019940558820962906
length O 0 0.010167268104851246
ATM O 0 0.034705277532339096
protein O 0 0.006692736875265837
at O 0 0.004254235420376062
a O 0 0.0031769140623509884
level O 0 0.00575001398101449
comparable O 0 0.006312401499599218
with O 0 0.0013797959545627236
that O 0 0.001659801579080522
in O 0 0.005347367841750383
unaffected O 0 0.0321124829351902
individuals O 0 0.006569490768015385
. O 0 0.009777189232409

In O 0 0.011032800190150738
addition O 0 0.006777260918170214
, O 0 0.0026156825479120016
we O 0 0.000867808994371444
have O 0 0.0005825403495691717
studied O 0 0.005151811521500349
18 O 0 0.008589008823037148
A B-Disease 1 0.9999788999557495
- I-Disease 1 0.9999991655349731
T I-Disease 1 1.0
patients O 1 0.857231855392456
, O 0 0.002286977134644985
in O 0 0.0020161911379545927
15 O 0 0.0029484229162335396
families O 0 0.0016383451875299215
, O 0 0.0012956890277564526
who O 0 0.0032513567712157965
developed O 0 0.17774207890033722
leukemia B-Disease 1 1.0
, O 1 0.9999485015869141
lymphoma B-Disease 1 1.0
, O 1 0.9999874830245972
preleukemic O 1 1.0
T O 1 1.0
- O 1 0.9588896036148071
cell O 0 0.012113632634282112
proliferation O 0 0.012840288691222668
, O 0 0.00440794276073575
or O 0 0.016138821840286255
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.2795649766921997
mostly O 0 0.008158894255757332
in O 0 0.009978227317333221
childhood O 1 0.9999955892562866
. O 0 0.01974422298371792

A O 0 0.01641089655458927
wide O 0 0.007862834259867668
variety O 0 0.007610729895532131
of O 0 0.0118866553530097
ATM O 1 0.9879222512245178
mutation O 0 0.012493870221078396
types O 0 0.004489092156291008
, O 0 0.0025339708663523197
including O 0 0.003874662332236767
missense O 0 0.03830994665622711
mutations O 0 0.011599313467741013
and O 0 0.003528823144733906
in O 0 0.008815044537186623
- O 0 0.05216680467128754
frame O 0 0.02370232716202736
deletions O 0 0.015447466634213924
, O 0 0.0029102349653840065
were O 0 0.001967888092622161
seen O 0 0.0041709234938025475
in O 0 0.00352355744689703
these O 0 0.003932974301278591
patients O 1 0.8956037163734436
. O 0 0.01524587906897068

We O 0 0.006932142190635204
also O 0 0.0043928055092692375
show O 0 0.0037131118588149548
that O 0 0.0011003975523635745
25 O 0 0.0030218700412660837
% O 0 0.001640247879549861
of O 0 0.001848250045441091
all O 0 0.002399076009169221
A B-Disease 1 0.9996610879898071
- I-Disease 1 0.999990701675415
T I-Disease 1 1.0
patients O 1 0.6091185212135315
carried O 0 0.008318311534821987
in O 0 0.006636951584368944
- O 0 0.022175652906298637
frame O 0 0.024718143045902252
deletions O 0 0.02462928555905819
or O 0 0.008035418577492237
missense O 0 0.03896582871675491
mutations O 0 0.01112503930926323
, O 0 0.002831683959811926
many O 0 0.0016236555529758334
of O 0 0.003373524872586131
which O 0 0.0023244868498295546
were O 0 0.0018859016709029675
also O 0 0.002527788281440735
associated O 0 0.002938648918643594
with O 0 0.0018146588699892163
expression O 0 0.007410453166812658
of O 0 0.012515338137745857
mutant O 1 0.9535151720046997
ATM O 1 0.9645670056343079
protein O 0 0.020099930465221405
. O 0 0.007519529201090336

The O 0 0.023125873878598213
DMPK O 1 0.9999798536300659
gene O 0 0.016759730875492096
of O 0 0.012527153827250004
severely O 1 0.9999986886978149
affected O 1 0.9999895095825195
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
is O 1 0.9856860041618347
hypermethylated O 1 0.9999992847442627
proximal O 1 0.999947190284729
to O 0 0.004168891813606024
the O 0 0.0047608609311282635
largely O 0 0.009024142287671566
expanded O 0 0.020677370950579643
CTG O 1 0.9999836683273315
repeat O 0 0.08935748785734177
. O 0 0.013591754250228405

Using O 0 0.02042078599333763
methylation O 0 0.039452023804187775
- O 0 0.028751196339726448
sensitive O 0 0.017567746341228485
restriction O 0 0.013343245722353458
enzymes O 0 0.008280586451292038
, O 0 0.003044088836759329
we O 0 0.0019513450097292662
characterized O 0 0.010664336383342743
the O 0 0.005335476249456406
methylation O 0 0.011762346141040325
pattern O 0 0.009190354496240616
on O 0 0.0036092731170356274
the O 0 0.003996747545897961
5 O 0 0.005114801228046417
side O 0 0.004034531302750111
of O 0 0.004105834756046534
the O 0 0.00940774567425251
CTG O 1 0.9999979734420776
repeat O 0 0.02192964218556881
in O 0 0.003736987244337797
the O 0 0.006531076040118933
DMPK O 1 0.9999706745147705
gene O 0 0.005839189048856497
of O 0 0.0025732044596225023
normal O 0 0.003987317439168692
individuals O 0 0.0011846403358504176
and O 0 0.0017698269803076982
of O 0 0.00817915890365839
patients O 1 1.0
affected O 1 0.9975076913833618
with O 0 0.09592770785093307
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.1592937409877777
showing O 0 0.01753534935414791
expansions O 0 0.015773624181747437
of O 0 0.00592348026111722
the O 0 0.010763938538730145
repetitive O 1 0.5183231234550476
sequence O 0 0.017843205481767654
. O 0 0.008105529472231865

The O 0 0.020813826471567154
gene O 0 0.013929160311818123
segment O 0 0.011594935320317745
analyzed O 0 0.006285009905695915
corresponds O 0 0.006331207230687141
to O 0 0.0020591258071362972
the O 0 0.005795071367174387
genomic O 0 0.048159804195165634
SacI O 1 0.9999083280563354
- O 0 0.03904866427183151
HindIII O 0 0.08805334568023682
fragment O 0 0.019318172708153725
carrying O 0 0.010723252780735493
exons O 0 0.03366492688655853
11 O 0 0.016384834423661232
- O 0 0.02227761037647724
15 O 0 0.012620889581739902
. O 0 0.010250198654830456

There O 0 0.011185781098902225
is O 0 0.009482331573963165
constitutive O 0 0.05330348014831543
methylation O 0 0.019494501873850822
in O 0 0.008775374852120876
intron O 1 0.8140515089035034
12 O 0 0.011564170010387897
at O 0 0.007299587596207857
restriction O 0 0.005900715943425894
sites O 0 0.0036023345310240984
of O 0 0.005319903139024973
SacII O 1 0.9984788298606873
and O 0 0.006862662732601166
HhaI O 1 0.9978938698768616
, O 0 0.00704963831230998
localized O 0 0.023381879553198814
1 O 0 0.011032487265765667
, O 0 0.0041241939179599285
159 O 0 0.03132801875472069
- O 0 0.016773847863078117
1 O 0 0.009075233712792397
, O 0 0.003830880159512162
232 O 0 0.031064793467521667
bp O 0 0.02423189952969551
upstream O 0 0.011885691434144974
of O 0 0.005499863997101784
the O 0 0.012343899346888065
CTG O 1 0.9999998807907104
repeat O 0 0.3274604082107544
, O 0 0.004748709965497255
whereas O 0 0.006115836091339588
most O 0 0.0019279674161225557
, O 0 0.002195514040067792
if O 0 0.0011043507838621736
not O 0 0.000668459280859679
all O 0 0.0006881324807181954
, O 0 0.0015468141064047813
of O 0 0.002187074162065983
the O 0 0.0030567338690161705
other O 0 0.0014019921654835343
sites O 0 0.0031581902876496315
of O 0 0.007051798515021801
SacII O 1 0.9999880790710449
, O 0 0.009367869235575199
HhaI O 1 0.9999516010284424
, O 0 0.005436886567622423
and O 0 0.0048734997399151325
HpaII O 1 0.999108612537384
in O 0 0.00448084669187665
this O 0 0.0023173156660050154
region O 0 0.007161940913647413
are O 0 0.0026575878728181124
unmethylated O 0 0.12812401354312897
, O 0 0.004658204037696123
in O 0 0.004184556659311056
normal O 0 0.006369364447891712
individuals O 0 0.0012525622732937336
and O 0 0.0013245554873719811
most O 0 0.0018811362097039819
of O 0 0.006009477656334639
the O 0 0.021565090864896774
patients O 1 0.9999988079071045
. O 0 0.016694555059075356

In O 0 0.007524007931351662
a O 0 0.0034938612952828407
number O 0 0.0023943970445543528
of O 0 0.004760050214827061
young O 0 0.017279531806707382
and O 0 0.008010894991457462
severely O 1 0.9999997615814209
affected O 1 0.9569178819656372
patients O 1 0.9999994039535522
, O 0 0.007537920959293842
however O 0 0.003726694267243147
, O 0 0.003307986306026578
complete O 0 0.006340296473354101
methylation O 0 0.0069551775231957436
of O 0 0.0030352396424859762
these O 0 0.0015982837649062276
restriction O 0 0.004980001132935286
sites O 0 0.0031308955512940884
was O 0 0.004395863972604275
found O 0 0.0025194641202688217
in O 0 0.003285546088591218
the O 0 0.00856119953095913
mutated O 0 0.03722070902585983
allele O 0 0.029933754354715347
. O 0 0.00847691111266613

In O 0 0.007275330368429422
most O 0 0.0025481281336396933
of O 0 0.0031715433578938246
these O 0 0.0019408984808251262
patients O 0 0.02285103127360344
, O 0 0.003276308299973607
the O 0 0.004287914838641882
onset O 1 0.9999951124191284
of O 0 0.03986366093158722
the O 1 0.999963641166687
disease O 1 1.0
was O 1 1.0
congenital O 1 1.0
. O 1 0.9801145195960999

Preliminary O 0 0.020199064165353775
in O 0 0.012118331156671047
vivo O 0 0.07425422221422195
footprinting O 1 0.7020573616027832
data O 0 0.0030271699652075768
gave O 0 0.003055301494896412
evidence O 0 0.002501537324860692
for O 0 0.002653961768373847
protein O 0 0.0100191505625844
- O 0 0.009503631852567196
DNA O 0 0.005964754149317741
contact O 0 0.004213847219944
in O 0 0.0029350523836910725
normal O 0 0.007277444936335087
genes O 0 0.005173259414732456
at O 0 0.0055837444961071014
an O 0 0.004594352561980486
Sp1 O 1 0.99763023853302
consensus O 0 0.012168439105153084
binding O 0 0.00408296100795269
site O 0 0.006830349564552307
upstream O 0 0.009034625254571438
of O 0 0.0043484969064593315
the O 0 0.010449976660311222
CTG O 1 0.9999996423721313
repeat O 0 0.029475431889295578
and O 0 0.0021595240104943514
for O 0 0.0019686250016093254
a O 0 0.0032746801152825356
significant O 0 0.0042121149599552155
reduction O 0 0.005931872874498367
of O 0 0.002338744467124343
this O 0 0.0013922660145908594
interaction O 0 0.002786012599244714
in O 0 0.002168093342334032
cells O 0 0.003057905239984393
with O 0 0.0011118371039628983
a O 0 0.007435706444084644
hypermethylated O 1 0.9999943971633911
DMPK O 1 0.9999998807907104
gene O 0 0.017587490379810333
. O 0 0.004034772980958223
. O 0 0.0066081453114748

The O 0 0.06744073331356049
hemochromatosis B-Disease 1 1.0
gene O 0 0.027736609801650047
product O 0 0.010993992909789085
complexes O 0 0.017688486725091934
with O 0 0.0033339615911245346
the O 0 0.011460069566965103
transferrin O 1 0.9999834299087524
receptor O 0 0.027719074860215187
and O 0 0.006006328389048576
lowers O 0 0.4068663418292999
its O 0 0.004099403973668814
affinity O 0 0.011412004940211773
for O 0 0.00515219708904624
ligand O 0 0.0354192815721035
binding O 0 0.011049711145460606
. O 0 0.009830283001065254

We O 0 0.009805669076740742
recently O 0 0.01335823442786932
reported O 0 0.007890147157013416
the O 0 0.0050035640597343445
positional O 0 0.018999550491571426
cloning O 0 0.006750844419002533
of O 0 0.0027357707731425762
a O 0 0.003798567457124591
candidate O 0 0.00984112173318863
gene O 0 0.008657999336719513
for O 0 0.008128667250275612
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 1.0
HFE O 1 1.0
. O 0 0.03672267869114876

The O 0 0.017335619777441025
gene O 0 0.012770256958901882
product O 0 0.004461275413632393
, O 0 0.001784829655662179
a O 0 0.001948036951944232
member O 0 0.002564906608313322
of O 0 0.0026075777132064104
the O 0 0.005962504539638758
major O 1 0.9020543098449707
histocompatibility O 1 1.0
complex O 1 0.9994768500328064
class O 1 0.9442163705825806
I O 0 0.17337560653686523
- O 0 0.012648294679820538
like O 0 0.0027721214573830366
family O 0 0.005154862068593502
, O 0 0.0023867187555879354
was O 0 0.00375203974545002
found O 0 0.0018028513295575976
to O 0 0.001149246352724731
have O 0 0.0007552523748017848
a O 0 0.002940974896773696
mutation O 0 0.00886915810406208
, O 0 0.006618466693907976
Cys O 1 0.9999998807907104
- O 0 0.3680478632450104
282 O 1 0.977104127407074
- O 0 0.07443644851446152
- O 0 0.038005150854587555
> O 0 0.054160717874765396
Tyr O 1 0.9999816417694092
( O 0 0.014855809509754181
C282Y O 1 0.5849078297615051
) O 0 0.003907207399606705
, O 0 0.0014376805629581213
in O 0 0.00211447780020535
85 O 0 0.011733105406165123
% O 0 0.0043406919576227665
of O 0 0.0071856495924293995
patient O 1 0.9999532699584961
chromosomes O 0 0.04195874556899071
. O 0 0.011314266361296177

This O 0 0.0094528216868639
mutation O 0 0.018402142450213432
eliminates O 0 0.025431372225284576
the O 0 0.0051804352551698685
ability O 0 0.004982558079063892
of O 0 0.0074949972331523895
HFE O 1 0.9999963045120239
to O 0 0.0040306090377271175
associate O 0 0.015328980050981045
with O 0 0.0034557953476905823
beta2 O 1 0.9999920129776001
- O 0 0.25386297702789307
microglobulin O 1 0.9994764924049377
( O 0 0.011127037927508354
beta2m O 1 0.996921956539154
) O 0 0.005734434351325035
and O 0 0.004056818317621946
prevents O 0 0.037195201963186264
cell O 0 0.11973133683204651
- O 0 0.03221423178911209
surface O 0 0.015003876760601997
expression O 0 0.014848686754703522
. O 0 0.0088197011500597

A O 0 0.02380782924592495
second O 0 0.015089902095496655
mutation O 0 0.009355797432363033
that O 0 0.0014965870650485158
has O 0 0.0019343032035976648
no O 0 0.0022514318116009235
effect O 0 0.004238343797624111
on O 0 0.0057714954018592834
beta2m O 1 0.998915433883667
association O 0 0.018123304471373558
, O 0 0.008230801671743393
H63D O 1 0.9999998807907104
, O 0 0.004587908275425434
was O 0 0.005165475886315107
found O 0 0.0020474574994295835
in O 0 0.0015340048121288419
eight O 0 0.002070874208584428
out O 0 0.001268358901143074
of O 0 0.0027892098296433687
nine O 0 0.007533769588917494
patients O 0 0.06497607380151749
heterozygous O 0 0.010189307853579521
for O 0 0.0027299646753817797
the O 0 0.009688518941402435
C282Y O 1 0.998569130897522
mutant O 0 0.07111360877752304
. O 0 0.013115332461893559

In O 0 0.008558658882975578
this O 0 0.002773310523480177
report O 0 0.004555084276944399
, O 0 0.0021014560479670763
we O 0 0.0011655865237116814
demonstrate O 0 0.005322396755218506
in O 0 0.004450724460184574
cultured O 0 0.03339598700404167
293 O 0 0.08229361474514008
cells O 0 0.019061176106333733
overexpressing O 1 0.6356673240661621
wild O 0 0.018501106649637222
- O 0 0.021065695211291313
type O 0 0.014831001870334148
or O 0 0.008079367689788342
mutant O 0 0.05606492981314659
HFE O 1 0.99998939037323
proteins O 0 0.004592123907059431
that O 0 0.0009171937126666307
both O 0 0.0012302504619583488
the O 0 0.004005393944680691
wild O 0 0.01207603607326746
- O 0 0.021272365003824234
type O 0 0.014678501524031162
and O 0 0.007431396748870611
H63D O 1 1.0
HFE O 1 1.0
proteins O 0 0.009726133197546005
form O 0 0.006341800093650818
stable O 0 0.018577152863144875
complexes O 0 0.014692606404423714
with O 0 0.0029779134783893824
the O 0 0.011607686057686806
transferrin O 1 0.9999547004699707
receptor O 0 0.05017804354429245
( O 0 0.019010812044143677
TfR O 1 0.9999768733978271
) O 0 0.011547442525625229
. O 0 0.008623963221907616

The O 0 0.024630630388855934
C282Y O 1 0.9939066767692566
mutation O 0 0.018768126145005226
nearly O 0 0.007414936553686857
completely O 0 0.010254775173962116
prevents O 0 0.00903326366096735
the O 0 0.004285565577447414
association O 0 0.007325039245188236
of O 0 0.004972605966031551
the O 0 0.010492882691323757
mutant O 1 0.6996943950653076
HFE O 1 0.9999922513961792
protein O 0 0.01010147575289011
with O 0 0.0029207165353000164
the O 0 0.0137648805975914
TfR O 1 0.9999364614486694
. O 0 0.020438337698578835

Studies O 0 0.015487316995859146
on O 0 0.013543305918574333
cell O 0 0.028419477865099907
- O 0 0.02275117114186287
associated O 0 0.010846477933228016
transferrin O 0 0.07670007646083832
at O 0 0.009973004460334778
37 O 0 0.01489898469299078
degrees O 0 0.01073663029819727
C O 0 0.021163858473300934
suggest O 0 0.004132323432713747
that O 0 0.001355418935418129
the O 0 0.004566853400319815
overexpressed O 0 0.07602559030056
wild O 0 0.018330136314034462
- O 0 0.03175605833530426
type O 0 0.040062446147203445
HFE O 1 0.9999992847442627
protein O 0 0.02214047685265541
decreases O 0 0.0122187165543437
the O 0 0.004189522936940193
affinity O 0 0.008555025793612003
of O 0 0.006163830868899822
the O 0 0.015176257118582726
TfR O 1 0.9999982118606567
for O 0 0.02129397913813591
transferrin O 1 0.9985367059707642
. O 0 0.0162298996001482

The O 0 0.03706413134932518
overexpressed O 1 0.9999938011169434
H63D O 1 1.0
protein O 0 0.01971019059419632
does O 0 0.002548843389376998
not O 0 0.0009859866695478559
have O 0 0.0007331817760132253
this O 0 0.001241060672327876
effect O 0 0.004029395524412394
, O 0 0.0021940439473837614
providing O 0 0.004245357122272253
the O 0 0.0028674311470240355
first O 0 0.002756995614618063
direct O 0 0.002046919660642743
evidence O 0 0.001969666453078389
for O 0 0.00164181983564049
a O 0 0.003415694460272789
functional O 0 0.009944790042936802
consequence O 0 0.010710225440561771
of O 0 0.006028471980243921
the O 0 0.01620626263320446
H63D O 1 1.0
mutation O 0 0.025808075442910194
. O 0 0.00997703056782484

Addition O 0 0.01173024158924818
of O 0 0.010522566735744476
soluble O 0 0.40749961137771606
wild O 0 0.023947684094309807
- O 0 0.05673348158597946
type O 0 0.10380051285028458
HFE O 1 1.0
/ O 1 0.9998435974121094
beta2m O 1 0.9995194673538208
heterodimers O 1 0.9998637437820435
to O 0 0.010746668092906475
cultured O 0 0.1207965612411499
cells O 0 0.013068053871393204
also O 0 0.0047578997910022736
decreased O 0 0.015044056810438633
the O 0 0.006733252666890621
apparent O 0 0.0181749127805233
affinity O 0 0.012834269553422928
of O 0 0.007971204817295074
the O 0 0.012673091143369675
TfR O 1 0.9999785423278809
for O 0 0.004784789867699146
its O 0 0.0040315124206244946
ligand O 0 0.019992399960756302
under O 0 0.008117073215544224
steady O 0 0.02414669655263424
- O 0 0.011602599173784256
state O 0 0.0024220645427703857
conditions O 0 0.003902842989191413
, O 0 0.00188589992467314
both O 0 0.0013040009653195739
in O 0 0.003393005346879363
293 O 1 0.92616868019104
cells O 0 0.00938591081649065
and O 0 0.003337975824251771
in O 0 0.010991694405674934
HeLa O 1 0.9999996423721313
cells O 0 0.023731188848614693
. O 0 0.009388571605086327

Furthermore O 0 0.021630210801959038
, O 0 0.005401727743446827
at O 0 0.008884663693606853
4 O 0 0.009361076168715954
degrees O 0 0.007961937226355076
C O 0 0.018574628978967667
, O 0 0.0024423038121312857
the O 0 0.0038083200342953205
added O 0 0.009146494790911674
soluble O 0 0.03043409064412117
complex O 0 0.016906043514609337
of O 0 0.025745002552866936
HFE O 1 1.0
/ O 1 0.9999914169311523
beta2m O 1 0.9991440773010254
inhibited O 0 0.029401199892163277
binding O 0 0.005412559490650892
of O 0 0.008267867378890514
transferrin O 1 0.9745292067527771
to O 0 0.010969804599881172
HeLa O 1 0.9999945163726807
cell O 0 0.030317172408103943
TfR O 1 0.9911407828330994
in O 0 0.005192606244236231
a O 0 0.007975022308528423
concentration O 1 0.6635366678237915
- O 0 0.02666773833334446
dependent O 0 0.013149084523320198
manner O 0 0.011837766505777836
. O 0 0.009217209182679653

Scatchard O 0 0.11650463938713074
plots O 0 0.01713600941002369
of O 0 0.004650030750781298
these O 0 0.001597292604856193
data O 0 0.0022393495310097933
indicate O 0 0.0037770511116832495
that O 0 0.0011747332755476236
the O 0 0.004488213453441858
added O 0 0.010881506837904453
heterodimer O 0 0.3404727578163147
substantially O 0 0.013387997634708881
reduced O 0 0.006902161054313183
the O 0 0.004706122912466526
affinity O 0 0.012710925191640854
of O 0 0.012645467184484005
TfR O 1 0.9999971389770508
for O 0 0.023550251498818398
transferrin O 1 0.9993116855621338
. O 0 0.017027245834469795

These O 0 0.004985125735402107
results O 0 0.00517653115093708
establish O 0 0.006389985792338848
a O 0 0.00430531520396471
molecular O 0 0.014070570468902588
link O 0 0.015410574153065681
between O 0 0.007949710823595524
HFE O 1 0.9999982118606567
and O 0 0.0034217543434351683
a O 0 0.004131040535867214
key O 0 0.009961151517927647
protein O 0 0.005818320903927088
involved O 0 0.0032845186069607735
in O 0 0.005657195579260588
iron O 1 0.9999924898147583
transport O 0 0.02735336311161518
, O 0 0.007083712611347437
the O 0 0.012258687987923622
TfR O 1 0.9999997615814209
, O 0 0.005842195358127356
and O 0 0.0024369515012949705
raise O 0 0.005237455479800701
the O 0 0.002698152558878064
possibility O 0 0.0042899842374026775
that O 0 0.0016318113775923848
alterations O 0 0.010908813215792179
in O 0 0.003212974639609456
this O 0 0.002303901594132185
regulatory O 0 0.012437423691153526
mechanism O 0 0.008967257104814053
may O 0 0.002495509572327137
play O 0 0.001633685315027833
a O 0 0.001511460985057056
role O 0 0.0031967998947948217
in O 0 0.00261847791261971
the O 0 0.006393165327608585
pathogenesis O 1 1.0
of O 1 0.9999953508377075
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9999212026596069
. O 0 0.022236712276935577

Genomic O 0 0.0334155447781086
organization O 0 0.007301702629774809
of O 0 0.00642408337444067
the O 0 0.016241690143942833
UBE3A O 1 1.0
/ O 1 0.9999996423721313
E6 O 1 1.0
- O 1 0.9287468791007996
AP O 1 0.5019482374191284
gene O 0 0.008503870107233524
and O 0 0.002601712243631482
related O 0 0.013388987630605698
pseudogenes O 1 0.9878755211830139
. O 0 0.01826711744070053

The O 0 0.03474665805697441
UBE3A O 1 0.9999852180480957
gene O 0 0.021690523251891136
encodes O 0 0.019177809357643127
the O 0 0.011849848553538322
E6 O 1 0.9999949932098389
- O 0 0.1441742181777954
AP O 1 0.742709755897522
ubiquitin O 0 0.1199643462896347
- O 0 0.03399432823061943
protein O 0 0.01325910072773695
ligase O 0 0.024063168093562126
and O 0 0.002352830721065402
has O 0 0.0031435773707926273
recently O 0 0.006351503077894449
been O 0 0.00218837964348495
shown O 0 0.0021701462101191282
to O 0 0.0013623180566355586
be O 0 0.0015660998178645968
mutated O 0 0.015775319188833237
in O 0 0.01636628992855549
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
who O 1 0.9999254941940308
lack O 1 0.999946117401123
15q11 O 1 1.0
- O 1 0.9807557463645935
q13 O 1 0.9393271207809448
deletions O 0 0.028772862628102303
or O 0 0.00858323648571968
chromosome O 0 0.030639126896858215
15 O 0 0.02111065201461315
paternal O 1 0.9999005794525146
uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999994039535522
. O 0 0.029726611450314522

Previous O 0 0.05473737418651581
UBE3A O 1 0.999996542930603
cDNA O 0 0.05205691605806351
analysis O 0 0.004856145475059748
has O 0 0.0023443230893462896
shown O 0 0.00403935881331563
a O 0 0.004311579745262861
coding O 0 0.020649045705795288
region O 0 0.0071937814354896545
of O 0 0.0057596019469201565
approximately O 0 0.011739316396415234
2 O 0 0.01945202797651291
. O 0 0.008870282210409641

6 O 0 0.04777918756008148
kb O 0 0.08585920929908752
and O 0 0.004034615587443113
a O 0 0.006995986681431532
3 O 0 0.01890033483505249
- O 0 0.028378624469041824
untranslated O 1 0.874789834022522
region O 0 0.015498911030590534
( O 0 0.0156167671084404
UTR O 1 0.9968289732933044
) O 0 0.006181894801557064
of O 0 0.008324041031301022
< O 0 0.05510764196515083
50 O 0 0.013187223114073277
bp O 0 0.019800111651420593
, O 0 0.003400612622499466
whereas O 0 0.006591057404875755
Northern O 0 0.006661521270871162
analysis O 0 0.0037459558807313442
has O 0 0.0026000968646258116
indicated O 0 0.006929864175617695
mRNA O 0 0.005898523610085249
sizes O 0 0.0032374816946685314
of O 0 0.003777874866500497
5 O 0 0.014835216104984283
- O 0 0.022371428087353706
8 O 0 0.020830761641263962
kb O 0 0.15713860094547272
. O 0 0.010889674536883831

We O 0 0.005508197471499443
have O 0 0.0014348153490573168
analyzed O 0 0.007806210778653622
additional O 0 0.006972429808229208
cDNA O 0 0.03991883993148804
clones O 0 0.020897742360830307
and O 0 0.002096639946103096
provide O 0 0.002735489746555686
evidence O 0 0.002554308157414198
for O 0 0.0019469414837658405
an O 0 0.0024038623087108135
additional O 0 0.0065929782576859
0 O 0 0.018484607338905334
. O 0 0.006294959224760532

5 O 0 0.026669509708881378
kb O 0 0.06486718356609344
of O 0 0.011228508315980434
5 O 0 0.02180185727775097
- O 0 0.03273417800664902
UTR O 1 0.7948789000511169
and O 0 0.0047295065596699715
> O 0 0.024565299972891808
2 O 0 0.012273523956537247
kb O 0 0.04883047938346863
of O 0 0.009584479965269566
3 O 0 0.030588312074542046
- O 0 0.047494661062955856
UTR O 1 0.9777660369873047
. O 0 0.013741512782871723

We O 0 0.005100224632769823
have O 0 0.0015350420726463199
established O 0 0.005615883506834507
the O 0 0.004189212806522846
genomic O 0 0.018046529963612556
organization O 0 0.00782790221273899
of O 0 0.008637764491140842
UBE3A O 1 0.9999986886978149
and O 0 0.0032578615937381983
the O 0 0.004704434424638748
sequence O 0 0.005752866622060537
of O 0 0.008845532312989235
intron O 1 0.9999947547912598
- O 0 0.05553726106882095
exon O 0 0.06916207075119019
borders O 0 0.020081844180822372
. O 0 0.012487906031310558

We O 0 0.006498624105006456
have O 0 0.00177984987385571
also O 0 0.0024897169787436724
mapped O 0 0.007237928919494152
two O 0 0.0015373526839539409
highly O 0 0.008748258464038372
homologous O 0 0.029341047629714012
processed O 0 0.0185470599681139
pseudogenes O 0 0.06703376770019531
, O 0 0.010791243985295296
UBE3AP1 O 1 0.9999979734420776
and O 0 0.008716005831956863
UBE3AP2 O 1 0.9999963045120239
, O 0 0.004470578394830227
to O 0 0.003297751536592841
chromosomes O 0 0.008802883327007294
2 O 0 0.0052477652207016945
and O 0 0.0017166612669825554
21 O 0 0.007663358002901077
, O 0 0.00325756729580462
respectively O 0 0.0064968327060341835
, O 0 0.0021681739017367363
and O 0 0.0018068375065922737
determined O 0 0.005129093769937754
their O 0 0.0027759545482695103
genomic O 0 0.0228718351572752
organization O 0 0.012381958775222301
. O 0 0.009957325644791126

These O 0 0.005831887945532799
results O 0 0.004989198409020901
will O 0 0.0014851444866508245
form O 0 0.0015847469912841916
the O 0 0.0015113947447389364
basis O 0 0.001576235401444137
for O 0 0.001439265557564795
studies O 0 0.003170761978253722
of O 0 0.0041599576361477375
mutation O 0 0.01078218687325716
and O 0 0.005137198138982058
imprinting O 1 0.8523509502410889
of O 0 0.03550765663385391
UBE3A O 1 1.0
. O 0 0.02126230113208294

Mutation O 0 0.03744444251060486
spectrum O 0 0.021401697769761086
and O 0 0.008032158017158508
genotype O 0 0.0545586422085762
- O 0 0.018866118043661118
phenotype O 0 0.015193029306828976
analyses O 0 0.008059059269726276
in O 0 0.0072638364508748055
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.9343363046646118
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.011581194587051868
two O 0 0.010811235755681992
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
with O 1 0.6481794118881226
germline O 1 1.0
PTEN O 1 1.0
mutation O 0 0.06078404560685158
. O 0 0.014873041771352291

The O 0 0.12380099296569824
tumour B-Disease 1 1.0
suppressor O 1 0.9999998807907104
gene O 0 0.10276953130960464
PTEN O 1 0.9999525547027588
, O 0 0.004997094627469778
which O 0 0.0020179706625640392
maps O 0 0.008041296154260635
to O 0 0.006520808674395084
10q23 O 1 0.8745100498199463
. O 0 0.014176209457218647

3 O 0 0.019426506012678146
and O 0 0.004749498330056667
encodes O 0 0.013923201709985733
a O 0 0.005850670393556356
403 O 0 0.04553918167948723
amino O 0 0.015383068472146988
acid O 0 0.020880861207842827
dual O 0 0.02939649298787117
specificity O 0 0.03614308312535286
phosphatase O 1 0.9786880016326904
( O 0 0.016528330743312836
protein O 0 0.019073065370321274
tyrosine O 0 0.04944285750389099
phosphatase O 1 0.5154080390930176
; O 0 0.008530635386705399
PTPase O 1 0.9993033409118652
) O 0 0.006150982808321714
, O 0 0.0029971927870064974
was O 0 0.006872497033327818
shown O 0 0.004307552706450224
recently O 0 0.004114813636988401
to O 0 0.0012629763223230839
play O 0 0.001615274348296225
a O 0 0.0020909130107611418
broad O 0 0.006786440499126911
role O 0 0.008801127783954144
in O 0 0.007232462055981159
human O 0 0.3121987283229828
malignancy B-Disease 1 1.0
. O 0 0.02577033080160618

Somatic O 1 0.9996569156646729
PTEN O 1 0.9999896287918091
deletions O 0 0.04364663362503052
and O 0 0.005564393941313028
mutations O 0 0.005980930291116238
were O 0 0.0017531950725242496
observed O 0 0.002786494791507721
in O 0 0.003280465491116047
sporadic B-Disease 1 0.8333897590637207
breast I-Disease 1 1.0
, I-Disease 0 0.046520162373781204
brain I-Disease 1 0.9999997615814209
, I-Disease 0 0.03205360844731331
prostate I-Disease 1 1.0
and I-Disease 1 0.9999985694885254
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999967813491821
lines O 0 0.006201113108545542
and O 0 0.0011166055919602513
in O 0 0.0018506073392927647
several O 0 0.0023685223422944546
primary O 0 0.03013472445309162
tumours B-Disease 1 0.9999998807907104
such O 0 0.004505352582782507
as O 0 0.015319368802011013
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 1.0
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9998825788497925

In O 0 0.009586336091160774
addition O 0 0.00980968214571476
, O 0 0.009663578122854233
PTEN O 1 0.9999985694885254
was O 0 0.009337898343801498
identified O 0 0.005470565985888243
as O 0 0.0026758164167404175
the O 0 0.004118551500141621
susceptibility O 0 0.031087713316082954
gene O 0 0.0062348563224077225
for O 0 0.002841157140210271
two O 0 0.007258865982294083
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9999128580093384
CD B-Disease 1 0.9998525381088257
; O 0 0.01032180804759264
MIM O 1 1.0
158350 O 1 0.999911904335022
) O 0 0.005579079035669565
and O 0 0.0038569681346416473
Bannayan B-Disease 1 0.9999970197677612
- I-Disease 1 0.8514894843101501
Zonana I-Disease 1 0.9999966621398926
( I-Disease 0 0.02463001385331154
BZS I-Disease 1 0.9999939203262329
) I-Disease 0 0.0073666381649672985
or I-Disease 0 0.006554914638400078
Ruvalcaba I-Disease 1 0.9999986886978149
- I-Disease 1 0.5767999887466431
Riley I-Disease 1 0.9995315074920654
- I-Disease 1 0.7301723957061768
Smith I-Disease 1 0.9896281957626343
syndrome I-Disease 1 1.0
( O 1 0.9995805621147156
MIM O 1 1.0
153480 O 1 1.0
) O 0 0.018154801800847054
. O 0 0.008865876123309135

Constitutive O 0 0.10979662835597992
DNA O 0 0.019925056025385857
from O 0 0.005336524453014135
37 O 0 0.015436097979545593
CD B-Disease 0 0.018543899059295654
families O 0 0.0033371751196682453
and O 0 0.002312629483640194
seven O 0 0.009685132652521133
BZS B-Disease 1 0.9999591112136841
families O 0 0.008358243852853775
was O 0 0.008367235772311687
screened O 0 0.017562411725521088
for O 0 0.00923570804297924
germline O 1 0.9999582767486572
PTEN O 1 0.9999998807907104
mutations O 0 0.038800910115242004
. O 0 0.013835513032972813

PTEN O 1 0.9999806880950928
mutations O 0 0.01747320592403412
were O 0 0.0035277502611279488
identified O 0 0.0051259854808449745
in O 0 0.002798868576064706
30 O 0 0.004107668064534664
of O 0 0.003671016078442335
37 O 0 0.01614118553698063
( O 0 0.006769671104848385
81 O 0 0.024191491305828094
% O 0 0.00613567465916276
) O 0 0.00445898063480854
CD B-Disease 0 0.015575404278934002
families O 0 0.003596981056034565
, O 0 0.002245154930278659
including O 0 0.0032154310029000044
missense O 0 0.028931817039847374
and O 0 0.00566102983430028
nonsense O 0 0.07078654319047928
point O 0 0.01660778932273388
mutations O 0 0.012194466777145863
, O 0 0.005235212855041027
deletions O 0 0.021691609174013138
, O 0 0.005697946064174175
insertions O 0 0.03157350793480873
, O 0 0.004848343785852194
a O 0 0.007904618047177792
deletion O 1 0.9100102186203003
/ O 1 0.9970928430557251
insertion O 0 0.045172374695539474
and O 0 0.009229480288922787
splice O 1 0.9865753054618835
site O 0 0.028600309044122696
mutations O 0 0.018957404419779778
. O 0 0.008436894044280052

These O 0 0.006443916354328394
mutations O 0 0.00759464455768466
were O 0 0.001878253766335547
scattered O 0 0.004298420622944832
over O 0 0.0026645127218216658
the O 0 0.004961247555911541
entire O 0 0.010569950565695763
length O 0 0.007313297595828772
of O 0 0.008954628370702267
PTEN O 1 1.0
, O 0 0.00294400192797184
with O 0 0.0011291740229353309
the O 0 0.0026300975587219
exception O 0 0.005624056328088045
of O 0 0.0025774447713047266
the O 0 0.0032856049947440624
first O 0 0.003801163053140044
, O 0 0.002619698643684387
fourth O 0 0.009674112312495708
and O 0 0.0033310698345303535
last O 0 0.012010949663817883
exons O 0 0.056954097002744675
. O 0 0.011120617389678955

A O 0 0.02752215415239334
hot O 0 0.04093628749251366
spot O 0 0.027915282174944878
for O 0 0.010875510051846504
PTEN O 1 0.9999990463256836
mutation O 0 0.013254278339445591
in O 0 0.004446664825081825
CD B-Disease 0 0.020679926499724388
was O 0 0.006699028890579939
identified O 0 0.00498241139575839
in O 0 0.0034451738465577364
exon O 0 0.02857181988656521
5 O 0 0.004643321968615055
that O 0 0.0009864959865808487
contains O 0 0.0035638902336359024
the O 0 0.0057541485875844955
PTPase O 1 0.9997660517692566
core O 0 0.02130557782948017
motif O 0 0.0177695844322443
, O 0 0.0017572966171428561
with O 0 0.0010536391055211425
13 O 0 0.0039658513851463795
of O 0 0.0032453034073114395
30 O 0 0.0059446971863508224
( O 0 0.004416887182742357
43 O 0 0.00958353839814663
% O 0 0.004435449372977018
) O 0 0.004304518923163414
CD B-Disease 0 0.01847148686647415
mutations O 0 0.006991327740252018
identified O 0 0.004412507172673941
in O 0 0.0033123029861599207
this O 0 0.0045555708929896355
exon O 0 0.06572838872671127
. O 0 0.010477175936102867

Seven O 0 0.011305190622806549
of O 0 0.007355331908911467
30 O 0 0.01067234855145216
( O 0 0.006256834603846073
23 O 0 0.009577891789376736
% O 0 0.0036184140481054783
) O 0 0.0018009652849286795
were O 0 0.001023584045469761
within O 0 0.001522866659797728
the O 0 0.004387453198432922
core O 0 0.022219758480787277
motif O 0 0.02569223754107952
, O 0 0.0024782675318419933
the O 0 0.002689428860321641
majority O 0 0.002767798490822315
( O 0 0.003044210374355316
five O 0 0.0017192780505865812
of O 0 0.0027241609059274197
seven O 0 0.004889886360615492
) O 0 0.0025169679429382086
of O 0 0.0018696177285164595
which O 0 0.0021218371111899614
were O 0 0.004261537920683622
missense O 0 0.039927560836076736
mutations O 0 0.013487880118191242
, O 0 0.0045487103052437305
possibly O 0 0.008149728178977966
pointing O 0 0.009407220408320427
to O 0 0.0026337774470448494
the O 0 0.004610832314938307
functional O 0 0.008955107070505619
significance O 0 0.008522271178662777
of O 0 0.004999455995857716
this O 0 0.003484510350972414
region O 0 0.014618376269936562
. O 0 0.008949307724833488

Germline O 1 0.999987006187439
PTEN O 1 0.9999967813491821
mutations O 0 0.015483907423913479
were O 0 0.0024582433979958296
identified O 0 0.0031773943919688463
in O 0 0.001308797742240131
four O 0 0.0012772510526701808
of O 0 0.002374176401644945
seven O 0 0.0045714895240962505
( O 0 0.00499187596142292
57 O 0 0.014999931678175926
% O 0 0.006658372934907675
) O 0 0.009888699278235435
BZS B-Disease 1 0.9986221790313721
families O 0 0.012578419409692287
studied O 0 0.026205047965049744
. O 0 0.01293402910232544

Interestingly O 0 0.05524302273988724
, O 0 0.005462820176035166
none O 0 0.004126091953366995
of O 0 0.0027508288621902466
these O 0 0.0019733028020709753
mutations O 0 0.007207921240478754
was O 0 0.004692780319601297
observed O 0 0.0037162532098591328
in O 0 0.00322187808342278
the O 0 0.00895771011710167
PTPase O 1 0.9999616146087646
core O 0 0.05587460845708847
motif O 0 0.06993382424116135
. O 0 0.01405294518917799

It O 0 0.005217398051172495
is O 0 0.0030334480106830597
also O 0 0.003502524457871914
worthy O 0 0.012432177551090717
of O 0 0.003863269928842783
note O 0 0.005720111075788736
that O 0 0.0013691493077203631
a O 0 0.002723335986956954
single O 0 0.005119156092405319
nonsense O 0 0.017232300713658333
point O 0 0.009330198168754578
mutation O 0 0.010050124488770962
, O 0 0.0041101048700511456
R233X O 1 0.7459125518798828
, O 0 0.0036784110125154257
was O 0 0.0048612868413329124
observed O 0 0.002940885256975889
in O 0 0.0025624618865549564
the O 0 0.0057474360801279545
germline O 0 0.05282190442085266
DNA O 0 0.007767736446112394
from O 0 0.002104249782860279
two O 0 0.0017844457179307938
unrelated O 0 0.013644828461110592
CD B-Disease 0 0.024441365152597427
families O 0 0.005424549803137779
and O 0 0.003810227382928133
one O 0 0.008239214308559895
BZS B-Disease 1 0.9999986886978149
family O 0 0.03401830047369003
. O 0 0.01321075763553381

Genotype O 1 0.9739970564842224
- O 0 0.05356569215655327
phenotype O 0 0.025202324613928795
studies O 0 0.005052532535046339
were O 0 0.002223410177975893
not O 0 0.0012219585478305817
performed O 0 0.005042052362114191
on O 0 0.002398872748017311
this O 0 0.001255793496966362
small O 0 0.002246649470180273
group O 0 0.0037798185367137194
of O 0 0.011678195558488369
BZS B-Disease 1 0.9999991655349731
families O 0 0.027315204963088036
. O 0 0.013844241388142109

However O 0 0.016395526006817818
, O 0 0.012352773919701576
genotype O 0 0.058594342321157455
- O 0 0.02196749486029148
phenotype O 0 0.01735825650393963
analysis O 0 0.004823816940188408
inthe O 0 0.03686533495783806
group O 0 0.004242682829499245
of O 0 0.005377827677875757
CD B-Disease 0 0.042071256786584854
families O 0 0.005483511369675398
revealed O 0 0.00886555016040802
two O 0 0.0014260208699852228
possible O 0 0.002875144360587001
associations O 0 0.00506743835285306
worthy O 0 0.015052621252834797
of O 0 0.0055822036229074
follow O 0 0.00923781655728817
- O 0 0.010542904026806355
up O 0 0.002354241907596588
in O 0 0.0023320207837969065
independent O 0 0.004028576426208019
analyses O 0 0.01405566930770874
. O 0 0.00808554608374834

The O 0 0.012214320711791515
first O 0 0.006906414870172739
was O 0 0.006674448028206825
an O 0 0.0027640105690807104
association O 0 0.008587523363530636
noted O 0 0.004818902816623449
in O 0 0.0018188725225627422
the O 0 0.0025290122721344233
group O 0 0.00190687773283571
of O 0 0.00332959764637053
CD B-Disease 0 0.07005590945482254
families O 0 0.006818088237196207
with O 0 0.0073950509540736675
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.05738167464733124

A O 0 0.02282358519732952
correlation O 0 0.015662729740142822
was O 0 0.006271557416766882
observed O 0 0.0033565338235348463
between O 0 0.0028268974274396896
the O 0 0.0049432506784796715
presence O 0 0.010666556656360626
/ O 0 0.04025648906826973
absence O 0 0.01114656776189804
of O 0 0.0070493449456989765
a O 0 0.01508070807904005
PTEN O 1 1.0
mutation O 0 0.008242691867053509
and O 0 0.0017012001480907202
the O 0 0.003877270268276334
type O 0 0.013063940219581127
of O 0 0.013804188929498196
breast O 1 1.0
involvement O 1 0.9999897480010986
( O 0 0.03726375848054886
unaffected O 1 0.8707912564277649
versus O 1 0.986271858215332
benign O 1 0.9999996423721313
versus O 1 0.9999983310699463
malignant O 1 1.0
) O 0 0.024017062038183212
. O 0 0.012894470244646072

Specifically O 0 0.013515671715140343
and O 0 0.002652627881616354
more O 0 0.0012257624184712768
directly O 0 0.0028380975127220154
, O 0 0.002295464277267456
an O 0 0.0025668384041637182
association O 0 0.010430596768856049
was O 0 0.0072572920471429825
also O 0 0.0027063265442848206
observed O 0 0.0025082628708332777
between O 0 0.001610049162991345
the O 0 0.0021718349307775497
presence O 0 0.003190327435731888
of O 0 0.004366184119135141
a O 0 0.011399981565773487
PTEN O 1 1.0
mutation O 0 0.026089534163475037
and O 0 0.01622479222714901
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9914509654045105

Secondly O 0 0.22894881665706635
, O 0 0.006625035777688026
there O 0 0.0034873425029218197
appeared O 0 0.005703764967620373
to O 0 0.0016990992007777095
be O 0 0.0015063673490658402
an O 0 0.002978553296998143
interdependent O 0 0.06094414368271828
association O 0 0.01732771284878254
between O 0 0.008192782290279865
mutations O 0 0.014320746064186096
upstream O 0 0.013056755065917969
and O 0 0.0018985330825671554
within O 0 0.0026326002553105354
the O 0 0.007896876893937588
PTPase O 1 0.9999978542327881
core O 0 0.03466223180294037
motif O 0 0.026813223958015442
, O 0 0.0036100721918046474
the O 0 0.005317667964845896
core O 0 0.017270328477025032
motif O 0 0.022274494171142578
containing O 0 0.006099695339798927
the O 0 0.0037415986880660057
majority O 0 0.003151783486828208
of O 0 0.006491448730230331
missense O 0 0.065394826233387
mutations O 0 0.010678574442863464
, O 0 0.003106968244537711
and O 0 0.0016032822895795107
the O 0 0.0037152254953980446
involvement O 0 0.009211973287165165
of O 0 0.005258247256278992
all O 0 0.003330501262098551
major O 0 0.022617358714342117
organ O 1 0.9999991655349731
systems O 1 0.5267950296401978
( O 0 0.009876618161797523
central O 0 0.01688685268163681
nervous O 1 0.9059335589408875
system O 0 0.00872455071657896
, O 0 0.007280800957232714
thyroid O 1 1.0
, O 1 0.9589136242866516
breast O 1 1.0
, O 1 0.9989200830459595
skin O 1 1.0
and O 1 0.9999885559082031
gastrointestinal O 1 1.0
tract O 1 1.0
) O 1 0.9997754693031311
. O 0 0.01499822549521923

However O 0 0.01260191760957241
, O 0 0.0043167369440197945
these O 0 0.0017494236817583442
observations O 0 0.006111909169703722
would O 0 0.0018991251708939672
need O 0 0.0024273283779621124
to O 0 0.0013982292730361223
be O 0 0.0009505026391707361
confirmed O 0 0.002968722255900502
by O 0 0.0009770250180736184
studying O 0 0.003835381008684635
a O 0 0.0024590829852968454
larger O 0 0.0022065495140850544
number O 0 0.0020261015743017197
of O 0 0.005460841581225395
CD B-Disease 0 0.13612744212150574
families O 0 0.013714635744690895
. O 0 0.010806707665324211

Molecular O 0 0.2782277464866638
defects O 1 0.9999853372573853
leading O 0 0.017089946195483208
to O 0 0.004505397751927376
human O 0 0.010137940756976604
complement B-Disease 1 0.8556568026542664
component I-Disease 1 0.9999995231628418
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.008159798569977283
an O 0 0.0043254150077700615
African O 0 0.01777379773557186
- O 0 0.015958162024617195
American O 0 0.0070688771083951
family O 0 0.011678816750645638
. O 0 0.008059687912464142

Complement B-Disease 0 0.19077706336975098
component I-Disease 1 0.9999955892562866
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9989927411079407
C6D B-Disease 1 1.0
) O 0 0.00802403874695301
was O 0 0.009525075554847717
diagnosed O 1 1.0
in O 0 0.0033823633566498756
a O 0 0.00415872922167182
16 O 0 0.007574164774268866
- O 0 0.009988388046622276
year O 0 0.003618322778493166
- O 0 0.00766672333702445
old O 0 0.009731222875416279
African O 0 0.010025630705058575
- O 0 0.010140572674572468
American O 0 0.007281235884875059
male O 0 0.012629146687686443
with O 0 0.010949884541332722
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.661161482334137

The O 0 0.025063568726181984
patients O 1 0.9987119436264038
father O 0 0.04718473553657532
and O 0 0.0034900614991784096
two O 0 0.002578309504315257
brothers O 0 0.015056934207677841
also O 0 0.005204938817769289
had O 0 0.009070525877177715
C6D B-Disease 1 0.9999998807907104
, O 0 0.0032423967495560646
but O 0 0.001103328075259924
gave O 0 0.002804234391078353
no O 0 0.0016460613114759326
history O 0 0.0056146238930523396
of O 0 0.011045416817069054
meningitis B-Disease 1 1.0
or O 0 0.018507549539208412
other O 0 0.009210883639752865
neisserial B-Disease 1 0.9999998807907104
infection I-Disease 1 1.0
. O 0 0.02266913279891014

By O 0 0.007533901371061802
using O 0 0.008763802237808704
exon O 0 0.05871155112981796
- O 0 0.013809877447783947
specific O 0 0.00467767333611846
polymerase O 0 0.02843412384390831
chain O 0 0.018679803237318993
reaction O 0 0.010771064087748528
( O 0 0.012091324664652348
PCR O 0 0.05231275036931038
) O 0 0.008506604470312595
/ O 0 0.027377421036362648
single O 0 0.008361462503671646
- O 0 0.020049745216965675
strand O 0 0.019189370796084404
conformation O 0 0.017360689118504524
polymorphism O 0 0.010987372137606144
as O 0 0.002283902373164892
a O 0 0.0038798705209046602
screening O 0 0.010938910767436028
step O 0 0.008236728608608246
and O 0 0.002682615304365754
nucleotide O 0 0.009929263032972813
sequencing O 0 0.005512958858162165
of O 0 0.0037453919649124146
target O 0 0.007466149982064962
exons O 0 0.01703893393278122
, O 0 0.0019481575582176447
we O 0 0.0009432812803424895
determined O 0 0.002690037479624152
that O 0 0.0008948351605795324
the O 0 0.004111777991056442
proband O 1 0.7526411414146423
was O 0 0.00855947658419609
a O 0 0.004938174970448017
compound O 0 0.02287493459880352
heterozygote O 0 0.040705036371946335
for O 0 0.0033642183989286423
two O 0 0.0052837892435491085
C6 O 1 1.0
gene O 0 0.027202492579817772
mutations O 0 0.016807127743959427
. O 0 0.010822566226124763

The O 0 0.010418067686259747
first O 0 0.0072430395521223545
, O 0 0.004918619059026241
1195delC O 0 0.10371948778629303
located O 0 0.009780190885066986
in O 0 0.004937214311212301
exon O 0 0.038579024374485016
7 O 0 0.008380668237805367
, O 0 0.001953861443325877
is O 0 0.001584141980856657
a O 0 0.0029362968634814024
novel O 0 0.012231869623064995
mutation O 0 0.0064198337495327
, O 0 0.001897337264381349
while O 0 0.0019032936543226242
the O 0 0.0034241063985973597
second O 0 0.007343803066760302
, O 0 0.0042174081318080425
1936delG O 1 0.5742148160934448
in O 0 0.006753258407115936
exon O 0 0.04673466086387634
12 O 0 0.006803187076002359
, O 0 0.002095865784212947
has O 0 0.0016788768116384745
been O 0 0.0018888786435127258
described O 0 0.005126257427036762
before O 0 0.0033358128275722265
to O 0 0.003125054994598031
cause O 0 0.016988247632980347
C6D B-Disease 1 0.9999951124191284
in O 0 0.0047080256044864655
an O 0 0.003018567804247141
unrelated O 0 0.017855951562523842
African O 0 0.025609593838453293
- O 0 0.021017659455537796
American O 0 0.008409851230680943
individual O 0 0.006764030549675226
. O 0 0.007868862710893154

Both O 0 0.00808712188154459
mutations O 0 0.00990082137286663
result O 0 0.003908729646354914
in O 0 0.006306312046945095
premature O 1 0.9997326731681824
termination O 1 0.9996125102043152
codons O 0 0.16342835128307343
and O 0 0.011362158693373203
C6 O 1 0.9999998807907104
null O 0 0.061739228665828705
alleles O 0 0.0427895188331604
. O 0 0.01251339353621006

Allele O 0 0.07500611245632172
- O 0 0.025640467181801796
specific O 0 0.00617979746311903
PCR O 0 0.028134025633335114
indicated O 0 0.0056635532528162
that O 0 0.0013163118856027722
the O 0 0.004220851697027683
probands O 0 0.04335901513695717
two O 0 0.0029751539696007967
brothers O 0 0.013576229102909565
also O 0 0.006752417888492346
inherited O 1 0.9890303015708923
the O 0 0.014677903614938259
1195delC O 1 0.9999078512191772
mutation O 0 0.010519442148506641
from O 0 0.002515961416065693
their O 0 0.0020327363163232803
heterozygous O 0 0.011292528361082077
mother O 0 0.010157199576497078
and O 0 0.002062760293483734
the O 0 0.00676465779542923
1936delG O 1 0.9997182488441467
mutation O 0 0.006635571829974651
from O 0 0.00204266095533967
their O 0 0.0025621524546295404
homozygous O 0 0.0215825866907835
father O 0 0.022569935768842697
. O 0 0.005555032752454281
. O 0 0.0071015371941030025

PAX6 O 1 0.9999945163726807
mutations O 0 0.052815020084381104
reviewed O 0 0.03765399754047394
. O 0 0.016876164823770523

Mutations O 0 0.030127564445137978
in O 0 0.01086271833628416
PAX6 O 1 0.9999988079071045
are O 0 0.002402756130322814
responsible O 0 0.006523955147713423
for O 0 0.004625472705811262
human O 0 0.48202377557754517
aniridia B-Disease 1 1.0
and O 0 0.003479311941191554
have O 0 0.0010029628174379468
also O 0 0.0014934941427782178
been O 0 0.0014433433534577489
found O 0 0.0021001906134188175
in O 0 0.002938572084531188
patients O 1 0.9879137873649597
with O 0 0.005655171349644661
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 0.014469349756836891
with O 1 0.7202672362327576
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9999997615814209
with O 1 0.9575079083442688
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 0 0.013080606237053871
and O 0 0.0035265956539660692
with O 0 0.00544818164780736
isolated B-Disease 1 0.9999988079071045
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.8469887375831604

No O 0 0.014574932865798473
locus O 0 0.03149183467030525
other O 0 0.002899897750467062
than O 0 0.0031165650580078363
chromosome O 0 0.020122839137911797
11p13 O 1 0.5662592649459839
has O 0 0.003099974012002349
been O 0 0.003932008985430002
implicated O 0 0.27702897787094116
in O 0 0.011829648166894913
aniridia B-Disease 1 1.0
, O 0 0.010019377805292606
and O 0 0.010062395595014095
PAX6 O 1 1.0
is O 0 0.007476974278688431
clearly O 0 0.0064202407374978065
the O 0 0.003929448779672384
major O 0 0.007461611181497574
, O 0 0.003037517424672842
if O 0 0.0013160868547856808
not O 0 0.0007404614589177072
only O 0 0.0012650856515392661
, O 0 0.0036738773342221975
gene O 0 0.010041016153991222
responsible O 0 0.013021029531955719
. O 0 0.01105250883847475

Twenty O 0 0.03901602700352669
- O 0 0.01496359147131443
eight O 0 0.004428707994520664
percent O 0 0.0035399491898715496
of O 0 0.003892777021974325
identified O 0 0.020044850185513496
PAX6 O 1 0.9999997615814209
mutations O 0 0.014736663550138474
are O 0 0.003147259820252657
C O 1 0.7711819410324097
- O 0 0.055084530264139175
T O 0 0.07369236648082733
changes O 0 0.0038407754618674517
at O 0 0.01043322030454874
CpG O 1 0.5887385606765747
dinucleotides O 1 0.9904290437698364
, O 0 0.005471027921885252
20 O 0 0.006405110936611891
% O 0 0.003567908890545368
are O 0 0.0017902104882523417
splicing O 0 0.02122890017926693
errors O 0 0.015759577974677086
, O 0 0.004513176158070564
and O 0 0.002326701767742634
more O 0 0.0013148222351446748
than O 0 0.0017326384549960494
30 O 0 0.0057351551949977875
% O 0 0.0034405733458697796
are O 0 0.0016716246027499437
deletion O 0 0.02335805632174015
or O 0 0.008621765300631523
insertion O 0 0.04644488915801048
events O 0 0.01910800114274025
. O 0 0.01364122238010168

There O 0 0.00939202681183815
is O 0 0.0063149393536150455
a O 0 0.008668201044201851
noticeably O 0 0.048499926924705505
elevated O 1 0.9258408546447754
level O 0 0.009201506152749062
of O 0 0.005516319535672665
mutation O 0 0.007650415878742933
in O 0 0.003085486823692918
the O 0 0.005021760240197182
paired O 0 0.011752119287848473
domain O 0 0.006771530490368605
compared O 0 0.00315959588624537
with O 0 0.0012563031632453203
the O 0 0.0034588989801704884
rest O 0 0.005695114843547344
of O 0 0.00437673507258296
the O 0 0.009533817879855633
gene O 0 0.017275370657444
. O 0 0.0076949335634708405

Increased O 0 0.019151657819747925
mutation O 0 0.011183017864823341
in O 0 0.004185843747109175
the O 0 0.007788363378494978
homeodomain O 1 0.9946205615997314
is O 0 0.003936590161174536
accounted O 0 0.005762152839452028
for O 0 0.0016680664848536253
by O 0 0.0020778211764991283
the O 0 0.010232140310108662
hypermutable O 1 0.9999762773513794
CpG O 1 0.9948727488517761
dinucleotide O 1 0.9810847043991089
in O 0 0.013090656138956547
codon O 0 0.05612274631857872
240 O 0 0.03782249242067337
. O 0 0.011686393059790134

Very O 0 0.01073917280882597
nearly O 0 0.007424390409141779
all O 0 0.0026449887081980705
mutations O 0 0.007800779305398464
appear O 0 0.00467957416549325
to O 0 0.0031370522920042276
cause O 0 0.014988057315349579
loss O 0 0.03895982354879379
of O 0 0.008334674872457981
function O 0 0.007921616546809673
of O 0 0.006680011749267578
the O 0 0.010196478106081486
mutant O 0 0.03609378635883331
allele O 0 0.009392186999320984
, O 0 0.0017210990190505981
and O 0 0.000920207123272121
more O 0 0.0006549858371727169
than O 0 0.0010089720599353313
80 O 0 0.004823445808142424
% O 0 0.0027678338810801506
of O 0 0.004536919295787811
exonic O 1 0.9934476017951965
substitutions O 0 0.021306689828634262
result O 0 0.00628353375941515
in O 0 0.009180251508951187
nonsense O 0 0.06761390715837479
codons O 0 0.07094224542379379
. O 0 0.014052550308406353

In O 0 0.00986776314675808
a O 0 0.006856142543256283
gene O 0 0.005618386901915073
with O 0 0.0012507799547165632
such O 0 0.0022354896645992994
extraordinarily O 0 0.03145036846399307
high O 0 0.012397940270602703
sequence O 0 0.00619957922026515
conservation O 0 0.0062364377081394196
throughout O 0 0.0027595742139965296
evolution O 0 0.004977799020707607
, O 0 0.0018354547210037708
there O 0 0.0018873276421800256
are O 0 0.0022770152427256107
presumed O 0 0.0369374081492424
undiscovered O 1 0.9701486825942993
missense O 0 0.0895676463842392
mutations O 0 0.016085440292954445
, O 0 0.003410027828067541
these O 0 0.001561066135764122
are O 0 0.0012786953011527658
hypothesized O 0 0.012626790441572666
to O 0 0.0025248732417821884
exist O 0 0.003210589988157153
in O 0 0.0037178918719291687
as O 0 0.0057054846547544
- O 0 0.016010506078600883
yet O 0 0.006343596149235964
unidentified O 0 0.03244563937187195
phenotypes O 0 0.036420684307813644
. O 0 0.006331159267574549
. O 0 0.009365095756947994

Genetic O 0 0.049771346151828766
heterogeneity O 0 0.0579572431743145
and O 0 0.008626522496342659
penetrance O 0 0.059743817895650864
analysis O 0 0.004438979551196098
of O 0 0.0060487971641123295
the O 0 0.010294051840901375
BRCA1 O 1 0.9999406337738037
and O 0 0.007354934699833393
BRCA2 O 1 0.9999974966049194
genes O 0 0.012098424136638641
in O 0 0.01170801930129528
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.03156675025820732
. O 0 0.013208717107772827

The O 1 0.9495299458503723
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999998807907104
Consortium O 0 0.0450829453766346
. O 0 0.012526138685643673

The O 0 0.010190904140472412
contribution O 0 0.014053408056497574
of O 0 0.009028211236000061
BRCA1 O 1 0.9998846054077148
and O 0 0.007680996786803007
BRCA2 O 1 0.9999995231628418
to O 0 0.018572542816400528
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.999998927116394
assessed O 0 0.02223508432507515
by O 0 0.002880231710150838
linkage O 0 0.016143174842000008
and O 0 0.0025647368747740984
mutation O 0 0.005640838760882616
analysis O 0 0.0026720475871115923
in O 0 0.0029036710038781166
237 O 0 0.026384418830275536
families O 0 0.003139875130727887
, O 0 0.0013529601274058223
each O 0 0.0007546917768195271
with O 0 0.0009106514626182616
at O 0 0.002887612907215953
least O 0 0.0011472107144072652
four O 0 0.0013313700910657644
cases O 0 0.003698587417602539
of O 0 0.01688508503139019
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.004073947202414274
collected O 0 0.00281337508931756
by O 0 0.0015469120116904378
the O 0 0.010135299526154995
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999998807907104
Consortium O 0 0.03684737905859947
. O 0 0.008501836098730564

Families O 0 0.012278913520276546
were O 0 0.003319347044453025
included O 0 0.003505788277834654
without O 0 0.0020746716763824224
regard O 0 0.0045277890749275684
to O 0 0.0020430816803127527
the O 0 0.003377022920176387
occurrence O 0 0.02248246967792511
of O 1 0.5361267328262329
ovarian B-Disease 1 1.0
or I-Disease 1 0.8801240921020508
other I-Disease 0 0.013995766639709473
cancers I-Disease 1 1.0
. O 0 0.021429648622870445

Overall O 1 0.7424386143684387
, O 0 0.014886296354234219
disease O 1 1.0
was O 1 0.5377420783042908
linked O 0 0.02956734225153923
to O 0 0.005616384092718363
BRCA1 O 1 0.9992139339447021
in O 0 0.003401408204808831
an O 0 0.0024976138956844807
estimated O 0 0.005164123605936766
52 O 0 0.010049655102193356
% O 0 0.0025182454846799374
of O 0 0.0022359055001288652
families O 0 0.0038425528910011053
, O 0 0.003253080416470766
to O 0 0.004230564925819635
BRCA2 O 1 0.9958930015563965
in O 0 0.005237582605332136
32 O 0 0.010652813129127026
% O 0 0.002663956256583333
of O 0 0.0024922736920416355
families O 0 0.004181950353085995
, O 0 0.0025779204443097115
and O 0 0.0020770588889718056
to O 0 0.0024553053081035614
neither O 0 0.006330955773591995
gene O 0 0.004596985410898924
in O 0 0.002373762894421816
16 O 0 0.007081043440848589
% O 0 0.004113387316465378
( O 0 0.005360379349440336
95 O 0 0.010439173318445683
% O 0 0.004729284439235926
confidence O 0 0.013129696249961853
interval O 0 0.02414853684604168
[ O 0 0.03792687505483627
CI O 1 0.9999995231628418
] O 0 0.026229994371533394
6 O 0 0.011474383063614368
% O 0 0.0057553984224796295
- O 0 0.009546675719320774
28 O 0 0.00834432803094387
% O 0 0.00400423351675272
) O 0 0.0027908561751246452
, O 0 0.0023983113933354616
suggesting O 0 0.008820009417831898
other O 0 0.004794957581907511
predisposition O 1 0.9993271827697754
genes O 0 0.025452040135860443
. O 0 0.013770624995231628

The O 0 0.011620461009442806
majority O 0 0.006350639276206493
( O 0 0.007011277601122856
81 O 0 0.014936191961169243
% O 0 0.0031288766767829657
) O 0 0.001751587027683854
of O 0 0.0026235387194901705
the O 0 0.024307379499077797
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.01529492437839508
were O 0 0.003685210132971406
due O 0 0.005482029635459185
to O 0 0.004943097475916147
BRCA1 O 1 0.9995304346084595
, O 0 0.0026293746195733547
with O 0 0.0010864255018532276
most O 0 0.0014775848248973489
others O 0 0.0027698588091880083
( O 0 0.0049114287830889225
14 O 0 0.006653782911598682
% O 0 0.003697469597682357
) O 0 0.0029893037863075733
due O 0 0.005932385567575693
to O 0 0.009377876296639442
BRCA2 O 1 0.9999980926513672
. O 0 0.01716136373579502

Conversely O 0 0.04194493964314461
, O 0 0.0039043580181896687
the O 0 0.003220510669052601
majority O 0 0.002047679852694273
of O 0 0.002348120091482997
families O 0 0.002918440382927656
with O 0 0.0018511589150875807
male B-Disease 0 0.009012504480779171
and I-Disease 0 0.004592608194798231
female I-Disease 1 0.9999556541442871
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.007160954177379608
due O 0 0.00869227945804596
to O 0 0.0075072296895086765
BRCA2 O 1 0.9999982118606567
( O 0 0.01202582847326994
76 O 0 0.039824459701776505
% O 0 0.0083005977794528
) O 0 0.00787041150033474
. O 0 0.006069375667721033

The O 0 0.014085422269999981
largest O 0 0.018174558877944946
proportion O 0 0.012093501165509224
( O 0 0.006740301847457886
67 O 0 0.016170227900147438
% O 0 0.003900643438100815
) O 0 0.0022949969861656427
of O 0 0.0021630001720041037
families O 0 0.003493879223242402
due O 0 0.004204282071441412
to O 0 0.002440833719447255
other O 0 0.002099670236930251
genes O 0 0.004871532320976257
was O 0 0.005215460434556007
found O 0 0.0025860979221761227
in O 0 0.0018966294592246413
families O 0 0.0019926652312278748
with O 0 0.0009655607864260674
four O 0 0.0017156562535092235
or O 0 0.0016060774214565754
five O 0 0.0018554703565314412
cases O 0 0.00411355122923851
of O 0 0.011317926459014416
female O 1 0.9999992847442627
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
only O 0 0.016613956540822983
. O 0 0.013047566637396812

These O 0 0.007117293309420347
estimates O 0 0.008420395664870739
were O 0 0.0027253024745732546
not O 0 0.0023109184112399817
substantially O 0 0.009514164179563522
affected O 0 0.004552916157990694
either O 0 0.0022506690584123135
by O 0 0.0013043201761320233
changing O 0 0.005765782203525305
the O 0 0.005170717369765043
assumed O 0 0.027998169884085655
penetrance O 1 0.6687199473381042
model O 0 0.010378431528806686
for O 0 0.007117835339158773
BRCA1 O 1 0.9986020922660828
or O 0 0.003634385298937559
by O 0 0.0014586796751245856
including O 0 0.0036450219340622425
or O 0 0.008671171963214874
excluding O 0 0.05206657573580742
BRCA1 O 1 0.9999959468841553
mutation O 0 0.021144390106201172
data O 0 0.009099019691348076
. O 0 0.009393605403602123

Among O 0 0.008766536600887775
those O 0 0.002624432323500514
families O 0 0.005289049353450537
with O 0 0.0055603692308068275
disease O 1 1.0
due O 1 0.9968935251235962
to O 0 0.01671677641570568
BRCA1 O 1 0.9999943971633911
that O 0 0.0020473941694945097
were O 0 0.0017795938765630126
tested O 0 0.006008266471326351
by O 0 0.0008435694617219269
one O 0 0.0012231370201334357
of O 0 0.0026395528111606836
the O 0 0.005095479544252157
standard O 0 0.00952826626598835
screening O 0 0.00826019886881113
methods O 0 0.004793590400367975
, O 0 0.0033411881886422634
mutations O 0 0.004800870548933744
were O 0 0.0018285511760041118
detected O 0 0.006435729563236237
in O 0 0.002781549235805869
the O 0 0.005873449146747589
coding O 0 0.026546254754066467
sequence O 0 0.006748280953615904
or O 0 0.003933547995984554
splice O 0 0.0230975653976202
sites O 0 0.0027876931708306074
in O 0 0.0019302453147247434
an O 0 0.0021235712338238955
estimated O 0 0.006195490714162588
63 O 0 0.017648622393608093
% O 0 0.005143859889358282
( O 0 0.005510893650352955
95 O 0 0.012474935501813889
% O 0 0.008760489523410797
CI O 1 0.9999531507492065
51 O 0 0.03528238832950592
% O 0 0.009770441800355911
- O 0 0.018912602216005325
77 O 0 0.02548489347100258
% O 0 0.009287731721997261
) O 0 0.007446229923516512
. O 0 0.007191427983343601

The O 0 0.016363412141799927
estimated O 0 0.014429369010031223
sensitivity O 0 0.016563571989536285
was O 0 0.0076799276284873486
identical O 0 0.004112711641937494
for O 0 0.002352598123252392
direct O 0 0.004360235296189785
sequencing O 0 0.00797212589532137
and O 0 0.002095838077366352
other O 0 0.002634522970765829
techniques O 0 0.01811201497912407
. O 0 0.010525698773562908

The O 0 0.02150697261095047
penetrance O 1 0.9497004151344299
of O 0 0.023715313524007797
BRCA2 O 1 0.9999994039535522
was O 0 0.013099048286676407
estimated O 0 0.004985939711332321
by O 0 0.0019414196722209454
maximizing O 0 0.02133096754550934
the O 0 0.008416375145316124
LOD O 1 0.9999877214431763
score O 0 0.009898204356431961
in O 0 0.009785936214029789
BRCA2 O 1 0.9999964237213135
- O 0 0.032536830753088
mutation O 0 0.008354407735168934
families O 0 0.002511619823053479
, O 0 0.0017720304895192385
over O 0 0.0017530565382912755
all O 0 0.0016745013417676091
possible O 0 0.00806363858282566
penetrance O 1 0.9206094741821289
functions O 0 0.015262998640537262
. O 0 0.01064731553196907

The O 0 0.011205973103642464
estimated O 0 0.013243206776678562
cumulative O 0 0.025498315691947937
risk O 0 0.012968835420906544
of O 0 0.01642674393951893
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
reached O 0 0.11917820572853088
28 O 0 0.012940063141286373
% O 0 0.003546510124579072
( O 0 0.00393173610791564
95 O 0 0.009730400517582893
% O 0 0.008206813596189022
CI O 1 0.9999974966049194
9 O 0 0.02048884704709053
% O 0 0.006970072630792856
- O 0 0.009931419976055622
44 O 0 0.009061504155397415
% O 0 0.0032827751711010933
) O 0 0.0019298457773402333
by O 0 0.0008075343212112784
age O 0 0.004281847737729549
50 O 0 0.0038645120803266764
years O 0 0.002676754491403699
and O 0 0.00235870573669672
84 O 0 0.02077299915254116
% O 0 0.005073618143796921
( O 0 0.005302427802234888
95 O 0 0.012089798226952553
% O 0 0.008431367576122284
CI O 1 0.9999980926513672
43 O 0 0.025320254266262054
% O 0 0.007996826432645321
- O 0 0.010578500106930733
95 O 0 0.008760315366089344
% O 0 0.002970719011500478
) O 0 0.0019117610063403845
by O 0 0.0011511539341881871
age O 0 0.006913856137543917
70 O 0 0.011928929947316647
years O 0 0.010540497489273548
. O 0 0.00997762382030487

The O 0 0.024133745580911636
corresponding O 1 0.999219536781311
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9999992847442627
were O 0 0.014837251976132393
0 O 0 0.028208686038851738
. O 0 0.007824564352631569

4 O 0 0.024370506405830383
% O 0 0.008441074751317501
( O 0 0.006838904693722725
95 O 0 0.013900385238230228
% O 0 0.009341567754745483
CI O 1 0.9999830722808838
0 O 0 0.0238045621663332
% O 0 0.007324951700866222
- O 0 0.010979555547237396
1 O 0 0.007820379920303822
% O 0 0.002902157139033079
) O 0 0.001807941123843193
by O 0 0.001058694557286799
age O 0 0.004926733206957579
50 O 0 0.003896824549883604
years O 0 0.0026546092703938484
and O 0 0.00222498900257051
27 O 0 0.011239833198487759
% O 0 0.004579421132802963
( O 0 0.004611970856785774
95 O 0 0.011349096894264221
% O 0 0.008753799833357334
CI O 1 0.9999972581863403
0 O 0 0.022197023034095764
% O 0 0.0061010075733065605
- O 0 0.009729963727295399
47 O 0 0.01200961321592331
% O 0 0.003830299712717533
) O 0 0.0022796059492975473
by O 0 0.0012522913748398423
age O 0 0.007326054852455854
70 O 0 0.013012667186558247
years O 0 0.011297608725726604
. O 0 0.010873482562601566

The O 0 0.019276300445199013
lifetime O 0 0.043422311544418335
risk O 0 0.025636939331889153
of O 1 0.9817848205566406
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 0 0.02990117110311985
similar O 0 0.0025240930262953043
to O 0 0.0018814558861777186
the O 0 0.004173935856670141
risk O 0 0.011679599061608315
in O 0 0.010510725900530815
BRCA1 O 1 0.9999998807907104
carriers O 0 0.013714796863496304
, O 0 0.0029163293074816465
but O 0 0.001394685823470354
there O 0 0.0015011635841801763
was O 0 0.0035796561278402805
some O 0 0.001064108801074326
suggestion O 0 0.007057232782244682
of O 0 0.0037546465173363686
a O 0 0.006725900340825319
lower O 0 0.021649297326803207
risk O 0 0.013271825388073921
in O 0 0.009671331383287907
BRCA2 O 1 0.9999877214431763
carriers O 0 0.024447277188301086
< O 0 0.035136424005031586
50 O 0 0.00534451799467206
years O 0 0.0037761323619633913
of O 0 0.006351581308990717
age O 0 0.020538976415991783
. O 0 0.014082761481404305

Eye B-Disease 1 0.9999953508377075
movement I-Disease 0 0.04933521896600723
abnormalities I-Disease 1 0.9998546838760376
correlate O 0 0.02416277676820755
with O 0 0.0041714999824762344
genotype O 0 0.032539721578359604
in O 0 0.007580992300063372
autosomal O 1 0.9999997615814209
dominant O 1 0.9999997615814209
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 0.024572905153036118

We O 0 0.010856776498258114
compared O 0 0.016856905072927475
horizontal O 0 0.038002654910087585
eye O 1 0.9772591590881348
movements O 0 0.01442014891654253
( O 0 0.01149801630526781
visually O 0 0.01852015219628811
guided O 0 0.03367675840854645
saccades O 1 0.9999715089797974
, O 0 0.00933235976845026
antisaccades O 1 0.9924910664558411
, O 0 0.003877263516187668
and O 0 0.0029531673062592745
smooth O 0 0.015780871734023094
pursuit O 0 0.08443453162908554
) O 0 0.004126679617911577
in O 0 0.0024630443658679724
control O 0 0.005825383588671684
subjects O 0 0.011305218562483788
( O 0 0.009141129441559315
n O 0 0.02052382007241249
= O 0 0.02162838540971279
14 O 0 0.006543763913214207
) O 0 0.0028897596057504416
and O 0 0.001395713072270155
patients O 0 0.0076955771073699
with O 0 0.0013309287605807185
three O 0 0.0020736213773489
forms O 0 0.004647211171686649
of O 0 0.010470054112374783
autosomal O 1 1.0
dominant O 1 0.9999971389770508
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 1.0
type I-Disease 1 0.9999991655349731
I I-Disease 1 0.9999504089355469
spinocerebellar B-Disease 1 1.0
ataxias I-Disease 1 0.9999986886978149
1 I-Disease 0 0.014796276576817036
and I-Disease 0 0.0029984386637806892
2 I-Disease 0 0.011097762733697891
( O 0 0.008113005198538303
SCA1 B-Disease 1 0.9998101592063904
, O 0 0.006115598138421774
n O 0 0.017079265788197517
= O 0 0.01506059244275093
11 O 0 0.005606833845376968
; O 0 0.003802831983193755
SCA2 B-Disease 1 0.9488078951835632
, O 0 0.00614966033026576
n O 0 0.017141468822956085
= O 0 0.01615932025015354
10 O 0 0.003203133586794138
) O 0 0.0028666434809565544
and O 0 0.0037891885731369257
SCA3 B-Disease 1 1.0
/ O 1 0.9999738931655884
Machado B-Disease 1 0.9999916553497314
- I-Disease 1 0.8705384731292725
Joseph I-Disease 1 0.9997426867485046
disease I-Disease 1 1.0
( O 0 0.13303889334201813
MJD B-Disease 1 1.0
) O 0 0.010866967029869556
( O 0 0.008109468035399914
n O 0 0.019387030974030495
= O 0 0.02672038972377777
16 O 0 0.010655988939106464
) O 0 0.007413588929921389
. O 0 0.008026134222745895

In O 0 0.023809734731912613
SCA1 B-Disease 1 0.9999881982803345
, O 0 0.01274845190346241
saccade O 1 0.8567088842391968
amplitude O 0 0.02386367879807949
was O 0 0.01011800579726696
significantly O 0 0.006970666814595461
increased O 0 0.004179973155260086
, O 0 0.0038533019833266735
resulting O 0 0.009160775691270828
in O 0 0.01178367156535387
hypermetria B-Disease 1 0.9997134804725647
. O 0 0.015409988351166248

The O 0 0.021732628345489502
smooth O 0 0.03486404940485954
pursuit O 0 0.05173112824559212
gain O 0 0.021498315036296844
was O 0 0.02418329566717148
decreased O 0 0.2303939163684845
. O 0 0.016036052256822586

In O 0 0.026284746825695038
SCA2 B-Disease 1 0.9999722242355347
, O 0 0.016082631424069405
saccade O 0 0.3004516065120697
velocity O 0 0.020543070510029793
was O 0 0.01778719387948513
markedly O 0 0.04403097555041313
decreased O 0 0.04178992658853531
. O 0 0.014166823588311672

The O 0 0.014516363851726055
percentage O 0 0.011445731855928898
of O 0 0.004834078252315521
errors O 0 0.021377064287662506
in O 0 0.012671557255089283
antisaccades O 1 0.9999988079071045
was O 0 0.01929434947669506
greatly O 0 0.009565657936036587
increased O 0 0.004012688063085079
and O 0 0.0025493293069303036
was O 0 0.006496111862361431
significantly O 0 0.005028159357607365
correlated O 0 0.007040141616016626
with O 0 0.0016259761760011315
age O 0 0.010905212722718716
at O 1 0.8928847908973694
disease O 1 1.0
onset O 1 1.0
. O 0 0.0680440291762352

In O 0 0.009412065148353577
addition O 0 0.006504617631435394
, O 0 0.00350876129232347
a O 0 0.004305025562644005
correlation O 0 0.010855158790946007
between O 0 0.004675662145018578
smooth O 0 0.01770702376961708
pursuit O 0 0.024278931319713593
gain O 0 0.006033971440047026
and O 0 0.0016799225704744458
the O 0 0.0026331788394600153
number O 0 0.0026466776616871357
of O 0 0.007457071449607611
trinucleotide O 1 0.9999983310699463
repeats O 0 0.05761517584323883
was O 0 0.0128531064838171
found O 0 0.006961579900234938
. O 0 0.008248290978372097

In O 0 0.029444435611367226
SCA3 B-Disease 1 1.0
, O 0 0.02063934877514839
gaze B-Disease 1 0.997136116027832
- I-Disease 1 0.692205548286438
evoked I-Disease 1 0.7488086223602295
nystagmus I-Disease 1 0.9998607635498047
was O 0 0.009496866725385189
often O 0 0.0026515559293329716
present O 0 0.004028685390949249
as O 0 0.004085843916982412
was O 0 0.014851651154458523
saccade O 1 0.9994995594024658
hypometria O 1 0.9975287318229675
and O 0 0.006237598601728678
smooth O 0 0.02410964109003544
pursuit O 0 0.18155844509601593
gain O 0 0.019532067701220512
was O 0 0.02384974993765354
markedly O 0 0.06083608791232109
decreased O 0 0.04900549724698067
. O 0 0.01594146527349949

Three O 0 0.011211083270609379
major O 0 0.016423847526311874
criteria O 0 0.022694578394293785
, O 0 0.01170860230922699
saccade O 1 0.6201220750808716
amplitude O 0 0.0273631289601326
, O 0 0.008014889433979988
saccade O 0 0.08129588514566422
velocity O 0 0.01060765702277422
, O 0 0.0029534592758864164
and O 0 0.002465483732521534
presence O 0 0.006688715424388647
of O 0 0.013080088421702385
gaze B-Disease 1 0.9999637603759766
- I-Disease 1 0.9234552979469299
evoked I-Disease 0 0.2071331888437271
nystagmus I-Disease 1 0.9807135462760925
, O 0 0.0038686778862029314
permitted O 0 0.004657839424908161
the O 0 0.0038882936351001263
correct O 0 0.01338491216301918
assignment O 0 0.014735817909240723
of O 0 0.0042932359501719475
90 O 0 0.006453132722526789
% O 0 0.002379702404141426
of O 0 0.002676478587090969
the O 0 0.007676952984184027
SCA1 B-Disease 1 0.9999974966049194
, O 0 0.005235222168266773
90 O 0 0.005309016443789005
% O 0 0.0024037365801632404
of O 0 0.0025940544437617064
the O 0 0.007777525577694178
SCA2 B-Disease 1 0.9999942779541016
, O 0 0.004216148518025875
and O 0 0.0023826370015740395
93 O 0 0.01546238549053669
% O 0 0.0026078715454787016
of O 0 0.0027630538679659367
the O 0 0.007451913319528103
patients O 1 0.9991819262504578
with O 0 0.0050781527534127235
SCA3 B-Disease 1 1.0
to O 0 0.003145186696201563
their O 0 0.001913187326863408
genetically O 0 0.005454491823911667
confirmed O 0 0.00844333041459322
patient O 0 0.3608417510986328
group O 0 0.003755492391064763
and O 0 0.0018411708297207952
, O 0 0.002527377102524042
therefore O 0 0.003641428891569376
, O 0 0.0028159208595752716
may O 0 0.0038409780245274305
help O 0 0.008502809330821037
orient O 0 0.06831187754869461
diagnoses O 1 0.9990484118461609
of O 0 0.02255563996732235
SCA1 B-Disease 1 1.0
, O 0 0.012918776832520962
SCA2 B-Disease 1 0.9999964237213135
, O 0 0.0053847795352339745
and O 0 0.005165138281881809
SCA3 B-Disease 1 0.9999998807907104
at O 0 0.008928920142352581
early O 0 0.005580817349255085
clinical O 0 0.1193043440580368
stages O 0 0.014856716617941856
of O 0 0.00898288656026125
the O 1 0.5529168844223022
diseases O 1 1.0
. O 0 0.009306306019425392
. O 0 0.011079826392233372

Genetic O 0 0.014151263050734997
basis O 0 0.004417403135448694
and O 0 0.003079360816627741
molecular O 0 0.012541613541543484
mechanism O 0 0.015806391835212708
for O 0 0.01682584546506405
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9999841451644897

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 1 0.9999101161956787
more O 0 0.004278344567865133
than O 0 0.002220895839855075
300 O 0 0.006458742544054985
, O 0 0.0036878911778330803
000 O 0 0.021821729838848114
sudden O 0 0.017777368426322937
deaths O 0 0.009382377378642559
each O 0 0.00166376493871212
year O 0 0.0027949137147516012
in O 0 0.0026241778396070004
the O 0 0.007139468565583229
USA O 0 0.08436219394207001
alone O 0 0.013804021291434765
. O 0 0.007346539758145809

In O 0 0.011540119536221027
approximately O 0 0.010815825313329697
5 O 0 0.013113665394484997
- O 0 0.013285521417856216
12 O 0 0.005345851648598909
% O 0 0.0021145683713257313
of O 0 0.0016235867515206337
these O 0 0.0012344232527539134
cases O 0 0.003612668253481388
, O 0 0.0026702398899942636
there O 0 0.0016358598368242383
are O 0 0.0013114317553117871
no O 0 0.004511276725679636
demonstrable O 1 0.9999996423721313
cardiac O 1 1.0
or O 1 0.9998823404312134
non O 1 0.9999997615814209
- O 1 0.9999997615814209
cardiac O 1 1.0
causes O 0 0.24275518953800201
to O 0 0.0020847159903496504
account O 0 0.0020097922533750534
for O 0 0.001274781534448266
the O 0 0.0032318010926246643
episode O 0 0.010650882497429848
, O 0 0.0016627798322588205
which O 0 0.0009014320676214993
is O 0 0.001208424218930304
therefore O 0 0.0024449166376143694
classified O 0 0.011492039076983929
as O 0 0.013121888972818851
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 1.0
IVF B-Disease 1 1.0
) O 0 0.022655609995126724
. O 0 0.009426862932741642

A O 0 0.014646523632109165
distinct O 0 0.007246795110404491
group O 0 0.006008577533066273
of O 0 0.017077278345823288
IVF B-Disease 1 1.0
patients O 1 0.9999997615814209
has O 0 0.0048685683868825436
been O 0 0.0022303415462374687
found O 0 0.0015501967864111066
to O 0 0.001176914549432695
present O 0 0.0023303695488721132
with O 0 0.001665234100073576
a O 0 0.007159431464970112
characteristic O 0 0.06297793239355087
electrocardiographic O 1 0.9999966621398926
pattern O 0 0.1698225736618042
. O 0 0.01657339371740818

Because O 0 0.007960277609527111
of O 0 0.0056431228294968605
the O 0 0.005826159380376339
small O 0 0.0030971544329077005
size O 0 0.0034264191053807735
of O 0 0.002591765485703945
most O 0 0.0028988684061914682
pedigrees O 0 0.018563352525234222
and O 0 0.0029839822091162205
the O 0 0.006823893636465073
high O 0 0.024081461131572723
incidence O 1 0.9999750852584839
of O 0 0.02249935455620289
sudden B-Disease 1 0.9999991655349731
death I-Disease 1 0.9996589422225952
, O 0 0.004251981619745493
however O 0 0.0022944118827581406
, O 0 0.0024121119640767574
molecular O 0 0.008468948304653168
genetic O 0 0.005898322444409132
studies O 0 0.006136791780591011
of O 0 0.012254595756530762
IVF B-Disease 1 1.0
have O 0 0.0028561861254274845
not O 0 0.0013869920512661338
yet O 0 0.0027951581869274378
been O 0 0.00313925719819963
done O 0 0.008131621405482292
. O 0 0.008904951624572277

Because O 0 0.03879943862557411
IVF B-Disease 1 1.0
causes O 1 1.0
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 0.9999995231628418
, O 0 0.00599250802770257
we O 0 0.0021849649492651224
investigated O 0 0.011047023348510265
whether O 0 0.006117441225796938
malfunction O 1 0.9999444484710693
of O 0 0.015559780411422253
ion O 1 0.9357728958129883
channels O 0 0.0077209374867379665
could O 0 0.002496264409273863
cause O 0 0.008328119292855263
the O 0 0.006992929615080357
disorder O 1 0.999998927116394
by O 0 0.00429580919444561
studying O 0 0.008726253174245358
mutations O 0 0.005384784657508135
in O 0 0.003484738990664482
the O 0 0.00967023428529501
cardiac O 1 1.0
sodium O 1 0.9989271759986877
channel O 0 0.0292778629809618
gene O 0 0.021780114620923996
SCN5A O 1 0.9986465573310852
. O 0 0.014631466008722782

We O 0 0.0056294589303433895
have O 0 0.00147972849663347
now O 0 0.0028602550737559795
identified O 0 0.005236990749835968
a O 0 0.0046862149611115456
missense O 0 0.02893069200217724
mutation O 0 0.009143742732703686
, O 0 0.0032449914142489433
a O 0 0.008101554587483406
splice O 1 0.9981915354728699
- O 0 0.052844323217868805
donor O 0 0.024294374510645866
mutation O 0 0.008216312155127525
, O 0 0.002364123472943902
and O 0 0.0025015731807798147
a O 0 0.008295830339193344
frameshift O 1 0.7738805413246155
mutation O 0 0.0077430917881429195
in O 0 0.002720991615206003
the O 0 0.004983844235539436
coding O 0 0.020082032307982445
region O 0 0.007237918209284544
of O 0 0.006957358680665493
SCN5A O 1 0.9999829530715942
in O 0 0.006265522446483374
three O 0 0.008286933414638042
IVF B-Disease 1 0.9999986886978149
families O 0 0.014380164444446564
. O 0 0.009722184389829636

We O 0 0.006719289813190699
show O 0 0.007250874303281307
that O 0 0.0028313929215073586
sodium O 0 0.014950146898627281
channels O 0 0.002348547102883458
with O 0 0.0010995519114658237
the O 0 0.005617761518806219
missense O 0 0.049934469163417816
mutation O 0 0.017323896288871765
recover O 0 0.08885174244642258
from O 0 0.007768147625029087
inactivation O 1 0.9506809115409851
more O 0 0.002779147122055292
rapidly O 0 0.007644285913556814
than O 0 0.0015686554834246635
normal O 0 0.003813674906268716
and O 0 0.0014489925233647227
that O 0 0.0016563350800424814
the O 0 0.006346536800265312
frameshift O 0 0.4885826110839844
mutation O 0 0.015801265835762024
causes O 0 0.01441135536879301
the O 0 0.010351408272981644
sodium O 0 0.028085913509130478
channel O 0 0.005781838204711676
to O 0 0.0018653059378266335
be O 0 0.002322159241884947
non O 0 0.015602164901793003
- O 0 0.028420493006706238
functional O 0 0.03033367358148098
. O 0 0.011628186330199242

Our O 0 0.014046051539480686
results O 0 0.007549651898443699
indicate O 0 0.007159456145018339
that O 0 0.0019847231451421976
mutations O 0 0.009641175158321857
in O 0 0.010096251964569092
cardiac O 1 1.0
ion O 1 0.9999474287033081
- O 0 0.06822755187749863
channel O 0 0.011046512052416801
genes O 0 0.003727537114173174
contribute O 0 0.0025659806560724974
to O 0 0.0014405969996005297
the O 0 0.0033865724690258503
risk O 0 0.00886145792901516
of O 0 0.008975209668278694
developing O 1 0.9662978053092957
IVF B-Disease 1 1.0
. O 0 0.011110181920230389
. O 0 0.010593743994832039

Molecular O 0 0.04606662318110466
heterogeneity O 0 0.05109919607639313
in O 0 0.015084291808307171
mucopolysaccharidosis B-Disease 1 0.9999951124191284
IVA I-Disease 1 1.0
in O 0 0.006932004354894161
Australia O 0 0.00684917951002717
and O 0 0.0016521408688277006
Northern O 0 0.00542950676754117
Ireland O 0 0.005802988540381193
: O 0 0.002839841414242983
nine O 0 0.0037225503474473953
novel O 0 0.012647871859371662
mutations O 0 0.008468583226203918
including O 0 0.004864851478487253
T312S O 1 0.9946216344833374
, O 0 0.0052042994648218155
a O 0 0.005589958745986223
common O 0 0.011082461103796959
allele O 0 0.01655813679099083
that O 0 0.003079571295529604
confers O 0 0.05303996801376343
a O 0 0.014793889597058296
mild O 1 0.9997327923774719
phenotype O 1 0.5112738013267517
. O 0 0.021236257627606392

Mucopolysaccharidosis B-Disease 1 0.9999947547912598
IVA I-Disease 1 1.0
( O 0 0.17270250618457794
MPS B-Disease 1 0.9999914169311523
IVA I-Disease 1 1.0
) O 0 0.006440616212785244
is O 0 0.002055530669167638
an O 0 0.003539078403264284
autosomal B-Disease 1 0.9999879598617554
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999958276748657
by O 0 0.00512481527402997
a O 0 0.00983525812625885
genetic B-Disease 1 0.9461157917976379
defect I-Disease 1 0.9999995231628418
in O 0 0.01409163512289524
N O 1 0.995500385761261
- O 0 0.03502192348241806
acetylgalactosamine O 1 0.9467761516571045
- O 0 0.02364041469991207
6 O 0 0.02260465919971466
- O 0 0.0432770662009716
sulfate O 1 0.9998173117637634
sulfatase O 1 0.9999998807907104
( O 0 0.04778485372662544
GALNS O 1 0.9999992847442627
) O 0 0.01569710671901703
. O 0 0.009730607271194458

Previous O 0 0.011767270043492317
studies O 0 0.00564912986010313
of O 0 0.005298126023262739
patients O 1 0.9368248581886292
from O 0 0.003481332678347826
a O 0 0.004881691187620163
British O 0 0.010425342246890068
- O 0 0.011817746795713902
Irish O 0 0.00829025823622942
population O 0 0.002293516881763935
showed O 0 0.00373827270232141
that O 0 0.0013960587093606591
the O 0 0.005576746072620153
I113F O 1 0.9974519610404968
mutation O 0 0.00744521152228117
is O 0 0.0017032632604241371
the O 0 0.0019771999213844538
most O 0 0.0015611908165737987
common O 0 0.0038210623897612095
single O 0 0.004917073994874954
mutation O 0 0.008522553369402885
among O 0 0.006833889987319708
MPS B-Disease 1 0.9999946355819702
IVA I-Disease 1 1.0
patients O 1 1.0
and O 0 0.009079248644411564
produces O 0 0.013751036487519741
a O 0 0.012330734170973301
severe O 1 1.0
clinical O 1 1.0
phenotype O 1 0.9999462366104126
. O 0 0.018770109862089157

We O 0 0.00560718821361661
studied O 0 0.010205021128058434
mutations O 0 0.0060670520178973675
in O 0 0.003397333901375532
the O 0 0.008433603681623936
GALNS O 1 0.9999901056289673
gene O 0 0.006320225540548563
from O 0 0.0018221689388155937
23 O 0 0.006567459087818861
additional O 0 0.006590221077203751
MPS B-Disease 1 0.9924516081809998
IVA I-Disease 1 1.0
patients O 1 0.9999997615814209
( O 0 0.010001656599342823
15 O 0 0.004464996047317982
from O 0 0.0015641892096027732
Australia O 0 0.003636848647147417
, O 0 0.0016035586595535278
8 O 0 0.003607985330745578
from O 0 0.0013715011300519109
Northern O 0 0.004710770677775145
Ireland O 0 0.007314589340239763
) O 0 0.0027647465467453003
, O 0 0.0012344750575721264
with O 0 0.0010597283253446221
various O 0 0.004481214564293623
clinical O 1 0.9999988079071045
phenotypes O 1 0.9999827146530151
( O 0 0.039269380271434784
severe O 1 0.9999995231628418
, O 0 0.008240184746682644
16 O 0 0.010872581042349339
cases O 0 0.006525382865220308
; O 0 0.003909836057573557
intermediate O 0 0.018897930160164833
, O 0 0.003970883786678314
4 O 0 0.008423454128205776
cases O 0 0.00571450823917985
; O 0 0.005020554177463055
mild O 0 0.34487929940223694
, O 0 0.00606958894059062
3 O 0 0.011542879976332188
cases O 0 0.010283801704645157
) O 0 0.008279264904558659
. O 0 0.006427223328500986

We O 0 0.006829618941992521
found O 0 0.004300363827496767
two O 0 0.002071873750537634
common O 0 0.006212866865098476
mutations O 0 0.00658788625150919
that O 0 0.0012892448576167226
together O 0 0.0023130588233470917
accounted O 0 0.006291833706200123
for O 0 0.0021675466559827328
32 O 0 0.007950447499752045
% O 0 0.0027762185782194138
of O 0 0.0029686237685382366
the O 0 0.005170383956283331
44 O 0 0.013676606118679047
unrelated O 0 0.016638202592730522
alleles O 0 0.01696155220270157
in O 0 0.0050826165825128555
these O 0 0.004615146201103926
patients O 1 0.8482768535614014
. O 0 0.01942649483680725

One O 0 0.009647712111473083
is O 0 0.005289922934025526
the O 0 0.008188564330339432
T312S O 1 0.7286953330039978
mutation O 0 0.011711936444044113
, O 0 0.002781071700155735
a O 0 0.004046797286719084
novel O 0 0.01590646617114544
mutation O 0 0.007866209372878075
found O 0 0.0035885607358068228
exclusively O 0 0.007928026840090752
in O 0 0.0092391949146986
milder O 0 0.27887049317359924
patients O 1 0.9975882768630981
. O 0 0.023549407720565796

The O 0 0.008348160423338413
other O 0 0.001972840866073966
is O 0 0.0025786415208131075
the O 0 0.003356287954375148
previously O 0 0.007612260524183512
described O 0 0.011952209286391735
I113F O 0 0.4497162997722626
that O 0 0.0032251751981675625
produces O 0 0.010362028144299984
a O 0 0.011440508998930454
severe O 1 1.0
phenotype O 1 0.9991983771324158
. O 0 0.02168431505560875

The O 0 0.024127958342432976
I113F O 0 0.37827572226524353
and O 0 0.009256381541490555
T312S O 1 0.9847784638404846
mutations O 0 0.012392950244247913
accounted O 0 0.008714400231838226
for O 0 0.003333532251417637
8 O 0 0.01028644572943449
( O 0 0.004830933641642332
18 O 0 0.004940345883369446
% O 0 0.0032553260680288076
) O 0 0.002259130124002695
and O 0 0.0018510320223867893
6 O 0 0.009984202682971954
( O 0 0.004609685856848955
14 O 0 0.005685025826096535
% O 0 0.002646711887791753
) O 0 0.0017983467550948262
of O 0 0.0028984807431697845
44 O 0 0.011980748735368252
unrelated O 0 0.02175881527364254
alleles O 0 0.023565486073493958
, O 0 0.006839603651314974
respectively O 0 0.02270001918077469
. O 0 0.01153540052473545

The O 0 0.01963425800204277
relatively O 0 0.016073988750576973
high O 0 0.028229225426912308
residual O 1 0.9896893501281738
GALNS O 1 0.9999988079071045
activity O 0 0.008382807485759258
seen O 0 0.004842938389629126
when O 0 0.002119701821357012
the O 0 0.004894598852843046
T312S O 0 0.355769544839859
mutant O 0 0.03744323179125786
cDNA O 0 0.03072863444685936
is O 0 0.004642200656235218
overexpressed O 0 0.03967837244272232
in O 0 0.005832033697515726
mutant O 0 0.030986711382865906
cells O 0 0.006193090230226517
provides O 0 0.0028848820365965366
an O 0 0.0014107319293543696
explanation O 0 0.004230804275721312
for O 0 0.0023974513169378042
the O 0 0.005741570144891739
mild O 1 0.9973541498184204
phenotype O 0 0.038429275155067444
in O 0 0.00631306366994977
patients O 1 0.5243353843688965
with O 0 0.0029462340753525496
this O 0 0.004493091721087694
mutation O 0 0.016056854277849197
. O 0 0.008874744176864624

The O 0 0.012577899731695652
distribution O 0 0.0060224081389606
and O 0 0.0028076316229999065
relative O 0 0.007555785588920116
frequencies O 0 0.0026767889503389597
of O 0 0.0023686543572694063
the O 0 0.0064674317836761475
I113F O 1 0.9951460957527161
and O 0 0.006817207671701908
T312S O 1 0.9981305003166199
mutations O 0 0.008177082985639572
in O 0 0.0032612853683531284
Australia O 0 0.0057268464006483555
corresponded O 0 0.009072600863873959
to O 0 0.001696466002613306
those O 0 0.0013279577251523733
observed O 0 0.003385307965800166
in O 0 0.0027074632234871387
Northern O 0 0.0069890497252345085
Ireland O 0 0.006328897550702095
and O 0 0.0015503803733736277
are O 0 0.0007960874936543405
unique O 0 0.0025882574263960123
to O 0 0.0012114120181649923
these O 0 0.0008630459778942168
two O 0 0.0013883050996810198
populations O 0 0.0034693186171352863
, O 0 0.0026964775752276182
suggesting O 0 0.0067992121912539005
that O 0 0.0016496385214850307
both O 0 0.0024956543929874897
mutations O 0 0.006778744049370289
were O 0 0.0023655027616769075
probably O 0 0.004481365438550711
introduced O 0 0.0030759631190449
to O 0 0.0014353126753121614
Australia O 0 0.0033781661186367273
by O 0 0.001166992005892098
Irish O 0 0.00723381107673049
migrants O 0 0.006375868804752827
during O 0 0.00619198614731431
the O 0 0.006152046844363213
19th O 0 0.024054234847426414
century O 0 0.030273914337158203
. O 0 0.013065950945019722

Haplotype O 0 0.07180390506982803
analysis O 0 0.007691085338592529
using O 0 0.00545598566532135
6 O 0 0.018031906336545944
RFLPs O 0 0.07711103558540344
provides O 0 0.006902873516082764
additional O 0 0.002508789300918579
data O 0 0.0016781713347882032
that O 0 0.0009106606594286859
the O 0 0.004725836683064699
I113F O 0 0.21004356443881989
mutation O 0 0.00981932133436203
originated O 0 0.007477426901459694
from O 0 0.002542647533118725
a O 0 0.0047206091694533825
common O 0 0.011402465403079987
ancestor O 0 0.04852619767189026
. O 0 0.01786985620856285

The O 0 0.010265165939927101
other O 0 0.0034020578023046255
9 O 0 0.011623265221714973
novel O 0 0.013608156703412533
mutations O 0 0.007456498686224222
identified O 0 0.0047596837393939495
in O 0 0.0022269354667514563
these O 0 0.0018411690834909678
23 O 0 0.01285500731319189
patients O 0 0.024784810841083527
were O 0 0.0018725325353443623
each O 0 0.0008557029068470001
limited O 0 0.001449517090804875
to O 0 0.0011859947117045522
a O 0 0.0033952100202441216
single O 0 0.006299900822341442
family O 0 0.01277132611721754
. O 0 0.009591118432581425

These O 0 0.0040508355014026165
data O 0 0.0029450308065861464
provide O 0 0.002692681970074773
further O 0 0.0021223360672593117
evidence O 0 0.0027674969751387835
for O 0 0.0027645824011415243
extensive O 0 0.015394427813589573
allelic O 0 0.3749251365661621
heterogeneity O 0 0.05137115716934204
in O 0 0.010862348601222038
MPS B-Disease 1 0.9982709884643555
IVA I-Disease 1 1.0
in O 0 0.01011448260396719
British O 0 0.021808506920933723
- O 0 0.02647406794130802
Irish O 0 0.015201878733932972
patients O 0 0.24761943519115448
and O 0 0.001981063513085246
provide O 0 0.0028650215826928616
evidence O 0 0.0026268847286701202
for O 0 0.0018064221367239952
their O 0 0.0018442043801769614
transmission O 0 0.006135209463536739
to O 0 0.0013565871631726623
Australia O 0 0.003160190535709262
by O 0 0.0009767778683453798
British O 0 0.006830544210970402
- O 0 0.011458244174718857
Irish O 0 0.01068706065416336
migrants O 0 0.010260642506182194
. O 0 0.00422316137701273
. O 0 0.006333000957965851

Identification O 0 0.018900521099567413
of O 0 0.013135677203536034
constitutional O 0 0.04279470443725586
WT1 O 1 1.0
mutations O 0 0.012387248687446117
, O 0 0.003152712481096387
in O 0 0.0035434479359537363
patients O 1 0.7612481713294983
with O 0 0.004872601013630629
isolated O 1 0.999981164932251
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.212061807513237
and O 0 0.005328688304871321
analysis O 0 0.004842871800065041
of O 0 0.00971627701073885
genotype O 1 0.9973721504211426
/ O 1 0.8928357362747192
phenotype O 0 0.018021896481513977
correlations O 0 0.008748993277549744
by O 0 0.001189770526252687
use O 0 0.0018074371619150043
of O 0 0.004419849254190922
a O 0 0.009100529365241528
computerized O 0 0.05432963743805885
mutation O 0 0.019933298230171204
database O 0 0.016587667167186737
. O 0 0.011253349483013153

Constitutional O 0 0.026576220989227295
mutations O 0 0.011554477736353874
of O 0 0.005647759418934584
the O 0 0.013424767181277275
WT1 O 1 0.9999995231628418
gene O 0 0.008214851841330528
, O 0 0.0026773668359965086
encoding O 0 0.007836534641683102
a O 0 0.007706344593316317
zinc O 1 0.9999973773956299
- O 0 0.04446595907211304
finger O 0 0.04648503288626671
transcription O 0 0.02438538335263729
factor O 0 0.01022051926702261
involved O 0 0.005296872928738594
in O 0 0.013943850062787533
renal O 1 1.0
and O 1 0.9999929666519165
gonadal O 1 1.0
development O 1 0.9109304547309875
, O 0 0.002540882444009185
are O 0 0.0005549986381083727
found O 0 0.0010460029589012265
in O 0 0.0012181038036942482
most O 0 0.0016751661896705627
patients O 0 0.07514993101358414
with O 0 0.005765147507190704
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999959468841553
DDS B-Disease 1 1.0
) O 0 0.009191465564072132
, O 0 0.003940015099942684
or O 0 0.009574675001204014
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 1.0
DMS B-Disease 1 1.0
) O 0 0.00649820314720273
associated O 0 0.0031700204126536846
with O 0 0.0027104339096695185
pseudohermaphroditism B-Disease 1 1.0
and O 0 0.010113220661878586
/ O 1 0.9999970197677612
or O 0 0.1184227243065834
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 1 0.999895453453064
WT B-Disease 1 1.0
) O 0 0.01529665570706129
. O 0 0.008953757584095001

Most O 0 0.011419457383453846
mutations O 0 0.020945237949490547
in O 0 0.015985285863280296
DDS B-Disease 1 1.0
patients O 1 0.9999959468841553
lie O 0 0.04802336171269417
in O 0 0.009462520480155945
exon O 0 0.044386714696884155
8 O 0 0.009507241658866405
or O 0 0.004284906666725874
exon O 0 0.03360229730606079
9 O 0 0.011818470433354378
, O 0 0.004524619318544865
encoding O 0 0.021023346111178398
zinc O 1 0.9982118606567383
finger O 1 0.7692998647689819
2 O 0 0.02856847271323204
or O 0 0.013157143257558346
zinc O 1 0.9999943971633911
finger O 1 0.994113028049469
3 O 0 0.012912691570818424
, O 0 0.003610981162637472
respectively O 0 0.005399724468588829
, O 0 0.0016802487662062049
with O 0 0.001182349631562829
a O 0 0.004123306833207607
hot O 0 0.025583524256944656
spot O 0 0.02286270074546337
( O 0 0.007962842471897602
R394W O 0 0.1410486251115799
) O 0 0.003961159847676754
in O 0 0.004134449176490307
exon O 0 0.05696357786655426
9 O 0 0.02103353664278984
. O 0 0.007669720333069563

We O 0 0.004766650963574648
analyzed O 0 0.005392584018409252
a O 0 0.0021123045589774847
series O 0 0.0034308263566344976
of O 0 0.003949531354010105
24 O 0 0.009505374357104301
patients O 0 0.02754010073840618
, O 0 0.003143229056149721
10 O 0 0.0031787510961294174
with O 0 0.0021387161687016487
isolated B-Disease 1 0.5705864429473877
DMS I-Disease 1 1.0
( O 1 0.6365042924880981
IDMS B-Disease 1 1.0
) O 0 0.006207937374711037
, O 0 0.002881486201658845
10 O 0 0.0036710717249661684
with O 0 0.003416675142943859
DDS B-Disease 1 1.0
, O 0 0.005119263660162687
and O 0 0.0028744435403496027
4 O 0 0.009784042835235596
with O 0 0.004293919075280428
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 1.0
and O 1 0.9999425411224365
/ O 1 1.0
or O 1 0.522016704082489
WT B-Disease 1 1.0
. O 0 0.019598577171564102

We O 0 0.01183195598423481
report O 0 0.01684992015361786
WT1 O 1 0.9994674324989319
heterozygous O 0 0.022377347573637962
mutations O 0 0.007614782080054283
in O 0 0.0031664303969591856
16 O 0 0.011104144155979156
patients O 0 0.12558677792549133
, O 0 0.004332304000854492
4 O 0 0.006930113770067692
of O 0 0.003920149523764849
whom O 0 0.009558537043631077
presented O 0 0.015249122865498066
with O 0 0.008071951568126678
IDMS B-Disease 1 1.0
. O 0 0.02821141481399536

One O 0 0.009619250893592834
male O 0 0.0078032901510596275
and O 0 0.0020354890730232
two O 0 0.0032044886611402035
female O 0 0.09799562394618988
IDMS B-Disease 1 1.0
patients O 1 0.9999997615814209
with O 0 0.019306421279907227
WT1 O 1 1.0
mutations O 1 0.8925461173057556
underwent O 1 1.0
normal O 1 0.9912523627281189
puberty O 1 0.9999634027481079
. O 0 0.01530415378510952

Two O 0 0.009868070483207703
mutations O 0 0.01728307269513607
associated O 0 0.00866190530359745
with O 0 0.005743863061070442
IDMS B-Disease 1 1.0
are O 0 0.0016692023491486907
different O 0 0.000762757146731019
from O 0 0.0012360775144770741
those O 0 0.0014138063415884972
described O 0 0.010857237502932549
in O 0 0.018002530559897423
DDS B-Disease 1 1.0
patients O 1 1.0
. O 0 0.02462947368621826

No O 0 0.036769311875104904
WT1 O 1 0.999994158744812
mutations O 0 0.015991931781172752
were O 0 0.0028397710993885994
detected O 0 0.006467284634709358
in O 0 0.001933837542310357
the O 0 0.0029125602450221777
six O 0 0.0042721861973404884
other O 0 0.00541519932448864
IDMS B-Disease 1 1.0
patients O 1 0.9999873638153076
, O 0 0.007254475727677345
suggesting O 0 0.011740914545953274
genetic O 0 0.008913464844226837
heterogeneity O 0 0.02139846421778202
of O 0 0.007312847301363945
this O 0 0.009069523774087429
disease O 1 1.0
. O 0 0.021776467561721802

We O 0 0.011739886365830898
analyzed O 0 0.03167207911610603
genotype O 0 0.1195942759513855
/ O 0 0.2945822775363922
phenotype O 0 0.026573117822408676
correlations O 0 0.012820127420127392
, O 0 0.0023072075564414263
on O 0 0.0021682954393327236
the O 0 0.0017559679690748453
basis O 0 0.0019469470717012882
of O 0 0.002204315736889839
the O 0 0.0029193146619945765
constitution O 0 0.0047064535319805145
of O 0 0.004756423644721508
a O 0 0.01000951137393713
WT1 O 1 0.9999948740005493
mutation O 0 0.008542877621948719
database O 0 0.004778092261403799
of O 0 0.005770321004092693
84 O 1 0.9288681149482727
germ O 1 0.9999998807907104
- O 0 0.07187770307064056
line O 0 0.011241666972637177
mutations O 0 0.005978419911116362
, O 0 0.0016621887916699052
to O 0 0.0018051121151074767
compare O 0 0.007530084811151028
the O 0 0.0036633119452744722
distribution O 0 0.003410555887967348
and O 0 0.002613220363855362
type O 0 0.010088028386235237
of O 0 0.006121379788964987
mutations O 0 0.007576093543320894
, O 0 0.0020192116498947144
according O 0 0.00205260724760592
to O 0 0.0016408632509410381
the O 0 0.0037478571757674217
different O 0 0.003933592699468136
symptoms O 1 0.9999988079071045
. O 0 0.024849675595760345

This O 0 0.006567085161805153
demonstrated O 0 0.017848405987024307
( O 0 0.00927029363811016
1 O 0 0.009624403901398182
) O 0 0.002879151375964284
the O 0 0.002527670469135046
association O 0 0.00686092721298337
between O 0 0.004448814783245325
mutations O 0 0.007468408439308405
in O 0 0.0038789636455476284
exons O 0 0.025409210473299026
8 O 0 0.00812085997313261
and O 0 0.002772072795778513
9 O 0 0.01156547386199236
and O 0 0.005000793840736151
DMS B-Disease 1 1.0
; O 0 0.005857357755303383
( O 0 0.005488537717610598
2 O 0 0.006768296472728252
) O 0 0.002443119417876005
among O 0 0.00293864612467587
patients O 1 0.9005380868911743
with O 0 0.007067009806632996
DMS B-Disease 1 1.0
, O 0 0.005776413716375828
a O 0 0.004316780250519514
higher O 0 0.005353542510420084
frequency O 0 0.002881034277379513
of O 0 0.0034399551805108786
exon O 0 0.039167143404483795
8 O 0 0.01001366600394249
mutations O 0 0.005357776768505573
among O 0 0.003204884473234415
46 O 0 0.014655685983598232
, O 0 0.009629248641431332
XY O 1 0.9999994039535522
patients O 1 0.9802271127700806
with O 0 0.005858291871845722
female O 0 0.01935737207531929
phenotype O 0 0.012078107334673405
than O 0 0.0013039438053965569
among O 0 0.00262545351870358
46 O 0 0.013100885786116123
, O 0 0.008381777442991734
XY O 1 0.9999998807907104
patients O 1 0.9884307384490967
with O 0 0.003436475060880184
sexual O 0 0.0151185542345047
ambiguity O 0 0.17583876848220825
or O 0 0.009408206678926945
male O 0 0.022698838263750076
phenotype O 0 0.02940397523343563
; O 0 0.0035599470138549805
and O 0 0.0033972770906984806
( O 0 0.008231795392930508
3 O 0 0.009599355049431324
) O 0 0.0032150703482329845
statistically O 0 0.0036789944861084223
significant O 0 0.002178363036364317
evidence O 0 0.002533271675929427
that O 0 0.001525227795355022
mutations O 0 0.005201671272516251
in O 0 0.003978007938712835
exons O 0 0.025531625375151634
8 O 0 0.009756951592862606
and O 0 0.002933486830443144
9 O 0 0.013062077574431896
preferentially O 0 0.01612447202205658
affect O 0 0.00603689206764102
amino O 0 0.005446502007544041
acids O 0 0.0028122863732278347
with O 0 0.0008119746344164014
different O 0 0.001216864213347435
functions O 0 0.006113039329648018
. O 0 0.004395530093461275
. O 0 0.007396587636321783

The O 0 0.03502027690410614
185delAG O 1 0.9999760389328003
BRCA1 O 1 0.9999486207962036
mutation O 0 0.016484038904309273
originated O 0 0.008943041786551476
before O 0 0.0031056227162480354
the O 0 0.0029921645764261484
dispersion O 0 0.009516982361674309
of O 0 0.0037213549949228764
Jews O 0 0.01007307879626751
in O 0 0.004149868153035641
the O 0 0.004421040881425142
diaspora O 0 0.00866487342864275
and O 0 0.0021940991282463074
is O 0 0.0029120754916220903
not O 0 0.0013085558312013745
limited O 0 0.003678017994388938
to O 0 0.005299159791320562
Ashkenazim O 0 0.4453296959400177
. O 0 0.016302814707159996

The O 0 0.024360045790672302
185delAG O 1 0.9973690509796143
mutation O 0 0.021530546247959137
in O 0 0.00888441689312458
BRCA1 O 1 0.9994826316833496
is O 0 0.005057130474597216
detected O 0 0.008496780879795551
in O 0 0.0032197071705013514
Ashkenazi O 0 0.024152444675564766
Jews O 0 0.006557398941367865
both O 0 0.00233547599054873
in O 0 0.006174359004944563
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.4774305820465088
in O 0 0.005819202866405249
the O 0 0.005540603306144476
general O 0 0.011509890668094158
population O 0 0.004989324137568474
. O 0 0.006533328909426928

All O 0 0.009889881126582623
tested O 0 0.03463257476687431
Ashkenazi O 1 0.6127047538757324
mutation O 0 0.01609119214117527
carriers O 0 0.008265220560133457
share O 0 0.0033731996081769466
the O 0 0.003049431601539254
same O 0 0.0033492837101221085
allelic O 0 0.04085611179471016
pattern O 0 0.015616906806826591
at O 0 0.012451183050870895
the O 0 0.01706515997648239
BRCA1 O 1 0.9999954700469971
locus O 0 0.4634285867214203
. O 0 0.016914039850234985

Our O 0 0.012367757968604565
previous O 0 0.008523678407073021
study O 0 0.006378430873155594
showed O 0 0.006316040176898241
that O 0 0.0012285244883969426
this O 0 0.002165765268728137
Ashkenazi O 1 0.6858150959014893
mutation O 0 0.012153418734669685
also O 0 0.003758697770535946
occurs O 0 0.004482865799218416
in O 0 0.0035066562704741955
Iraqi O 0 0.009734302759170532
Jews O 0 0.006121110171079636
with O 0 0.0017002698732540011
a O 0 0.004899157676845789
similar O 0 0.00704887043684721
allelic O 0 0.1319684237241745
pattern O 0 0.044534776359796524
. O 0 0.016282761469483376

We O 0 0.006663219537585974
extended O 0 0.0070426189340651035
our O 0 0.0026974112261086702
analysis O 0 0.0018711978336796165
to O 0 0.0014163926243782043
other O 0 0.0019653404597193003
non O 0 0.01307092048227787
- O 0 0.021101046353578568
Ashkenazi O 0 0.056174419820308685
subsets O 0 0.0333341509103775
354 O 0 0.037439845502376556
of O 0 0.0068922159262001514
Moroccan O 0 0.024137983098626137
origin O 0 0.005368118640035391
, O 0 0.004560462664812803
200 O 0 0.010335417464375496
Yemenites O 0 0.10220770537853241
and O 0 0.004859342705458403
150 O 0 0.01079819817095995
Iranian O 0 0.012918563559651375
Jews O 0 0.02219223603606224
. O 0 0.0114486925303936

Heteroduplex O 0 0.4883353114128113
analysis O 0 0.01213911548256874
complemented O 0 0.016863228753209114
by O 0 0.0022896728478372097
direct O 0 0.005420409608632326
DNA O 0 0.011063340120017529
sequencing O 0 0.010866356082260609
of O 0 0.007521037943661213
abnormally O 0 0.07401319593191147
migrating O 0 0.016946524381637573
bands O 0 0.007818388752639294
were O 0 0.0036261342465877533
employed O 0 0.020545389503240585
. O 0 0.010997927747666836

Four O 0 0.007031284272670746
of O 0 0.006717833224684
Moroccan O 0 0.02918378822505474
origin O 0 0.006850201170891523
( O 0 0.006319093517959118
1 O 0 0.007588023319840431
. O 0 0.0020052907057106495
1 O 0 0.00703218299895525
% O 0 0.003540164092555642
) O 0 0.002409552223980427
and O 0 0.0013777174754068255
none O 0 0.002863706089556217
of O 0 0.003475623670965433
the O 0 0.010557480156421661
Yemenites O 1 0.9999957084655762
or O 0 0.006161059718579054
Iranians O 0 0.007399545982480049
was O 0 0.004525674972683191
a O 0 0.0028630623128265142
carrier O 0 0.01035358663648367
of O 0 0.005483029875904322
the O 0 0.013934964314103127
185delAG O 1 0.9998569488525391
mutation O 0 0.029278548434376717
. O 0 0.010276863351464272

BRCA1 O 1 0.9999727010726929
allelic O 0 0.1946854144334793
patterns O 0 0.010461905039846897
were O 0 0.002869499148800969
determined O 0 0.003745682304725051
for O 0 0.0014313916908577085
four O 0 0.0014928884338587523
of O 0 0.0019009661627933383
these O 0 0.0009480059961788356
individuals O 0 0.0009066417696885765
and O 0 0.0010865781223401427
for O 0 0.002144044730812311
12 O 0 0.005586480256170034
additional O 0 0.004304125905036926
non O 0 0.011314778588712215
- O 0 0.01965605840086937
Ashkenazi O 0 0.08537605404853821
185delAG O 0 0.3578963875770569
mutation O 0 0.010380874387919903
carriers O 0 0.0070863524451851845
who O 0 0.006088148336857557
had O 0 0.022359801456332207
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9756550788879395

Six O 0 0.021214067935943604
non O 0 0.03169596195220947
- O 0 0.028586043044924736
Ashkenazi O 0 0.04024530574679375
individuals O 0 0.002768705366179347
shared O 0 0.006164949852973223
the O 0 0.006232499610632658
common O 0 0.015079834498465061
Ashkenazi O 1 0.9999713897705078
haplotype O 0 0.06849902868270874
, O 0 0.003939148969948292
four O 0 0.0025162678211927414
had O 0 0.002828737022355199
a O 0 0.002775875385850668
closely O 0 0.004737436771392822
related O 0 0.0061861262656748295
pattern O 0 0.011720864102244377
, O 0 0.0029411299619823694
and O 0 0.0020991256460547447
the O 0 0.005554145202040672
rest O 0 0.011941874399781227
( O 0 0.009352323599159718
n O 0 0.01987757533788681
= O 0 0.021341800689697266
6 O 0 0.007997476495802402
) O 0 0.0022652691695839167
displayed O 0 0.006349634844809771
a O 0 0.0048563433811068535
distinct O 0 0.017162233591079712
BRCA1 O 1 0.999948263168335
allelic O 1 0.9964120984077454
pattern O 0 0.0773349404335022
. O 0 0.02301299013197422

We O 0 0.006466463673859835
conclude O 0 0.011740516871213913
that O 0 0.0020380441565066576
the O 0 0.009919237345457077
185delAG O 1 0.9999629259109497
BRCA1 O 1 0.9999898672103882
mutation O 0 0.014816892333328724
occurs O 0 0.004582521505653858
in O 0 0.0023713656701147556
some O 0 0.002581977052614093
non O 0 0.017107944935560226
- O 0 0.0325598418712616
Ashkenazi O 0 0.06435007601976395
populations O 0 0.006941694300621748
at O 0 0.006493005435913801
rates O 0 0.005936472211033106
comparable O 0 0.006199258845299482
with O 0 0.001551825669594109
that O 0 0.002047909889370203
of O 0 0.010341974906623363
Ashkenazim O 1 0.9991611242294312
. O 0 0.018420083448290825

The O 0 0.010444574058055878
majority O 0 0.005191790871322155
of O 0 0.007795374374836683
Jewish O 0 0.03559854254126549
185delAG O 1 0.999880313873291
mutation O 0 0.018978094682097435
carriers O 0 0.00875681359320879
have O 0 0.0012183324433863163
a O 0 0.003199371974915266
common O 0 0.009378261864185333
allelic O 1 0.6947261095046997
pattern O 0 0.02511373907327652
, O 0 0.0055912029929459095
supporting O 0 0.008908419869840145
the O 0 0.009059174917638302
founder O 1 0.9955398440361023
effect O 0 0.00761547451838851
notion O 0 0.00807666964828968
, O 0 0.0026144597213715315
but O 0 0.0015063077444210649
dating O 0 0.009898404590785503
the O 0 0.0051345787942409515
mutations O 0 0.005423927679657936
origin O 0 0.0019872919656336308
to O 0 0.0014135250821709633
an O 0 0.0018639375921338797
earlier O 0 0.0041506486013531685
date O 0 0.005276506766676903
than O 0 0.0013169778976589441
currently O 0 0.004910388961434364
estimated O 0 0.00990730244666338
. O 0 0.008559144102036953

However O 0 0.008451467379927635
, O 0 0.0027266712859272957
the O 0 0.002912194700911641
different O 0 0.0016908482648432255
allelic O 0 0.03574395179748535
pattern O 0 0.014361240901052952
at O 0 0.011964412406086922
the O 0 0.013406099751591682
BRCA1 O 1 0.9999985694885254
locus O 0 0.036921799182891846
even O 0 0.002767795929685235
in O 0 0.0025591806042939425
some O 0 0.001978646032512188
Jewish O 0 0.01520541962236166
mutation O 0 0.017323320731520653
carriers O 0 0.01108462456613779
, O 0 0.003773338859900832
might O 0 0.0031860480085015297
suggest O 0 0.003759240498766303
that O 0 0.0013226545415818691
the O 0 0.004012617748230696
mutation O 0 0.009212111122906208
arose O 0 0.010265723802149296
independently O 0 0.006811146158725023
. O 0 0.004761111456900835
. O 0 0.007909218780696392

Crystal O 0 0.05717228725552559
structure O 0 0.01856793649494648
of O 0 0.013874081894755363
the O 0 0.07954848557710648
hemochromatosis B-Disease 1 1.0
protein O 1 0.9959478974342346
HFE O 1 0.9999996423721313
and O 0 0.00553769338876009
characterization O 0 0.018861664459109306
of O 0 0.007035113405436277
its O 0 0.004270301666110754
interaction O 0 0.007992438971996307
with O 0 0.006903530098497868
transferrin O 1 0.9990383386611938
receptor O 0 0.04543568566441536
. O 0 0.011593525297939777

HFE O 1 0.9999909400939941
is O 0 0.010316913947463036
an O 0 0.009730532765388489
MHC O 1 0.9999973773956299
- O 0 0.038654692471027374
related O 0 0.008778216317296028
protein O 0 0.004384238738566637
that O 0 0.0007754678372293711
is O 0 0.0014783411752432585
mutated O 0 0.006995015777647495
in O 0 0.0025178841315209866
the O 0 0.008909075520932674
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9999884366989136

HFE O 1 0.9999897480010986
binds O 0 0.04965253546833992
to O 0 0.01220244076102972
transferrin O 1 0.9740962386131287
receptor O 0 0.0485893152654171
( O 0 0.016749611124396324
TfR O 1 0.9999667406082153
) O 0 0.007352261338382959
and O 0 0.0030120783485472202
reduces O 0 0.013955585658550262
its O 0 0.002908948343247175
affinity O 0 0.009138417430222034
for O 0 0.006769734900444746
iron O 1 0.9999918937683105
- O 0 0.05435241386294365
loaded O 0 0.03381721302866936
transferrin O 0 0.12502412497997284
, O 0 0.012106998823583126
implicating O 1 0.9999359846115112
HFE O 1 1.0
in O 0 0.0632077232003212
iron O 1 1.0
metabolism O 1 0.9998337030410767
. O 0 0.022239411249756813

The O 0 0.029107028618454933
2 O 0 0.032791562378406525
. O 0 0.013030800968408585

6 O 0 0.03065108321607113
A O 0 0.01574767380952835
crystal O 0 0.03712455928325653
structure O 0 0.015284205786883831
of O 0 0.015431239269673824
HFE O 1 1.0
reveals O 0 0.03345078229904175
the O 0 0.005541304592043161
locations O 0 0.007182748522609472
of O 0 0.011537672951817513
hemochromatosis B-Disease 1 1.0
mutations O 0 0.05293315649032593
and O 0 0.004872910678386688
a O 0 0.009894494898617268
patch O 1 0.9999997615814209
of O 0 0.14202085137367249
histidines O 1 0.9999960660934448
that O 0 0.001975046470761299
could O 0 0.0012879179557785392
be O 0 0.000827146228402853
involved O 0 0.002946640131995082
in O 0 0.006698274053633213
pH O 1 0.9969899654388428
- O 0 0.03509768843650818
dependent O 0 0.013164266012609005
interactions O 0 0.011510432697832584
. O 0 0.00926581583917141

We O 0 0.006287655793130398
also O 0 0.0048473370261490345
demonstrate O 0 0.011476108804345131
that O 0 0.004785898607224226
soluble O 1 0.8499557971954346
TfR O 1 0.9999955892562866
and O 0 0.012582152150571346
HFE O 1 0.9999998807907104
bind O 0 0.024581214413046837
tightly O 0 0.011874065734446049
at O 0 0.006524201948195696
the O 0 0.0051615373231470585
basic O 0 0.0165310837328434
pH O 0 0.027062904089689255
of O 0 0.005107515025883913
the O 0 0.009288214147090912
cell O 0 0.013607542030513287
surface O 0 0.006083163898438215
, O 0 0.0019495171727612615
but O 0 0.0010982098756358027
not O 0 0.0010927467374131083
at O 0 0.005234020296484232
the O 0 0.008548136800527573
acidic O 0 0.061681266874074936
pH O 0 0.07157985121011734
of O 0 0.022528396919369698
intracellular O 1 0.9987978935241699
vesicles O 1 0.9877233505249023
. O 0 0.016129164025187492

TfR O 1 0.9999897480010986
HFE O 1 0.9999978542327881
stoichiometry O 0 0.10969636589288712
( O 0 0.016697954386472702
2 O 0 0.014957001432776451
1 O 0 0.013412016443908215
) O 0 0.004388274159282446
differs O 0 0.008925284259021282
from O 0 0.008055237121880054
TfR O 1 0.9999090433120728
transferrin O 1 0.9933311343193054
stoichiometry O 0 0.06813743710517883
( O 0 0.012054858729243279
2 O 0 0.01363704726099968
2 O 0 0.010517456568777561
) O 0 0.004154406487941742
, O 0 0.002377295633777976
implying O 0 0.00813656859099865
a O 0 0.00229960260912776
different O 0 0.0009236680925823748
mode O 0 0.005834927316755056
of O 0 0.0027557529974728823
binding O 0 0.004423835314810276
for O 0 0.006555256433784962
HFE O 1 0.9999998807907104
and O 0 0.010529791936278343
transferrin O 1 0.9993632435798645
to O 0 0.009746959432959557
TfR O 1 0.9999845027923584
, O 0 0.0051139285787940025
consistent O 0 0.006579622160643339
with O 0 0.001916398759931326
our O 0 0.004039374180138111
demonstration O 0 0.013182646594941616
that O 0 0.004423549864441156
HFE O 1 0.9999998807907104
, O 0 0.010942338034510612
transferrin O 1 0.9886674284934998
, O 0 0.005475430283695459
and O 0 0.004307544324547052
TfR O 1 0.999971866607666
form O 0 0.00804674532264471
a O 0 0.009629576466977596
ternary O 0 0.13536936044692993
complex O 0 0.03026633895933628
. O 0 0.013053031638264656

Identification O 0 0.01219701673835516
of O 0 0.0052846018224954605
three O 0 0.00465957960113883
novel O 0 0.01626720279455185
mutations O 0 0.00711805047467351
and O 0 0.0017962706042453647
a O 0 0.0036825307179242373
high O 0 0.007403932511806488
frequency O 0 0.0022870535030961037
of O 0 0.002279731910675764
the O 0 0.00559168541803956
Arg778Leu O 1 0.9881537556648254
mutation O 0 0.007398572750389576
in O 0 0.0034913981799036264
Korean O 0 0.36624303460121155
patients O 1 0.7196940183639526
with O 0 0.006510558538138866
Wilson B-Disease 1 0.9999996423721313
disease I-Disease 1 1.0
. O 0 0.0229777991771698

Four O 0 0.01663334295153618
mutations O 0 0.028937721624970436
- O 0 0.04529321938753128
- O 0 0.0345291830599308
R778L O 0 0.1277957707643509
, O 0 0.00664422707632184
A874V O 0 0.07195529341697693
, O 0 0.007286434527486563
L1083F O 0 0.06782270967960358
, O 0 0.005547875072807074
and O 0 0.006033806130290031
2304delC O 1 0.9999760389328003
- O 0 0.03494839370250702
- O 0 0.009317020885646343
in O 0 0.002110775327309966
the O 0 0.005545749329030514
copper O 1 0.9724828600883484
- O 0 0.027256833389401436
transporting O 0 0.024519402533769608
enzyme O 0 0.013638271950185299
, O 0 0.005716776009649038
P O 0 0.17392626404762268
- O 0 0.028597459197044373
type O 0 0.02813613787293434
ATPase O 1 0.9932483434677124
( O 0 0.01437792181968689
ATP7B O 1 0.9999854564666748
) O 0 0.0030587047804147005
, O 0 0.0011391048319637775
were O 0 0.0009229598217643797
identified O 0 0.0027980185113847256
in O 0 0.002891777316108346
Korean O 1 0.9844602942466736
Patients O 1 0.9999732971191406
with O 0 0.006163907237350941
Wilson B-Disease 1 0.9999995231628418
disease I-Disease 1 1.0
. O 0 0.022209692746400833

Arg778Leu O 1 0.9973828196525574
, O 0 0.006704234518110752
the O 0 0.004312816075980663
most O 0 0.002386607462540269
frequently O 0 0.004739526193588972
reported O 0 0.00784202292561531
mutation O 0 0.006242282222956419
of O 0 0.003485487075522542
this O 0 0.003146909410133958
enzyme O 0 0.008875086903572083
, O 0 0.00218053231947124
was O 0 0.0035532754845917225
found O 0 0.0017898081569001079
in O 0 0.0016763948369771242
six O 0 0.0018206285312771797
of O 0 0.003163782646879554
eight O 0 0.008049698546528816
unrelated O 0 0.024911563843488693
patients O 1 0.9747075438499451
studied O 0 0.015313313342630863
, O 0 0.004190318752080202
an O 0 0.0033810394816100597
allele O 0 0.009843389503657818
frequency O 0 0.004093235358595848
of O 0 0.005386189091950655
37 O 0 0.029008740559220314
. O 0 0.013243193738162518

5 O 0 0.028087979182600975
% O 0 0.007843676954507828
, O 0 0.003004224505275488
which O 0 0.0021232408471405506
is O 0 0.002855409635230899
considerably O 0 0.0060895592905581
higher O 0 0.002509182784706354
than O 0 0.0007387512596324086
those O 0 0.0008759878692217171
in O 0 0.0022910130210220814
other O 0 0.0026063923723995686
Asian O 0 0.01943417638540268
populations O 0 0.00991771463304758
. O 0 0.007640528026968241

The O 0 0.012546409852802753
novel O 0 0.021324118599295616
single O 0 0.009298778139054775
nucleotide O 0 0.021548084914684296
deletion O 0 0.021063577383756638
, O 0 0.006281455047428608
2304delC O 1 0.8180330991744995
, O 0 0.004406130872666836
was O 0 0.00619842205196619
found O 0 0.003113878658041358
in O 0 0.0033480164129287004
one O 0 0.007002930156886578
patient O 1 0.9985036849975586
. O 0 0.01416539866477251

Since O 0 0.010143072344362736
a O 0 0.005742479115724564
mutation O 0 0.010467258282005787
at O 0 0.010773594491183758
cDNA O 0 0.04822303354740143
nucleotide O 0 0.03728099167346954
2302 O 1 0.9982604384422302
( O 0 0.015543275512754917
2302insC O 1 0.9116496443748474
) O 0 0.004318688064813614
had O 0 0.002660863334313035
been O 0 0.0023317059967666864
previously O 0 0.004414304159581661
described O 0 0.005459039006382227
, O 0 0.00208836467936635
this O 0 0.0010512357112020254
region O 0 0.0035824652295559645
of O 0 0.004552196711301804
the O 0 0.013447655364871025
ATP7B O 1 1.0
gene O 0 0.011202860623598099
may O 0 0.003321628784760833
be O 0 0.001352047547698021
susceptible O 0 0.010888488031923771
to O 0 0.003982551861554384
gene O 0 0.014330952428281307
rearrangements O 1 0.9518463015556335
causing O 1 0.9998551607131958
Wilson B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.033056676387786865

Disruption O 0 0.057617779821157455
of O 0 0.012097951956093311
splicing O 0 0.023318922147154808
regulated O 0 0.0054805688560009
by O 0 0.0012926192721351981
a O 0 0.006414804607629776
CUG O 1 0.9999959468841553
- O 0 0.024064110592007637
binding O 0 0.007332878652960062
protein O 0 0.011565024964511395
in O 0 0.011832674965262413
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.32010596990585327

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.021671785041689873
is O 0 0.004029946867376566
caused O 0 0.006908063311129808
by O 0 0.0022270986810326576
a O 0 0.009336763992905617
CTG O 1 0.9999803304672241
expansion O 0 0.009658141992986202
in O 0 0.0031081498600542545
the O 0 0.0036736067850142717
3 O 0 0.009605549275875092
untranslated O 0 0.041580382734537125
region O 0 0.0071691120974719524
of O 0 0.006937263999134302
the O 0 0.029879130423069
DM B-Disease 1 1.0
gene O 0 0.032366205006837845
. O 0 0.009894125163555145

One O 0 0.008910642936825752
model O 0 0.014407292008399963
of O 0 0.020086033269762993
DM B-Disease 1 1.0
pathogenesis O 1 1.0
suggests O 0 0.019680442288517952
that O 0 0.003148701973259449
RNAs O 0 0.018737055361270905
from O 0 0.0025184517726302147
the O 0 0.003526367712765932
expanded O 0 0.009089953266084194
allele O 0 0.009975100867450237
create O 0 0.003268118714913726
a O 0 0.004797028843313456
gain O 0 0.012358685955405235
- O 0 0.015158591791987419
of O 0 0.007052670232951641
- O 0 0.01739383675158024
function O 0 0.007261911407113075
mutation O 0 0.004556308034807444
by O 0 0.0013379595475271344
the O 0 0.0034610081929713488
inappropriate O 0 0.011759442277252674
binding O 0 0.0030847268644720316
of O 0 0.0032325354404747486
proteins O 0 0.003333641681820154
to O 0 0.0024597919546067715
the O 0 0.008408968336880207
CUG O 1 0.9999974966049194
repeats O 0 0.06938835233449936
. O 0 0.011375079862773418

Data O 0 0.011563891544938087
presented O 0 0.009681859984993935
here O 0 0.004922113846987486
indicate O 0 0.004141631536185741
that O 0 0.0011742633068934083
the O 0 0.003432205645367503
conserved O 0 0.012812417931854725
heterogeneous O 0 0.025621434673666954
nuclear O 0 0.019514521583914757
ribonucleoprotein O 1 0.9550121426582336
, O 0 0.00986909493803978
CUG O 1 0.9999474287033081
- O 0 0.021874001249670982
binding O 0 0.006992251146584749
protein O 0 0.00905272364616394
( O 0 0.010131626389920712
CUG O 1 0.9999502897262573
- O 0 0.03332044929265976
BP O 0 0.035534486174583435
) O 0 0.003344855038449168
, O 0 0.0018475110409781337
may O 0 0.0027812980115413666
mediate O 0 0.0162563007324934
the O 0 0.010268147103488445
trans O 1 0.9966050386428833
- O 0 0.02364087663590908
dominant O 0 0.012002282775938511
effect O 0 0.003955585416406393
of O 0 0.004822786431759596
the O 0 0.011640973389148712
RNA O 0 0.03989314287900925
. O 0 0.010629969649016857

CUG O 1 0.9999992847442627
- O 0 0.32391855120658875
BP O 0 0.05011110380291939
was O 0 0.008795185945928097
found O 0 0.002514324616640806
to O 0 0.0018407946918159723
bind O 0 0.005380799062550068
to O 0 0.0019000608008354902
the O 0 0.005666427779942751
human O 0 0.06570043414831161
cardiac O 1 1.0
troponin O 1 1.0
T O 1 1.0
( O 0 0.01529377605766058
cTNT O 1 0.9917225241661072
) O 0 0.0054491483606398106
pre O 0 0.027834543958306313
- O 0 0.023777605965733528
messenger O 0 0.025323770940303802
RNA O 0 0.010332023724913597
and O 0 0.0016200552927330136
regulate O 0 0.007727237418293953
its O 0 0.003272340167313814
alternative O 0 0.013631499372422695
splicing O 0 0.03668646141886711
. O 0 0.00926948431879282

Splicing O 0 0.038002531975507736
of O 0 0.011695285327732563
cTNT O 1 0.9908822774887085
was O 0 0.01832742430269718
disrupted O 0 0.05619661882519722
in O 0 0.024142727255821228
DM B-Disease 1 1.0
striated O 1 1.0
muscle O 1 0.9999994039535522
and O 0 0.005577661097049713
in O 0 0.0067764041014015675
normal O 0 0.012198641896247864
cells O 0 0.006184608209878206
expressing O 0 0.008662953972816467
transcripts O 0 0.009269073605537415
that O 0 0.0023405365645885468
contain O 0 0.014005246572196484
CUG O 1 0.9999182224273682
repeats O 0 0.05901196226477623
. O 0 0.012375452555716038

Altered O 0 0.02802288345992565
expression O 0 0.009138072840869427
of O 0 0.006016836501657963
genes O 0 0.010888436809182167
regulated O 0 0.01414634007960558
posttranscriptionally O 0 0.061112601310014725
by O 0 0.0071707963943481445
CUG O 1 0.9999996423721313
- O 0 0.08333992213010788
BP O 0 0.04064161702990532
therefore O 0 0.004460932221263647
may O 0 0.00346958776935935
contribute O 0 0.009043248370289803
to O 0 0.012392244301736355
DM B-Disease 1 1.0
pathogenesis O 1 1.0
. O 0 0.014307666569948196
. O 0 0.01234361995011568

Identification O 0 0.01660733111202717
of O 0 0.006174844689667225
a O 0 0.008493246510624886
novel O 0 0.02754003182053566
nonsense O 0 0.04550696536898613
mutation O 0 0.009313308633863926
and O 0 0.002472539199516177
a O 0 0.004664188716560602
missense O 0 0.02302946150302887
substitution O 0 0.010330092161893845
in O 0 0.003953439183533192
the O 0 0.009433562867343426
vasopressin O 1 0.9993615746498108
- O 0 0.10645186901092529
neurophysin O 1 0.9996148347854614
II O 1 0.9999960660934448
gene O 0 0.0059412745758891106
in O 0 0.0020397051703184843
two O 0 0.0016230210894718766
Spanish O 0 0.01107867807149887
kindreds O 0 0.05123993009328842
with O 0 0.00851946696639061
familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 1 0.7032279372215271

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9999986886978149
FNDI B-Disease 1 1.0
) O 0 0.006170567590743303
is O 0 0.001662059803493321
an O 0 0.0025942442007362843
autosomal B-Disease 1 0.9999988079071045
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
caused O 1 1.0
by O 1 0.9960944056510925
deficiency O 1 1.0
in O 1 0.9855799674987793
the O 1 0.9963317513465881
antidiuretic O 1 1.0
hormone O 1 0.9999980926513672
arginine O 1 0.9851813316345215
vasopressin O 1 0.9378441572189331
( O 0 0.015306929126381874
AVP O 1 0.9998787641525269
) O 0 0.0035936636850237846
encoded O 0 0.0017820335924625397
by O 0 0.0009878284763544798
the O 0 0.005952287930995226
AVP O 1 1.0
- O 1 0.5645785927772522
neurophysin O 1 0.9999206066131592
II O 1 1.0
( O 0 0.04188017174601555
AVP O 1 1.0
- O 1 0.8415579795837402
NPII O 1 0.9999934434890747
) O 0 0.006401561200618744
gene O 0 0.005914729088544846
on O 0 0.005433474201709032
chromosome O 0 0.03473830223083496
20p13 O 1 0.9832512736320496
. O 0 0.01774962991476059

In O 0 0.009365875273942947
this O 0 0.002706474857404828
study O 0 0.0052900840528309345
, O 0 0.0023565373849123716
we O 0 0.0011353121371939778
analyzed O 0 0.00317514780908823
two O 0 0.0009118475718423724
families O 0 0.0024275800678879023
with O 0 0.002962730126455426
FNDI B-Disease 1 0.9999996423721313
using O 0 0.005533597897738218
direct O 0 0.0073079755529761314
automated O 0 0.026565004140138626
fluorescent O 0 0.028412500396370888
, O 0 0.0038635029923170805
solid O 0 0.01128265168517828
phase O 0 0.016466477885842323
, O 0 0.0038361570332199335
single O 0 0.005381680093705654
- O 0 0.011118846014142036
stranded O 0 0.014534047804772854
DNA O 0 0.006828153505921364
sequencing O 0 0.00783602986484766
of O 0 0.006670876871794462
PCR O 0 0.07520365715026855
- O 0 0.03776070475578308
amplified O 0 0.05029677227139473
AVP O 1 0.9999995231628418
- O 0 0.0821707621216774
NPII O 1 0.999842643737793
DNA O 0 0.02954895608127117
. O 0 0.010988746769726276

In O 0 0.00829901173710823
one O 0 0.003775207092985511
of O 0 0.004839074797928333
the O 0 0.006097371689975262
families O 0 0.0058862897567451
, O 0 0.003591676941141486
affected O 0 0.004451307468116283
individuals O 0 0.0016553670866414905
presented O 0 0.005435912404209375
a O 0 0.004263103939592838
novel O 0 0.020008480176329613
nonsense O 0 0.029609423130750656
mutation O 0 0.008741289377212524
in O 0 0.0039017219096422195
exon O 0 0.02610408514738083
3 O 0 0.004605049733072519
of O 0 0.0023876475170254707
the O 0 0.004466424696147442
gene O 0 0.00452669570222497
, O 0 0.0014803854282945395
consisting O 0 0.002979022217914462
in O 0 0.0023916219361126423
a O 0 0.005305864382535219
G O 0 0.14719782769680023
to O 0 0.005069653503596783
T O 1 0.5637596845626831
transition O 0 0.014895276166498661
at O 0 0.010343901813030243
nucleotide O 0 0.021856756880879402
2101 O 1 0.5888290405273438
, O 0 0.0036342167295515537
which O 0 0.0017790484707802534
produces O 0 0.004497007001191378
a O 0 0.0036779148504137993
stop O 0 0.008275584317743778
signal O 0 0.008204744197428226
in O 0 0.0037907694932073355
codon O 0 0.02829275093972683
82 O 0 0.03323889151215553
( O 0 0.015486925840377808
Glu O 1 0.9999946355819702
) O 0 0.007911257445812225
of O 0 0.01150604523718357
NPII O 1 0.9999984502792358
. O 0 0.017913920804858208

The O 0 0.02749212644994259
premature O 1 0.9200659990310669
termination O 0 0.3911857008934021
eliminates O 0 0.03097551129758358
part O 0 0.005246991291642189
of O 0 0.0039969924837350845
the O 0 0.0082695372402668
C O 1 0.9960617423057556
- O 0 0.020163865759968758
terminal O 0 0.020252911373972893
domain O 0 0.007556439843028784
of O 0 0.006740680895745754
NPII O 1 0.9999923706054688
, O 0 0.0032662556041032076
including O 0 0.002206771168857813
a O 0 0.005277617368847132
cysteine O 0 0.01841927133500576
residue O 0 0.02498692460358143
in O 0 0.004231720231473446
position O 0 0.008418262004852295
85 O 0 0.01308459509164095
, O 0 0.002400863915681839
which O 0 0.0012006303295493126
could O 0 0.0009982773335650563
be O 0 0.0007353124092333019
involved O 0 0.001676811370998621
in O 0 0.002349657705053687
the O 0 0.005035463720560074
correct O 0 0.021372675895690918
folding O 0 0.04457501694560051
of O 0 0.009951900690793991
the O 0 0.022236356511712074
prohormone O 1 0.9999997615814209
. O 0 0.01884830929338932

In O 0 0.009278492070734501
the O 0 0.0071146078407764435
second O 0 0.009309629909694195
family O 0 0.008210287429392338
, O 0 0.002974939066916704
a O 0 0.004300588276237249
G279A O 0 0.066019706428051
substitution O 0 0.013757102191448212
at O 0 0.007171301171183586
position O 0 0.008715152740478516
- O 0 0.009581690654158592
1 O 0 0.004901278298348188
of O 0 0.0027508512139320374
the O 0 0.0061825476586818695
signal O 0 0.014270083978772163
peptide O 0 0.014164399355649948
was O 0 0.005095740780234337
observed O 0 0.003111080965027213
in O 0 0.002568101044744253
all O 0 0.0029159439727663994
affected O 0 0.010546864941716194
individuals O 0 0.006847428157925606
. O 0 0.011788559146225452

This O 0 0.00963121373206377
missense O 0 0.04675767570734024
mutation O 0 0.014555538073182106
, O 0 0.0045029520988464355
which O 0 0.004837873857468367
replaces O 1 0.9998037219047546
Ala O 1 1.0
with O 0 0.009224959649145603
Thr O 1 1.0
, O 0 0.0056040119379758835
is O 0 0.003397537162527442
frequent O 0 0.01014378946274519
among O 0 0.014207779429852962
FNDI B-Disease 1 1.0
patients O 1 0.9999997615814209
and O 0 0.0053358254954218864
is O 0 0.003975778818130493
thought O 0 0.004030877258628607
to O 0 0.0023208162747323513
reduce O 0 0.007712641265243292
the O 0 0.005128077231347561
efficiency O 0 0.014379233121871948
of O 0 0.009319425560534
cleavage O 0 0.3588586747646332
by O 0 0.005140791647136211
signal O 0 0.02342548407614231
peptidases O 0 0.380034476518631
. O 0 0.006499208975583315
. O 0 0.008608768694102764

Genetic O 0 0.031176069751381874
heterogeneity O 0 0.042691804468631744
of O 0 0.024838324636220932
Saethre B-Disease 1 1.0
- I-Disease 1 0.9999988079071045
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.007766916416585445
due O 0 0.00885778944939375
to O 0 0.0060636368580162525
TWIST O 1 0.9995539784431458
and O 0 0.009060168638825417
FGFR O 1 1.0
mutations O 0 0.03429403528571129
. O 0 0.011700748465955257

Thirty O 0 0.048609331250190735
- O 0 0.01868543028831482
two O 0 0.0022864912170916796
unrelated O 0 0.012221560813486576
patients O 0 0.011928895488381386
with O 0 0.0018066834891214967
features O 0 0.004746918100863695
of O 0 0.010999488644301891
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0054309130646288395
a O 0 0.005387093871831894
common O 0 0.015522736124694347
autosomal B-Disease 1 0.9999996423721313
dominant I-Disease 1 0.9999696016311646
condition I-Disease 1 1.0
of O 1 1.0
craniosynostosis B-Disease 1 1.0
and O 1 0.9999997615814209
limb B-Disease 1 1.0
anomalies I-Disease 1 1.0
, O 0 0.007841452024877071
were O 0 0.002661088714376092
screened O 0 0.0073466915637254715
for O 0 0.0021975028794258833
mutations O 0 0.005285029299557209
in O 0 0.0038703063037246466
TWIST O 1 0.9875378012657166
, O 0 0.008447295986115932
FGFR2 O 1 0.9999971389770508
, O 0 0.007448457647114992
and O 0 0.0088222436606884
FGFR3 O 1 0.9999991655349731
. O 0 0.01695994660258293

Nine O 0 0.01344054564833641
novel O 0 0.015052126720547676
and O 0 0.00457020103931427
three O 0 0.007066467311233282
recurrent O 1 1.0
TWIST O 1 0.9999951124191284
mutations O 0 0.011737627908587456
were O 0 0.0023329684045165777
found O 0 0.002766853664070368
in O 0 0.003314104164019227
12 O 0 0.010548547841608524
families O 0 0.00824146717786789
. O 0 0.008960191160440445

Seven O 0 0.012055255472660065
families O 0 0.0051928553730249405
were O 0 0.002052863361313939
found O 0 0.002479629823938012
to O 0 0.0019391966052353382
have O 0 0.001652389531955123
the O 0 0.009023980237543583
FGFR3 O 1 1.0
P250R O 1 0.9999853372573853
mutation O 0 0.014647169038653374
, O 0 0.0027767494320869446
and O 0 0.0016342586604878306
one O 0 0.0021442549768835306
individual O 0 0.0023464453406631947
was O 0 0.004522496368736029
found O 0 0.0021336055360734463
to O 0 0.0014106795424595475
have O 0 0.0010699342237785459
an O 0 0.003973375540226698
FGFR2 O 1 0.9999992847442627
VV269 O 1 0.9999154806137085
- O 0 0.03947468101978302
270 O 0 0.03761168196797371
deletion O 0 0.03716744855046272
. O 0 0.010221029631793499

To O 0 0.009903721511363983
date O 0 0.010876446962356567
, O 0 0.00421642092987895
our O 0 0.0037358051631599665
detection O 0 0.008510952815413475
rate O 0 0.003826482454314828
for O 0 0.002875799313187599
TWIST O 0 0.1238328143954277
or O 0 0.008025686256587505
FGFR O 1 0.9999933242797852
mutations O 0 0.008333918638527393
is O 0 0.0023958757519721985
68 O 0 0.011403035372495651
% O 0 0.002439639298245311
in O 0 0.0028249945025891066
our O 0 0.007953840307891369
Saethre B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999934434890747
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
, O 0 0.006362476386129856
including O 0 0.003530280664563179
our O 0 0.004934324882924557
five O 0 0.004983815364539623
patients O 0 0.04862740635871887
elsewhere O 0 0.008537006564438343
reported O 0 0.007402418181300163
with O 0 0.0039160531014204025
TWIST O 1 0.9991884827613831
mutations O 0 0.022497059777379036
. O 0 0.010271873325109482

More O 0 0.0035420977510511875
than O 0 0.0019684124272316694
35 O 0 0.005616914480924606
different O 0 0.002447227481752634
TWIST O 0 0.05155544728040695
mutations O 0 0.0074226404540240765
are O 0 0.0011797761544585228
now O 0 0.002679313300177455
known O 0 0.004047108814120293
in O 0 0.002857801504433155
the O 0 0.006221572868525982
literature O 0 0.017753763124346733
. O 0 0.011462186463177204

The O 0 0.011893091723322868
most O 0 0.004089348949491978
common O 0 0.008531470783054829
phenotypic O 0 0.03221683204174042
features O 0 0.009232315234839916
, O 0 0.0036216131411492825
present O 0 0.0032565488945692778
in O 0 0.0018308772705495358
more O 0 0.0006843233131803572
than O 0 0.0006832347135059536
a O 0 0.0018783101113513112
third O 0 0.0044465446844697
of O 0 0.0037772664800286293
our O 0 0.006047677248716354
patients O 0 0.15834052860736847
with O 0 0.004131820984184742
TWIST O 1 0.9996077418327332
mutations O 0 0.009962355718016624
, O 0 0.002737300004810095
are O 0 0.001972573110833764
coronal B-Disease 0 0.4514741897583008
synostosis I-Disease 1 0.9999264478683472
, O 0 0.011466898955404758
brachycephaly B-Disease 1 0.9995889067649841
, O 0 0.010953500866889954
low B-Disease 0 0.044381413608789444
frontal I-Disease 1 0.9999998807907104
hairline I-Disease 1 1.0
, O 1 0.9988148212432861
facial B-Disease 1 1.0
asymmetry I-Disease 1 1.0
, O 1 0.9995220899581909
ptosis B-Disease 1 1.0
, O 0 0.03271670266985893
hypertelorism B-Disease 1 0.9999998807907104
, O 0 0.009324753656983376
broad B-Disease 0 0.01952645368874073
great I-Disease 0 0.07316451519727707
toes I-Disease 1 0.9994213581085205
, O 0 0.00862518884241581
and O 0 0.00927889533340931
clinodactyly B-Disease 1 0.9999703168869019
. O 0 0.021449469029903412

Significant O 0 0.03673941642045975
intra O 1 0.9996635913848877
- O 0 0.04829161986708641
and O 0 0.008350477553904057
interfamilial O 1 0.9835681915283203
phenotypic O 0 0.04510441794991493
variability O 0 0.020041488111019135
is O 0 0.003143216948956251
present O 0 0.0029739916790276766
for O 0 0.002679624129086733
either O 0 0.005876492243260145
TWIST O 0 0.4783707857131958
mutations O 0 0.019414780661463737
or O 0 0.01405530609190464
FGFR O 1 0.9999991655349731
mutations O 0 0.03540317341685295
. O 0 0.011807916685938835

The O 0 0.017356794327497482
overlap O 0 0.013113418594002724
in O 0 0.006417020224034786
clinical O 1 0.992002010345459
features O 0 0.009354899637401104
and O 0 0.002933325245976448
the O 0 0.004105682484805584
presence O 0 0.004521646071225405
, O 0 0.001818951452150941
in O 0 0.0015307610156014562
the O 0 0.002449598629027605
same O 0 0.0020195040851831436
genes O 0 0.002351766685023904
, O 0 0.001323429518379271
of O 0 0.0023571564815938473
mutations O 0 0.0038364813663065434
for O 0 0.00128237868193537
more O 0 0.0006627548718824983
than O 0 0.0009341269615106285
one O 0 0.003001596312969923
craniosynostotic B-Disease 1 0.9981379508972168
condition I-Disease 1 0.9644936323165894
- O 0 0.012068245559930801
such O 0 0.0017753433203324676
as O 0 0.006331698969006538
Saethre B-Disease 1 0.9999969005584717
- I-Disease 0 0.06837420165538788
Chotzen I-Disease 1 0.9980960488319397
, I-Disease 0 0.007902818731963634
Crouzon I-Disease 1 0.9988558292388916
, I-Disease 0 0.008971814066171646
and I-Disease 0 0.011107704602181911
Pfeiffer I-Disease 1 1.0
syndromes I-Disease 1 1.0
- O 1 0.999054491519928
support O 0 0.008164746686816216
the O 0 0.0057746837846934795
hypothesis O 0 0.011631508357822895
that O 0 0.0028406246565282345
TWIST O 0 0.04779253900051117
and O 0 0.005696009378880262
FGFRs O 1 0.892149031162262
are O 0 0.0015547762159258127
components O 0 0.003459697822108865
of O 0 0.0030519189313054085
the O 0 0.005064492113888264
same O 0 0.0037841268349438906
molecular O 0 0.010334987193346024
pathway O 0 0.006566251628100872
involved O 0 0.0016644865972921252
in O 0 0.0018654463347047567
the O 0 0.004303382709622383
modulation O 0 0.02242344059050083
of O 0 0.015174333937466145
craniofacial O 1 1.0
and O 1 0.9999663829803467
limb O 1 1.0
development O 0 0.2089240849018097
in O 0 0.005832371301949024
humans O 0 0.006519617512822151
. O 0 0.0031714492943137884
. O 0 0.006038331426680088

Mutation O 0 0.017604481428861618
analysis O 0 0.005408287048339844
of O 0 0.010988164693117142
UBE3A O 1 1.0
in O 1 0.9996477365493774
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
. O 1 0.9035855531692505

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999998807907104
AS B-Disease 1 0.9999998807907104
) O 0 0.006902961991727352
is O 0 0.0029217349365353584
caused O 0 0.00929113756865263
by O 0 0.006228316109627485
chromosome O 0 0.052508387714624405
15q11 O 1 0.9998838901519775
- O 0 0.05078883841633797
q13 O 0 0.12336554378271103
deletions O 0 0.021692652255296707
of O 0 0.008242059499025345
maternal O 1 0.9953643083572388
origin O 0 0.006463639438152313
, O 0 0.0038875623140484095
by O 0 0.0043451739475131035
paternal O 1 0.9993305206298828
uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
( O 1 0.9693775177001953
UPD B-Disease 1 1.0
) O 0 0.008825763128697872
15 O 0 0.005029594525694847
, O 0 0.0026069164741784334
by O 0 0.0036954188253730536
imprinting O 1 0.9999985694885254
defects O 1 0.9999998807907104
, O 0 0.006906296592205763
and O 0 0.003202856285497546
by O 0 0.002481148112565279
mutations O 0 0.005658443085849285
in O 0 0.0046415310353040695
the O 0 0.015999991446733475
UBE3A O 1 1.0
gene O 0 0.02773027867078781
. O 0 0.010139384306967258

UBE3A O 1 0.9999881982803345
encodes O 0 0.03957907855510712
a O 0 0.013412199914455414
ubiquitin O 0 0.0744118019938469
- O 0 0.03271656855940819
protein O 0 0.012792333029210567
ligase O 0 0.026557089760899544
and O 0 0.005198888946324587
shows O 0 0.017802730202674866
brain O 1 0.999883770942688
- O 0 0.03021961823105812
specific O 0 0.012388006784021854
imprinting O 0 0.1673383265733719
. O 0 0.016728991642594337

Here O 0 0.0144050857052207
we O 0 0.005090497434139252
describe O 0 0.03298472240567207
UBE3A O 1 0.9999985694885254
coding O 1 0.7118687033653259
- O 0 0.034742217510938644
region O 0 0.016550110653042793
mutations O 0 0.012731456197798252
detected O 0 0.011588063091039658
by O 0 0.0029510173480957747
SSCP O 1 0.9908402562141418
analysis O 0 0.0037355886306613684
in O 0 0.0030555136036127806
13 O 0 0.007726879324764013
AS B-Disease 0 0.0140912514179945
individuals O 0 0.002475047018378973
or O 0 0.005011249799281359
families O 0 0.00822530034929514
. O 0 0.008952479809522629

Two O 0 0.006347463000565767
identical O 0 0.014153677970170975
de O 0 0.05989603325724602
novo O 1 0.5447014570236206
5 O 0 0.026076093316078186
- O 0 0.024569518864154816
bp O 0 0.024897487834095955
duplications O 0 0.035221148282289505
in O 0 0.006897838320583105
exon O 0 0.044099435210227966
16 O 0 0.009478882886469364
were O 0 0.0032477518543601036
found O 0 0.007266449276357889
. O 0 0.009427076205611229

Among O 0 0.00910102017223835
the O 0 0.005242587998509407
other O 0 0.0024635554291307926
11 O 0 0.007336138281971216
unique O 0 0.006488496903330088
mutations O 0 0.007676364853978157
, O 0 0.0031787510961294174
8 O 0 0.007197528146207333
were O 0 0.0024316739290952682
small O 0 0.004304189700633287
deletions O 0 0.02044791355729103
or O 0 0.0075216651894152164
insertions O 0 0.03859587013721466
predicted O 0 0.014614762738347054
to O 0 0.0044375257566571236
cause O 0 0.025136884301900864
frameshifts O 1 0.9999867677688599
, O 0 0.006238181609660387
1 O 0 0.010150743648409843
was O 0 0.005508442874997854
a O 0 0.002887509996071458
mutation O 0 0.004490034654736519
to O 0 0.0015339741948992014
a O 0 0.0035576103255152702
stop O 0 0.009442470036447048
codon O 0 0.017753878608345985
, O 0 0.0035417815670371056
1 O 0 0.0071507906541228294
was O 0 0.004937424790114164
a O 0 0.00452402513474226
missense O 0 0.03146523982286453
mutation O 0 0.008805675432085991
, O 0 0.0027847280725836754
and O 0 0.0026610405184328556
1 O 0 0.011709872633218765
was O 0 0.008098575286567211
predicted O 0 0.007523423992097378
to O 0 0.0029953864868730307
cause O 0 0.009940659627318382
insertion O 0 0.0178914126008749
of O 0 0.006934748962521553
an O 0 0.0069084265269339085
isoleucine O 1 0.9995699524879456
in O 0 0.004596812650561333
the O 0 0.00652688555419445
hect O 0 0.05573003366589546
domain O 0 0.007264468818902969
of O 0 0.005450742784887552
the O 0 0.012862553820014
UBE3A O 1 1.0
protein O 0 0.010770658031105995
, O 0 0.002212327206507325
which O 0 0.0012924190377816558
functions O 0 0.004186619073152542
in O 0 0.007042408920824528
E2 O 1 0.9889916181564331
binding O 0 0.007952907122671604
and O 0 0.005910088773816824
ubiquitin O 0 0.047118835151195526
transfer O 0 0.01607164926826954
. O 0 0.011048429645597935

Eight O 0 0.010471289977431297
of O 0 0.006087083835154772
the O 0 0.006310177035629749
cases O 0 0.006797016132622957
were O 0 0.005076659377664328
familial O 1 0.9999481439590454
, O 0 0.005786247551441193
and O 0 0.002946901135146618
five O 0 0.0041367486119270325
were O 0 0.004336905665695667
sporadic O 0 0.026312151923775673
. O 0 0.013257608748972416

In O 0 0.007956852205097675
two O 0 0.0043228487484157085
familial O 1 0.9999434947967529
cases O 0 0.01567133329808712
and O 0 0.004632263444364071
one O 0 0.004634651821106672
sporadic O 0 0.019426017999649048
case O 0 0.011961103416979313
, O 0 0.007910988293588161
mosaicism O 1 0.9998810291290283
for O 0 0.013642813079059124
UBE3A O 1 1.0
mutations O 0 0.018393732607364655
was O 0 0.009154425002634525
detected O 0 0.008117280900478363
in O 0 0.002289404859766364
the O 0 0.0033399974927306175
mother O 0 0.009570312686264515
of O 0 0.004156080074608326
three O 0 0.004172906279563904
AS B-Disease 1 0.8775952458381653
sons O 0 0.09754081070423126
, O 0 0.0027941043954342604
in O 0 0.0027034906670451164
the O 0 0.00647346768528223
maternal O 1 0.9958561062812805
grandfather O 0 0.13833221793174744
of O 0 0.005697605200111866
two O 0 0.003348875790834427
AS B-Disease 0 0.0228141937404871
first O 0 0.006697740405797958
cousins O 0 0.012337692081928253
, O 0 0.0017680159071460366
and O 0 0.001371885184198618
in O 0 0.0023286263458430767
the O 0 0.004330424591898918
mother O 0 0.013292248360812664
of O 0 0.004427122883498669
an O 0 0.0057531557977199554
AS B-Disease 1 0.9999462366104126
daughter O 1 0.999907374382019
. O 0 0.014661106280982494

The O 0 0.014784746803343296
frequencies O 0 0.0052382927387952805
with O 0 0.0015843892470002174
which O 0 0.001980431843549013
we O 0 0.0019221093971282244
detected O 0 0.00791718065738678
mutations O 0 0.005312820430845022
were O 0 0.002119729993864894
5 O 0 0.0073563517071306705
( O 0 0.005036323796957731
14 O 0 0.006617297884076834
% O 0 0.0035275123082101345
) O 0 0.0024219262413680553
of O 0 0.002880083629861474
35 O 0 0.00611758092418313
in O 0 0.003322172211483121
sporadic O 0 0.012760869227349758
cases O 0 0.006319650448858738
and O 0 0.0036668831016868353
8 O 0 0.010858522728085518
( O 0 0.004807623568922281
80 O 0 0.0050895847380161285
% O 0 0.002525973366573453
) O 0 0.0015059872530400753
of O 0 0.0020078476518392563
10 O 0 0.00409653689712286
in O 0 0.0045185573399066925
familial O 1 0.9999915361404419
cases O 0 0.050420504063367844
. O 0 0.008755753748118877
. O 0 0.010353004559874535

The O 0 0.0558050237596035
hemochromatosis B-Disease 1 1.0
845 O 1 1.0
G O 1 0.9999997615814209
- O 1 0.862149715423584
- O 0 0.02439919300377369
> O 0 0.014781726524233818
A O 0 0.004219032358378172
and O 0 0.0021086239721626043
187 O 0 0.021173963323235512
C O 0 0.08872517198324203
- O 0 0.029675884172320366
- O 0 0.022283468395471573
> O 0 0.032243601977825165
G O 0 0.041766323149204254
mutations O 0 0.007762136869132519
: O 0 0.005256516858935356
prevalence O 0 0.14240039885044098
in O 0 0.0064428686164319515
non O 0 0.07113582640886307
- O 0 0.3318420946598053
Caucasian O 1 0.9626079797744751
populations O 0 0.013640747405588627
. O 0 0.007968461140990257

Hemochromatosis B-Disease 1 1.0
, O 0 0.014171872287988663
the O 0 0.07091861218214035
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 0.007368057034909725
leads O 0 0.012741828337311745
, O 0 0.0037019061855971813
if O 0 0.0034535443410277367
untreated O 1 0.999995231628418
, O 0 0.0052587068639695644
to O 0 0.007337319198995829
progressive O 1 0.9999995231628418
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 0 0.030248530209064484
premature B-Disease 1 0.9999922513961792
death I-Disease 1 0.9989221096038818
. O 0 0.018827693536877632

The O 0 0.2506747245788574
hemochromatosis B-Disease 1 1.0
gene O 1 0.8985431790351868
, O 0 0.014179255813360214
HFE O 1 1.0
, O 0 0.008260296657681465
recently O 0 0.00943284947425127
has O 0 0.0028495369479060173
been O 0 0.0023723000194877386
identified O 0 0.004928895737975836
, O 0 0.002512152772396803
and O 0 0.002335240365937352
characterization O 0 0.018507590517401695
of O 0 0.007115625310689211
this O 0 0.004454854875802994
gene O 0 0.007652022875845432
has O 0 0.0024955617263913155
shown O 0 0.002793284598737955
that O 0 0.0008648455259390175
it O 0 0.0008428076980635524
contains O 0 0.002370604546740651
two O 0 0.001440643798559904
mutations O 0 0.004158542025834322
that O 0 0.0010033758589997888
result O 0 0.002632647752761841
in O 0 0.003879719413816929
amino O 0 0.01035222876816988
acid O 0 0.016037791967391968
substitutions O 0 0.020388972014188766
- O 0 0.019936589524149895
cDNA O 0 0.03817739710211754
nucleotides O 0 0.030179381370544434
845 O 0 0.16442839801311493
G O 1 0.9709860682487488
- O 0 0.03907005488872528
- O 0 0.020974205806851387
> O 0 0.019118474796414375
A O 0 0.007609804626554251
( O 0 0.007096132729202509
C282Y O 0 0.04309435561299324
) O 0 0.00313140288926661
and O 0 0.0025183665566146374
187 O 0 0.024053821340203285
C O 0 0.3278575539588928
- O 0 0.04443074390292168
- O 0 0.03309909999370575
> O 0 0.04861519858241081
G O 0 0.13848422467708588
( O 0 0.01929815672338009
H63D O 1 0.9999709129333496
) O 0 0.013303891755640507
. O 0 0.009280008263885975

Although O 0 0.03586800768971443
hemochromatosis B-Disease 1 1.0
is O 0 0.01031484454870224
common O 0 0.008805414661765099
in O 0 0.008404831402003765
Caucasians O 1 0.9993870258331299
, O 0 0.009355435147881508
affecting O 0 0.03281831368803978
> O 0 0.38894933462142944
= O 0 0.057340387254953384
1 O 0 0.0187053345143795
/ O 0 0.023756103590130806
300 O 0 0.004553129896521568
individuals O 0 0.0011511308839544654
of O 0 0.0023438995704054832
northern O 0 0.00606957171112299
European O 0 0.004718910902738571
origin O 0 0.0043951584957540035
, O 0 0.002938970224931836
it O 0 0.001358726411126554
has O 0 0.0015411144122481346
not O 0 0.0008589026401750743
been O 0 0.0015817530220374465
recognized O 0 0.003997138701379299
in O 0 0.0025839991867542267
other O 0 0.0025554103776812553
populations O 0 0.009008500725030899
. O 0 0.008168439380824566

The O 0 0.011214382015168667
present O 0 0.006469583138823509
study O 0 0.006775560323148966
used O 0 0.006246265023946762
PCR O 0 0.03213949501514435
and O 0 0.004586377181112766
restriction O 0 0.018423566594719887
- O 0 0.02734276093542576
enzyme O 0 0.015473654493689537
digestion O 0 0.022606555372476578
to O 0 0.002594684949144721
analyze O 0 0.006462916731834412
the O 0 0.002162368968129158
frequency O 0 0.0023633339442312717
of O 0 0.0020431973971426487
the O 0 0.00725350109860301
845 O 1 0.9998880624771118
G O 1 0.9999760389328003
- O 0 0.03815832361578941
- O 0 0.01604955643415451
> O 0 0.012305699288845062
A O 0 0.003842448815703392
and O 0 0.002482158364728093
187 O 0 0.02118641324341297
C O 0 0.05568092316389084
- O 0 0.03055414929986
- O 0 0.02502848580479622
> O 0 0.03171689808368683
G O 0 0.03942444548010826
mutations O 0 0.009137963876128197
in O 0 0.007994703948497772
HLA O 1 1.0
- O 0 0.02470383420586586
typed O 0 0.01267952285706997
samples O 0 0.004511334002017975
from O 0 0.0036950940266251564
non O 0 0.014557561837136745
- O 0 0.02184624783694744
Caucasian O 0 0.10247448086738586
populations O 0 0.0040784538723528385
, O 0 0.0021450838539749384
comprising O 0 0.0062278760597109795
Australian O 0 0.01647910661995411
Aboriginal O 0 0.037546414881944656
, O 0 0.00439241761341691
Chinese O 0 0.010659473016858101
, O 0 0.004081185907125473
and O 0 0.004557151813060045
Pacific O 0 0.031493280082941055
Islanders O 0 0.05551626533269882
. O 0 0.015168135054409504

Results O 0 0.01612192951142788
showed O 0 0.008552009239792824
that O 0 0.0020572540815919638
the O 0 0.008027022704482079
845 O 1 0.9998138546943665
G O 1 0.999976396560669
- O 0 0.1382060945034027
- O 0 0.03241436928510666
> O 0 0.026003045961260796
A O 0 0.010011623613536358
mutation O 0 0.009260152466595173
was O 0 0.005146574229001999
present O 0 0.0031219637021422386
in O 0 0.002460346557199955
these O 0 0.001314336434006691
populations O 0 0.004399049561470747
( O 0 0.005398472771048546
allele O 0 0.008959176018834114
frequency O 0 0.003539170604199171
0 O 0 0.00579623831436038
. O 0 0.0014540966367349029
32 O 0 0.0069479430094361305
% O 0 0.004573052283376455
) O 0 0.003212409559637308
, O 0 0.002083362312987447
and O 0 0.0021480764262378216
, O 0 0.003413056256249547
furthermore O 0 0.007951624691486359
, O 0 0.002641161670908332
it O 0 0.0014163426822051406
was O 0 0.004442601464688778
always O 0 0.0032401939388364553
seen O 0 0.0028787830378860235
in O 0 0.002131920773535967
conjunction O 0 0.012794782407581806
with O 0 0.005567582324147224
HLA O 1 1.0
haplotypes O 0 0.2740304172039032
common O 0 0.007098067551851273
in O 0 0.005416103173047304
Caucasians O 1 0.6665962934494019
, O 0 0.0034158502239733934
suggesting O 0 0.006094840355217457
that O 0 0.0029328258242458105
845 O 1 0.999984860420227
G O 1 0.9999996423721313
- O 1 0.996316134929657
- O 0 0.10174622386693954
> O 0 0.028952250257134438
A O 0 0.008025079034268856
may O 0 0.0033285943791270256
have O 0 0.0009512723190709949
been O 0 0.0015791677869856358
introduced O 0 0.0028446658980101347
into O 0 0.001306215999647975
these O 0 0.0009321190300397575
populations O 0 0.0031203879043459892
by O 0 0.0038262351881712675
Caucasian O 1 0.9994087219238281
admixture O 1 0.9954604506492615
. O 0 0.022578977048397064

187 O 0 0.07919846475124359
C O 1 0.7746369242668152
- O 0 0.08050753176212311
- O 0 0.040802497416734695
> O 0 0.04491814970970154
G O 0 0.036574095487594604
was O 0 0.006487470120191574
present O 0 0.003298663767054677
at O 0 0.005034730304032564
an O 0 0.0028812752570956945
allele O 0 0.009034578688442707
frequency O 0 0.0032284141052514315
of O 0 0.0043853712268173695
2 O 0 0.01795448549091816
. O 0 0.008746967650949955

68 O 0 0.04512941837310791
% O 0 0.005556976888328791
in O 0 0.0025106153916567564
the O 0 0.0028669023886322975
two O 0 0.0018036641413345933
populations O 0 0.004152867943048477
analyzed O 0 0.008015398867428303
( O 0 0.005916405934840441
Australian O 0 0.011302685365080833
Aboriginal O 0 0.026406314224004745
and O 0 0.004252724349498749
Chinese O 0 0.02394404634833336
) O 0 0.010434937663376331
. O 0 0.008542893454432487

In O 0 0.00632069306448102
the O 0 0.005517807323485613
Australian O 0 0.011920849792659283
Aboriginal O 0 0.016874568536877632
samples O 0 0.005022646393626928
, O 0 0.003115579951554537
187 O 0 0.018945783376693726
C O 0 0.12346109747886658
- O 0 0.04589615389704704
- O 0 0.03348854184150696
> O 0 0.03837067261338234
G O 0 0.035669051110744476
was O 0 0.005231729242950678
found O 0 0.0022515603341162205
to O 0 0.001496246550232172
be O 0 0.0014070944162085652
associated O 0 0.004494187887758017
with O 0 0.0063949706964194775
HLA O 1 1.0
haplotypes O 1 0.9931691884994507
common O 0 0.011805935762822628
in O 0 0.008517913520336151
Caucasians O 1 0.9996408224105835
, O 0 0.005757319275289774
suggesting O 0 0.008279467932879925
that O 0 0.0011854796903207898
it O 0 0.0011697587324306369
was O 0 0.004057069309055805
introduced O 0 0.004377454519271851
by O 0 0.0019192573381587863
recent O 0 0.009301646612584591
admixture O 0 0.06055388227105141
. O 0 0.015264568850398064

In O 0 0.007637878879904747
the O 0 0.005813677795231342
Chinese O 0 0.008873132057487965
samples O 0 0.004939529579132795
analyzed O 0 0.005356252193450928
, O 0 0.002580974018201232
187 O 0 0.02157752960920334
C O 0 0.18308882415294647
- O 0 0.041938915848731995
- O 0 0.03322650119662285
> O 0 0.04285545274615288
G O 0 0.043123360723257065
was O 0 0.006475703790783882
present O 0 0.003749042982235551
in O 0 0.0028150612488389015
association O 0 0.006461447570472956
with O 0 0.0015377735253423452
a O 0 0.0030070822685956955
wide O 0 0.004277459345757961
variety O 0 0.006677702534943819
of O 0 0.027850346639752388
HLA O 1 1.0
haplotypes O 1 0.9983158111572266
, O 0 0.0061918748542666435
showing O 0 0.010064523667097092
this O 0 0.002308170311152935
mutation O 0 0.0054198140278458595
to O 0 0.0017151925712823868
be O 0 0.001190425711683929
widespread O 0 0.0049328734166920185
and O 0 0.0030815659556537867
likely O 0 0.004641176201403141
to O 0 0.0029650975484400988
predate O 0 0.018883593380451202
the O 0 0.002930121961981058
more O 0 0.001332063227891922
genetically O 0 0.0058882650919258595
restricted O 0 0.00883700791746378
845 O 1 0.9971599578857422
G O 1 0.9999839067459106
- O 1 0.6472882628440857
- O 0 0.040705181658267975
> O 0 0.032660823315382004
A O 0 0.01682676002383232
mutation O 0 0.0210203155875206
. O 0 0.008498620241880417

Genotype O 0 0.17186270654201508
- O 0 0.04261775314807892
phenotype O 0 0.028588412329554558
correlations O 0 0.023006267845630646
in O 0 0.012678192928433418
attenuated B-Disease 1 0.9998816251754761
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 0.0667949989438057

Germ O 1 0.9999849796295166
- O 0 0.03930579125881195
line O 0 0.011195543222129345
mutations O 0 0.005515323020517826
of O 0 0.00488880043849349
the O 0 0.021954838186502457
tumor B-Disease 1 1.0
suppressor O 1 0.9999991655349731
APC O 1 0.9995566010475159
are O 0 0.0023147736210376024
implicated O 0 0.02366771176457405
in O 0 0.010357730090618134
attenuated B-Disease 1 0.9999887943267822
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999760389328003
AAPC B-Disease 1 1.0
) O 0 0.0065819937735795975
, O 0 0.0019002542831003666
a O 0 0.0026843687519431114
variant O 0 0.018913399428129196
of O 0 0.015111356042325497
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 1.0
FAP B-Disease 1 1.0
) O 0 0.037964459508657455
. O 0 0.010797588154673576

AAPC B-Disease 1 0.9999998807907104
is O 0 0.010883740149438381
recognized O 0 0.007572795730084181
by O 0 0.001800594967789948
the O 0 0.005054608918726444
occurrence O 0 0.022815367206931114
of O 0 0.017101380974054337
< O 1 0.9810009598731995
100 O 0 0.025885283946990967
colonic B-Disease 1 0.999998927116394
adenomas I-Disease 1 0.999992847442627
and O 0 0.00391231058165431
a O 0 0.004045373294502497
later O 0 0.007654985412955284
onset O 1 0.9999998807907104
of O 1 0.9999949932098389
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999872446060181
age O 0 0.026527348905801773
> O 0 0.026234498247504234
40 O 0 0.005845303647220135
years O 0 0.004926197696477175
) O 0 0.005750025622546673
. O 0 0.005806753411889076

The O 0 0.011831765994429588
aim O 0 0.011147219687700272
of O 0 0.0034359493292868137
this O 0 0.0018172207055613399
study O 0 0.004261980764567852
was O 0 0.0053065442480146885
to O 0 0.003470313036814332
assess O 0 0.0288871917873621
genotype O 0 0.05075473710894585
- O 0 0.022569026798009872
phenotype O 0 0.02506454847753048
correlations O 0 0.024969525635242462
in O 0 0.015378721058368683
AAPC B-Disease 1 1.0
families O 0 0.023234955966472626
. O 0 0.013094641268253326

By O 0 0.009941664524376392
protein O 0 0.020766837522387505
- O 0 0.019475707784295082
truncation O 0 0.0525171160697937
test O 0 0.013819374144077301
( O 0 0.013238908722996712
PTT O 0 0.32680046558380127
) O 0 0.00517469784244895
assay O 0 0.011705657467246056
, O 0 0.0018560286844149232
the O 0 0.003214876400306821
entire O 0 0.00876033678650856
coding O 0 0.01852717436850071
region O 0 0.005461172666400671
of O 0 0.00526350736618042
the O 0 0.01123807393014431
APC B-Disease 1 0.9999983310699463
gene O 0 0.00926374550908804
was O 0 0.006539289373904467
screened O 0 0.010819245129823685
in O 0 0.003137043444439769
affected O 0 0.005166814662516117
individuals O 0 0.002024424495175481
from O 0 0.005701720714569092
11 O 0 0.032507870346307755
AAPC B-Disease 1 1.0
kindreds O 1 0.9998372793197632
, O 0 0.005694178398698568
and O 0 0.002198462840169668
their O 0 0.0020250468514859676
phenotypic O 0 0.018831543624401093
differences O 0 0.009698908776044846
were O 0 0.004979320336133242
examined O 0 0.03865474462509155
. O 0 0.012967114336788654

Five O 0 0.0140285799279809
novel O 0 0.04927326366305351
germ O 1 0.9999991655349731
- O 1 0.575602650642395
line O 0 0.02779644913971424
APC B-Disease 1 0.9991579055786133
mutations O 0 0.007531427778303623
were O 0 0.002041637198999524
identified O 0 0.005336462985724211
in O 0 0.004975097719579935
seven O 0 0.015219192020595074
kindreds O 1 0.9532399773597717
. O 0 0.019178811460733414

Mutations O 0 0.023741725832223892
were O 0 0.004024471156299114
located O 0 0.007004737388342619
in O 0 0.002000002423301339
three O 0 0.0011234681587666273
different O 0 0.0006521682371385396
regions O 0 0.001802313607186079
of O 0 0.003277089912444353
the O 0 0.011813700199127197
APC B-Disease 1 0.9999988079071045
gene O 0 0.009805075824260712
( O 0 0.004148086998611689
1 O 0 0.005431709345430136
) O 0 0.0018696755869314075
at O 0 0.0024530277587473392
the O 0 0.0024560296442359686
5 O 0 0.005089282989501953
end O 0 0.004551416262984276
spanning O 0 0.015161233022809029
exons O 0 0.025185683742165565
4 O 0 0.006941989995539188
and O 0 0.0021841125562787056
5 O 0 0.005538120865821838
, O 0 0.00265800510533154
( O 0 0.004566504154354334
2 O 0 0.006060780957341194
) O 0 0.001907121972180903
within O 0 0.0018156352452933788
exon O 0 0.02749042958021164
9 O 0 0.0068738581612706184
, O 0 0.002145714359357953
and O 0 0.0018544781487435102
( O 0 0.00480717234313488
3 O 0 0.005394623149186373
) O 0 0.001896760193631053
at O 0 0.002886532573029399
the O 0 0.0035159846302121878
3 O 0 0.010283593088388443
distal O 0 0.36067500710487366
end O 0 0.008933009579777718
of O 0 0.007425079122185707
the O 0 0.014238459058105946
gene O 0 0.018815841525793076
. O 0 0.009273269213736057

Variability O 0 0.025196576490998268
in O 0 0.0044625550508499146
the O 0 0.005025830585509539
number O 0 0.005305822007358074
of O 1 0.5677331686019897
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9999896287918091
most O 0 0.0049369800835847855
apparent O 0 0.010511226952075958
in O 0 0.002399780321866274
individuals O 0 0.0012978590093553066
with O 0 0.0015353484777733684
mutations O 0 0.004586482420563698
in O 0 0.002227596938610077
region O 0 0.00848008506000042
1 O 0 0.009570494294166565
, O 0 0.0032479881774634123
and O 0 0.004302408080548048
upper O 1 0.9999994039535522
- O 1 0.9999997615814209
gastrointestinal O 1 1.0
manifestations O 1 1.0
were O 0 0.006898112595081329
more O 0 0.002775521483272314
severe O 1 0.9999834299087524
in O 0 0.008175667375326157
them O 0 0.005338539369404316
. O 0 0.009755976498126984

In O 0 0.008620102889835835
individuals O 0 0.0027198155876249075
with O 0 0.0022508425172418356
mutations O 0 0.0065732672810554504
in O 0 0.0031636806670576334
either O 0 0.004297127015888691
region O 0 0.010046552866697311
2 O 0 0.011080915108323097
or O 0 0.003198155900463462
region O 0 0.007767016533762217
3 O 0 0.006755200680345297
, O 0 0.002329195849597454
the O 0 0.0032436191104352474
average O 0 0.00524619547650218
number O 0 0.002739259507507086
of O 0 0.007497941609472036
adenomas B-Disease 1 0.9999996423721313
tended O 0 0.023014342412352562
to O 0 0.004398874472826719
be O 0 0.002351256785914302
lower O 0 0.005569332744926214
than O 0 0.0008572032093070447
those O 0 0.0007237144745886326
in O 0 0.0016128807328641415
individuals O 0 0.0011377763003110886
with O 0 0.001729902345687151
mutations O 0 0.006379313301295042
in O 0 0.003381497459486127
region O 0 0.008155709132552147
1 O 0 0.00764350825920701
, O 0 0.0018322636606171727
although O 0 0.0018409611657261848
age O 0 0.0051504275761544704
at O 0 0.012333997525274754
diagnosis O 1 1.0
was O 0 0.020932350307703018
similar O 0 0.007823961786925793
. O 0 0.009695145301520824

In O 0 0.016393711790442467
all O 0 0.011754832230508327
AAPC B-Disease 1 1.0
kindreds O 1 0.5826740860939026
, O 0 0.004425202962011099
a O 0 0.005410768091678619
predominance O 0 0.04565342515707016
of O 0 0.01249956525862217
right O 1 0.823828399181366
- O 1 0.9999974966049194
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999996423721313
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.9999998807907104
was O 0 0.16749925911426544
observed O 0 0.013867651112377644
. O 0 0.009013896808028221

No O 0 0.03566344082355499
desmoid B-Disease 1 0.9999996423721313
tumors I-Disease 1 1.0
were O 0 0.006082253530621529
found O 0 0.00505837332457304
in O 0 0.004593575373291969
these O 0 0.0048827724531292915
kindreds O 0 0.1823701560497284
. O 0 0.01676028035581112

Our O 0 0.012854509986937046
data O 0 0.004948236979544163
suggest O 0 0.0044944738037884235
that O 0 0.001380582107231021
, O 0 0.003222112311050296
in O 0 0.0081533407792449
AAPC B-Disease 1 1.0
families O 0 0.00751460948958993
, O 0 0.003161204745993018
the O 0 0.0031040480826050043
location O 0 0.005857652518898249
of O 0 0.005943970289081335
the O 0 0.013016530312597752
APC B-Disease 1 0.999995231628418
mutation O 0 0.021101726219058037
may O 0 0.008480910211801529
partially O 0 0.02079448290169239
predict O 0 0.011042105965316296
specific O 0 0.006205686833709478
phenotypic O 0 0.03807276487350464
expression O 0 0.024073058739304543
. O 0 0.012013903819024563

This O 0 0.006071717943996191
should O 0 0.003334703389555216
help O 0 0.003826176980510354
in O 0 0.0018845057347789407
the O 0 0.002781275426968932
design O 0 0.005768010392785072
of O 0 0.007083216216415167
tailored O 0 0.061197202652692795
clinical O 1 0.9999997615814209
- O 1 0.8423600196838379
management O 0 0.012834589928388596
protocols O 0 0.012594124302268028
in O 0 0.002310472074896097
this O 0 0.0014656989369541407
subset O 0 0.013919352553784847
of O 0 0.012670311145484447
FAP B-Disease 1 1.0
patients O 1 0.9999998807907104
. O 0 0.010105634108185768
. O 0 0.009547793306410313

Wilms B-Disease 1 1.0
' I-Disease 1 0.9961985945701599
tumor I-Disease 1 0.9999886751174927
1 O 0 0.022356294095516205
and O 0 0.007416607346385717
Dax O 1 0.9999997615814209
- O 0 0.039891667664051056
1 O 0 0.015114706940948963
modulate O 0 0.021138522773981094
the O 0 0.006942904554307461
orphan O 1 0.9919015765190125
nuclear O 0 0.023734869435429573
receptor O 0 0.044810619205236435
SF O 1 0.9999971389770508
- O 0 0.019395550712943077
1 O 0 0.007445331662893295
in O 0 0.0033137325663119555
sex O 0 0.011857378296554089
- O 0 0.015936020761728287
specific O 0 0.005688317585736513
gene O 0 0.012914661318063736
expression O 0 0.011892312206327915
. O 0 0.008631054311990738

Products O 0 0.02281906269490719
of O 0 0.015080133453011513
steroidogenic O 1 0.9999793767929077
factor O 0 0.02642188034951687
1 O 0 0.018890051171183586
( O 0 0.011673100292682648
SF O 1 0.9999997615814209
- O 0 0.029253311455249786
1 O 0 0.010447333566844463
) O 0 0.004036674275994301
and O 0 0.004945560824126005
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
1 O 1 0.9001320600509644
( O 0 0.02238534949719906
WT1 O 1 0.9999996423721313
) O 0 0.0051737260073423386
genes O 0 0.0025999483186751604
are O 0 0.0007224156288430095
essential O 0 0.004513694904744625
for O 0 0.003740259213373065
mammalian O 0 0.028651302680373192
gonadogenesis O 1 0.5482301115989685
prior O 0 0.008398454636335373
to O 0 0.004774828441441059
sexual O 0 0.01767026074230671
differentiation O 1 0.743966817855835
. O 0 0.015895184129476547

In O 0 0.0119159035384655
males O 0 0.01367152575403452
, O 0 0.011987854726612568
SF O 1 1.0
- O 0 0.09882429987192154
1 O 0 0.015748629346489906
participates O 0 0.013418908230960369
in O 0 0.003511666553094983
sexual O 0 0.006784903816878796
development O 0 0.006465085316449404
by O 0 0.0022714324295520782
regulating O 0 0.010762105695903301
expression O 0 0.005413781851530075
of O 0 0.005573790520429611
the O 0 0.01526061911135912
polypeptide O 1 0.999760091304779
hormone O 1 0.9994137287139893
Mullerian O 1 0.9999988079071045
inhibiting O 0 0.39553993940353394
substance O 1 0.9714652299880981
( O 0 0.038541268557310104
MIS O 1 1.0
) O 0 0.01199339795857668
. O 0 0.007169587537646294

Here O 0 0.016465064138174057
, O 0 0.0046276794746518135
we O 0 0.002468500519171357
show O 0 0.006319111678749323
that O 0 0.005603102967143059
WT1 O 1 0.9999994039535522
- O 0 0.1897287517786026
KTS O 1 0.9999567270278931
isoforms O 0 0.023956404998898506
associate O 0 0.016752367839217186
and O 0 0.004813737701624632
synergize O 1 0.9965835213661194
with O 0 0.010949940420687199
SF O 1 1.0
- O 0 0.054596975445747375
1 O 0 0.011134570464491844
to O 0 0.004109556321054697
promote O 0 0.026762858033180237
MIS O 1 0.9999957084655762
expression O 0 0.026991771534085274
. O 0 0.01227794773876667

In O 0 0.012856562621891499
contrast O 0 0.019342083483934402
, O 0 0.01348102930933237
WT1 O 1 0.9999991655349731
missense O 0 0.058486342430114746
mutations O 0 0.00980041828006506
, O 0 0.0021257419139146805
associated O 0 0.0030015904922038317
with O 0 0.0022040661424398422
male B-Disease 0 0.028976844623684883
pseudohermaphroditism I-Disease 1 1.0
in O 0 0.03194313496351242
Denys B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.010921766050159931
fail O 0 0.015737634152173996
to O 0 0.005252066068351269
synergize O 1 0.9973281621932983
with O 0 0.009667440317571163
SF O 1 1.0
- O 1 0.9587681889533997
1 O 0 0.02258308231830597
. O 0 0.008291790261864662

Additionally O 0 0.023156339302659035
, O 0 0.005347393453121185
the O 0 0.008586443029344082
X O 1 0.9962344765663147
- O 0 0.026912054046988487
linked O 0 0.011189177632331848
, O 0 0.003623654367402196
candidate O 0 0.011616584844887257
dosage O 1 0.8449171781539917
- O 0 0.02876991219818592
sensitive O 0 0.014697887934744358
sex O 0 0.01576768048107624
- O 0 0.021718209609389305
reversal O 0 0.026925761252641678
gene O 0 0.010361793451011181
, O 0 0.005936098285019398
Dax O 1 0.9999983310699463
- O 0 0.03758352994918823
1 O 0 0.01418238878250122
, O 0 0.005848008673638105
antagonizes O 0 0.10600636899471283
synergy O 0 0.048707734793424606
between O 0 0.016818588599562645
SF O 1 1.0
- O 1 0.5140681862831116
1 O 0 0.01670529879629612
and O 0 0.006339429412037134
WT1 O 1 0.9999977350234985
, O 0 0.004045558162033558
most O 0 0.002035363344475627
likely O 0 0.002441625576466322
through O 0 0.0016425561625510454
a O 0 0.002508151810616255
direct O 0 0.0033427926246076822
interaction O 0 0.005281195975840092
with O 0 0.0069909365847706795
SF O 1 1.0
- O 1 0.8054545521736145
1 O 0 0.02361787110567093
. O 0 0.007394048850983381

We O 0 0.008189838379621506
propose O 0 0.01785692386329174
that O 0 0.005733078345656395
WT1 O 1 0.999988317489624
and O 0 0.012940269894897938
Dax O 1 0.9999998807907104
- O 0 0.14260531961917877
1 O 0 0.018403539434075356
functionally O 0 0.018012287095189095
oppose O 0 0.0035511909518390894
each O 0 0.0010302866576239467
other O 0 0.0011329525150358677
in O 0 0.004819812718778849
testis O 1 0.9999747276306152
development O 0 0.009947814978659153
by O 0 0.004987051710486412
modulating O 1 0.9999804496765137
SF O 1 1.0
- O 1 0.538482129573822
1 O 0 0.02540828287601471
- O 0 0.0230986550450325
mediated O 0 0.03509065508842468
transactivation O 1 0.6657368540763855
. O 0 0.008117695339024067
. O 0 0.009310985915362835

A O 0 0.023347746580839157
mouse O 0 0.020176798105239868
model O 0 0.009259449318051338
for O 0 0.011424621567130089
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9999977350234985
centre O 1 0.9427945613861084
mutations O 0 0.02777157723903656
. O 0 0.011193927377462387

Imprinting O 0 0.0853513851761818
in O 0 0.008786685764789581
the O 0 0.013174515217542648
15q11 O 1 0.9998886585235596
- O 0 0.04949052259325981
q13 O 0 0.09489802271127701
region O 0 0.009507906623184681
involves O 0 0.008033769205212593
an O 0 0.006238066125661135
imprinting O 1 0.9989511966705322
centre O 1 0.9665309190750122
( O 0 0.02284911833703518
IC O 1 0.9999955892562866
) O 0 0.006192549131810665
, O 0 0.0024365808349102736
mapping O 0 0.005688090808689594
in O 0 0.002025241730734706
part O 0 0.003449422772973776
to O 0 0.0023157652467489243
the O 0 0.00414147786796093
promoter O 0 0.09874596446752548
and O 0 0.003411972662433982
first O 0 0.0077308365143835545
exon O 0 0.053044240921735764
of O 0 0.015923574566841125
SNRPN O 1 0.9999991655349731
. O 0 0.020811347290873528

Deletion O 0 0.05246094986796379
of O 0 0.014773493632674217
this O 0 0.011539816856384277
IC O 1 0.9999972581863403
abolishes O 1 0.999133288860321
local O 0 0.013336938805878162
paternally O 0 0.06833220273256302
derived O 0 0.01131943054497242
gene O 0 0.006271688267588615
expression O 0 0.002757926704362035
and O 0 0.0014965577283874154
results O 0 0.005096417386084795
in O 0 0.01285124383866787
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
PWS B-Disease 1 1.0
) O 0 0.0415412001311779
. O 0 0.009833011776208878

We O 0 0.004992193542420864
have O 0 0.0016007814556360245
created O 0 0.005318798124790192
two O 0 0.0028028134256601334
deletion O 0 0.02924075908958912
mutations O 0 0.012409552931785583
in O 0 0.005968889221549034
mice O 0 0.014653384685516357
to O 0 0.005797198042273521
understand O 0 0.02402677573263645
PWS B-Disease 1 1.0
and O 0 0.006473774090409279
the O 0 0.00652418052777648
mechanism O 0 0.0106322867795825
of O 0 0.0061854347586631775
this O 0 0.005749196745455265
IC O 1 0.9999940395355225
. O 0 0.014471812173724174

Mice O 0 0.10313737392425537
harbouring O 1 0.8869897723197937
an O 0 0.012462558224797249
intragenic O 1 0.9994574189186096
deletion O 0 0.04996343329548836
in O 0 0.011028243228793144
Snrpn O 1 0.9995563626289368
are O 0 0.004857449792325497
phenotypically O 0 0.28807228803634644
normal O 0 0.010669485665857792
, O 0 0.003309177700430155
suggesting O 0 0.007452081888914108
that O 0 0.0021388318855315447
mutations O 0 0.007330980617552996
of O 0 0.0071397931315004826
SNRPN O 1 0.9999980926513672
are O 0 0.00221979315392673
not O 0 0.0013057633768767118
sufficient O 0 0.00823378935456276
to O 0 0.008411395363509655
induce O 1 0.9796519875526428
PWS B-Disease 1 1.0
. O 0 0.032142069190740585

Mice O 0 0.028140099719166756
with O 0 0.002625518711283803
a O 0 0.004461349453777075
larger O 0 0.0052368068136274815
deletion O 0 0.018230531364679337
involving O 0 0.006995651870965958
both O 0 0.0046936809085309505
Snrpn O 1 0.9999310970306396
and O 0 0.006723237689584494
the O 0 0.016702935099601746
putative O 1 0.9999969005584717
PWS O 1 1.0
- O 1 0.9999462366104126
IC O 1 0.9999475479125977
lack O 0 0.016152743250131607
expression O 0 0.007078999187797308
of O 0 0.004871548619121313
the O 0 0.010112477466464043
imprinted O 0 0.4353365898132324
genes O 0 0.012968994677066803
Zfp127 O 1 0.8642441630363464
( O 0 0.01133054681122303
mouse O 0 0.016191542148590088
homologue O 0 0.04412655159831047
of O 0 0.009004615247249603
ZNF127 O 1 1.0
) O 0 0.009119206108152866
, O 0 0.00609310157597065
Ndn O 1 0.999936580657959
and O 0 0.008051260374486446
Ipw O 1 0.9999945163726807
, O 0 0.005101124756038189
and O 0 0.0027688804548233747
manifest O 0 0.02180657535791397
several O 0 0.0052390857599675655
phenotypes O 0 0.051494766026735306
common O 0 0.014743824489414692
to O 0 0.021698197349905968
PWS B-Disease 1 1.0
infants O 1 1.0
. O 0 0.024835681542754173

These O 0 0.005156899802386761
data O 0 0.004203115589916706
demonstrate O 0 0.005945365410298109
that O 0 0.0010715649696066976
both O 0 0.0010236474918201566
the O 0 0.0027914869133383036
position O 0 0.005619407631456852
of O 0 0.004364919848740101
the O 0 0.009098006412386894
IC O 1 0.9999982118606567
and O 0 0.0026800548657774925
its O 0 0.0022050426341593266
role O 0 0.004009329713881016
in O 0 0.0024463266599923372
the O 0 0.0033744690008461475
coordinate O 0 0.009179467335343361
expression O 0 0.004395041614770889
of O 0 0.004249498713761568
genes O 0 0.004907933529466391
is O 0 0.0022052619606256485
conserved O 0 0.007539654616266489
between O 0 0.004395498428493738
mouse O 0 0.0145488902926445
and O 0 0.003443402936682105
human O 0 0.005424004979431629
, O 0 0.003977610729634762
and O 0 0.002765927230939269
indicate O 0 0.006727773230522871
that O 0 0.0014740426559001207
the O 0 0.004193391650915146
mouse O 0 0.008953088894486427
is O 0 0.001926824334077537
a O 0 0.0025764117017388344
suitable O 0 0.008817516267299652
model O 0 0.0057892766781151295
system O 0 0.0029213556554168463
in O 0 0.0011882171966135502
which O 0 0.0008609351352788508
to O 0 0.0012646941468119621
investigate O 0 0.00744484132155776
the O 0 0.004721796605736017
molecular O 0 0.012295196764171124
mechanisms O 0 0.007632299792021513
of O 0 0.005810333415865898
imprinting O 0 0.2798501253128052
in O 0 0.0038211459759622812
this O 0 0.0016797034768387675
region O 0 0.004026725422590971
of O 0 0.004127079620957375
the O 0 0.008827866055071354
genome O 0 0.01336334366351366
. O 0 0.004021916538476944
. O 0 0.006682872772216797

Mutations O 0 0.016796542331576347
of O 0 0.007042766083031893
the O 0 0.01250515878200531
ATM O 1 0.7137831449508667
gene O 0 0.007768059615045786
detected O 0 0.007518668193370104
in O 0 0.004772489424794912
Japanese O 1 0.9996868371963501
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.999996542930603
: O 0 0.00933919008821249
possible O 0 0.004973304457962513
preponderance O 0 0.02751651592552662
of O 0 0.0038384355138987303
the O 0 0.0039380211383104324
two O 0 0.0026954044587910175
founder O 1 0.7794972062110901
mutations O 0 0.01813701167702675
4612del165 O 1 0.9543092250823975
and O 0 0.010926789604127407
7883del5 O 1 0.9986909031867981
. O 0 0.021953264251351357

The O 0 0.02098659612238407
ATM O 1 0.8130354881286621
( O 0 0.013745862059295177
A O 1 0.9806397557258606
- O 1 0.9984128475189209
T O 1 0.999994158744812
, O 0 0.005179877392947674
mutated O 0 0.015878736972808838
) O 0 0.004068309441208839
gene O 0 0.004730164539068937
on O 0 0.004265610594302416
human O 0 0.013931694440543652
chromosome O 0 0.05254490673542023
11q22 O 1 0.9983994364738464
. O 0 0.015947392210364342

3 O 0 0.02089533768594265
has O 0 0.00421351520344615
recently O 0 0.006318638566881418
been O 0 0.0021198964677751064
identified O 0 0.0030008384492248297
as O 0 0.0016938435146585107
the O 0 0.0028561565559357405
gene O 0 0.003008994273841381
responsible O 0 0.002165614627301693
for O 0 0.0013762309681624174
the O 0 0.0038299011066555977
human O 0 0.044161416590213776
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9996980428695679
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999984502792358
T I-Disease 1 0.9999998807907104
) O 0 0.010242682881653309
. O 0 0.006897648796439171

In O 0 0.0071764737367630005
order O 0 0.004369501955807209
to O 0 0.0022195796482264996
define O 0 0.005849150940775871
the O 0 0.0030376112554222345
types O 0 0.004903757944703102
of O 0 0.01692533679306507
disease O 1 1.0
- O 1 0.9999961853027344
causing O 1 0.5804892778396606
ATM O 1 0.5679096579551697
mutations O 0 0.005253408569842577
in O 0 0.0026839144993573427
Japanese O 0 0.2008039802312851
A B-Disease 1 0.9999984502792358
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
patients O 1 0.9933011531829834
as O 0 0.002585784299299121
well O 0 0.0013116166228428483
as O 0 0.0013131514424458146
to O 0 0.001369617530144751
look O 0 0.0032424693927168846
for O 0 0.0026169391348958015
possible O 0 0.009717356413602829
mutational O 1 0.9744040966033936
hotspots O 0 0.07125392556190491
, O 0 0.00770112918689847
reverse O 0 0.02559632994234562
- O 0 0.02049555815756321
transcribed O 0 0.021420171484351158
RNA O 0 0.01259782537817955
derived O 0 0.003606201382353902
from O 0 0.002165620680898428
ten O 0 0.006838091183453798
patients O 0 0.01293962448835373
belonging O 0 0.008115698583424091
to O 0 0.002534381812438369
eight O 0 0.004126718733459711
unrelated O 0 0.013761949725449085
Japanese O 1 0.8537392616271973
A B-Disease 1 0.9999964237213135
- I-Disease 1 0.9999297857284546
T I-Disease 1 0.9999934434890747
families O 0 0.005181634332984686
was O 0 0.005446792114526033
analyzed O 0 0.0067213051952421665
for O 0 0.002977157710120082
mutations O 0 0.00670963479205966
by O 0 0.0019256988307461143
the O 0 0.008297811262309551
restriction O 0 0.026093024760484695
endonuclease O 0 0.09832111746072769
fingerprinting O 0 0.04439551383256912
method O 0 0.018467701971530914
. O 0 0.011951003223657608

As O 0 0.010795998387038708
has O 0 0.004243246745318174
been O 0 0.0033106249757111073
reported O 0 0.005026808474212885
by O 0 0.0016995635814964771
others O 0 0.0035562210250645876
, O 0 0.0031600133515894413
mutations O 0 0.004499633330851793
that O 0 0.0011031569447368383
lead O 0 0.004891561809927225
to O 0 0.004264763556420803
exon O 0 0.05762986093759537
skipping O 0 0.04217083379626274
or O 0 0.008946804329752922
premature O 0 0.4949774742126465
protein O 0 0.01499009970575571
truncation O 0 0.033431440591812134
were O 0 0.00303517933934927
also O 0 0.0037743968423455954
predominant O 0 0.017236661165952682
in O 0 0.0057129585184156895
our O 0 0.011282242834568024
mutants O 0 0.05407135188579559
. O 0 0.010467633605003357

Six O 0 0.009467978961765766
different O 0 0.0024635109584778547
mutations O 0 0.005582395009696484
were O 0 0.001621454139240086
identified O 0 0.00401570787653327
on O 0 0.0025815891567617655
12 O 0 0.0035768577363342047
of O 0 0.002814698498696089
the O 0 0.00587040651589632
16 O 0 0.015409654937684536
alleles O 0 0.02519327588379383
examined O 0 0.03228821977972984
. O 0 0.01258221734315157

Four O 0 0.009089157916605473
were O 0 0.004564902279525995
deletions O 0 0.01728481985628605
involving O 0 0.007120896130800247
a O 0 0.006863546557724476
loss O 0 0.015118013136088848
of O 0 0.006215670146048069
a O 0 0.007778711151331663
single O 0 0.009707280434668064
exon O 0 0.04707535356283188
exon O 0 0.039413370192050934
7 O 0 0.009302938356995583
, O 0 0.003985004033893347
exon O 0 0.0319477915763855
16 O 0 0.008368926122784615
, O 0 0.004346676170825958
exon O 0 0.04191543161869049
33 O 0 0.018051888793706894
or O 0 0.007832079194486141
exon O 0 0.06285147368907928
35 O 0 0.020769663155078888
. O 0 0.011548368260264397

The O 0 0.01125796977430582
others O 0 0.005456734914332628
were O 0 0.0032496140338480473
minute O 0 0.006732822861522436
deletions O 0 0.01774672046303749
, O 0 0.006051671225577593
4649delA O 0 0.13111214339733124
in O 0 0.008512340486049652
exon O 0 0.05045337975025177
33 O 0 0.01440559234470129
and O 0 0.004909014794975519
7883del5 O 1 0.5868163108825684
in O 0 0.010081889107823372
exon O 0 0.08142170310020447
55 O 0 0.025964397937059402
. O 0 0.00894541759043932

The O 0 0.024695968255400658
mutations O 0 0.029781166464090347
4612del165 O 1 0.9950044751167297
and O 0 0.006629184819757938
7883del5 O 1 0.9899376630783081
were O 0 0.00337694282643497
found O 0 0.002657044678926468
in O 0 0.0015995966969057918
more O 0 0.0005566891632042825
than O 0 0.0005482806591317058
two O 0 0.0009711702587082982
unrelated O 0 0.007279102690517902
families O 0 0.003834011033177376
; O 0 0.0030586118809878826
44 O 0 0.008324013091623783
% O 0 0.004626234527677298
( O 0 0.004363001324236393
7 O 0 0.005581478588283062
of O 0 0.0033740713261067867
16 O 0 0.007992735132575035
) O 0 0.0023489356972277164
of O 0 0.002314063487574458
the O 0 0.0057125333696603775
mutant O 0 0.024728134274482727
alleles O 0 0.01107228547334671
had O 0 0.0025676956865936518
one O 0 0.0014408015413209796
of O 0 0.002694537164643407
the O 0 0.00568578764796257
two O 0 0.0048565324395895
mutations O 0 0.018170729279518127
. O 0 0.009752373211085796

The O 0 0.028034379705786705
4612del165 O 1 0.9626139998435974
mutations O 0 0.01003501657396555
in O 0 0.0025530848652124405
three O 0 0.0015457702102139592
different O 0 0.000714331166818738
families O 0 0.0016670076875016093
were O 0 0.0009155501029454172
all O 0 0.0009536162251606584
ascribed O 0 0.010336470790207386
to O 0 0.001888429163955152
the O 0 0.004644399508833885
same O 0 0.0076629361137747765
T O 1 0.9999991655349731
- O 0 0.15565234422683716
- O 0 0.021394066512584686
> O 0 0.015773920342326164
A O 0 0.005856342148035765
substitution O 0 0.00844576209783554
at O 0 0.005912374705076218
the O 0 0.006082069128751755
splice O 0 0.05880586802959442
donor O 0 0.01809983141720295
site O 0 0.011669755913317204
in O 0 0.008318382315337658
intron O 1 0.9975538849830627
33 O 0 0.03754443675279617
. O 0 0.012035349383950233

Microsatellite O 1 0.7527956962585449
genotyping O 0 0.0918317511677742
around O 0 0.010585404932498932
the O 0 0.012651820667088032
ATM O 1 0.9130764603614807
locus O 0 0.04444863274693489
also O 0 0.004703626502305269
indicated O 0 0.005602784920483828
that O 0 0.0012199128977954388
a O 0 0.0028991205617785454
common O 0 0.00620801979675889
haplotype O 0 0.026726344600319862
was O 0 0.005508678499609232
shared O 0 0.003660747315734625
by O 0 0.001378836459480226
the O 0 0.0054691447876393795
mutant O 0 0.024890681728720665
alleles O 0 0.011545136570930481
in O 0 0.003645553719252348
both O 0 0.005151542369276285
mutations O 0 0.020454803481698036
. O 0 0.012654971331357956

This O 0 0.005875289440155029
suggests O 0 0.006649618037045002
that O 0 0.000995750306174159
these O 0 0.0008497560047544539
two O 0 0.0020164838060736656
founder O 0 0.2242249697446823
mutations O 0 0.01097056083381176
may O 0 0.0038340145256370306
be O 0 0.0019529623677954078
predominant O 0 0.013873963616788387
among O 0 0.006020371336489916
Japanese O 0 0.05998218432068825
ATM O 1 0.9934060573577881
mutant O 0 0.07047402113676071
alleles O 0 0.03513619676232338
. O 0 0.009261639788746834

W474C O 1 0.9715477824211121
amino O 0 0.04453511908650398
acid O 0 0.03498700633645058
substitution O 0 0.023193595930933952
affects O 0 0.012882530689239502
early O 0 0.005242267157882452
processing O 0 0.0055207544937729836
of O 0 0.004067158792167902
the O 0 0.006398025434464216
alpha O 0 0.022054292261600494
- O 0 0.010124747641384602
subunit O 0 0.008176425471901894
of O 0 0.004907030612230301
beta O 0 0.026909856125712395
- O 0 0.022098129615187645
hexosaminidase O 0 0.05730345472693443
A O 0 0.006683663465082645
and O 0 0.0016692247008904815
is O 0 0.001997241983190179
associated O 0 0.003933669067919254
with O 0 0.004497576970607042
subacute O 1 1.0
G B-Disease 1 1.0
( I-Disease 1 0.851202130317688
M2 I-Disease 1 0.9999998807907104
) I-Disease 0 0.015060952864587307
gangliosidosis I-Disease 1 0.8085839152336121
. O 0 0.011037076823413372

Mutations O 0 0.02169129066169262
in O 0 0.007801199797540903
the O 0 0.017006326466798782
HEXA O 1 0.9999998807907104
gene O 0 0.010891272686421871
, O 0 0.0025864422786980867
encoding O 0 0.005015959031879902
the O 0 0.0044730957597494125
alpha O 0 0.017913803458213806
- O 0 0.0079822838306427
subunit O 0 0.006623953115195036
of O 0 0.004300764296203852
beta O 0 0.026500308886170387
- O 0 0.021305136382579803
hexosaminidase O 0 0.07293052971363068
A O 0 0.014823157340288162
( O 0 0.011005112901329994
Hex O 0 0.05076271668076515
A O 0 0.01106773316860199
) O 0 0.003786942921578884
, O 0 0.0020256945863366127
that O 0 0.0015387038001790643
abolish O 0 0.033519163727760315
Hex O 0 0.057452403008937836
A O 0 0.013272806070744991
enzyme O 0 0.015982361510396004
activity O 0 0.010627501644194126
cause O 1 0.9797887206077576
Tay B-Disease 1 1.0
- I-Disease 1 0.9999990463256836
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.7571280002593994
TSD B-Disease 1 1.0
) O 0 0.0058256955817341805
, O 0 0.0020119529217481613
the O 0 0.0052551208063960075
fatal O 1 1.0
infantile B-Disease 1 1.0
form I-Disease 0 0.028150590136647224
of I-Disease 1 0.9887218475341797
G I-Disease 1 1.0
( I-Disease 0 0.02036849595606327
M2 I-Disease 1 0.9999853372573853
) I-Disease 0 0.007580917328596115
gangliosidosis I-Disease 0 0.06312905997037888
, I-Disease 0 0.0056069702841341496
Type I-Disease 0 0.02422073297202587
1 I-Disease 0 0.02333264984190464
. O 0 0.010726955719292164

Less O 0 0.01835494115948677
severe O 1 0.9999915361404419
, O 0 0.026636658236384392
subacute O 1 1.0
( O 1 0.9998213648796082
juvenile O 1 1.0
- O 1 0.9998457431793213
onset O 1 1.0
) O 0 0.010920333676040173
and O 0 0.005756620783358812
chronic O 1 1.0
( O 1 0.9999932050704956
adult O 1 0.999825656414032
- O 1 0.9998093247413635
onset O 1 1.0
) O 0 0.00723008718341589
variants O 0 0.007080574054270983
are O 0 0.0010706771863624454
characterized O 0 0.007150969933718443
by O 0 0.0020080332178622484
a O 0 0.005127886775881052
broad O 0 0.01209663599729538
spectrum O 0 0.01339340303093195
of O 0 0.009472774341702461
clinical O 1 1.0
manifestations O 1 1.0
and O 0 0.0062395259737968445
are O 0 0.001614208915270865
associated O 0 0.0033768177963793278
with O 0 0.0026276931166648865
residual O 1 0.665937066078186
levels O 0 0.01214755978435278
of O 0 0.008995607495307922
Hex O 1 0.9817700982093811
A O 0 0.022671647369861603
enzyme O 0 0.018938623368740082
activity O 0 0.008948655799031258
. O 0 0.006786420941352844

We O 0 0.006241025868803263
identified O 0 0.008338253945112228
a O 0 0.008875692263245583
1422 O 1 0.9999994039535522
G O 1 0.9999939203262329
- O 0 0.09703119844198227
- O 0 0.025262249633669853
> O 0 0.026749512180685997
C O 0 0.02909557707607746
( O 0 0.008164994418621063
amino O 0 0.011142132803797722
acid O 0 0.021173374727368355
W474C O 0 0.07111994177103043
) O 0 0.004892133176326752
substitution O 0 0.00600865762680769
in O 0 0.002001532120630145
the O 0 0.0023957472294569016
first O 0 0.002958892844617367
position O 0 0.004292025230824947
of O 0 0.004540289286524057
exon O 0 0.03127634897828102
13 O 0 0.007620311342179775
of O 0 0.0062668961472809315
HEXA O 1 0.9999988079071045
of O 0 0.007024715654551983
a O 0 0.007117438595741987
non O 0 0.01735275238752365
- O 0 0.0144047187641263
Jewish O 0 0.013296814635396004
proband O 1 0.65622478723526
who O 0 0.00757197942584753
manifested O 0 0.034665822982788086
a O 0 0.011755989864468575
subacute O 1 1.0
variant O 1 0.9866452813148499
of O 0 0.4251832067966461
G B-Disease 1 1.0
( I-Disease 0 0.0336945466697216
M2 I-Disease 1 0.9999988079071045
) I-Disease 0 0.013068189844489098
gangliosidosis I-Disease 0 0.11991209536790848
. O 0 0.012092936784029007

On O 0 0.010370152071118355
the O 0 0.008148455992341042
second O 0 0.020389221608638763
maternally O 1 0.9561915397644043
inherited O 1 0.9999412298202515
allele O 0 0.020443368703126907
, O 0 0.002556668594479561
we O 0 0.0009909694781526923
identified O 0 0.0030402878765016794
the O 0 0.0036359885707497597
common O 0 0.024592941626906395
infantile O 1 1.0
disease O 1 1.0
- O 1 1.0
causing O 1 0.9998090863227844
4 O 0 0.08998213708400726
- O 0 0.02366158366203308
bp O 0 0.017513921484351158
insertion O 0 0.01792101003229618
, O 0 0.007525708992034197
+ O 0 0.06386849284172058
TATC O 1 0.9999812841415405
1278 O 1 0.999823272228241
, O 0 0.006105236709117889
in O 0 0.007189362309873104
exon O 0 0.0652913972735405
11 O 0 0.019543714821338654
. O 0 0.012005524709820747

Pulse O 1 0.5150160193443298
- O 0 0.033183567225933075
chase O 0 0.022806257009506226
analysis O 0 0.004966051317751408
using O 0 0.006464788690209389
proband O 1 0.8822357654571533
fibroblasts O 0 0.04139779135584831
revealed O 0 0.010607857257127762
that O 0 0.001883433316834271
the O 0 0.005977122578769922
W474C O 1 0.9370800256729126
- O 0 0.02079768106341362
containing O 0 0.013075681403279305
alpha O 0 0.02780471183359623
- O 0 0.015043518505990505
subunit O 0 0.017162958160042763
precursor O 0 0.022739548236131668
was O 0 0.009625044651329517
normally O 0 0.00681272754445672
synthesized O 0 0.012525619938969612
, O 0 0.002631321083754301
but O 0 0.0014962258283048868
not O 0 0.0017057119403034449
phosphorylated O 0 0.026375912129878998
or O 0 0.004649927373975515
secreted O 0 0.010919499211013317
, O 0 0.002285508904606104
and O 0 0.0018658565822988749
the O 0 0.006241548806428909
mature O 0 0.025039810687303543
lysosomal O 1 0.9999991655349731
alpha O 0 0.09719675034284592
- O 0 0.02066006138920784
subunit O 0 0.0127715477719903
was O 0 0.007135313004255295
not O 0 0.0027250382117927074
detected O 0 0.017225267365574837
. O 0 0.009161628782749176

When O 0 0.008616798557341099
the O 0 0.009616897441446781
W474C O 1 0.8897562623023987
- O 0 0.022180430591106415
containing O 0 0.013753802515566349
alpha O 0 0.028316447511315346
- O 0 0.013517453335225582
subunit O 0 0.01289172749966383
was O 0 0.009363459423184395
transiently O 0 0.054126471281051636
co O 0 0.02690262719988823
- O 0 0.010559167712926865
expressed O 0 0.0040277657099068165
with O 0 0.0018668603152036667
the O 0 0.007303223479539156
beta O 0 0.025489287450909615
- O 0 0.010391481220722198
subunit O 0 0.0055170441046357155
to O 0 0.0015487144701182842
produce O 0 0.003027981845661998
Hex O 0 0.03402486816048622
A O 0 0.010565422475337982
( O 0 0.008732140995562077
alphabeta O 1 0.5376244187355042
) O 0 0.005333747714757919
in O 0 0.006836884189397097
COS O 1 1.0
- O 0 0.041043929755687714
7 O 0 0.013450952246785164
cells O 0 0.004619827028363943
, O 0 0.0016550857108086348
the O 0 0.003320703748613596
mature O 0 0.014310208149254322
alpha O 0 0.024335194379091263
- O 0 0.012759487144649029
subunit O 0 0.00996465515345335
was O 0 0.004796343389898539
present O 0 0.003378461115062237
, O 0 0.0019757081754505634
but O 0 0.0011093999492004514
its O 0 0.0023275818675756454
level O 0 0.006846672389656305
was O 0 0.006456790491938591
much O 0 0.0030634140130132437
lower O 0 0.005510631948709488
than O 0 0.0009937707800418139
that O 0 0.0008584930910728872
from O 0 0.002230666112154722
normal O 0 0.009898204356431961
alpha O 0 0.02918960712850094
- O 0 0.018333308398723602
subunit O 0 0.019488321617245674
transfections O 0 0.045906126499176025
, O 0 0.003342693904414773
although O 0 0.0022246334701776505
higher O 0 0.0030002864077687263
than O 0 0.0009969582315534353
in O 0 0.0020651782397180796
those O 0 0.0025970616843551397
cells O 0 0.009648444131016731
transfected O 0 0.04126439243555069
with O 0 0.002017638646066189
an O 0 0.003936829976737499
alpha O 0 0.024996379390358925
- O 0 0.013650542125105858
subunit O 0 0.01236719824373722
associated O 0 0.007449906785041094
with O 0 0.008584722876548767
infantile O 1 1.0
TSD B-Disease 1 1.0
. O 0 0.0396416001021862

Furthermore O 0 0.026630163192749023
, O 0 0.005238133482635021
the O 0 0.0049821846187114716
precursor O 0 0.01818094030022621
level O 0 0.005324413534253836
of O 0 0.004297812934964895
the O 0 0.0075182304717600346
W474C O 1 0.9994334578514099
alpha O 0 0.032404620200395584
- O 0 0.01260022260248661
subunit O 0 0.008826510049402714
was O 0 0.0037059038877487183
found O 0 0.002112662186846137
to O 0 0.001970991026610136
accumulate O 0 0.008442624472081661
in O 0 0.0019350898219272494
comparison O 0 0.0036135350819677114
to O 0 0.0016713764052838087
the O 0 0.003587764222174883
normal O 0 0.011019675061106682
alpha O 0 0.024052532389760017
- O 0 0.014342548325657845
subunit O 0 0.018194742500782013
precursor O 0 0.03158777579665184
levels O 0 0.014260333962738514
. O 0 0.008611549623310566

We O 0 0.006063263397663832
conclude O 0 0.010557599365711212
that O 0 0.0018677054904401302
the O 0 0.0074268789030611515
1422 O 1 0.9999991655349731
G O 1 0.9999886751174927
- O 0 0.1393655389547348
- O 0 0.029823273420333862
> O 0 0.03201097249984741
C O 0 0.028339877724647522
mutation O 0 0.005947544239461422
is O 0 0.0016362547175958753
the O 0 0.0031425985507667065
cause O 0 0.009876959025859833
of O 0 0.013776318170130253
Hex B-Disease 1 0.9999939203262329
A I-Disease 1 0.9958731532096863
enzyme I-Disease 1 0.9999667406082153
deficiency I-Disease 1 1.0
in O 0 0.011567129753530025
the O 0 0.015308322384953499
proband O 1 0.9999147653579712
. O 0 0.01606656052172184

The O 0 0.017998281866312027
resulting O 0 0.02254047617316246
W474C O 1 0.9852383732795715
substitution O 0 0.033655691891908646
clearly O 0 0.01748696342110634
interferes O 0 0.030848819762468338
with O 0 0.0048788683488965034
alpha O 0 0.03349854424595833
- O 0 0.016681497916579247
subunit O 0 0.012879573740065098
processing O 0 0.005904818419367075
, O 0 0.0024849215988069773
but O 0 0.0011059705866500735
because O 0 0.0017190375365316868
the O 0 0.003363711526617408
base O 0 0.011729715391993523
substitution O 0 0.015392923727631569
falls O 0 0.023297609761357307
at O 0 0.005535172764211893
the O 0 0.0028261004481464624
first O 0 0.003506175009533763
position O 0 0.004809435456991196
of O 0 0.005510060116648674
exon O 0 0.05232778936624527
13 O 0 0.011508583091199398
, O 0 0.004997227340936661
aberrant O 0 0.03711821883916855
splicing O 0 0.020835459232330322
may O 0 0.004178960341960192
also O 0 0.0027434888761490583
contribute O 0 0.006038777530193329
to O 0 0.0051382798701524734
Hex B-Disease 1 0.9985490441322327
A I-Disease 1 0.5082976222038269
deficiency I-Disease 1 1.0
in O 0 0.008016088046133518
this O 0 0.005395469721406698
proband O 1 0.9992203712463379
. O 0 0.006402962375432253
. O 0 0.009381602518260479

Two O 0 0.006084159016609192
frequent O 0 0.017291875556111336
missense O 0 0.06156167760491371
mutations O 0 0.02532769739627838
in O 0 0.03014233522117138
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9478979706764221

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.024384422227740288
an O 0 0.02850433997809887
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 1.0
by O 1 0.8811044692993164
early O 1 0.9999998807907104
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 1.0
goiter B-Disease 1 1.0
. O 1 0.9999251365661621

A O 0 0.015338815748691559
century O 0 0.011720997281372547
after O 0 0.005332788918167353
its O 0 0.0020898906514048576
recognition O 0 0.004961009602993727
as O 0 0.0038981838151812553
a O 0 0.008688749745488167
syndrome O 1 1.0
by O 0 0.007310881279408932
Vaughan O 1 0.9998801946640015
Pendred O 1 0.9999550580978394
, O 0 0.005518168676644564
the O 0 0.009006155654788017
disease O 1 1.0
gene O 0 0.08601988852024078
( O 0 0.022729361429810524
PDS O 1 1.0
) O 0 0.00621782336384058
was O 0 0.006660978775471449
mapped O 0 0.010158545337617397
to O 0 0.005323504563421011
chromosome O 0 0.03298940882086754
7q22 O 1 0.9993093013763428
- O 0 0.1368330717086792
q31 O 1 0.9607381224632263
. O 0 0.018244022503495216

1 O 0 0.02584395930171013
and O 0 0.004099105950444937
, O 0 0.0038108571898192167
recently O 0 0.007181881461292505
, O 0 0.0026043441612273455
found O 0 0.0020030082669109106
to O 0 0.00213339040055871
encode O 0 0.009135265834629536
a O 0 0.007709411904215813
putative O 1 0.9934948086738586
sulfate O 1 0.9999995231628418
transporter O 1 0.9995672106742859
. O 0 0.021134028211236

We O 0 0.0074630724266171455
performed O 0 0.010293710976839066
mutation O 0 0.005705266259610653
analysis O 0 0.0022491328418254852
of O 0 0.0041484772227704525
the O 0 0.011117362417280674
PDS B-Disease 1 1.0
gene O 0 0.011117404326796532
in O 0 0.0042069219052791595
patients O 0 0.15072570741176605
from O 0 0.005432257894426584
14 O 0 0.014873405918478966
Pendred B-Disease 1 0.9957711100578308
families O 0 0.005624040029942989
originating O 0 0.0075030638836324215
from O 0 0.002308296738192439
seven O 0 0.0031502305064350367
countries O 0 0.0013342172605916858
and O 0 0.0018976812716573477
identified O 0 0.007570352870970964
all O 0 0.003839989425614476
mutations O 0 0.01929854229092598
. O 0 0.011642339639365673

The O 0 0.01595580391585827
mutations O 0 0.010411998257040977
include O 0 0.00401193555444479
three O 0 0.0027701370418071747
single O 0 0.004909656010568142
base O 0 0.009459709748625755
deletions O 0 0.014451274648308754
, O 0 0.0031887353397905827
one O 0 0.004031054675579071
splice O 0 0.05897583067417145
site O 0 0.01210441067814827
mutation O 0 0.008074990473687649
and O 0 0.0030310077127069235
10 O 0 0.01086697168648243
missense O 0 0.06255410611629486
mutations O 0 0.024776749312877655
. O 0 0.010581879876554012

One O 0 0.015557823702692986
missense O 0 0.05855898559093475
mutation O 0 0.023476164788007736
( O 0 0.01401436235755682
L236P O 1 0.9992383718490601
) O 0 0.006305239629000425
was O 0 0.00484934076666832
found O 0 0.0024222119245678186
in O 0 0.002475196495652199
a O 0 0.0036726538091897964
homozygous O 0 0.010439105331897736
state O 0 0.002357153221964836
in O 0 0.0021608718670904636
two O 0 0.002616197569295764
consanguineous O 0 0.1687486320734024
families O 0 0.00458065140992403
and O 0 0.0019997491035610437
in O 0 0.0029487507417798042
a O 0 0.004214385524392128
heterozygous O 0 0.007079987321048975
state O 0 0.0013605075655505061
in O 0 0.0014371633296832442
five O 0 0.002201768336817622
additional O 0 0.005901895929127932
non O 0 0.02087661251425743
- O 0 0.03800559788942337
consanguineous O 0 0.25493618845939636
families O 0 0.01569000631570816
. O 0 0.010928783565759659

Another O 0 0.02440614439547062
missense O 0 0.06379961222410202
mutation O 0 0.023698164150118828
( O 0 0.014786436222493649
T416P O 1 0.9957376718521118
) O 0 0.005585288628935814
was O 0 0.004596603102982044
found O 0 0.002642665524035692
in O 0 0.00250346795655787
a O 0 0.0036738389171659946
homozygous O 0 0.009269887581467628
state O 0 0.0018591019324958324
in O 0 0.001803431543521583
one O 0 0.002129604108631611
family O 0 0.004645111970603466
and O 0 0.0014914062339812517
in O 0 0.002452914835885167
a O 0 0.004304113797843456
heterozygous O 0 0.007189811207354069
state O 0 0.0016208845190703869
in O 0 0.0018747993744909763
four O 0 0.002880120649933815
families O 0 0.006484216079115868
. O 0 0.00757509283721447

Pendred B-Disease 1 0.9996700286865234
patients O 1 0.6630000472068787
in O 0 0.007056938949972391
three O 0 0.006217838265001774
non O 0 0.028334863483905792
- O 0 0.03214766085147858
consanguineous O 0 0.22693340480327606
families O 0 0.005170924123376608
were O 0 0.00248635932803154
shown O 0 0.0034762148279696703
to O 0 0.002376515418291092
be O 0 0.002659843536093831
compound O 0 0.023059869185090065
heterozygotes O 0 0.0777476578950882
for O 0 0.008797118440270424
L236P O 1 0.997958779335022
and O 0 0.012015125714242458
T416P O 1 0.999150276184082
. O 0 0.01726495660841465

In O 0 0.009061358869075775
total O 0 0.006541148293763399
, O 0 0.0029815007001161575
one O 0 0.002412196947261691
or O 0 0.001900482107885182
both O 0 0.0015397561946883798
of O 0 0.0030660685151815414
these O 0 0.0024807846639305353
mutations O 0 0.005460020620375872
were O 0 0.001794576644897461
found O 0 0.0020281989127397537
in O 0 0.0023421351797878742
nine O 0 0.003654953557997942
of O 0 0.0038680436555296183
the O 0 0.006506041623651981
14 O 0 0.010894972831010818
families O 0 0.006847962737083435
analyzed O 0 0.016496196389198303
. O 0 0.008106646127998829

The O 0 0.012441091239452362
identification O 0 0.009059753268957138
of O 0 0.005382123868912458
two O 0 0.003832740243524313
frequent O 0 0.030319584533572197
PDS B-Disease 1 1.0
mutations O 0 0.010213015601038933
will O 0 0.001784943393431604
facilitate O 0 0.0047412654384970665
the O 0 0.005042587406933308
molecular O 0 0.01950719580054283
diagnosis O 1 0.9999994039535522
of O 1 0.999962568283081
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9106037020683289

Insertional O 1 0.9881388545036316
mutation O 0 0.02130485698580742
by O 0 0.005292246583849192
transposable O 1 0.9720054268836975
element O 0 0.02349006198346615
, O 0 0.008006834425032139
L1 O 1 0.9898185133934021
, O 0 0.0032863111700862646
in O 0 0.0035358001478016376
the O 0 0.008425669744610786
DMD B-Disease 1 1.0
gene O 0 0.007919787429273129
results O 0 0.0034375530667603016
in O 0 0.004688421729952097
X B-Disease 1 0.9999731779098511
- I-Disease 1 0.970615804195404
linked I-Disease 1 0.9821908473968506
dilated I-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 1.0
. O 1 0.6852162480354309

X B-Disease 1 0.9997316002845764
- I-Disease 1 0.9488281011581421
linked I-Disease 1 0.98763507604599
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
( O 1 0.9999996423721313
XLDCM B-Disease 1 1.0
) O 0 0.006015456281602383
is O 0 0.0017234719125553966
a O 0 0.0032344867940992117
clinical O 1 0.9997579455375671
phenotype O 0 0.046040259301662445
of O 0 0.010543507523834705
dystrophinopathy B-Disease 1 0.9999946355819702
which O 0 0.0026331536937505007
is O 0 0.002785980701446533
characterized O 0 0.010748406872153282
by O 0 0.004540976602584124
preferential O 1 0.999570906162262
myocardial B-Disease 1 1.0
involvement I-Disease 1 0.999735414981842
without O 0 0.00564512750133872
any O 0 0.0037042528856545687
overt O 0 0.025629578158259392
clinical O 1 0.9999948740005493
signs O 1 0.9994730353355408
of O 1 0.9999576807022095
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.994019627571106

To O 0 0.00552209559828043
date O 0 0.0056264461018145084
, O 0 0.0014688357478007674
several O 0 0.001222863793373108
mutations O 0 0.0039970120415091515
in O 0 0.0037896332796663046
the O 0 0.020677722990512848
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9999996423721313
, O 0 0.21916444599628448
DMD O 1 1.0
, O 0 0.00511649576947093
have O 0 0.0010088997660204768
been O 0 0.0016316971741616726
identified O 0 0.0037610805593430996
in O 0 0.0035601973067969084
patients O 1 0.9777870178222656
with O 0 0.007101355120539665
XLDCM B-Disease 1 1.0
, O 0 0.00563802057877183
but O 0 0.001713057979941368
a O 0 0.0037335448432713747
pathogenic O 0 0.014895906671881676
correlation O 0 0.005728552117943764
of O 0 0.003183751367032528
these O 0 0.0026494332123547792
cardiospecific O 1 0.9847804307937622
mutations O 0 0.012079734355211258
in O 0 0.009005231782793999
DMD O 1 1.0
with O 0 0.005607279017567635
the O 0 0.018959783017635345
XLDCM B-Disease 1 1.0
phenotype O 0 0.029447009786963463
has O 0 0.002776864217594266
remained O 0 0.009042949415743351
to O 0 0.002785166259855032
be O 0 0.0032689981162548065
elucidated O 0 0.09258043766021729
. O 0 0.012683555483818054

We O 0 0.007812170311808586
report O 0 0.005883399397134781
here O 0 0.0034865972120314837
the O 0 0.0026022098027169704
identification O 0 0.0037255226634442806
of O 0 0.0026754678692668676
a O 0 0.004031095188111067
unique O 0 0.008753858506679535
de O 0 0.10884391516447067
novo O 1 0.9931371212005615
L1 O 1 0.9993919134140015
insertion O 0 0.021661486476659775
in O 0 0.004654500167816877
the O 0 0.008475099690258503
muscle O 1 0.9586635231971741
exon O 0 0.09284332394599915
1 O 0 0.013407625257968903
in O 0 0.006772922817617655
DMD O 1 1.0
in O 0 0.007080765441060066
three O 0 0.008092195726931095
XLDCM B-Disease 1 0.9999983310699463
patients O 0 0.39228329062461853
from O 0 0.003735720179975033
two O 0 0.002599424449726939
unrelated O 0 0.017271146178245544
Japanese O 0 0.034954965114593506
families O 0 0.01422645803540945
. O 0 0.010920384898781776

The O 0 0.018349412828683853
insertion O 0 0.03635484352707863
was O 0 0.011021171696484089
a O 0 0.006789539474993944
5 O 0 0.013034272938966751
- O 0 0.013927619904279709
truncated O 0 0.020584184676408768
form O 0 0.0034857061691582203
of O 0 0.006576486863195896
human O 0 0.017053676769137383
L1 O 1 0.9999363422393799
inversely O 0 0.02749716117978096
integrated O 0 0.012040061876177788
in O 0 0.0034951926209032536
the O 0 0.005656592082232237
5 O 0 0.012283597141504288
- O 0 0.017283493652939796
untranslated O 0 0.05113103240728378
region O 0 0.007203520741313696
in O 0 0.003690271405503154
the O 0 0.008283094502985477
muscle O 1 0.9997777342796326
exon O 1 0.9711387157440186
1 O 0 0.011730141937732697
, O 0 0.002325502224266529
which O 0 0.0014726017834618688
affected O 0 0.004760067909955978
the O 0 0.004984681494534016
transcription O 0 0.017813364043831825
or O 0 0.0033676158636808395
the O 0 0.004589644260704517
stability O 0 0.011706352233886719
of O 0 0.005770446732640266
the O 0 0.01184389740228653
muscle O 1 0.9992006421089172
form O 0 0.00795271247625351
of O 0 0.01729617267847061
dystrophin O 1 0.9999831914901733
transcripts O 0 0.012331603094935417
but O 0 0.0009563805069774389
not O 0 0.00044149800669401884
that O 0 0.0005230290698818862
of O 0 0.0028437383007258177
the O 0 0.012830282561480999
brain O 1 0.9999998807907104
or O 0 0.02897970750927925
Purkinje O 1 1.0
cell O 0 0.024551665410399437
form O 0 0.004799011629074812
, O 0 0.0029783379286527634
probably O 0 0.0035637158434838057
due O 0 0.003156971884891391
to O 0 0.0015896116383373737
its O 0 0.001579951262101531
unique O 0 0.0036347550339996815
site O 0 0.006816461216658354
of O 0 0.006425042636692524
integration O 0 0.021194394677877426
. O 0 0.011092249304056168

We O 0 0.008150579407811165
speculate O 0 0.010910572484135628
that O 0 0.0012455264804884791
this O 0 0.0012363437563180923
insertion O 0 0.009486026130616665
of O 0 0.004413428716361523
an O 0 0.006440084893256426
L1 O 1 0.9999634027481079
sequence O 0 0.0111037353053689
in O 0 0.008085251785814762
DMD O 1 1.0
is O 0 0.004640178754925728
responsible O 0 0.004744767211377621
for O 0 0.001558170304633677
some O 0 0.0009079609881155193
of O 0 0.0020019952207803726
the O 0 0.0027881250716745853
population O 0 0.0017995480448007584
of O 0 0.0032647033222019672
Japanese O 1 0.7806471586227417
patients O 1 0.9989200830459595
with O 0 0.0068089310079813
XLDCM B-Disease 1 1.0
. O 0 0.00843762792646885
. O 0 0.00841979868710041

Severe O 1 0.9999980926513672
early O 1 0.9943607449531555
- O 1 0.9999980926513672
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999902248382568
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999977350234985
red O 1 1.0
hair O 1 1.0
pigmentation O 1 1.0
caused O 1 0.9999915361404419
by O 0 0.014255482703447342
POMC O 1 1.0
mutations O 0 0.015322720631957054
in O 0 0.00545840198174119
humans O 0 0.009996803477406502
. O 0 0.008030444383621216

Sequential O 0 0.05211985483765602
cleavage O 0 0.04573554918169975
of O 0 0.007751207798719406
the O 0 0.008771082386374474
precursor O 0 0.03680163621902466
protein O 0 0.010802630335092545
pre O 0 0.02549060247838497
- O 0 0.021568158641457558
pro O 0 0.02645130641758442
- O 0 0.029477108269929886
opiomelanocortin O 1 0.9805424213409424
( O 0 0.02057444490492344
POMC O 1 0.9999977350234985
) O 0 0.006372933275997639
generates O 0 0.0077030169777572155
the O 0 0.0075987898744642735
melanocortin O 1 0.9999297857284546
peptides O 0 0.03460688516497612
adrenocorticotrophin O 1 0.996565043926239
( O 0 0.022885628044605255
ACTH O 1 0.9999994039535522
) O 0 0.008306369185447693
, O 0 0.006943992339074612
melanocyte O 1 0.9999959468841553
- O 1 0.6522967219352722
stimulating O 1 0.9933957457542419
hormones O 1 0.9620398879051208
( O 0 0.025933653116226196
MSH O 1 1.0
) O 0 0.011417369358241558
alpha O 0 0.019141165539622307
, O 0 0.0038463862147182226
beta O 0 0.013053227216005325
and O 0 0.002604785142466426
gamma O 0 0.012871414422988892
as O 0 0.0019391165114939213
well O 0 0.0013970601139590144
as O 0 0.002386607462540269
the O 0 0.006723677273839712
opioid O 1 0.9998519420623779
- O 0 0.053861331194639206
receptor O 0 0.0339186005294323
ligand O 0 0.057334575802087784
beta O 0 0.06726235151290894
- O 0 0.06571922451257706
endorphin O 1 0.8337640762329102
. O 0 0.013596842996776104

While O 0 0.006762261968106031
a O 0 0.0041281599551439285
few O 0 0.0032321386970579624
cases O 0 0.006069174502044916
of O 0 0.0161458570510149
isolated O 1 0.9999998807907104
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 0.0034877369180321693
been O 0 0.0037100049667060375
reported O 0 0.009836857207119465
( O 0 0.015669958665966988
OMIM O 1 1.0
201400 O 1 0.9998718500137329
) O 0 0.004899964202195406
, O 0 0.002636140678077936
an O 0 0.006815660744905472
inherited O 1 1.0
POMC O 1 1.0
defect O 1 1.0
has O 0 0.007628862280398607
not O 0 0.0020484915003180504
been O 0 0.002813854021951556
described O 0 0.007273966446518898
so O 0 0.002665660809725523
far O 0 0.005639068316668272
. O 0 0.008522319607436657

Recent O 0 0.01371395867317915
studies O 0 0.007345374673604965
in O 0 0.005430001765489578
animal O 0 0.013547255657613277
models O 0 0.006817823275923729
elucidated O 0 0.027685996145009995
a O 0 0.0036628644447773695
central O 0 0.008318575099110603
role O 0 0.0059759607538580894
of O 0 0.008197348564863205
alpha O 1 0.9890740513801575
- O 0 0.07820012420415878
MSH O 1 0.9999923706054688
in O 0 0.004012007731944323
the O 0 0.004212794825434685
regulation O 0 0.005461659748107195
of O 0 0.003851925954222679
food O 0 0.014349657110869884
intake O 0 0.015853818506002426
by O 0 0.001958617940545082
activation O 0 0.006281261797994375
of O 0 0.003701563458889723
the O 0 0.011163188144564629
brain O 1 0.999968409538269
melanocortin O 1 1.0
- O 0 0.034663792699575424
4 O 0 0.015562820248305798
- O 0 0.015645043924450874
receptor O 0 0.01950782537460327
( O 0 0.012620045803487301
MC4 O 1 0.9999994039535522
- O 0 0.04524017870426178
R O 0 0.05241946876049042
; O 0 0.005643609911203384
refs O 0 0.040869809687137604
3 O 0 0.013334955088794231
- O 0 0.01315074972808361
5 O 0 0.0057455976493656635
) O 0 0.001973270671442151
and O 0 0.001141957240179181
the O 0 0.003644657088443637
linkage O 0 0.019760461524128914
of O 0 0.00893934816122055
human O 1 0.5582070350646973
obesity B-Disease 1 1.0
to O 0 0.01195653434842825
chromosome O 0 0.01612909324467182
2 O 0 0.005922144278883934
in O 0 0.0020214454270899296
close O 0 0.0038254898972809315
proximity O 0 0.006278494372963905
to O 0 0.003419836051762104
the O 0 0.012117491103708744
POMC O 1 1.0
locus O 0 0.0641956701874733
, O 0 0.0031876082066446543
led O 0 0.0038908952847123146
to O 0 0.0015533356927335262
the O 0 0.0021576418075710535
proposal O 0 0.0024280836805701256
of O 0 0.0019529103301465511
an O 0 0.0022143616806715727
association O 0 0.011024000123143196
of O 0 0.01269481610506773
POMC O 1 1.0
with O 0 0.009063458070158958
human O 1 0.8432881236076355
obesity B-Disease 1 1.0
. O 0 0.028899183496832848

The O 0 0.01209801435470581
dual O 0 0.01793668605387211
role O 0 0.010845066979527473
of O 0 0.011911367997527122
alpha O 1 0.9755176305770874
- O 0 0.21330799162387848
MSH O 1 0.999998927116394
in O 0 0.006650927476584911
regulating O 0 0.019877931103110313
food O 0 0.02031799592077732
intake O 0 0.03820952773094177
and O 0 0.007609840948134661
influencing O 1 0.5413036346435547
hair O 1 0.9998822212219238
pigmentation O 1 0.9999998807907104
predicts O 0 0.05528238043189049
that O 0 0.00364784081466496
the O 0 0.005992320831865072
phenotype O 0 0.012312129139900208
associated O 0 0.0031749531626701355
with O 0 0.0016858011949807405
a O 0 0.007423750590533018
defect O 1 0.9999970197677612
in O 0 0.018464842811226845
POMC O 1 1.0
function O 0 0.00798963475972414
would O 0 0.0026771656703203917
include O 0 0.006992432754486799
obesity B-Disease 1 1.0
, O 0 0.013374765403568745
alteration O 1 0.9991828799247742
in O 0 0.09126941859722137
pigmentation O 1 1.0
and O 1 0.9999864101409912
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.05589158833026886

The O 0 0.012677178718149662
observation O 0 0.023190323263406754
of O 0 0.008475411683321
these O 0 0.004696060437709093
symptoms O 1 0.9999964237213135
in O 0 0.008433958515524864
two O 0 0.0053810980170965195
probands O 1 0.9951446652412415
prompted O 0 0.011362030170857906
us O 0 0.0031324641313403845
to O 0 0.0011061507975682616
search O 0 0.0031857751309871674
for O 0 0.001960413996130228
mutations O 0 0.005256666801869869
within O 0 0.0027552105020731688
their O 0 0.006102855317294598
POMC O 1 1.0
genes O 0 0.021756751462817192
. O 0 0.008630361407995224

Patient O 1 0.999768078327179
1 O 0 0.028079526498913765
was O 0 0.009683696553111076
found O 0 0.002925194799900055
to O 0 0.0017877850914373994
be O 0 0.0014092869823798537
a O 0 0.0033575419802218676
compound O 0 0.022399740293622017
heterozygote O 0 0.036331091076135635
for O 0 0.0020311642438173294
two O 0 0.0015720354858785868
mutations O 0 0.0054632266983389854
in O 0 0.004296963568776846
exon O 0 0.04586813226342201
3 O 0 0.012143967673182487
( O 0 0.009345999918878078
G7013T O 1 0.5829024314880371
, O 0 0.00814983993768692
C7133delta O 1 0.999369204044342
) O 0 0.005200383253395557
which O 0 0.0014725582441315055
interfere O 0 0.005346124991774559
with O 0 0.0015212188009172678
appropriate O 0 0.007139577064663172
synthesis O 0 0.011854690499603748
of O 0 0.011536280624568462
ACTH O 1 1.0
and O 0 0.012751368805766106
alpha O 1 0.7968193292617798
- O 0 0.2605554461479187
MSH O 1 0.9999994039535522
. O 0 0.015457521192729473

Patient O 1 0.9987144470214844
2 O 0 0.01876932941377163
was O 0 0.008517445996403694
homozygous O 0 0.008824361488223076
for O 0 0.001758373575285077
a O 0 0.0037189284339547157
mutation O 0 0.006609228439629078
in O 0 0.004670348018407822
exon O 0 0.0434582382440567
2 O 0 0.013863320462405682
( O 0 0.010349277406930923
C3804A O 0 0.10737397521734238
) O 0 0.008073835633695126
which O 0 0.006285159382969141
abolishes O 1 0.9991855025291443
POMC O 1 0.9999998807907104
translation O 0 0.05261591449379921
. O 0 0.0176745243370533

These O 0 0.004836693871766329
findings O 0 0.00665615638718009
represent O 0 0.0034707977902144194
the O 0 0.0030786171555519104
first O 0 0.0024239385966211557
examples O 0 0.004238363821059465
of O 0 0.004247185308486223
a O 0 0.00919097475707531
genetic B-Disease 1 0.9495441317558289
defect I-Disease 1 0.9999996423721313
within O 0 0.00792987272143364
the O 0 0.014307599514722824
POMC O 1 1.0
gene O 0 0.007795157376676798
and O 0 0.0016450678231194615
define O 0 0.00556637579575181
a O 0 0.004458087030798197
new O 0 0.010720314458012581
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 1 0.9804643392562866
in O 0 0.01378842443227768
early O 1 0.9149255156517029
- O 1 0.9999723434448242
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.999913215637207
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999996423721313
red O 1 1.0
hair O 1 1.0
pigmentation O 1 1.0
. O 0 0.012638877145946026
. O 0 0.010729198344051838

A O 0 0.017193587496876717
European O 0 0.010690811090171337
multicenter O 0 0.4154127836227417
study O 0 0.010997548699378967
of O 0 0.02699490636587143
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.014630276709794998
classification O 0 0.02303382381796837
of O 0 0.009066009894013405
105 O 0 0.04538630694150925
mutations O 0 0.005410260055214167
and O 0 0.0012293871259316802
a O 0 0.002235191874206066
general O 0 0.008618113584816456
system O 0 0.006036785896867514
for O 0 0.0037885194178670645
genotype O 0 0.02725643664598465
- O 0 0.008508414961397648
based O 0 0.0031758390832692385
prediction O 0 0.015516040846705437
of O 0 0.011316176503896713
metabolic O 1 0.9999978542327881
phenotype O 1 0.8689600825309753
. O 0 0.014437968842685223

Phenylketonuria B-Disease 1 1.0
( O 1 0.9863410592079163
PKU B-Disease 1 1.0
) O 0 0.010604414157569408
and O 0 0.005092560779303312
mild B-Disease 1 0.9999969005584717
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9999974966049194
MHP B-Disease 1 1.0
) O 0 0.010779949836432934
are O 0 0.0035201837308704853
allelic B-Disease 1 0.9998592138290405
disorders I-Disease 1 1.0
caused O 1 0.9996507167816162
by O 0 0.006365805398672819
mutations O 0 0.008179033175110817
in O 0 0.003735567210242152
the O 0 0.006829321384429932
gene O 0 0.011766004376113415
encoding O 0 0.020106960088014603
phenylalanine O 1 0.7300959229469299
hydroxylase O 1 0.9994497895240784
( O 0 0.07658439129590988
PAH O 1 1.0
) O 0 0.02215786650776863
. O 0 0.010806635953485966

Previous O 0 0.017675714567303658
studies O 0 0.006115516647696495
have O 0 0.0014236978022381663
suggested O 0 0.0030097609851509333
that O 0 0.001035363064147532
the O 0 0.0030786050483584404
highly O 0 0.009546107612550259
variable O 0 0.016182081773877144
metabolic O 1 0.9984912872314453
phenotypes O 1 0.9975058436393738
of O 1 0.9999938011169434
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9999502897262573
with O 0 0.030348440632224083
PAH O 1 1.0
genotypes O 1 0.9987428784370422
. O 0 0.019225357100367546

We O 0 0.005814286880195141
identified O 0 0.007298261858522892
both O 0 0.003651876002550125
causative O 1 0.9154292941093445
mutations O 0 0.01447741873562336
in O 0 0.008230351842939854
686 O 1 0.9999614953994751
patients O 1 0.9617146253585815
from O 0 0.0056690932251513
seven O 0 0.006733696907758713
European O 0 0.0069441236555576324
centers O 0 0.019995931535959244
. O 0 0.009987170808017254

On O 0 0.008336463943123817
the O 0 0.003444270696491003
basis O 0 0.002762286690995097
of O 0 0.0028092768043279648
the O 0 0.0051544783636927605
phenotypic O 0 0.019612664356827736
characteristics O 0 0.011076441965997219
of O 0 0.01177339255809784
297 O 1 0.9999812841415405
functionally O 1 0.9997497200965881
hemizygous O 1 0.9999831914901733
patients O 1 0.8453967571258545
, O 0 0.005291112698614597
105 O 0 0.016413681209087372
of O 0 0.003895954927429557
the O 0 0.004815743304789066
mutations O 0 0.004878354724496603
were O 0 0.0015167825622484088
assigned O 0 0.005112051032483578
to O 0 0.0013192696496844292
one O 0 0.0016165038105100393
of O 0 0.0029223919846117496
four O 0 0.004582126159220934
arbitrary O 0 0.013531281612813473
phenotype O 0 0.034298378974199295
categories O 0 0.02265784703195095
. O 0 0.01310865581035614

We O 0 0.006894160993397236
proposed O 0 0.005629376042634249
and O 0 0.002684683073312044
tested O 0 0.010188279673457146
a O 0 0.002779851434752345
simple O 0 0.004540513269603252
model O 0 0.0043220133520662785
for O 0 0.0022277263924479485
correlation O 0 0.01032850332558155
between O 0 0.005871825851500034
genotype O 0 0.025718359276652336
and O 0 0.0042692371644079685
phenotypic O 0 0.03797236829996109
outcome O 0 0.02302449755370617
. O 0 0.012870004400610924

The O 0 0.01607273519039154
observed O 0 0.015403262339532375
phenotype O 0 0.02237139642238617
matched O 0 0.008703515864908695
the O 0 0.004824513103812933
predicted O 0 0.012457798235118389
phenotype O 0 0.012625579722225666
in O 0 0.0037674212362617254
79 O 0 0.01970740593969822
% O 0 0.003195124212652445
of O 0 0.002650640672072768
the O 0 0.00454022828489542
cases O 0 0.005841568578034639
, O 0 0.00329729076474905
and O 0 0.0016670194454491138
in O 0 0.002055624732747674
only O 0 0.0012891157530248165
5 O 0 0.004191259387880564
of O 0 0.004337440710514784
184 O 0 0.07242941856384277
patients O 1 0.9178056716918945
was O 0 0.010076378472149372
the O 0 0.0055754403583705425
observed O 0 0.006214088294655085
phenotype O 0 0.008702383376657963
more O 0 0.0007104454562067986
than O 0 0.0009077996364794672
one O 0 0.0020367915276437998
category O 0 0.006781197153031826
away O 0 0.003840395947918296
from O 0 0.002209866652265191
that O 0 0.001997587038204074
expected O 0 0.007073975633829832
. O 0 0.008876069448888302

Among O 0 0.008114493452012539
the O 0 0.00576717359945178
seven O 0 0.0061662704683840275
contributing O 0 0.011800641193985939
centers O 0 0.009830190800130367
, O 0 0.0026792343705892563
the O 0 0.0035100148525089025
proportion O 0 0.006861082743853331
of O 0 0.005209617782384157
patients O 1 0.9953349232673645
for O 0 0.004912649746984243
whom O 0 0.008729462511837482
the O 0 0.005848308093845844
observed O 0 0.008620081469416618
phenotype O 0 0.012275777757167816
did O 0 0.002099710749462247
not O 0 0.0007825426291674376
match O 0 0.004142915830016136
the O 0 0.0033245158847421408
predicted O 0 0.010794639587402344
phenotype O 0 0.014442136511206627
was O 0 0.005810492672026157
4 O 0 0.007512749172747135
% O 0 0.004415525123476982
- O 0 0.008755471557378769
23 O 0 0.008919325657188892
% O 0 0.005762838758528233
( O 0 0.011966475285589695
P O 1 0.7367950677871704
< O 0 0.05505162850022316
. O 0 0.0063517894595861435
0001 O 1 0.9993577599525452
) O 0 0.005930489860475063
, O 0 0.0025979832280427217
suggesting O 0 0.00490362336859107
that O 0 0.0011017597280442715
differences O 0 0.002692446345463395
in O 0 0.0022625173442065716
methods O 0 0.004216086585074663
used O 0 0.0033108897041529417
for O 0 0.004270968958735466
mutation O 0 0.013265246525406837
detection O 0 0.0202172938734293
or O 0 0.0073456414975225925
phenotype O 0 0.024938257411122322
classification O 0 0.021572576835751534
may O 0 0.004453579895198345
account O 0 0.0025768170598894358
for O 0 0.001980661880224943
a O 0 0.002862900262698531
considerable O 0 0.007370212115347385
proportion O 0 0.010046391747891903
of O 0 0.011401493102312088
genotype O 1 0.9331264495849609
- O 0 0.04759983345866203
phenotype O 0 0.03902958333492279
inconsistencies O 0 0.04854053258895874
. O 0 0.01829087920486927

Our O 0 0.010776521638035774
data O 0 0.003949475008994341
indicate O 0 0.004970647860318422
that O 0 0.002222275361418724
the O 0 0.01220149826258421
PAH O 1 1.0
- O 0 0.06667549163103104
mutation O 0 0.013927673920989037
genotype O 0 0.012697834521532059
is O 0 0.0015311780152842402
the O 0 0.0029918828513473272
main O 0 0.012692042626440525
determinant O 1 0.7564468383789062
of O 0 0.017535103484988213
metabolic O 1 0.9999988079071045
phenotype O 0 0.031743649393320084
in O 0 0.005228420253843069
most O 0 0.005393945146352053
patients O 1 0.9999834299087524
with O 1 0.9754415154457092
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.043817464262247086

In O 0 0.007125107105821371
the O 0 0.004461466334760189
present O 0 0.003805166343227029
study O 0 0.0032449502032250166
, O 0 0.001944032497704029
the O 0 0.0027365554124116898
classification O 0 0.017161741852760315
of O 0 0.01497700810432434
105 O 1 0.9999793767929077
PAH O 1 1.0
mutations O 0 0.016401570290327072
may O 0 0.00384169677272439
allow O 0 0.0017102111596614122
the O 0 0.0025359950959682465
prediction O 0 0.008661503903567791
of O 0 0.0034831061493605375
the O 0 0.0063748895190656185
biochemical O 0 0.034398503601551056
phenotype O 0 0.024495508521795273
in O 0 0.006550599820911884
> O 0 0.02488916553556919
10 O 0 0.005252260249108076
, O 0 0.004354000091552734
000 O 0 0.03069811686873436
genotypes O 0 0.048180658370256424
, O 0 0.0035259088035672903
which O 0 0.0018753934418782592
may O 0 0.0023002317175269127
be O 0 0.0008441314566880465
useful O 0 0.0019382789032533765
for O 0 0.0014372029108926654
the O 0 0.003932774532586336
management O 0 0.012411878444254398
of O 0 0.012327922508120537
hyperphenylalaninemia B-Disease 1 1.0
in O 0 0.03048555739223957
newborns O 1 0.9999076128005981
. O 0 0.014417707920074463

Somatic O 0 0.12625911831855774
instability O 0 0.036914337426424026
of O 0 0.011906501837074757
the O 0 0.020827095955610275
CTG O 1 0.9999992847442627
repeat O 0 0.031836993992328644
in O 0 0.005550038069486618
mice O 0 0.012690058909356594
transgenic O 0 0.014484822750091553
for O 0 0.0035606203600764275
the O 0 0.018315032124519348
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9999805688858032
is O 0 0.012756694108247757
age O 0 0.011515951715409756
dependent O 0 0.007290610112249851
but O 0 0.0011327519314363599
not O 0 0.0010619931854307652
correlated O 0 0.006213861517608166
to O 0 0.0017998804105445743
the O 0 0.004752845037728548
relative O 0 0.020303869619965553
intertissue O 1 0.9991976618766785
transcription O 0 0.04885602742433548
levels O 0 0.018899239599704742
and O 0 0.011233581230044365
proliferative O 1 0.9999998807907104
capacities O 1 0.903578519821167
. O 0 0.021786242723464966

A O 0 0.031833864748477936
( O 0 0.023744730278849602
CTG O 1 0.9999903440475464
) O 0 0.00843442976474762
nexpansion O 0 0.03529650345444679
in O 0 0.0032058474607765675
the O 0 0.005885854363441467
3 O 0 0.01527654193341732
- O 0 0.02104249969124794
untranslated O 0 0.0776028260588646
region O 0 0.012647676281630993
( O 0 0.010530238039791584
UTR O 0 0.3719947338104248
) O 0 0.0033178862649947405
of O 0 0.0037895666901022196
the O 0 0.013444241136312485
DM O 1 1.0
protein O 0 0.026456646621227264
kinase O 0 0.02622784674167633
gene O 0 0.007451637648046017
( O 0 0.006795912981033325
DMPK O 1 0.9993911981582642
) O 0 0.003443585941568017
is O 0 0.0015651755966246128
responsible O 0 0.005361635237932205
for O 0 0.006322471424937248
causing O 1 0.9999991655349731
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.029414307326078415
. O 0 0.00937161035835743

Major O 1 0.6342257857322693
instability O 1 0.9963879585266113
, O 0 0.005981304682791233
with O 0 0.002632470102980733
very O 0 0.0027517196722328663
large O 0 0.0031493157148361206
expansions O 0 0.015865525230765343
between O 0 0.004217670299112797
generations O 0 0.009323264472186565
and O 0 0.002798850182443857
high O 0 0.010540477931499481
levels O 0 0.011274510063230991
of O 0 0.009759504348039627
somatic O 1 0.9994826316833496
mosaicism O 1 0.9999949932098389
, O 0 0.0050183869898319244
is O 0 0.0034719426184892654
observed O 0 0.005188710987567902
in O 0 0.006192039232701063
patients O 1 0.9823509454727173
. O 0 0.017354898154735565

There O 0 0.006971661001443863
is O 0 0.0037482597399502993
a O 0 0.003549023764207959
good O 0 0.00510786660015583
correlation O 0 0.007359364535659552
between O 0 0.00410438422113657
repeat O 0 0.01678779534995556
size O 0 0.004875984508544207
( O 0 0.0031949132680892944
at O 0 0.0026186099275946617
least O 0 0.0013860315084457397
in O 0 0.0031995484605431557
leucocytes O 1 0.9991360306739807
) O 0 0.004360669758170843
, O 0 0.0030685325618833303
clinical O 1 0.9719080328941345
severity O 1 0.9999836683273315
and O 0 0.0064882999286055565
age O 0 0.01731981337070465
of O 0 0.044608693569898605
onset O 1 1.0
. O 0 0.025442631915211678

The O 0 0.02795201539993286
trinucleotide O 1 0.9999759197235107
repeat O 1 0.5865105986595154
instability O 0 0.2838243246078491
mechanisms O 0 0.01687464863061905
involved O 0 0.0075811967253685
in O 0 0.011846615932881832
DM B-Disease 1 1.0
and O 0 0.0047864168882369995
other O 0 0.0034476236905902624
human O 0 0.01985308527946472
genetic B-Disease 1 0.9999979734420776
diseases I-Disease 1 1.0
are O 0 0.006601565517485142
unknown O 0 0.018940474838018417
. O 0 0.009465538896620274

We O 0 0.009609215892851353
studied O 0 0.024426545947790146
somatic O 0 0.054656971246004105
instability O 0 0.028748197481036186
by O 0 0.004156072158366442
measuring O 0 0.025697525590658188
the O 0 0.01297012995928526
CTG O 1 0.9999982118606567
repeat O 0 0.027018407359719276
length O 0 0.004921074490994215
at O 0 0.003304962534457445
several O 0 0.0014801202341914177
ages O 0 0.005291543900966644
in O 0 0.00224339310079813
various O 0 0.0038933020550757647
tissues O 0 0.021180452778935432
of O 0 0.011423718184232712
transgenic O 0 0.42718684673309326
mice O 0 0.013640131801366806
carrying O 0 0.0055565424263477325
a O 0 0.006282520480453968
( O 0 0.01438998244702816
CTG O 1 0.9999868869781494
) O 0 0.010263520292937756
55expansion O 0 0.05016952008008957
surrounded O 0 0.01662513241171837
by O 0 0.002686161547899246
45 O 0 0.007917525246739388
kb O 0 0.04449164867401123
of O 0 0.006460223346948624
the O 0 0.012717247009277344
human O 0 0.22437015175819397
DM B-Disease 1 1.0
region O 0 0.017221273854374886
, O 0 0.0036913480143994093
using O 0 0.0030819526873528957
small O 0 0.004944609012454748
- O 0 0.01911996863782406
pool O 0 0.036701466888189316
PCR O 0 0.06454042345285416
. O 0 0.00977113377302885

These O 0 0.010799935087561607
mice O 0 0.016133831813931465
have O 0 0.0013123626122251153
been O 0 0.0018409822368994355
shown O 0 0.0031046441290527582
to O 0 0.0017222367459908128
reproduce O 0 0.005894669331610203
the O 0 0.00502238841727376
intergenerational O 1 0.7285005450248718
and O 0 0.006142555736005306
somatic O 0 0.20030754804611206
instability O 0 0.028915908187627792
of O 0 0.009336759336292744
the O 0 0.016038324683904648
55 O 0 0.04352213069796562
CTG O 1 0.9999954700469971
repeat O 0 0.036104146391153336
suggesting O 0 0.01085752435028553
that O 0 0.0017107640160247684
surrounding O 0 0.007124517112970352
sequences O 0 0.004549900069832802
and O 0 0.00215905555523932
the O 0 0.005357029382139444
chromatin O 0 0.01868107169866562
environment O 0 0.005854323972016573
are O 0 0.0011361176148056984
involved O 0 0.0038652871735394
in O 0 0.0071753463707864285
instability O 1 0.9971796274185181
mechanisms O 0 0.13932077586650848
. O 0 0.015334098599851131

As O 0 0.007615914102643728
observed O 0 0.003856171388179064
in O 0 0.001551886205561459
some O 0 0.000920106191188097
of O 0 0.0029613978695124388
the O 0 0.007584146689623594
tissues O 1 0.9985767602920532
of O 1 0.9993122816085815
DM B-Disease 1 1.0
patients O 1 1.0
, O 0 0.004232210572808981
there O 0 0.0017013541655614972
is O 0 0.0016295119421556592
a O 0 0.0021546368952840567
tendency O 0 0.007523822132498026
for O 0 0.0035677531268447638
repeat O 0 0.03228138014674187
length O 0 0.009034313261508942
and O 0 0.005639875773340464
somatic O 0 0.2644409239292145
mosaicism O 1 0.9966616630554199
to O 0 0.0037528295069932938
increase O 0 0.002600814215838909
with O 0 0.0013042170321568847
the O 0 0.003314869711175561
age O 0 0.006095785181969404
of O 0 0.005927755031734705
the O 0 0.013046619482338428
mouse O 0 0.033367227762937546
. O 0 0.008993670344352722

Furthermore O 0 0.03844790533185005
, O 0 0.0068002366460859776
we O 0 0.002105957828462124
observed O 0 0.003267026972025633
no O 0 0.0018854638328775764
correlation O 0 0.005074357148259878
between O 0 0.0025668067391961813
the O 0 0.006349165458232164
somatic O 0 0.07217227667570114
mutation O 0 0.01460852287709713
rate O 0 0.00832845363765955
and O 0 0.0063951462507247925
tissue O 1 0.9995806813240051
proliferation O 1 0.8487366437911987
capacity O 0 0.02188592404127121
. O 0 0.010538628324866295

The O 0 0.029737742617726326
somatic O 0 0.13010360300540924
mutation O 0 0.016688985750079155
rates O 0 0.0059949541464447975
in O 0 0.002790857572108507
different O 0 0.002144287806004286
tissues O 0 0.012176088988780975
were O 0 0.0024524154141545296
also O 0 0.002477402798831463
not O 0 0.0012808700557798147
correlated O 0 0.007208419032394886
to O 0 0.0017455143388360739
the O 0 0.003997985739260912
relative O 0 0.017838995903730392
inter O 1 0.985395610332489
- O 0 0.051203157752752304
tissue O 0 0.02113546058535576
difference O 0 0.007189437281340361
in O 0 0.0035912711173295975
transcriptional O 0 0.01581045798957348
levels O 0 0.004278474487364292
of O 0 0.00199642195366323
the O 0 0.0030351283494383097
three O 0 0.003089405596256256
genes O 0 0.0070144785568118095
( O 0 0.008156988769769669
DMAHP O 1 0.9999980926513672
, O 0 0.007747192867100239
DMPK O 1 0.9999008178710938
and O 0 0.005382364150136709
59 O 0 0.02267591841518879
) O 0 0.004440982360392809
surrounding O 0 0.007237730082124472
the O 0 0.007734538987278938
repeat O 0 0.42641034722328186
. O 0 0.006422547623515129
. O 0 0.008591093122959137

A O 0 0.0239727720618248
novel O 0 0.030364761129021645
missense O 0 0.052780184894800186
mutation O 0 0.014504588209092617
in O 0 0.0055243452079594135
patients O 0 0.3591088652610779
from O 0 0.005848887376487255
a O 0 0.012663239613175392
retinoblastoma B-Disease 1 0.9999997615814209
pedigree O 0 0.07240571826696396
showing O 0 0.012624919414520264
only O 0 0.002985097002238035
mild O 0 0.02874416671693325
expression O 0 0.0075250971131026745
of O 0 0.009130330756306648
the O 0 0.08972109109163284
tumor B-Disease 1 1.0
phenotype O 1 0.5017056465148926
. O 0 0.013449940830469131

We O 0 0.0051811132580041885
have O 0 0.0015563530614599586
used O 0 0.0033453896176069975
single O 0 0.006873668637126684
strand O 0 0.018833016976714134
conformation O 0 0.014470520429313183
polymorphism O 0 0.007562313694506884
analysis O 0 0.001326457946561277
to O 0 0.0008422087994404137
study O 0 0.0024924231693148613
the O 0 0.0029835819732397795
27 O 0 0.010755132883787155
exons O 0 0.01579364575445652
of O 0 0.004102909471839666
the O 0 0.012405265122652054
RB1 O 1 1.0
gene O 0 0.006544365081936121
in O 0 0.0015424899756908417
individuals O 0 0.0009779669344425201
from O 0 0.0015250345459207892
a O 0 0.003418604377657175
family O 0 0.009665614925324917
showing O 0 0.015670575201511383
mild O 1 0.9209654927253723
expression O 0 0.01090245507657528
of O 0 0.01050481665879488
the O 0 0.07500799000263214
retinoblastoma B-Disease 1 1.0
phenotype O 1 0.5416523218154907
. O 0 0.016333715990185738

In O 0 0.008015602827072144
this O 0 0.0036420293617993593
family O 0 0.009858760982751846
affected O 0 0.007874790579080582
individuals O 0 0.003723285859450698
developed O 0 0.02707153931260109
unilateral B-Disease 1 0.9999822378158569
tumors I-Disease 1 1.0
and O 0 0.02057468332350254
, O 0 0.004876736085861921
as O 0 0.002889459952712059
a O 0 0.0027894354425370693
result O 0 0.0034228195436298847
of O 0 0.005527540110051632
linkage O 0 0.03711611405014992
analysis O 0 0.007139394525438547
, O 0 0.005945480428636074
unaffected O 0 0.034259356558322906
mutation O 0 0.012436780147254467
carriers O 0 0.006806364748626947
were O 0 0.001776178483851254
also O 0 0.0029367886018007994
identified O 0 0.0058870152570307255
within O 0 0.0031396602280437946
the O 0 0.009287175722420216
pedigree O 0 0.06003504619002342
. O 0 0.012532499618828297

A O 0 0.022777415812015533
single O 0 0.010112210176885128
band O 0 0.013094487600028515
shift O 0 0.009833485819399357
using O 0 0.005020597483962774
SSCP O 1 0.9991486072540283
was O 0 0.009252622723579407
identified O 0 0.006979214958846569
in O 0 0.004509458784013987
exon O 0 0.03320132941007614
21 O 0 0.007368866354227066
which O 0 0.001570699387229979
resulted O 0 0.004758473485708237
in O 0 0.0029984244611114264
a O 0 0.00525993388146162
missense O 0 0.02553490549325943
mutation O 0 0.008399098180234432
converting O 0 0.011324746534228325
a O 0 0.011207087896764278
cys O 1 0.9999998807907104
- O 1 0.7059419751167297
- O 0 0.04545357823371887
> O 0 0.03877171501517296
arg O 0 0.05364716798067093
at O 0 0.008688531816005707
nucleotide O 0 0.009439940564334393
position O 0 0.004339706618338823
28 O 0 0.006173937581479549
in O 0 0.002989542670547962
the O 0 0.00847047008574009
exon O 0 0.07597576081752777
. O 0 0.011709783226251602

The O 0 0.01846235804259777
mutation O 0 0.017086878418922424
destroyed O 0 0.01915067248046398
an O 0 0.007089274935424328
NdeI O 1 0.999948263168335
restriction O 0 0.02891642227768898
enzyme O 0 0.022180095314979553
site O 0 0.01902509480714798
. O 0 0.009805473499000072

Analysis O 0 0.007565581705421209
of O 0 0.00498135294765234
all O 0 0.002182143274694681
family O 0 0.005637068767100573
members O 0 0.002437802730128169
demonstrated O 0 0.006112268660217524
that O 0 0.0011890409514307976
the O 0 0.004737324081361294
missense O 0 0.0314905121922493
mutation O 0 0.015445848926901817
co O 0 0.03939944878220558
- O 0 0.02232593297958374
segregated O 0 0.023679327219724655
with O 0 0.0036452766507864
patients O 1 0.9999916553497314
with O 0 0.09818587452173233
tumors B-Disease 1 1.0
or O 0 0.07434510439634323
who O 0 0.007891177199780941
, O 0 0.0030414762441068888
as O 0 0.002369188703596592
a O 0 0.0027350359596312046
result O 0 0.0033175458665937185
of O 0 0.005002887453883886
linkage O 0 0.03132714703679085
analysis O 0 0.005162774119526148
had O 0 0.0035294622648507357
been O 0 0.0023368829861283302
predicted O 0 0.00504658930003643
to O 0 0.0017539262771606445
carry O 0 0.003980427980422974
the O 0 0.009050541557371616
predisposing O 1 0.998955249786377
mutation O 0 0.032411348074674606
. O 0 0.011207194067537785

These O 0 0.003912626765668392
observations O 0 0.007778555620461702
point O 0 0.004650527611374855
to O 0 0.0016312584048137069
another O 0 0.0029742689803242683
region O 0 0.005545318126678467
of O 0 0.006127387750893831
the O 0 0.0209495946764946
RB1 O 1 1.0
gene O 0 0.01054489053785801
where O 0 0.003804729087278247
mutations O 0 0.004203726537525654
only O 0 0.0012618015753105283
modify O 0 0.00591997429728508
the O 0 0.0033318486530333757
function O 0 0.0040319873951375484
of O 0 0.0032929356675595045
the O 0 0.005605787038803101
gene O 0 0.0062085227109491825
and O 0 0.0018284128746017814
raise O 0 0.004321584943681955
important O 0 0.002470556413754821
questions O 0 0.003321016440168023
for O 0 0.0028628238942474127
genetic O 0 0.011488551273941994
counseling O 0 0.13514363765716553
in O 0 0.003103475784882903
families O 0 0.002260010689496994
with O 0 0.0011074477806687355
these O 0 0.0019085656385868788
distinctive O 0 0.021749764680862427
phenotypes O 0 0.28530922532081604
. O 0 0.006486794911324978
. O 0 0.008286659605801105

Maternal B-Disease 1 0.999915361404419
disomy I-Disease 1 0.9999768733978271
and O 0 0.06344541907310486
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9993433356285095
with O 0 0.009534952230751514
gamete O 1 0.9999709129333496
complementation O 1 0.9999853372573853
in O 0 0.0044163549318909645
a O 0 0.004213882610201836
case O 0 0.006349640898406506
of O 0 0.007634882815182209
familial O 1 0.9999991655349731
translocation O 1 0.9986454844474792
( O 0 0.009397586807608604
3 O 0 0.006680590566247702
; O 0 0.0019784066826105118
15 O 0 0.003978740889579058
) O 0 0.0035776938311755657
( O 0 0.005970912054181099
p25 O 1 0.7694496512413025
; O 0 0.0053899455815553665
q11 O 0 0.1795334666967392
. O 0 0.004173099063336849
2 O 0 0.012815904803574085
) O 0 0.007281435653567314
. O 0 0.007228495087474585

Maternal B-Disease 1 0.9999979734420776
uniparental I-Disease 1 1.0
disomy I-Disease 1 1.0
( I-Disease 1 0.9499147534370422
UPD I-Disease 1 1.0
) I-Disease 0 0.009549173526465893
for I-Disease 0 0.004739240277558565
chromosome I-Disease 0 0.01518731564283371
15 I-Disease 0 0.005403890740126371
is O 0 0.0021633529104292393
responsible O 0 0.003436651546508074
for O 0 0.0017167051555588841
an O 0 0.0020732050761580467
estimated O 0 0.00390307093039155
30 O 0 0.0033303762320429087
% O 0 0.0014498247765004635
of O 0 0.001926250522956252
cases O 0 0.005677133332937956
of O 1 0.5331541299819946
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
PWS B-Disease 1 1.0
) O 0 0.05841968208551407
. O 0 0.012112658470869064

We O 0 0.006729542277753353
report O 0 0.00440437626093626
on O 0 0.0020394236780703068
an O 0 0.0014356899773702025
unusual O 0 0.003592349821701646
case O 0 0.005521042738109827
of O 0 0.009091967716813087
maternal B-Disease 1 0.9999990463256836
disomy I-Disease 1 0.9999979734420776
15 I-Disease 0 0.01739576645195484
in O 0 0.0106664402410388
PWS B-Disease 1 1.0
that O 0 0.003251352347433567
is O 0 0.0021910646464675665
most O 0 0.0012162629282101989
consistent O 0 0.004126634914427996
with O 0 0.0017377811018377542
adjacent O 0 0.01711895875632763
- O 0 0.023763462901115417
1 O 0 0.010809696279466152
segregation O 0 0.020719917491078377
of O 0 0.004385081585496664
a O 0 0.009079419076442719
paternal O 1 0.9841110706329346
t O 0 0.3903689384460449
( O 0 0.006189401727169752
3 O 0 0.006148972548544407
; O 0 0.0020346022211015224
15 O 0 0.004832646809518337
) O 0 0.004003478679805994
( O 0 0.00678930152207613
p25 O 0 0.4096941351890564
; O 0 0.005797610618174076
q11 O 0 0.0575530007481575
. O 0 0.0031647845171391964
2 O 0 0.006736242212355137
) O 0 0.0019269527401775122
with O 0 0.0013843706110492349
simultaneous O 0 0.011866794899106026
maternal O 1 0.9998841285705566
meiotic O 1 0.9999996423721313
nondisjunction O 1 0.9998956918716431
for O 0 0.013821844942867756
chromosome O 0 0.03269466757774353
15 O 0 0.014689760282635689
. O 0 0.00933148991316557

The O 0 0.021259525790810585
patient O 1 0.9999414682388306
( O 0 0.027795320376753807
J O 1 0.9999969005584717
. O 0 0.0038705598562955856
B O 0 0.02254093810915947
. O 0 0.0016432537231594324
) O 0 0.0013719185953959823
, O 0 0.000897628313396126
a O 0 0.0022344517055898905
17 O 0 0.009371481835842133
- O 0 0.011798784136772156
year O 0 0.005873576737940311
- O 0 0.013478340581059456
old O 0 0.01491224579513073
white O 0 0.013492741622030735
male O 0 0.013072002679109573
with O 0 0.007976463064551353
PWS B-Disease 1 1.0
, O 0 0.011723973788321018
was O 0 0.010554850101470947
found O 0 0.0025853170081973076
to O 0 0.0016280898125842214
have O 0 0.0010947895934805274
47 O 0 0.008386431261897087
chromosomes O 0 0.00608062231913209
with O 0 0.0014134725788608193
a O 0 0.006411523092538118
supernumerary O 1 0.9999088048934937
, O 0 0.010020880959928036
paternal O 1 0.9996569156646729
der O 1 0.9999982118606567
( O 0 0.010010273195803165
15 O 0 0.006089380476623774
) O 0 0.0023148739710450172
consisting O 0 0.0030886817257851362
of O 0 0.002960899379104376
the O 0 0.006470183841884136
short O 0 0.011544570326805115
arm O 0 0.02529153786599636
and O 0 0.004072846844792366
the O 0 0.011363434605300426
proximal O 1 0.9999998807907104
long O 0 0.0813126191496849
arm O 0 0.21332211792469025
of O 0 0.01331257726997137
chromosome O 0 0.025117596611380577
15 O 0 0.00875786505639553
, O 0 0.0045354897156357765
and O 0 0.007636180147528648
distal O 1 1.0
chromosome O 1 0.99998939037323
arm O 1 0.9999948740005493
3p O 1 0.9999637603759766
. O 0 0.01909477263689041

The O 0 0.025932375341653824
t O 0 0.1405676305294037
( O 0 0.008361054584383965
3 O 0 0.007781338412314653
; O 0 0.0026548898313194513
15 O 0 0.005067288875579834
) O 0 0.0031547483522444963
was O 0 0.004135432653129101
present O 0 0.002387765794992447
in O 0 0.0018711264710873365
the O 0 0.0030847874004393816
balanced O 0 0.004194458946585655
state O 0 0.0013526825932785869
in O 0 0.0017524975119158626
the O 0 0.0053093815222382545
patients O 1 0.9999152421951294
father O 1 0.9000492095947266
and O 0 0.004483380354940891
a O 0 0.009624393656849861
sister O 1 0.7414456605911255
. O 0 0.012967906892299652

Fluorescent O 0 0.0777411088347435
in O 0 0.01201398205012083
situ O 0 0.09964534640312195
hybridization O 0 0.012678426690399647
analysis O 0 0.0038158241659402847
demonstrated O 0 0.007276370655745268
that O 0 0.00238710711710155
the O 0 0.009963206015527248
PWS B-Disease 1 1.0
critical O 0 0.041071176528930664
region O 0 0.012742282822728157
resided O 0 0.026979835703969002
on O 0 0.004857606254518032
the O 0 0.006473090033978224
derivative O 0 0.03140171244740486
chromosome O 0 0.017303701490163803
3 O 0 0.006117766723036766
and O 0 0.0015198476612567902
that O 0 0.0010387414367869496
there O 0 0.002128316555172205
was O 0 0.005413458216935396
no O 0 0.0030123863834887743
deletion O 0 0.012612281367182732
of O 0 0.007553208153694868
the O 0 0.028550097718834877
PWS B-Disease 1 1.0
region O 0 0.01756264455616474
on O 0 0.005175468511879444
the O 0 0.005319204647094011
normal O 0 0.007123162038624287
pair O 0 0.005203640088438988
of O 0 0.006517949514091015
15s O 1 0.983342170715332
present O 0 0.011182880029082298
in O 0 0.011804216541349888
J O 1 0.9999973773956299
. O 0 0.01446262001991272

B O 1 0.8824027180671692
. O 0 0.02521221898496151

Methylation O 0 0.02550017647445202
analysis O 0 0.005860950332134962
at O 0 0.009637747891247272
exon O 0 0.03780701011419296
alpha O 0 0.011206399649381638
of O 0 0.002640433143824339
the O 0 0.0039379894733428955
small O 0 0.004942954983562231
nuclear O 0 0.01597151905298233
ribonucleoprotein O 1 0.9605991840362549
- O 0 0.019245702773332596
associated O 0 0.00978044793009758
polypeptide O 0 0.060189925134181976
N O 0 0.05316222086548805
( O 0 0.014969238080084324
SNRPN O 1 0.9999969005584717
) O 0 0.007864240556955338
gene O 0 0.0059459093026816845
showed O 0 0.004496787674725056
a O 0 0.003462493885308504
pattern O 0 0.00929930992424488
characteristic O 0 0.009114683605730534
of O 0 0.005322671495378017
only O 0 0.00348709081299603
the O 0 0.007134562823921442
maternal O 1 0.999054491519928
chromosome O 0 0.01927434466779232
15 O 0 0.009763136506080627
in O 0 0.009175841696560383
J O 1 0.9999963045120239
. O 0 0.016132976859807968

B O 1 0.8686579465866089
. O 0 0.022318603470921516

Maternal B-Disease 1 0.9999914169311523
disomy I-Disease 1 0.9999396800994873
was O 0 0.018044255673885345
confirmed O 0 0.01088595762848854
by O 0 0.003224857384338975
polymerase O 0 0.026371659711003304
chain O 0 0.013019558042287827
reaction O 0 0.004665310960263014
analysis O 0 0.002637628000229597
of O 0 0.004365110769867897
microsatellite O 0 0.046821434050798416
repeats O 0 0.019977150484919548
at O 0 0.0061357272788882256
the O 0 0.005566714331507683
gamma O 0 0.030669908970594406
- O 0 0.023284517228603363
aminobutyric O 0 0.1628781259059906
acid O 0 0.030111970379948616
receptor O 0 0.024800453335046768
beta3 O 0 0.07461383193731308
subunit O 0 0.026493296027183533
( O 0 0.015526467002928257
GABRB3 O 1 0.9999200105667114
) O 0 0.01514178141951561
locus O 0 0.05870659649372101
. O 0 0.013161126524209976

A O 0 0.03348050266504288
niece O 1 0.9998981952667236
( O 0 0.021129323169589043
B O 0 0.10584215819835663
. O 0 0.003616137197241187
B O 0 0.022759350016713142
. O 0 0.0016805967316031456
) O 0 0.0015612505376338959
with O 0 0.0009488273644819856
45 O 0 0.004289837088435888
chromosomes O 0 0.006867669057101011
and O 0 0.0019483707146719098
the O 0 0.004295668099075556
derivative O 0 0.017211640253663063
3 O 0 0.006589066237211227
but O 0 0.0010458903852850199
without O 0 0.0014344656374305487
the O 0 0.005626230034977198
der O 1 0.999993085861206
( O 0 0.009937483817338943
15 O 0 0.0077301920391619205
) O 0 0.00383662898093462
demonstrated O 0 0.00781796034425497
a O 0 0.005352590698748827
phenotype O 0 0.015868019312620163
consistent O 0 0.005899480078369379
with O 0 0.0011298938188701868
that O 0 0.0013422071933746338
reported O 0 0.005417351145297289
for O 0 0.004649933893233538
haploinsufficiency O 1 0.9966521859169006
of O 0 0.016730664297938347
distal O 1 0.9999994039535522
3 O 0 0.0974639281630516
p O 0 0.06055397912859917
. O 0 0.01131390780210495

Uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999964237213135
associated O 0 0.018206071108579636
with O 0 0.006736950017511845
unbalanced O 1 0.9771255254745483
segregation O 1 0.9593241810798645
of O 0 0.02293023094534874
non O 1 0.9998762607574463
- O 1 0.9991959929466248
Robertsonian O 1 0.9999911785125732
translocations O 0 0.060533471405506134
has O 0 0.003877123584970832
been O 0 0.0031503757927566767
reported O 0 0.006919915787875652
previously O 0 0.005448814947158098
but O 0 0.001536266296170652
has O 0 0.0023086918517947197
not O 0 0.0012052708771079779
, O 0 0.0017897128127515316
to O 0 0.001965508796274662
our O 0 0.0030456141103059053
knowledge O 0 0.005293441936373711
, O 0 0.0022329725325107574
been O 0 0.001744193839840591
observed O 0 0.0023730427492409945
in O 0 0.002040757331997156
a O 0 0.003510110080242157
case O 0 0.011203009635210037
of O 0 0.03358129411935806
PWS B-Disease 1 1.0
. O 0 0.0356578528881073

Furthermore O 0 0.03502446413040161
, O 0 0.007087114732712507
our O 0 0.004848841577768326
findings O 0 0.005221002735197544
are O 0 0.0010380031308159232
best O 0 0.0032823150977492332
interpreted O 0 0.004428081680089235
as O 0 0.003780226456001401
true O 0 0.014489410445094109
gamete O 0 0.11853732913732529
complementation O 1 0.9976916313171387
resulting O 0 0.02269987389445305
in O 0 0.02018302120268345
maternal B-Disease 1 1.0
UPD I-Disease 1 1.0
15 I-Disease 0 0.08858780562877655
and O 0 0.027242964133620262
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9993497729301453
- I-Disease 1 0.9984192848205566
Jampel I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
type I-Disease 1 0.987946093082428
2 I-Disease 0 0.03176722303032875
and O 0 0.007684345357120037
Stuve B-Disease 1 1.0
- I-Disease 1 0.9999988079071045
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 0.010184683836996555
a O 0 0.004488810431212187
case O 0 0.005654835607856512
for O 0 0.004476477857679129
" O 0 0.01637106016278267
lumping O 0 0.05850306898355484
" O 0 0.01902633160352707
. O 0 0.010309229604899883

Recent O 0 0.015865508466959
studies O 0 0.00902869738638401
demonstrated O 0 0.010600193403661251
the O 0 0.004333727527409792
existence O 0 0.006862207781523466
of O 0 0.004581280052661896
a O 0 0.006224085111171007
genetically O 0 0.007576818112283945
distinct O 0 0.004243474453687668
, O 0 0.002604456851258874
usually O 0 0.003495930228382349
lethal O 0 0.008555657230317593
form O 0 0.002318630227819085
of O 0 0.004362489562481642
the O 0 0.009774169884622097
Schwartz B-Disease 1 0.9999656677246094
- I-Disease 1 0.99903404712677
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999631643295288
SJS B-Disease 1 1.0
) O 0 0.011658279225230217
of O 0 0.015619494020938873
myotonia B-Disease 1 1.0
and O 1 0.999009370803833
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.048080429434776306
which O 0 0.004616151563823223
we O 0 0.004154548514634371
called O 0 0.021331317722797394
SJS B-Disease 1 1.0
type I-Disease 0 0.03233141079545021
2 I-Disease 0 0.023112377151846886
. O 0 0.008113224059343338

This O 0 0.01480239350348711
disorder O 1 0.9999998807907104
is O 0 0.009877094998955727
reminiscent O 0 0.02815600112080574
of O 0 0.0065894657745957375
another O 0 0.00671934150159359
rare O 0 0.011380620300769806
condition O 1 0.6387075185775757
, O 0 0.005101298913359642
the O 0 0.009930660016834736
Stuve B-Disease 1 1.0
- I-Disease 1 0.9999961853027344
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9998409748077393
SWS B-Disease 1 1.0
) O 0 0.005301062483340502
, O 0 0.001563870464451611
which O 0 0.0012660836800932884
comprises O 0 0.008979257196187973
campomelia B-Disease 1 0.6317609548568726
at O 0 0.011044173501431942
birth O 1 0.5784974694252014
with O 0 0.012398267164826393
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.9999687671661377
contractures B-Disease 1 1.0
, O 0 0.009253313764929771
and O 0 0.0043382649309933186
early B-Disease 0 0.013499386608600616
death I-Disease 1 0.5721724629402161
. O 0 0.01318859588354826

To O 0 0.005612409207969904
test O 0 0.004796252585947514
for O 0 0.0027812581975013018
possible O 0 0.005680379923433065
nosologic O 1 0.9714007377624512
identity O 0 0.008072424679994583
between O 0 0.004466569051146507
these O 0 0.004483358934521675
disorders O 1 1.0
, O 0 0.008811675012111664
we O 0 0.002827018266543746
reviewed O 0 0.0049518682062625885
the O 0 0.0024166556540876627
literature O 0 0.003519728546962142
and O 0 0.0017453997861593962
obtained O 0 0.0034652340691536665
a O 0 0.0036149569787085056
follow O 0 0.005420198664069176
- O 0 0.006764646153897047
up O 0 0.0014748387038707733
of O 0 0.0015006347093731165
the O 0 0.0017883189721032977
only O 0 0.0009424063027836382
two O 0 0.0013706719037145376
surviving O 0 0.02654596045613289
patients O 0 0.4573513865470886
, O 0 0.003670152509585023
one O 0 0.0035627896431833506
with O 0 0.005013979971408844
SJS B-Disease 1 1.0
type I-Disease 0 0.021574266254901886
2 I-Disease 0 0.009668202139437199
at O 0 0.00520744314417243
age O 0 0.0052229370921850204
10 O 0 0.0028285726439207792
years O 0 0.0019301065476611257
and O 0 0.001287211081944406
another O 0 0.0036418247036635876
with O 0 0.0036850646138191223
SWS B-Disease 1 1.0
at O 0 0.010795092210173607
age O 0 0.009284183382987976
7 O 0 0.011540033854544163
years O 0 0.0072146225720644
. O 0 0.007820142433047295

Patients O 1 0.9998924732208252
reported O 0 0.015524442307651043
as O 0 0.005529039539396763
having O 0 0.009913777001202106
either O 0 0.019379951059818268
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.028939107432961464
SWS B-Disease 1 0.9999986886978149
presented O 0 0.00819642934948206
a O 0 0.002970965811982751
combination O 0 0.004857643507421017
of O 0 0.0032262576278299093
a O 0 0.006389373913407326
severe O 1 1.0
, O 1 0.6793316602706909
prenatal O 1 1.0
- O 1 1.0
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999998807907104
with O 1 0.9639254808425903
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 1.0
respiratory O 1 1.0
and O 1 0.9999939203262329
feeding O 1 0.9999698400497437
difficulties O 1 0.999967098236084
, O 0 0.006978326011449099
tendency O 0 0.017204253003001213
to O 0 0.007640206720679998
hyperthermia B-Disease 1 1.0
, O 0 0.004257646389305592
and O 0 0.0023098699748516083
frequent O 0 0.008694494143128395
death O 0 0.21809245645999908
in O 0 0.005734969861805439
infancy O 1 0.9982975125312805
) O 0 0.002018422121182084
with O 0 0.000730871397536248
a O 0 0.003231321694329381
distinct O 0 0.012846357189118862
campomelic B-Disease 1 0.9999982118606567
- I-Disease 1 0.9999569654464722
metaphyseal I-Disease 1 1.0
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.0889815166592598

The O 0 0.012178050354123116
similarity O 0 0.012055890634655952
of O 0 0.006255601532757282
the O 0 0.011711628176271915
clinical O 1 0.9999958276748657
and O 0 0.009502623230218887
radiographic O 1 0.9999990463256836
findings O 0 0.01549443043768406
is O 0 0.0026718289591372013
so O 0 0.0015407709870487452
extensive O 0 0.004789142869412899
that O 0 0.0018335653003305197
these O 0 0.003016588045284152
disorders O 1 1.0
appear O 0 0.009300592355430126
to O 0 0.003223152132704854
be O 0 0.0014603905146941543
a O 0 0.0028542138170450926
single O 0 0.005799413193017244
entity O 0 0.01639958657324314
. O 0 0.011398219503462315

The O 0 0.016051018610596657
follow O 0 0.012059868313372135
- O 0 0.013255039229989052
up O 0 0.002843455644324422
observation O 0 0.007619251497089863
of O 0 0.002552550984546542
an O 0 0.00192602863535285
identical O 0 0.00320121250115335
and O 0 0.0013504724483937025
unique O 0 0.004095778334885836
pattern O 0 0.010062139481306076
of O 0 0.15759678184986115
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.44735515117645264
the O 0 0.008300048299133778
two O 0 0.002868655836209655
patients O 1 0.9898571968078613
( O 0 0.005353303626179695
one O 0 0.0027119682636111975
with O 0 0.004484483040869236
SJS B-Disease 1 1.0
type I-Disease 0 0.019190536811947823
2 I-Disease 0 0.00793637614697218
, O 0 0.0018653877777978778
one O 0 0.0020279071759432554
with O 0 0.003112792270258069
SWS B-Disease 1 1.0
) O 0 0.008531437255442142
surviving O 0 0.02470344491302967
beyond O 0 0.014172205701470375
infancy O 0 0.40022099018096924
adds O 0 0.010575181804597378
to O 0 0.0021596690639853477
the O 0 0.0024919749703258276
evidence O 0 0.0029531545005738735
in O 0 0.0025813556276261806
favor O 0 0.004185284022241831
of O 0 0.005988118704408407
identity O 0 0.018274879083037376
. O 0 0.011607838794589043

The O 0 0.018958745524287224
hypothesis O 0 0.027647141367197037
that O 0 0.00730705913156271
SWS B-Disease 1 0.999998927116394
and O 0 0.017691800370812416
SJS B-Disease 1 1.0
type I-Disease 0 0.024349089711904526
2 I-Disease 0 0.008511672727763653
are O 0 0.001016649417579174
the O 0 0.0034902135375887156
same O 0 0.005564399529248476
disorder O 1 1.0
should O 0 0.0051084235310554504
be O 0 0.002266818191856146
testable O 0 0.011336429975926876
by O 0 0.0017748464597389102
molecular O 0 0.009495304897427559
methods O 0 0.008945557288825512
. O 0 0.004285732749849558
. O 0 0.007165637332946062

A O 0 0.020628077909350395
mouse O 0 0.0156510379165411
model O 0 0.005798897240310907
of O 0 0.006710118148475885
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 1.0
defects O 1 1.0
in O 1 0.9993942975997925
hemostasis O 1 1.0
and O 1 0.9486128687858582
thrombosis B-Disease 1 1.0
. O 0 0.08661998808383942

von B-Disease 1 0.9998146891593933
Willebrand I-Disease 1 1.0
factor I-Disease 1 0.9943976402282715
( I-Disease 0 0.24367199838161469
vWf I-Disease 1 0.9999978542327881
) I-Disease 0 0.36651143431663513
deficiency I-Disease 1 1.0
causes O 1 0.9999998807907104
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9999983310699463
humans O 0 0.03486708551645279
. O 0 0.010603713802993298

We O 0 0.005474235862493515
generated O 0 0.003980615641921759
a O 0 0.004420226905494928
mouse O 0 0.009281542152166367
model O 0 0.003927961923182011
for O 0 0.001635049469769001
this O 0 0.0025227221194654703
disease O 1 0.9999641180038452
by O 0 0.002749799517914653
using O 0 0.004939224570989609
gene O 0 0.010570728220045567
targeting O 0 0.012737234123051167
. O 0 0.008116612210869789

vWf B-Disease 1 0.9999912977218628
- I-Disease 1 0.996908962726593
deficient I-Disease 1 0.9999213218688965
mice O 0 0.02434847131371498
appeared O 0 0.009451750665903091
normal O 0 0.007314537186175585
at O 0 0.0077330865897238255
birth O 0 0.01605217717587948
; O 0 0.0021695795003324747
they O 0 0.000936912780161947
were O 0 0.0020725915674120188
viable O 0 0.012847420759499073
and O 0 0.004857069347053766
fertile O 0 0.0598558746278286
. O 0 0.016909435391426086

Neither O 0 0.06420339643955231
vWf O 1 0.9775545597076416
nor O 0 0.042802050709724426
vWf O 1 0.9804971218109131
propolypeptide O 1 0.9990274906158447
( O 0 0.03002229891717434
von B-Disease 1 0.9998431205749512
Willebrand I-Disease 1 1.0
antigen O 1 0.9999980926513672
II O 1 1.0
) O 0 0.008315538987517357
were O 0 0.0027969558723270893
detectable O 0 0.018617916852235794
in O 0 0.0045282295905053616
plasma O 0 0.022404324263334274
, O 0 0.00699369702488184
platelets O 1 0.8896675109863281
, O 0 0.00721842423081398
or O 0 0.008498050272464752
endothelial O 0 0.1267903447151184
cells O 0 0.008185849525034428
of O 0 0.005389230325818062
the O 0 0.010943927802145481
homozygous O 0 0.042323049157857895
mutant O 0 0.06262880563735962
mice O 0 0.032368771731853485
. O 0 0.010284059680998325

The O 0 0.02203953079879284
mutant O 1 0.5300334095954895
mice O 0 0.05552889034152031
exhibited O 1 0.9571087956428528
defects O 1 0.9999998807907104
in O 0 0.02150001935660839
hemostasis O 1 1.0
with O 0 0.003615286434069276
a O 0 0.007211402058601379
highly O 1 0.5658823847770691
prolonged O 1 1.0
bleeding O 1 1.0
time O 0 0.016453776508569717
and O 0 0.006193412933498621
spontaneous O 0 0.3036503493785858
bleeding O 1 1.0
events O 0 0.008390786126255989
in O 0 0.003413461847230792
approximately O 0 0.004091496113687754
10 O 0 0.00399259477853775
% O 0 0.003923594951629639
of O 0 0.008019402623176575
neonates O 1 0.998046875
. O 0 0.018521949648857117

As O 0 0.005231146235018969
in O 0 0.0031461974140256643
the O 0 0.005148640368133783
human O 0 0.16690468788146973
disease O 1 1.0
, O 0 0.006648710463196039
the O 0 0.008071056567132473
factor O 0 0.025776011869311333
VIII O 1 0.9999977350234985
level O 0 0.00861318688839674
in O 0 0.0029912355821579695
these O 0 0.0019461724441498518
mice O 0 0.010999074205756187
was O 0 0.006437571719288826
reduced O 0 0.005353569984436035
strongly O 0 0.003279404016211629
as O 0 0.002179478295147419
a O 0 0.0025619552470743656
result O 0 0.0026083309203386307
of O 0 0.003320962656289339
the O 0 0.005947234574705362
lack O 0 0.010108362883329391
of O 0 0.009630722925066948
protection O 0 0.09202656894922256
provided O 0 0.014131384901702404
by O 0 0.007748857140541077
vWf O 1 0.6594505310058594
. O 0 0.01642417721450329

Defective O 1 1.0
thrombosis B-Disease 1 1.0
in O 1 0.975338876247406
mutant O 1 0.9999643564224243
mice O 0 0.02405594103038311
was O 0 0.0062148901633918285
also O 0 0.002605196787044406
evident O 0 0.005757718347012997
in O 0 0.0016948033589869738
an O 0 0.0015114364214241505
in O 0 0.003427388146519661
vivo O 0 0.034890126436948776
model O 0 0.010933475568890572
of O 0 0.02043612115085125
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 1 0.7163621187210083

In O 0 0.006296736653894186
this O 0 0.002178575610741973
model O 0 0.00452711246907711
, O 0 0.002295425161719322
the O 0 0.005580197554081678
exteriorized O 1 0.9999516010284424
mesentery O 1 0.9999898672103882
was O 0 0.02579861506819725
superfused O 1 0.9988756775856018
with O 0 0.010117781348526478
ferric O 1 1.0
chloride O 1 0.9998894929885864
and O 0 0.005052444990724325
the O 0 0.007680789567530155
accumulation O 0 0.4259060025215149
of O 0 0.02459166944026947
fluorescently O 1 0.9999998807907104
labeled O 1 0.9915322661399841
platelets O 1 0.9310538172721863
was O 0 0.011942341923713684
observed O 0 0.0061067319475114346
by O 0 0.004310218617320061
intravital O 1 0.942321240901947
microscopy O 0 0.04591771587729454
. O 0 0.01145942136645317

We O 0 0.00821774173527956
conclude O 0 0.01444143708795309
that O 0 0.001819029450416565
these O 0 0.0016903927316889167
mice O 0 0.00840603094547987
very O 0 0.002670167712494731
closely O 0 0.006868483033031225
mimic O 1 0.6457146406173706
severe O 1 1.0
human O 1 0.9999997615814209
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.6217194199562073
will O 0 0.003999823704361916
be O 0 0.0011883480474352837
very O 0 0.0011357675539329648
useful O 0 0.0017624006140977144
for O 0 0.0012175708543509245
investigating O 0 0.00643177330493927
the O 0 0.0038902040105313063
role O 0 0.006977992132306099
of O 0 0.00608865637332201
vWf O 1 0.9947280287742615
in O 0 0.0056984457187354565
normal O 0 0.009981284849345684
physiology O 1 0.9974693059921265
and O 0 0.004512765444815159
in O 0 0.013242851942777634
disease O 1 1.0
models O 0 0.02186262421309948
. O 0 0.007223924156278372
. O 0 0.009075567126274109

Oral O 1 0.9986037611961365
contraceptives O 1 0.9959496259689331
and O 0 0.005493542645126581
the O 0 0.00782829336822033
risk O 0 0.019542524591088295
of O 1 0.7738295793533325
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999586343765259

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 1.0
Study O 1 0.9993422627449036
Group O 0 0.020431511104106903
. O 0 0.008940303698182106

BACKGROUND O 0 0.04966933652758598
Women O 0 0.01443233247846365
with O 0 0.0034016151912510395
mutations O 0 0.005962215829640627
in O 0 0.0026593906804919243
either O 0 0.0029785195365548134
the O 0 0.00693894037976861
BRCA1 O 1 0.9999977350234985
or O 0 0.00686250627040863
the O 0 0.01120984647423029
BRCA2 O 1 0.9999946355819702
gene O 0 0.005432031117379665
have O 0 0.0008523908909410238
a O 0 0.002769328188151121
high O 0 0.009170666337013245
lifetime O 0 0.030712658539414406
risk O 0 0.054987989366054535
of O 1 0.9990155696868896
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9975132942199707

Oral O 1 0.9997431635856628
contraceptives O 1 0.9999980926513672
protect O 1 0.9972111582756042
against O 1 0.9999545812606812
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.9974215030670166
general O 1 0.7168962359428406
, O 0 0.0034172271843999624
but O 0 0.0009874013485386968
it O 0 0.0007764269248582423
is O 0 0.001280294032767415
not O 0 0.000805454037617892
known O 0 0.003090605605393648
whether O 0 0.0016592472093179822
they O 0 0.0008181234006769955
also O 0 0.00212195236235857
protect O 0 0.007519119884818792
against O 0 0.0082726264372468
hereditary B-Disease 1 0.9999996423721313
forms I-Disease 1 0.9952310919761658
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999088048934937

METHODS O 0 0.02285848930478096
We O 0 0.005613785237073898
enrolled O 0 0.023352686315774918
207 O 0 0.04255183786153793
women O 0 0.009333109483122826
with O 0 0.006440372206270695
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9998748302459717
161 O 1 0.9973326921463013
of O 0 0.006993595045059919
their O 0 0.003166370326653123
sisters O 0 0.015111304819583893
as O 0 0.002736111870035529
controls O 0 0.0036838112864643335
in O 0 0.0022465609945356846
a O 0 0.00400744890794158
case O 0 0.011579719372093678
- O 0 0.021322179585695267
control O 0 0.008073088712990284
study O 0 0.009791732765734196
. O 0 0.008585518226027489

All O 0 0.005965076386928558
the O 0 0.007963621988892555
patients O 0 0.048125360161066055
carried O 0 0.008489283733069897
a O 0 0.004965768661350012
pathogenic O 0 0.022572854533791542
mutation O 0 0.00565314432606101
in O 0 0.0032373908907175064
either O 0 0.006965305656194687
BRCA1 O 1 0.9969865679740906
( O 0 0.009287714958190918
179 O 0 0.023761942982673645
women O 0 0.009838315658271313
) O 0 0.005746479611843824
or O 0 0.005928050260990858
BRCA2 O 1 0.999984622001648
( O 0 0.01292894221842289
28 O 0 0.017564307898283005
women O 0 0.013975159265100956
) O 0 0.008846360258758068
. O 0 0.007740630302578211

The O 0 0.014686254784464836
control O 0 0.01330510713160038
women O 0 0.008247097954154015
were O 0 0.0033208238892257214
enrolled O 0 0.017382701858878136
regardless O 0 0.005637763999402523
of O 0 0.0038362445775419474
whether O 0 0.003833271563053131
or O 0 0.0025733306538313627
not O 0 0.0010933965677395463
they O 0 0.001126123359426856
had O 0 0.004052501637488604
either O 0 0.0067232027649879456
mutation O 0 0.021514588966965675
. O 0 0.011840431950986385

Lifetime O 0 0.051978837698698044
histories O 0 0.03922718018293381
of O 0 0.023668168112635612
oral O 1 1.0
- O 1 0.999970555305481
contraceptive O 1 0.998768150806427
use O 0 0.003433073638007045
were O 0 0.0015443844022229314
obtained O 0 0.0028288953471928835
by O 0 0.001351690967567265
interview O 0 0.007263808976858854
or O 0 0.0020740001928061247
by O 0 0.001229042885825038
written O 0 0.002521565416827798
questionnaire O 0 0.009081488475203514
and O 0 0.002276634331792593
were O 0 0.00201470241881907
compared O 0 0.004649717826396227
between O 0 0.00490278797224164
patients O 1 0.9994015693664551
and O 0 0.004650207702070475
control O 0 0.02036675438284874
women O 0 0.01044063176959753
, O 0 0.003291744738817215
after O 0 0.004458171781152487
adjustment O 0 0.015014994889497757
for O 0 0.0022248830646276474
year O 0 0.0030520064756274223
of O 0 0.0041816639713943005
birth O 0 0.1436581015586853
and O 0 0.008350390940904617
parity O 0 0.08949507772922516
. O 0 0.012258666567504406

RESULTS O 0 0.016463788226246834
The O 0 0.007376550231128931
adjusted O 0 0.018529696390032768
odds O 0 0.022542808204889297
ratio O 0 0.016153031960129738
for O 0 0.012143977917730808
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.017941206693649292
with O 0 0.0020120562985539436
any O 0 0.0014266105135902762
past O 0 0.0021499667782336473
use O 0 0.0015608090907335281
of O 0 0.004409056156873703
oral O 1 0.9996918439865112
contraceptives O 1 0.9999997615814209
was O 0 0.11327620595693588
0 O 0 0.027318067848682404
. O 0 0.007668726611882448

5 O 0 0.023004161193966866
( O 0 0.010289539583027363
95 O 0 0.011600456200540066
percent O 0 0.006430212873965502
confidence O 0 0.010185317136347294
interval O 0 0.008585769683122635
, O 0 0.002695164643228054
0 O 0 0.006312007550150156
. O 0 0.0010614448692649603
3 O 0 0.0027972031384706497
to O 0 0.0016238566022366285
0 O 0 0.008227556943893433
. O 0 0.002461971715092659
8 O 0 0.010758440010249615
) O 0 0.006312950048595667
. O 0 0.00641223369166255

The O 0 0.027791770175099373
risk O 0 0.025516169145703316
decreased O 0 0.018239423632621765
with O 0 0.003021261189132929
increasing O 0 0.007349023129791021
duration O 0 0.01160950306802988
of O 0 0.005202560219913721
use O 0 0.004858228377997875
( O 0 0.007101450115442276
P O 0 0.027007045224308968
for O 0 0.0030817242804914713
trend O 0 0.011478384956717491
, O 0 0.004738156218081713
< O 0 0.03185078874230385
0 O 0 0.012902849353849888
. O 0 0.0034343560691922903
001 O 1 0.5039697289466858
) O 0 0.004281758330762386
; O 0 0.0015344154089689255
use O 0 0.0011885279091075063
for O 0 0.0016266596503555775
six O 0 0.0026949159801006317
or O 0 0.0022114652674645185
more O 0 0.0011157458648085594
years O 0 0.0030915196985006332
was O 0 0.00472595077008009
associated O 0 0.0029225086327642202
with O 0 0.0011411529267206788
a O 0 0.003947384189814329
60 O 0 0.008322545327246189
percent O 0 0.007902789860963821
reduction O 0 0.012319356203079224
in O 0 0.006856925785541534
risk O 0 0.0211317241191864
. O 0 0.01143097784370184

Oral O 1 0.9998687505722046
- O 1 0.7426484823226929
contraceptive O 1 0.9846140146255493
use O 0 0.006063257809728384
protected O 0 0.017658619210124016
against O 0 0.08280610293149948
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.006759867072105408
for O 0 0.00395543035119772
carriers O 0 0.005593976471573114
of O 0 0.003669565077871084
the O 0 0.010815264657139778
BRCA1 O 1 0.9999570846557617
mutation O 0 0.01493566669523716
( O 0 0.007056123111397028
odds O 0 0.02024492807686329
ratio O 0 0.010234653018414974
, O 0 0.0029178133700042963
0 O 0 0.0076454211957752705
. O 0 0.001498970901593566
5 O 0 0.00455380417406559
; O 0 0.002406805520877242
95 O 0 0.009178430773317814
percent O 0 0.005834351759403944
confidence O 0 0.009019657969474792
interval O 0 0.0074740126729011536
, O 0 0.002546347212046385
0 O 0 0.0051445188000798225
. O 0 0.00117199937812984
3 O 0 0.002754657529294491
to O 0 0.001524651306681335
0 O 0 0.006018331274390221
. O 0 0.0014233860420063138
9 O 0 0.0062625654973089695
) O 0 0.0017046201974153519
and O 0 0.001001295866444707
for O 0 0.0016138816718012094
carriers O 0 0.005639528390020132
of O 0 0.004784113727509975
the O 0 0.011541948653757572
BRCA2 O 1 0.9999977350234985
mutation O 0 0.019788311794400215
( O 0 0.00904033426195383
odds O 0 0.021726533770561218
ratio O 0 0.010048629716038704
, O 0 0.0026293920818716288
0 O 0 0.006972222123295069
. O 0 0.0015349648892879486
4 O 0 0.005663575604557991
; O 0 0.0023683984763920307
95 O 0 0.008746959269046783
percent O 0 0.005324368365108967
confidence O 0 0.008463392034173012
interval O 0 0.00611107237637043
, O 0 0.002140774391591549
0 O 0 0.004679268226027489
. O 0 0.0009357620147056878
2 O 0 0.00302692549303174
to O 0 0.0014942395500838757
1 O 0 0.0058107515797019005
. O 0 0.00215401453897357
1 O 0 0.010558616369962692
) O 0 0.005737537518143654
. O 0 0.0066406275145709515

CONCLUSIONS O 0 0.06809607893228531
Oral O 1 0.9999067783355713
- O 1 0.843941330909729
contraceptive O 1 0.9150168299674988
use O 0 0.0054306709207594395
may O 0 0.004850019235163927
reduce O 0 0.0072249132208526134
the O 0 0.003935852088034153
risk O 0 0.013248167932033539
of O 1 0.9708355069160461
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.9652780294418335
women O 0 0.011478147469460964
with O 0 0.002635378623381257
pathogenic O 0 0.019924871623516083
mutations O 0 0.006129441317170858
in O 0 0.0032565766014158726
the O 0 0.01129393931478262
BRCA1 O 1 0.9999966621398926
or O 0 0.02720811404287815
BRCA2 O 1 0.9999977350234985
gene O 0 0.0722021833062172

A O 0 0.02340095490217209
Japanese O 0 0.033563271164894104
family O 0 0.013673699460923672
with O 0 0.006497625727206469
adrenoleukodystrophy B-Disease 1 1.0
with O 0 0.005442759022116661
a O 0 0.011556516401469707
codon O 0 0.0415811650454998
291 O 0 0.0422636941075325
deletion O 0 0.02213815040886402
: O 0 0.004400399513542652
a O 0 0.004349844995886087
clinical O 1 0.9077326655387878
, O 0 0.007139303721487522
biochemical O 0 0.03584621846675873
, O 0 0.00688899215310812
pathological O 1 0.9996169805526733
, O 0 0.00678492384031415
and O 0 0.004881188273429871
genetic O 0 0.016512418165802956
report O 0 0.014989303424954414
. O 0 0.01037777028977871

We O 0 0.004726260434836149
report O 0 0.003722646040841937
a O 0 0.003140638815239072
Japanese O 0 0.012895830906927586
family O 0 0.009697086177766323
with O 0 0.006776965688914061
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.999994158744812
ALD B-Disease 1 1.0
) O 0 0.0070715416222810745
with O 0 0.0012091553071513772
a O 0 0.0026816560421139
three O 0 0.0024048483464866877
base O 0 0.007690787315368652
pair O 0 0.008291621692478657
deletion O 0 0.02622140571475029
( O 0 0.01153076346963644
delGAG O 1 0.9096064567565918
291 O 0 0.0420716218650341
) O 0 0.0037858174182474613
in O 0 0.003358004614710808
the O 0 0.0146696288138628
ALD B-Disease 1 1.0
gene O 0 0.04500076174736023
. O 0 0.011568144895136356

A O 0 0.02201729826629162
variety O 0 0.00984336156398058
of O 0 0.00900290533900261
phenotypes O 0 0.030602145940065384
were O 0 0.0035390511620789766
observed O 0 0.0036736621987074614
within O 0 0.002075584139674902
this O 0 0.0022296879906207323
family O 0 0.011967962607741356
. O 0 0.01061958447098732

While O 0 0.008577249944210052
the O 0 0.008873200975358486
proband O 1 0.9997116923332214
( O 0 0.014269976876676083
patient O 1 0.997410237789154
1 O 0 0.01676776073873043
) O 0 0.0035423755180090666
was O 0 0.003934761974960566
classified O 0 0.0055502429604530334
as O 0 0.0019093179143965244
having O 0 0.0029403201770037413
a O 0 0.003362002782523632
rare O 0 0.009675131179392338
intermediate O 0 0.03448060527443886
type O 0 0.012092726305127144
of O 0 0.008687181398272514
adult O 0 0.24546809494495392
cerebral O 1 0.9999996423721313
and O 0 0.01953945681452751
cerebello O 1 1.0
- O 1 0.9999823570251465
brain O 1 0.9998600482940674
stem O 0 0.017277872189879417
forms O 0 0.0049403076991438866
, O 0 0.0032072311732918024
his O 0 0.007136048749089241
younger O 0 0.01925704814493656
brother O 0 0.04014160484075546
( O 0 0.008730091154575348
patient O 1 0.7974907755851746
2 O 0 0.01213095337152481
) O 0 0.0032841188367456198
and O 0 0.002357024233788252
nephew O 1 0.9931123852729797
( O 0 0.010604013688862324
patient O 1 0.9894987344741821
3 O 0 0.011161082424223423
) O 0 0.0028431785758584738
had O 0 0.002752648899331689
a O 0 0.008191379718482494
childhood O 1 1.0
ALD B-Disease 1 1.0
type O 1 0.9999940395355225
. O 0 0.025634462013840675

Another O 0 0.02545318752527237
nephew O 1 0.9994428753852844
( O 0 0.015172211453318596
patient O 1 0.7940371036529541
4 O 0 0.010829241015017033
) O 0 0.0024661626666784286
of O 0 0.003135883482173085
patient O 1 0.9999502897262573
1 O 0 0.01581001840531826
was O 0 0.00586908170953393
classified O 0 0.006481603253632784
as O 0 0.00199456256814301
having O 0 0.0034980452619493008
an O 0 0.004593789577484131
adolescent O 1 0.9999978542327881
form O 0 0.022748859599232674
. O 0 0.014206782914698124

The O 0 0.017732039093971252
tau O 0 0.06674505770206451
level O 0 0.008854023180902004
in O 0 0.003870262298732996
the O 0 0.009868806228041649
cerebrospinal O 1 0.9999997615814209
fluid O 1 0.9999250173568726
( O 0 0.10155713558197021
CSF O 1 0.9999996423721313
) O 0 0.0047277770936489105
in O 0 0.0033524557948112488
patient O 1 0.8903459310531616
1 O 0 0.010342316702008247
was O 0 0.004880678839981556
as O 0 0.0021687245462089777
high O 0 0.0031916347797960043
as O 0 0.0011742018396034837
that O 0 0.0006453532841987908
of O 0 0.0028284757863730192
patients O 1 0.9997637867927551
with O 0 0.030624644830822945
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9997894167900085
AD B-Disease 1 0.9998255372047424
) O 0 0.009597977623343468
. O 0 0.006905135698616505

His O 0 0.05089766904711723
brain O 1 0.9996603727340698
magnetic O 0 0.03551295027136803
resonance O 0 0.032681334763765335
image O 0 0.029018186032772064
( O 0 0.013387054204940796
MRI O 1 0.999990701675415
) O 0 0.006634452845901251
showed O 0 0.008516897447407246
abnormalities B-Disease 0 0.08929000049829483
in I-Disease 0 0.004113879520446062
the I-Disease 0 0.007885546423494816
bilateral I-Disease 1 0.9996615648269653
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.999998927116394
and O 1 0.9796679615974426
brain O 1 1.0
stem O 1 0.9986749291419983
, O 0 0.003613953711465001
but O 0 0.0010619496461004019
not O 0 0.0008764271042309701
in O 0 0.0024289709981530905
the O 0 0.007589427754282951
cerebral O 1 0.9999994039535522
white O 0 0.02683943696320057
matter O 0 0.0058222003281116486
, O 0 0.002848875941708684
where O 0 0.002974150236696005
marked O 0 0.009384850040078163
reductions O 0 0.009216716513037682
of O 0 0.0059675597585737705
the O 0 0.019689468666911125
cerebral O 1 1.0
blood O 1 0.9999998807907104
flow O 0 0.027933228760957718
and O 0 0.00834973156452179
oxygen O 0 0.03710540756583214
metabolism O 0 0.01599869318306446
were O 0 0.0022042777854949236
clearly O 0 0.0045351930893957615
demonstrated O 0 0.007007991895079613
by O 0 0.002500456990674138
positron O 0 0.04093014448881149
emission O 0 0.015694350004196167
tomography O 0 0.03657989576458931
( O 0 0.015596695244312286
PET O 1 0.998771607875824
) O 0 0.010007507167756557
. O 0 0.006904786452651024

In O 0 0.0151185542345047
patients O 1 0.9277793765068054
2 O 0 0.012851400300860405
and O 0 0.00285579776391387
3 O 0 0.0060517084784805775
, O 0 0.0017764507792890072
the O 0 0.0037588048726320267
autopsy O 0 0.03180333599448204
findings O 0 0.011527758091688156
showed O 0 0.01144502405077219
massive O 0 0.030446307733654976
demyelination B-Disease 1 1.0
of I-Disease 1 0.5319144129753113
the I-Disease 1 0.9726603627204895
cerebral I-Disease 1 1.0
white I-Disease 0 0.019479868933558464
matter I-Disease 0 0.0032754119019955397
with O 0 0.0012826278107240796
sparing O 0 0.016013136133551598
of O 0 0.006531611550599337
the O 0 0.06779274344444275
U O 1 1.0
- O 1 0.9986257553100586
fibers O 0 0.02730969712138176
, O 0 0.0032810268457978964
compatible O 0 0.0042229327373206615
with O 0 0.0009685193072073162
the O 0 0.002768827835097909
findings O 0 0.008876178413629532
of O 0 0.013593914918601513
childhood O 1 1.0
ALD B-Disease 1 1.0
. O 0 0.05431997403502464

Oleic O 1 0.9721717834472656
and O 0 0.023804979398846626
erucic O 1 0.999962329864502
acids O 0 0.034016311168670654
( O 0 0.01836899295449257
Lorenzos O 1 0.9978863596916199
Oil O 0 0.012411375530064106
) O 0 0.002701174933463335
were O 0 0.0015392180066555738
administered O 0 0.01074265968054533
to O 0 0.003799982601776719
patients O 1 0.9674637317657471
1 O 0 0.013847959227859974
and O 0 0.003285770770162344
4 O 0 0.009029550477862358
, O 0 0.0024575102142989635
but O 0 0.0013543081004172564
sufficient O 0 0.007105912547558546
effectiveness O 0 0.018124643713235855
was O 0 0.007022946607321501
not O 0 0.0017958310199901462
obtained O 0 0.006808962672948837
. O 0 0.007479472551494837

The O 0 0.01362578198313713
findings O 0 0.009587807580828667
in O 0 0.0031667633447796106
this O 0 0.0019612833857536316
family O 0 0.00578894792124629
suggest O 0 0.00558640668168664
that O 0 0.0020168281625956297
delGAG291 O 0 0.09099949896335602
is O 0 0.0026128848548978567
part O 0 0.0034055872820317745
of O 0 0.0041585080325603485
the O 0 0.006936009973287582
cause O 0 0.02189413458108902
of O 0 0.017949894070625305
Japanese O 1 0.9999946355819702
ALD B-Disease 1 1.0
with O 0 0.00954562146216631
phenotypic O 0 0.054964955896139145
variations O 0 0.025062117725610733
. O 0 0.014670959673821926

Moreover O 0 0.03241841495037079
, O 0 0.005105793010443449
although O 0 0.0026299948804080486
the O 0 0.003187950700521469
scale O 0 0.005521650426089764
of O 0 0.0031925453804433346
the O 0 0.0042712329886853695
study O 0 0.004746961407363415
is O 0 0.0020332159474492073
limited O 0 0.0020313214045017958
, O 0 0.0014427814166992903
there O 0 0.0011778672924265265
is O 0 0.0018227942055091262
a O 0 0.0028959326446056366
possibility O 0 0.006006205920130014
that O 0 0.00279310648329556
PET O 0 0.05186297744512558
can O 0 0.003182128071784973
detect O 0 0.01375225093215704
an O 0 0.006085788831114769
insidious B-Disease 1 0.9999858140945435
lesion I-Disease 1 1.0
which O 0 0.004810325801372528
is O 0 0.004034726414829493
undetectable O 0 0.036769937723875046
by O 0 0.002191244624555111
computed O 0 0.017407484352588654
tomogram O 1 0.9973050355911255
( O 0 0.027339525520801544
CT O 1 1.0
) O 0 0.008774764835834503
or O 0 0.005751618184149265
MRI O 1 0.9976832866668701
analysis O 0 0.004364314954727888
, O 0 0.0018986632348969579
and O 0 0.0010677115060389042
that O 0 0.0008865812560543418
the O 0 0.0027267260011285543
higher O 0 0.004357089288532734
level O 0 0.0042745317332446575
of O 0 0.0042353300377726555
tau O 0 0.19062259793281555
reflects O 0 0.006756486836820841
the O 0 0.002640986815094948
process O 0 0.002886400790885091
of O 0 0.007426343858242035
neuronal B-Disease 1 0.9999133348464966
degeneration I-Disease 1 1.0
in O 1 0.9998800754547119
ALD B-Disease 1 1.0
. O 0 0.031175818294286728

Lorenzos O 1 0.9983229041099548
Oil O 0 0.019264603033661842
should O 0 0.00279617914929986
be O 0 0.0011772705474868417
given O 0 0.0017908461159095168
in O 0 0.0021731529850512743
the O 0 0.0036555835977196693
early O 0 0.007812255062162876
stage O 0 0.017054907977581024
. O 0 0.005165686830878258
. O 0 0.007758571766316891

Nonsense O 0 0.07781887799501419
mutation O 0 0.016067173331975937
in O 0 0.006700856611132622
exon O 0 0.03824980929493904
4 O 0 0.008859599009156227
of O 0 0.004532760940492153
human O 0 0.010889136232435703
complement O 0 0.036518942564725876
C9 O 1 1.0
gene O 0 0.008215643465518951
is O 0 0.001774403965100646
the O 0 0.0025355403777211905
major O 0 0.007606592029333115
cause O 0 0.012589250691235065
of O 0 0.018576286733150482
Japanese O 1 0.9999969005584717
complement B-Disease 1 0.9999712705612183
C9 I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.026450373232364655

Deficiency B-Disease 1 1.0
of I-Disease 0 0.022599656134843826
the I-Disease 0 0.020809143781661987
ninth I-Disease 1 0.999599277973175
component I-Disease 0 0.018266741186380386
of I-Disease 0 0.006176846567541361
human I-Disease 0 0.010423373430967331
complement I-Disease 0 0.026379890739917755
( O 0 0.018300188705325127
C9 O 1 0.9999996423721313
) O 0 0.004478882998228073
is O 0 0.0015935288975015283
the O 0 0.00213239761069417
most O 0 0.002514052204787731
common O 0 0.015508627519011497
complement B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
in O 1 0.520779013633728
Japan O 1 0.9937418103218079
but O 0 0.0020282105542719364
is O 0 0.0018083906034007668
rare O 0 0.004156904760748148
in O 0 0.0027372699696570635
other O 0 0.002107011154294014
countries O 0 0.0027670508716255426
. O 0 0.007679525762796402

We O 0 0.004694990813732147
studied O 0 0.007388137746602297
the O 0 0.0037086985539644957
molecular O 0 0.00681266188621521
basis O 0 0.005132394377142191
of O 0 0.013554190285503864
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.00814426876604557
four O 0 0.0070209079422056675
Japanese O 1 0.9995571970939636
C9 B-Disease 1 1.0
- I-Disease 1 0.9999730587005615
deficient I-Disease 1 0.9999929666519165
patients O 1 0.8366280198097229
who O 0 0.007050446700304747
had O 0 0.011300896294414997
suffered O 1 1.0
from O 1 0.9998459815979004
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.7448062300682068

Direct O 0 0.017435947433114052
sequencing O 0 0.02017923630774021
of O 0 0.013546057045459747
amplified O 0 0.05501609295606613
C9 O 1 0.9999853372573853
cDNA O 0 0.043955978006124496
and O 0 0.0038974981289356947
DNA O 0 0.0085086515173316
revealed O 0 0.01007034070789814
a O 0 0.005614443216472864
nonsense O 0 0.026571860536932945
substitution O 0 0.023956602439284325
( O 0 0.014061300083994865
CGA O 1 0.9915586709976196
- O 0 0.04753420501947403
- O 0 0.03680514916777611
> O 0 0.05347718670964241
TGA O 1 0.999215841293335
) O 0 0.005083773750811815
at O 0 0.005545250605791807
codon O 0 0.015431983396410942
95 O 0 0.0075594051741063595
in O 0 0.003321764525026083
exon O 0 0.02441450022161007
4 O 0 0.005873106420040131
in O 0 0.002260517096146941
the O 0 0.005334155634045601
four O 0 0.014226737432181835
C9 B-Disease 1 1.0
- I-Disease 1 0.999893069267273
deficient I-Disease 1 0.9988002777099609
individuals O 0 0.008608406409621239
. O 0 0.011569136753678322

An O 0 0.016234345734119415
allele O 0 0.03700770065188408
- O 0 0.019332487136125565
specific O 0 0.007166543509811163
polymerase O 0 0.04173663631081581
chain O 0 0.02586565911769867
reaction O 0 0.012046718038618565
system O 0 0.007591683883219957
designed O 0 0.00639320770278573
to O 0 0.003037908812984824
detect O 0 0.009572012349963188
exclusively O 0 0.003867938881739974
only O 0 0.0010032342979684472
one O 0 0.0011933424975723028
of O 0 0.002638074802234769
the O 0 0.005739849992096424
normal O 0 0.010516947135329247
and O 0 0.0047609261237084866
mutant O 0 0.031051188707351685
alleles O 0 0.014865959994494915
indicated O 0 0.0051509118638932705
that O 0 0.000815932173281908
all O 0 0.0008920038235373795
the O 0 0.002700907876715064
four O 0 0.003588241757825017
patients O 0 0.01636672206223011
were O 0 0.003210156923159957
homozygous O 0 0.009237280115485191
for O 0 0.00173345603980124
the O 0 0.0038777843583375216
mutation O 0 0.007563047111034393
in O 0 0.00454158429056406
exon O 0 0.039148032665252686
4 O 0 0.0064866188913583755
and O 0 0.0010728463530540466
that O 0 0.0008182025630958378
the O 0 0.0023510842584073544
parents O 0 0.003960836678743362
of O 0 0.004945784341543913
patient O 1 0.9999547004699707
2 O 0 0.016295108944177628
were O 0 0.004483548924326897
heterozygous O 0 0.017523031681776047
. O 0 0.007716715335845947

The O 0 0.013457977212965488
common O 0 0.013349958695471287
mutation O 0 0.012821431271731853
at O 0 0.009067611768841743
codon O 0 0.022637775167822838
95 O 0 0.010790551081299782
in O 0 0.005217506550252438
exon O 0 0.04045218601822853
4 O 0 0.008436148054897785
might O 0 0.0018284557154402137
be O 0 0.0007834171410650015
responsible O 0 0.0031178866047412157
for O 0 0.002789989812299609
most O 0 0.006389888934791088
Japanese O 1 0.9999881982803345
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.01461923960596323
. O 0 0.011308293789625168

BRCA1 O 1 0.5215208530426025
required O 0 0.006309167016297579
for O 0 0.006239727605134249
transcription O 1 0.782181441783905
- O 0 0.04572191834449768
coupled O 0 0.03171033412218094
repair O 1 0.9967709183692932
of O 0 0.021338051185011864
oxidative O 1 0.9999489784240723
DNA O 0 0.08967234194278717
damage O 0 0.07570166140794754
. O 0 0.013401937671005726

The O 0 0.02452104724943638
breast B-Disease 1 1.0
and I-Disease 1 0.9866190552711487
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 1.0
gene O 1 0.9948887228965759
BRCA1 O 1 0.9999618530273438
encodes O 0 0.02532150410115719
a O 0 0.011129641905426979
zinc O 1 0.9997878670692444
finger O 0 0.044841498136520386
protein O 0 0.00854778103530407
of O 0 0.005023447331041098
unknown O 0 0.011548020876944065
function O 0 0.01240004412829876
. O 0 0.010271233506500721

Association O 0 0.024902986362576485
of O 0 0.011193009093403816
the O 0 0.016640648245811462
BRCA1 O 1 0.9998350143432617
protein O 0 0.007483255118131638
with O 0 0.001610475592315197
the O 0 0.006447015330195427
DNA O 0 0.03005128912627697
repair O 1 0.9999234676361084
protein O 0 0.027436571195721626
Rad51 O 1 0.8630780577659607
and O 0 0.0028148391284048557
changes O 0 0.0022863864433020353
in O 0 0.0026426350232213736
the O 0 0.00413033040240407
phosphorylation O 0 0.009405571967363358
and O 0 0.002869482384994626
cellular O 0 0.008706411346793175
localization O 0 0.011111077852547169
of O 0 0.003721793880686164
the O 0 0.005527579225599766
protein O 0 0.006666454486548901
after O 0 0.004436327610164881
exposure O 0 0.013573802076280117
to O 0 0.005140000954270363
DNA O 0 0.027760067954659462
- O 0 0.021487504243850708
damaging O 0 0.01330821868032217
agents O 0 0.003335606772452593
are O 0 0.0007268129847943783
consistent O 0 0.0025472957640886307
with O 0 0.0007892783614806831
a O 0 0.002288303803652525
role O 0 0.005315802060067654
for O 0 0.005258826073259115
BRCA1 O 1 0.9999948740005493
in O 0 0.011003656312823296
DNA O 0 0.038108017295598984
repair O 1 0.999601423740387
. O 0 0.01481728907674551

Here O 0 0.014200313948094845
, O 0 0.0031960189808160067
it O 0 0.001062550232745707
is O 0 0.0013637914089486003
shown O 0 0.0024586946237832308
that O 0 0.0015136833535507321
mouse O 0 0.017577169463038445
embryonic O 0 0.03055969811975956
stem O 0 0.04871765524148941
cells O 0 0.026988497003912926
deficient B-Disease 1 0.9989359974861145
in I-Disease 0 0.01078622043132782
BRCA1 I-Disease 1 0.9998364448547363
are O 0 0.003776215249672532
defective O 0 0.3853619396686554
in O 0 0.004111110232770443
the O 0 0.0036383855622261763
ability O 0 0.002575121819972992
to O 0 0.0012488295324146748
carry O 0 0.002909598173573613
out O 0 0.003106900257989764
transcription O 0 0.026666982099413872
- O 0 0.02218439429998398
coupled O 0 0.027406759560108185
repair O 1 0.9347386360168457
of O 0 0.01901387609541416
oxidative O 1 0.9999791383743286
DNA O 0 0.35385289788246155
damage O 0 0.026853200048208237
, O 0 0.003897265298292041
and O 0 0.002528478391468525
are O 0 0.0022253997158259153
hypersensitive O 0 0.09937265515327454
to O 0 0.00890215765684843
ionizing O 1 0.9984936714172363
radiation O 0 0.34714919328689575
and O 0 0.007330015767365694
hydrogen O 0 0.026682376861572266
peroxide O 0 0.07879713177680969
. O 0 0.011783171445131302

These O 0 0.0050059095956385136
results O 0 0.006671000737696886
suggest O 0 0.007765196729451418
that O 0 0.004321753047406673
BRCA1 O 1 0.999954104423523
participates O 0 0.020014125853776932
, O 0 0.003243127604946494
directly O 0 0.003526474582031369
or O 0 0.002955378033220768
indirectly O 0 0.008836322464048862
, O 0 0.0030498625710606575
in O 0 0.005302936304360628
transcription O 0 0.4464649558067322
- O 0 0.04102475196123123
coupled O 0 0.023518869653344154
repair O 1 0.995412290096283
of O 0 0.01977767050266266
oxidative O 1 0.9999504089355469
DNA O 0 0.11517760902643204
damage O 0 0.03260957449674606
. O 0 0.005791972391307354
. O 0 0.00831296294927597

Truncation O 0 0.4829891622066498
mutations O 0 0.01826181635260582
in O 0 0.005497313104569912
the O 0 0.008819254115223885
transactivation O 1 0.9556021094322205
region O 0 0.014834372326731682
of O 0 0.012034907937049866
PAX6 O 1 1.0
result O 0 0.008551888167858124
in O 0 0.00744170555844903
dominant O 0 0.054923463612794876
- O 0 0.030088644474744797
negative O 0 0.016201619058847427
mutants O 0 0.04636120796203613
. O 0 0.008835404179990292

PAX6 O 1 0.9999837875366211
is O 0 0.009711498394608498
a O 0 0.00649793166667223
transcription O 0 0.018906332552433014
factor O 0 0.006067023146897554
with O 0 0.0012253490276634693
two O 0 0.0021275735925883055
DNA O 0 0.014971944503486156
- O 0 0.013188830576837063
binding O 0 0.004769211634993553
domains O 0 0.012148142792284489
( O 0 0.006629345007240772
paired O 0 0.014758279547095299
box O 0 0.01838977262377739
and O 0 0.006109363865107298
homeobox O 1 0.9999725818634033
) O 0 0.005264542065560818
and O 0 0.0023723950143903494
a O 0 0.008097747340798378
proline O 1 0.9972345232963562
- O 0 0.04798256605863571
serine O 0 0.07854393124580383
- O 0 0.03506549075245857
threonine O 0 0.07726317644119263
( O 0 0.024659251794219017
PST O 1 0.9999901056289673
) O 0 0.014538994990289211
- O 0 0.020998356863856316
rich O 0 0.01702907495200634
transactivation O 0 0.16012635827064514
domain O 0 0.03125657141208649
. O 0 0.0148908831179142

PAX6 O 1 1.0
regulates O 1 0.9995971322059631
eye O 1 0.9981321692466736
development O 0 0.008764108642935753
in O 0 0.003909628372639418
animals O 0 0.0038744008634239435
ranging O 0 0.006456722505390644
from O 0 0.0049807289615273476
jellyfish O 0 0.016309775412082672
to O 0 0.003749712835997343
Drosophila O 0 0.02211259864270687
to O 0 0.004546625539660454
humans O 0 0.009162914007902145
. O 0 0.007874621078372002

Heterozygous O 0 0.04229570925235748
mutations O 0 0.009875854477286339
in O 0 0.0035156169906258583
the O 0 0.007364054676145315
human O 0 0.02045685611665249
PAX6 O 1 1.0
gene O 0 0.012448117136955261
result O 0 0.0031526379752904177
in O 0 0.0022346526384353638
various O 0 0.0031000874005258083
phenotypes O 0 0.02375510148704052
, O 0 0.004001207649707794
including O 0 0.0067957802675664425
aniridia B-Disease 1 1.0
, O 0 0.01851998083293438
Peters B-Disease 1 0.9999998807907104
anomaly I-Disease 1 0.9999990463256836
, O 0 0.014138702303171158
autosomal B-Disease 1 0.9999988079071045
dominant I-Disease 1 0.9999957084655762
keratitis I-Disease 1 1.0
, O 0 0.26841238141059875
and O 0 0.0721793919801712
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9982230067253113

It O 0 0.0043774996884167194
is O 0 0.0030418711248785257
believed O 0 0.00434044050052762
that O 0 0.0012853703228756785
the O 0 0.0045778690837323666
mutated O 0 0.01942286267876625
allele O 0 0.013904476538300514
of O 0 0.008502679876983166
PAX6 O 1 0.9999998807907104
produces O 0 0.012976663187146187
an O 0 0.0054310220293700695
inactive O 0 0.035450927913188934
protein O 0 0.010688381269574165
and O 0 0.004067258909344673
aniridia B-Disease 1 0.9999973773956299
is O 0 0.00620789872482419
caused O 0 0.01160676684230566
due O 0 0.009882164187729359
to O 0 0.0071403346955776215
genetic O 0 0.03275236114859581
haploinsufficiency O 1 0.999944806098938
. O 0 0.01287156157195568

However O 0 0.01283184066414833
, O 0 0.006062815431505442
several O 0 0.005400226917117834
truncation O 1 0.9387115240097046
mutations O 0 0.01170602161437273
have O 0 0.001666541094891727
been O 0 0.0023274498526006937
found O 0 0.002358195139095187
to O 0 0.0019496683962643147
occur O 0 0.002473834902048111
in O 0 0.0030068946070969105
the O 0 0.007540183141827583
C O 1 0.7066580057144165
- O 0 0.020630858838558197
terminal O 0 0.0213297288864851
half O 0 0.004040306434035301
of O 0 0.0063821799121797085
PAX6 O 1 0.9999980926513672
in O 0 0.008922526612877846
patients O 1 0.897801399230957
with O 0 0.005532574839890003
Aniridia B-Disease 1 1.0
resulting O 0 0.013983026146888733
in O 0 0.007338110823184252
mutant O 0 0.024021705612540245
proteins O 0 0.0032555751968175173
that O 0 0.001229938818141818
retain O 0 0.009520924650132656
the O 0 0.007128836587071419
DNA O 0 0.021425999701023102
- O 0 0.01641465350985527
binding O 0 0.004615731071680784
domains O 0 0.007439029403030872
but O 0 0.001220414531417191
have O 0 0.0011181047884747386
lost O 0 0.007137468084692955
most O 0 0.0018707970157265663
of O 0 0.004734780173748732
the O 0 0.016392089426517487
transactivation O 1 0.9999605417251587
domain O 0 0.03517533466219902
. O 0 0.013243145309388638

It O 0 0.006202793680131435
is O 0 0.0033512639347463846
not O 0 0.0011535084340721369
clear O 0 0.002917530247941613
whether O 0 0.0021118733566254377
such O 0 0.0021577219013124704
mutants O 0 0.039277516305446625
really O 0 0.007889341562986374
behave O 0 0.00802493467926979
as O 0 0.004051308613270521
loss O 0 0.018977193161845207
- O 0 0.01737094298005104
of O 0 0.007733566220849752
- O 0 0.020895658060908318
function O 0 0.009068314917385578
mutants O 0 0.020540859550237656
as O 0 0.003100290661677718
predicted O 0 0.00873042456805706
by O 0 0.004655901342630386
haploinsufficiency O 1 0.9422131180763245
. O 0 0.015383328311145306

Contrary O 0 0.02140641398727894
to O 0 0.003746578935533762
this O 0 0.002477070316672325
theory O 0 0.007340028882026672
, O 0 0.003422959242016077
our O 0 0.003359690308570862
data O 0 0.002553014550358057
showed O 0 0.0037117854226380587
that O 0 0.0011130510829389095
these O 0 0.001451045973226428
mutants O 0 0.015552859753370285
are O 0 0.00202959100715816
dominant O 0 0.016773736104369164
- O 0 0.016697587445378304
negative O 0 0.008555956184864044
in O 0 0.007772883400321007
transient O 1 0.8950070738792419
transfection O 1 0.9996997117996216
assays O 0 0.017898643389344215
when O 0 0.0028085566591471434
they O 0 0.0010453230934217572
are O 0 0.0010409456444904208
coexpressed O 0 0.03088010847568512
with O 0 0.0033589943777769804
wild O 0 0.020962301641702652
- O 0 0.05604887008666992
type O 0 0.06737026572227478
PAX6 O 1 0.9999991655349731
. O 0 0.025341814383864403

We O 0 0.00535396346822381
found O 0 0.0029589009936898947
that O 0 0.0012959938030689955
the O 0 0.004703592974692583
dominant O 0 0.07711096107959747
- O 0 0.0329696387052536
negative O 0 0.01195486169308424
effects O 0 0.009740720503032207
result O 0 0.004052374511957169
from O 0 0.003390447236597538
the O 0 0.00566859869286418
enhanced O 0 0.01892693154513836
DNA O 0 0.008991728536784649
binding O 0 0.0024791473988443613
ability O 0 0.0021020083222538233
of O 0 0.0033144508488476276
these O 0 0.0034827091731131077
mutants O 0 0.047794949263334274
. O 0 0.011155716143548489

Kinetic O 0 0.03202091529965401
studies O 0 0.007525430992245674
of O 0 0.005100911483168602
binding O 0 0.005519554018974304
and O 0 0.003713141893967986
dissociation O 0 0.029231829568743706
revealed O 0 0.009210122749209404
that O 0 0.0012792915804311633
various O 0 0.0029286816716194153
truncation O 0 0.13820138573646545
mutants O 0 0.026001838967204094
have O 0 0.0022029674146324396
3 O 0 0.010472455993294716
- O 0 0.01673370786011219
5 O 0 0.00990295223891735
- O 0 0.01480662077665329
fold O 0 0.010478905402123928
higher O 0 0.004745848011225462
affinity O 0 0.005194653756916523
to O 0 0.0022927490063011646
various O 0 0.003915106412023306
DNA O 0 0.016572225838899612
- O 0 0.011377316899597645
binding O 0 0.002313041128218174
sites O 0 0.001957447500899434
when O 0 0.0014646259369328618
compared O 0 0.00204757833853364
with O 0 0.0011682143667712808
the O 0 0.0048565189354121685
wild O 0 0.017970889806747437
- O 0 0.04393012821674347
type O 0 0.06690743565559387
PAX6 O 1 0.9999995231628418
. O 0 0.02101878821849823

These O 0 0.005653251428157091
results O 0 0.004865442868322134
provide O 0 0.0033896577078849077
a O 0 0.0021619824692606926
new O 0 0.0025864175986498594
insight O 0 0.00805334746837616
into O 0 0.0015320334350690246
the O 0 0.0019726501777768135
role O 0 0.005163859575986862
of O 0 0.006994756869971752
mutant O 1 0.9474089741706848
PAX6 O 1 1.0
in O 0 0.014415541663765907
causing O 1 0.9984877109527588
aniridia B-Disease 1 1.0
. O 0 0.009774391539394855
. O 0 0.008669664151966572

Reversal O 0 0.25823643803596497
of O 0 0.18639716506004333
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9999998807907104
excellent O 1 0.9999651908874512
neuropsychologic O 1 0.9999785423278809
outcome O 0 0.006513720378279686
in O 0 0.0026025809347629547
very B-Disease 0 0.0030680205672979355
- I-Disease 0 0.010785075835883617
long I-Disease 0 0.008320435881614685
- I-Disease 0 0.01721636764705181
chain I-Disease 0 0.02350357361137867
acyl I-Disease 0 0.2994248569011688
- I-Disease 0 0.05008827522397041
coenzyme I-Disease 0 0.2815616726875305
A I-Disease 1 0.7393971085548401
dehydrogenase I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.03590448945760727

Very B-Disease 0 0.013747278600931168
- I-Disease 0 0.025697879493236542
long I-Disease 0 0.012565593235194683
- I-Disease 0 0.022842619568109512
chain I-Disease 0 0.027622811496257782
acyl I-Disease 0 0.07589977979660034
- I-Disease 0 0.027686765417456627
coenzyme I-Disease 0 0.047229260206222534
A I-Disease 0 0.024700583890080452
dehydrogenase I-Disease 1 0.9997312426567078
( I-Disease 0 0.03222212940454483
VLCAD I-Disease 1 1.0
) I-Disease 0 0.02751494012773037
deficiency I-Disease 1 1.0
is O 0 0.0070010097697377205
a O 0 0.010450641624629498
disorder O 1 1.0
of O 1 0.9999971389770508
fatty O 1 1.0
acid O 1 0.9999707937240601
beta O 0 0.04768948256969452
oxidation O 0 0.011748652905225754
that O 0 0.001830253517255187
reportedly O 0 0.00990795623511076
has O 0 0.0026489668525755405
high O 0 0.006922517903149128
rates O 0 0.006277614273130894
of O 0 0.0077756126411259174
morbidity O 1 0.9999997615814209
and O 0 0.013232710771262646
mortality O 1 0.999984622001648
. O 0 0.018064480274915695

We O 0 0.005095029715448618
describe O 0 0.006353010889142752
the O 0 0.002488443860784173
outcome O 0 0.0030387421138584614
of O 0 0.0023080066312104464
a O 0 0.003807781031355262
5 O 0 0.0074111055582761765
- O 0 0.008371740579605103
year O 0 0.004485283512622118
- O 0 0.01061710063368082
old O 0 0.014688906259834766
girl O 0 0.1299588978290558
with O 0 0.010255559347569942
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.25775063037872314
was O 0 0.013483216986060143
first O 0 0.003955892287194729
seen O 0 0.003358561312779784
at O 0 0.003044772194698453
5 O 0 0.0029207165353000164
months O 0 0.0017195891123265028
of O 0 0.00221992377191782
age O 0 0.007299218326807022
with O 0 0.005570242181420326
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 1.0
encephalopathy B-Disease 1 1.0
, O 1 0.9528305530548096
and O 0 0.028510073199868202
hypotonia B-Disease 1 1.0
. O 0 0.023901356384158134

Biochemical O 0 0.06963209062814713
studies O 0 0.02862660400569439
indicated O 1 0.9526179432868958
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9986770749092102
by O 0 0.0036337331403046846
a O 0 0.0061953323893249035
stable O 0 0.03975142911076546
yet O 0 0.007869216613471508
inactive O 0 0.047285400331020355
enzyme O 0 0.02529544197022915
. O 0 0.008542994037270546

Molecular O 0 0.024453463032841682
genetic O 0 0.00905541516840458
analysis O 0 0.003132784739136696
of O 0 0.005248663946986198
her O 0 0.022547829896211624
VLCAD O 1 1.0
gene O 0 0.011080371215939522
revealed O 0 0.009708624333143234
a O 0 0.005763194523751736
T1372C O 1 0.9952371120452881
( O 0 0.013657881878316402
F458L O 1 0.9806250333786011
) O 0 0.006247721612453461
missense O 0 0.023363454267382622
mutation O 0 0.007307885680347681
and O 0 0.0028271893970668316
a O 0 0.012079671025276184
1668 O 1 0.9999996423721313
ACAG O 1 1.0
1669 O 1 0.9999909400939941
splice O 1 0.9610130786895752
site O 0 0.03610105440020561
mutation O 0 0.027773667126893997
. O 0 0.009906469844281673

After O 0 0.01734384335577488
initial O 0 0.019691217690706253
treatment O 1 0.9988941550254822
with O 0 0.009016606025397778
intravenous O 1 1.0
glucose O 1 0.999911904335022
and O 0 0.011997443623840809
carnitine O 1 0.9999943971633911
, O 0 0.006052210461348295
the O 0 0.006855607498437166
patient O 0 0.2268996238708496
has O 0 0.004541751928627491
thrived O 0 0.017572643235325813
on O 0 0.0034840002190321684
a O 0 0.00465924758464098
low O 0 0.015738625079393387
- O 0 0.0257719773799181
fat O 0 0.0246958676725626
diet O 0 0.02120848558843136
supplemented O 0 0.013607642613351345
with O 0 0.003048331942409277
medium O 0 0.01933036372065544
- O 0 0.03294447436928749
chain O 0 0.04243609309196472
triglyceride O 1 0.6367168426513672
oil O 0 0.016632121056318283
and O 0 0.00951454695314169
carnitine O 1 0.9999650716781616
and O 0 0.010744107887148857
avoidance O 1 0.9995294809341431
of O 0 0.29518046975135803
fasting O 1 0.999440610408783
. O 0 0.018099777400493622

Her O 1 0.9994718432426453
ventricular O 1 1.0
hypertrophy O 1 1.0
resolved O 1 0.661568820476532
significantly O 0 0.010774234309792519
over O 0 0.003874709829688072
1 O 0 0.010905901901423931
year O 0 0.004761075135320425
, O 0 0.003279739059507847
and O 0 0.004583235364407301
cognitively O 1 0.9970808625221252
, O 0 0.0058683836832642555
she O 0 0.005838432349264622
is O 0 0.002543138572946191
in O 0 0.00268758786842227
the O 0 0.004286656621843576
superior O 0 0.013675474561750889
range O 0 0.005524495150893927
for O 0 0.005415281280875206
age O 0 0.017342673614621162
. O 0 0.01285080797970295

Clinical O 1 0.999478280544281
recognition O 0 0.4410127103328705
of O 1 0.9999929666519165
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.01939975470304489
important O 0 0.005830983631312847
because O 0 0.0014765060041099787
it O 0 0.000678883632645011
is O 0 0.0009457244304940104
one O 0 0.0009071532404050231
of O 0 0.001842735568061471
the O 0 0.003087968099862337
few O 0 0.0037419048603624105
directly O 0 0.007429199293255806
treatable O 1 1.0
causes O 1 0.9999271631240845
of O 1 0.9999877214431763
cardiomyopathy B-Disease 1 1.0
in O 1 0.9999992847442627
children O 1 0.9998735189437866
. O 0 0.006393087096512318
. O 0 0.006636521779000759

Cloning O 0 0.021000953391194344
of O 0 0.004352969117462635
a O 0 0.004076953046023846
novel O 0 0.009804658591747284
member O 0 0.00441002706065774
of O 0 0.0039937798865139484
the O 0 0.008347326889634132
low O 0 0.025467898696660995
- O 0 0.029157746583223343
density O 0 0.025402946397662163
lipoprotein O 1 0.9969913959503174
receptor O 0 0.03847615793347359
family O 0 0.018612872809171677
. O 0 0.011696333065629005

A O 0 0.02468598447740078
gene O 0 0.012047613970935345
encoding O 0 0.007426299154758453
a O 0 0.005229647736996412
novel O 0 0.020685167983174324
transmembrane O 0 0.049325939267873764
protein O 0 0.010449730791151524
was O 0 0.005942313466221094
identified O 0 0.005156089551746845
by O 0 0.0015956198330968618
DNA O 0 0.004673714749515057
sequence O 0 0.002037182915955782
analysis O 0 0.0012378065148368478
within O 0 0.001506573986262083
the O 0 0.005655005108565092
insulin B-Disease 1 0.999955415725708
- I-Disease 1 0.9146696329116821
dependent I-Disease 0 0.06826149672269821
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 1 0.9997567534446716
IDDM B-Disease 1 1.0
) O 0 0.015361071564257145
locus O 0 0.07498103380203247
IDDM4 O 1 0.9998247027397156
on O 0 0.0156844612210989
chromosome O 0 0.05222249776124954
11q13 O 1 0.9235920310020447
. O 0 0.01830088160932064

Based O 0 0.009169419296085835
on O 0 0.005726164672523737
its O 0 0.005433116108179092
chromosomal O 0 0.047930680215358734
position O 0 0.01082901656627655
, O 0 0.00370256369933486
this O 0 0.002066086744889617
gene O 0 0.004098151810467243
is O 0 0.0015520175220444798
a O 0 0.0022611096501350403
candidate O 0 0.005599849857389927
for O 0 0.003620405215770006
conferring O 0 0.04848643019795418
susceptibility O 1 0.9996215105056763
to O 0 0.021487057209014893
diabetes B-Disease 1 1.0
. O 0 0.04207317531108856

The O 0 0.016311336308717728
gene O 0 0.01170738972723484
, O 0 0.004292608238756657
termed O 0 0.03294961526989937
low O 0 0.030267322435975075
- O 0 0.03005673922598362
density O 0 0.020758941769599915
lipoprotein O 1 0.7663394212722778
receptor O 0 0.01696431264281273
related O 0 0.007143066730350256
protein O 0 0.009508651681244373
5 O 0 0.008312680758535862
( O 0 0.00891979318112135
LRP5 O 1 0.9997953772544861
) O 0 0.0049586910754442215
, O 0 0.002901023253798485
encodes O 0 0.00904255174100399
a O 0 0.0035730565432459116
protein O 0 0.00611322745680809
of O 0 0.006269736215472221
1615 O 1 0.8195492625236511
amino O 0 0.013257782906293869
acids O 0 0.005595695693045855
that O 0 0.0014268358936533332
contains O 0 0.005204376298934221
conserved O 0 0.009193559177219868
modules O 0 0.008590511046350002
which O 0 0.0012288556899875402
are O 0 0.0007074720342643559
characteristic O 0 0.005628751125186682
of O 0 0.005528561770915985
the O 0 0.01059295330196619
low O 0 0.027333302423357964
- O 0 0.034363653510808945
density O 0 0.023083660751581192
lipoprotein O 1 0.9997625946998596
( O 0 0.033074866980314255
LDL O 1 0.9999996423721313
) O 0 0.01612064614892006
receptor O 0 0.025173867121338844
family O 0 0.014327102340757847
. O 0 0.010313919745385647

These O 0 0.006685469299554825
modules O 0 0.015417296439409256
include O 0 0.005927224177867174
a O 0 0.007757400628179312
putative O 0 0.04779928922653198
signal O 0 0.01446517650038004
peptide O 0 0.014094225130975246
for O 0 0.0029516848735511303
protein O 0 0.006791913416236639
export O 0 0.005439532455056906
, O 0 0.0038083945401012897
four O 0 0.006231323815882206
epidermal O 1 0.9815845489501953
growth O 0 0.015986260026693344
factor O 0 0.021645598113536835
( O 0 0.01624365523457527
EGF O 1 0.9999027252197266
) O 0 0.006796563044190407
repeats O 0 0.01305141020566225
with O 0 0.0023073083721101284
associated O 0 0.008814028464257717
spacer O 0 0.09986545145511627
domains O 0 0.014389414340257645
, O 0 0.00456234160810709
three O 0 0.008241310715675354
LDL O 1 1.0
- O 1 0.6143214702606201
receptor O 0 0.024738291278481483
( O 0 0.010509312152862549
LDLR O 1 0.9995102882385254
) O 0 0.006728496868163347
repeats O 0 0.014088238589465618
, O 0 0.0022812148090451956
a O 0 0.004264978691935539
single O 0 0.007760469801723957
transmembrane O 0 0.0383819118142128
spanning O 0 0.02123412676155567
domain O 0 0.013245576061308384
, O 0 0.004374030977487564
and O 0 0.0035508722066879272
a O 0 0.008909742347896099
cytoplasmic O 0 0.04833348095417023
domain O 0 0.02710411138832569
. O 0 0.01120952982455492

The O 0 0.017386136576533318
encoded O 0 0.012437810190021992
protein O 0 0.006533127743750811
has O 0 0.0015793241327628493
a O 0 0.002173766726627946
unique O 0 0.003971155267208815
organization O 0 0.006390945520251989
of O 0 0.010807064361870289
EGF O 1 1.0
and O 0 0.012384332716464996
LDLR O 1 1.0
repeats O 0 0.1331125944852829
; O 0 0.004385299980640411
therefore O 0 0.004643383901566267
, O 0 0.0044784280471503735
LRP5 O 1 0.9999160766601562
likely O 0 0.004464759025722742
represents O 0 0.00400196760892868
a O 0 0.002194462576881051
new O 0 0.002142543438822031
category O 0 0.004621163010597229
of O 0 0.003488284070044756
the O 0 0.01133662648499012
LDLR O 1 1.0
family O 0 0.034049589186906815
. O 0 0.01455614622682333

Both O 0 0.009428279474377632
human O 0 0.011360027827322483
and O 0 0.007550631184130907
mouse O 1 0.7907187342643738
LRP5 O 1 0.9999998807907104
cDNAs O 1 0.9970294237136841
have O 0 0.0023201850708574057
been O 0 0.0029571305494755507
isolated O 0 0.009042342193424702
and O 0 0.0027222484350204468
the O 0 0.00631461339071393
encoded O 0 0.008871383965015411
mature O 0 0.00785623025149107
proteins O 0 0.002608844079077244
are O 0 0.0010179135715588927
95 O 0 0.008818208239972591
% O 0 0.003748618997633457
identical O 0 0.004465138539671898
, O 0 0.0030979395378381014
indicating O 0 0.008758303709328175
a O 0 0.00457789096981287
high O 0 0.008431303314864635
degree O 0 0.008200117386877537
of O 0 0.006600971333682537
evolutionary O 0 0.020650656893849373
conservation O 0 0.01582447811961174
. O 0 0.004073564428836107
. O 0 0.007068977225571871

The O 0 0.031765710562467575
APC B-Disease 1 0.999718964099884
variants O 0 0.025911035016179085
I1307K O 1 0.5236092209815979
and O 0 0.005070872604846954
E1317Q O 1 0.8427997827529907
are O 0 0.0023984964936971664
associated O 0 0.009940903633832932
with O 1 0.7090181708335876
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.9968706965446472
but O 0 0.002447823528200388
not O 0 0.000936256954446435
always O 0 0.0016106364782899618
with O 0 0.0007333180983550847
a O 0 0.0029531631153076887
family O 0 0.008842614479362965
history O 0 0.01693486049771309
. O 0 0.011496118269860744

Classical O 0 0.14054395258426666
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 1.0
FAP B-Disease 1 1.0
) O 0 0.00923909991979599
is O 0 0.002203514566645026
a O 0 0.004615726415067911
high O 0 0.01821841299533844
- O 0 0.35505223274230957
penetrance O 1 0.9999613761901855
autosomal B-Disease 1 0.9999994039535522
dominant I-Disease 1 0.9999990463256836
disease I-Disease 1 1.0
that O 0 0.00826036836951971
predisposes O 1 0.9998071789741516
to O 0 0.0035445070825517178
hundreds O 0 0.004662614781409502
or O 0 0.0028230100870132446
thousands O 0 0.006552437320351601
of O 1 0.6701520681381226
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
and O 0 0.2022351324558258
that O 0 0.0025421094615012407
results O 0 0.004255534149706364
from O 0 0.0028608671855181456
truncating O 0 0.21847344934940338
mutations O 0 0.007435178849846125
in O 0 0.003830141155049205
the O 0 0.011626476421952248
APC B-Disease 1 0.9999727010726929
gene O 0 0.02366887591779232
. O 0 0.010680850595235825

A O 0 0.02185235358774662
variant O 0 0.03659280017018318
of O 0 0.020407086238265038
FAP B-Disease 1 1.0
is O 0 0.03199941664934158
attenuated B-Disease 1 0.9999798536300659
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 0.00997974444180727
which O 0 0.003118755528703332
results O 0 0.0047841183841228485
from O 0 0.005716139450669289
germ O 1 0.9999972581863403
- O 0 0.02914869226515293
line O 0 0.007612570188939571
mutations O 0 0.003832663642242551
in O 0 0.001567633356899023
the O 0 0.003225030843168497
5 O 0 0.005503127351403236
and O 0 0.0018295793561264873
3 O 0 0.004697977565228939
regions O 0 0.0024601288605481386
of O 0 0.0042894985526800156
the O 0 0.014680280350148678
APC B-Disease 1 0.9999997615814209
gene O 0 0.021782930940389633
. O 0 0.007966507226228714

Attenuated B-Disease 1 0.9999681711196899
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 1.0
have O 0 0.00571462232619524
" O 0 0.012035067193210125
multiple O 0 0.017748523503541946
" O 1 0.9985277652740479
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 1 0.576936662197113
typically O 0 0.006332950200885534
fewer O 0 0.0036662158090621233
than O 0 0.001352745690383017
100 O 0 0.004498561844229698
) O 0 0.0021327182184904814
without O 0 0.0014150968054309487
the O 0 0.005377868190407753
florid O 1 0.950415313243866
phenotype O 0 0.027454275637865067
of O 0 0.012174631468951702
classical O 0 0.10140148550271988
FAP B-Disease 1 1.0
. O 0 0.02431289292871952

Another O 0 0.009702509269118309
group O 0 0.004809362813830376
of O 0 0.005623843055218458
patients O 1 0.9998086094856262
with O 0 0.004692246206104755
multiple O 1 0.8665960431098938
adenomas B-Disease 1 1.0
has O 0 0.0059470534324646
no O 0 0.0037712957710027695
mutations O 0 0.005200284533202648
in O 0 0.002865623915567994
the O 0 0.009207603521645069
APC B-Disease 1 0.999998927116394
gene O 0 0.01100272685289383
, O 0 0.002855292521417141
and O 0 0.0022851196117699146
their O 0 0.003621940268203616
phenotype O 0 0.016267264261841774
probably O 0 0.004961223341524601
results O 0 0.002704123267903924
from O 0 0.0018051862716674805
variation O 0 0.005185342393815517
at O 0 0.005717025604099035
a O 0 0.006131222005933523
locus O 0 0.032632797956466675
, O 0 0.003736424958333373
or O 0 0.004799476359039545
loci O 0 0.02646842785179615
, O 0 0.0032611179631203413
elsewhere O 0 0.004006760194897652
in O 0 0.003408476011827588
the O 0 0.008414545096457005
genome O 0 0.024518832564353943
. O 0 0.011613135226070881

Recently O 0 0.026884794235229492
, O 0 0.004798852372914553
however O 0 0.002274460159242153
, O 0 0.001902815536595881
a O 0 0.0040559289045631886
missense O 0 0.02913317084312439
variant O 0 0.022905448451638222
of O 0 0.015470270998775959
APC B-Disease 1 1.0
( O 0 0.023979967460036278
I1307K O 1 0.9995563626289368
) O 0 0.006045215297490358
was O 0 0.00439222389832139
described O 0 0.0051901512779295444
that O 0 0.0018282673554494977
confers O 0 0.01634259708225727
an O 0 0.0029050076846033335
increased O 0 0.00839989259839058
risk O 0 0.42749297618865967
of O 1 0.9999927282333374
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.9105901718139648
including O 0 0.010872897692024708
multiple O 1 0.6702601909637451
adenomas B-Disease 1 1.0
, O 0 0.008887575007975101
in O 0 0.010700327344238758
Ashkenazim O 1 0.9974645376205444
. O 0 0.015073052607476711

We O 0 0.005026799160987139
have O 0 0.001206049695611
studied O 0 0.00385307683609426
a O 0 0.002120652236044407
set O 0 0.0025711136404424906
of O 0 0.004249342251569033
164 O 0 0.04099255055189133
patients O 0 0.3371089696884155
with O 0 0.005026038736104965
multiple O 1 0.9999487400054932
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
/ I-Disease 1 1.0
or I-Disease 1 0.9420619010925293
carcinoma I-Disease 1 1.0
and O 0 0.016954222694039345
analyzed O 0 0.02823890745639801
codons O 0 0.05641292408108711
1263 O 1 0.9996803998947144
- O 0 0.048604194074869156
1377 O 1 0.9737246036529541
( O 0 0.01656685210764408
exon O 0 0.059938691556453705
15G O 0 0.0905982106924057
) O 0 0.003783692140132189
of O 0 0.003356281667947769
the O 0 0.007519600447267294
APC B-Disease 1 0.999505877494812
gene O 0 0.009104430675506592
for O 0 0.005779925733804703
germ O 1 0.9999997615814209
- O 0 0.13379281759262085
line O 0 0.014772438444197178
variants O 0 0.01895618997514248
. O 0 0.0077972374856472015

Three O 0 0.011514062993228436
patients O 0 0.02843927964568138
with O 0 0.0041267466731369495
the O 0 0.010949833318591118
I1307K O 1 0.997312068939209
allele O 0 0.01566869206726551
were O 0 0.0025935436133295298
detected O 0 0.0071877967566251755
, O 0 0.0019524734234437346
each O 0 0.0014103357680141926
of O 0 0.00611306494101882
Ashkenazi O 1 0.9990395903587341
descent O 0 0.0500863641500473
. O 0 0.017956888303160667

Four O 0 0.011928238905966282
patients O 0 0.07706212252378464
had O 0 0.006478318013250828
a O 0 0.01229711901396513
germ O 1 0.9999997615814209
- O 0 0.04665089771151543
line O 0 0.0140014523640275
E1317Q O 0 0.07498599588871002
missense O 0 0.042618729174137115
variant O 0 0.03347138687968254
of O 0 0.012550746090710163
APC O 1 0.9999991655349731
that O 0 0.0024858994875103235
was O 0 0.005211629904806614
not O 0 0.0010463108774274588
present O 0 0.0025283510331064463
in O 0 0.00278285495005548
controls O 0 0.006474148482084274
; O 0 0.002182147465646267
one O 0 0.0013693396467715502
of O 0 0.002128222258761525
these O 0 0.0013361374149098992
individuals O 0 0.0013704618904739618
had O 0 0.002528740791603923
an O 0 0.002282736822962761
unusually O 0 0.008533285930752754
large O 0 0.00225173681974411
number O 0 0.0020633081439882517
of O 0 0.006357567384839058
metaplastic B-Disease 1 0.9999977350234985
polyps I-Disease 1 0.999698281288147
of I-Disease 0 0.015320713631808758
the I-Disease 0 0.02476559206843376
colorectum I-Disease 1 0.999993085861206
. O 0 0.01366358157247305

There O 0 0.008431646972894669
is O 0 0.0035544743295758963
increasing O 0 0.003632997628301382
evidence O 0 0.003023614641278982
that O 0 0.0011685247300192714
there O 0 0.0017580854473635554
exist O 0 0.005989509634673595
germ O 1 0.9999548196792603
- O 0 0.019210688769817352
line O 0 0.006973545998334885
variants O 0 0.005103908944875002
of O 0 0.003916471730917692
the O 0 0.010630141012370586
APC B-Disease 1 0.9999735355377197
gene O 0 0.008477848954498768
that O 0 0.0017861758824437857
predispose O 0 0.015461178496479988
to O 0 0.0015631603309884667
the O 0 0.0026409716811031103
development O 0 0.004636451601982117
of O 0 0.009933932684361935
multiple O 1 0.9999995231628418
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 1 0.8406831622123718
but O 0 0.0024730439763516188
without O 0 0.001893357140943408
the O 0 0.004819227382540703
florid O 1 0.9041624069213867
phenotype O 0 0.021328698843717575
of O 0 0.008449932560324669
classical O 0 0.3915785253047943
FAP B-Disease 1 1.0
, O 0 0.005273694172501564
and O 0 0.0017589946510270238
possibly O 0 0.003701884998008609
with O 0 0.001430623815394938
importance O 0 0.016253912821412086
for O 1 0.9673780202865601
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9999996423721313
in O 0 0.006341550499200821
the O 0 0.0045443251729011536
general O 0 0.008522641845047474
population O 0 0.003606170415878296
. O 0 0.002389949979260564
. O 0 0.005386076867580414

Genomic O 0 0.03189140558242798
structure O 0 0.007805605418980122
of O 0 0.004332196898758411
the O 0 0.01008811965584755
human O 1 0.9998921155929565
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 0 0.03326265513896942
gene O 0 0.01294826902449131
. O 0 0.005767428316175938

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 0 0.019999992102384567
is O 0 0.003658782225102186
caused O 0 0.0064796810038387775
by O 0 0.0016530046705156565
mutations O 0 0.003685791278257966
in O 0 0.0020801755599677563
a O 0 0.003424005350098014
gene O 0 0.0036776976194232702
which O 0 0.0013846508227288723
encodes O 0 0.010694150812923908
an O 0 0.006312812212854624
intestinal O 1 1.0
anion O 1 1.0
transporter O 1 0.9999986886978149
. O 0 0.019920766353607178

We O 0 0.00616481015458703
report O 0 0.004612211603671312
here O 0 0.002692427020519972
the O 0 0.002427934668958187
complete O 0 0.005789096001535654
genomic O 0 0.012986077927052975
organization O 0 0.0038596107624471188
of O 0 0.003251476213335991
the O 0 0.007311597932130098
human O 0 0.025176038965582848
CLD B-Disease 1 1.0
gene O 0 0.01195917185395956
which O 0 0.002975974464789033
spans O 0 0.016776960343122482
approximately O 0 0.008921614848077297
39kb O 1 0.690295398235321
, O 0 0.004186885431408882
and O 0 0.003661789232864976
comprises O 0 0.022838691249489784
21 O 0 0.0262456052005291
exons O 0 0.060866810381412506
. O 0 0.011762740090489388

All O 0 0.017896346747875214
exon O 0 0.3327845335006714
/ O 0 0.1400706171989441
intron O 0 0.12793101370334625
boundaries O 0 0.006356780417263508
conform O 0 0.010306299664080143
to O 0 0.004105022177100182
the O 0 0.014584057964384556
GT O 1 0.9999991655349731
/ O 1 0.9999938011169434
AG O 1 0.9999997615814209
rule O 0 0.031936366111040115
. O 0 0.015689793974161148

An O 0 0.005693794693797827
analysis O 0 0.0037682445254176855
of O 0 0.00428455276414752
the O 0 0.009237013757228851
putative O 0 0.3497125208377838
promoter O 0 0.3451504707336426
region O 0 0.011331786401569843
sequence O 0 0.0056510670110583305
shows O 0 0.004301830194890499
a O 0 0.0062826164066791534
putative O 1 0.9615721106529236
TATA O 1 0.9999994039535522
box O 0 0.03044527769088745
and O 0 0.005712105892598629
predicts O 0 0.034912385046482086
multiple O 0 0.012544932775199413
transcription O 0 0.03245997801423073
factor O 0 0.015167849138379097
binding O 0 0.005764150060713291
sites O 0 0.00798244308680296
. O 0 0.007700535003095865

The O 0 0.01830292120575905
genomic O 0 0.033787548542022705
structure O 0 0.010535059496760368
was O 0 0.006769510451704264
determined O 0 0.004224099218845367
using O 0 0.0015976493014022708
DNA O 0 0.003367758123204112
from O 0 0.0007405013311654329
several O 0 0.0007158815860748291
sources O 0 0.0017606901237741113
including O 0 0.001447336282581091
multiple O 0 0.005061312112957239
large O 0 0.007580013480037451
- O 0 0.048138778656721115
insert O 0 0.06790468096733093
libaries O 0 0.0684332475066185
and O 0 0.004201208706945181
genomic O 0 0.02017666958272457
DNA O 0 0.011053192429244518
from O 0 0.006627506110817194
Finnish O 1 0.9999092817306519
CLD B-Disease 1 1.0
patients O 1 0.9999963045120239
and O 0 0.010356225073337555
controls O 0 0.025715133175253868
. O 0 0.01267731562256813

Exon O 1 0.5277301669120789
- O 0 0.03373720869421959
specific O 0 0.006424427963793278
primers O 0 0.04125738888978958
developed O 0 0.006552524399012327
in O 0 0.0022064880467951298
this O 0 0.0012938552536070347
study O 0 0.003260662080720067
will O 0 0.0016438107704743743
facilitate O 0 0.00694351876154542
mutation O 0 0.005999704357236624
screening O 0 0.00694696931168437
studies O 0 0.0034892356488853693
of O 0 0.00438925763592124
patients O 1 0.9875613451004028
with O 0 0.004330354742705822
the O 0 0.10351590067148209
disease O 1 1.0
. O 0 0.02337862364947796

Genomic O 0 0.04076077789068222
sequencing O 0 0.013391205109655857
of O 0 0.0059701623395085335
a O 0 0.01588546112179756
BAC O 1 1.0
clone O 1 0.9999657869338989
H O 1 0.9999978542327881
_ O 0 0.011754022911190987
RG364P16 O 0 0.07531260699033737
revealed O 0 0.014924648217856884
the O 0 0.004231911152601242
presence O 0 0.004141299054026604
of O 0 0.003428257768973708
another O 0 0.005719075445085764
, O 0 0.003617578651756048
highly O 0 0.00782370287925005
homologous O 0 0.01999129354953766
gene O 0 0.005709868855774403
3 O 0 0.005211881827563047
of O 0 0.004081324674189091
the O 0 0.013762317597866058
CLD B-Disease 1 1.0
gene O 0 0.009547996334731579
, O 0 0.0018837004899978638
with O 0 0.0009353693458251655
a O 0 0.002276194281876087
similar O 0 0.0027310485020279884
genomic O 0 0.01440040860325098
structure O 0 0.0056524635292589664
, O 0 0.0017813805025070906
recently O 0 0.004518977366387844
identified O 0 0.003995832987129688
as O 0 0.002733929082751274
the O 0 0.010879257693886757
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 1 0.9994762539863586
( O 1 0.7315137982368469
PDS B-Disease 1 1.0
) O 0 0.010707598179578781
. O 0 0.004756617359817028
. O 0 0.007314364425837994

The O 0 0.02996532805263996
APCI1307K O 1 0.9999996423721313
allele O 0 0.04063143581151962
and O 0 0.008958040736615658
cancer B-Disease 1 1.0
risk O 0 0.031161073595285416
in O 0 0.004607037175446749
a O 0 0.004715531133115292
community O 0 0.005202509928494692
- O 0 0.006937301252037287
based O 0 0.0021098963916301727
study O 0 0.003486706642434001
of O 0 0.005663570016622543
Ashkenazi O 1 0.9718841314315796
Jews O 0 0.03828407824039459
. O 0 0.017453260719776154

Mutations O 0 0.03061050735414028
in O 0 0.009844839572906494
APC O 1 0.9989232420921326
are O 0 0.00240912358276546
classically O 0 0.029669135808944702
associated O 0 0.006349592469632626
with O 0 0.006392293144017458
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 1.0
FAP B-Disease 1 1.0
) O 0 0.008803659118711948
, O 0 0.002119236160069704
a O 0 0.0033972435630857944
highly O 0 0.015338268131017685
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 1.0
by O 1 0.703285276889801
multiple O 1 1.0
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 1 0.9794588685035706
, O 0 0.008937802165746689
without O 0 0.005170193035155535
surgical O 1 1.0
intervention O 1 0.9840587973594666
, O 0 0.0026529356837272644
the O 0 0.002582026179879904
development O 0 0.0054823365062475204
of O 0 0.024322660639882088
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 1.0
CRC B-Disease 1 1.0
) O 0 0.014575083740055561
. O 0 0.00680047832429409

APC B-Disease 1 0.9994930028915405
is O 0 0.010589171200990677
a O 0 0.01880129799246788
tumour O 1 1.0
- O 1 0.9999587535858154
suppressor O 1 0.9818834066390991
gene O 0 0.009046914987266064
, O 0 0.0030685458332300186
and O 0 0.003971160855144262
somatic O 0 0.11457230895757675
loss O 0 0.18598951399326324
occurs O 0 0.014245755970478058
in O 0 0.017815249040722847
tumours B-Disease 1 1.0
. O 0 0.022874953225255013

The O 0 0.038469843566417694
germline O 1 0.9999563694000244
T O 1 0.9999946355819702
- O 0 0.021674595773220062
to O 0 0.00526467664167285
- O 0 0.012392126955091953
A O 0 0.009763279929757118
transversion O 0 0.05970679968595505
responsible O 0 0.007143864408135414
for O 0 0.0036341436207294464
the O 0 0.011582033708691597
APC O 1 0.9999830722808838
I1307K O 1 0.9840785264968872
allele O 0 0.0174050685018301
converts O 0 0.006583556067198515
the O 0 0.0037419539876282215
wild O 0 0.009045923128724098
- O 0 0.00949595496058464
type O 0 0.006134852301329374
sequence O 0 0.003115683561190963
to O 0 0.0017474920023232698
a O 0 0.0060341255739331245
homopolymer O 1 0.9999984502792358
tract O 1 1.0
( O 1 0.9974966645240784
A8 O 1 1.0
) O 0 0.005438219755887985
that O 0 0.0015479825669899583
is O 0 0.0030593040864914656
genetically O 0 0.010607021860778332
unstable O 0 0.24341164529323578
and O 0 0.005606010090559721
prone O 1 0.8163828253746033
to O 0 0.013382802717387676
somatic O 1 0.9990615248680115
mutation O 0 0.02796238102018833
. O 0 0.010159583762288094

The O 0 0.02485037036240101
I1307K O 1 0.9607784748077393
allele O 0 0.024592071771621704
was O 0 0.006861639209091663
found O 0 0.004099606070667505
in O 0 0.005313878413289785
6 O 0 0.023218493908643723
. O 0 0.011688237078487873

1 O 0 0.02297864481806755
% O 0 0.006064447108656168
of O 0 0.007611915003508329
unselected O 1 0.9998596906661987
Ashkenazi O 1 0.9995952248573303
Jews O 0 0.021884022280573845
and O 0 0.005217328201979399
higher O 0 0.009336812421679497
proportions O 0 0.019603131338953972
of O 0 0.007802101783454418
Ashkenazim O 1 0.6305904984474182
with O 0 0.003596321679651737
family O 0 0.008840391412377357
or O 0 0.003684427123516798
personal O 0 0.010101724416017532
histories O 0 0.2366458922624588
of O 1 0.9305455088615417
CRC B-Disease 1 1.0
( O 0 0.13958436250686646
ref O 1 0.9957161545753479
. O 0 0.003870659042149782
2 O 0 0.010765386745333672
) O 0 0.006240333896130323
. O 0 0.005623768083751202

To O 0 0.0072168693877756596
evaluate O 0 0.013981330208480358
the O 0 0.004293563775718212
role O 0 0.007091578561812639
of O 0 0.007222738116979599
I1307K O 1 0.9999932050704956
in O 0 0.013099863193929195
cancer B-Disease 1 0.9999998807907104
, O 0 0.00579578522592783
we O 0 0.0035422893706709146
genotyped O 0 0.07448036223649979
5 O 0 0.01034556608647108
, O 0 0.006470257416367531
081 O 1 0.9994507431983948
Ashkenazi O 1 0.6926754713058472
volunteers O 0 0.01975862681865692
in O 0 0.0038054734468460083
a O 0 0.004886509384959936
community O 0 0.007888717576861382
survey O 0 0.01414948608726263
. O 0 0.009590845555067062

Risk O 0 0.032730862498283386
of O 0 0.0169228445738554
developing O 1 0.9999746084213257
colorectal B-Disease 1 1.0
, I-Disease 1 0.999982476234436
breast I-Disease 1 1.0
and I-Disease 0 0.007460237480700016
other I-Disease 0 0.004768451675772667
cancers I-Disease 1 0.9998358488082886
were O 0 0.003930546343326569
compared O 0 0.006760193035006523
between O 0 0.007029286585748196
genotyped O 1 0.9999228715896606
I1307K O 1 0.9996763467788696
carriers O 0 0.015292597003281116
and O 0 0.004223347641527653
non O 0 0.01944902539253235
- O 0 0.017592625692486763
carriers O 0 0.005749943666160107
and O 0 0.0014705263311043382
their O 0 0.0016881298506632447
first O 0 0.006550854537636042
- O 0 0.01642768271267414
degree O 0 0.0145333930850029
relatives O 0 0.024722615256905556
. O 0 0.009949468076229095

Sperm O 0 0.027542080730199814
DNA O 0 0.009824310429394245
analysis O 0 0.003297359449788928
in O 0 0.0031863024923950434
a O 0 0.011281806044280529
Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
premutation O 1 0.9999998807907104
carrier O 0 0.28292232751846313
suggests O 0 0.014498877339065075
both O 0 0.004968810826539993
meiotic O 1 0.9999678134918213
and O 0 0.0072714295238256454
mitotic O 1 0.9891123175621033
expansion O 0 0.010678613558411598
in O 0 0.004459845833480358
the O 0 0.009791945107281208
FRDA B-Disease 1 0.9999980926513672
gene O 0 0.01962050423026085
. O 0 0.007256787735968828

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 0.022748172283172607
usually O 0 0.0076864250004291534
caused O 0 0.008806516416370869
by O 0 0.0015462655574083328
an O 0 0.002115435665473342
expansion O 0 0.006367234513163567
of O 0 0.004642440937459469
a O 0 0.010806845501065254
GAA O 1 0.9683972001075745
trinucleotide O 1 0.9868034720420837
repeat O 0 0.026153383776545525
in O 0 0.007521401159465313
intron O 0 0.3291141390800476
1 O 0 0.009677670896053314
of O 0 0.004169561434537172
the O 0 0.010540925897657871
FRDA B-Disease 1 0.9999998807907104
gene O 0 0.020379388704895973
. O 0 0.007566928397864103

Occasionally O 0 0.018632203340530396
, O 0 0.005309675820171833
a O 0 0.005697397515177727
fully O 0 0.01112465187907219
expanded O 0 0.01076469011604786
allele O 0 0.012139132246375084
has O 0 0.002368788467720151
been O 0 0.0017083577113226056
found O 0 0.0021843495778739452
to O 0 0.002000808482989669
arise O 0 0.005355093162506819
from O 0 0.003399711335077882
a O 0 0.0061607155948877335
premutation O 1 0.8696081638336182
of O 0 0.008918250910937786
100 O 0 0.0101670753210783
or O 0 0.004405745770782232
less O 0 0.00661345012485981
triplet O 1 0.6320063471794128
repeats O 0 0.05913638696074486
. O 0 0.012970606796443462

We O 0 0.006230662576854229
have O 0 0.001825526705943048
examined O 0 0.011431518010795116
the O 0 0.005890733562409878
sperm O 0 0.009047484025359154
DNA O 0 0.005360625684261322
of O 0 0.0038647218607366085
a O 0 0.009491145610809326
premutation O 1 0.9987448453903198
carrier O 0 0.046929579228162766
. O 0 0.012478090822696686

This O 0 0.012802289798855782
mans O 0 0.1213201954960823
leucocyte O 1 0.748831570148468
DNA O 0 0.017723610624670982
showed O 0 0.008797568269073963
one O 0 0.0037047804798930883
normal O 0 0.007954352535307407
allele O 0 0.00771706597879529
and O 0 0.0017379928613081574
one O 0 0.002841636771336198
allele O 0 0.007627822458744049
of O 0 0.0035385971423238516
approximately O 0 0.008294971659779549
100 O 0 0.013937205076217651
repeats O 0 0.039877697825431824
. O 0 0.010960915125906467

His O 0 0.03134622052311897
sperm O 0 0.02007279358804226
showed O 0 0.008170833811163902
an O 0 0.0026473598554730415
expanded O 0 0.008368819952011108
allele O 0 0.009503156878054142
in O 0 0.0024102358147501945
a O 0 0.004013345576822758
tight O 0 0.00902614276856184
range O 0 0.0034251511096954346
centering O 0 0.014489328488707542
on O 0 0.0029977457597851753
a O 0 0.002579751890152693
size O 0 0.0029554821085184813
of O 0 0.003615007968619466
approximately O 0 0.010834213346242905
320 O 0 0.052197545766830444
trinucleotide O 1 0.9993867874145508
repeats O 0 0.0717492625117302
. O 0 0.012876717373728752

His O 0 0.03436465561389923
affected O 0 0.03514854237437248
son O 1 0.9976525902748108
has O 0 0.006673136726021767
repeat O 0 0.022327158600091934
sizes O 0 0.009579095058143139
of O 0 0.009105170145630836
1040 O 1 0.9946883916854858
and O 0 0.011256390251219273
540 O 0 0.08441300690174103
. O 0 0.013398873619735241

These O 0 0.005700840149074793
data O 0 0.004184457007795572
suggest O 0 0.00428913626819849
that O 0 0.0014548897743225098
expansion O 0 0.006313326768577099
occurs O 0 0.00306049850769341
in O 0 0.0018084421753883362
two O 0 0.0017258083680644631
stages O 0 0.009378309361636639
, O 0 0.0027127850335091352
the O 0 0.003476931946352124
first O 0 0.0043115136213600636
during O 0 0.007770773023366928
meiosis O 0 0.028979582712054253
followed O 0 0.005298431031405926
by O 0 0.0016476607415825129
a O 0 0.005143138114362955
second O 0 0.014748805202543736
mitotic O 1 0.9952254295349121
expansion O 0 0.031207766383886337
. O 0 0.011300427839159966

We O 0 0.006361415144056082
also O 0 0.0035402013454586267
show O 0 0.003610037500038743
that O 0 0.0007840851903893054
in O 0 0.0011809387942776084
all O 0 0.0010261557763442397
informative O 0 0.010880675166845322
carrier O 0 0.015000276267528534
father O 0 0.011344999074935913
to O 0 0.004138033837080002
affected O 0 0.01194116659462452
child O 1 0.8271353840827942
transmissions O 0 0.015093608759343624
, O 0 0.0020575919188559055
with O 0 0.0011080660624429584
the O 0 0.002864596899598837
notable O 0 0.006175189279019833
exception O 0 0.006970581132918596
of O 0 0.004457355011254549
the O 0 0.009468229487538338
premutation O 1 0.999990701675415
carrier O 0 0.02023635059595108
, O 0 0.0032319040037691593
the O 0 0.00421757809817791
expansion O 0 0.011949460953474045
size O 0 0.009834321215748787
decreases O 0 0.01819263957440853
. O 0 0.0047375806607306
. O 0 0.008287991397082806

The O 0 0.02640731818974018
R496H O 1 0.8024293780326843
mutation O 0 0.016123201698064804
of O 0 0.009710731916129589
arylsulfatase O 1 0.9999617338180542
A O 0 0.016202377155423164
does O 0 0.005243786610662937
not O 0 0.004017296712845564
cause O 0 0.048937708139419556
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 0.04045672342181206

Deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.036646824330091476
arylsulfatase I-Disease 1 0.999997615814209
A I-Disease 0 0.22948132455348969
( O 0 0.034303754568099976
ARSA O 1 1.0
) O 0 0.00890411902219057
enzyme O 0 0.010978241451084614
activity O 0 0.007240834180265665
causes O 0 0.06611864268779755
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9999849796295166
MLD B-Disease 1 1.0
) O 0 0.018320443108677864
. O 0 0.009516199119389057

A O 0 0.014210224151611328
number O 0 0.005573493894189596
of O 0 0.013281021267175674
ARSA O 1 1.0
gene O 0 0.020822515711188316
mutations O 0 0.009975015185773373
responsible O 0 0.010326961986720562
for O 0 0.009494084864854813
MLD B-Disease 1 1.0
have O 0 0.003707238705828786
been O 0 0.004492294043302536
identified O 0 0.010715167969465256
. O 0 0.00755592854693532

Recently O 0 0.02112116850912571
, O 0 0.00460053002461791
the O 0 0.007128653582185507
R496H O 1 0.8548822402954102
mutation O 0 0.013772030360996723
of O 0 0.009524213150143623
ARSA O 1 1.0
was O 0 0.011128650046885014
proposed O 0 0.0031563204247504473
to O 0 0.0011917701922357082
be O 0 0.0007321540033444762
a O 0 0.002636040560901165
cause O 0 0.009048241190612316
of O 0 0.020602019503712654
MLD B-Disease 1 1.0
( O 0 0.16518831253051758
Draghia O 1 0.9999938011169434
et O 1 0.9992684721946716
al O 0 0.026224493980407715
. O 0 0.002084346953779459
, O 0 0.003262630896642804
1997 O 0 0.013885893858969212
) O 0 0.008186283521354198
. O 0 0.007213579956442118

We O 0 0.004966668784618378
have O 0 0.0019453050335869193
investigated O 0 0.013141093775629997
the O 0 0.010255792178213596
R496H O 1 0.9997842907905579
mutation O 0 0.012479640543460846
and O 0 0.002266618888825178
found O 0 0.0030734874308109283
this O 0 0.0018588665407150984
mutation O 0 0.005894862115383148
at O 0 0.0042534638196229935
a O 0 0.003164546797052026
relatively O 0 0.004046626389026642
high O 0 0.005269438493996859
frequency O 0 0.0020751175470650196
in O 0 0.0011112653883174062
an O 0 0.001594966510310769
African O 0 0.006238456815481186
American O 0 0.005419731140136719
population O 0 0.003244892694056034
( O 0 0.005791632458567619
f O 0 0.018347732722759247
= O 0 0.01807158999145031
0 O 0 0.008162315003573895
. O 0 0.0024462989531457424
09 O 0 0.040726784616708755
, O 0 0.005444962996989489
n O 0 0.02185055986046791
= O 0 0.026105521246790886
61 O 0 0.02032960020005703
subjects O 0 0.02021501213312149
) O 0 0.011262154206633568
. O 0 0.009320041164755821

The O 0 0.05497226119041443
ARSA O 1 0.9999998807907104
enzyme O 0 0.024904442951083183
activity O 0 0.0049843271262943745
in O 0 0.002767627127468586
subjects O 0 0.006273227743804455
with O 0 0.0014375026803463697
and O 0 0.0021385084837675095
without O 0 0.002171879168599844
the O 0 0.006485791876912117
R496H O 1 0.9998865127563477
mutation O 0 0.010995210148394108
was O 0 0.005975966341793537
determined O 0 0.004830996505916119
and O 0 0.0014307056553661823
found O 0 0.002886235946789384
to O 0 0.0027331493329256773
be O 0 0.0034067656379193068
normal O 0 0.011588281951844692
. O 0 0.008174901828169823

It O 0 0.005803203675895929
is O 0 0.003854744601994753
therefore O 0 0.004019229672849178
concluded O 0 0.007607412990182638
that O 0 0.0016173874028027058
the O 0 0.005324975121766329
R496H O 1 0.9222714900970459
mutation O 0 0.018479885533452034
of O 0 0.014989641495049
ARSA O 1 1.0
does O 0 0.006331002805382013
not O 0 0.0021236813627183437
negatively O 0 0.005533729214221239
influence O 0 0.004034535493701696
the O 0 0.004239785019308329
activity O 0 0.0053034997545182705
of O 0 0.010703528299927711
ARSA O 1 1.0
and O 0 0.005180405452847481
is O 0 0.0034730741754174232
not O 0 0.0015307829016819596
a O 0 0.004706770647317171
cause O 0 0.021686965599656105
of O 0 0.19474388659000397
MLD B-Disease 1 1.0

Down O 0 0.0439632423222065
- O 0 0.021828893572092056
regulation O 0 0.00814295094460249
of O 0 0.007818714715540409
transmembrane O 1 0.5584688186645508
carbonic O 1 0.9986967444419861
anhydrases O 1 0.9999573230743408
in O 0 0.14210191369056702
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9947187900543213
lines O 0 0.006367090158164501
by O 0 0.0016238867538049817
wild O 0 0.009663497097790241
- O 0 0.01920059509575367
type O 0 0.02417416125535965
von B-Disease 1 0.9920658469200134
Hippel I-Disease 1 0.9999992847442627
- I-Disease 1 0.9992181062698364
Lindau I-Disease 1 0.9999973773956299
transgenes O 1 0.9694352746009827
. O 0 0.022274041548371315

To O 0 0.009717493318021297
discover O 0 0.020466841757297516
genes O 0 0.005399826914072037
involved O 0 0.0033562176395207644
in O 0 0.005029079504311085
von B-Disease 1 0.9970929622650146
Hippel I-Disease 1 0.9999998807907104
- I-Disease 1 0.9998928308486938
Lindau I-Disease 1 1.0
( O 0 0.0331159383058548
VHL B-Disease 1 1.0
) O 0 0.012760365381836891
- O 0 0.019005849957466125
mediated O 0 0.025391528382897377
carcinogenesis O 1 0.9999912977218628
, O 0 0.0041823117062449455
we O 0 0.002932954113930464
used O 0 0.010301943868398666
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.999985933303833
lines O 0 0.01977456547319889
stably O 0 0.10044477134943008
transfected O 0 0.05572819337248802
with O 0 0.002877997700124979
wild O 0 0.012501203455030918
- O 0 0.03127751499414444
type O 0 0.056014735251665115
VHL O 1 1.0
- O 0 0.0908738449215889
expressing O 0 0.05566197633743286
transgenes O 0 0.497414767742157
. O 0 0.01793629862368107

Large O 0 0.024382106959819794
- O 0 0.035388022661209106
scale O 0 0.019917329773306847
RNA O 0 0.027366891503334045
differential O 0 0.017642131075263023
display O 0 0.0102925356477499
technology O 0 0.0057942527346313
applied O 0 0.0042877946980297565
to O 0 0.0017316690646111965
these O 0 0.0013293850934132934
cell O 0 0.006654498167335987
lines O 0 0.0038327258080244064
identified O 0 0.00371139426715672
several O 0 0.002170006511732936
differentially O 0 0.025866711512207985
expressed O 0 0.0059791081584990025
genes O 0 0.0040236362256109715
, O 0 0.0014915341744199395
including O 0 0.0021502054296433926
an O 0 0.005277102347463369
alpha O 0 0.050909142941236496
carbonic O 1 0.915692925453186
anhydrase O 1 0.999377429485321
gene O 0 0.019300203770399094
, O 0 0.007462914567440748
termed O 0 0.12535825371742249
CA12 O 1 0.9999980926513672
. O 0 0.022565146908164024

The O 0 0.021722298115491867
deduced O 0 0.038983557373285294
protein O 0 0.010619625449180603
sequence O 0 0.005172042176127434
was O 0 0.005643058568239212
classified O 0 0.00793954823166132
as O 0 0.0023956832010298967
a O 0 0.0044836788438260555
one O 0 0.0056555247865617275
- O 0 0.017264463007450104
pass O 0 0.010978396050632
transmembrane O 0 0.06864073127508163
CA O 0 0.025484465062618256
possessing O 0 0.013595808297395706
an O 0 0.005120623391121626
apparently O 0 0.014691127464175224
intact O 0 0.024567270651459694
catalytic O 0 0.019523249939084053
domain O 0 0.008119480684399605
in O 0 0.004525193013250828
the O 0 0.010485459119081497
extracellular O 0 0.21806365251541138
CA O 1 0.8749562501907349
module O 0 0.0760665163397789
. O 0 0.013253018260002136

Reintroduced O 0 0.08876025676727295
wild O 0 0.03967564180493355
- O 0 0.05634825676679611
type O 0 0.05962958559393883
VHL B-Disease 1 0.9999991655349731
strongly O 0 0.015681833028793335
inhibited O 0 0.019870081916451454
the O 0 0.0048999059945344925
overexpression O 0 0.020085975527763367
of O 0 0.004824513103812933
the O 0 0.0080695990473032
CA12 O 1 0.9999991655349731
gene O 0 0.004933954682201147
in O 0 0.002145361388102174
the O 0 0.0064750961028039455
parental O 1 0.9977514147758484
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999946355819702
lines O 0 0.022723950445652008
. O 0 0.010253913700580597

Similar O 0 0.0095880888402462
results O 0 0.005446404684334993
were O 0 0.0025349038187414408
obtained O 0 0.005123264621943235
with O 0 0.004564746282994747
CA9 O 1 0.9999998807907104
, O 0 0.008238598704338074
encoding O 0 0.014280449599027634
another O 0 0.009586440399289131
transmembrane O 0 0.05017287656664848
CA O 0 0.018926676362752914
with O 0 0.0022155705373734236
an O 0 0.005066145211458206
intact O 0 0.033500999212265015
catalytic O 0 0.031970422714948654
domain O 0 0.0225993525236845
. O 0 0.009519563987851143

Although O 0 0.007036749739199877
both O 0 0.003207957139238715
domains O 0 0.011096936650574207
of O 0 0.008799073286354542
the O 0 0.025154786184430122
VHL B-Disease 1 1.0
protein O 0 0.013609269633889198
contribute O 0 0.005169173236936331
to O 0 0.002168285194784403
regulation O 0 0.006073479540646076
of O 0 0.007530255243182182
CA12 O 1 0.9999994039535522
expression O 0 0.011850273236632347
, O 0 0.005133738741278648
the O 0 0.007886330597102642
elongin O 0 0.46208620071411133
binding O 0 0.007392992731183767
domain O 0 0.008400099352002144
alone O 0 0.006792363710701466
could O 0 0.00393341388553381
effectively O 0 0.018324892967939377
regulate O 0 0.04895902797579765
CA9 O 1 0.9999988079071045
expression O 0 0.037419382482767105
. O 0 0.016929499804973602

We O 0 0.013210209086537361
mapped O 0 0.03958062827587128
CA12 O 1 0.9998565912246704
and O 0 0.015366898849606514
CA9 O 1 1.0
loci O 0 0.08144484460353851
to O 0 0.008274911902844906
chromosome O 0 0.026112940162420273
bands O 0 0.017587080597877502
15q22 O 1 0.9996265172958374
and O 0 0.011021534912288189
17q21 O 1 0.9995881915092468
. O 0 0.017378032207489014

2 O 0 0.027349982410669327
respectively O 0 0.015222079120576382
, O 0 0.005547607317566872
regions O 0 0.008718259632587433
prone O 0 0.031491898000240326
to O 0 0.0056799305602908134
amplification O 0 0.01734171435236931
in O 0 0.0039505744352936745
some O 0 0.0039060942362993956
human O 0 0.020302262157201767
cancers B-Disease 1 0.9999990463256836
. O 0 0.019937563687562943

Additional O 0 0.01440448872745037
experiments O 0 0.011431259103119373
are O 0 0.0014187981141731143
needed O 0 0.003943521995097399
to O 0 0.001677887630648911
define O 0 0.005622923374176025
the O 0 0.003884474979713559
role O 0 0.007594788912683725
of O 0 0.009958208538591862
CA O 1 0.9999825954437256
IX O 1 1.0
and O 0 0.011325334198772907
CA O 1 0.9967026114463806
XII O 1 0.9999997615814209
enzymes O 0 0.009074659086763859
in O 0 0.0032267330680042505
the O 0 0.004382540937513113
regulation O 0 0.007410810794681311
of O 0 0.006416597869247198
pH O 0 0.03824692592024803
in O 0 0.005330356303602457
the O 0 0.008674295619130135
extracellular O 0 0.0336797721683979
microenvironment O 0 0.07076802104711533
and O 0 0.0027393458876758814
its O 0 0.002632647752761841
potential O 0 0.004836863372474909
impact O 0 0.007566455285996199
on O 0 0.011727742850780487
cancer B-Disease 1 1.0
cell O 1 0.8735591173171997
growth O 0 0.01865621842443943
. O 0 0.00924893468618393

A O 0 0.023959970101714134
gene O 0 0.01251122634857893
encoding O 0 0.007365595083683729
a O 0 0.005420949775725603
transmembrane O 0 0.02936387248337269
protein O 0 0.006281443405896425
is O 0 0.0019065174274146557
mutated O 0 0.007634446024894714
in O 0 0.0034114394802600145
patients O 1 0.9994593262672424
with O 0 0.11796607077121735
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 1.0
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 1 0.9638503193855286
. O 0 0.011509250849485397

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999994039535522
WFS B-Disease 1 1.0
; O 0 0.03464345633983612
OMIM O 1 1.0
222300 O 1 0.9999843835830688
) O 0 0.004737470764666796
is O 0 0.001971739809960127
an O 0 0.003681295784190297
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 1 0.9995330572128296
by O 0 0.0066740792244672775
young O 1 0.9373496174812317
- O 1 0.9934723377227783
onset O 1 1.0
non O 1 0.999954342842102
- O 1 0.9999125003814697
immune O 1 0.9999995231628418
insulin B-Disease 1 1.0
- I-Disease 1 0.999915361404419
dependent I-Disease 1 0.9522144198417664
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 1 0.8010922074317932

Linkage O 0 0.058281101286411285
to O 0 0.007601978722959757
markers O 0 0.03436091169714928
on O 0 0.012976131401956081
chromosome O 0 0.038639724254608154
4p O 1 0.996933102607727
was O 0 0.011437267065048218
confirmed O 0 0.007195245008915663
in O 0 0.0032111438922584057
five O 0 0.004208044148981571
families O 0 0.007896533235907555
. O 0 0.008930004201829433

On O 0 0.0059789810329675674
the O 0 0.0029409355483949184
basis O 0 0.0028465494979172945
of O 0 0.006486542988568544
meiotic O 1 0.9999998807907104
recombinants O 1 1.0
and O 0 0.036964770406484604
disease O 1 1.0
- O 1 0.997194766998291
associated O 0 0.009373695589601994
haplotypes O 0 0.02861073799431324
, O 0 0.004003476817160845
the O 0 0.008771277964115143
WFS B-Disease 1 1.0
gene O 0 0.011701530776917934
was O 0 0.006789951119571924
localized O 0 0.014226604253053665
to O 0 0.004009375814348459
a O 0 0.01360246166586876
BAC O 1 1.0
/ O 1 0.9999639987945557
P1 O 1 0.9999105930328369
contig O 0 0.06542514264583588
of O 0 0.005413806531578302
less O 0 0.00336531363427639
than O 0 0.0025194978807121515
250 O 0 0.01667662523686886
kb O 0 0.24617062509059906
. O 0 0.013052725233137608

Mutations O 0 0.01720636524260044
in O 0 0.003859764663502574
a O 0 0.004830549471080303
novel O 0 0.020534787327051163
gene O 0 0.016277529299259186
( O 0 0.010829281993210316
WFS1 O 1 0.9992189407348633
) O 0 0.006214214954525232
encoding O 0 0.008375224657356739
a O 0 0.006572948768734932
putative O 0 0.05991735681891441
transmembrane O 0 0.05423131212592125
protein O 0 0.009717576205730438
were O 0 0.00215436820872128
found O 0 0.0028685659635812044
in O 0 0.0023468201979994774
all O 0 0.002122927689924836
affected O 0 0.004891571588814259
individuals O 0 0.0016351396916434169
in O 0 0.003838019445538521
six O 0 0.011579861864447594
WFS B-Disease 1 1.0
families O 0 0.008563960902392864
, O 0 0.0025467348750680685
and O 0 0.001715130521915853
these O 0 0.0012786095030605793
mutations O 0 0.004416423849761486
were O 0 0.0014102905988693237
associated O 0 0.0031583511736243963
with O 0 0.0029072309844195843
the O 0 0.15057672560214996
disease O 1 1.0
phenotype O 1 0.9999167919158936
. O 0 0.01687871478497982

WFS1 O 1 0.9999672174453735
appears O 0 0.01566588506102562
to O 0 0.0024005670566111803
function O 0 0.0032885142136365175
in O 0 0.0029177661053836346
survival O 0 0.023226795718073845
of O 0 0.009258490987122059
islet O 1 0.9975317716598511
beta O 1 0.9685187339782715
- O 0 0.24112607538700104
cells O 0 0.01184102427214384
and O 0 0.004349926020950079
neurons O 0 0.015487033873796463
. O 0 0.0040561603382229805
. O 0 0.008995302021503448

Stable O 0 0.04229997470974922
interaction O 0 0.005666244775056839
between O 0 0.00272696977481246
the O 0 0.0032581835985183716
products O 0 0.004515116102993488
of O 0 0.004633182659745216
the O 0 0.013232355937361717
BRCA1 O 1 0.9999997615814209
and O 0 0.01319896336644888
BRCA2 O 1 1.0
tumor B-Disease 1 1.0
suppressor O 1 0.9996693134307861
genes O 0 0.008440069854259491
in O 0 0.005678656976670027
mitotic O 1 0.835782527923584
and O 0 0.011358270421624184
meiotic O 1 0.9999992847442627
cells O 0 0.04221983253955841
. O 0 0.01246972568333149

BRCA1 O 1 0.9999909400939941
and O 0 0.014700097031891346
BRCA2 O 1 0.9998637437820435
account O 0 0.005244911648333073
for O 0 0.0018912876257672906
most O 0 0.0015661295037716627
cases O 0 0.002893512835726142
of O 0 0.004907189402729273
familial O 1 0.9999998807907104
, O 0 0.007959486916661263
early O 0 0.04211542010307312
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9947147965431213
/ I-Disease 1 1.0
or I-Disease 1 0.9985201954841614
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.8990214467048645
encode O 0 0.0162496455013752
products O 0 0.004736501257866621
that O 0 0.001046883873641491
each O 0 0.0012793426867574453
interact O 0 0.004140291828662157
with O 0 0.0037105053197592497
hRAD51 O 1 0.9983647465705872
. O 0 0.016337722539901733

Results O 0 0.012743893079459667
presented O 0 0.009302465245127678
here O 0 0.004576822277158499
show O 0 0.005358650349080563
that O 0 0.0031253360211849213
BRCA1 O 1 0.9997556805610657
and O 0 0.006326364818960428
BRCA2 O 1 0.9999939203262329
coexist O 0 0.015340869314968586
in O 0 0.0037054517306387424
a O 0 0.005224653985351324
biochemical O 0 0.017664607614278793
complex O 0 0.011517498642206192
and O 0 0.004229418002068996
colocalize O 1 0.9937352538108826
in O 0 0.008085109293460846
subnuclear O 1 0.9994770884513855
foci O 1 0.9544579982757568
in O 0 0.009583374485373497
somatic O 0 0.3890000879764557
cells O 0 0.007170150522142649
and O 0 0.001426429720595479
on O 0 0.0028958197217434645
the O 0 0.003836142597720027
axial O 0 0.015084050595760345
elements O 0 0.00533131742849946
of O 0 0.00892733410000801
developing O 0 0.039429403841495514
synaptonemal O 1 0.9999145269393921
complexes O 0 0.08641363680362701
. O 0 0.01583242043852806

Like O 0 0.036503784358501434
BRCA1 O 1 0.9999375343322754
and O 0 0.019026579335331917
RAD51 O 1 0.9999998807907104
, O 0 0.01929882913827896
BRCA2 O 1 0.9999485015869141
relocates O 1 0.6086513996124268
to O 0 0.01614644192159176
PCNA O 1 0.9999581575393677
+ O 0 0.047494180500507355
replication O 0 0.017012782394886017
sites O 0 0.003609870094805956
following O 0 0.00437058974057436
exposure O 0 0.014060494489967823
of O 0 0.009909332729876041
S O 1 0.9999890327453613
phase O 0 0.05060598999261856
cells O 0 0.010675673373043537
to O 0 0.0059813447296619415
hydroxyurea O 1 0.9990518689155579
or O 0 0.023772547021508217
UV O 1 0.9999833106994629
irradiation O 0 0.18220655620098114
. O 0 0.013307079672813416

Thus O 0 0.01911291293799877
, O 0 0.01382452342659235
BRCA1 O 1 0.999966025352478
and O 0 0.008608252741396427
BRCA2 O 1 0.9999785423278809
participate O 0 0.006642182357609272
, O 0 0.0024679875932633877
together O 0 0.0017266192007809877
, O 0 0.0017030733870342374
in O 0 0.0026565210428088903
a O 0 0.005388366058468819
pathway O 0 0.02014223486185074
( O 0 0.008865227922797203
s O 0 0.024392182007431984
) O 0 0.003138138446956873
associated O 0 0.0019019226310774684
with O 0 0.0009951788233593106
the O 0 0.0036097699776291847
activation O 0 0.008008250035345554
of O 0 0.005569816567003727
double O 0 0.02323531173169613
- O 0 0.029122833162546158
strand O 0 0.017349060624837875
break O 0 0.012523932382464409
repair O 1 0.9966123700141907
and O 0 0.00824164692312479
/ O 1 0.924206554889679
or O 0 0.010498898103833199
homologous O 0 0.05642576888203621
recombination O 0 0.036598581820726395
. O 0 0.01105643529444933

Dysfunction O 1 1.0
of O 0 0.1057765856385231
this O 0 0.012096213176846504
pathway O 0 0.02877696231007576
may O 0 0.004614471457898617
be O 0 0.001215637312270701
a O 0 0.002798067405819893
general O 0 0.008310376666486263
phenomenon O 0 0.00906884204596281
in O 0 0.00235496973618865
the O 0 0.0021748626604676247
majority O 0 0.0014785988023504615
of O 0 0.0022103639785200357
cases O 0 0.00568482605740428
of O 0 0.019551509991288185
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999936819076538
/ I-Disease 1 1.0
or I-Disease 1 0.9999910593032837
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.39255255460739136
. O 0 0.01113271713256836

A O 0 0.022631267085671425
novel O 0 0.035039022564888
Arg362Ser O 1 0.7171534299850464
mutation O 0 0.009551226161420345
in O 0 0.003275629598647356
the O 0 0.007006763480603695
sterol O 0 0.1382250040769577
27 O 0 0.030793337151408195
- O 0 0.03581054136157036
hydroxylase O 0 0.15677158534526825
gene O 0 0.014294667169451714
( O 0 0.010589206591248512
CYP27 O 1 0.9987497329711914
) O 0 0.004910892806947231
: O 0 0.0027890081983059645
its O 0 0.0018243809463456273
effects O 0 0.00667558703571558
on O 0 0.005429156590253115
pre O 0 0.047631893306970596
- O 0 0.026256922632455826
mRNA O 0 0.017023136839270592
splicing O 0 0.016050461679697037
and O 0 0.004172536078840494
enzyme O 0 0.01640968956053257
activity O 0 0.009042026475071907
. O 0 0.010413896292448044

A O 0 0.023517340421676636
novel O 0 0.030124779790639877
C O 0 0.03269829601049423
to O 0 0.0029617920517921448
A O 0 0.006623528897762299
mutation O 0 0.00584960263222456
in O 0 0.0022378871217370033
the O 0 0.0064968750812113285
sterol O 0 0.3655882179737091
27 O 0 0.024386147037148476
- O 0 0.030888183042407036
hydroxylase O 0 0.19538813829421997
gene O 0 0.014901756308972836
( O 0 0.010960838757455349
CYP27 O 1 0.9995143413543701
) O 0 0.005730670876801014
was O 0 0.005177471786737442
identified O 0 0.0044457511976361275
by O 0 0.0021785933058708906
sequencing O 0 0.01618385687470436
amplified O 0 0.024511903524398804
CYP27 O 1 0.9998016953468323
gene O 0 0.008754204958677292
products O 0 0.003775178687646985
from O 0 0.0023278421722352505
a O 0 0.004230366088449955
patient O 0 0.19763578474521637
with O 0 0.006115699652582407
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 1 0.6555323004722595
CTX B-Disease 1 1.0
) O 0 0.01446134876459837
. O 0 0.009379763156175613

The O 0 0.017930570989847183
mutation O 0 0.016613654792308807
changed O 0 0.010441627353429794
the O 0 0.00889092218130827
adrenodoxin O 1 0.9619247317314148
cofactor O 0 0.13626447319984436
binding O 0 0.01273302547633648
residue O 0 0.04247532784938812
362Arg O 0 0.0719919502735138
to O 0 0.006887406576424837
362Ser O 1 0.9968423843383789
( O 0 0.021024856716394424
CGT O 1 0.9999971389770508
362Arg O 1 0.999321460723877
to O 0 0.016752656549215317
AGT O 1 1.0
362Ser O 1 0.9999994039535522
) O 0 0.005810475908219814
, O 0 0.0018540862947702408
and O 0 0.0016376731218770146
was O 0 0.00594317028298974
responsible O 0 0.01305654551833868
for O 0 0.011122836731374264
deficiency O 1 1.0
in O 0 0.012909737415611744
the O 0 0.024560721591114998
sterol O 1 0.9998200535774231
27 O 0 0.11957480758428574
- O 0 0.07061100751161575
hydroxylase O 0 0.20722165703773499
activity O 0 0.0036570902448147535
, O 0 0.001995421014726162
as O 0 0.0018531951354816556
confirmed O 0 0.003389183897525072
by O 0 0.0010613914346322417
expression O 0 0.003684486960992217
of O 0 0.0056450548581779
mutant O 0 0.033555708825588226
cDNA O 0 0.036103248596191406
into O 0 0.01057870127260685
COS O 1 0.9999998807907104
- O 0 0.058479536324739456
1 O 0 0.02598605304956436
cells O 0 0.014856507070362568
. O 0 0.00807509757578373

Quantitative O 0 0.034222621470689774
analysis O 0 0.006923776585608721
showed O 0 0.005776972975581884
that O 0 0.0011763977818191051
the O 0 0.003060285933315754
expression O 0 0.005690956022590399
of O 0 0.007755845319479704
CYP27 O 1 0.999997615814209
gene O 0 0.00997235905379057
mRNA O 0 0.0056606861762702465
in O 0 0.0016441002953797579
the O 0 0.00338116311468184
patient O 0 0.025511333718895912
represented O 0 0.00923607125878334
52 O 0 0.02653430588543415
. O 0 0.009399025700986385

5 O 0 0.01687505841255188
% O 0 0.004811312071979046
of O 0 0.00379920587874949
the O 0 0.0082256980240345
normal O 0 0.015913886949419975
level O 0 0.01690053567290306
. O 0 0.01015693973749876

As O 0 0.010423294268548489
the O 0 0.008007332682609558
mutation O 0 0.009981685318052769
occurred O 0 0.008403846062719822
at O 0 0.006033997517079115
the O 0 0.0053549520671367645
penultimate O 0 0.4161122739315033
nucleotide O 0 0.011061608791351318
of O 0 0.005181394051760435
exon O 0 0.04036659747362137
6 O 0 0.01376382540911436
( O 0 0.006118932273238897
- O 0 0.007649293635040522
2 O 0 0.0048349155113101006
position O 0 0.00417425436899066
of O 0 0.005034401081502438
exon O 0 0.0557158961892128
6 O 0 0.02689817175269127
- O 0 0.026718879118561745
intron O 1 0.5516909956932068
6 O 0 0.018820876255631447
splice O 0 0.041001323610544205
site O 0 0.009227767586708069
) O 0 0.002472592517733574
of O 0 0.0026681162416934967
the O 0 0.005524766631424427
gene O 0 0.007586713880300522
, O 0 0.00244199950248003
we O 0 0.0015722002135589719
hypothesized O 0 0.009595144540071487
that O 0 0.0014252102700993419
the O 0 0.004918868653476238
mutation O 0 0.011875912547111511
may O 0 0.006777630187571049
partially O 0 0.01693362183868885
affect O 0 0.005753722973167896
the O 0 0.005073589738458395
normal O 0 0.01091444306075573
splicing O 0 0.017433423548936844
efficiency O 0 0.011458201333880424
in O 0 0.004811207298189402
exon O 0 0.04240280017256737
6 O 0 0.013478289358317852
and O 0 0.003664896124973893
cause O 0 0.013411764986813068
alternative O 0 0.015042162500321865
splicing O 0 0.02007162757217884
elsewhere O 0 0.005694724153727293
, O 0 0.0022430315148085356
which O 0 0.0018152515403926373
resulted O 0 0.007148485165089369
in O 0 0.006036260165274143
decreased O 0 0.023933496326208115
transcript O 0 0.021409954875707626
in O 0 0.0047025419771671295
the O 0 0.009782744571566582
patient O 1 0.9963721036911011
. O 0 0.013036947697401047

Transfection O 1 0.9472978711128235
of O 0 0.016836749389767647
constructed O 0 0.4178105294704437
minigenes O 1 0.9991253018379211
, O 0 0.0034856628626585007
with O 0 0.0016514880117028952
or O 0 0.001980727771297097
without O 0 0.0014713752316311002
the O 0 0.003296154784038663
mutation O 0 0.006291004829108715
, O 0 0.0026703758630901575
into O 0 0.00730702793225646
COS O 1 1.0
- O 0 0.05316828936338425
1 O 0 0.013356178998947144
cells O 0 0.004577971994876862
confirmed O 0 0.0030746215488761663
that O 0 0.0008616683771833777
the O 0 0.003550214460119605
mutant O 0 0.03262531757354736
minigene O 1 0.9435487389564514
was O 0 0.008319011889398098
responsible O 0 0.0056568956933915615
for O 0 0.0023128872271627188
a O 0 0.004118883516639471
mRNA O 0 0.007200315594673157
species O 0 0.0018712939927354455
alternatively O 0 0.009558659046888351
spliced O 0 0.012853928841650486
at O 0 0.005495038349181414
an O 0 0.00453562568873167
activated O 0 0.035264305770397186
cryptic O 0 0.04054877161979675
5 O 0 0.01580817811191082
splice O 0 0.05120857432484627
site O 0 0.017259836196899414
88 O 0 0.030530257150530815
bp O 0 0.021944396197795868
upstream O 0 0.010671201162040234
from O 0 0.002333754440769553
the O 0 0.003524146741256118
3 O 0 0.007250445894896984
end O 0 0.0052463095635175705
of O 0 0.00787170697003603
exon O 0 0.21870127320289612
6 O 0 0.026626206934452057
. O 0 0.008444028906524181

Our O 0 0.012284952215850353
data O 0 0.0034726187586784363
suggest O 0 0.0037177714984863997
that O 0 0.0011288471287116408
the O 0 0.003502998733893037
C O 0 0.018958136439323425
to O 0 0.0023975565563887358
A O 0 0.007138560060411692
mutation O 0 0.0055909538641572
at O 0 0.004968252498656511
the O 0 0.004896685481071472
penultimate O 1 0.5659540295600891
nucleotide O 0 0.010771043598651886
of O 0 0.00426615821197629
exon O 0 0.0275017898529768
6 O 0 0.007108399644494057
of O 0 0.0034571487922221422
the O 0 0.008151787333190441
CYP27 O 1 0.9999947547912598
gene O 0 0.0073989154770970345
not O 0 0.0011378569761291146
only O 0 0.0018598003080114722
causes O 0 0.014349433593451977
the O 0 0.01919378526508808
deficiency B-Disease 1 1.0
in I-Disease 0 0.013623245060443878
the I-Disease 0 0.02215808816254139
sterol I-Disease 1 0.9996334314346313
27 I-Disease 0 0.042380232363939285
- I-Disease 0 0.047029729932546616
hydroxylase I-Disease 0 0.09497327357530594
activity I-Disease 0 0.006171836517751217
, O 0 0.0027522656600922346
but O 0 0.0015053204260766506
also O 0 0.0038501699455082417
partially O 0 0.014892463572323322
leads O 0 0.009009774774312973
to O 0 0.003982627764344215
alternative O 0 0.009508148767054081
pre O 0 0.029967350885272026
- O 0 0.017712082713842392
mRNA O 0 0.010347242467105389
splicing O 0 0.008804884739220142
of O 0 0.003574176924303174
the O 0 0.008115177042782307
gene O 0 0.017918149009346962
. O 0 0.010035660117864609

To O 0 0.008938233368098736
our O 0 0.0059393406845629215
knowledge O 0 0.007449677679687738
, O 0 0.002623959444463253
this O 0 0.0011437779758125544
is O 0 0.0017757255118340254
the O 0 0.0025333825033158064
first O 0 0.0037300451658666134
report O 0 0.0046526165679097176
regarding O 0 0.007404941134154797
effects O 0 0.011013035662472248
on O 0 0.006435162387788296
pre O 0 0.03730374574661255
- O 0 0.018693313002586365
mRNA O 0 0.008557561784982681
splicing O 0 0.006591089069843292
of O 0 0.002025633119046688
a O 0 0.0029289519879966974
mutation O 0 0.006420690566301346
at O 0 0.005334712099283934
the O 0 0.005109529010951519
- O 0 0.011057958006858826
2 O 0 0.005201824475079775
position O 0 0.003143632085993886
of O 0 0.0023432481102645397
a O 0 0.005344750825315714
5 O 0 0.014063064940273762
splice O 0 0.06923306733369827
site O 0 0.022152649238705635
. O 0 0.010325910523533821

ATM O 1 0.8960790038108826
germline O 0 0.13607195019721985
mutations O 0 0.012987501919269562
in O 0 0.006183834280818701
classical O 0 0.13844753801822662
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.999996542930603
in O 0 0.0068892198614776134
the O 0 0.006211656611412764
Dutch O 0 0.021321432664990425
population O 0 0.006304935086518526
. O 0 0.007430704310536385

Germline O 1 0.9360213279724121
mutations O 0 0.016119232401251793
in O 0 0.004858371801674366
the O 0 0.008152784779667854
ATM O 0 0.06536288559436798
gene O 0 0.004011449404060841
are O 0 0.0005520882550626993
responsible O 0 0.002454588422551751
for O 0 0.002305482979863882
the O 0 0.01054454781115055
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999995231628418
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
) O 0 0.009952662512660027
. O 0 0.006391175556927919

In O 0 0.011816092766821384
our O 0 0.006840546149760485
study O 0 0.0064918603748083115
, O 0 0.00260449037887156
we O 0 0.0012437847908586264
have O 0 0.0009643012890592217
determined O 0 0.004910188727080822
the O 0 0.005418764427304268
ATM O 0 0.04429620876908302
mutation O 0 0.008011182770133018
spectrum O 0 0.005233082454651594
in O 0 0.002694554626941681
19 O 0 0.00792364776134491
classical O 0 0.013346467167139053
A B-Disease 1 0.9999972581863403
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
patients O 1 0.9926418662071228
, O 0 0.002368599409237504
including O 0 0.0014746435917913914
some O 0 0.0016244519501924515
immigrant O 0 0.008203103207051754
populations O 0 0.004373757168650627
, O 0 0.0020584340672940016
as O 0 0.0019308250630274415
well O 0 0.0014311483828350902
as O 0 0.0019096668111160398
12 O 0 0.003082488663494587
of O 0 0.00286217057146132
Dutch O 0 0.015413173474371433
ethnic O 0 0.008225121535360813
origin O 0 0.010659684427082539
. O 0 0.01016021054238081

Both O 0 0.008761200122535229
the O 0 0.010106975212693214
protein O 0 0.01377867627888918
truncation O 0 0.05068497732281685
test O 0 0.014182055369019508
( O 0 0.012578373774886131
PTT O 0 0.16533306241035461
) O 0 0.003241295460611582
and O 0 0.0017309009563177824
the O 0 0.006066862493753433
restriction O 0 0.022042345255613327
endonuclease O 0 0.11314541846513748
fingerprinting O 0 0.05360155180096626
( O 0 0.0219971165060997
REF O 1 0.9981339573860168
) O 0 0.0043707736767828465
method O 0 0.003558776807039976
were O 0 0.0015558809973299503
used O 0 0.001968802185729146
and O 0 0.0019551420118659735
compared O 0 0.003940526861697435
for O 0 0.0027355030179023743
their O 0 0.003052595304325223
detection O 0 0.015481124632060528
efficiency O 0 0.012788466177880764
, O 0 0.003137249033898115
identifying O 0 0.012102984823286533
76 O 0 0.02069193311035633
% O 0 0.0029226895421743393
and O 0 0.0013121513184159994
60 O 0 0.0038003181107342243
% O 0 0.002084221923723817
of O 0 0.0027202321216464043
the O 0 0.0061630429700016975
mutations O 0 0.010573900304734707
, O 0 0.005544024985283613
respectively O 0 0.018327802419662476
. O 0 0.010041397996246815

Most O 0 0.014784525148570538
patients O 0 0.4338000416755676
were O 0 0.0035049922298640013
found O 0 0.003938363399356604
to O 0 0.0030728005804121494
be O 0 0.004168329760432243
compound O 0 0.04807847738265991
heterozygote O 1 0.7614614367485046
. O 0 0.013463043607771397

Seventeen O 0 0.06239849701523781
mutations O 0 0.014411503449082375
were O 0 0.0032878699712455273
distinct O 0 0.004421385005116463
, O 0 0.0022775125689804554
of O 0 0.0031504235230386257
which O 0 0.0024523406755179167
10 O 0 0.003432042896747589
were O 0 0.0014753430150449276
not O 0 0.001293762819841504
reported O 0 0.008233785629272461
previously O 0 0.011600413359701633
. O 0 0.008138678036630154

Mutations O 0 0.025399047881364822
are O 0 0.0026451549492776394
small O 0 0.005041573662310839
deletions O 0 0.0205399077385664
or O 0 0.006773839704692364
point O 0 0.013320358470082283
mutations O 0 0.015254894271492958
frequently O 0 0.012269478291273117
affecting O 0 0.03193610906600952
splice O 1 0.7380460500717163
sites O 0 0.02023869752883911
. O 0 0.012179977260529995

Moreover O 0 0.030451683327555656
, O 0 0.006752686109393835
a O 0 0.007067946717143059
16 O 0 0.019610904157161713
. O 0 0.011398538015782833

7 O 0 0.05835391953587532
- O 0 0.045734748244285583
kb O 0 0.11113838851451874
genomic O 0 0.03151855245232582
deletion O 0 0.01622178591787815
of O 0 0.004587335512042046
the O 0 0.006598486099392176
3 O 0 0.009336628019809723
end O 0 0.004806149750947952
of O 0 0.004236686043441296
the O 0 0.007486335933208466
gene O 0 0.00718813668936491
, O 0 0.001958641689270735
most O 0 0.0014557059621438384
likely O 0 0.0025079024489969015
a O 0 0.002020197920501232
result O 0 0.002463581273332238
of O 0 0.003435608232393861
recombination O 0 0.009430932812392712
between O 0 0.0018999133026227355
two O 0 0.001643634052015841
LINE O 0 0.010400704108178616
elements O 0 0.004468515515327454
, O 0 0.0034008778166025877
was O 0 0.009670362807810307
identified O 0 0.014121491461992264
. O 0 0.009266515262424946

The O 0 0.011168047785758972
most O 0 0.0035849083214998245
frequently O 0 0.005936046596616507
found O 0 0.005024097394198179
mutation O 0 0.006746536586433649
, O 0 0.0020708623342216015
identified O 0 0.0030367348808795214
in O 0 0.0016260743141174316
three O 0 0.0019198475638404489
unrelated O 0 0.010719065554440022
Turkish O 0 0.03899303078651428
A B-Disease 1 0.9999988079071045
- I-Disease 1 0.9999964237213135
T I-Disease 1 0.9999986886978149
individuals O 0 0.001978502608835697
, O 0 0.0018883446464315057
was O 0 0.005000398028641939
previously O 0 0.004470446612685919
described O 0 0.00424007885158062
to O 0 0.0011093514040112495
be O 0 0.0006447784835472703
a O 0 0.0020037812646478415
Turkish O 0 0.016364339739084244
A B-Disease 1 0.9997233748435974
- I-Disease 1 0.9999654293060303
T I-Disease 1 0.9999997615814209
founder O 1 0.9349203109741211
mutation O 0 0.026574186980724335
. O 0 0.009212234057486057

The O 0 0.01394088938832283
presence O 0 0.007513720076531172
of O 0 0.007032036315649748
a O 0 0.010690216906368732
founder O 1 0.9845949411392212
mutation O 0 0.011058459058403969
among O 0 0.0031550652347505093
relatively O 0 0.00334880780428648
small O 0 0.0022782450541853905
ethnic O 0 0.0038402117788791656
population O 0 0.0025761041324585676
groups O 0 0.0013021233025938272
in O 0 0.003019939875230193
Western O 0 0.009710576385259628
Europe O 0 0.008470147848129272
could O 0 0.0028926024679094553
indicate O 0 0.006732628680765629
a O 0 0.005001601297408342
high O 0 0.013531510718166828
carrier O 0 0.0182674378156662
frequency O 0 0.004243894014507532
in O 0 0.002397620351985097
such O 0 0.00210175896063447
communities O 0 0.0074546500109136105
. O 0 0.009153606370091438

In O 0 0.011721952818334103
patients O 0 0.02610914036631584
of O 0 0.006712205708026886
Dutch O 0 0.023407133296132088
ethnic O 0 0.005146821029484272
origin O 0 0.004599846433848143
, O 0 0.0028445441275835037
however O 0 0.002627691952511668
, O 0 0.002620542421936989
no O 0 0.0028178011998534203
significant O 0 0.005617694929242134
founder O 0 0.38646870851516724
effect O 0 0.0069643659517169
could O 0 0.0022721716668456793
be O 0 0.0022904572542756796
identified O 0 0.011025132611393929
. O 0 0.008915646001696587

The O 0 0.012142924591898918
observed O 0 0.009217122569680214
genetic O 0 0.009919446893036366
heterogeneity O 0 0.019822878763079643
including O 0 0.0028396740090101957
the O 0 0.004214107058942318
relative O 0 0.009637434035539627
high O 0 0.00905598234385252
percentage O 0 0.008488276042044163
of O 0 0.005748472176492214
splice O 1 0.9946984052658081
- O 0 0.02411714196205139
site O 0 0.011832132935523987
mutations O 0 0.007704711519181728
had O 0 0.0035572077613323927
no O 0 0.0029988503083586693
reflection O 0 0.012012877501547337
on O 0 0.005932516884058714
the O 0 0.00982956774532795
phenotype O 0 0.042749468237161636
. O 0 0.010217787697911263

All O 0 0.007021476048976183
patients O 0 0.09533179551362991
manifested O 0 0.43015870451927185
classical O 0 0.04083288088440895
A B-Disease 1 0.9999997615814209
- I-Disease 1 0.999998927116394
T I-Disease 1 0.9999997615814209
and O 0 0.003275028895586729
increased O 0 0.006254428066313267
cellular O 0 0.022469298914074898
radioresistant O 1 0.998680055141449
DNA O 0 0.023964175954461098
synthesis O 0 0.02447754144668579
. O 0 0.00880358275026083

Determination O 0 0.03244037181138992
of O 0 0.008366120979189873
the O 0 0.00853841844946146
genomic O 0 0.017572849988937378
structure O 0 0.0056102038361132145
of O 0 0.0035845849197357893
the O 0 0.008787743747234344
COL4A4 O 1 0.9999995231628418
gene O 0 0.0047200401313602924
and O 0 0.0011850958690047264
of O 0 0.0037997260224074125
novel O 0 0.039006900042295456
mutations O 0 0.030598921701312065
causing O 1 0.9987327456474304
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999880790710449

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.9805193543434143
a O 0 0.13336864113807678
progressive O 1 0.9999998807907104
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9999977350234985
by O 0 0.025215178728103638
glomerular B-Disease 1 1.0
basement I-Disease 1 1.0
membrane I-Disease 1 0.9998781681060791
abnormalities I-Disease 1 0.9999852180480957
and O 0 0.0031046560034155846
associated O 0 0.004617749247699976
with O 0 0.0020538445096462965
mutations O 0 0.004630711395293474
in O 0 0.002074422547593713
either O 0 0.002790043130517006
the O 0 0.00501607870683074
COL4A3 O 1 0.9999990463256836
or O 0 0.004391863010823727
the O 0 0.00728484895080328
COL4A4 O 1 0.9999998807907104
gene O 0 0.006548447068780661
, O 0 0.0014408811694011092
which O 0 0.0009321597754023969
encode O 0 0.004592166747897863
the O 0 0.0039787935093045235
alpha3 O 0 0.4251885414123535
and O 0 0.00630263751372695
alpha4 O 1 0.9999980926513672
type O 1 0.9999632835388184
IV O 1 1.0
collagen O 1 1.0
chains O 1 0.989105761051178
, O 0 0.011622619815170765
respectively O 0 0.021975262090563774
. O 0 0.010819868184626102

To O 0 0.007481717970222235
date O 0 0.009857098571956158
, O 0 0.004862315487116575
mutation O 0 0.006724269594997168
screening O 0 0.006305209826678038
in O 0 0.002400715369731188
the O 0 0.002965301740914583
two O 0 0.001966927433386445
genes O 0 0.003862871555611491
has O 0 0.0018510152585804462
been O 0 0.002508703386411071
hampered O 0 0.019107922911643982
by O 0 0.0019267877796664834
the O 0 0.004151117522269487
lack O 0 0.009779173880815506
of O 0 0.009724650532007217
genomic O 0 0.04406094551086426
structure O 0 0.01547846570611
information O 0 0.008255806751549244
. O 0 0.008647153154015541

We O 0 0.007395169697701931
report O 0 0.004755579400807619
here O 0 0.0030914051458239555
the O 0 0.0028462246991693974
complete O 0 0.0060056219808757305
characterization O 0 0.013235506601631641
of O 0 0.004262660164386034
the O 0 0.006112508941441774
48 O 0 0.01075957715511322
exons O 0 0.013794883154332638
of O 0 0.0037474443670362234
the O 0 0.009669129736721516
COL4A4 O 1 0.9999992847442627
gene O 0 0.008189556188881397
, O 0 0.0022399441804736853
a O 0 0.003523979103192687
comprehensive O 0 0.019747205078601837
gene O 0 0.010217658244073391
screen O 0 0.0060930270701646805
, O 0 0.0019988869316875935
and O 0 0.0015298138605430722
the O 0 0.003700766246765852
subsequent O 0 0.006718291435390711
detection O 0 0.008814415894448757
of O 0 0.003700460772961378
10 O 0 0.0041425516828894615
novel O 0 0.007208876311779022
mutations O 0 0.003027547150850296
in O 0 0.0019431266700848937
eight O 0 0.005608675070106983
patients O 1 0.9999995231628418
diagnosed O 1 1.0
with O 1 0.9453861713409424
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999667406082153

Furthermore O 0 0.033009469509124756
, O 0 0.005763464141637087
we O 0 0.0021697443444281816
identified O 0 0.005144148133695126
a O 0 0.005061513278633356
glycine O 0 0.032313063740730286
to O 0 0.004919582977890968
alanine O 0 0.04103375971317291
substitution O 0 0.015315691940486431
in O 0 0.005098950117826462
the O 0 0.011102176271378994
collagenous O 1 0.999987006187439
domain O 0 0.014268714934587479
that O 0 0.0023624617606401443
is O 0 0.0032553323544561863
apparently O 0 0.006572874262928963
silent O 0 0.011598213575780392
in O 0 0.002975709969177842
the O 0 0.005307465326040983
heterozygous O 0 0.01228449959307909
carriers O 0 0.006528975907713175
, O 0 0.002598020015284419
in O 0 0.004507729317992926
11 O 0 0.015103770419955254
. O 0 0.009865405969321728

5 O 0 0.019781848415732384
% O 0 0.005317705683410168
of O 0 0.003519307356327772
all O 0 0.0024078930728137493
control O 0 0.006653127260506153
individuals O 0 0.002156717935577035
, O 0 0.002634521806612611
and O 0 0.0020106425508856773
in O 0 0.0034263196866959333
one O 0 0.003708496456965804
control O 0 0.00591757008805871
individual O 0 0.0033232930582016706
homozygous O 0 0.009541843086481094
for O 0 0.002612299518659711
this O 0 0.0036863707937300205
glycine O 0 0.05563533306121826
substitution O 0 0.03483683988451958
. O 0 0.012633509933948517

There O 0 0.0076371850445866585
has O 0 0.0037041138857603073
been O 0 0.0027396841906011105
no O 0 0.0021343273110687733
previous O 0 0.003997941967099905
finding O 0 0.005005539394915104
of O 0 0.005376230925321579
a O 0 0.009169470518827438
glycine O 0 0.05299804359674454
substitution O 0 0.011420260183513165
that O 0 0.001404967624694109
is O 0 0.0017313113203272223
not O 0 0.0008402576786465943
associated O 0 0.0022100829519331455
with O 0 0.0015729765873402357
any O 0 0.0033060184214264154
obvious O 0 0.022716181352734566
phenotype O 0 0.028114160522818565
in O 0 0.007178852800279856
homozygous O 0 0.025620054453611374
individuals O 0 0.004928830545395613
. O 0 0.008449237793684006

Founder O 1 0.9996015429496765
BRCA1 O 1 0.9998897314071655
and O 0 0.012806388549506664
BRCA2 O 1 0.9998910427093506
mutations O 0 0.008526413701474667
in O 0 0.0037991777062416077
French O 0 0.04170035943388939
Canadian O 1 0.9998769760131836
breast B-Disease 1 1.0
and I-Disease 1 0.9999940395355225
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9972641468048096
. O 0 0.015442224219441414

We O 0 0.005103390663862228
have O 0 0.0013325409963726997
identified O 0 0.00370574533008039
four O 0 0.001845298451371491
mutations O 0 0.002804230200126767
in O 0 0.0009821277344599366
each O 0 0.0008956642705015838
of O 0 0.0031389824580401182
the O 0 0.01755235530436039
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 0.9999979734420776
susceptibility O 1 0.9990904331207275
genes O 0 0.0102809714153409
, O 0 0.006391881033778191
BRCA1 O 1 0.9972665309906006
and O 0 0.006533372215926647
BRCA2 O 1 0.981590986251831
, O 0 0.0027805957943201065
in O 0 0.0026257431600242853
French O 0 0.014991020783782005
Canadian O 1 0.9819615483283997
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999892711639404
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.45262670516967773
from O 0 0.009012683294713497
Quebec O 0 0.11052509397268295
. O 0 0.01394264493137598

To O 0 0.011242588050663471
identify O 0 0.023669222369790077
founder O 1 0.9993531107902527
effects O 0 0.02600681036710739
, O 0 0.0039918613620102406
we O 0 0.0018862382275983691
examined O 0 0.00884188711643219
independently O 0 0.004126738756895065
ascertained O 0 0.01811206340789795
French O 0 0.01872595213353634
Canadian O 1 0.7902311086654663
cancer B-Disease 1 0.9999998807907104
families O 0 0.005578700453042984
for O 0 0.0024248934350907803
the O 0 0.003068663878366351
distribution O 0 0.0027710485737770796
of O 0 0.002984174992889166
these O 0 0.0020167515613138676
eight O 0 0.00745880464091897
mutations O 0 0.01594163104891777
. O 0 0.00864782277494669

Mutations O 0 0.02476220764219761
were O 0 0.00354613084346056
found O 0 0.003393203252926469
in O 0 0.0038752141408622265
41 O 0 0.01361620333045721
of O 0 0.008748059161007404
97 O 0 0.0569772869348526
families O 0 0.011429091915488243
. O 0 0.01144783478230238

Six O 0 0.009575530886650085
of O 0 0.006069330498576164
eight O 0 0.006881707813590765
mutations O 0 0.0057762498036026955
were O 0 0.0016507565742358565
observed O 0 0.0033784902188926935
at O 0 0.005414890591055155
least O 0 0.003620917908847332
twice O 0 0.01017302181571722
. O 0 0.008465823717415333

The O 0 0.03582397475838661
BRCA1 O 1 0.999969482421875
C4446T O 1 0.9996378421783447
mutation O 0 0.01673763245344162
was O 0 0.006817494053393602
the O 0 0.003093268722295761
most O 0 0.0020970392506569624
common O 0 0.005030936561524868
mutation O 0 0.007142194081097841
found O 0 0.0031696108635514975
, O 0 0.0025190901942551136
followed O 0 0.0038785820361226797
by O 0 0.00199622823856771
the O 0 0.011503760702908039
BRCA2 O 1 0.9999997615814209
8765delAG O 1 0.9999890327453613
mutation O 0 0.03800591453909874
. O 0 0.011881542392075062

Together O 0 0.008959260769188404
, O 0 0.0045023830607533455
these O 0 0.0018341158283874393
mutations O 0 0.005063737276941538
were O 0 0.0015422586584463716
found O 0 0.0024656583555042744
in O 0 0.0030110401567071676
28 O 0 0.008214800618588924
of O 0 0.005184913985431194
41 O 0 0.0133560411632061
families O 0 0.003906088648363948
identified O 0 0.004819387570023537
to O 0 0.0015116753056645393
have O 0 0.0012362223351374269
a O 0 0.005856642499566078
mutation O 0 0.019625261425971985
. O 0 0.009313469752669334

The O 0 0.014762787148356438
odds O 0 0.023328572511672974
of O 0 0.005461612716317177
detection O 0 0.009707825258374214
of O 0 0.003346876008436084
any O 0 0.0014495707582682371
of O 0 0.0024608944077044725
the O 0 0.004442517179995775
four O 0 0.005616213660687208
BRCA1 O 1 0.9995620846748352
mutations O 0 0.013148008845746517
was O 0 0.013906098902225494
18 O 0 0.014788777567446232
. O 0 0.010714075528085232

7x O 1 0.9990648627281189
greater O 0 0.011782827787101269
if O 0 0.002174106426537037
one O 0 0.0015283405082300305
or O 0 0.001295555615797639
more O 0 0.0007576570496894419
cases O 0 0.005619959440082312
of O 1 0.9978299736976624
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.011557654477655888
also O 0 0.003127921838313341
present O 0 0.002212662948295474
in O 0 0.0022015413269400597
the O 0 0.00487093860283494
family O 0 0.011967737227678299
. O 0 0.00803651288151741

The O 0 0.015796804800629616
odds O 0 0.026449905708432198
of O 0 0.00621101213619113
detection O 0 0.008254369720816612
of O 0 0.00307120056822896
any O 0 0.0013371538370847702
of O 0 0.0025858446024358273
the O 0 0.005203897133469582
four O 0 0.007415174972265959
BRCA2 O 1 0.999925971031189
mutations O 0 0.01534851174801588
was O 0 0.013883700594305992
5 O 0 0.016584886237978935
. O 0 0.009636900387704372

3x O 1 0.983352541923523
greater O 0 0.011711970902979374
if O 0 0.0020627090707421303
there O 0 0.0014245264464989305
were O 0 0.0011271955445408821
at O 0 0.0022161798551678658
least O 0 0.0011656619608402252
five O 0 0.0016221373807638884
cases O 0 0.003723236732184887
of O 0 0.017651623114943504
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.03123609535396099
the O 0 0.010618331842124462
family O 0 0.013598891906440258
. O 0 0.006457481533288956

Interestingly O 0 0.04297587275505066
, O 0 0.003955737687647343
the O 0 0.0034980205819010735
presence O 0 0.004161391872912645
of O 0 0.006108588073402643
a O 0 0.02526010572910309
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
case O 1 0.6932072043418884
< O 0 0.06742110848426819
36 O 0 0.007486527785658836
years O 0 0.0029572995845228434
of O 0 0.0037027434445917606
age O 0 0.008950373157858849
was O 0 0.010352653451263905
strongly O 0 0.007210972718894482
predictive O 0 0.01389706414192915
of O 0 0.004073295742273331
the O 0 0.004317868500947952
presence O 0 0.0037656049244105816
of O 0 0.0021296862978488207
any O 0 0.0014208690263330936
of O 0 0.002765296259894967
the O 0 0.005542700178921223
eight O 0 0.008395520970225334
mutations O 0 0.014454344287514687
screened O 0 0.026700977236032486
. O 0 0.010491476394236088

Carriers O 0 0.02041461318731308
of O 0 0.006963442545384169
the O 0 0.006515356246381998
same O 0 0.004456397145986557
mutation O 0 0.006289497017860413
, O 0 0.0019467526581138372
from O 0 0.0014913055347278714
different O 0 0.0010539551731199026
families O 0 0.002431065309792757
, O 0 0.002566298935562372
shared O 0 0.006788291968405247
similar O 0 0.005615678150206804
haplotypes O 0 0.0458720326423645
, O 0 0.005088594742119312
indicating O 0 0.011933348141610622
that O 0 0.0022266695741564035
the O 0 0.006751071661710739
mutant O 0 0.033604662865400314
alleles O 0 0.012642959132790565
were O 0 0.0021885044407099485
likely O 0 0.0029137018136680126
to O 0 0.0015720520168542862
be O 0 0.0009913500398397446
identical O 0 0.0023744236677885056
by O 0 0.0010609132004901767
descent O 0 0.006035779602825642
for O 0 0.0024541961029171944
a O 0 0.004412602633237839
mutation O 0 0.005365100223571062
in O 0 0.0027519110590219498
the O 0 0.006142637226730585
founder O 0 0.4554849863052368
population O 0 0.00795031152665615
. O 0 0.009253518655896187

The O 0 0.010382683016359806
identification O 0 0.009539739228785038
of O 0 0.007845785468816757
common O 0 0.03655308857560158
BRCA1 O 1 0.9999997615814209
and O 0 0.015044084750115871
BRCA2 O 1 0.9999992847442627
mutations O 0 0.012428606860339642
will O 0 0.002752340165898204
facilitate O 0 0.008231817744672298
carrier O 0 0.011218315921723843
detection O 0 0.006647684145718813
in O 0 0.002235851250588894
French O 0 0.014615654945373535
Canadian O 1 0.9270141124725342
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9996914863586426
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9947581887245178
. O 0 0.015771618112921715

Are O 0 0.010696819052100182
Dp71 O 1 0.920632004737854
and O 0 0.015312651172280312
Dp140 O 1 0.9999853372573853
brain O 1 0.9999903440475464
dystrophin O 1 0.9995889067649841
isoforms O 0 0.018549315631389618
related O 0 0.0076371850445866585
to O 0 0.006002969574183226
cognitive B-Disease 1 0.9998494386672974
impairment I-Disease 1 1.0
in O 1 0.9999994039535522
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999135732650757

Molecular O 0 0.031922824680805206
study O 0 0.01067325472831726
and O 0 0.0040186322294175625
neuropsychological O 0 0.02616511844098568
analysis O 0 0.0033019091933965683
were O 0 0.0017003127140924335
performed O 0 0.00517235416918993
concurrently O 0 0.01112276315689087
on O 0 0.0043982770293951035
49 O 0 0.018711131066083908
patients O 1 0.9962013363838196
with O 0 0.019442018121480942
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DMD B-Disease 1 1.0
) O 0 0.006768298335373402
in O 0 0.002070895629003644
order O 0 0.0018789333989843726
to O 0 0.0012229226995259523
find O 0 0.0025051638949662447
a O 0 0.002075295662507415
molecular O 0 0.005596557632088661
explanation O 0 0.0042121149599552155
for O 0 0.002621540566906333
the O 0 0.007122568786144257
cognitive B-Disease 1 0.9820870161056519
impairment I-Disease 1 0.9999805688858032
observed O 0 0.0102152144536376
in O 0 0.00697635393589735
most O 0 0.009504714980721474
DMD B-Disease 1 1.0
patients O 1 1.0
. O 0 0.021200910210609436

Complete O 0 0.010993835516273975
analysis O 0 0.00443100044503808
of O 0 0.004592014942318201
the O 0 0.011059792712330818
dystrophin O 1 0.9997574687004089
gene O 0 0.011055387556552887
was O 0 0.005921691656112671
performed O 0 0.0054457588121294975
to O 0 0.0017904677661135793
define O 0 0.007108102552592754
the O 0 0.005460805259644985
localization O 0 0.018083160743117332
of O 0 0.005582522135227919
deletions O 0 0.02008739858865738
and O 0 0.004412127658724785
duplications O 0 0.03428145498037338
in O 0 0.004352268297225237
relation O 0 0.00910498108714819
to O 0 0.003184311557561159
the O 0 0.006522415671497583
different O 0 0.00714402599260211
DMD B-Disease 1 1.0
promoters O 1 0.9988549947738647
. O 0 0.0214301198720932

Qualitative O 0 0.028017383068799973
analysis O 0 0.0040901415050029755
of O 0 0.004796930588781834
the O 0 0.00934602227061987
Dp71 O 1 0.9997491240501404
transcript O 0 0.02076740376651287
and O 0 0.0022950798738747835
testing O 0 0.0035378977190703154
for O 0 0.001451376243494451
the O 0 0.0022184511180967093
specific O 0 0.0018227729015052319
first O 0 0.004053980112075806
exon O 0 0.025035694241523743
of O 0 0.005733110476285219
Dp140 O 1 0.8678831458091736
were O 0 0.0035259926225990057
also O 0 0.003439942141994834
carried O 0 0.006294731982052326
out O 0 0.004193730186671019
. O 0 0.007550552021712065

Neuropsychological O 0 0.1108621284365654
analysis O 0 0.013295802287757397
assessed O 0 0.02380012907087803
verbal O 0 0.026420440524816513
and O 0 0.010124369524419308
visuospatial O 1 0.9999938011169434
intelligence O 0 0.02009265497326851
, O 0 0.006041737738996744
verbal O 0 0.028603486716747284
memory O 1 0.9998003840446472
, O 0 0.006136693526059389
and O 0 0.004464966244995594
reading O 0 0.020939074456691742
skills O 0 0.034597501158714294
. O 0 0.010860884562134743

Comparison O 0 0.02256772853434086
of O 0 0.011757486499845982
molecular O 0 0.02095920220017433
and O 0 0.005521351471543312
psychometric O 0 0.10675615817308426
findings O 0 0.017561664804816246
demonstrated O 0 0.014818423427641392
that O 0 0.0037397132255136967
deletions O 0 0.017678068950772285
and O 0 0.004435546230524778
duplications O 0 0.03051076829433441
that O 0 0.002304846653714776
were O 0 0.0027032061479985714
localized O 0 0.016128407791256905
in O 0 0.004868322983384132
the O 0 0.008675731718540192
distal O 1 0.9997788071632385
part O 0 0.010172299109399319
of O 0 0.008400377817451954
the O 0 0.010801570490002632
gene O 0 0.007447047624737024
seemed O 0 0.004160512704402208
to O 0 0.001554942224174738
be O 0 0.0014303752686828375
preferentially O 0 0.011016018688678741
associated O 0 0.005367899779230356
with O 0 0.005539839155972004
cognitive B-Disease 1 0.9999978542327881
impairment I-Disease 1 1.0
. O 0 0.0668092593550682

Two O 0 0.010684490203857422
altered O 0 0.02594006061553955
Dp71 O 0 0.1807328462600708
transcripts O 0 0.016995390877127647
and O 0 0.0038556749932467937
two O 0 0.0040627336129546165
deleted O 0 0.027006318792700768
Dp140 O 0 0.06076831370592117
DNA O 0 0.00898244883865118
sequences O 0 0.0029708570800721645
were O 0 0.0009065449703484774
found O 0 0.0010409426176920533
in O 0 0.0016333448002114892
four O 0 0.003706343937665224
patients O 1 0.9994871616363525
with O 0 0.013123785145580769
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9999966621398926

These O 0 0.006967413239181042
findings O 0 0.008021504618227482
suggest O 0 0.0043963100761175156
that O 0 0.0010252177016809583
some O 0 0.0011241607135161757
sequences O 0 0.003070015227422118
located O 0 0.005273768678307533
in O 0 0.002858248772099614
the O 0 0.00567718967795372
distal O 1 0.980307936668396
part O 0 0.009636742062866688
of O 0 0.007314247079193592
the O 0 0.010069768875837326
gene O 0 0.007145704701542854
and O 0 0.001752991578541696
, O 0 0.002029239432886243
in O 0 0.002465707715600729
particular O 0 0.004164222627878189
, O 0 0.004199076443910599
some O 0 0.005300876684486866
DMD B-Disease 1 1.0
isoforms O 0 0.0145612433552742
expressed O 0 0.005585706327110529
in O 0 0.00468162726610899
the O 0 0.008681823499500751
brain O 1 0.9997692704200745
may O 0 0.004405390005558729
be O 0 0.0012597469612956047
related O 0 0.002733957953751087
to O 0 0.002357721561565995
the O 0 0.00710982596501708
cognitive B-Disease 1 0.9999825954437256
impairment I-Disease 1 1.0
associated O 1 0.9884834885597229
with O 0 0.12170521914958954
DMD B-Disease 1 1.0
. O 0 0.014604466035962105
. O 0 0.010965771973133087

I1307K O 1 0.9994590878486633
APC O 1 0.9998375177383423
and O 0 0.010859009809792042
hMLH1 O 1 0.9948123693466187
mutations O 0 0.00851330254226923
in O 0 0.003044928191229701
a O 0 0.0045003085397183895
non O 0 0.010928597301244736
- O 0 0.009185449220240116
Jewish O 0 0.005549674853682518
family O 0 0.005469570867717266
with O 0 0.003391551086679101
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9998868703842163

We O 0 0.0038738632574677467
describe O 0 0.006062510423362255
a O 0 0.0036201956681907177
French O 0 0.015083646401762962
Canadian O 0 0.03402285277843475
hereditary B-Disease 1 1.0
non I-Disease 1 0.9999997615814209
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 1.0
HNPCC B-Disease 1 1.0
) O 0 0.031096559017896652
kindred O 1 0.9929649829864502
which O 0 0.00247711269184947
carries O 0 0.005044444929808378
a O 0 0.0043144505470991135
novel O 0 0.021965328603982925
truncating O 1 0.7379307746887207
mutation O 0 0.018215905874967575
in O 0 0.011549022048711777
hMLH1 O 1 0.9983077049255371
. O 0 0.01682298257946968

Interestingly O 0 0.051095299422740936
, O 0 0.008029548451304436
the O 0 0.012570114806294441
I1307K O 1 0.9999210834503174
APC O 1 0.9999827146530151
polymorphism O 0 0.020524801686406136
, O 0 0.003211446339264512
associated O 0 0.0027464712038636208
with O 0 0.00120261509437114
an O 0 0.002433605259284377
increased O 0 0.007912889122962952
risk O 0 0.3332829177379608
of O 1 0.999972939491272
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.8681593537330627
is O 0 0.0034687991719692945
also O 0 0.0016942104557529092
present O 0 0.0019018222810700536
in O 0 0.0019415859133005142
this O 0 0.0023638668935745955
family O 0 0.009841442108154297
. O 0 0.008984299376606941

The O 0 0.032788969576358795
I1307K O 1 0.9913971424102783
polymorphism O 0 0.024373995140194893
has O 0 0.0031392944511026144
previously O 0 0.004136804025620222
only O 0 0.0012367629678919911
been O 0 0.0015451228246092796
identified O 0 0.0026360570918768644
in O 0 0.0013775578700006008
individuals O 0 0.0012577850138768554
of O 0 0.004008750896900892
self O 1 0.9333342909812927
- O 0 0.14593274891376495
reported O 0 0.01343334186822176
Ashkenazi O 0 0.07208056002855301
Jewish O 0 0.02004190906882286
origins O 0 0.03520425409078598
. O 0 0.01369938999414444

In O 0 0.01009984128177166
addition O 0 0.005745739210397005
, O 0 0.0025099478662014008
in O 0 0.002489847131073475
this O 0 0.0016335004474967718
family O 0 0.005722560454159975
, O 0 0.0026816560421139
there O 0 0.0020455080084502697
appears O 0 0.0049397870898246765
to O 0 0.0016899245092645288
be O 0 0.0012083322508260608
no O 0 0.0018552213441580534
relationship O 0 0.004610325209796429
between O 0 0.00398043729364872
the O 0 0.008677789941430092
I1307K O 1 0.9962204098701477
polymorphism O 0 0.014168914407491684
and O 0 0.0021898408886045218
the O 0 0.0032291985116899014
presence O 0 0.004800310358405113
or O 0 0.0034958405885845423
absence O 0 0.01590896025300026
of O 1 0.9251916408538818
cancer B-Disease 1 1.0
. O 0 0.01099629420787096
. O 0 0.010175740346312523

Identification O 0 0.013139795511960983
of O 0 0.005772553849965334
a O 0 0.005390758626163006
novel O 0 0.015847234055399895
mutation O 0 0.006937195546925068
of O 0 0.004482080694288015
the O 0 0.009376087225973606
CPO O 1 0.9973702430725098
gene O 0 0.005567458458244801
in O 0 0.002027403563261032
a O 0 0.004491492640227079
Japanese O 0 0.15667575597763062
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
family O 0 0.07053348422050476
. O 0 0.01623406447470188

Hereditary B-Disease 1 0.9999998807907104
coproporphyria I-Disease 1 0.9999998807907104
( O 1 0.5732277631759644
HCP B-Disease 1 0.9999998807907104
) O 0 0.006997086573392153
is O 0 0.0021562438923865557
an O 0 0.0030773410107940435
autosomal B-Disease 1 0.999988317489624
dominant I-Disease 1 0.9999945163726807
disease I-Disease 1 1.0
characterized O 1 0.9999960660934448
by O 0 0.007623911835253239
a O 0 0.49335557222366333
deficiency B-Disease 1 1.0
of I-Disease 1 0.9999977350234985
coproporphyrinogen I-Disease 1 1.0
oxidase I-Disease 1 0.9999874830245972
( O 0 0.02560010738670826
CPO O 1 0.9999929666519165
) O 0 0.005283904727548361
caused O 0 0.00458465376868844
by O 0 0.0014959508553147316
a O 0 0.004007553681731224
mutation O 0 0.005521969869732857
in O 0 0.003600045572966337
the O 0 0.011988663114607334
CPO O 1 0.9999923706054688
gene O 0 0.024708542972803116
. O 0 0.010469436645507812

Only O 0 0.00694071501493454
11 O 0 0.010236402042210102
mutations O 0 0.00582094956189394
of O 0 0.003185967681929469
the O 0 0.005150062032043934
gene O 0 0.00501372292637825
have O 0 0.0009908098727464676
been O 0 0.001978066051378846
reported O 0 0.007509045302867889
in O 0 0.010434958152472973
HCP B-Disease 1 1.0
patients O 1 0.9999821186065674
. O 0 0.01852637156844139

We O 0 0.005883578211069107
report O 0 0.005208500660955906
another O 0 0.004893739242106676
mutation O 0 0.005798681639134884
in O 0 0.00280461716465652
a O 0 0.005400467664003372
Japanese O 0 0.03692182898521423
family O 0 0.020060399547219276
. O 0 0.011000599712133408

Polymerase O 0 0.12481939047574997
chain O 0 0.048403624445199966
reaction O 0 0.022781265899538994
- O 0 0.027141788974404335
single O 0 0.011235525831580162
strand O 0 0.02300298400223255
conformational O 0 0.021240796893835068
polymorphism O 0 0.012334438972175121
and O 0 0.002398354932665825
direct O 0 0.0032925803679972887
sequence O 0 0.00451710494235158
analyses O 0 0.0060825045220553875
demonstrated O 0 0.008262645453214645
a O 0 0.0047842408530414104
C O 0 0.026267291978001595
to O 0 0.005720952060073614
T O 0 0.05078713595867157
substitution O 0 0.009858235716819763
in O 0 0.00448240153491497
exon O 0 0.030361730605363846
1 O 0 0.0060484567657113075
of O 0 0.003229050897061825
the O 0 0.008673097938299179
CPO O 1 0.9839124083518982
gene O 0 0.009913009591400623
at O 0 0.006865627598017454
nucleotide O 0 0.009457608684897423
position O 0 0.005148161668330431
85 O 0 0.009640405885875225
, O 0 0.0022024516947567463
which O 0 0.0013596038334071636
lies O 0 0.006551642436534166
in O 0 0.002887452021241188
the O 0 0.006403654348105192
putative O 0 0.06074920669198036
presequence O 0 0.08161889016628265
for O 0 0.0053834980353713036
targeting O 0 0.011676413007080555
to O 0 0.007240522652864456
mitochondria O 0 0.03493442013859749
. O 0 0.011679163202643394

This O 0 0.008760596625506878
mutation O 0 0.009528703056275845
changes O 0 0.0027253637090325356
the O 0 0.004008808173239231
codon O 0 0.016543004661798477
for O 0 0.0031918624881654978
glutamine O 0 0.014926339499652386
to O 0 0.0017970178741961718
a O 0 0.0038574261125177145
termination O 0 0.026834789663553238
codon O 0 0.02428470551967621
at O 0 0.009599899873137474
amino O 0 0.010028254240751266
acid O 0 0.013003428466618061
position O 0 0.011614438146352768
29 O 0 0.024439869448542595
. O 0 0.009414305910468102

MaeI O 1 0.8424853682518005
restriction O 0 0.01865791156888008
analysis O 0 0.0049403635784983635
showed O 0 0.004846234805881977
two O 0 0.0012830254854634404
other O 0 0.0015351439360529184
carriers O 0 0.005948142148554325
in O 0 0.0032252699602395296
the O 0 0.007440776098519564
family O 0 0.017564905807375908
. O 0 0.011111414059996605

The O 0 0.02923104539513588
C O 1 0.9999663829803467
- O 1 0.9992725253105164
T O 1 0.9994229078292847
mutation O 0 0.009692971594631672
is O 0 0.002142584417015314
located O 0 0.004636777564883232
within O 0 0.001594524597749114
a O 0 0.0024840645492076874
recently O 0 0.006115896161645651
proposed O 0 0.005518420599400997
putative O 0 0.023152247071266174
alternative O 0 0.007161808665841818
translation O 0 0.011296506971120834
initiation O 0 0.030471228063106537
codon O 0 0.0410807766020298
( O 0 0.016267690807580948
TIC O 1 0.9999994039535522
- O 0 0.02397354692220688
1 O 0 0.01013061311095953
) O 0 0.002411479828879237
, O 0 0.0017062592087313533
supporting O 0 0.005517258308827877
that O 0 0.003995665814727545
TIC O 1 0.9999998807907104
- O 0 0.02730553410947323
1 O 0 0.008301995694637299
is O 0 0.0019743358716368675
the O 0 0.0038914054166525602
real O 0 0.012861186638474464
TIC O 1 0.9998360872268677
rather O 0 0.005759078077971935
than O 0 0.005403280258178711
TIC O 1 0.9999994039535522
- O 0 0.040591683238744736
2 O 0 0.014001927338540554
. O 0 0.004445335827767849
. O 0 0.007317487616091967

Human B-Disease 0 0.024674372747540474
complement I-Disease 0 0.04408133774995804
factor I-Disease 1 0.9974651336669922
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 1 0.9990321397781372
with O 1 0.9979296922683716
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999995231628418

This O 0 0.004545351956039667
study O 0 0.004388937260955572
reports O 0 0.0036618709564208984
on O 0 0.0027183392085134983
six O 0 0.003042918164283037
cases O 0 0.006256158463656902
of O 0 0.01819607987999916
deficiency B-Disease 1 1.0
in I-Disease 0 0.008518017828464508
the I-Disease 0 0.006853906437754631
human I-Disease 0 0.006031014956533909
complement I-Disease 0 0.01222438644617796
regulatory I-Disease 0 0.014845512807369232
protein I-Disease 0 0.010622085072100163
Factor I-Disease 0 0.023269936442375183
H I-Disease 1 0.9999992847442627
( O 0 0.01638755388557911
FH O 1 0.9999990463256836
) O 0 0.002400687662884593
in O 0 0.0010259514674544334
the O 0 0.0013509728014469147
context O 0 0.0030282435473054647
of O 0 0.004321744665503502
an O 0 0.2989497184753418
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 1.0

Five O 0 0.007510595489293337
of O 0 0.004851566161960363
the O 0 0.004360048100352287
cases O 0 0.004282762762159109
were O 0 0.001982427202165127
observed O 0 0.0026209547650069
in O 0 0.0021618714090436697
children O 0 0.0046570454724133015
presenting O 0 0.015496996231377125
with O 0 0.011853651143610477
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 1 0.9988289475440979
. O 0 0.015466805547475815

Two O 0 0.003913440275937319
of O 0 0.004745560232549906
the O 0 0.006152948830276728
children O 0 0.012014394626021385
exhibited O 0 0.3850977420806885
a O 0 0.021122030913829803
homozygous O 1 0.999762237071991
deficiency O 1 1.0
characterized O 0 0.3180699646472931
by O 0 0.0031584107782691717
the O 0 0.004855076316744089
absence O 0 0.01051059179008007
of O 0 0.005534558091312647
the O 0 0.007550709415227175
150 O 0 0.01579238474369049
- O 0 0.021336782723665237
kD O 0 0.08926171809434891
form O 0 0.0037275974173098803
of O 0 0.00637675728648901
Factor O 0 0.3884221017360687
H O 1 0.9999984502792358
and O 0 0.0027483408339321613
the O 0 0.0033621180336922407
presence O 0 0.004359024111181498
, O 0 0.002180679701268673
upon O 0 0.004480563569813967
immunoblotting O 0 0.04691723361611366
, O 0 0.002063465304672718
of O 0 0.0027842780109494925
the O 0 0.006451411172747612
42 O 0 0.02699180692434311
- O 0 0.03639087453484535
kD O 1 0.9985213875770569
Factor O 0 0.03233475238084793
H O 1 0.9999572038650513
- O 0 0.01174250803887844
like O 0 0.002952860901132226
protein O 0 0.005455530248582363
1 O 0 0.008639242500066757
( O 0 0.008883235976099968
FHL O 1 0.9999946355819702
- O 0 0.02197924070060253
1 O 0 0.007352648768573999
) O 0 0.0019003069028258324
and O 0 0.0012153803836554289
other O 0 0.003304994199424982
FH O 1 1.0
- O 0 0.030262086540460587
related O 0 0.011409273371100426
protein O 0 0.013349758461117744
( O 0 0.010568294674158096
FHR O 1 0.9999489784240723
) O 0 0.009374022483825684
bands O 0 0.0123656140640378
. O 0 0.008182497695088387

Southern O 0 0.054974015802145004
blot O 0 0.13747826218605042
and O 0 0.007347178645431995
PCR O 0 0.024625662714242935
analysis O 0 0.0028361601289361715
of O 0 0.002709418535232544
DNA O 0 0.005907648708671331
of O 0 0.0030727132689207792
one O 0 0.003908385988324881
patient O 1 0.525393545627594
with O 0 0.007296810392290354
homozygous O 1 0.9985874891281128
deficiency O 1 1.0
ruled O 0 0.022967930883169174
out O 0 0.003991167526692152
the O 0 0.003587657120078802
presence O 0 0.004081591032445431
of O 0 0.0027553599793463945
a O 0 0.003422834211960435
large O 0 0.0034464772325009108
deletion O 0 0.01079903356730938
of O 0 0.005525041837245226
the O 0 0.012450609356164932
FH O 1 1.0
gene O 0 0.0067048827186226845
as O 0 0.0021928884088993073
the O 0 0.004138252232223749
underlying O 1 0.9967632293701172
defect O 1 0.9999957084655762
for O 0 0.010875617153942585
the O 1 0.9467218518257141
deficiency O 1 1.0
. O 0 0.023836931213736534

The O 0 0.007905754260718822
other O 0 0.001992135075852275
four O 0 0.0024715696927160025
children O 0 0.005668066907674074
presented O 0 0.009313730522990227
with O 0 0.005249122157692909
heterozygous O 1 0.9741873145103455
deficiency O 1 1.0
and O 0 0.007374693173915148
exhibited O 1 0.95424884557724
a O 0 0.012767311185598373
normal O 0 0.017231952399015427
immunoblotting O 1 0.9070498943328857
pattern O 0 0.009152192622423172
of O 0 0.003882270073518157
proteins O 0 0.004543548449873924
of O 0 0.004858675878494978
the O 0 0.018011119216680527
FH O 1 1.0
family O 0 0.030055591836571693
. O 0 0.014387723058462143

Factor B-Disease 1 0.9998759031295776
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.006107858382165432
the O 0 0.005911438260227442
only O 0 0.005757559090852737
complement B-Disease 1 0.9998922348022461
deficiency I-Disease 1 1.0
associated O 1 0.9454897046089172
with O 0 0.030436381697654724
HUS B-Disease 1 1.0
. O 0 0.0412023663520813

These O 0 0.0036890865303575993
observations O 0 0.006392328999936581
suggest O 0 0.004042427055537701
a O 0 0.0025028891395777464
role O 0 0.007054319605231285
for O 0 0.007538428530097008
FH O 1 1.0
and O 0 0.01018836535513401
/ O 1 0.9998955726623535
or O 0 0.01143903099000454
FH O 1 1.0
receptors O 0 0.009673832915723324
in O 0 0.002560658613219857
the O 0 0.0049500176683068275
pathogenesis O 1 1.0
of O 1 0.9999212026596069
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.1899884194135666
. O 0 0.013680684380233288

Further O 0 0.007625975646078587
evidence O 0 0.0037578693591058254
for O 0 0.0016856888541951776
a O 0 0.003303681267425418
major O 0 0.00848864484578371
ancient O 0 0.03384694829583168
mutation O 0 0.40582236647605896
underlying O 1 0.9999998807907104
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9998195767402649
linkage O 1 0.9999804496765137
disequilibrium O 1 0.9999443292617798
studies O 0 0.008097708225250244
in O 0 0.00382400956004858
the O 0 0.005620324518531561
Japanese O 0 0.02693362906575203
population O 0 0.007178077939897776
. O 0 0.007956934161484241

The O 0 0.14669294655323029
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 0.011960409581661224
mutation O 0 0.005962328985333443
is O 0 0.0016761617735028267
an O 0 0.003347318386659026
unstable O 1 0.9996053576469421
( O 0 0.021893395110964775
CTG O 1 0.9999997615814209
) O 0 0.009408092126250267
n O 0 0.014205001294612885
repeat O 0 0.01278171967715025
, O 0 0.002506529912352562
present O 0 0.003235297277569771
at O 0 0.00431277509778738
a O 0 0.003178357845172286
copy O 0 0.00582794938236475
number O 0 0.0018695616163313389
of O 0 0.004059852100908756
5 O 0 0.011146608740091324
- O 0 0.013448890298604965
37 O 0 0.012044413015246391
repeats O 0 0.01811160147190094
on O 0 0.004757240880280733
normal O 0 0.00803676713258028
chromosomes O 0 0.00863624643534422
but O 0 0.0017256595892831683
amplified O 0 0.007594040594995022
to O 0 0.002257897984236479
50 O 0 0.006262120325118303
- O 0 0.012528982013463974
3000 O 0 0.025185760110616684
copies O 0 0.008129529654979706
on O 0 0.011954298242926598
DM B-Disease 1 1.0
chromosomes O 0 0.0415877103805542
. O 0 0.011472695507109165

Previous O 0 0.01724121905863285
findings O 0 0.012458249926567078
in O 0 0.005861902609467506
Caucasian O 0 0.05295589193701744
populations O 0 0.006126754451543093
of O 0 0.008310946635901928
a O 0 0.03832462802529335
DM B-Disease 1 1.0
founder O 1 0.9999984502792358
chromosome O 0 0.02912129834294319
raise O 0 0.0072478787042200565
a O 0 0.0026812253054231405
question O 0 0.002947834087535739
about O 0 0.0016222300473600626
the O 0 0.0025798610877245665
molecular O 0 0.006390918046236038
events O 0 0.003353398758918047
involved O 0 0.0029897328931838274
in O 0 0.003866723272949457
the O 0 0.007849683985114098
expansion O 0 0.023871783167123795
mutation O 0 0.020682819187641144
. O 0 0.010139926336705685

To O 0 0.006894687656313181
investigate O 0 0.013057085685431957
whether O 0 0.00370617164298892
a O 0 0.005106364376842976
founder O 0 0.0451485700905323
chromosome O 0 0.013343478552997112
for O 0 0.0037849722430109978
the O 0 0.017512237653136253
DM B-Disease 1 1.0
mutation O 0 0.01683843322098255
exists O 0 0.004882652312517166
in O 0 0.002032740041613579
the O 0 0.003159254789352417
Japanese O 0 0.014390334486961365
population O 0 0.003145795315504074
, O 0 0.0022751919459551573
we O 0 0.0021444549784064293
genotyped O 0 0.03387345373630524
families O 0 0.004420974291861057
using O 0 0.003826391650363803
polymorphic O 0 0.02689257264137268
markers O 0 0.02647651545703411
near O 0 0.016768798232078552
the O 0 0.009333937428891659
( O 0 0.01557327713817358
CTG O 1 0.999990701675415
) O 0 0.008368502371013165
n O 0 0.01628096029162407
repeat O 0 0.018919330090284348
region O 0 0.009307211264967918
and O 0 0.004643944092094898
constructed O 0 0.05483817309141159
haplotypes O 0 0.22615483403205872
. O 0 0.015825623646378517

Six O 0 0.010081075131893158
different O 0 0.003071112558245659
haplotypes O 0 0.026754284277558327
were O 0 0.003195645520463586
found O 0 0.006756375078111887
and O 0 0.012040091678500175
DM B-Disease 1 1.0
alleles O 0 0.039581459015607834
were O 0 0.005777454935014248
always O 0 0.010314718820154667
haplotype O 0 0.04209741950035095
A O 0 0.02137942425906658
. O 0 0.013815411366522312

To O 0 0.006063045002520084
find O 0 0.004026682581752539
an O 0 0.001443868619389832
origin O 0 0.002154687186703086
of O 0 0.0038651477079838514
the O 0 0.008918318897485733
( O 0 0.015711037442088127
CTG O 1 0.999998927116394
) O 0 0.00975571759045124
n O 0 0.01715998910367489
repeat O 0 0.022890154272317886
mutation O 0 0.006608107127249241
and O 0 0.001274649752303958
to O 0 0.001728985458612442
investigate O 0 0.008329383097589016
the O 0 0.004575225990265608
mechanism O 0 0.0075219604186713696
of O 0 0.003186135785654187
the O 0 0.004941611085087061
expansion O 0 0.009492535144090652
mutation O 0 0.004837139043956995
in O 0 0.001833191723562777
the O 0 0.003045380115509033
Japanese O 0 0.01211901567876339
population O 0 0.0017654922557994723
we O 0 0.0006831968785263598
have O 0 0.0005319396732375026
studied O 0 0.0057560778222978115
90 O 0 0.009097244590520859
Japanese O 0 0.15388774871826172
DM B-Disease 1 1.0
families O 0 0.00844932533800602
comprising O 0 0.010137327946722507
190 O 0 0.0198624636977911
affected O 0 0.006298545747995377
and O 0 0.0029233437962830067
130 O 0 0.016833152621984482
unaffected O 0 0.030819743871688843
members O 0 0.006101551000028849
. O 0 0.008104437962174416

The O 0 0.015446467325091362
results O 0 0.007417154498398304
suggest O 0 0.004598807077854872
that O 0 0.0010152057511731982
a O 0 0.0020976278465241194
few O 0 0.0026095565408468246
common O 0 0.006538468413054943
ancestral O 0 0.041903190314769745
mutations O 0 0.008205377496778965
in O 0 0.0034164604730904102
both O 0 0.004225058481097221
Caucasian O 1 0.9998592138290405
and O 0 0.004783259704709053
Japanese O 0 0.2416563779115677
populations O 0 0.004989603068679571
have O 0 0.001056306529790163
originated O 0 0.0040235272608697414
by O 0 0.0009196583996526897
expansion O 0 0.003907741978764534
of O 0 0.0030692722648382187
an O 0 0.0044416519813239574
ancestral O 0 0.046877894550561905
n O 0 0.02288200706243515
= O 0 0.018538137897849083
5 O 0 0.004948969930410385
repeat O 0 0.009355125017464161
to O 0 0.003347531659528613
n O 0 0.017661308869719505
= O 0 0.023121260106563568
19 O 0 0.011876868084073067
- O 0 0.012704919092357159
37 O 0 0.01142669003456831
copies O 0 0.009426728822290897
. O 0 0.008057836443185806

These O 0 0.0047644926235079765
data O 0 0.004226956516504288
support O 0 0.005234611686319113
multistep O 0 0.0431508868932724
models O 0 0.010384035296738148
of O 0 0.011690682731568813
triplet O 1 0.9999809265136719
repeat O 0 0.07816009968519211
expansion O 0 0.007794674020260572
that O 0 0.0010699067497625947
have O 0 0.0006175442831590772
been O 0 0.0009341309778392315
proposed O 0 0.0018564668716862798
for O 0 0.0022198616061359644
both O 0 0.006975669879466295
DM B-Disease 1 1.0
and O 0 0.03600862994790077
Friedreichs B-Disease 1 1.0
ataxia I-Disease 1 1.0
. O 0 0.013950565829873085
. O 0 0.011767534539103508

The O 0 0.010009260848164558
molecular O 0 0.012525963596999645
basis O 0 0.007846961729228497
of O 0 0.03345149755477905
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.016741139814257622
the O 0 0.008114601485431194
western O 0 0.009599156677722931
Cape O 0 0.029990941286087036
, O 0 0.00557711860165
South O 0 0.013253848068416119
Africa O 0 0.021147195249795914
. O 0 0.009671896696090698

Deficiency B-Disease 1 1.0
of I-Disease 0 0.018539613112807274
the I-Disease 0 0.017530743032693863
sixth I-Disease 1 0.9952020645141602
component I-Disease 0 0.015456289052963257
of I-Disease 0 0.006464141421020031
human I-Disease 0 0.011279497295618057
complement I-Disease 0 0.058254092931747437
( O 0 0.0440606065094471
C6 O 1 1.0
) O 0 0.005734475329518318
has O 0 0.0020702730398625135
been O 0 0.0020236503332853317
reported O 0 0.004031809512525797
in O 0 0.0016873938729986548
a O 0 0.0017681329045444727
number O 0 0.001292529865168035
of O 0 0.0022956696338951588
families O 0 0.003176409751176834
from O 0 0.0021000888664275408
the O 0 0.0034032724797725677
western O 0 0.008084203116595745
Cape O 0 0.03852199763059616
, O 0 0.00504148518666625
South O 0 0.011798111721873283
Africa O 0 0.020722361281514168
. O 0 0.007179049775004387

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 0.02326730079948902
endemic O 1 0.8102740049362183
in O 0 0.005613833665847778
the O 0 0.00755078112706542
Cape O 0 0.025841886177659035
and O 0 0.001978331245481968
almost O 0 0.0019903460051864386
all O 0 0.0013278307160362601
pedigrees O 0 0.015502795577049255
of O 0 0.009211546741425991
total O 1 0.943779468536377
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9999794960021973
C6Q0 O 1 1.0
) O 0 0.0054813227616250515
have O 0 0.0008890014141798019
been O 0 0.00187122100032866
ascertained O 0 0.011545233428478241
because O 0 0.0029217489063739777
of O 0 0.012945471331477165
recurrent O 1 1.0
disease O 1 1.0
. O 1 0.9481493234634399

We O 0 0.005314009729772806
have O 0 0.0017842641100287437
sequenced O 0 0.007638016249984503
the O 0 0.002922370098531246
expressed O 0 0.0058008600026369095
exons O 0 0.018796272575855255
of O 0 0.005789656192064285
the O 0 0.016100313514471054
C6 O 1 1.0
gene O 0 0.008471867069602013
from O 0 0.002300618216395378
selected O 0 0.00466866884380579
cases O 0 0.003736568382009864
and O 0 0.0016406929353252053
have O 0 0.0011738402536138892
found O 0 0.0022692957427352667
three O 0 0.0037623061798512936
molecular O 0 0.03180382400751114
defects O 1 0.9999986886978149
leading O 1 0.9689508676528931
to O 0 0.011060538701713085
total O 1 0.7600663900375366
deficiency O 1 1.0
879delG O 1 1.0
, O 0 0.004140697419643402
which O 0 0.0014840366784483194
is O 0 0.0015941071324050426
the O 0 0.0035185213200747967
common O 0 0.009797170758247375
defect O 1 0.9996077418327332
in O 0 0.007211689371615648
the O 0 0.010544557124376297
Cape O 0 0.1939155012369156
and O 0 0.00505551602691412
hitherto O 0 0.04048484191298485
unreported O 0 0.06088836118578911
, O 0 0.0064179180189967155
and O 0 0.0065199630334973335
1195delC O 1 0.9999852180480957
and O 0 0.00980879832059145
1936delG O 1 0.999991774559021
, O 0 0.005124540999531746
which O 0 0.0017001809319481254
have O 0 0.0007555157644674182
been O 0 0.0015786010771989822
previously O 0 0.0037750867195427418
reported O 0 0.005193003453314304
in O 0 0.004112563095986843
African O 0 0.024143939837813377
- O 0 0.02717074193060398
Americans O 0 0.011724322102963924
. O 0 0.007626964710652828

We O 0 0.006854198407381773
also O 0 0.0032817882020026445
show O 0 0.0038920631632208824
that O 0 0.001209111651405692
the O 0 0.005187527276575565
879delG O 1 0.9991334080696106
and O 0 0.008388993330299854
1195delC O 1 0.9999992847442627
defects O 1 0.9999678134918213
are O 0 0.002354744588956237
associated O 0 0.005081256851553917
with O 0 0.004412498790770769
characteristic O 1 0.9999995231628418
C6 O 1 1.0
/ O 1 1.0
C7 O 1 1.0
region O 0 0.041870709508657455
DNA O 0 0.03146650642156601
marker O 0 0.17022576928138733
haplotypes O 0 0.03420533612370491
, O 0 0.0027320445515215397
although O 0 0.0020316289737820625
small O 0 0.002111949725076556
variations O 0 0.006491098087280989
were O 0 0.003989518154412508
observed O 0 0.01197072770446539
. O 0 0.011113733984529972

The O 0 0.03842022269964218
1936delG O 1 0.9999922513961792
defect O 1 0.9999449253082275
was O 0 0.01447917241603136
observed O 0 0.004859596025198698
only O 0 0.0014199147699400783
once O 0 0.0034143405500799417
in O 0 0.0023176707327365875
the O 0 0.004741206299513578
Cape O 0 0.03344077989459038
, O 0 0.0029932144097983837
but O 0 0.001320464420132339
its O 0 0.00269826827570796
associated O 0 0.008942280896008015
haplotype O 0 0.03470657765865326
could O 0 0.0034821596927940845
be O 0 0.0032819530460983515
deduced O 0 0.03420091047883034
. O 0 0.00954671110957861

The O 0 0.01077656727284193
data O 0 0.004107597749680281
from O 0 0.0032063534017652273
the O 0 0.004833671730011702
haplotypes O 0 0.026137003675103188
indicate O 0 0.004516875836998224
that O 0 0.0007489202544093132
these O 0 0.0007265429012477398
three O 0 0.0025732642970979214
molecular O 0 0.021876569837331772
defects O 1 0.998824417591095
account O 0 0.005420438013970852
for O 0 0.0038430294953286648
the O 0 0.008559681475162506
defects O 1 0.99998939037323
in O 0 0.0039023240096867085
all O 0 0.0019585099071264267
the O 0 0.004233488813042641
38 O 0 0.014326831325888634
unrelated O 0 0.029922617599368095
C6Q0 O 1 0.9999960660934448
individuals O 0 0.0026429642457515
we O 0 0.0011767480755224824
have O 0 0.0007484550587832928
studied O 0 0.005226681474596262
from O 0 0.003318190574645996
the O 0 0.008002596907317638
Cape O 0 0.3452286124229431
. O 0 0.015237340703606606

We O 0 0.005272413603961468
have O 0 0.0014964024303480983
also O 0 0.0022319206036627293
observed O 0 0.0043421098962426186
the O 0 0.0061188191175460815
879delG O 1 0.99921715259552
defect O 1 0.830698549747467
in O 0 0.00439881207421422
two O 0 0.004395102150738239
Dutch O 1 0.9996824264526367
C6 B-Disease 1 1.0
- I-Disease 1 0.9999986886978149
deficient I-Disease 1 0.9999998807907104
kindreds O 0 0.09600197523832321
, O 0 0.003887699218466878
but O 0 0.001625692006200552
the O 0 0.0061174300499260426
879delG O 1 0.9999943971633911
defect O 1 0.9997089505195618
in O 0 0.005917761009186506
the O 0 0.008334367536008358
Cape O 1 0.6120314002037048
probably O 0 0.005852595902979374
did O 0 0.0017624140018597245
not O 0 0.0007035586168058217
come O 0 0.0011939428513869643
from O 0 0.001512683229520917
The O 0 0.004216678906232119
Netherlands O 0 0.020941035822033882
. O 0 0.004502895753830671
. O 0 0.007051287218928337

Complement B-Disease 1 0.9999873638153076
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.019641133025288582
seven O 0 0.008324205875396729
further O 0 0.006608498282730579
molecular O 0 0.04236892983317375
defects O 1 0.9999985694885254
and O 0 0.004767949227243662
their O 0 0.005890912376344204
associated O 0 0.01721581071615219
marker O 1 0.9995790123939514
haplotypes O 0 0.16188395023345947
. O 0 0.014373409561812878

Seven O 0 0.011283667758107185
further O 0 0.005357078276574612
molecular O 0 0.011918536387383938
bases O 0 0.014440128579735756
of O 1 0.5759773850440979
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.009184576570987701
described O 0 0.020814260467886925
. O 0 0.012740185484290123

All O 0 0.003937581554055214
these O 0 0.0021051892545074224
new O 0 0.006290955003350973
molecular O 0 0.028871748596429825
defects O 1 0.9998902082443237
involve O 0 0.01663905382156372
single O 0 0.015764549374580383
- O 0 0.024379227310419083
nucleotide O 0 0.01276768371462822
events O 0 0.003943784162402153
, O 0 0.003034027758985758
deletions O 0 0.01220015436410904
and O 0 0.0027046091854572296
substitutions O 0 0.009886350482702255
, O 0 0.0021874511148780584
some O 0 0.0010913631413131952
of O 0 0.0032598034013062716
which O 0 0.0034462970215827227
alter O 0 0.019064102321863174
splice O 0 0.04209505021572113
sites O 0 0.005269208457320929
, O 0 0.002836839994415641
and O 0 0.002800833899527788
others O 0 0.009269948117434978
codons O 0 0.051460400223731995
. O 0 0.01181549672037363

They O 0 0.0033825484570115805
are O 0 0.0012308810837566853
distributed O 0 0.003352452302351594
along O 0 0.004973139148205519
the O 0 0.012588112615048885
C7 O 1 1.0
gene O 0 0.012059525586664677
, O 0 0.0023557529784739017
but O 0 0.0010479888878762722
predominantly O 0 0.0034229187294840813
towards O 0 0.005078379064798355
the O 0 0.005870314314961433
3 O 0 0.014914249069988728
end O 0 0.013896189630031586
. O 0 0.010228287428617477

All O 0 0.004534721840173006
were O 0 0.0025097988545894623
found O 0 0.003396920394152403
in O 0 0.004538225010037422
compound O 0 0.04065210372209549
heterozygous O 0 0.019089316949248314
individuals O 0 0.003968127071857452
. O 0 0.00690065510571003

The O 0 0.09845577925443649
C6 O 1 1.0
/ O 1 0.9999990463256836
C7 O 1 1.0
marker O 1 0.9020553827285767
haplotypes O 0 0.050568487495183945
associated O 0 0.007127898279577494
with O 0 0.0037882854230701923
most O 0 0.012377120554447174
C7 B-Disease 1 1.0
defects I-Disease 1 1.0
are O 0 0.007004182785749435
tabulated O 0 0.04618252068758011
. O 0 0.005307238548994064
. O 0 0.007187708746641874

A O 0 0.030662762001156807
genome O 0 0.02419467084109783
- O 0 0.01052924431860447
wide O 0 0.0030471812933683395
search O 0 0.00430521322414279
for O 0 0.0038561986293643713
chromosomal O 1 0.8977879285812378
loci O 1 0.9774978756904602
linked O 0 0.03929263353347778
to O 0 0.008392690680921078
mental O 1 1.0
health O 1 1.0
wellness O 1 1.0
in O 0 0.007573147304356098
relatives O 0 0.011919042095541954
at O 0 0.006445420905947685
high O 0 0.008454672992229462
risk O 0 0.010400370694696903
for O 0 0.011265839450061321
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.8812524676322937
the O 0 0.0291235763579607
Old O 1 0.8554093837738037
Order O 0 0.015222994610667229
Amish O 0 0.06744269281625748
. O 0 0.010471200570464134

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 1.0
BPAD B-Disease 1 1.0
; O 1 0.9997096657752991
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.31036099791526794
is O 0 0.0038093551993370056
characterized O 0 0.008639479987323284
by O 0 0.0023336110170930624
episodes O 0 0.015879953280091286
of O 0 0.018271554261446
mania B-Disease 1 1.0
and O 1 0.9091261625289917
/ O 1 0.9999998807907104
or O 0 0.014774796552956104
hypomania B-Disease 1 1.0
interspersed O 0 0.03797793388366699
with O 0 0.004175015725195408
periods O 0 0.019910266622900963
of O 0 0.026486866176128387
depression B-Disease 1 1.0
. O 0 0.03658512234687805

Compelling O 0 0.02973434142768383
evidence O 0 0.009381943382322788
supports O 0 0.008721677586436272
a O 0 0.0039061831776052713
significant O 0 0.004650472663342953
genetic O 0 0.009113806299865246
component O 0 0.011644923128187656
in O 0 0.0038162192795425653
the O 0 0.006605629809200764
susceptibility O 0 0.08577513694763184
to O 0 0.009886004962027073
develop O 0 0.30665144324302673
BPAD B-Disease 1 1.0
. O 0 0.022452479228377342

To O 0 0.007407584693282843
date O 0 0.008859523572027683
, O 0 0.002907858695834875
however O 0 0.003253711387515068
, O 0 0.0032221595756709576
linkage O 0 0.01587691903114319
studies O 0 0.004008822608739138
have O 0 0.0010876967571675777
attempted O 0 0.005077154841274023
only O 0 0.0015636205207556486
to O 0 0.0026997760869562626
identify O 0 0.0140510443598032
chromosomal O 1 0.9934306740760803
loci O 1 0.6120368838310242
that O 0 0.0033135355915874243
cause O 0 0.011000050231814384
or O 0 0.004240437410771847
increase O 0 0.004895913880318403
the O 0 0.005522221326828003
risk O 0 0.011397323571145535
of O 0 0.009603169746696949
developing O 1 0.9800094962120056
BPAD B-Disease 1 1.0
. O 0 0.02138005755841732

To O 0 0.0085177356377244
determine O 0 0.008699747733771801
whether O 0 0.003558974713087082
there O 0 0.0025927741080522537
could O 0 0.0022770410869270563
be O 0 0.0025959068443626165
protective O 0 0.030979439616203308
alleles O 0 0.01476343348622322
that O 0 0.002133747562766075
prevent O 0 0.009473257698118687
or O 0 0.0051242392510175705
reduce O 0 0.010276930406689644
the O 0 0.006323790643364191
risk O 0 0.012635331600904465
of O 0 0.010605545714497566
developing O 1 0.9693843126296997
BPAD B-Disease 1 1.0
, O 0 0.003752425080165267
similar O 0 0.0016576034249737859
to O 0 0.0011832008603960276
what O 0 0.0009167145472019911
is O 0 0.001041088835336268
observed O 0 0.00168798363301903
in O 0 0.0016992188757285476
other O 0 0.002797200344502926
genetic B-Disease 1 0.9999955892562866
disorders I-Disease 1 1.0
, O 0 0.09567312151193619
we O 0 0.004887863527983427
used O 0 0.009338779374957085
mental O 1 1.0
health O 1 1.0
wellness O 1 1.0
( O 0 0.013401875272393227
absence O 0 0.008804315701127052
of O 0 0.0047940886579453945
any O 0 0.006285868119448423
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.07911869138479233
as O 0 0.003321927273645997
the O 0 0.004322700668126345
phenotype O 0 0.011919401586055756
in O 0 0.0034384403843432665
our O 0 0.00577067956328392
genome O 0 0.014137213118374348
- O 0 0.012573209591209888
wide O 0 0.006420639343559742
linkage O 0 0.026228725910186768
scan O 0 0.014042696915566921
of O 0 0.003908026032149792
several O 0 0.0023614484816789627
large O 0 0.00570392981171608
multigeneration O 1 0.9670777320861816
Old O 0 0.030466297641396523
Order O 0 0.00960854534059763
Amish O 0 0.04628157615661621
pedigrees O 0 0.027017509564757347
exhibiting O 0 0.018065406009554863
an O 0 0.004764603450894356
extremely O 0 0.013720551505684853
high O 0 0.0232489425688982
incidence O 1 0.9999938011169434
of O 1 0.9873835444450378
BPAD B-Disease 1 1.0
. O 0 0.03213205561041832

We O 0 0.00707246595993638
have O 0 0.0015994140412658453
found O 0 0.0026129665784537792
strong O 0 0.0026367641985416412
evidence O 0 0.0027539883740246296
for O 0 0.002153664128854871
a O 0 0.005048577208071947
locus O 0 0.030495326966047287
on O 0 0.009495431557297707
chromosome O 0 0.02939319983124733
4p O 1 0.9939619898796082
at O 0 0.016442090272903442
D4S2949 O 1 0.5700894594192505
( O 0 0.009948129765689373
maximum O 0 0.0157164353877306
GENEHUNTER O 1 0.9999996423721313
- O 0 0.03329886496067047
PLUS O 0 0.02923211269080639
nonparametric O 0 0.07075101882219315
linkage O 0 0.024953428655862808
score O 0 0.007183068431913853
= O 0 0.0202716626226902
4 O 0 0.007263678591698408
. O 0 0.0030114410910755396
05 O 0 0.08221135288476944
, O 0 0.009126672521233559
P O 0 0.07013894617557526
= O 0 0.023656265810132027
5 O 0 0.004712472204118967
. O 0 0.0013979418436065316
22 O 0 0.005903816316276789
x O 0 0.010082640685141087
10 O 0 0.004395029041916132
( O 0 0.0049474225379526615
- O 0 0.009892522357404232
4 O 0 0.007551206275820732
) O 0 0.003528117435052991
; O 0 0.0037346624303609133
SIBPAL O 1 0.9998894929885864
Pempirical O 1 0.9970934391021729
value O 0 0.008760323747992516
< O 0 0.027526874095201492
3 O 0 0.007300569210201502
x O 0 0.00997557956725359
10 O 0 0.00467403419315815
( O 0 0.006081824190914631
- O 0 0.011041450314223766
5 O 0 0.006866284180432558
) O 0 0.0032889018766582012
) O 0 0.0021094169933348894
and O 0 0.0014652537647634745
suggestive O 0 0.014257103204727173
evidence O 0 0.0038237206172198057
for O 0 0.0025989816058427095
a O 0 0.005973632447421551
locus O 0 0.030446629971265793
on O 0 0.009337046183645725
chromosome O 0 0.03357997164130211
4q O 1 0.9993394017219543
at O 0 0.019435346126556396
D4S397 O 1 0.9976446032524109
( O 0 0.011469395831227303
maximum O 0 0.014214017428457737
GENEHUNTER O 1 0.9999915361404419
- O 0 0.030893737450242043
PLUS O 0 0.0320245698094368
nonparametric O 0 0.07506527751684189
linkage O 0 0.028203677386045456
score O 0 0.007384312804788351
= O 0 0.017969749867916107
3 O 0 0.005238391924649477
. O 0 0.001902789226733148
29 O 0 0.00827716663479805
, O 0 0.004297785926610231
P O 0 0.05976269394159317
= O 0 0.01867588981986046
2 O 0 0.005109689198434353
. O 0 0.0014367622788995504
57 O 0 0.009088209830224514
x O 0 0.010581595823168755
10 O 0 0.0050464170053601265
( O 0 0.006044235546141863
- O 0 0.009353923611342907
3 O 0 0.007322982419282198
) O 0 0.0038985467981547117
; O 0 0.0042976695112884045
SIBPAL O 1 0.9984800219535828
Pempirical O 1 0.9823325276374817
value O 0 0.01133654173463583
< O 0 0.033741455525159836
1 O 0 0.009725406765937805
x O 0 0.011999242007732391
10 O 0 0.005256542004644871
( O 0 0.007002667523920536
- O 0 0.012601147405803204
3 O 0 0.006909012328833342
) O 0 0.00237985304556787
) O 0 0.0012675805483013391
that O 0 0.0005460656830109656
are O 0 0.0008945090812630951
linked O 0 0.010945371352136135
to O 0 0.008893964812159538
mental O 1 1.0
health O 1 1.0
wellness O 1 1.0
. O 0 0.034953970462083817

These O 0 0.00618250435218215
findings O 0 0.008244148455560207
are O 0 0.0013656411319971085
consistent O 0 0.0055278753861784935
with O 0 0.0017098627286031842
the O 0 0.005194318480789661
hypothesis O 0 0.01054664608091116
that O 0 0.0013770308578386903
certain O 0 0.0027409298345446587
alleles O 0 0.011554609052836895
could O 0 0.002434711903333664
prevent O 0 0.007431413978338242
or O 0 0.003932214342057705
modify O 0 0.010476508177816868
the O 0 0.006084697786718607
clinical O 1 0.9995338916778564
manifestations O 1 0.9999954700469971
of O 1 0.9981909394264221
BPAD B-Disease 1 1.0
and O 0 0.005683287512511015
perhaps O 0 0.00678174989297986
other O 0 0.003976677544414997
related O 1 0.6079511642456055
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 1 0.999040424823761

Segregation O 1 0.9999674558639526
distortion O 1 0.9999088048934937
in O 1 0.8362839818000793
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9763917326927185

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.00892335269600153
is O 0 0.0022983753588050604
an O 0 0.003332691267132759
autosomal B-Disease 1 0.9999990463256836
dominant I-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
which O 0 0.006277381908148527
, O 0 0.003950687125325203
in O 0 0.0036646313965320587
the O 0 0.005953495390713215
typical O 0 0.01511765830218792
pedigree O 0 0.021330419927835464
, O 0 0.0027733768802136183
shows O 0 0.0030518698040395975
a O 0 0.0028215593192726374
three O 0 0.004272171761840582
generation O 0 0.023175422102212906
anticipation O 0 0.04139195382595062
cascade O 0 0.08899205178022385
. O 0 0.016724728047847748

This O 0 0.003782658837735653
results O 0 0.0063685267232358456
in O 0 0.008112620562314987
infertility B-Disease 1 1.0
and O 1 0.9999891519546509
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
CDM B-Disease 1 1.0
) O 0 0.003998900763690472
with O 0 0.000973630987573415
the O 0 0.0034613602329045534
disappearance O 0 0.03262483701109886
of O 0 0.1656266152858734
DM B-Disease 1 1.0
in O 0 0.014325929805636406
that O 0 0.005399745423346758
pedigree O 0 0.04227681830525398
. O 0 0.010092020034790039

The O 0 0.011127504520118237
concept O 0 0.013406181707978249
of O 0 0.012575969099998474
segregation O 1 0.9999905824661255
distortion O 1 0.9991161227226257
, O 0 0.004901273176074028
where O 0 0.003987317439168692
there O 0 0.002460520016029477
is O 0 0.003966033924371004
preferential O 0 0.020009830594062805
transmission O 0 0.010552738793194294
of O 0 0.003346289275214076
the O 0 0.004327123984694481
larger O 0 0.0038606319576501846
allele O 0 0.007627822458744049
at O 0 0.006240773946046829
the O 0 0.013155287131667137
DM B-Disease 1 1.0
locus O 1 0.9987388253211975
, O 0 0.005523949861526489
has O 0 0.0024141736794263124
been O 0 0.0025016595609486103
put O 0 0.0034681616816669703
forward O 0 0.002486003329977393
to O 0 0.0018796464428305626
explain O 0 0.008046372793614864
partially O 0 0.014292529784142971
the O 0 0.006358564365655184
maintenance O 1 0.9811766743659973
of O 0 0.0754452720284462
DM B-Disease 1 1.0
in O 0 0.010495630092918873
the O 0 0.008874993771314621
population O 0 0.0052847969345748425
. O 0 0.00589080061763525

In O 0 0.006435162387788296
a O 0 0.005328195169568062
survey O 0 0.008888213895261288
of O 0 0.009411895647644997
DM B-Disease 1 1.0
in O 0 0.007570208981633186
Northern O 0 0.010015045292675495
Ireland O 0 0.007807611022144556
, O 0 0.003787288209423423
59 O 0 0.02074725367128849
pedigrees O 0 0.03594542667269707
were O 0 0.007364145014435053
ascertained O 0 0.04689923673868179
. O 0 0.013108199462294579

Sibships O 1 0.8623409867286682
where O 0 0.008159609511494637
the O 0 0.004634304437786341
status O 0 0.005594417452812195
of O 0 0.003247899003326893
all O 0 0.0017982997233048081
the O 0 0.00293352291919291
members O 0 0.002146770479157567
had O 0 0.0029188983608037233
been O 0 0.0019290741765871644
identified O 0 0.0039568315260112286
were O 0 0.0017083397833630443
examined O 0 0.008340020664036274
to O 0 0.0023013250902295113
determine O 0 0.003608854254707694
the O 0 0.0037189729046076536
transmission O 0 0.01038234494626522
of O 0 0.00633486220613122
the O 0 0.027464205399155617
DM B-Disease 1 1.0
expansion O 0 0.018871719017624855
from O 0 0.004326696507632732
affected O 0 0.005358291789889336
parents O 0 0.003873629728332162
to O 0 0.0025708924513310194
their O 0 0.003857869654893875
offspring O 0 0.021383915096521378
. O 0 0.010006358847022057

Where O 0 0.011980633251369
the O 0 0.011492103338241577
transmitting O 0 0.05981738120317459
parent O 0 0.01905418187379837
was O 0 0.01206186693161726
male O 0 0.012922151945531368
, O 0 0.005944421514868736
58 O 0 0.030949309468269348
. O 0 0.01124794315546751

3 O 0 0.01953219249844551
% O 0 0.005379423964768648
of O 0 0.004212190397083759
the O 0 0.00816887617111206
offspring O 0 0.0150507977232337
were O 0 0.003962883725762367
affected O 0 0.0065299756824970245
, O 0 0.002307394053786993
and O 0 0.0015321201644837856
in O 0 0.0021352272015064955
the O 0 0.0028079035691916943
case O 0 0.003470675554126501
of O 0 0.0032905370462685823
a O 0 0.006571398116648197
female O 0 0.020337095484137535
transmitting O 0 0.061711929738521576
parent O 0 0.017170390114188194
, O 0 0.006844432093203068
68 O 0 0.03485182672739029
. O 0 0.011780407279729843

7 O 0 0.03779207915067673
% O 0 0.010913794860243797
were O 0 0.00583232194185257
affected O 0 0.018311087042093277
. O 0 0.015517768450081348

Studies O 0 0.017170969396829605
on O 0 0.013619297184050083
meiotic O 1 0.9999794960021973
drive O 0 0.02563665434718132
in O 0 0.015544282272458076
DM B-Disease 1 1.0
have O 0 0.004418231546878815
shown O 0 0.006573920603841543
increased O 0 0.005558065138757229
transmission O 0 0.008028382435441017
of O 0 0.003274748334661126
the O 0 0.004497937858104706
larger O 0 0.0038174446672201157
allele O 0 0.007021050900220871
at O 0 0.005744428839534521
the O 0 0.009716741740703583
DM B-Disease 1 1.0
locus O 0 0.24364928901195526
in O 0 0.0086826728656888
non O 0 0.2155679613351822
- O 1 0.9973064661026001
DM O 1 1.0
heterozygotes O 1 0.985547661781311
for O 0 0.015134450979530811
CTGn O 1 0.9967895150184631
. O 0 0.019596436992287636

This O 0 0.005042367614805698
study O 0 0.0056639378890395164
provides O 0 0.004653342068195343
further O 0 0.0023157873656600714
evidence O 0 0.003183763474225998
that O 0 0.0020085126161575317
the O 0 0.010436848737299442
DM B-Disease 1 1.0
expansion O 0 0.023734746500849724
tends O 0 0.013043365441262722
to O 0 0.0026710033416748047
be O 0 0.0031001081224530935
transmitted O 0 0.021351592615246773
preferentially O 0 0.030111657455563545
. O 0 0.009815563447773457

Diagnosis O 1 1.0
of O 1 0.9999607801437378
hemochromatosis B-Disease 1 1.0
. O 1 0.6367146968841553

If O 0 0.02229825221002102
untreated O 1 1.0
, O 1 0.8326701521873474
hemochromatosis B-Disease 1 1.0
can O 0 0.02636226825416088
cause O 1 0.9999865293502808
serious O 1 1.0
illness O 1 1.0
and O 0 0.02820737659931183
early B-Disease 0 0.05547803267836571
death I-Disease 1 0.7130926251411438
, O 0 0.0023429004941135645
but O 0 0.0010122435633093119
the O 0 0.004394640680402517
disease O 1 1.0
is O 0 0.004515460692346096
still O 0 0.005065135657787323
substantially O 0 0.01130102388560772
under O 0 0.012686640955507755
- O 1 0.9993867874145508
diagnosed O 1 1.0
. O 0 0.021317055448889732

The O 0 0.02013017050921917
cornerstone O 1 0.5200256109237671
of O 0 0.01196572557091713
screening O 0 0.018384767696261406
and O 0 0.0036523735616356134
case O 0 0.007137508597224951
detection O 0 0.011669283732771873
is O 0 0.002785570453852415
the O 0 0.004464253783226013
measurement O 0 0.01506023108959198
of O 0 0.014388319104909897
serum O 1 0.9999616146087646
transferrin O 1 0.9814046025276184
saturation O 0 0.03997286036610603
and O 0 0.005502480082213879
the O 0 0.014513581059873104
serum O 1 0.9996150732040405
ferritin O 1 0.9993403553962708
level O 0 0.024964764714241028
. O 0 0.011594606563448906

Once O 0 0.0196399949491024
the O 0 0.011505990289151669
diagnosis O 1 0.9999983310699463
is O 0 0.007356908638030291
suspected O 0 0.017787978053092957
, O 0 0.004325402434915304
physicians O 0 0.02171754091978073
must O 0 0.005156598519533873
use O 0 0.007717248518019915
serum O 1 0.999242901802063
ferritin O 1 0.9997732043266296
levels O 0 0.01978534273803234
and O 0 0.008587061427533627
hepatic O 1 1.0
iron O 1 1.0
stores O 0 0.05215562880039215
on O 0 0.025220224633812904
liver O 1 1.0
biopsy O 1 0.9999972581863403
specimens O 0 0.017702652141451836
to O 0 0.00428997166454792
assess O 0 0.015263836830854416
patients O 0 0.012616843916475773
for O 0 0.0024103366304188967
the O 0 0.003981668967753649
presence O 0 0.007515181787312031
of O 0 0.014151408337056637
iron B-Disease 1 1.0
overload I-Disease 1 1.0
. O 0 0.023490577936172485

Liver O 1 1.0
biopsy O 1 1.0
is O 0 0.00835808552801609
also O 0 0.0031896240543574095
used O 0 0.0019676389638334513
to O 0 0.0013816270511597395
establish O 0 0.004454292356967926
the O 0 0.002531397622078657
presence O 0 0.0038127622101455927
or O 0 0.0028461546171456575
absence O 0 0.012373407371342182
of O 0 0.32161566615104675
cirrhosis B-Disease 1 1.0
, O 0 0.029927033931016922
which O 0 0.004316946025937796
can O 0 0.003368131350725889
affect O 0 0.01217062957584858
prognosis O 1 1.0
and O 0 0.009025327861309052
management O 1 0.6489068865776062
. O 0 0.016247587278485298

A O 0 0.028434451669454575
DNA O 0 0.022055117413401604
- O 0 0.009622231125831604
based O 0 0.0020452800672501326
test O 0 0.002799821784719825
for O 0 0.0023261287715286016
the O 0 0.007894724607467651
HFE O 1 0.9999998807907104
gene O 0 0.013306195847690105
is O 0 0.002939470810815692
commercially O 0 0.004773382563143969
available O 0 0.0017995241796597838
, O 0 0.001175351208075881
but O 0 0.0006612596334889531
its O 0 0.0009859857382252812
place O 0 0.0023535999935120344
in O 0 0.002403238322585821
the O 0 0.006586469244211912
diagnosis O 1 1.0
of O 1 0.9999309778213501
hemochromatosis B-Disease 1 1.0
is O 0 0.02280077524483204
still O 0 0.007908978499472141
being O 0 0.006543807685375214
evaluated O 0 0.024034922942519188
. O 0 0.009521720930933952

Currently O 0 0.01504850760102272
, O 0 0.0038201098795980215
the O 0 0.0029460268560796976
most O 0 0.0016712314682081342
useful O 0 0.0036267582327127457
role O 0 0.004250790923833847
for O 0 0.0015430585481226444
this O 0 0.0012640366330742836
test O 0 0.002877885475754738
is O 0 0.0012902588350698352
in O 0 0.001547010149806738
the O 0 0.0033823412377387285
detection O 0 0.011931357905268669
of O 0 0.0107125798240304
hemochromatosis B-Disease 1 1.0
in O 0 0.00837844517081976
the O 0 0.005696485284715891
family O 0 0.005106844007968903
members O 0 0.0016988679999485612
of O 0 0.0034069858957082033
patients O 1 0.7922500371932983
with O 0 0.002520294627174735
a O 0 0.005134101491421461
proven O 0 0.013963842764496803
case O 0 0.004365761298686266
of O 0 0.005730452947318554
the O 0 0.022846216335892677
disease O 1 1.0
. O 0 0.02142462134361267

It O 0 0.003565853228792548
is O 0 0.0027497396804392338
crucial O 0 0.008450084365904331
to O 0 0.007412472739815712
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999996423721313
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 1.0
because O 1 0.8858906030654907
phlebotomy O 1 1.0
therapy O 1 0.9999994039535522
can O 0 0.00626926077529788
avert O 1 0.9999648332595825
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 1 0.9719369411468506
can O 0 0.002768964972347021
even O 0 0.0017493803752586246
lead O 0 0.00305221532471478
to O 0 0.002022533444687724
normal O 0 0.007916267029941082
life O 0 0.012218566611409187
expectancy O 1 0.6636562347412109
. O 0 0.00667380029335618
. O 0 0.009370028972625732

Prevalence O 1 0.7908081412315369
of O 0 0.01405030395835638
the O 0 0.024049600586295128
I1307K O 1 0.9999954700469971
APC B-Disease 1 0.999990701675415
gene O 0 0.013332949951291084
variant O 0 0.011886436492204666
in O 0 0.0021186594385653734
Israeli O 0 0.004729309119284153
Jews O 0 0.004610530566424131
of O 0 0.002151567256078124
differing O 0 0.0023523352574557066
ethnic O 0 0.002855659229680896
origin O 0 0.0037067383527755737
and O 0 0.003795098979026079
risk O 0 0.16408023238182068
for O 1 0.990934431552887
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9993550181388855

BACKGROUND O 0 0.07797884196043015
& O 1 0.7452706098556519
AIMS O 0 0.0372261106967926
Israeli O 0 0.009899101220071316
Jews O 0 0.0076519506983459
of O 0 0.004242727067321539
European O 0 0.008704534731805325
birth O 1 0.8260719776153564
, O 0 0.005640672519803047
i O 0 0.005919408053159714
. O 0 0.0018909105565398932
e O 0 0.006518082693219185
. O 0 0.0016607344150543213
, O 0 0.0028433692641556263
Ashkenazim O 0 0.03631201386451721
, O 0 0.002347709145396948
have O 0 0.0011060895631089807
the O 0 0.006153951399028301
highest O 1 0.9999983310699463
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 1.0
of O 1 0.9728589057922363
any O 0 0.004972346127033234
Israeli O 0 0.009278777986764908
ethnic O 0 0.006231997162103653
group O 0 0.006989949848502874
. O 0 0.007486860733479261

The O 0 0.03008192405104637
I1307K O 1 0.9998078942298889
APC B-Disease 1 0.9999529123306274
gene O 0 0.019635271281003952
variant O 0 0.01988258585333824
was O 0 0.006733683869242668
found O 0 0.004440604709088802
in O 0 0.00566965201869607
6 O 0 0.023247212171554565
. O 0 0.010295703075826168

1 O 0 0.021403325721621513
% O 0 0.0042203264310956
of O 0 0.002581328619271517
American O 0 0.0057175955735147
Jews O 0 0.007939082570374012
, O 0 0.0029982018750160933
28 O 0 0.007215900346636772
% O 0 0.002614070661365986
of O 0 0.003648592857643962
their O 0 0.008625597693026066
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 1.0
, O 0 0.012228782288730145
but O 0 0.0017857084749266505
not O 0 0.0010332445381209254
in O 0 0.0030544360633939505
non O 0 0.015466015785932541
- O 0 0.026772990822792053
Jews O 0 0.025541778653860092
. O 0 0.013025895692408085

We O 0 0.00801632646471262
assessed O 0 0.01619553379714489
the O 0 0.010706346482038498
I1307K O 1 0.9958674907684326
prevalence O 0 0.2581852972507477
in O 0 0.0035646355245262384
Israeli O 0 0.006577913649380207
Jews O 0 0.005379306618124247
of O 0 0.002281191758811474
differing O 0 0.0026626961771398783
ethnic O 0 0.002915453165769577
origin O 0 0.0036426002625375986
and O 0 0.003390147350728512
risk O 0 0.18582652509212494
for O 1 0.9867498278617859
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9997915625572205

METHODS O 0 0.03439096361398697
DNA O 0 0.015163463540375233
samples O 0 0.0068047079257667065
from O 0 0.003340197494253516
500 O 0 0.009244191460311413
unrelated O 0 0.01048818975687027
Jews O 0 0.0077367424964904785
of O 0 0.005000666715204716
European O 0 0.007415330037474632
or O 0 0.006148167420178652
non O 0 0.014222010970115662
- O 0 0.010587237775325775
European O 0 0.002752062398940325
origin O 0 0.0025917482562363148
, O 0 0.001681947149336338
with O 0 0.001373618608340621
or O 0 0.002648997353389859
without O 0 0.0019744636956602335
a O 0 0.003890973050147295
personal O 0 0.01306138839572668
and O 0 0.006223524454981089
/ O 1 0.9988106489181519
or O 0 0.003443301422521472
family O 0 0.006031947210431099
history O 0 0.00888779666274786
of O 0 0.01208437792956829
neoplasia B-Disease 1 1.0
, O 0 0.005094005726277828
were O 0 0.002766879741102457
examined O 0 0.008367861621081829
for O 0 0.002615625038743019
the O 0 0.006780728232115507
I1307K O 1 0.8265059590339661
variant O 0 0.013844599016010761
by O 0 0.0018677687039598823
the O 0 0.0051948754116892815
allele O 0 0.017382405698299408
- O 0 0.012211732566356659
specific O 0 0.005471101030707359
oligonucleotide O 0 0.07581887394189835
( O 0 0.01909223571419716
ASO O 1 0.9999991655349731
) O 0 0.008884823881089687
method O 0 0.01217597909271717
. O 0 0.008090817369520664

RESULTS O 0 0.015150666236877441
In O 0 0.0035645540338009596
persons O 0 0.004203578922897577
at O 0 0.00551395770162344
average O 0 0.006746363826096058
risk O 0 0.010548598133027554
for O 0 0.015414562076330185
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.97640061378479
I1307K O 1 0.9999469518661499
was O 0 0.008297481574118137
found O 0 0.0033167509827762842
in O 0 0.0037909422535449266
5 O 0 0.011121660470962524
. O 0 0.006214138586074114

0 O 0 0.02280324324965477
% O 0 0.004201156552881002
of O 0 0.0031901062466204166
120 O 0 0.008481982164084911
European O 0 0.004651390947401524
and O 0 0.0036092933733016253
1 O 0 0.01926182210445404
. O 0 0.00899996142834425

6 O 0 0.02481978014111519
% O 0 0.005976220592856407
of O 0 0.005499433260411024
188 O 0 0.03957514092326164
non O 0 0.016213439404964447
- O 0 0.01151476800441742
European O 0 0.004162339027971029
Jews O 0 0.011336380615830421
( O 0 0.011266806162893772
P O 0 0.0620950423181057
= O 0 0.023150380700826645
0 O 0 0.009764133021235466
. O 0 0.0031814761459827423
08 O 0 0.05123993009328842
) O 0 0.008233574219048023
. O 0 0.007177310064435005

It O 0 0.006577490363270044
occurred O 0 0.012925893068313599
in O 0 0.007181408349424601
15 O 0 0.017127320170402527
. O 0 0.010857084766030312

4 O 0 0.018105119466781616
% O 0 0.0038984171114861965
of O 0 0.003168420633301139
52 O 0 0.01615782082080841
Ashkenazi O 0 0.05108468979597092
Israelis O 0 0.008402347564697266
with O 0 0.003906509838998318
familial O 1 1.0
cancer B-Disease 1 1.0
( O 1 0.9967837333679199
P O 1 0.999984860420227
= O 0 0.028465017676353455
0 O 0 0.010176893323659897
. O 0 0.003032044041901827
02 O 1 0.9923737645149231
) O 0 0.0048347897827625275
and O 0 0.0019901918713003397
was O 0 0.005102869588881731
not O 0 0.0013187602162361145
detected O 0 0.005666954442858696
in O 0 0.0029106999281793833
51 O 0 0.014391780830919743
non O 0 0.008999936282634735
- O 0 0.0076137809082865715
European O 0 0.0031978366896510124
Jews O 0 0.009570466354489326
at O 0 0.013553794473409653
increased O 0 0.02244650013744831
cancer B-Disease 1 1.0
risk O 1 0.9920803904533386
. O 0 0.018817296251654625

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
occurred O 1 0.9814029932022095
personally O 0 0.13297969102859497
or O 0 0.004251422360539436
in O 0 0.00280774082057178
the O 0 0.002718976465985179
families O 0 0.0022584102116525173
of O 0 0.002244688104838133
13 O 0 0.006276718340814114
of O 0 0.004782470408827066
20 O 0 0.010225918143987656
Ashkenazi O 1 0.9988370537757874
I1307K O 1 0.9985789060592651
carriers O 0 0.011366729624569416
, O 0 0.0026317816227674484
8 O 0 0.005743519403040409
of O 0 0.0029866457916796207
whom O 0 0.005691314581781626
also O 0 0.0028849150985479355
had O 0 0.0030652289278805256
a O 0 0.003394735511392355
personal O 0 0.008342939428985119
or O 0 0.003733248682692647
family O 0 0.007556478958576918
history O 0 0.014469697140157223
of O 0 0.03169822692871094
noncolonic O 1 1.0
neoplasia B-Disease 1 1.0
. O 0 0.03237559646368027

CONCLUSIONS O 0 0.03455633670091629
The O 0 0.020064355805516243
I1307K O 1 0.9998766183853149
APC O 1 0.9999812841415405
variant O 0 0.026818661019206047
may O 0 0.003295592265203595
represent O 0 0.003221776569262147
a O 0 0.004773881286382675
susceptibility O 1 0.8314456343650818
gene O 0 0.011654345318675041
for O 0 0.007380252704024315
colorectal B-Disease 1 1.0
, I-Disease 0 0.01128262560814619
or I-Disease 0 0.0046227313578128815
other I-Disease 0 0.0024221038911491632
, I-Disease 0 0.005446592811495066
cancers I-Disease 1 0.9995748400688171
in O 0 0.008816433139145374
Ashkenazi O 1 0.9999110698699951
Jews O 0 0.014586169272661209
, O 0 0.003325277240946889
and O 0 0.002626033965498209
partially O 0 0.01355224009603262
explains O 0 0.011255667544901371
the O 0 0.0050176349468529224
higher O 0 0.010148904286324978
incidence O 1 0.999993085861206
of O 1 0.9999921321868896
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.9975441098213196
European O 0 0.015472984872758389
Israelis O 0 0.018785949796438217
. O 0 0.0080488920211792

Systematic O 0 0.03482086583971977
analysis O 0 0.007957370020449162
of O 0 0.011325301602482796
coproporphyrinogen O 1 0.9999918937683105
oxidase O 1 0.992312490940094
gene O 0 0.03508264571428299
defects O 1 0.9999188184738159
in O 0 0.01319289579987526
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
and O 0 0.01482661347836256
mutation O 0 0.029276167973876
update O 0 0.047983743250370026
. O 0 0.009930809959769249

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 1 0.9095554351806641
HC B-Disease 1 1.0
) O 0 0.011738690547645092
is O 0 0.0038514742627739906
an O 0 0.007853927090764046
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9999960660934448
autosomal O 1 1.0
dominant O 1 1.0
inheritance O 1 0.9999992847442627
caused O 1 0.9999902248382568
by O 0 0.008085185661911964
deficient B-Disease 1 0.9999972581863403
activity I-Disease 0 0.005860474891960621
of I-Disease 0 0.008990814909338951
coproporphyrinogen I-Disease 1 0.9999998807907104
III I-Disease 1 1.0
oxidase I-Disease 1 0.999508261680603
( O 0 0.02169923298060894
CPO O 1 0.9998162388801575
) O 0 0.009978161193430424
. O 0 0.006751650013029575

Clinical O 1 0.9961491823196411
manifestations O 1 0.9995753169059753
of O 0 0.3503621518611908
the O 1 0.9975765347480774
disease O 1 1.0
are O 0 0.0025267882738262415
characterized O 0 0.012205693870782852
by O 0 0.0036471541970968246
acute O 1 1.0
attacks O 1 0.9961703419685364
of O 1 0.9999980926513672
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.9999788999557495
precipitated O 1 1.0
by O 0 0.0057565500028431416
drugs O 1 0.5906809568405151
, O 0 0.006095042917877436
fasting O 0 0.036027297377586365
, O 0 0.008248649537563324
cyclical O 1 0.9961435794830322
hormonal O 1 0.9999728202819824
changes O 0 0.00847096461802721
, O 0 0.0073717194609344006
or O 0 0.018296565860509872
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 1 0.7324839234352112

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 0.027756555005908012
also O 0 0.006625207606703043
be O 0 0.0026851478032767773
present O 0 0.007858683355152607
. O 0 0.008560795336961746

The O 0 0.01577194407582283
seven O 0 0.011168542318046093
exons O 0 0.02886764332652092
, O 0 0.004945998080074787
the O 0 0.010457147844135761
exon O 1 0.500491201877594
/ O 0 0.34605109691619873
intron O 0 0.15103080868721008
boundaries O 0 0.0053052837029099464
and O 0 0.002071807626634836
part O 0 0.0047263652086257935
of O 0 0.006193509325385094
3 O 0 0.013300856575369835
noncoding O 0 0.0345444418489933
sequence O 0 0.00429127924144268
of O 0 0.0034565147943794727
the O 0 0.00803802628070116
CPO O 1 0.9988909363746643
gene O 0 0.007149737793952227
were O 0 0.002018583472818136
systematically O 0 0.009567094966769218
analyzed O 0 0.00381275312975049
by O 0 0.001180032268166542
an O 0 0.0031747918110340834
exon O 0 0.0590425506234169
- O 0 0.01499645784497261
by O 0 0.0036282094661146402
- O 0 0.027776699513196945
exon O 0 0.07206075638532639
denaturing O 0 0.309454083442688
gradient O 0 0.09254247695207596
gel O 1 0.9231486916542053
electrophoresis O 1 0.5787385702133179
( O 0 0.02913094498217106
DGGE O 1 0.9999744892120361
) O 0 0.006618526764214039
strategy O 0 0.006624994333833456
followed O 0 0.002928561996668577
by O 0 0.0013096356997266412
direct O 0 0.003123304108157754
sequencing O 0 0.0055604781955480576
in O 0 0.002252835314720869
seven O 0 0.005037585739046335
unrelated O 0 0.020818347111344337
heterozygous O 0 0.036169372498989105
HC B-Disease 1 1.0
patients O 1 0.9999986886978149
from O 0 0.009211433120071888
France O 0 0.031218362972140312
, O 0 0.006402777507901192
Holland O 0 0.10400784015655518
, O 0 0.0035641612485051155
and O 0 0.0035605391021817923
Czech O 0 0.047988682985305786
Republic O 0 0.042678698897361755
. O 0 0.013781552202999592

Seven O 0 0.02059701271355152
novel O 0 0.025777531787753105
mutations O 0 0.010345103219151497
and O 0 0.0021993271075189114
two O 0 0.0018449611961841583
new O 0 0.006438298150897026
polymorphisms O 0 0.027361877262592316
were O 0 0.005740094929933548
detected O 0 0.022358959540724754
. O 0 0.010286178439855576

Among O 0 0.009303184226155281
these O 0 0.0027156579308211803
mutations O 0 0.0049806577153503895
two O 0 0.0013165728887543082
are O 0 0.0015339171513915062
missense O 0 0.03169340267777443
( O 0 0.011929109692573547
G197W O 1 0.997645914554596
, O 0 0.008566608652472496
W427R O 1 0.9986202716827393
) O 0 0.004450445529073477
, O 0 0.001615435117855668
two O 0 0.0009579480392858386
are O 0 0.001324999495409429
nonsense O 0 0.02515234611928463
( O 0 0.012840009294450283
Q306X O 1 0.9930171966552734
, O 0 0.009253409691154957
Q385X O 1 0.9976015686988831
) O 0 0.0046030390076339245
, O 0 0.0019507384859025478
two O 0 0.0009509062510915101
are O 0 0.0008347834809683263
small O 0 0.0033819377422332764
deletions O 0 0.025736872106790543
( O 0 0.01537283044308424
662de14bp O 1 0.9436216950416565
; O 0 0.008114593103528023
1168del3bp O 0 0.3883621096611023
removing O 0 0.021152570843696594
a O 0 0.006949120666831732
glycine O 0 0.03306569159030914
at O 0 0.0077379136346280575
position O 0 0.01084098033607006
390 O 0 0.03985411301255226
) O 0 0.0034013951662927866
, O 0 0.0013377071591094136
and O 0 0.0011158728739246726
one O 0 0.0016783783212304115
is O 0 0.0017492921324446797
a O 0 0.0035303947515785694
splicing O 0 0.01787329465150833
mutation O 0 0.010197347030043602
( O 0 0.010966525413095951
IVS1 O 1 0.9999974966049194
- O 0 0.06532391160726547
15c O 1 0.9990828037261963
- O 0 0.23581460118293762
- O 0 0.04029121622443199
> O 0 0.042147837579250336
g O 0 0.02250429056584835
) O 0 0.0034014564007520676
which O 0 0.0011105007724836469
creates O 0 0.005470239091664553
a O 0 0.004306836519390345
new O 0 0.0078426543623209
acceptor O 0 0.06412990391254425
splice O 0 0.11735374480485916
site O 0 0.031023891642689705
. O 0 0.012207367457449436

The O 0 0.018650108948349953
pathological O 0 0.09787562489509583
significance O 0 0.017398426309227943
of O 0 0.007223764434456825
the O 0 0.00757058197632432
point O 0 0.013235369697213173
mutations O 0 0.012691539712250233
G197W O 1 0.7639578580856323
, O 0 0.0066917408257722855
W427R O 1 0.8400120139122009
, O 0 0.003403755836188793
and O 0 0.0023630307987332344
the O 0 0.004914827179163694
in O 0 0.0073601799085736275
- O 0 0.035492848604917526
frame O 0 0.029453126713633537
deletion O 0 0.03501639887690544
390delGly O 0 0.25151699781417847
were O 0 0.003707742318511009
assessed O 0 0.007760840468108654
by O 0 0.0014237520517781377
their O 0 0.001601865515112877
respective O 0 0.006203728727996349
expression O 0 0.004418804310262203
in O 0 0.0022570353467017412
a O 0 0.004086678382009268
prokaryotic O 0 0.017668647691607475
system O 0 0.005457601975649595
using O 0 0.0029986922163516283
site O 0 0.012094407342374325
- O 0 0.018508974462747574
directed O 0 0.010730554349720478
mutagenesis O 0 0.04607703909277916
. O 0 0.013168695382773876

These O 0 0.006939600687474012
mutations O 0 0.011034662835299969
resulted O 0 0.007876606658101082
in O 0 0.00409886846318841
the O 0 0.006536985281854868
absence O 0 0.0168311707675457
or O 0 0.004343843553215265
a O 0 0.0057252985425293446
dramatic O 0 0.018360354006290436
decrease O 0 0.02296573668718338
of O 0 0.020562561228871346
CPO O 1 0.9999996423721313
activity O 0 0.017807042226195335
. O 0 0.0122981620952487

The O 0 0.011605092324316502
two O 0 0.0046262722462415695
polymorphisms O 0 0.0243679266422987
were O 0 0.004089295398443937
localized O 0 0.019557472318410873
in O 0 0.006700234487652779
noncoding O 0 0.038363099098205566
part O 0 0.0047365827485919
of O 0 0.003607342718169093
the O 0 0.0061162360943853855
gene O 0 0.00650568725541234
1 O 0 0.006982970517128706
) O 0 0.002422979334369302
a O 0 0.004723495338112116
C O 0 0.32660847902297974
/ O 0 0.2667205333709717
G O 0 0.058818306773900986
polymorphism O 0 0.011599237099289894
in O 0 0.003306577680632472
the O 0 0.006897344719618559
promotor O 1 0.9996941089630127
region O 0 0.016825562343001366
, O 0 0.007688636425882578
142 O 0 0.04058706760406494
bp O 0 0.02384696714580059
upstream O 0 0.010549214668571949
from O 0 0.0018709806026890874
the O 0 0.004059462808072567
transcriptional O 0 0.024287167936563492
initiation O 0 0.022189343348145485
site O 0 0.013820791617035866
( O 0 0.011790958233177662
- O 0 0.027791397646069527
142C O 1 0.9991446733474731
/ O 1 0.9163893461227417
G O 0 0.4124116599559784
) O 0 0.002991250017657876
, O 0 0.0014316098531708121
and O 0 0.001785407424904406
2 O 0 0.0078018722124397755
) O 0 0.0027530286461114883
a O 0 0.0037942281924188137
6 O 0 0.01575472764670849
bp O 0 0.02223232202231884
deletion O 0 0.01832594908773899
polymorphism O 0 0.008288324810564518
in O 0 0.0024562058970332146
the O 0 0.004637943580746651
3 O 0 0.010272939689457417
noncoding O 0 0.027896245941519737
part O 0 0.004005884286016226
of O 0 0.005343473982065916
the O 0 0.013324138708412647
CPO O 1 0.9999980926513672
gene O 0 0.016043759882450104
, O 0 0.0065626418218016624
574 O 0 0.09009551256895065
bp O 0 0.024330539628863335
downstream O 0 0.009681547060608864
of O 0 0.00285799871198833
the O 0 0.0037293084897100925
last O 0 0.004647026304155588
base O 0 0.00469485716894269
of O 0 0.0027234579902142286
the O 0 0.005247501656413078
normal O 0 0.013191414065659046
termination O 0 0.043755870312452316
codon O 0 0.0473974384367466
( O 0 0.017616383731365204
+ O 0 0.05200304836034775
574 O 0 0.36631742119789124
delATTCTT O 1 0.9933443069458008
) O 0 0.012651004828512669
. O 0 0.009051122702658176

Five O 0 0.025158461183309555
intragenic O 1 0.9995799660682678
dimorphisms O 1 0.9303985238075256
are O 0 0.0026405449025332928
now O 0 0.003652585670351982
well O 0 0.002282946603372693
characterized O 0 0.009277693927288055
and O 0 0.0026964363642036915
the O 0 0.00555346580222249
high O 0 0.00993336085230112
degree O 0 0.00905916653573513
of O 0 0.009525098837912083
allelic O 1 0.99985671043396
heterogeneity O 1 0.9400079846382141
in O 0 0.015215633437037468
HC B-Disease 1 1.0
is O 0 0.009703174233436584
demonstrated O 0 0.007933264598250389
with O 0 0.001446253270842135
seven O 0 0.0026932277251034975
new O 0 0.0020530635956674814
different O 0 0.000824965420179069
mutations O 0 0.003321404568850994
making O 0 0.0020696348510682583
a O 0 0.002553133759647608
total O 0 0.003539957571774721
of O 0 0.00745278038084507
nineteen O 1 0.9994577765464783
CPO O 1 1.0
gene B-Disease 0 0.1621558517217636
defects I-Disease 1 0.9999823570251465
reported O 0 0.016149332746863365
so O 0 0.003754762466996908
far O 0 0.0036952642258256674
. O 0 0.003362680785357952
. O 0 0.007754816673696041

Coincidence O 0 0.02595430612564087
of O 0 0.00527756754308939
two O 0 0.0028779632411897182
novel O 0 0.023056192323565483
arylsulfatase O 0 0.48960283398628235
A O 0 0.018753429874777794
alleles O 0 0.019588584080338478
and O 0 0.0066442592069506645
mutation O 0 0.02744811214506626
459 O 1 0.9998664855957031
+ O 1 0.9918912649154663
1G O 1 0.9998512268066406
> O 0 0.02494150772690773
A O 0 0.005347915925085545
within O 0 0.001953165978193283
a O 0 0.002641730709001422
family O 0 0.006874782964587212
with O 0 0.00528374407440424
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 0.013863452710211277
molecular O 0 0.010107580572366714
basis O 0 0.004424189683049917
of O 0 0.008384701795876026
phenotypic O 0 0.06865914911031723
heterogeneity O 1 0.5044757723808289
. O 0 0.01967722550034523

In O 0 0.007973521016538143
a O 0 0.005391906946897507
family O 0 0.005642652045935392
with O 0 0.0017686209175735712
three O 0 0.0033310160506516695
siblings O 0 0.013329893350601196
, O 0 0.0022008458618074656
one O 0 0.0017651744419708848
developed O 0 0.0053150225430727005
classical O 0 0.012447066605091095
late O 0 0.07513660937547684
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9999213218688965
MLD B-Disease 1 1.0
) O 0 0.010782847180962563
, O 0 0.004825928248465061
fatal O 1 0.9977695941925049
at O 0 0.010915514081716537
age O 0 0.008331711404025555
5 O 0 0.006056089419871569
years O 0 0.0028996621258556843
, O 0 0.002102719619870186
with O 0 0.002945574466139078
deficient O 1 0.9999972581863403
arylsulfatase O 1 0.9999629259109497
A O 0 0.06638658046722412
( O 0 0.025190535932779312
ARSA O 1 1.0
) O 0 0.004432279616594315
activity O 0 0.002648971974849701
and O 0 0.0018424339359626174
increased O 0 0.007936770096421242
galactosylsulfatide O 1 0.9999994039535522
( O 1 0.5204578638076782
GS O 1 1.0
) O 0 0.020519491285085678
excretion O 0 0.06951478123664856
. O 0 0.013195597566664219

The O 0 0.009195049293339252
two O 0 0.002303993795067072
other O 0 0.0020276217255741358
siblings O 0 0.015677373856306076
, O 0 0.003967124503105879
apparently O 0 0.007991017773747444
healthy O 0 0.012157084420323372
at O 0 0.0070120603777468204
12 O 0 0.007037966046482325
( O 0 0.00619256729260087
1 O 0 0.012112862430512905
/ O 0 0.02999826893210411
2 O 0 0.00750335119664669
) O 0 0.0022111558355391026
and O 0 0.0011617590207606554
15 O 0 0.0038562738336622715
years O 0 0.0032398258335888386
, O 0 0.003099064575508237
respectively O 0 0.007479550316929817
, O 0 0.002274544443935156
and O 0 0.0016873761778697371
their O 0 0.002253144048154354
father O 1 0.5742821097373962
, O 0 0.0043882825411856174
apparently O 0 0.00948115810751915
healthy O 0 0.011039810255169868
as O 0 0.002856862498447299
well O 0 0.0025058577302843332
, O 0 0.003923116251826286
presented O 0 0.02206464111804962
ARSA O 1 0.9999998807907104
and O 0 0.01619427651166916
GS O 1 1.0
values O 0 0.0044922176748514175
within O 0 0.0016043458599597216
the O 0 0.002900089602917433
range O 0 0.005030802451074123
of O 0 0.013950095511972904
MLD B-Disease 1 1.0
patients O 1 0.9999996423721313
. O 0 0.022357122972607613

Mutation O 0 0.04094944894313812
screening O 0 0.017137566581368446
and O 0 0.003050019033253193
sequence O 0 0.004554301965981722
analysis O 0 0.0032025030814111233
disclosed O 0 0.011269633658230305
the O 0 0.0035052583552896976
involvement O 0 0.00932804774492979
of O 0 0.004249402321875095
three O 0 0.0036697499454021454
different O 0 0.003407615702599287
ARSA O 1 0.9999994039535522
mutations O 0 0.010875169187784195
being O 0 0.002932257018983364
the O 0 0.002831839956343174
molecular O 0 0.006652012001723051
basis O 0 0.004456627182662487
of O 0 0.009602956473827362
intrafamilial O 1 0.9985342025756836
phenotypic O 0 0.21754254400730133
heterogeneity O 1 0.6256977915763855
. O 0 0.02057669870555401

The O 0 0.01686657965183258
late O 0 0.050298117101192474
infantile O 1 1.0
patient O 1 1.0
inherited O 1 0.9999997615814209
from O 0 0.0066679175943136215
his O 0 0.010983720421791077
mother O 0 0.2057141810655594
the O 0 0.006517495959997177
frequent O 0 0.013281058520078659
0 O 0 0.021059442311525345
- O 0 0.016412904486060143
type O 0 0.01678726077079773
mutation O 0 0.019829168915748596
459 O 1 0.9935537576675415
+ O 1 0.7089750170707703
1G O 1 0.9994668364524841
> O 0 0.03751927986741066
A O 0 0.00891656894236803
, O 0 0.0026617629919201136
and O 0 0.0015656554605811834
from O 0 0.0018065182957798243
his O 0 0.005751290824264288
father O 0 0.016483435407280922
a O 0 0.004216885194182396
novel O 0 0.010843542404472828
, O 0 0.00407509645447135
single O 0 0.006436071824282408
basepair O 0 0.14414745569229126
microdeletion O 0 0.0663602203130722
of O 0 0.010172019712626934
guanine O 0 0.026258213445544243
at O 0 0.007742675021290779
nucleotide O 0 0.007627520244568586
7 O 0 0.004238816909492016
in O 0 0.0029364689253270626
exon O 0 0.03556859865784645
1 O 0 0.014564266428351402
( O 0 0.011647623963654041
7delG O 1 0.9724297523498535
) O 0 0.01272392924875021
. O 0 0.009418750181794167

The O 0 0.012347277253866196
two O 0 0.0075250971131026745
clinically O 1 0.9997807145118713
unaffected O 0 0.11780770123004913
siblings O 0 0.026394477114081383
carried O 0 0.009709155187010765
the O 0 0.009778888896107674
maternal O 1 0.9972913861274719
mutation O 0 0.041104864329099655
459 O 1 0.9999282360076904
+ O 1 0.996687114238739
1G O 1 0.999947190284729
> O 0 0.03733789175748825
A O 0 0.00907179992645979
and O 0 0.0024684739764779806
, O 0 0.0025595142506062984
on O 0 0.0033780827652662992
their O 0 0.0030793165788054466
paternal O 0 0.04304831102490425
allele O 0 0.014413989149034023
, O 0 0.003005668753758073
a O 0 0.003809007816016674
novel O 0 0.020137667655944824
cytosine O 0 0.027828408405184746
to O 0 0.0048016454093158245
thymidine O 0 0.05022719129920006
transition O 0 0.01809941604733467
at O 0 0.012184682302176952
nucleotide O 0 0.024849144741892815
2435 O 1 0.7274778485298157
in O 0 0.007444721646606922
exon O 0 0.04270437732338905
8 O 0 0.008504175581037998
, O 0 0.0021669589914381504
resulting O 0 0.0041636195965111256
in O 0 0.003057018620893359
substitution O 0 0.011417095549404621
of O 0 0.00829178187996149
alanine O 0 0.07537919282913208
464 O 1 0.8380775451660156
by O 0 0.006022017914801836
valine O 1 0.9998610019683838
( O 0 0.025075824931263924
A464V O 1 0.9996616840362549
) O 0 0.011199286207556725
. O 0 0.00846207793802023

The O 0 0.01723172701895237
fathers O 0 0.033316485583782196
genotype O 0 0.035466864705085754
thus O 0 0.008096016012132168
was O 0 0.019255174323916435
7delG O 1 0.9999958276748657
/ O 1 0.9995372295379639
A464V O 1 0.9980092644691467
. O 0 0.017092229798436165

Mutation O 0 0.056336697190999985
A464V O 0 0.24233277142047882
was O 0 0.008418970741331577
not O 0 0.0013012852286919951
found O 0 0.0018901117146015167
in O 0 0.0025725336745381355
18 O 0 0.010811510495841503
unrelated O 1 0.9750467538833618
MLD B-Disease 1 1.0
patients O 1 0.9999998807907104
and O 0 0.008256485685706139
50 O 0 0.014282671734690666
controls O 0 0.018898840993642807
. O 0 0.012353205122053623

A464V O 1 0.5034775137901306
, O 0 0.006955315824598074
although O 0 0.00448865769430995
clearly O 0 0.012131765484809875
modifying O 0 0.07857082039117813
ARSA O 1 1.0
and O 0 0.022677060216665268
GS O 1 1.0
levels O 0 0.020526224747300148
, O 0 0.004597012884914875
apparently O 0 0.008871031925082207
bears O 0 0.01280835922807455
little O 0 0.004875748883932829
significance O 0 0.007585674989968538
for O 0 0.003584542777389288
clinical O 1 0.9997944235801697
manifestation O 1 1.0
of O 1 0.9999637603759766
MLD B-Disease 1 1.0
, O 0 0.014048362150788307
mimicking O 0 0.04177439585328102
the O 0 0.01043608132749796
frequent O 0 0.04043726250529289
ARSA O 1 1.0
pseudodeficiency O 1 0.9999009370803833
allele O 0 0.05149168148636818
. O 0 0.011365078389644623

Our O 0 0.014483325183391571
results O 0 0.005744480527937412
demonstrate O 0 0.006064668297767639
that O 0 0.0008763322257436812
in O 0 0.001614574808627367
certain O 0 0.00293446215800941
genetic O 0 0.015416964888572693
conditions O 1 0.9560831785202026
MLD B-Disease 1 1.0
- O 1 0.9998424053192139
like O 0 0.01963573321700096
ARSA O 1 1.0
and O 0 0.016911249607801437
GS O 1 1.0
values O 0 0.00939195603132248
need O 0 0.0030636615119874477
not O 0 0.0008163949241861701
be O 0 0.0010609891032800078
paralleled O 0 0.012249943800270557
by O 0 0.0032782244961708784
clinical O 1 1.0
disease O 1 1.0
, O 0 0.006638822611421347
a O 0 0.003904732409864664
finding O 0 0.00549928518012166
with O 0 0.002106616273522377
serious O 1 0.9859046339988708
diagnostic O 1 0.9999997615814209
and O 0 0.019059227779507637
prognostic O 1 1.0
implications O 0 0.07055678963661194
. O 0 0.016091885045170784

Moreover O 0 0.03532871603965759
, O 0 0.009330895729362965
further O 0 0.01745426468551159
ARSA O 1 0.9999988079071045
alleles O 0 0.04602082446217537
functionally O 0 0.032307274639606476
similar O 0 0.0048040891997516155
to O 0 0.004872441291809082
A464V O 0 0.21478311717510223
might O 0 0.0038905367255210876
exist O 0 0.002198761096224189
which O 0 0.0008940663537941873
, O 0 0.0012296295026317239
together O 0 0.0012739282101392746
with O 0 0.001763545093126595
0 O 0 0.017553677782416344
- O 0 0.016084233298897743
type O 0 0.012580552138388157
mutations O 0 0.008279114961624146
, O 0 0.0040922765620052814
may O 0 0.007909971289336681
cause O 1 0.938467264175415
pathological O 1 1.0
ARSA O 1 1.0
and O 1 0.999224066734314
GS O 1 1.0
levels O 0 0.01262903306633234
, O 0 0.0018374089850112796
but O 0 0.0008374209864996374
not O 0 0.0009165084338746965
clinical O 0 0.029667533934116364
outbreak O 1 0.999977707862854
of O 0 0.018985100090503693
the O 1 0.9877227544784546
disease O 1 1.0
. O 0 0.009171959012746811
. O 0 0.009366211481392384

Human O 1 0.9976937174797058
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 0.9999998807907104
to O 0 0.029665648937225342
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 1 0.9744568467140198
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.999985933303833
1 I-Disease 0 0.117554672062397
. O 0 0.010994588024914265

Heterozygous O 0 0.08127714693546295
germ O 1 0.999976396560669
- O 0 0.03292157128453255
line O 0 0.009931175038218498
mutations O 0 0.00546460784971714
in O 0 0.0021742675453424454
the O 0 0.006268901750445366
DNA O 0 0.025028958916664124
mismatch O 1 0.9993909597396851
repair O 1 0.999752938747406
genes O 0 0.008520466275513172
lead O 0 0.006235213950276375
to O 0 0.005815254990011454
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.999840259552002

The O 0 0.23835137486457825
disease O 1 1.0
susceptibility O 1 0.9999738931655884
of O 0 0.019771089777350426
individuals O 0 0.00538537697866559
who O 0 0.008265736512839794
constitutionally O 0 0.02226909063756466
lack O 0 0.009762773290276527
both O 0 0.004217218142002821
wild O 0 0.01628412865102291
- O 0 0.02857103943824768
type O 0 0.019910473376512527
alleles O 0 0.019799882546067238
is O 0 0.005654109176248312
unknown O 0 0.015932999551296234
. O 0 0.010647637769579887

We O 0 0.004012587014585733
have O 0 0.0013061476638540626
identified O 0 0.0036911130882799625
three O 0 0.0017905060667544603
offspring O 0 0.005354220513254404
in O 0 0.0024912767112255096
a O 0 0.007732665166258812
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 1.0
who O 1 0.930348813533783
developed O 1 0.9893748760223389
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
at O 0 0.06199166923761368
a O 0 0.004783534910529852
very O 0 0.002348540350794792
early O 0 0.0036507986951619387
age O 0 0.0045126620680093765
, O 0 0.0020445219706743956
and O 0 0.001283953431993723
at O 0 0.003300413489341736
least O 0 0.0011216357816010714
two O 0 0.0005938767571933568
of O 0 0.0017585987225174904
them O 0 0.001582284807227552
displayed O 0 0.009445194154977798
signs O 0 0.014336242340505123
of O 0 0.012955608777701855
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9983097314834595
1 I-Disease 0 0.10353289544582367
( O 0 0.022124936804175377
NF1 B-Disease 1 0.9999990463256836
) O 0 0.012949793599545956
. O 0 0.00858343206346035

DNA O 0 0.018729841336607933
sequence O 0 0.006769760511815548
analysis O 0 0.00410661892965436
and O 0 0.003442408051341772
allele O 0 0.01671520061790943
- O 0 0.009893923997879028
specific O 0 0.003400483401492238
amplification O 0 0.00877344235777855
in O 0 0.0018620392074808478
two O 0 0.001978849060833454
siblings O 0 0.016069721430540085
revealed O 0 0.01248684711754322
a O 0 0.007115645799785852
homozygous O 0 0.04063313081860542
MLH1 O 1 0.9999991655349731
mutation O 0 0.0259755477309227
( O 0 0.016024800017476082
C676T O 1 0.9998897314071655
- O 1 0.8580873012542725
- O 0 0.05970282480120659
> O 0 0.06432275474071503
Arg226Stop O 1 0.9987964630126953
) O 0 0.012119118124246597
. O 0 0.008232220076024532

Thus O 0 0.010014370083808899
, O 0 0.0043016704730689526
a O 0 0.0071808164939284325
homozygous O 0 0.04843924939632416
germ O 1 0.9999969005584717
- O 0 0.11965059489011765
line O 0 0.02591065689921379
MLH1 O 1 0.9999996423721313
mutation O 0 0.02231113612651825
and O 0 0.007437990978360176
consequent O 1 1.0
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.02180192805826664
in O 0 0.00551692396402359
a O 0 0.007692778017371893
mutator O 1 0.9999964237213135
phenotype O 0 0.022722244262695312
characterized O 0 0.012790060602128506
by O 0 0.004284654278308153
leukemia B-Disease 1 1.0
and O 1 0.9588757157325745
/ O 1 1.0
or O 1 0.9794211387634277
lymphoma B-Disease 1 1.0
associated O 1 0.9993208646774292
with O 0 0.01766527071595192
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999967813491821
1 I-Disease 0 0.13070470094680786
. O 0 0.006230054423213005
. O 0 0.007754274178296328

Missense O 0 0.10414808243513107
mutations O 0 0.014002966694533825
in O 0 0.00340216769836843
the O 0 0.0037706976290792227
most O 0 0.00230370438657701
ancient O 0 0.011945768259465694
residues O 0 0.01462295651435852
of O 0 0.0076344674453139305
the O 0 0.016631552949547768
PAX6 O 1 0.9999997615814209
paired O 0 0.04083913937211037
domain O 0 0.01686139591038227
underlie O 0 0.029607824981212616
a O 0 0.00701281800866127
spectrum O 0 0.013567418791353703
of O 0 0.01990571804344654
human O 1 0.9999998807907104
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9999526739120483

Mutations O 0 0.015089930035173893
of O 0 0.00513096759095788
the O 0 0.00804518535733223
human O 0 0.01981346867978573
PAX6 O 1 1.0
gene O 0 0.07392553985118866
underlie O 1 0.9999899864196777
aniridia B-Disease 1 1.0
( O 1 0.9999274015426636
congenital B-Disease 1 1.0
absence I-Disease 1 0.9999921321868896
of I-Disease 1 0.9986681938171387
the I-Disease 1 0.9940289258956909
iris I-Disease 1 0.999998927116394
) O 0 0.004688706714659929
, O 0 0.0015615663724020123
a O 0 0.003010380547493696
rare O 0 0.014003784395754337
dominant O 1 0.95869380235672
malformation B-Disease 1 1.0
of I-Disease 1 0.9999388456344604
the I-Disease 1 0.9999920129776001
eye I-Disease 1 1.0
. O 0 0.023235036060214043

The O 0 0.014743788167834282
spectrum O 0 0.01817149855196476
of O 0 0.015015296638011932
PAX6 O 1 1.0
mutations O 0 0.025831075385212898
in O 0 0.013170157559216022
aniridia B-Disease 1 1.0
patients O 1 0.9999960660934448
is O 0 0.006165698170661926
highly O 0 0.009229153394699097
biased O 0 0.009461693465709686
, O 0 0.0021868159528821707
with O 0 0.0018019858980551362
92 O 0 0.02004268206655979
% O 0 0.003028016071766615
of O 0 0.002346351509913802
all O 0 0.002169936429709196
reported O 0 0.00793998409062624
mutations O 0 0.006860004737973213
leading O 0 0.007390374783426523
to O 0 0.004514140076935291
premature O 0 0.04872932657599449
truncation O 0 0.04465777426958084
of O 0 0.006904518231749535
the O 0 0.008229495026171207
protein O 0 0.011319920420646667
( O 0 0.006883350200951099
nonsense O 0 0.01910940371453762
, O 0 0.005017317831516266
splicing O 0 0.018345406278967857
, O 0 0.004141786601394415
insertions O 0 0.023986583575606346
and O 0 0.003916032612323761
deletions O 0 0.021411286666989326
) O 0 0.004552395083010197
and O 0 0.002228831872344017
just O 0 0.004061965737491846
2 O 0 0.007634070236235857
% O 0 0.0025938593316823244
leading O 0 0.0044822911731898785
to O 0 0.0023449701257050037
substitution O 0 0.006243086885660887
of O 0 0.0031601397786289454
one O 0 0.003756405785679817
amino O 0 0.006725677754729986
acid O 0 0.008159960620105267
by O 0 0.001990875694900751
another O 0 0.006642496213316917
( O 0 0.012255975976586342
missense O 0 0.04660438373684883
) O 0 0.01219119317829609
. O 0 0.008828917518258095

The O 0 0.014721648767590523
extraordinary O 0 0.018114378675818443
conservation O 0 0.011429334059357643
of O 0 0.005016392562538385
the O 0 0.012362749315798283
PAX6 O 1 0.9999992847442627
protein O 0 0.009371383115649223
at O 0 0.005155238788574934
the O 0 0.003795088268816471
amino O 0 0.00939954537898302
acid O 0 0.014044161885976791
level O 0 0.008872631005942822
amongst O 0 0.017696203663945198
vertebrates O 0 0.03105529397726059
predicts O 0 0.03521561250090599
that O 0 0.004576778504997492
pathological O 1 0.9982630610466003
missense O 1 0.8812993168830872
mutations O 0 0.01434652041643858
should O 0 0.002816807245835662
in O 0 0.0025568120181560516
fact O 0 0.0038365379441529512
be O 0 0.0018111779354512691
common O 0 0.003467824077233672
even O 0 0.002126411534845829
though O 0 0.0017565279267728329
they O 0 0.000872440286912024
are O 0 0.0008092282805591822
hardly O 0 0.006818427704274654
ever O 0 0.0049310107715427876
seen O 0 0.006313646677881479
in O 0 0.008533818647265434
aniridia B-Disease 1 1.0
patients O 1 0.9999979734420776
. O 0 0.019929837435483932

This O 0 0.008288797922432423
indicates O 0 0.01243587862700224
that O 0 0.001452576369047165
there O 0 0.0018475886899977922
is O 0 0.002431962639093399
a O 0 0.0048917802050709724
heavy O 0 0.036991462111473083
ascertainment O 1 0.999995231628418
bias O 0 0.019311489537358284
in O 0 0.003502831095829606
the O 0 0.0030656077433377504
selection O 0 0.005057279486209154
of O 0 0.005741015076637268
patients O 1 0.9998977184295654
for O 0 0.011515196412801743
PAX6 O 1 1.0
mutation O 0 0.009686148725450039
analysis O 0 0.0025021322071552277
and O 0 0.0012845111778005958
that O 0 0.0011948022292926908
the O 0 0.0054666996002197266
missing O 0 0.027460584416985512
PAX6 O 1 0.9999991655349731
missense O 0 0.1499110758304596
mutations O 0 0.016423815861344337
frequently O 0 0.008919160813093185
may O 0 0.009187215007841587
underlie O 1 0.5951485633850098
phenotypes O 0 0.03759976476430893
distinct O 0 0.010581794194877148
from O 0 0.009856810793280602
textbook O 1 0.9999929666519165
aniridia B-Disease 1 1.0
. O 0 0.026806501671671867

Here O 0 0.012572132982313633
we O 0 0.0029927578289061785
present O 0 0.0039380379021167755
four O 0 0.004211118444800377
novel O 0 0.0365862213075161
PAX6 O 1 0.9999995231628418
missense O 0 0.08927939087152481
mutations O 0 0.011309039779007435
, O 0 0.0021154216956347227
two O 0 0.0013224524445831776
in O 0 0.002913115778937936
association O 0 0.00861644372344017
with O 0 0.004815679509192705
atypical O 1 1.0
phenotypes O 1 0.999889612197876
ectopia B-Disease 1 0.9999998807907104
pupillae I-Disease 1 0.9999994039535522
( O 0 0.013967237435281277
displaced B-Disease 0 0.02396438643336296
pupils I-Disease 0 0.40782982110977173
) O 0 0.010002902708947659
and O 0 0.01049849297851324
congenital B-Disease 1 1.0
nystagmus I-Disease 1 1.0
( O 1 0.9999287128448486
searching B-Disease 0 0.27889421582221985
gaze I-Disease 1 0.5847685933113098
) O 0 0.00392931466922164
, O 0 0.0015097376890480518
and O 0 0.001030251383781433
two O 0 0.0009752073092386127
in O 0 0.00213939999230206
association O 0 0.0059084524400532246
with O 0 0.0021430656779557467
more O 0 0.0031989552080631256
recognizable O 1 0.9732644557952881
aniridia B-Disease 1 1.0
phenotypes O 1 0.965993344783783
. O 0 0.018289437517523766

Strikingly O 0 0.05414530262351036
, O 0 0.005720794666558504
all O 0 0.002253197366371751
four O 0 0.003782319137826562
mutations O 0 0.006469622254371643
are O 0 0.0011266415240243077
located O 0 0.006749073509126902
within O 0 0.0035292841494083405
the O 0 0.011293875984847546
PAX6 O 1 1.0
paired O 0 0.04162080958485603
domain O 0 0.014320529997348785
and O 0 0.004047931171953678
affect O 0 0.00915027316659689
amino O 0 0.009581845253705978
acids O 0 0.004645180888473988
which O 0 0.0010532025480642915
are O 0 0.0006525448989123106
highly O 0 0.003932115621864796
conserved O 0 0.00503563042730093
in O 0 0.0019399713492020965
all O 0 0.0017075348878279328
known O 0 0.00831241812556982
paired O 0 0.022028213366866112
domain O 0 0.016211379319429398
proteins O 0 0.010953453369438648
. O 0 0.009115596301853657

Our O 0 0.012914209626615047
results O 0 0.005419530905783176
support O 0 0.003557921154424548
the O 0 0.003201512387022376
hypothesis O 0 0.00704566715285182
that O 0 0.000984259182587266
the O 0 0.0027584077324718237
under O 0 0.00535849342122674
- O 0 0.009717530570924282
representation O 0 0.004453535191714764
of O 0 0.006406087893992662
missense O 0 0.058300744742155075
mutations O 0 0.015258340165019035
is O 0 0.005244149826467037
caused O 0 0.014043567702174187
by O 0 0.006372867617756128
ascertainment O 1 1.0
bias O 0 0.3543667197227478
and O 0 0.003982889000326395
suggest O 0 0.00507205119356513
that O 0 0.0014148348709568381
a O 0 0.0027245483361184597
substantial O 0 0.007491596508771181
burden O 0 0.04060083627700806
of O 0 0.020820509642362595
PAX6 B-Disease 1 1.0
- I-Disease 1 0.999997615814209
related I-Disease 1 0.971880316734314
disease I-Disease 1 1.0
remains O 0 0.03607707843184471
to O 0 0.0038111142348498106
be O 0 0.0025590138975530863
uncovered O 0 0.023592881858348846
. O 0 0.005280542187392712
. O 0 0.008849633857607841

The O 0 0.018135376274585724
chromosomal O 0 0.033312905579805374
order O 0 0.006615148391574621
of O 0 0.007413575425744057
genes O 0 0.009457779116928577
controlling O 0 0.012378910556435585
the O 0 0.007931170985102654
major O 0 0.05830300971865654
histocompatibility O 1 1.0
complex O 0 0.05201764777302742
, O 0 0.008469771593809128
properdin O 1 0.9999450445175171
factor O 0 0.02913404069840908
B O 1 0.6678897142410278
, O 0 0.005594942253082991
and O 0 0.005958487279713154
deficiency B-Disease 1 1.0
of I-Disease 0 0.012598489411175251
the I-Disease 0 0.012856168672442436
second I-Disease 0 0.017476946115493774
component I-Disease 0 0.01797536574304104
of I-Disease 0 0.010126844979822636
complement I-Disease 0 0.026608360931277275
. O 0 0.010271363891661167

The O 0 0.009893093258142471
relationship O 0 0.00621685991063714
of O 0 0.0041293068788945675
the O 0 0.006392959505319595
genes O 0 0.008377766236662865
coding O 0 0.017650829628109932
for O 0 0.006147853098809719
HLA O 1 0.9999947547912598
to O 0 0.0027253078296780586
those O 0 0.0017674713162705302
coding O 0 0.013512404635548592
for O 0 0.004667902365326881
properdin O 1 0.9766770601272583
Factor O 0 0.02985464781522751
B O 1 0.5581903457641602
allotypes O 1 0.6989762187004089
and O 0 0.0036115713883191347
for O 0 0.006908494979143143
deficiency B-Disease 1 1.0
of I-Disease 0 0.011068062856793404
the I-Disease 0 0.009611629880964756
second I-Disease 0 0.01086517795920372
component I-Disease 0 0.01052539050579071
of I-Disease 0 0.005712376907467842
complement I-Disease 0 0.019982587546110153
( O 0 0.016489017754793167
C2 O 1 1.0
) O 0 0.004577367566525936
was O 0 0.0034034710843116045
studied O 0 0.0037640973459929228
in O 0 0.0015849446645006537
families O 0 0.0023232221137732267
of O 0 0.004035719204694033
patients O 1 0.9999986886978149
with O 1 0.5677590370178223
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9986623525619507

Patients O 1 0.9580721855163574
were O 0 0.006464160513132811
selected O 0 0.005997085478156805
because O 0 0.0018618364119902253
they O 0 0.0008781967917457223
were O 0 0.0017475795466452837
heterozygous O 0 0.008592817932367325
or O 0 0.004751067142933607
homozygous O 0 0.02900831028819084
for O 0 0.02659912034869194
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.5622276663780212

12 O 0 0.014165917411446571
families O 0 0.004810558632016182
with O 0 0.002167816972360015
15 O 0 0.007665061857551336
matings O 0 0.03986424580216408
informative O 0 0.027432547882199287
for O 0 0.022763047367334366
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.01841164380311966
found O 0 0.012605918571352959
. O 0 0.010635597631335258

Of O 0 0.020014284178614616
57 O 0 0.04718941077589989
informative O 0 0.03256960213184357
meioses O 0 0.06617354601621628
, O 0 0.0035594229120761156
two O 0 0.0015720294322818518
crossovers O 0 0.00823166687041521
were O 0 0.0017656013369560242
noted O 0 0.004154023714363575
between O 0 0.004243591800332069
the O 0 0.022299837321043015
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.020271066576242447
and O 0 0.0040366859175264835
the O 0 0.016190798953175545
HLA O 1 1.0
- O 1 0.9982731342315674
B O 0 0.3484109044075012
gene O 0 0.004803340882062912
, O 0 0.0011722376802936196
with O 0 0.0008384043467231095
a O 0 0.003948953468352556
recombinant O 0 0.02420715242624283
fraction O 0 0.009606730192899704
of O 0 0.008319519460201263
0 O 0 0.024220116436481476
. O 0 0.008382529951632023

035 O 1 0.9978411197662354
. O 0 0.030733207240700722

A O 0 0.03231309726834297
lod O 1 0.61202073097229
score O 0 0.005511641502380371
of O 0 0.004072055220603943
13 O 0 0.006030440330505371
was O 0 0.003905070014297962
calculated O 0 0.0035777585580945015
for O 0 0.002231977181509137
linkage O 0 0.04524604603648186
between O 0 0.0339469239115715
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9999974966049194
HLA O 1 1.0
- O 1 0.9999077320098877
B O 0 0.07065919041633606
at O 0 0.005399155896157026
a O 0 0.002461268799379468
maximum O 0 0.00358246685937047
likelihood O 0 0.0058050742372870445
value O 0 0.0023182362783700228
of O 0 0.002769251586869359
the O 0 0.00659267557784915
recombinant O 0 0.028233306482434273
fraction O 0 0.009179683402180672
of O 0 0.007015747483819723
0 O 0 0.02554635889828205
. O 0 0.008715092204511166

04 O 1 0.9971439242362976
. O 0 0.030312836170196533

18 O 0 0.017678365111351013
families O 0 0.0053584882989525795
with O 0 0.0026132178027182817
21 O 0 0.010171731002628803
informative O 0 0.014619776979088783
matings O 0 0.01858559437096119
for O 0 0.0027686331886798143
both O 0 0.003857272444292903
properdin O 1 0.9933847784996033
Factor O 0 0.0324813611805439
B O 1 0.8111180663108826
allotype O 1 0.9917062520980835
and O 0 0.01189681887626648
HLA O 1 1.0
- O 1 0.8688899874687195
B O 0 0.047227222472429276
were O 0 0.003835501382127404
found O 0 0.0069635710678994656
. O 0 0.008763578720390797

Of O 0 0.020763592794537544
72 O 0 0.05061695724725723
informative O 0 0.029905302450060844
meioses O 0 0.1370602697134018
, O 0 0.003820325480774045
three O 0 0.003714581485837698
recombinants O 0 0.08915384113788605
were O 0 0.002504053758457303
found O 0 0.002903321757912636
, O 0 0.0026014770846813917
giving O 0 0.00393690075725317
a O 0 0.005007703322917223
recombinant O 0 0.028073852881789207
fraction O 0 0.010009057819843292
of O 0 0.007228529546409845
0 O 0 0.026842597872018814
. O 0 0.009098281152546406

042 O 1 0.9935729503631592
. O 0 0.03660403564572334

A O 0 0.02528023160994053
lod O 0 0.12146551162004471
score O 0 0.004554401151835918
of O 0 0.003866557963192463
16 O 0 0.010622153989970684
between O 0 0.012052342295646667
HLA O 1 1.0
- O 1 0.5697690844535828
B O 0 0.04329807683825493
and O 0 0.0036432784982025623
Factor O 0 0.022061584517359734
B O 0 0.0797368586063385
allotypes O 0 0.0952858254313469
was O 0 0.009271806105971336
calculated O 0 0.006686247419565916
at O 0 0.004632545169442892
a O 0 0.0035080211237072945
maximum O 0 0.005368785932660103
likelihood O 0 0.007107705343514681
value O 0 0.002570217475295067
of O 0 0.0036474959924817085
the O 0 0.007755668833851814
recombinant O 0 0.03493843600153923
fraction O 0 0.010406548157334328
of O 0 0.007432174868881702
0 O 0 0.027834594249725342
. O 0 0.009495377540588379

04 O 1 0.9944831728935242
. O 0 0.030846431851387024

A O 0 0.027907999232411385
crossover O 0 0.02305464819073677
was O 0 0.010429557412862778
shown O 0 0.004466021899133921
to O 0 0.0015968407969921827
have O 0 0.0008820905350148678
occurred O 0 0.003908796235918999
between O 0 0.002501534763723612
genes O 0 0.0032788021489977837
for O 0 0.002546953968703747
Factor O 0 0.01879921928048134
B O 0 0.2392173558473587
and O 0 0.00994565524160862
HLA O 1 1.0
- O 1 0.6103586554527283
D O 0 0.12140275537967682
, O 0 0.0022129409480839968
in O 0 0.0029551787301898003
which O 0 0.005419841501861811
HLA O 1 1.0
- O 0 0.08615990728139877
D O 1 0.996364951133728
segregared O 1 0.7925288677215576
with O 0 0.007604519370943308
HLA O 1 1.0
- O 0 0.03770415484905243
A O 0 0.013105770573019981
and O 0 0.0058564250357449055
B O 0 0.46063482761383057
. O 0 0.009704144671559334

These O 0 0.005026727914810181
studies O 0 0.005083433352410793
suggest O 0 0.004025967791676521
that O 0 0.0011124096345156431
the O 0 0.003035107161849737
genes O 0 0.003850288689136505
for O 0 0.0034964687656611204
Factor O 0 0.03151695057749748
B O 1 0.9998530149459839
and O 0 0.02337781712412834
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.005234576296061277
located O 0 0.010381571017205715
outside O 0 0.004490198567509651
those O 0 0.002141845179721713
for O 0 0.006127957254648209
HLA O 1 0.9999998807907104
, O 0 0.003395658452063799
that O 0 0.0008109999471344054
the O 0 0.0018495136173442006
order O 0 0.0027187021914869547
of O 0 0.00592383136972785
genese O 1 0.9997606873512268
is O 0 0.01316123642027378
HLA O 1 1.0
- O 0 0.02046394534409046
A O 0 0.009185905568301678
, O 0 0.004997150972485542
- O 0 0.015502403490245342
B O 0 0.02856171689927578
, O 0 0.00441837590187788
- O 0 0.014742777682840824
D O 0 0.04296477884054184
, O 0 0.0033562465105205774
Factor O 0 0.018900303170084953
B O 1 0.8174067139625549
allotype O 1 0.9999469518661499
, O 0 0.059508975595235825
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.006828457582741976
that O 0 0.0017546226736158133
the O 0 0.003738223109394312
genes O 0 0.005985093768686056
coding O 0 0.02638203464448452
for O 0 0.01485964935272932
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.10407082736492157
Factor O 1 0.8473706245422363
B O 1 0.679057776927948
allotypes O 0 0.031820300966501236
are O 0 0.000856866012327373
approximately O 0 0.002896734047681093
3 O 0 0.007246444933116436
- O 0 0.012028570286929607
- O 0 0.009274863637983799
5 O 0 0.005416508764028549
centimorgans O 0 0.026147663593292236
from O 0 0.003192335832864046
the O 0 0.008341744542121887
HLA O 1 1.0
- O 0 0.02767667919397354
A O 0 0.01198718324303627
and O 0 0.007908271625638008
HLA O 1 1.0
- O 1 0.9934563040733337
B O 1 0.96161949634552
loci O 0 0.027009733021259308
, O 0 0.0023108655586838722
and O 0 0.0013979891082271934
that O 0 0.0011901955585926771
the O 0 0.004008689895272255
apparent O 0 0.017209630459547043
lack O 0 0.010506338439881802
of O 0 0.007571294903755188
recombinants O 1 0.9996740818023682
between O 0 0.004230986814945936
the O 0 0.005950290709733963
Factor O 0 0.024999262765049934
B O 1 0.9521191716194153
gene O 0 0.018636146560311317
and O 0 0.014033575542271137
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.02997288852930069
suggests O 0 0.007093599531799555
that O 0 0.0009710416779853404
these O 0 0.0008489980828016996
two O 0 0.0013046135427430272
genes O 0 0.003972724545747042
lie O 0 0.008383156731724739
in O 0 0.0028727506287395954
close O 0 0.005274566821753979
proximity O 0 0.006671543698757887
to O 0 0.0026485188864171505
one O 0 0.0032264383044093847
another O 0 0.008007233962416649
. O 0 0.00814372580498457

Distribution O 0 0.014496417716145515
of O 0 0.013160666450858116
emerin O 1 0.9998188614845276
and O 0 0.008908361196517944
lamins O 1 0.9986376166343689
in O 0 0.005686241667717695
the O 0 0.00858734454959631
heart O 1 0.9999939203262329
and O 0 0.0049639600329101086
implications O 0 0.013710171915590763
for O 0 0.009995605796575546
Emery B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999983310699463
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.47815945744514465

Emerin O 1 0.9105324745178223
is O 0 0.007339469622820616
a O 0 0.006436071824282408
nuclear O 0 0.011040574871003628
membrane O 0 0.011813269928097725
protein O 0 0.004531827289611101
which O 0 0.0011149580823257565
is O 0 0.0019731579814106226
missing O 0 0.00849992223083973
or O 0 0.005163511727005243
defective O 1 0.9932754039764404
in O 0 0.01272796280682087
Emery B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999971389770508
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999995231628418
EDMD B-Disease 1 1.0
) O 0 0.01924704574048519
. O 0 0.008274786174297333

It O 0 0.004224703647196293
is O 0 0.0020055226050317287
one O 0 0.0012918912107124925
member O 0 0.0023361470084637403
of O 0 0.0020529383327811956
a O 0 0.004459073767066002
family O 0 0.010042731650173664
of O 0 0.01325052510946989
lamina O 1 1.0
- O 0 0.2129334807395935
associated O 0 0.00684061786159873
proteins O 0 0.003430373268201947
which O 0 0.0017623922321945429
includes O 0 0.005307843443006277
LAP1 O 1 0.999925971031189
, O 0 0.009387767873704433
LAP2 O 1 0.9997836947441101
and O 0 0.008261015638709068
lamin O 1 0.9997809529304504
B O 1 0.9985030889511108
receptor O 0 0.05296077951788902
( O 0 0.024875815957784653
LBR O 1 0.9999998807907104
) O 0 0.013850277289748192
. O 0 0.008343026041984558

A O 0 0.015368949621915817
panel O 0 0.012456730008125305
of O 0 0.008526225574314594
16 O 0 0.023898791521787643
monoclonal O 1 0.6254345774650574
antibodies O 0 0.05188801884651184
( O 0 0.018390238285064697
mAbs O 1 0.7422016263008118
) O 0 0.004810414742678404
has O 0 0.0017753653228282928
been O 0 0.00183104386087507
mapped O 0 0.005713996477425098
to O 0 0.0012197199976071715
six O 0 0.0019547773990780115
specific O 0 0.001603290787898004
sites O 0 0.0025787753984332085
throughout O 0 0.003164086490869522
the O 0 0.005916352849453688
emerin O 0 0.16998720169067383
molecule O 0 0.012762804515659809
using O 0 0.0073881302960217
phage O 1 0.7305706143379211
- O 0 0.026223074644804
displayed O 0 0.019227584823966026
peptide O 0 0.019623463973402977
libraries O 0 0.0061333030462265015
and O 0 0.0019368892535567284
has O 0 0.0019095304887741804
been O 0 0.0018064083997160196
used O 0 0.0025616930797696114
to O 0 0.0036152934189885855
localize O 1 0.6925258040428162
emerin O 1 0.7173634767532349
in O 0 0.005434798076748848
human O 0 0.009925223886966705
and O 0 0.007926968857645988
rabbit O 1 0.999994158744812
heart O 1 0.9999997615814209
. O 0 0.023320220410823822

Several O 0 0.016198160126805305
mAbs O 0 0.11533042788505554
against O 0 0.009645086713135242
different O 0 0.004605394788086414
emerin O 1 0.9840324521064758
epitopes O 0 0.060253292322158813
did O 0 0.004571324680000544
not O 0 0.0018635560991242528
recognize O 0 0.011776462197303772
intercalated O 1 0.999432384967804
discs O 0 0.0331168957054615
in O 0 0.005727946292608976
the O 0 0.009996388107538223
heart O 1 0.9999990463256836
, O 0 0.0049055591225624084
though O 0 0.002341692568734288
they O 0 0.0012885486939921975
recognized O 0 0.008632682263851166
cardiomyocyte O 1 0.9965810179710388
nuclei O 0 0.013512022793293
strongly O 0 0.004581345245242119
, O 0 0.002452499233186245
both O 0 0.002145706210285425
at O 0 0.007275853306055069
the O 0 0.007450325880199671
rim O 0 0.02289692312479019
and O 0 0.0033459821715950966
in O 0 0.007577420677989721
intranuclear O 1 0.9999136924743652
spots O 0 0.032578036189079285
or O 0 0.007515935692936182
channels O 0 0.011366337537765503
. O 0 0.008298274129629135

A O 0 0.05741223692893982
polyclonal O 1 0.998515784740448
rabbit O 1 0.9537062048912048
antiserum O 1 0.8015090227127075
against O 0 0.019159069284796715
emerin O 1 0.9739536046981812
did O 0 0.00696731498464942
recognize O 0 0.009335437789559364
both O 0 0.004543625749647617
nuclear O 0 0.015321612358093262
membrane O 0 0.017882145941257477
and O 0 0.006372413598001003
intercalated O 1 0.9938657879829407
discs O 0 0.024253657087683678
but O 0 0.00242372858338058
, O 0 0.0025787102058529854
after O 0 0.005441834684461355
affinity O 0 0.011516233906149864
purification O 0 0.041501451283693314
against O 0 0.006518042180687189
a O 0 0.007672580424696207
pure O 0 0.024985112249851227
- O 0 0.02595302276313305
emerin O 0 0.053360309451818466
band O 0 0.007405189797282219
on O 0 0.0025773493107408285
a O 0 0.003638438880443573
western O 0 0.00888318195939064
blot O 1 0.984104573726654
, O 0 0.005839778576046228
it O 0 0.0027420015539973974
stained O 0 0.12412090599536896
only O 0 0.0036715774331241846
the O 0 0.008358900435268879
nuclear O 0 0.016607142984867096
membrane O 0 0.022485483437776566
. O 0 0.008708273060619831

These O 0 0.007467758376151323
results O 0 0.0065995268523693085
would O 0 0.0019289953634142876
not O 0 0.0008966492605395615
be O 0 0.0009524766355752945
expected O 0 0.002456826623529196
if O 0 0.0025807900819927454
immunostaining O 1 0.5928123593330383
at O 0 0.013525441288948059
intercalated O 1 0.976428210735321
discs O 0 0.01962406374514103
were O 0 0.002691007684916258
due O 0 0.004129844252020121
to O 0 0.0018277621129527688
a O 0 0.0028544459491968155
product O 0 0.0042159780859947205
of O 0 0.004480218980461359
the O 0 0.010450282134115696
emerin O 1 0.9999986886978149
gene O 0 0.008754399605095387
and O 0 0.0020718686282634735
, O 0 0.0026698133442550898
therefore O 0 0.0035597137175500393
, O 0 0.002413177164271474
cast O 0 0.002724416321143508
some O 0 0.0009838584810495377
doubt O 0 0.0038610813207924366
upon O 0 0.00300107104703784
the O 0 0.004184742923825979
hypothesis O 0 0.015536367893218994
that O 0 0.005435592960566282
cardiac B-Disease 1 1.0
defects I-Disease 1 1.0
in O 1 0.9969209432601929
EDMD B-Disease 1 1.0
are O 0 0.0035304517950862646
caused O 0 0.007055038120597601
by O 0 0.0021738591603934765
absence O 0 0.013925284147262573
of O 0 0.012989996001124382
emerin O 1 0.9999971389770508
from O 0 0.014942185953259468
intercalated O 1 0.999969482421875
discs O 0 0.1567804515361786
. O 0 0.013295914977788925

Although O 0 0.017375102266669273
emerin O 1 0.928964376449585
was O 0 0.01182856597006321
abundant O 0 0.008252089843153954
in O 0 0.0029364197980612516
the O 0 0.005571134854108095
membranes O 0 0.015015284530818462
of O 0 0.01151856780052185
cardiomyocyte O 1 0.9999990463256836
nuclei O 0 0.014084137976169586
, O 0 0.002707169856876135
it O 0 0.0011683822376653552
was O 0 0.004857882857322693
absent O 0 0.007916155271232128
from O 0 0.0019427540246397257
many O 0 0.0021824899595230818
non O 0 0.01789272576570511
- O 0 0.16450175642967224
myocyte O 1 0.9999980926513672
cells O 0 0.00985121913254261
in O 0 0.004056363832205534
the O 0 0.010282758623361588
heart O 1 0.9999830722808838
. O 0 0.019802330061793327

This O 0 0.005733303725719452
distribution O 0 0.006613788194954395
of O 0 0.010284562595188618
emerin O 1 0.9999220371246338
was O 0 0.009833569638431072
similar O 0 0.002080123871564865
to O 0 0.001483379048295319
that O 0 0.0012865252792835236
of O 0 0.00503029627725482
lamin O 1 0.9998667240142822
A O 0 0.010543309152126312
, O 0 0.0026966966688632965
a O 0 0.0030978848226368427
candidate O 0 0.006136867217719555
gene O 0 0.0029891442973166704
for O 0 0.001280419179238379
an O 0 0.0028750132769346237
autosomal O 0 0.37725216150283813
form O 0 0.012445789761841297
of O 1 0.9900082349777222
EDMD B-Disease 1 1.0
. O 0 0.03653344511985779

In O 0 0.013579575344920158
contrast O 0 0.020434493198990822
, O 0 0.017801621928811073
lamin O 1 0.9999935626983643
B1 O 1 1.0
was O 0 0.021001454442739487
absent O 0 0.025364961475133896
from O 0 0.008366167545318604
cardiomyocyte O 1 0.9962092638015747
nuclei O 0 0.018582794815301895
, O 0 0.004982359707355499
showing O 0 0.01721734181046486
that O 0 0.007522255182266235
lamin O 1 0.999996542930603
B1 O 1 0.9999998807907104
is O 0 0.004610388074070215
not O 0 0.001169117633253336
essential O 0 0.005076957866549492
for O 0 0.002946007065474987
localization O 0 0.017546048387885094
of O 0 0.007287994027137756
emerin O 1 0.9667447805404663
to O 0 0.005878721363842487
the O 0 0.00930224359035492
nuclear O 0 0.027170108631253242
lamina O 1 0.9999406337738037
. O 0 0.019669581204652786

Lamin O 1 0.9999942779541016
B1 O 1 0.9999990463256836
is O 0 0.007373470813035965
also O 0 0.0034826709888875484
almost O 0 0.0037617324851453304
completely O 0 0.01121152751147747
absent O 0 0.026406658813357353
from O 0 0.014922049827873707
skeletal O 1 1.0
muscle O 1 1.0
nuclei O 1 0.9969424605369568
. O 0 0.01633451320230961

In O 0 0.02446218766272068
EDMD B-Disease 1 0.9999996423721313
, O 0 0.005487621296197176
the O 0 0.0038163550198078156
additional O 0 0.003611036343500018
absence O 0 0.010294964537024498
of O 0 0.014130827970802784
lamin O 1 1.0
B1 O 1 1.0
from O 0 0.015516352839767933
heart O 1 1.0
and O 1 0.8538256883621216
skeletal O 1 1.0
muscle O 1 1.0
nuclei O 0 0.3769493103027344
which O 0 0.005468968767672777
already O 0 0.008085615001618862
lack O 0 0.018158644437789917
emerin O 1 0.9998797178268433
may O 0 0.005381072871387005
offer O 0 0.003051459090784192
an O 0 0.001821288838982582
alternative O 0 0.005258227698504925
explanation O 0 0.006157504394650459
of O 0 0.003722391091287136
why O 0 0.006554147694259882
these O 0 0.002707566600292921
tissues O 0 0.014740271493792534
are O 0 0.002178282244130969
particularly O 0 0.007884535007178783
affected O 0 0.012741493061184883
. O 0 0.006216827314347029
. O 0 0.00969447661191225

Genetic O 0 0.021841421723365784
mapping O 0 0.012166067026555538
of O 0 0.006943988613784313
the O 0 0.014192752540111542
copper B-Disease 1 0.9999983310699463
toxicosis I-Disease 1 1.0
locus O 1 0.9339796304702759
in O 0 0.013371091336011887
Bedlington O 1 0.9999961853027344
terriers O 1 0.7510911822319031
to O 0 0.005998157896101475
dog O 0 0.04059683531522751
chromosome O 0 0.013901855796575546
10 O 0 0.003585000755265355
, O 0 0.001893560984171927
in O 0 0.0019360219594091177
a O 0 0.004016750957816839
region O 0 0.010965874418616295
syntenic O 1 0.9740513563156128
to O 0 0.0045962948352098465
human O 0 0.010658210143446922
chromosome O 0 0.02493087202310562
region O 0 0.02304428443312645
2p13 O 1 0.9999834299087524
- O 0 0.2469889372587204
p16 O 0 0.15978191792964935
. O 0 0.013555721379816532

Abnormal O 1 1.0
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.9999943971633911
is O 0 0.006106147542595863
recognized O 0 0.005169697105884552
as O 0 0.0027265071403235197
an O 0 0.004912873264402151
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9999501705169678
man O 1 0.9999769926071167
, O 0 0.008126922883093357
mouse O 0 0.0203117523342371
, O 0 0.007717423606663942
rat O 1 0.8290819525718689
and O 0 0.007783297449350357
dog O 0 0.1028236672282219
. O 0 0.015242529101669788

The O 0 0.017733491957187653
major O 0 0.026856141164898872
cause O 1 0.8265910744667053
of O 1 0.9979343414306641
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.9999991655349731
in O 0 0.011042522266507149
man O 0 0.010460739955306053
is O 0 0.00224335677921772
a O 0 0.004244397860020399
dysfunctional O 1 0.9072920083999634
ATP7B O 1 0.9999986886978149
gene O 0 0.010919694788753986
, O 0 0.004490085411816835
causing O 0 0.04627610743045807
Wilson B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.999998927116394
WD B-Disease 1 1.0
) O 0 0.012070734985172749
. O 0 0.008626424707472324

Mutations O 0 0.022387295961380005
in O 0 0.007130315061658621
the O 0 0.01222248189151287
ATP7B O 1 0.9999996423721313
genes O 0 0.007232640404254198
have O 0 0.0008959092083387077
also O 0 0.0017676170682534575
been O 0 0.002078238409012556
demonstrated O 0 0.008004668168723583
in O 0 0.005489970091730356
mouse O 0 0.023603282868862152
and O 0 0.007588121108710766
rat O 1 0.9942240118980408
. O 0 0.012353077530860901

The O 0 0.03391481190919876
ATP7B O 1 0.9999991655349731
gene O 0 0.01364146638661623
has O 0 0.0029189346823841333
been O 0 0.0024263011291623116
excluded O 0 0.005942950956523418
in O 0 0.0021908902563154697
the O 0 0.0043621729128062725
much O 0 0.005722845438867807
rarer O 0 0.1281725913286209
human O 0 0.04076182842254639
copper B-Disease 1 1.0
overload I-Disease 1 1.0
disease O 1 1.0
non B-Disease 1 0.9999949932098389
- I-Disease 1 0.8339077234268188
Indian I-Disease 0 0.019511617720127106
childhood I-Disease 1 0.9999995231628418
cirrhosis I-Disease 1 1.0
, O 0 0.017736107110977173
indicating O 0 0.040660519152879715
genetic O 0 0.03408641740679741
heterogeneity O 0 0.4298170208930969
. O 0 0.016297265887260437

By O 0 0.005596719682216644
investigating O 0 0.014355842024087906
the O 0 0.008110457099974155
common O 0 0.01864568144083023
autosomal O 1 0.9999995231628418
recessive O 1 1.0
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 1 0.9999951124191284
CT B-Disease 1 1.0
) O 0 0.010336294770240784
in O 0 0.007817655801773071
Bedlington O 1 0.9999994039535522
terriers O 1 0.9871096611022949
, O 0 0.003315004985779524
we O 0 0.0011984987650066614
have O 0 0.0005766015383414924
identified O 0 0.002171146683394909
a O 0 0.0017086340812966228
new O 0 0.0028655831702053547
locus O 0 0.015915291383862495
involved O 0 0.004243252798914909
in O 0 0.011675521731376648
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9999974966049194

We O 0 0.005672973580658436
examined O 0 0.012687879614531994
whether O 0 0.004188613500446081
the O 0 0.008256133645772934
WD B-Disease 1 0.9999998807907104
gene O 0 0.0185489933937788
ATP7B O 1 0.9999290704727173
was O 0 0.009240844286978245
also O 0 0.004936328623443842
causative O 1 0.6914421916007996
for O 0 0.005561239086091518
CT B-Disease 1 0.9999889135360718
by O 0 0.0022518173791468143
investigating O 0 0.010329673066735268
the O 0 0.007057821378111839
chromosomal O 1 0.9994083642959595
co O 1 0.9959043860435486
- O 0 0.027617979794740677
localization O 0 0.01782676763832569
of O 0 0.00715999398380518
ATP7B O 1 0.9999994039535522
and O 0 0.00556339742615819
C04107 O 1 0.7342901825904846
, O 0 0.003350203623995185
using O 0 0.00298528210259974
fluorescence O 0 0.014068739488720894
in O 0 0.004339082632213831
situ O 0 0.27290526032447815
hybridization O 0 0.02181592583656311
( O 0 0.009268741123378277
FISH O 0 0.02373415045440197
) O 0 0.009301867336034775
. O 0 0.007625509984791279

C04107 O 0 0.1151103526353836
is O 0 0.004549180623143911
an O 0 0.003518086625263095
anonymous O 0 0.017726588994264603
microsatellite O 0 0.06327855587005615
marker O 0 0.03888091444969177
closely O 0 0.010432315059006214
linked O 0 0.018351169303059578
to O 0 0.010506427846848965
CT B-Disease 1 0.9999998807907104
. O 0 0.01683288998901844

However O 0 0.012356649152934551
, O 0 0.0116186598315835
BAC O 1 0.9999995231628418
clones O 0 0.11959347128868103
containing O 0 0.023625720292329788
ATP7B O 1 0.9999219179153442
and O 0 0.0067956713028252125
C04107 O 0 0.06187177449464798
mapped O 0 0.011603857390582561
to O 0 0.002386841457337141
the O 0 0.005860363133251667
canine O 1 0.9997280240058899
chromosome O 0 0.02770097367465496
regions O 0 0.009608612395823002
CFA22q11 O 1 0.9999935626983643
and O 0 0.0074729337356984615
CFA10q26 O 1 0.999997615814209
, O 0 0.00635289354249835
respectively O 0 0.009962102398276329
, O 0 0.003976273350417614
demonstrating O 0 0.01681710034608841
that O 0 0.005971221253275871
WD B-Disease 1 0.9999208450317383
cannot O 0 0.0051676989533007145
be O 0 0.0021390272304415703
homologous O 0 0.021335531026124954
to O 0 0.010011594742536545
CT B-Disease 1 0.9999997615814209
. O 0 0.016129661351442337

The O 0 0.0271516852080822
copper O 1 0.9991795420646667
transport O 0 0.04189498722553253
genes O 0 0.01855437643826008
CTR1 O 1 0.9999700784683228
and O 0 0.00808429904282093
CTR2 O 1 0.9999963045120239
were O 0 0.0033294870518147945
also O 0 0.002652780618518591
excluded O 0 0.006447399966418743
as O 0 0.0031123871449381113
candidate O 0 0.008736472576856613
genes O 0 0.004868096671998501
for O 0 0.005032196640968323
CT B-Disease 1 0.9999991655349731
since O 0 0.0038233790546655655
they O 0 0.000869568670168519
both O 0 0.0013089758576825261
mapped O 0 0.011151478625833988
to O 0 0.005730741191655397
canine O 1 0.9997468590736389
chromosome O 0 0.08718051016330719
region O 0 0.03821735456585884
CFA11q22 O 1 0.9999984502792358
. O 0 0.02131364308297634

2 O 0 0.049395851790905
- O 0 0.0347147099673748
22 O 0 0.019979707896709442
. O 0 0.008845691569149494

5 O 0 0.047495726495981216
. O 0 0.01850160025060177

A O 0 0.01692293956875801
transcribed O 0 0.016477037221193314
sequence O 0 0.005097032058984041
identified O 0 0.0037504895590245724
from O 0 0.0019866470247507095
the O 0 0.0061395904049277306
C04107 O 1 0.9998621940612793
- O 0 0.043533388525247574
containing O 0 0.021491462364792824
BAC O 1 0.9999967813491821
was O 0 0.00954364612698555
found O 0 0.0030295136384665966
to O 0 0.0015440653078258038
be O 0 0.0014758838806301355
homologous O 0 0.00971316359937191
to O 0 0.0019232479389756918
a O 0 0.004196144640445709
gene O 0 0.005206040572375059
expressed O 0 0.003983750939369202
from O 0 0.003977351356297731
human O 0 0.014516589231789112
chromosome O 0 0.06154681369662285
2p13 O 1 0.9999864101409912
- O 0 0.17402851581573486
p16 O 0 0.06748618185520172
, O 0 0.003933123778551817
a O 0 0.003811186645179987
region O 0 0.008174406364560127
devoid O 0 0.021823007613420486
of O 0 0.005807512905448675
any O 0 0.004170222207903862
positional O 0 0.04980950430035591
candidate O 0 0.02116638980805874
genes O 0 0.012326969765126705
. O 0 0.008317666128277779

Molecular O 0 0.016828401014208794
analysis O 0 0.004100149497389793
of O 0 0.005157675128430128
the O 0 0.00965461228042841
APC B-Disease 1 0.9993122816085815
gene O 0 0.008108140900731087
in O 0 0.0031823578756302595
205 O 0 0.02034929394721985
families O 0 0.004232170060276985
: O 0 0.004483959171921015
extended O 0 0.014540703035891056
genotype O 0 0.046502236276865005
- O 0 0.022288747131824493
phenotype O 0 0.021886881440877914
correlations O 0 0.020627697929739952
in O 0 0.009551962837576866
FAP B-Disease 1 1.0
and O 0 0.0036980181466788054
evidence O 0 0.0032382002100348473
for O 0 0.0019904212094843388
the O 0 0.0025799982249736786
role O 0 0.004956244956701994
of O 0 0.006276790052652359
APC B-Disease 1 0.9999604225158691
amino O 0 0.011047094129025936
acid O 0 0.01124947052448988
changes O 0 0.004867025185376406
in O 0 0.020161956548690796
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 0 0.22370533645153046

BACKGROUND O 0 0.10302689671516418
/ O 0 0.43314772844314575
AIMS O 0 0.03182282671332359
The O 0 0.007482277229428291
development O 0 0.011461658403277397
of O 1 0.9706210494041443
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.4123436510562897
a O 0 0.00658884784206748
variable O 0 0.004070702474564314
range O 0 0.00241999258287251
of O 0 0.003497598459944129
extracolonic O 1 0.997367799282074
manifestations O 1 0.9977625608444214
in O 0 0.022284958511590958
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 1.0
FAP B-Disease 1 1.0
) O 0 0.009455992840230465
is O 0 0.0018811793997883797
the O 0 0.0019084876403212547
result O 0 0.0017347123939543962
of O 0 0.0028057629242539406
the O 0 0.005569225177168846
dominant O 0 0.01923505961894989
inheritance O 0 0.02649456448853016
of O 0 0.04940735176205635
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999945163726807
APC B-Disease 1 1.0
) O 0 0.013966508209705353
gene O 0 0.014257238246500492
mutations O 0 0.01441284455358982
. O 0 0.008407075889408588

In O 0 0.006822859402745962
this O 0 0.0019837296567857265
study O 0 0.0040078675374388695
, O 0 0.002423143247142434
direct O 0 0.003086876356974244
mutation O 0 0.0043353368528187275
analysis O 0 0.002312048804014921
of O 0 0.0036863847635686398
the O 0 0.010179166682064533
APC B-Disease 1 0.9999947547912598
gene O 0 0.009635858237743378
was O 0 0.00588802807033062
performed O 0 0.006097925826907158
to O 0 0.0030847990419715643
determine O 0 0.010950691066682339
genotype O 0 0.04260794818401337
- O 0 0.017051447182893753
phenotype O 0 0.015418846160173416
correlations O 0 0.01064116321504116
for O 0 0.0035090711899101734
nine O 0 0.010252607055008411
extracolonic O 1 0.9990997314453125
manifestations O 0 0.2323068380355835
and O 0 0.0037126706447452307
to O 0 0.0033128003124147654
investigate O 0 0.01217687875032425
the O 0 0.008367541246116161
incidence O 1 0.8935872912406921
of O 0 0.01721610128879547
APC B-Disease 1 0.999997615814209
mutations O 0 0.010072031989693642
in O 0 0.006297804415225983
non O 1 0.7398346066474915
- O 1 0.9999972581863403
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7773631811141968

METHODS O 0 0.031364504247903824
The O 0 0.018367143347859383
APC B-Disease 1 0.9986698627471924
gene O 0 0.009513535536825657
was O 0 0.0063149333000183105
analysed O 0 0.009743315167725086
in O 0 0.0035550855100154877
190 O 0 0.018216300755739212
unrelated O 0 0.020567653700709343
FAP B-Disease 1 0.9999998807907104
and O 0 0.005733502097427845
15 O 0 0.012965929694473743
non O 1 0.8470162153244019
- O 1 0.9999974966049194
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
using O 0 0.02611217088997364
denaturing O 1 0.9998395442962646
gradient O 0 0.1439763456583023
gel O 1 0.5581383109092712
electrophoresis O 0 0.039215318858623505
, O 0 0.004081216640770435
the O 0 0.0057695768773555756
protein O 0 0.009816544130444527
truncation O 0 0.03524842858314514
test O 0 0.006725747138261795
, O 0 0.0027917653787881136
and O 0 0.002306981710717082
direct O 0 0.00651923380792141
sequencing O 0 0.02179594710469246
. O 0 0.009363853372633457

RESULTS O 0 0.049664586782455444
Chain O 0 0.052018385380506516
terminating O 0 0.04943541809916496
signals O 0 0.007842128165066242
were O 0 0.0015334316994994879
only O 0 0.0012178608449175954
identified O 0 0.004026767332106829
in O 0 0.003015135880559683
patients O 0 0.020039090886712074
belonging O 0 0.009435834363102913
to O 0 0.0031968136318027973
the O 0 0.008774744346737862
FAP B-Disease 1 1.0
group O 0 0.008934736251831055
( O 0 0.008703277446329594
105 O 0 0.036970268934965134
patients O 1 0.9887209534645081
) O 0 0.01051797904074192
. O 0 0.008433970622718334

Amino O 0 0.03851044923067093
acid O 0 0.01852705143392086
changes O 0 0.002960668411105871
were O 0 0.001762045780196786
identified O 0 0.003876878647133708
in O 0 0.002430399414151907
four O 0 0.0036456333473324776
patients O 0 0.03378245234489441
, O 0 0.0020086446311324835
three O 0 0.0014949497999623418
of O 0 0.0028940276242792606
whom O 0 0.0063264514319598675
belonged O 0 0.008535012602806091
to O 0 0.002150219865143299
the O 0 0.004211410414427519
non O 0 0.022015605121850967
- O 0 0.21308426558971405
FAP O 1 1.0
group O 0 0.01048818975687027
of O 0 0.3214777112007141
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 1 0.5352404713630676

Genotype O 1 0.8643184304237366
- O 0 0.0640796571969986
phenotype O 0 0.03298302739858627
correlations O 0 0.019214864820241928
identified O 0 0.00728647643700242
significant O 0 0.003433545120060444
differences O 0 0.0035936604253947735
in O 0 0.0025241179391741753
the O 0 0.00330947688780725
nature O 0 0.0043443432077765465
of O 0 0.0038082986138761044
certain O 0 0.00593697652220726
extracolonic O 1 0.999996542930603
manifestations O 1 0.9999885559082031
in O 0 0.27619650959968567
FAP B-Disease 1 1.0
patients O 1 0.9999926090240479
belonging O 0 0.01516068633645773
to O 0 0.0034421151503920555
three O 0 0.004031491931527853
mutation O 0 0.013708006590604782
subgroups O 0 0.037955403327941895
. O 0 0.013137185014784336

CONCLUSIONS O 0 0.05530920624732971
Extended O 0 0.04811163246631622
genotype O 0 0.18543966114521027
- O 0 0.034923404455184937
phenotype O 0 0.02533145248889923
correlations O 0 0.013961379416286945
made O 0 0.003319463925436139
in O 0 0.0024162624031305313
this O 0 0.0016187492292374372
study O 0 0.004409267567098141
may O 0 0.0027506770566105843
have O 0 0.0008978943806141615
the O 0 0.0020044823177158833
potential O 0 0.003115910105407238
to O 0 0.0014672963880002499
determine O 0 0.0025842352770268917
the O 0 0.002116013551130891
most O 0 0.0014674697304144502
appropriate O 0 0.004882631823420525
surveillance O 0 0.010365230031311512
and O 0 0.005553439259529114
prophylactic O 1 0.9999994039535522
treatment O 1 1.0
regimens O 1 0.9999990463256836
for O 0 0.006740767974406481
those O 0 0.0038425952661782503
patients O 0 0.261791855096817
with O 0 0.003252282738685608
mutations O 0 0.008237656205892563
associated O 0 0.004545805510133505
with O 0 0.002881971187889576
life O 0 0.059679798781871796
threatening O 1 0.8781958818435669
conditions O 1 0.76809161901474
. O 0 0.01612670347094536

This O 0 0.005469746887683868
study O 0 0.005683761555701494
also O 0 0.0026230495423078537
provided O 0 0.0028039878234267235
evidence O 0 0.0029505572747439146
for O 0 0.0021169139072299004
the O 0 0.004191791173070669
pathological O 0 0.4414510726928711
nature O 0 0.008625796996057034
of O 0 0.007495027966797352
amino O 0 0.011733359657227993
acid O 0 0.01267954707145691
changes O 0 0.0033148759976029396
in O 0 0.004994036629796028
APC O 1 0.9568384289741516
associated O 0 0.0037314705550670624
with O 0 0.0013264630688354373
both O 0 0.003619060618802905
FAP B-Disease 1 1.0
and O 0 0.009525949135422707
non O 1 0.9999423027038574
- O 1 0.9999998807907104
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 0 0.020604997873306274
. O 0 0.010201030410826206

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9999997615814209
cancer B-Disease 1 1.0
risk O 1 0.9999748468399048
of O 1 0.7514956593513489
the O 1 0.7385879755020142
APC O 1 0.9999998807907104
I1307K O 1 0.9995707869529724
polymorphism O 0 0.03995419293642044
. O 0 0.010977733880281448

Germ O 1 0.9999997615814209
- O 0 0.09276455640792847
line O 0 0.014604638330638409
and O 0 0.004689795430749655
somatic O 0 0.04359636828303337
truncating O 0 0.3087446093559265
mutations O 0 0.011023355647921562
of O 0 0.0065256208181381226
the O 0 0.012981880456209183
APC B-Disease 1 0.9999960660934448
gene O 0 0.004606949631124735
are O 0 0.0006520544993691146
thought O 0 0.002116021467372775
to O 0 0.002592680277302861
initiate O 0 0.06752368807792664
colorectal B-Disease 1 1.0
tumor I-Disease 1 1.0
formation O 1 0.9994187355041504
in O 1 0.5543277263641357
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 1.0
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 1 0.9971585273742676
respectively O 0 0.1121806800365448
. O 0 0.01150498166680336

Recently O 0 0.020466068759560585
, O 0 0.004740625619888306
an O 0 0.007353730034083128
isoleucine O 1 0.9999998807907104
- O 1 0.9847878217697144
- O 0 0.043725039809942245
> O 0 0.0434291772544384
lysine O 0 0.039320629090070724
polymorphism O 0 0.020084623247385025
at O 0 0.012596775777637959
codon O 0 0.050351519137620926
1307 O 0 0.32080742716789246
( O 0 0.011980002745985985
I1307K O 0 0.05311053991317749
) O 0 0.004147469066083431
of O 0 0.0042110709473490715
the O 0 0.010893215425312519
APC B-Disease 1 0.9999974966049194
gene O 0 0.008143937215209007
has O 0 0.002246601739898324
been O 0 0.002047574380412698
identified O 0 0.004215672612190247
in O 0 0.0029541251715272665
6 O 0 0.012622666545212269
% O 0 0.005522514693439007
- O 0 0.009442201815545559
7 O 0 0.006863572634756565
% O 0 0.001963059650734067
of O 0 0.002498139161616564
the O 0 0.006553350016474724
Ashkenazi O 1 0.9648046493530273
Jewish O 0 0.02059500850737095
population O 0 0.008230242878198624
. O 0 0.0108953220769763

To O 0 0.009397493675351143
assess O 0 0.02163405530154705
the O 0 0.005892031826078892
risk O 0 0.006804379168897867
of O 0 0.003394829109311104
this O 0 0.0027107279747724533
common O 0 0.009800668805837631
APC B-Disease 1 0.9999663829803467
allelic O 1 0.9976187348365784
variant O 1 0.9990899562835693
in O 0 0.10789027810096741
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.014041916467249393
we O 0 0.0022557289339601994
have O 0 0.0008574491366744041
analyzed O 0 0.004021030385047197
a O 0 0.0024797229561954737
large O 0 0.003258446929976344
cohort O 0 0.026665033772587776
of O 0 0.00768430158495903
unselected O 1 0.9987860321998596
Ashkenazi O 0 0.4442893862724304
Jewish O 0 0.01686587743461132
subjects O 0 0.017100980505347252
with O 0 0.0070529174990952015
adenomatous B-Disease 1 1.0
polyps I-Disease 1 1.0
and O 0 0.009139608591794968
. O 0 0.006865041796118021
or O 1 0.6848539710044861
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.27149951457977295
for O 0 0.008864641189575195
the O 0 0.01571141928434372
APC O 1 0.999998927116394
I1307K O 1 0.9987800717353821
polymorphism O 0 0.036548882722854614
. O 0 0.009739507921040058

The O 0 0.03264869749546051
APC O 1 0.9999827146530151
I1307K O 1 0.9978677034378052
allele O 0 0.018446365371346474
was O 0 0.005893989931792021
identified O 0 0.004316158592700958
in O 0 0.0024639375042170286
48 O 0 0.007331741042435169
( O 0 0.0032202366273850203
10 O 0 0.0020674606785178185
. O 0 0.0013185355346649885
1 O 0 0.005923095159232616
% O 0 0.0030819601379334927
) O 0 0.0027014114893972874
of O 0 0.0058523849584162235
476 O 1 0.9997822642326355
patients O 1 0.9999163150787354
. O 0 0.02058510296046734

Compared O 0 0.012332289479672909
with O 0 0.0025432235561311245
the O 0 0.0037282034754753113
frequency O 0 0.0026868872810155153
in O 0 0.0011640164302662015
two O 0 0.0007543261745013297
separate O 0 0.0015457193367183208
population O 0 0.001668199896812439
control O 0 0.003320782445371151
groups O 0 0.001209475565701723
, O 0 0.002995915012434125
the O 0 0.009964012540876865
APC O 1 0.9999982118606567
I1307K O 1 0.9998469352722168
allele O 0 0.018646452575922012
is O 0 0.002928814385086298
associated O 0 0.002606678754091263
with O 0 0.001156918704509735
an O 0 0.0025125748943537474
estimated O 0 0.007266622502356768
relative O 0 0.01214403472840786
risk O 0 0.011173984035849571
of O 0 0.0098606888204813
1 O 0 0.02924872562289238
. O 0 0.01208009384572506

5 O 0 0.04512396082282066
- O 0 0.038275256752967834
1 O 0 0.02318047545850277
. O 0 0.009602284990251064

7 O 0 0.027494654059410095
for O 0 0.015880003571510315
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
( O 0 0.03355913609266281
both O 0 0.00818959902971983
P O 1 0.9993807077407837
= O 0 0.042344480752944946
. O 0 0.0045881373807787895
01 O 1 0.9996445178985596
) O 0 0.010996242053806782
. O 0 0.0071894400753080845

Furthermore O 0 0.026037395000457764
, O 0 0.0059812371619045734
compared O 0 0.0057121766731143
with O 0 0.003875740570947528
noncarriers O 1 0.9999871253967285
, O 0 0.016463547945022583
APC O 1 0.9999992847442627
I1307K O 1 0.9997610449790955
carriers O 0 0.013881023973226547
had O 0 0.0034324536100029945
increased O 0 0.0030515885446220636
numbers O 0 0.0029767120722681284
of O 0 0.0072619738057255745
adenomas B-Disease 1 1.0
and O 0 0.27822405099868774
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 1 0.5081806182861328
patient O 1 0.9999970197677612
( O 0 0.020310964435338974
P O 1 0.9768983721733093
= O 0 0.02532838098704815
. O 0 0.0032897896599024534
03 O 1 0.9896079897880554
) O 0 0.0037285112775862217
, O 0 0.0016608922742307186
as O 0 0.0015196414897218347
well O 0 0.0011933344649150968
as O 0 0.002045786241069436
a O 0 0.003942552022635937
younger O 0 0.011830835603177547
age O 0 0.010938365012407303
at O 0 0.024173961952328682
diagnosis O 1 1.0
. O 0 0.02022094838321209

We O 0 0.005551443435251713
conclude O 0 0.010358106344938278
that O 0 0.0017995120724663138
the O 0 0.007051748689264059
APC O 1 0.9998419284820557
I1307K O 1 0.9996277093887329
variant O 0 0.041988227516412735
leads O 0 0.017382878810167313
to O 0 0.006881417240947485
increased O 0 0.024273205548524857
adenoma B-Disease 1 1.0
formation O 1 0.9075391888618469
and O 0 0.005011743865907192
directly O 0 0.004964082036167383
contributes O 0 0.00905605498701334
to O 0 0.0023273604456335306
3 O 0 0.0058080642484128475
% O 0 0.002994207665324211
- O 0 0.00671397102996707
4 O 0 0.004305417649447918
% O 0 0.0015165704535320401
of O 0 0.0017558500403538346
all O 0 0.0034734162036329508
Ashkenazi O 1 0.9999864101409912
Jewish O 1 0.9999570846557617
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9417550563812256

The O 0 0.01619325764477253
estimated O 0 0.01198799628764391
relative O 0 0.012619457207620144
risk O 0 0.011090449057519436
for O 0 0.004739829804748297
carriers O 0 0.011710595339536667
may O 0 0.004895179066807032
justify O 0 0.010798299685120583
specific O 0 0.003843965707346797
clinical O 0 0.09011953324079514
screening O 0 0.011327037587761879
for O 0 0.002854594960808754
the O 0 0.004578899592161179
360 O 0 0.017865540459752083
, O 0 0.0032176966778934
000 O 0 0.013275548815727234
Americans O 0 0.0035963421687483788
expected O 0 0.002493591047823429
to O 0 0.002642425475642085
harbor O 0 0.019891981035470963
this O 0 0.0026506201829761267
allele O 0 0.008423088118433952
, O 0 0.0020979612600058317
and O 0 0.0022691059857606888
genetic O 0 0.00648882519453764
testing O 0 0.005063632037490606
in O 0 0.0019064440857619047
the O 0 0.0021601293701678514
setting O 0 0.004248335491865873
of O 0 0.004653658717870712
long O 0 0.009688627906143665
- O 0 0.017851579934358597
term O 0 0.012514417991042137
- O 0 0.009148059412837029
outcome O 0 0.004123898223042488
studies O 0 0.0037474618293344975
may O 0 0.0035618655383586884
impact O 0 0.006895621307194233
significantly O 0 0.009171446785330772
on O 0 0.022189058363437653
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 1.0
in O 0 0.01570712774991989
this O 0 0.0036295922473073006
population O 0 0.004626392386853695
. O 0 0.006268069613724947

Localization O 0 0.05405072122812271
of O 0 0.014258202165365219
human O 0 0.020602846518158913
BRCA1 O 1 0.9996410608291626
and O 0 0.0032245127949863672
its O 0 0.002475276356562972
loss O 0 0.009102082811295986
in O 0 0.00386784877628088
high O 0 0.013080360367894173
- O 0 0.02049006149172783
grade O 0 0.030029544606804848
, O 0 0.004009348805993795
non B-Disease 0 0.02301841974258423
- I-Disease 1 0.9865561723709106
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.07410693168640137

Although O 0 0.004919750615954399
the O 0 0.003289748914539814
link O 0 0.007070356514304876
between O 0 0.0036455902736634016
the O 0 0.012843345291912556
BRCA1 O 1 1.0
tumour B-Disease 1 1.0
- O 1 0.9999885559082031
suppressor O 1 0.8335695266723633
gene O 0 0.008204787038266659
and O 0 0.0037055679131299257
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 1 0.9988486766815186
established O 0 0.01595129817724228
, O 0 0.0023965025320649147
the O 0 0.0025131050497293472
role O 0 0.004762950818985701
, O 0 0.0019044226501137018
if O 0 0.0008174640825018287
any O 0 0.0008417009958066046
, O 0 0.0016234786016866565
of O 0 0.004787074867635965
BRCA1 O 1 0.99998939037323
in O 0 0.010564102791249752
non B-Disease 1 0.9903519749641418
- I-Disease 1 0.9999616146087646
familial I-Disease 1 1.0
cancers I-Disease 1 1.0
is O 0 0.01508522592484951
unclear O 0 0.018248213455080986
. O 0 0.009783617220818996

BRCA1 O 1 0.9999463558197021
mutations O 0 0.016861308366060257
are O 0 0.0020099785178899765
rare O 0 0.007643627934157848
in O 0 0.006870008539408445
sporadic B-Disease 1 0.9984048008918762
cancers I-Disease 1 1.0
, O 0 0.006043232977390289
but O 0 0.002196467947214842
loss O 0 0.013038750737905502
of O 0 0.01623232290148735
BRCA1 O 1 1.0
resulting O 0 0.012115842662751675
from O 0 0.00640782481059432
reduced O 0 0.012538891285657883
expression O 0 0.009829276241362095
or O 0 0.0051307338289916515
incorrect O 0 0.020969301462173462
subcellular O 0 0.05502079427242279
localization O 0 0.02688836306333542
is O 0 0.0035914445761591196
postulated O 0 0.010696614161133766
to O 0 0.0011266646906733513
be O 0 0.0005942272255197167
important O 0 0.0015311504248529673
in O 0 0.0027501655276864767
non B-Disease 0 0.019745247438549995
- I-Disease 1 0.9425889253616333
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999990463256836
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.999879002571106

Epigenetic O 1 0.9651756286621094
loss O 1 0.9695706367492676
, O 0 0.0067065744660794735
however O 0 0.004018613137304783
, O 0 0.0025483244098722935
has O 0 0.001882578362710774
not O 0 0.0010871875565499067
received O 0 0.00483987620100379
general O 0 0.009843649342656136
acceptance O 0 0.014853298664093018
due O 0 0.0062073045410215855
to O 0 0.0033596567809581757
controversy O 0 0.007842431776225567
regarding O 0 0.006363109685480595
the O 0 0.006184370722621679
subcellular O 0 0.044974714517593384
localization O 0 0.032394953072071075
of O 0 0.012701665982604027
BRCA1 O 1 0.9999979734420776
proteins O 0 0.006484163925051689
, O 0 0.002518873428925872
reports O 0 0.0037361602298915386
of O 0 0.002506035380065441
which O 0 0.0017278811428695917
have O 0 0.001155939302407205
ranged O 0 0.008795348927378654
from O 0 0.0028241619002074003
exclusively O 0 0.006251295562833548
nuclear O 0 0.005474837962538004
, O 0 0.001838002004660666
to O 0 0.0023486330173909664
conditionally O 0 0.02384004183113575
nuclear O 0 0.005183581728488207
, O 0 0.0016786523628979921
to O 0 0.0023512321058660746
the O 0 0.012706630863249302
ER O 1 1.0
/ O 1 0.9999716281890869
golgi O 1 0.9999006986618042
, O 0 0.0056699104607105255
to O 0 0.004150123801082373
cytoplasmic O 0 0.026596661657094955
invaginations O 0 0.06754559278488159
into O 0 0.006081904750317335
the O 0 0.01153823733329773
nucleus O 0 0.0355655699968338
. O 0 0.011027545668184757

In O 0 0.006470379885286093
an O 0 0.002893617609515786
attempt O 0 0.007481335662305355
to O 0 0.0030145065393298864
resolve O 0 0.012321427464485168
this O 0 0.0020260976161807775
issue O 0 0.0042557911947369576
, O 0 0.001764815766364336
we O 0 0.0009273071773350239
have O 0 0.0010497536277398467
comprehensively O 0 0.02834729664027691
characterized O 0 0.022513587027788162
19 O 0 0.02938026562333107
anti O 1 0.9955442547798157
- O 1 0.9981788396835327
BRCA1 O 1 0.9999843835830688
antibodies O 0 0.051284320652484894
. O 0 0.01241931039839983

These O 0 0.007596635725349188
reagents O 0 0.04193081706762314
detect O 0 0.020933648571372032
a O 0 0.00856457557529211
220 O 0 0.04076847806572914
- O 0 0.04097837209701538
kD O 1 0.7909234762191772
protein O 0 0.010240624658763409
localized O 0 0.011141045019030571
in O 0 0.003525238949805498
discrete O 0 0.011163736693561077
nuclear O 0 0.008238723501563072
foci O 0 0.02939896285533905
in O 0 0.0033674330916255713
all O 0 0.0036725089885294437
epithelial O 1 0.9999935626983643
cell O 0 0.018579861149191856
lines O 0 0.004421305377036333
, O 0 0.0012572513660416007
including O 0 0.00121286790817976
those O 0 0.0014864284312352538
derived O 0 0.00851055420935154
from O 0 0.010599902831017971
breast B-Disease 1 1.0
malignancies I-Disease 1 1.0
. O 0 0.02995271049439907

Immunohistochemical O 1 0.9986554384231567
staining O 0 0.4152567386627197
of O 0 0.016619402915239334
human O 0 0.09021042287349701
breast O 1 1.0
specimens O 0 0.019009960815310478
also O 0 0.005212835967540741
revealed O 0 0.01784377358853817
BRCA1 O 1 0.9984468817710876
nuclear O 0 0.00833713449537754
foci O 0 0.05375099182128906
in O 0 0.006552806589752436
benign O 1 1.0
breast O 1 1.0
, O 0 0.4829084575176239
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 1 0.9829932451248169
low B-Disease 1 0.9998742341995239
- I-Disease 1 0.9999136924743652
grade I-Disease 1 0.9999897480010986
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.03340057656168938

Conversely O 0 0.061213746666908264
, O 0 0.01426613423973322
BRCA1 O 1 0.9998918771743774
expression O 0 0.013328447006642818
was O 0 0.012087970040738583
reduced O 0 0.008073966018855572
or O 0 0.004410534631460905
undetectable O 0 0.0368107371032238
in O 0 0.0020997128449380398
the O 0 0.0020590981002897024
majority O 0 0.0020194731187075377
of O 0 0.004034899175167084
high O 0 0.0236586332321167
- O 0 0.12149523198604584
grade O 1 0.8924475312232971
, O 0 0.012980145402252674
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 0.010071641765534878
suggesting O 0 0.010310095734894276
that O 0 0.0020656108390539885
absence O 0 0.01112270075827837
of O 0 0.013239138759672642
BRCA1 O 1 1.0
may O 0 0.006180834025144577
contribute O 0 0.004984425846487284
to O 0 0.0019106960389763117
the O 0 0.005056676920503378
pathogenesis O 1 0.999367892742157
of O 0 0.006582483649253845
a O 0 0.004789306316524744
significant O 0 0.0041794306598603725
percentage O 0 0.006483088713139296
of O 0 0.005494970362633467
sporadic B-Disease 1 0.9998713731765747
breast I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.016251247376203537
. O 0 0.012758905068039894

